{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "from bs4 import BeautifulSoup\n",
    "import pandas as pd\n",
    "from tqdm.notebook import tqdm"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Session Details"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "url = 'http://scientific.eaaci.org/site/api/programme/json_call.asp'\n",
    "sessionId = '2916553'\n",
    "sessParams = {'dataType': 'session_detail','sessionid': sessionId,'a': 'eaaci2020dc'}\n",
    "sessListParams = {'dataType': 'categories_days','trackid': '0','catId': '0','a': 'eaaci2020dc','_': '1589380829654'}\n",
    "data_sessions = requests.get(url,params = sessParams)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "SessionList = data_sessions.json()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'sessionid': '2921310',\n",
       " 'type': 'Digital Congress Poster Display',\n",
       " 'colortype': '#CC33FF',\n",
       " 'category': 'Allergen immunotherapy     ',\n",
       " 'session': 'DCPD 01 Allergen immunotherapy',\n",
       " 'description': '',\n",
       " 'time': '09:00-19:15',\n",
       " 'room': '',\n",
       " 'sessionfavourite': False,\n",
       " 'daycalendar': 'Recorded Scientific Content ',\n",
       " 'colorcategory': '',\n",
       " 'daycalendarCal': '09.06.2020',\n",
       " 'shared1': '',\n",
       " 'shared2': '',\n",
       " 'shared3': '',\n",
       " 'goal': '',\n",
       " 'tags': ''}"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "SessionList['data'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "225"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(SessionList['data'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Speaker Details"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "url = 'http://scientific.eaaci.org/site/api/programme/json_call.asp'\n",
    "sessionId = '2921289'\n",
    "speakerParams = {'dataType': 'speakers_detail','sessionid': sessionId,'a': 'eaaci2020dc'}\n",
    "# sessListParams = {'dataType': 'categories_days','trackid': '0','catId': '0','a': 'eaaci2020dc','_': '1589380829654'}\n",
    "speakers_sessions = requests.get(url,params = speakerParams)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'data': [{'speakerid': 29621,\n",
       "   'photo': '/static/upload/ow49/members/pic/002_Ben Marsden and Lab Group_20180911_small.jpg',\n",
       "   'name': 'Benjamin Marsland',\n",
       "   'country': 'Australia',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'The airway microbiome in asthma development',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '09:00',\n",
       "   'presentationtimeend': '09:15',\n",
       "   'presentationorder': 1,\n",
       "   'poster': False,\n",
       "   'assignid': 186382,\n",
       "   'memberguid': '{7322A23E-320F-425B-8167-64A9200A1D55}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Speaker',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 30664,\n",
       "   'photo': '/static/img/no_pic_speaker.jpg',\n",
       "   'name': 'Matteo Bonini',\n",
       "   'country': 'Italy',\n",
       "   'role': 'moderator',\n",
       "   'presentation': '',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '',\n",
       "   'presentationtimeend': '',\n",
       "   'presentationorder': 1,\n",
       "   'poster': False,\n",
       "   'assignid': 188396,\n",
       "   'memberguid': '{AF5661A1-CA65-4268-A844-972B4D2A703F}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Chair',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 30394,\n",
       "   'photo': '/static/upload/ow49/members/pic/1700_D14_0753.jpg',\n",
       "   'name': 'Kian Fan Chung',\n",
       "   'country': 'United Kingdom',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'Exposomes and gene interaction in asthma',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '09:15',\n",
       "   'presentationtimeend': '09:30',\n",
       "   'presentationorder': 2,\n",
       "   'poster': False,\n",
       "   'assignid': 186383,\n",
       "   'memberguid': '{3FD2F5E4-3DBB-44AF-8C2F-994D53B45028}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Speaker',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 30475,\n",
       "   'photo': '/static/upload/ow49/members/pic/LOM.jpg',\n",
       "   'name': \"Liam O'Mahony\",\n",
       "   'country': 'Ireland',\n",
       "   'role': 'moderator',\n",
       "   'presentation': '',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '',\n",
       "   'presentationtimeend': '',\n",
       "   'presentationorder': 2,\n",
       "   'poster': False,\n",
       "   'assignid': 188397,\n",
       "   'memberguid': '{036D4542-720C-443B-B38F-0AAF262EF058}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Chair',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 26968,\n",
       "   'photo': '/static/upload/ow49/members/pic/Holt.jpg',\n",
       "   'name': 'Patrick Holt',\n",
       "   'country': 'Australia',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'Trajectory of lung disease from childhood to adulthood',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '09:30',\n",
       "   'presentationtimeend': '09:45',\n",
       "   'presentationorder': 3,\n",
       "   'poster': False,\n",
       "   'assignid': 186384,\n",
       "   'memberguid': '{50D079AF-236B-4B78-94F6-E3812AF51E0A}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Speaker',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 30169,\n",
       "   'photo': '/static/upload/ow49/members/pic/IA_india_1.jpg',\n",
       "   'name': 'Ioana Octavia Agache',\n",
       "   'country': 'Romania',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'Big data and cluster analysis: a real life perspective',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '09:45',\n",
       "   'presentationtimeend': '10:00',\n",
       "   'presentationorder': 4,\n",
       "   'poster': False,\n",
       "   'assignid': 186385,\n",
       "   'memberguid': '{757CA5E2-A5F6-488A-A3D5-46491F39B820}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Speaker',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 30169,\n",
       "   'photo': '/static/upload/ow49/members/pic/IA_india_1.jpg',\n",
       "   'name': 'Ioana Octavia Agache',\n",
       "   'country': 'Romania',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'Launch of the Biological guidelines',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '10:00',\n",
       "   'presentationtimeend': '10:05',\n",
       "   'presentationorder': 5,\n",
       "   'poster': False,\n",
       "   'assignid': 188384,\n",
       "   'memberguid': '{757CA5E2-A5F6-488A-A3D5-46491F39B820}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Speaker',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 26652,\n",
       "   'photo': '/static/upload/ow49/members/pic/Marek Jutel.jpg',\n",
       "   'name': 'Marek Jutel',\n",
       "   'country': 'Poland',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'Launch of the Biological guidelines',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '10:00',\n",
       "   'presentationtimeend': '10:05',\n",
       "   'presentationorder': 6,\n",
       "   'poster': False,\n",
       "   'assignid': 188385,\n",
       "   'memberguid': '{8FA75AED-BB19-4E1B-9B66-0F192509BC27}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Speaker',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 63543,\n",
       "   'photo': '/static/img/no_pic_speaker.jpg',\n",
       "   'name': 'Oscar Palomares',\n",
       "   'country': 'Spain',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'Launch of the Biological guidelines',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '10:00',\n",
       "   'presentationtimeend': '10:05',\n",
       "   'presentationorder': 7,\n",
       "   'poster': False,\n",
       "   'assignid': 188386,\n",
       "   'memberguid': '{E287335C-0D9A-425F-8CA5-954427760528}',\n",
       "   'state_id': '4',\n",
       "   'rolename': 'Speaker',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''},\n",
       "  {'speakerid': 0,\n",
       "   'photo': '/static/img/no_pic_speaker.jpg',\n",
       "   'name': '',\n",
       "   'country': '',\n",
       "   'role': 'speaker',\n",
       "   'presentation': 'Q & A',\n",
       "   'speakersfavourite': False,\n",
       "   'sessionid': 2921289,\n",
       "   'abstractid': None,\n",
       "   'abstractnumber': '',\n",
       "   'abstractauthors': '',\n",
       "   'presentationtimeststart': '10:05',\n",
       "   'presentationtimeend': '10:15',\n",
       "   'presentationorder': 8,\n",
       "   'poster': False,\n",
       "   'assignid': 0,\n",
       "   'memberguid': '',\n",
       "   'state_id': '2',\n",
       "   'rolename': '',\n",
       "   'curPage': 0,\n",
       "   'maxPage': 0,\n",
       "   'LinkedIn': '',\n",
       "   'speakerStyle': ',bold,',\n",
       "   'presentationStyle': ',',\n",
       "   'SamePresentation': ''}]}"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sessionSpeakers = speakers_sessions.json()\n",
    "sessionSpeakers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'speakerid': 29621,\n",
       " 'photo': '/static/upload/ow49/members/pic/002_Ben Marsden and Lab Group_20180911_small.jpg',\n",
       " 'name': 'Benjamin Marsland',\n",
       " 'country': 'Australia',\n",
       " 'role': 'speaker',\n",
       " 'presentation': 'The airway microbiome in asthma development',\n",
       " 'speakersfavourite': False,\n",
       " 'sessionid': 2921289,\n",
       " 'abstractid': None,\n",
       " 'abstractnumber': '',\n",
       " 'abstractauthors': '',\n",
       " 'presentationtimeststart': '09:00',\n",
       " 'presentationtimeend': '09:15',\n",
       " 'presentationorder': 1,\n",
       " 'poster': False,\n",
       " 'assignid': 186382,\n",
       " 'memberguid': '{7322A23E-320F-425B-8167-64A9200A1D55}',\n",
       " 'state_id': '4',\n",
       " 'rolename': 'Speaker',\n",
       " 'curPage': 0,\n",
       " 'maxPage': 0,\n",
       " 'LinkedIn': '',\n",
       " 'speakerStyle': ',bold,',\n",
       " 'presentationStyle': ',',\n",
       " 'SamePresentation': ''}"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sessionSpeakers['data'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "10"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(sessionSpeakers['data'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "url = 'http://scientific.eaaci.org/site/api/programme/json_call.asp'\n",
    "# sessionId = '2921289'\n",
    "speakerParams = {'dataType': 'speakers_detail','sessionid': sessionId,'a': 'eaaci2020dc'}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a35cd65864184c3286fca310554704cf",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=225.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4c581148908c4af6a634ffed798af7fd",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=13.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0810e22a65ad48268e54a4ba153d1fc6",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=16.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0eb13bd169b04b97b44eb1e9705f85a1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=11.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7c87ef6e7b1144e9a04c13b0c6de65b1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "fd3be5076c144674978ab92bd0b10531",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "198ea8d1d552489e9f3fe2c25bf336a8",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=12.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1437e39ffd464e99b72684324e75d8cc",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=16.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "35b452f58316425a933346991c838d3a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=28.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b9b9e4cfe9724e13a5ba419103c70a0c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ee0c9315afc24c93b0084b5cbbc476e1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=11.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c3d7a2bb10e8430d9dc280e48c3b0cd2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=3.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "dbc54cc3f5194402b8aeb93e48421570",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "fcd9c0d07e844823ba403fd81fbfd677",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=10.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f2f6b3b2714f422e840ad1f5912d91e5",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=7.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9968f8ae11fd4785bb6ccec9aff3f69e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=7.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2293ba9d1d6945a688233eb8abf4d348",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9ce176eb7cb246d1b91362dc97a78241",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "82bd10f7025c47018d49d42bbebb6a54",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f1080ea98a114c0cb731c2a8397cc728",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5a529e3ba908405ea4c44160ca4f81e5",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "46dfd4518a2f43a5bec24f1b23aa0353",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "45026dd7122342f1932071e501c47659",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9fe6b89f1b7d4cfc85bb8b67436454d3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "98351139bf8544e29aa0157618af34d3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "678d1c9047484aa6828dc1e52e87c3f7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7792c7fdfb2b43ec8abc39bd16116d85",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8f496bbf7a25449abc827c79c6bc2374",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9ad26593be024899a814d62bf1161e16",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=6.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ad21befc2c42478e82782e955ca55cbe",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c887c5720ca148698d69caf790454bab",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3445d2dc85cf46acb402868382740d40",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=3.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "84539b381ed945eb9d114b36ab0fd311",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=3.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e0df6dce63704600b5a18749c325a559",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=3.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b48baaa8ef7c4d659eb80adfd6a4d1fb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "02fb218127944c31a47577f1fb863354",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=3.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "63fe5bec751942899b8cc1776d7efee2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cd08d1db54cd47ab80fa2dea79d762e3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c1a6911eb16a4cdfbc9127d4a9ea640d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "103b8cc9af184b40b41bb63188f8929a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, max=4.0), HTML(value='')))"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "ename": "ConnectionError",
     "evalue": "HTTPConnectionPool(host='scientific.eaaci.org', port=80): Max retries exceeded with url: /site/api/programme/json_call.asp?dataType=speakers_detail&sessionid=2921419&a=eaaci2020dc (Caused by NewConnectionError('<urllib3.connection.HTTPConnection object at 0x000002E1528F9BC8>: Failed to establish a new connection: [WinError 10060] A connection attempt failed because the connected party did not properly respond after a period of time, or established connection failed because connected host has failed to respond'))",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mTimeoutError\u001b[0m                              Traceback (most recent call last)",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\connection.py\u001b[0m in \u001b[0;36m_new_conn\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    156\u001b[0m             conn = connection.create_connection(\n\u001b[1;32m--> 157\u001b[1;33m                 \u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_dns_host\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mport\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mtimeout\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mextra_kw\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    158\u001b[0m             )\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\util\\connection.py\u001b[0m in \u001b[0;36mcreate_connection\u001b[1;34m(address, timeout, source_address, socket_options)\u001b[0m\n\u001b[0;32m     83\u001b[0m     \u001b[1;32mif\u001b[0m \u001b[0merr\u001b[0m \u001b[1;32mis\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[1;32mNone\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 84\u001b[1;33m         \u001b[1;32mraise\u001b[0m \u001b[0merr\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     85\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\util\\connection.py\u001b[0m in \u001b[0;36mcreate_connection\u001b[1;34m(address, timeout, source_address, socket_options)\u001b[0m\n\u001b[0;32m     73\u001b[0m                 \u001b[0msock\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mbind\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0msource_address\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 74\u001b[1;33m             \u001b[0msock\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mconnect\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0msa\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     75\u001b[0m             \u001b[1;32mreturn\u001b[0m \u001b[0msock\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mTimeoutError\u001b[0m: [WinError 10060] A connection attempt failed because the connected party did not properly respond after a period of time, or established connection failed because connected host has failed to respond",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[1;31mNewConnectionError\u001b[0m                        Traceback (most recent call last)",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\connectionpool.py\u001b[0m in \u001b[0;36murlopen\u001b[1;34m(self, method, url, body, headers, retries, redirect, assert_same_host, timeout, pool_timeout, release_conn, chunked, body_pos, **response_kw)\u001b[0m\n\u001b[0;32m    671\u001b[0m                 \u001b[0mheaders\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mheaders\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 672\u001b[1;33m                 \u001b[0mchunked\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mchunked\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    673\u001b[0m             )\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\connectionpool.py\u001b[0m in \u001b[0;36m_make_request\u001b[1;34m(self, conn, method, url, timeout, chunked, **httplib_request_kw)\u001b[0m\n\u001b[0;32m    386\u001b[0m         \u001b[1;32melse\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 387\u001b[1;33m             \u001b[0mconn\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mrequest\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mmethod\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0murl\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mhttplib_request_kw\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    388\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\http\\client.py\u001b[0m in \u001b[0;36mrequest\u001b[1;34m(self, method, url, body, headers, encode_chunked)\u001b[0m\n\u001b[0;32m   1251\u001b[0m         \u001b[1;34m\"\"\"Send a complete request to the server.\"\"\"\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 1252\u001b[1;33m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_send_request\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mmethod\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0murl\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mbody\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mheaders\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mencode_chunked\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   1253\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\http\\client.py\u001b[0m in \u001b[0;36m_send_request\u001b[1;34m(self, method, url, body, headers, encode_chunked)\u001b[0m\n\u001b[0;32m   1297\u001b[0m             \u001b[0mbody\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0m_encode\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mbody\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'body'\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 1298\u001b[1;33m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mendheaders\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mbody\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mencode_chunked\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mencode_chunked\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   1299\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\http\\client.py\u001b[0m in \u001b[0;36mendheaders\u001b[1;34m(self, message_body, encode_chunked)\u001b[0m\n\u001b[0;32m   1246\u001b[0m             \u001b[1;32mraise\u001b[0m \u001b[0mCannotSendHeader\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 1247\u001b[1;33m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_send_output\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mmessage_body\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mencode_chunked\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mencode_chunked\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   1248\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\http\\client.py\u001b[0m in \u001b[0;36m_send_output\u001b[1;34m(self, message_body, encode_chunked)\u001b[0m\n\u001b[0;32m   1025\u001b[0m         \u001b[1;32mdel\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_buffer\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 1026\u001b[1;33m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mmsg\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   1027\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\http\\client.py\u001b[0m in \u001b[0;36msend\u001b[1;34m(self, data)\u001b[0m\n\u001b[0;32m    965\u001b[0m             \u001b[1;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mauto_open\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 966\u001b[1;33m                 \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mconnect\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    967\u001b[0m             \u001b[1;32melse\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\connection.py\u001b[0m in \u001b[0;36mconnect\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    183\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0mconnect\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 184\u001b[1;33m         \u001b[0mconn\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_new_conn\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    185\u001b[0m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_prepare_conn\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mconn\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\connection.py\u001b[0m in \u001b[0;36m_new_conn\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    168\u001b[0m             raise NewConnectionError(\n\u001b[1;32m--> 169\u001b[1;33m                 \u001b[0mself\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m\"Failed to establish a new connection: %s\"\u001b[0m \u001b[1;33m%\u001b[0m \u001b[0me\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    170\u001b[0m             )\n",
      "\u001b[1;31mNewConnectionError\u001b[0m: <urllib3.connection.HTTPConnection object at 0x000002E1528F9BC8>: Failed to establish a new connection: [WinError 10060] A connection attempt failed because the connected party did not properly respond after a period of time, or established connection failed because connected host has failed to respond",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[1;31mMaxRetryError\u001b[0m                             Traceback (most recent call last)",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\requests\\adapters.py\u001b[0m in \u001b[0;36msend\u001b[1;34m(self, request, stream, timeout, verify, cert, proxies)\u001b[0m\n\u001b[0;32m    448\u001b[0m                     \u001b[0mretries\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mmax_retries\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 449\u001b[1;33m                     \u001b[0mtimeout\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mtimeout\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    450\u001b[0m                 )\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\connectionpool.py\u001b[0m in \u001b[0;36murlopen\u001b[1;34m(self, method, url, body, headers, retries, redirect, assert_same_host, timeout, pool_timeout, release_conn, chunked, body_pos, **response_kw)\u001b[0m\n\u001b[0;32m    719\u001b[0m             retries = retries.increment(\n\u001b[1;32m--> 720\u001b[1;33m                 \u001b[0mmethod\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0murl\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0merror\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0me\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0m_pool\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0m_stacktrace\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0msys\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mexc_info\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    721\u001b[0m             )\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\urllib3\\util\\retry.py\u001b[0m in \u001b[0;36mincrement\u001b[1;34m(self, method, url, response, error, _pool, _stacktrace)\u001b[0m\n\u001b[0;32m    435\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0mnew_retry\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mis_exhausted\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 436\u001b[1;33m             \u001b[1;32mraise\u001b[0m \u001b[0mMaxRetryError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_pool\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0murl\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0merror\u001b[0m \u001b[1;32mor\u001b[0m \u001b[0mResponseError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mcause\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    437\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mMaxRetryError\u001b[0m: HTTPConnectionPool(host='scientific.eaaci.org', port=80): Max retries exceeded with url: /site/api/programme/json_call.asp?dataType=speakers_detail&sessionid=2921419&a=eaaci2020dc (Caused by NewConnectionError('<urllib3.connection.HTTPConnection object at 0x000002E1528F9BC8>: Failed to establish a new connection: [WinError 10060] A connection attempt failed because the connected party did not properly respond after a period of time, or established connection failed because connected host has failed to respond'))",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[1;31mConnectionError\u001b[0m                           Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-31-1438ab8f550a>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     11\u001b[0m     \u001b[0msessionDetails\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'Description'\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mi\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'description'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     12\u001b[0m     \u001b[0mspeakerParams\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m{\u001b[0m\u001b[1;34m'dataType'\u001b[0m\u001b[1;33m:\u001b[0m \u001b[1;34m'speakers_detail'\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;34m'sessionid'\u001b[0m\u001b[1;33m:\u001b[0m \u001b[0msessionDetails\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'Session Id'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;34m'a'\u001b[0m\u001b[1;33m:\u001b[0m \u001b[1;34m'eaaci2020dc'\u001b[0m\u001b[1;33m}\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 13\u001b[1;33m     \u001b[0mspeakers_sessions\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mrequests\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0murl\u001b[0m\u001b[1;33m,\u001b[0m\u001b[0mparams\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mspeakerParams\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     14\u001b[0m     \u001b[0msessionSpeakers\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mspeakers_sessions\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mjson\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     15\u001b[0m     \u001b[0msessionSpeakerPresentations\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0msessionSpeakers\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'data'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\requests\\api.py\u001b[0m in \u001b[0;36mget\u001b[1;34m(url, params, **kwargs)\u001b[0m\n\u001b[0;32m     73\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     74\u001b[0m     \u001b[0mkwargs\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msetdefault\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'allow_redirects'\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;32mTrue\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 75\u001b[1;33m     \u001b[1;32mreturn\u001b[0m \u001b[0mrequest\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'get'\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0murl\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mparams\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mparams\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     76\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     77\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\requests\\api.py\u001b[0m in \u001b[0;36mrequest\u001b[1;34m(method, url, **kwargs)\u001b[0m\n\u001b[0;32m     58\u001b[0m     \u001b[1;31m# cases, and look like a memory leak in others.\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     59\u001b[0m     \u001b[1;32mwith\u001b[0m \u001b[0msessions\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mSession\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0msession\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 60\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0msession\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mrequest\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mmethod\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mmethod\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0murl\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0murl\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     61\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     62\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\requests\\sessions.py\u001b[0m in \u001b[0;36mrequest\u001b[1;34m(self, method, url, params, data, headers, cookies, files, auth, timeout, allow_redirects, proxies, hooks, stream, verify, cert, json)\u001b[0m\n\u001b[0;32m    531\u001b[0m         }\n\u001b[0;32m    532\u001b[0m         \u001b[0msend_kwargs\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mupdate\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0msettings\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 533\u001b[1;33m         \u001b[0mresp\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mprep\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0msend_kwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    534\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    535\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[0mresp\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\requests\\sessions.py\u001b[0m in \u001b[0;36msend\u001b[1;34m(self, request, **kwargs)\u001b[0m\n\u001b[0;32m    644\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    645\u001b[0m         \u001b[1;31m# Send the request\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 646\u001b[1;33m         \u001b[0mr\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0madapter\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mrequest\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    647\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    648\u001b[0m         \u001b[1;31m# Total elapsed time of the request (approximately)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\requests\\adapters.py\u001b[0m in \u001b[0;36msend\u001b[1;34m(self, request, stream, timeout, verify, cert, proxies)\u001b[0m\n\u001b[0;32m    514\u001b[0m                 \u001b[1;32mraise\u001b[0m \u001b[0mSSLError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0me\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mrequest\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mrequest\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    515\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 516\u001b[1;33m             \u001b[1;32mraise\u001b[0m \u001b[0mConnectionError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0me\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mrequest\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mrequest\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    517\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    518\u001b[0m         \u001b[1;32mexcept\u001b[0m \u001b[0mClosedPoolError\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0me\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mConnectionError\u001b[0m: HTTPConnectionPool(host='scientific.eaaci.org', port=80): Max retries exceeded with url: /site/api/programme/json_call.asp?dataType=speakers_detail&sessionid=2921419&a=eaaci2020dc (Caused by NewConnectionError('<urllib3.connection.HTTPConnection object at 0x000002E1528F9BC8>: Failed to establish a new connection: [WinError 10060] A connection attempt failed because the connected party did not properly respond after a period of time, or established connection failed because connected host has failed to respond'))"
     ]
    }
   ],
   "source": [
    "dfDetails = pd.DataFrame()\n",
    "for i in tqdm(SessionList['data']):\n",
    "    sessionDetails = {}\n",
    "    sessionDetails['Session Id'] = i['sessionid']\n",
    "    sessionDetails['Session Type'] = i['type']\n",
    "    sessionDetails['Session Name'] = i['session']\n",
    "    sessionDetails['Session Category'] = i['category']\n",
    "    sessionDetails['Session Time'] = i['time']\n",
    "    sessionDetails['Location'] = i['room']\n",
    "    sessionDetails['Date'] = i['daycalendarCal']\n",
    "    sessionDetails['Description'] = i['description']\n",
    "    speakerParams = {'dataType': 'speakers_detail','sessionid': sessionDetails['Session Id'],'a': 'eaaci2020dc'}\n",
    "    speakers_sessions = requests.get(url,params = speakerParams)\n",
    "    sessionSpeakers = speakers_sessions.json()\n",
    "    sessionSpeakerPresentations = sessionSpeakers['data']\n",
    "    if(len(sessionSpeakerPresentations) == 0):\n",
    "        dfDetails = dfDetails.append(sessionDetails,ignore_index = True)\n",
    "    else:\n",
    "        for j in tqdm(sessionSpeakerPresentations):\n",
    "            presentationDetails = sessionDetails.copy()\n",
    "            presentationDetails['Presentation Name'] = j['presentation']\n",
    "            presentationDetails['Speaker Name'] = j['name']\n",
    "            presentationDetails['Speaker Role'] = j['role']\n",
    "            presentationDetails['Speaker Role Name'] = j['rolename']\n",
    "            presentationDetails['Presentation Start Time'] = j['presentationtimeststart']\n",
    "            presentationDetails['Presentation End Time'] = j['presentationtimeend']\n",
    "            presentationDetails['Speaker Country'] = j['country']\n",
    "            presentationDetails['Abstract Id'] = j['abstractid']\n",
    "            dfDetails = dfDetails.append(presentationDetails,ignore_index = True)\n",
    "dfDetails            "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "url = 'http://scientific.eaaci.org/site/api/programme/json_call.asp'\n",
    "sessionId = '2916553'\n",
    "sessParams = {'dataType': 'session_detail','sessionid': sessionId,'a': 'eaaci2020dc'}\n",
    "sessListParams = {'dataType': 'categories_days','trackid': '0','catId': '0','a': 'eaaci2020dc','_': '1589380829654'}\n",
    "data_sessions = requests.get(url,params = sessListParams)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "daySessionData = data_sessions.json()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'day': '4209',\n",
       "  'colortype': '#0000CC',\n",
       "  'type': 'Keynote  Symposia',\n",
       "  'category': 'Asthma > Pediatrics > Basic and clinical immunology',\n",
       "  'session': 'KS 1 The challenges of severe asthma ',\n",
       "  'room': '',\n",
       "  'time': '09:00-10:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921289,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Keynote  Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#0000CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Keynote  Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': \"KS 1 The challenges of severe asthma  Benjamin Marsland  The airway microbiome in asthma development  Matteo Bonini    Kian Fan Chung  Exposomes and gene interaction in asthma  Liam O'Mahony    Patrick Holt  Trajectory of lung disease from childhood to adulthood  Ioana Octavia Agache  Big data and cluster analysis: a real life perspective  Ioana Octavia Agache  Launch of the Biological guidelines  Marek Jutel  Launch of the Biological guidelines  Oscar Palomares  Launch of the Biological guidelines    Q & A  \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '10:15-10:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921384,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergy and clinical immunology > Basic and clinical immunology > Pediatrics',\n",
       "  'session': 'SYM 01 Novel insights into the development of allergic disease ',\n",
       "  'room': '',\n",
       "  'time': '10:45-12:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921243,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 01 Novel insights into the development of allergic disease  Barbara Bohle  How do allergens sensitize?  Jean Bousquet  Novel insight into development of allergic diseases  Cezmi Akdis  Epithelial cell barrier and allergic diseases  Isabella Annesi-Maesano  Lifelong exposure to multiple stressors through different environmental pathways and their impact on allergy  Stephen Holgate  Air pollution and allergy: call for action!     Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '12:15-12:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921385,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Food allergy > Pediatrics > Allied health and primary care  ',\n",
       "  'session': 'SYM 02 Food allergy: prevention is better that cure ',\n",
       "  'room': '',\n",
       "  'time': '12:45-14:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921297,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 02 Food allergy: prevention is better that cure  Gideon Lack  Prevention of food allergy: where are we now?  Edmond S. Chan  Challenges on the implementation of early introduction of allergenic foods  Michael Perkin  Over-the-counter allergy prevention weaning products  Nikolaos Papadopoulos  Latest developments in pre, pro and symbiotics in food allergy prevention  Carina Venter  Dietary and psychological issues related to food introductions    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '14:15-14:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921386,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Basic and clinical immunology > Asthma > ENT',\n",
       "  'session': 'SYM 03 Biologicals and other therapies in allergy: from clinical trials to clinical practice',\n",
       "  'room': '',\n",
       "  'time': '14:45-16:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921300,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 03 Biologicals and other therapies in allergy: from clinical trials to clinical practice Jonathan Corren  Tezepelumab (anti-TSLP) in asthma  Claus Bachert  Dupilumab (anti-IL4Ra) in CRSwNP  Marcus Maurer  Ligelizumab (anti-IgE) in chronic spontaneous urticaria    Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?  Matteo Bonini  Upcoming drug developments and biosimilars    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '16:15-16:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921387,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'SSS 01 EAACI - NIAID/NIH Joint Symposium: From bench to bedside: Potential therapeutics for allergic diseases from the NIAID-supported Asthma and Allergic Diseases Cooperative Research Centers',\n",
       "  'room': '',\n",
       "  'time': '16:45-17:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921302,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 01 EAACI - NIAID/NIH Joint Symposium: From bench to bedside: Potential therapeutics for allergic diseases from the NIAID-supported Asthma and Allergic Diseases Cooperative Research Centers James E Gern  Targeting rhinovirus infection as a strategy for asthma prevention and treatment  Ray Stokes Peebles, Jr.  Glucagon-like 1 receptor agonists: repurposing for asthma?  Bruce Scott Bochner  Siglecs on eosinophils and mast cells: from biology to therapeutic opportunities    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '17:45-18:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921388,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': 'Dermatology > Basic and clinical immunology > Allied health and primary care  ',\n",
       "  'session': 'SSS 02 EAACI \\x80\\x93 ACAAI joint symposium: Atopic dermatitis: what\\x80\\x99s new?',\n",
       "  'room': '',\n",
       "  'time': '18:15-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921304,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 02 EAACI \\x80\\x93 ACAAI joint symposium: Atopic dermatitis: what\\x80\\x99s new? James L Sublett  Using the \\x80\\x9catopic dermatitis yardstick\\x80\\x9d in clinical practice  Michael S. Blaiss  Managing quality of life and comorbidity issues in atopic dermatitis  Luz Fonacier  JAK inhibitors and monoclonals: the future of atopic dermatitis management    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '19:15-19:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921389,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#999999',\n",
       "  'type': 'Welcome Ceremony',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '19:45-20:00',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921323,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Welcome Ceremony' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#999999;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Welcome Ceremony</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4209',\n",
       "  'colortype': '#999999',\n",
       "  'type': 'Opening Keynote Lectures',\n",
       "  'category': 'Basic and clinical immunology > Allergen immunotherapy      > Asthma',\n",
       "  'session': 'OKS 1 The EAACI Congress 2020 opening Keynote Symposia: Solutions and challenges in modern medicine',\n",
       "  'room': '',\n",
       "  'time': '20:00-21:00',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921324,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Saturday, 6 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Opening Keynote Lectures' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#999999;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Opening Keynote Lectures</li>\",\n",
       "  'daycalendarCal': '2020-06-06 00:00:00',\n",
       "  'moreSearchInfo': 'OKS 1 The EAACI Congress 2020 opening Keynote Symposia: Solutions and challenges in modern medicine Mohamed Shamji      Paving the way for biologicals in modern medicine  Peter Openshaw  Corona virus and lung inflammation \\x80\\x93 the current pandemic  Marek Jutel    Marek Jutel  Immune modulation in the era of COVID19    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#0000CC',\n",
       "  'type': 'Keynote  Symposia',\n",
       "  'category': 'Allergen immunotherapy      > Food allergy > Allergy and clinical immunology',\n",
       "  'session': 'KS 2 Novel insights into Immunotherapy approaches for food and aeroallergens',\n",
       "  'room': '',\n",
       "  'time': '09:00-10:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921290,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Keynote  Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#0000CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Keynote  Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': 'KS 2 Novel insights into Immunotherapy approaches for food and aeroallergens Cezmi Akdis    George du Toit  Immunotherapy for food allergy: is tolerance too much of an expectation?  Stephen R Durham    Wayne G Shreffler  Mechanisms of Oral, SLIT and other approaches of food immunotherapy  Mbeccel Akdis  B cells tolerance: an essential mechanism for allergen immunotherapy in house dust mite allergy  Mohamed Shamji  Artificial intelligence approach to understanding the mechanisms and biomarker discovery for allergen immunotherapy    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '10:15-10:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921390,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': 'Allergy and clinical immunology > Dermatology > Allied health and primary care  ',\n",
       "  'session': 'SSS 03 EAACI \\x80\\x93 APAAACI joint symposium: allergies in asia pacific: insights and lessons learnt east versus west',\n",
       "  'room': '',\n",
       "  'time': '10:45-11:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921325,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 03 EAACI \\x80\\x93 APAAACI joint symposium: allergies in asia pacific: insights and lessons learnt east versus west Jiu-Yao Wang  House dust mite allergy in Asia Pacific   Ruby Pawankar  Prevalence, socio-economics and management of allergic rhinitis in Asia Pacific  Amir Hamzah Abdul Latiff  Burden and consensus on urticaria management in Asia Pacific    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '11:45-12:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921391,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Basic and clinical immunology > Food allergy > Allergy and clinical immunology',\n",
       "  'session': 'SYM 04 Utility of OMICs: a roadmap to precision medicine',\n",
       "  'room': '',\n",
       "  'time': '12:15-13:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921326,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 04 Utility of OMICs: a roadmap to precision medicine Nick Reynolds  Human and computational models of immune mediated inflammatory skin disease: challenges, insights and perspectives  Kari Christine Nadeau  Integrative OMICs data analysis reveals key drivers of peanut allergic reactions  Jonathan Coquet  Utility of single-cell RNA sequencing to identify distinct gene signature in airway Th2 cells  Domingo Barber  Utility of untargeted and targeted metabolomic approaches in phenotyping allergic diseases   Markus Ollert  Integrated systems biology strategies for diagnostics and immune monitoring in allergy    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '13:45-14:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921392,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Pediatrics',\n",
       "  'session': 'SSS 04 EAACI \\x80\\x93 ERS joint symposium: asthma for the roaring 20-twenties',\n",
       "  'room': '',\n",
       "  'time': '14:15-15:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921327,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 04 EAACI \\x80\\x93 ERS joint symposium: asthma for the roaring 20-twenties Luis Prez de Llano  Big changes in asthma treatment : GINA 2019  Arzu Yorgancioglu  Tailored therapy in severe asthma: is it a dream in low- and middle-income countries?  Adnan Custovic  A system biology and machine learning approach to childhood asthma    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '15:15-15:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921393,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Drug allergy > Pediatrics > Allergy diagnosis and systems medicine',\n",
       "  'session': 'SYM 05 Insights into the management of drug allergy',\n",
       "  'room': '',\n",
       "  'time': '15:45-17:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921328,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 05 Insights into the management of drug allergy Marina Atanaskovic-Markovic  NSAID hypersensitivity of children vs adults  Lene Heise Garvey  Drug reactions in the perioperative setting  Maria J Torres  Early biomarkers for severe drug hypersensitivity reactions  Mariana Castells  Management of adverse reactions to biologics  Jean-Christoph Caubet  Utility of provocation tests before deciding to desensitize    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '17:15-17:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921394,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4210',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'ENT > Basic and clinical immunology > Asthma',\n",
       "  'session': 'SYM 06 Novel mechanisms in united severe united airway disease ',\n",
       "  'room': '',\n",
       "  'time': '17:45-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921329,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Sunday, 7 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-07 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 06 Novel mechanisms in united severe united airway disease  Atsushi Kato  Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis  Hideaki Morita  Targeting innate lymphoid cells in lower and upper airway disease: what\\x80\\x99s new?  Anju Tripathi Peters  B cells in in chronic rhinosinusitis: friend or foe  Sanna Toppila-Salmi  Advances in genomics in severe airway disease  Philippe Gevaert  Novel therapeutic approaches targeting endotypes of severe airway disease    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#0000CC',\n",
       "  'type': 'Keynote  Symposia',\n",
       "  'category': 'Basic and clinical immunology > Asthma > Pediatrics',\n",
       "  'session': 'KS 3 Trained innate immunity and therapeutic target of immune-mediated disease',\n",
       "  'room': '',\n",
       "  'time': '09:00-10:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921292,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Keynote  Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#0000CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Keynote  Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': 'KS 3 Trained innate immunity and therapeutic target of immune-mediated disease Jrgen Schwarze    Alberto Mantovani  Trained innate immunity and regulation of inflammation by interleukin-1 related cytokines  Irene Heijink  Epithelial cell dysfunction, a major driver of asthma development  Karin  Hoffmann-Sommergruber    Clare M Lloyd  Targeting immune pathways in early-life for asthma prevention   Isabelle Meyts  Neutrophil dysfunction - beyond immune deficiency    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '10:15-10:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921395,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Dermatology > Basic and clinical immunology > Allied health and primary care  ',\n",
       "  'session': 'SYM 07 Targeting the skin immune response for disease prevention and control',\n",
       "  'room': '',\n",
       "  'time': '10:45-12:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921330,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 07 Targeting the skin immune response for disease prevention and control Alan Irvine  Impact of the exposome in atopic dermatitis \\t  Edward Frank Knol  Implementing biomarkers in immunophenotyping of atopic dermatitis  Helen A Brough  Skin care from birth for allergy prevention: results today  Emma Guttman Yassky  Novel targets for treatment in atopic dermatitis  Clive Grattan  Hereditary angioedema \\x80\\x93 the best way to prevent attacks    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '12:15-12:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921396,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Basic and clinical immunology > Food allergy > Allergen immunotherapy     ',\n",
       "  'session': 'SYM 08 Targeting the microbiome for clinical care',\n",
       "  'room': '',\n",
       "  'time': '12:45-14:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921331,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': \"SYM 08 Targeting the microbiome for clinical care   Microbiome and the immune response: a clinical perspective  Nonhlanhla Lunjani  Living environment-dependent modification of immune endotypes in allergic diseases  Anne Marie Singh  Gut microbiome and the development of food allergy and allergic disease.    Microbiota and successful immunotherapy: lessons learned from the oncology   Liam O'Mahony  Gut microbiome - based therapeutic approaches.     Q & A  \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '14:15-14:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921397,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergen immunotherapy      > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'SYM 09 Allergen immunotherapy: ourcome measures, mechanisms and biomarkers',\n",
       "  'room': '',\n",
       "  'time': '14:45-16:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921332,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 09 Allergen immunotherapy: ourcome measures, mechanisms and biomarkers Stephen R Durham  Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests   Constantinos Pitsios  Outcome measures for adult\\x80\\x99s vs children in the clinic during allergen immunotherapy  Erik R Wambre  T cell tolerance during allergen immunotherapy  Paul J Turner  Benefit, risk ratio and improving oral allergen immunotherapy   Mark Larch  Molecular immune biomarkers for protein-based and peptide immunotherapy    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '16:15-16:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921398,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': 'Environmental and occupational allergy > ENT > Asthma',\n",
       "  'session': 'SSS 05 EAACI \\x80\\x93 WAO joint symposium: world allergy forum: impact of climate change on allergic diseases',\n",
       "  'room': '',\n",
       "  'time': '16:45-17:45',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921333,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 05 EAACI \\x80\\x93 WAO joint symposium: world allergy forum: impact of climate change on allergic diseases David B. Peden  Impact of climate change on the immune system  Philip Wakim Rouadi  International expert consensus on the management of allergic rhinitis aggravated by air pollutants  Sandra Nora Gonzlez D\\xadaz  Impact of climate change on asthma exacerbations    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#99FFFF',\n",
       "  'type': 'Break',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '17:45-18:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921399,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Break' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FFFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Break</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': 'Asthma > Environmental and occupational allergy > Basic and clinical immunology',\n",
       "  'session': 'SSS 06 EAACI \\x80\\x93 AAAAI joint symposium: a new era in asthma management: perspectives from the united states',\n",
       "  'room': '',\n",
       "  'time': '18:15-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921334,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 06 EAACI \\x80\\x93 AAAAI joint symposium: a new era in asthma management: perspectives from the united states Thomas Casale  Personalized asthma care \\x80\\x93 the use of biologics  Wanda Phipatanakul  Allergen abatement: the impact of environmental interventions in different patient populations  Leonard Bacharier  Reconciling differences in asthma guidelines    Q & A  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4211',\n",
       "  'colortype': '#999999',\n",
       "  'type': 'Closing ceremony',\n",
       "  'category': ' ',\n",
       "  'session': ' ',\n",
       "  'room': '',\n",
       "  'time': '19:15-19:30',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921473,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Monday, 8 June 2020',\n",
       "  'label': \"<li torder='0' labelreader='Closing ceremony' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#999999;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Closing ceremony</li>\",\n",
       "  'daycalendarCal': '2020-06-08 00:00:00',\n",
       "  'moreSearchInfo': '  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC3366',\n",
       "  'type': 'Ethics Session',\n",
       "  'category': 'Basic and clinical immunology > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': ' Everything you need to know about ethics, but were afraid to ask',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921475,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Ethics Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC3366;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Ethics Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': ' Everything you need to know about ethics, but were afraid to ask Rouven Christian  Porz  Use and mis-use of ethics in medicine  Caroline Brall  Frequently Asked Questions  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': ' ',\n",
       "  'session': 'SSS 07 EAACI \\x80\\x93 KAAACI joint symposium',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921476,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 07 EAACI \\x80\\x93 KAAACI joint symposium Heung-Woo Park  Elderly asthma  Jeong-Hee  Choi  Aspirin hypersensitivity and AERD  Toms Chivato  Precision Medicine and integrated care pathways in 2020 and beyond  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': ' ',\n",
       "  'session': 'SSS 08 EAACI \\x80\\x93 SLAAI Joint Symposium',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921477,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 08 EAACI \\x80\\x93 SLAAI Joint Symposium Mario Sanchez-Borges  New and potential biological drugs in chronic urticaria  R Maximiliano Gomez  Chronic urticaria peculiarities in Latinoamerica  Luis Felipe Chiaverini Ensina  Is chronic urticaria in children the same as in adults?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': ' ',\n",
       "  'session': 'SSS 09 EAACI \\x80\\x93 JSA Joint Symposium: New insights into the clinical phenotypes and genotypes of allergic diseases in Japan',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921478,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 09 EAACI \\x80\\x93 JSA Joint Symposium: New insights into the clinical phenotypes and genotypes of allergic diseases in Japan Emiko Noguchi  What we learned from outbreak of hydrolyzed wheat allergy in Japan: Genetic basis of food allergy  Koichiro Asano  Allergic bronchopulmonary mycosis: clinical phenotypes and validation of diagnostic criteria based on nation-wide survey in Japan  Yukihiro Ohya  Birth cohort studies in Japan and findings of allergy and allergic disorders  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': ' ',\n",
       "  'session': 'SSS 10 EAACI \\x80\\x93 GARD Joint Symposium: Chronic respiratory diseases in diverse regions of the world',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921479,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 10 EAACI \\x80\\x93 GARD Joint Symposium: Chronic respiratory diseases in diverse regions of the world Arzu Yorgancioglu  GARD- A platform to bring together action on CRDs  Mina Gaga  Challenges and opportunities for CRD prevention and management in primary health care  Talant Sooronbaev  National action on CRDs  Kevin Montimer  Collective advocacy for action on CRDs  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': ' ',\n",
       "  'session': 'SSS 11 EAACI \\x80\\x93 APAPARI Joint Symposium: Molecular Allergology- Cutting edge science or fashion?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921480,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 11 EAACI \\x80\\x93 APAPARI Joint Symposium: Molecular Allergology- Cutting edge science or fashion? Ronald van Ree  Molecular Allergology and the conventional allergic testing  Motohiro Ebisawa  Molecular allergology in the diagnosis of food allergy  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFCC33',\n",
       "  'type': 'Sister Society Symposia',\n",
       "  'category': ' ',\n",
       "  'session': 'SSS 12 EAACI \\x80\\x93 ARIA Joint Symposium: The mHealth revolution in allergic diseases',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921481,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Sister Society Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFCC33;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Sister Society Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SSS 12 EAACI \\x80\\x93 ARIA Joint Symposium: The mHealth revolution in allergic diseases Matteo Bonini  mHealth in asthma  Jean Bousquet  ARIACARE digital network  Jean Bousquet  Assessment of adherence to treatment using mHealth  Joo Almeida Fonseca  The MASK e-platform for severe asthma  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'SYM 10 Food allergens: taking a closer look',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921402,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 10 Food allergens: taking a closer look Soheila June Maleki  Structural biology of food allergens and cross reactivity  Jens Brockmeyer  Detection of trace allergens in food  Barbara Ballmer-Weber  Hidden food allergens: Clinical perspectives  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Food allergy > Allergy diagnosis and systems medicine > Allergy and clinical immunology',\n",
       "  'session': 'SYM 11 Novel diagnostic tools in allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921403,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 11 Novel diagnostic tools in allergy Martin Metz  Novel diagnostic tools in skin allergy  Silvia Bulfone-Paus  New cellular activation tests  Thomas A Platts-Mills  Role of IgG4 in the pathogenesis of EoE  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Food allergy > Pediatrics > Allergy and clinical immunology',\n",
       "  'session': 'SYM 12 Core outcome measures for food allergy : what are they and why do they matter?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921404,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"SYM 12 Core outcome measures for food allergy : what are they and why do they matter? Daniel Munblit  Core outcome measures for food allergy  Kirsten Beyer  Relevant outcome measures for food allergy treatment trials - the clinician's perspective  Pablo Rodr\\xadguez del R\\xado  Relevant outcome measures for food allergy treatment trials - the patient's perspective  \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'SYM 13 Multiple tree nut allergy: epidemiology, prevention and treatment?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921405,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 13 Multiple tree nut allergy: epidemiology, prevention and treatment? Margitta Worm  Multiple tree nut allergies  Clare Mills  Can we prevent the spread of tree nut allergies?  Kari Christine Nadeau  Therapies for multiple-tree nut allergies  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergen immunotherapy      > Asthma > Pediatrics',\n",
       "  'session': 'SYM 14 Presidential symposium: allergen immunotherapy for allergic asthma from guidelines to implementation',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921413,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 14 Presidential symposium: allergen immunotherapy for allergic asthma from guidelines to implementation Marek Jutel  EAACI Guidelines for HDM-driven allergic asthma  David  M Lang  AAAAI Practice Parameters  Stefan Vieths  What are the best end-points in AIT asthma trials - the regulatory point of view?  David I Bernstein  What are the best end-points in AIT asthma trials - the clinician point of view?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergen immunotherapy      > ENT > Allergy and clinical immunology',\n",
       "  'session': 'SYM 15 Advances in allergen immunotherapy: clinical',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921414,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 15 Advances in allergen immunotherapy: clinical Musa Khaitov  Towards vaccination of birch pollen and birch pollen-associated food allergy  Milena Sokolowska  Metabolic regulation of Allergen-specific T cells during AIT  Tilo Biedermann  The tree pollen sublingual immunotherapy: An effective treatment for tree pollen induced rhinitis  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergy diagnosis and systems medicine > Basic and clinical immunology > Food allergy',\n",
       "  'session': 'SYM 16 T cell, basophil and mast cell tests for allergy diagnosis: why and when to use them',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921420,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 16 T cell, basophil and mast cell tests for allergy diagnosis: why and when to use them Monday Ogaba Ogese  T cell-based laboratory tests for diagnosis in clinical practice?  Hans Jrgen Hoffmann  The Basophil Activation Test  Alexandra F. Santos  Cultured mast cells as diagnostic tools for food allergy  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergy diagnosis and systems medicine > Allied health and primary care   > Food allergy',\n",
       "  'session': 'SYM 17 IgE molecular diagnosis in clinical practice: rationale, methods, advantages and limitations',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921421,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 17 IgE molecular diagnosis in clinical practice: rationale, methods, advantages and limitations Marianne van Hage  Evolution of airborne allergen specific IgE responses from childhood to adulthood  Ronald van Ree  Technologies for IgE molecular diagnosis: Analytical performance and clinical utility  Enrico Scala  Molecular test in allergy diagnosis: Application in daily clinical practice  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allied health and primary care   > Allergy and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'SYM 18 Innovative platforms to support clinical practice',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921423,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 18 Innovative platforms to support clinical practice Fraser Birrell  Can group consultations work in allergy? Learning from rheumatology    Telemedicine for consultations  Stephanie Dramburg  Virtual care, social media and mHealth for allergy management  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allied health and primary care   > Allergy and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'SYM 19 Breast feeding: prevention and outcomes of allergic diseases',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921424,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 19 Breast feeding: prevention and outcomes of allergic diseases Valrie Verhasselt  Insight from translational research for oral tolerance for breast milk  R.J. Joost van Neerven  Linking bovine milk components and their possible association with allergic diseases  Jon Genuneit  Role of human breast milk components on allergic outcomes  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Asthma > Allergy and clinical immunology > Environmental and occupational allergy',\n",
       "  'session': 'SYM 20 Epidemic asthma: multiple allergic triggers in the era of climate change',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921427,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 20 Epidemic asthma: multiple allergic triggers in the era of climate change Shuaib Nasser  Alternaria-induced thunderstorm asthma: An unrecognised trigger  Frank Thien  Grass pollen-induced thunderstorm asthma: How to manage exacerbations?  Josep M. Ant Boqu  Epidemic asthma due to soya bean in Barcelona \\x80\\x93 20yrs on  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Allergy and clinical immunology',\n",
       "  'session': 'SYM 21 Lipid mediators in asthma and allergy: from biology to treatment',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921428,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 21 Lipid mediators in asthma and allergy: from biology to treatment Grzegorz Woszczek  Leukotrienes in asthma \\x80\\x93 An unfinished story  Sven-Erik Dahln  Predicting response to drugs targeting prostaglandins and leukotrienes    Lipid mediators in asthma and allergy \\x80\\x93 good targets for treatment?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Pediatrics',\n",
       "  'session': 'SYM 22 Predictive markers for guiding the use of biologicals in asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921429,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 22 Predictive markers for guiding the use of biologicals in asthma Mina Gaga  Clinical and functional predictors  Ian Pavord  Inflammatory biomarkers  Paul Brinkman  Breathomics  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Asthma > Allergy and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'SYM 23 Novel concepts in driving biological development for allergic disorders',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921430,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 23 Novel concepts in driving biological development for allergic disorders Ioana Octavia Agache  Biologicals in allergy and asthma: A deep learning approach to optimized patient management  Ian Michael  Adcock  Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach  Onur Boyman  New analytical approaches to drive biological pipeline development  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergy and clinical immunology > Allergy diagnosis and systems medicine > Allergen immunotherapy     ',\n",
       "  'session': 'SYM 24 Insect venom allergy: risk factors, diagnostics and efficacy of treatment',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921433,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 24 Insect venom allergy: risk factors, diagnostics and efficacy of treatment Gunter Sturm  Risk factors predicting severe reactions in insect venom allergy  Thilo Jakob  Diagnostic workup in venom allergy: Deciding the optimal treatment  Mamidipudi Thirumala Krishna  Efficacy of venom immunotherapy: How long should patients be treated?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergy and clinical immunology > Allergy diagnosis and systems medicine > Allergen immunotherapy     ',\n",
       "  'session': 'SYM 25  Treatment implications for insect venom allergic patients with mastocytosis',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921434,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 25  Treatment implications for insect venom allergic patients with mastocytosis Sigurd Broesby-Olsen  Algorithms to identify underlying mastocytosis in insect venom allergic patients  Cem Akin  Elevated tryptase \\x80\\x93 Now what?  Beatrice Bil  Pre-cautions and side effects of venom immunotherapy  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Allergy and clinical immunology > Dermatology > ENT',\n",
       "  'session': 'SYM 26  Precision medicine and biomarkers of allergic diseases',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921435,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 26  Precision medicine and biomarkers of allergic diseases Claudia Traidl-Hoffmann  Precision medicine and biomarkers of atopic dermatitis  Luo Zhang  Precision medicine and biomarkers in chronic rhinosinusitis with nasal polyps  Hae-Sim Park  Precision medicine in united airways disease  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Basic and clinical immunology > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'SYM 27 Novel concepts in innate and trained immunity: from bench to bedside',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921440,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 27 Novel concepts in innate and trained immunity: from bench to bedside Uday Kishore  Innate immunity components as therapeutics for allergy  Jorge Dom\\xadnguez Andrs  Innate trained immunity: An evolutionary perspective  Oscar Palomares  A new paradigm for the development of trained immunity-based vaccines  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Basic and clinical immunology > Dermatology > Food allergy',\n",
       "  'session': 'SYM 28 Tissue imprinting on resident immune cells',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921441,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 28 Tissue imprinting on resident immune cells Stefanie  Eyerich  T lymphocytes in the skin  Andrew S. MacDonald  Innate cells in the lung  Thomas Eiwegger  Effector cells in the gut  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Basic and clinical immunology > Pediatrics > Food allergy',\n",
       "  'session': 'SYM 29 Manifestations of mast cell activation disease and mastocytosis',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921442,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 29 Manifestations of mast cell activation disease and mastocytosis   Mast cell activation syndrome \\x80\\x93 Does it exist?  Patrizia Bonadonna  Clinical variability of mastocytosis in adults  Melody Carter  Mastocytosis in children \\x80\\x93 Is it a different disease?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Dermatology > Environmental and occupational allergy > Basic and clinical immunology',\n",
       "  'session': 'SYM 31 Current issues in contact dermatitis and patch testing',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921448,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 31 Current issues in contact dermatitis and patch testing Thomas Rustemeyer  The clinical clues and pitfalls in contact dermatitis  Antti Ilmari Lauerma  New allergens and current trends in allergic contact dermatitis  Andrea Karolina Bauer  Trends in occupational contact dermatitis  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Dermatology > Basic and clinical immunology > Allergy and clinical immunology',\n",
       "  'session': 'SYM 32 Biologicals and biomarkers in immunophenotyping of atopic dermatitis',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921449,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 32 Biologicals and biomarkers in immunophenotyping of atopic dermatitis Martin Bachmann  Anti-Interleukin-31 Receptor A Antibody and other biologicals atopic dermatitis in humans  Umit Sahiner  Childhood\\xa0atopic dermatitis: current developments, treatment approaches, and future expectations  Angele Soria  Efficacy and side effects associated with biological treatments of atopic dermatitis  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'ENT > Basic and clinical immunology > Dermatology',\n",
       "  'session': 'SYM 33 Towards personalized medicine in atopic barrier disorders',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921450,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 33 Towards personalized medicine in atopic barrier disorders Kornel   Golebski  Targeting innate immune components in allergic rhinitis and nasal polyps  Antonella Cianferoni  Eosinophilic Esophagitis: How to stop the cross talk between innate and adaptive immune system    Atopic dermatitis: What did we learn from the use of biologicals?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Dermatology > Allergy diagnosis and systems medicine > Pediatrics',\n",
       "  'session': 'SYM 34  Latest insights into chronic urticaria in adults and children',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921451,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 34  Latest insights into chronic urticaria in adults and children Tabi Leslie  Advances in chronic spontaneous urticaria in adults and children   Torsten Zuberbier  New insights and approaches to inducible urticaria   Michael  Rudenko  The role of infection in chronic spontaneous urticaria   ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Drug allergy > Basic and clinical immunology > Dermatology',\n",
       "  'session': 'SYM 35  Severe cutaneous adverse drug reactions',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921456,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 35  Severe cutaneous adverse drug reactions Vincent Descamps  Role Viral reactivations  Knut Brockow  Clinical manifestations of severe cutaneous adverse drug reaction  Asli Gelincik  Treatment of severe cutaneous adverse drug reaction  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'ENT > Asthma > Basic and clinical immunology',\n",
       "  'session': 'SYM 36  Novel mechanisms in united severe united airway disease?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921459,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 36  Novel mechanisms in united severe united airway disease? Nan Zhang  Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis    Increased thrombin activatable fibrinolysis inhibitor (TAFI) in chronic rhinosinusitis with nasal polyps  Ian Sayers  Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'ENT > Allergy diagnosis and systems medicine > Allergy and clinical immunology',\n",
       "  'session': 'SYM 37  The eye as a sentinel for allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921460,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 37  The eye as a sentinel for allergy Jean-Luc Fauquert  What makes the eye a sentinel for allergy?  Andrea Leonardi  Pathophysiology and diagnostic innovation in ocular allergy  Vibha Sharma  Modern treatment options for ocular allergies  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Environmental and occupational allergy > Dermatology > Food allergy',\n",
       "  'session': 'SYM 38  New developments in occupational allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921462,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 38  New developments in occupational allergy Mohamed Fareed Jeebhay  Occupational respiratory allergy in food processing industries  Paul Cullinan  Airborne enzymes \\x80\\x93 New and re-emerging occupational hazards  Hille Suojalehto  Contact urticaria and protein contact dermatitis connecting skin and airways  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Environmental and occupational allergy > Allergy and clinical immunology > Asthma',\n",
       "  'session': 'SYM 39  Allergy in urban environment',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921463,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 39  Allergy in urban environment Frank James Kelly  Efforts to control traffic pollution: How is London doing?  Lorenzo Cecchi  Chemical air pollutants and the effect on allergies  Michel Thibaudon  Urban green spaces - The exposure and allergenicity index  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Pediatrics > Allied health and primary care   > Allergy and clinical immunology',\n",
       "  'session': 'SYM 40 Delivering an effective adolescent and young adult allergy service',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921465,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 40 Delivering an effective adolescent and young adult allergy service Audrey DunnGalvin  What\\x80\\x99s different about the adolescent brain?  Charlotte G. Mortz  Effective interventions and recommendations for transition to adult care  Elizabeth Ann Angier  Developing an adolescent and young adult allergy service  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Pediatrics > Asthma > Allergy diagnosis and systems medicine',\n",
       "  'session': 'SYM 41  Pre-school wheeze: past, present and future',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921466,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 41  Pre-school wheeze: past, present and future Gary W.K Wong  What is the basis of preschool wheeze?  Susanne Gabriele Lau  Managing preschool wheeze  Sejal Saglani  Preschool wheeze: Can we see into the future?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Food allergy > Pediatrics > Allied health and primary care  ',\n",
       "  'session': 'SYM 42 Preventing food allergy: what\\x80\\x99s new?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921470,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 42 Preventing food allergy: what\\x80\\x99s new? Susanne Halken  How can we successfully implement new food allergy prevention guidelines?  Brian Vickery  Novel approaches of oral immunotherapy to induce tolerance  Mary Jane Marchisotto  Patient focused outcomes for immunotherapy. What do patients really want?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Pediatrics',\n",
       "  'session': 'SYM 43 Epigenetic and omic approaches in asthma and immunological diseases',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921471,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 43 Epigenetic and omic approaches in asthma and immunological diseases Paul Lavender  Epigenetic approaches to identifying asthma phenotype    Recent progress in the analysis of T cell and B cell receptor repertoires  Rocio Martinez-Nunez  Small RNA Species and microRNA Profiles in Severe Asthma  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#3399FF',\n",
       "  'type': 'Symposia',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Allied health and primary care  ',\n",
       "  'session': 'SYM 44 National allergy society forum',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921472,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Symposia' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#3399FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Symposia</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'SYM 44 National allergy society forum Dominique Sabouraud  Gaps in the management of food-induced anaphylaxis reactions at school  Luciana Kase Tanno  New perspectives for anaphylaxis    One voice for anaphylaxis management and prevention  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#33CCFF',\n",
       "  'type': 'Interactive Symposium',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'ISYM 01 Feeding the immune system',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921406,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Symposium' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#33CCFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Symposium</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'ISYM 01 Feeding the immune system Eva Untersmayr  What is the link between nutrition and a healthy immune system?  Meghan Azad  Impact of early nutrition  Rosan Meyer  Practical recommendations and current guidelines  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#33CCFF',\n",
       "  'type': 'Interactive Symposium',\n",
       "  'category': 'Allergen immunotherapy      > Pediatrics > Basic and clinical immunology',\n",
       "  'session': 'ISYM 02 Outcome measures during allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921415,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Symposium' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#33CCFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Symposium</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'ISYM 02 Outcome measures during allergen immunotherapy Peter Socrates Creticos  Introductory lecture: Immunotherapy: how important is evidence-based clinical efficacy and safety?  Oliver Pfaar  Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#33CCFF',\n",
       "  'type': 'Interactive Symposium',\n",
       "  'category': 'Dermatology > Allergy diagnosis and systems medicine > Basic and clinical immunology',\n",
       "  'session': 'ISYM 03 Urticaria in clinical practice',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921452,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Symposium' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#33CCFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Symposium</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'ISYM 03 Urticaria in clinical practice Riccardo Asero  Potential biomarkers for diagnosis and treatment for CSU  Ana M Gimnez-Arnau  Treatment of CSU when omalizumab fails  Clive Grattan  Other diseases presenting with urticarial lesions  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Food allergy > Pediatrics > Allied health and primary care  ',\n",
       "  'session': 'IWS 01 Adrenaline auto-injectors: fit for purpose?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921407,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 01 Adrenaline auto-injectors: fit for purpose? Matthew Greenhawt  Do adrenaline auto-injectors save lives?  Paul J Turner  Does size matter?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Allied health and primary care  ',\n",
       "  'session': 'IWS 02 Complex nutritional topics in adult food hypersensitivity',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921408,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 02 Complex nutritional topics in adult food hypersensitivity Imke Reese  When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance  Isabel Janet Skypala  The ABC of pollen food syndrome (PFS) & Lipid transfer protein (LTP): nutritional issues of fruit and vegetable allergy  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Allergen immunotherapy      > Basic and clinical immunology > Allergy and clinical immunology',\n",
       "  'session': 'IWS 03 Peptide immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921416,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 03 Peptide immunotherapy Anne K Elis  T cell peptides for allergen immunotherapy: lesson learned from clinical studies  Jasper Kappen  The need to target B cell responses during peptide immunotherapy: revisiting the concept of tolerance  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Allied health and primary care   > Allergy diagnosis and systems medicine > Allergy and clinical immunology',\n",
       "  'session': 'IWS 04 How to use social media to enhance your clinical practice',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921425,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 04 How to use social media to enhance your clinical practice Florin Dan Popescu  Social media and Allergies: how can we support our patients?  Alberto Alvarez-Perea  How to use social media in your professional practice: the clinician perspective  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Allergy and clinical immunology > Allergy diagnosis and systems medicine > Asthma',\n",
       "  'session': 'IWS 05 The coming era of digital allergology and asthma care',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921436,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 05 The coming era of digital allergology and asthma care Paolo  Matricardi  Clinical decision support systems for allergic diseases  Dar\\xado Antol\\xadn-Amrigo  Digital solutions for asthma research and care  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Allergy and clinical immunology > Asthma > Dermatology',\n",
       "  'session': 'IWS 06  Allergy, asthma and sports',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921437,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 06  Allergy, asthma and sports Helena Pite  Exercise: induced asthma and rhinitis  Stefano R Del Giacco  Exercise-induced urticaria and anaphylaxis  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Allergy and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'IWS 07 Insect hypersensitivities: new invasive insects: new challenges for the clinician',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921438,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 07 Insect hypersensitivities: new invasive insects: new challenges for the clinician Isabella Pali-Schll  Comparing insect hypersensitivities in humans and animals  Carmen Vidal  New wasp (Vespa velutina) hypersensitivity: a challenge to diagnose and treat  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Drug allergy > Allergy diagnosis and systems medicine > Dermatology',\n",
       "  'session': 'IWS 08 Diagnostic workup for drug hypersensitivity',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921457,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 08 Diagnostic workup for drug hypersensitivity Didier G. Ebo  Is skin testing required in uncomplicated maculopapular exanteme?  Natasha Gunawardana  Are drug provocation tests required before decision to desensitize?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#6666FF',\n",
       "  'type': 'Interactive Workshops',\n",
       "  'category': 'Drug allergy > Basic and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'IWS 09 NSAIDs-Exacerbated respiratory disease (N-ERD) in clinical practice',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921458,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Workshops' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#6666FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Workshops</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IWS 09 NSAIDs-Exacerbated respiratory disease (N-ERD) in clinical practice Joshua A. Boyce  Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)  Ludger Klimek  Management of NSAIDs-Exacerbated respiratory disease (N-ERD)  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#99FF00',\n",
       "  'type': 'Pro & Con Sessions',\n",
       "  'category': 'Environmental and occupational allergy > Asthma > Basic and clinical immunology',\n",
       "  'session': 'P & C 5 COVID-19 and Air pollution',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921474,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Pro & Con Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Pro & Con Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'P & C 5 COVID-19 and Air pollution Isabella Annesi-Maesano  Pro  Francesco Forastiere  Con  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#99FF00',\n",
       "  'type': 'Pro & Con Sessions',\n",
       "  'category': 'Food allergy > Pediatrics > Allergy diagnosis and systems medicine',\n",
       "  'session': 'P&C 01 Proton pump inhibitor responsive esophageal eosinophilia is this EoE or not EoE: this is the dilemma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921409,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Pro & Con Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Pro & Con Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'P&C 01 Proton pump inhibitor responsive esophageal eosinophilia is this EoE or not EoE: this is the dilemma Alex Straumann  Pro  Jonathan M. Spergel  Con   ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#99FF00',\n",
       "  'type': 'Pro & Con Sessions',\n",
       "  'category': 'Food allergy > Pediatrics > Allergy diagnosis and systems medicine',\n",
       "  'session': \"P&C 02 Cow's milk allergy guidelines promote over-diagnosis of cow's milk allergy\",\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921410,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Pro & Con Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Pro & Con Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"P&C 02 Cow's milk allergy guidelines promote over-diagnosis of cow's milk allergy Robert Boyle  Pro  Sibylle Koletzko  Con   \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#99FF00',\n",
       "  'type': 'Pro & Con Sessions',\n",
       "  'category': 'Allergen immunotherapy      > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'P&C 03 Placebo effect is an integrated part of the treatment benefits of AIT',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921417,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Pro & Con Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Pro & Con Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'P&C 03 Placebo effect is an integrated part of the treatment benefits of AIT Roy Gerth van Wijk  Pro  Vera Mahler  Con   ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#99FF00',\n",
       "  'type': 'Pro & Con Sessions',\n",
       "  'category': 'Allergy diagnosis and systems medicine > Dermatology > Pediatrics',\n",
       "  'session': 'P&C 04 Should we do patch testing in children with eczema?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921422,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Pro & Con Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Pro & Con Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'P&C 04 Should we do patch testing in children with eczema? Flora B. de Waard-van der Spek  Pro    Con  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#99FF00',\n",
       "  'type': 'Pro & Con Sessions',\n",
       "  'category': 'Basic and clinical immunology > Food allergy > Pediatrics',\n",
       "  'session': 'P&C 06 Foecal transplantation: safe and efficient treatment option for gut dysbiosis?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921444,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Pro & Con Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#99FF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Pro & Con Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'P&C 06 Foecal transplantation: safe and efficient treatment option for gut dysbiosis?   Pro   Jens Walter  Con  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC0000',\n",
       "  'type': 'Hot Topic Sessions',\n",
       "  'category': 'Food allergy > Allergen immunotherapy      > Allergy and clinical immunology',\n",
       "  'session': 'HT 01 Food allergic reactions',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921411,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Hot Topic Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC0000;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Hot Topic Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'HT 01 Food allergic reactions Nandinee Patel  Unintended allergic reactions during food immunotherapy  Rodrigo Jimnez-Saiz  Route of exposure determines the immune response to food allergens  Esther  Florsheim  Immunological basis of food aversion  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC0000',\n",
       "  'type': 'Hot Topic Sessions',\n",
       "  'category': 'Basic and clinical immunology > Asthma > Allergy and clinical immunology',\n",
       "  'session': 'HT 02 Emerging threats to the immune system in 2020',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921445,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Hot Topic Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC0000;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Hot Topic Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"HT 02 Emerging threats to the immune system in 2020 Cezmi Akdis  Immune response to Corona virus infection  Liam O'Mahony  Hologenome and obesity  Andrea Matucci  Hypereosinophilic syndromes and autoimmunity  \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC0000',\n",
       "  'type': 'Hot Topic Sessions',\n",
       "  'category': 'Basic and clinical immunology > Food allergy > Pediatrics',\n",
       "  'session': 'HT 03 Infectious challenges for the immune system',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921446,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Hot Topic Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC0000;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Hot Topic Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'HT 03 Infectious challenges for the immune system Giovanni Rossi  Viral strategies predisposing to respiratory bacterial superinfections  Rik de Swart  Measles infection causes immune amnesia  Paolo  Matricardi  The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC0000',\n",
       "  'type': 'Hot Topic Sessions',\n",
       "  'category': 'Dermatology > Food allergy > Pediatrics',\n",
       "  'session': 'HT 04 Skin care interventions for preventing food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921453,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Hot Topic Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC0000;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Hot Topic Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'HT 04 Skin care interventions for preventing food allergy   PreventADALL study  Robert Boyle  Moisturisers for the primary prevention of food allergy  Yukihiro Ohya  Anti-inflammatory treatment for the prevention of food allergy  Maeve M. Kelleher  Using individual patient data meta-analysis in food allergy prevention studies  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC0000',\n",
       "  'type': 'Hot Topic Sessions',\n",
       "  'category': 'Environmental and occupational allergy > Asthma > Basic and clinical immunology',\n",
       "  'session': 'HT 05  Climate change and pollution',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921464,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Hot Topic Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC0000;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Hot Topic Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"HT 05  Climate change and pollution Gennaro D'Amato  Covid 19 and air pollution: is there a relationship?    Wildfires, heatwaves and pollution-effects on health  Farrah Kheradmand  E-cigarettes: mechanistic link to lung injury  \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF99FF',\n",
       "  'type': 'Year in Review Sessions',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'YIR 01 Asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921432,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Year in Review Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Year in Review Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'YIR 01 Asthma Toms Chivato  Lung function testing  Jrgen Schwarze  Viral infection and asthma  Ibon Eguiluz-Gracia  Novel pharamacological targets  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF99FF',\n",
       "  'type': 'Year in Review Sessions',\n",
       "  'category': 'Basic and clinical immunology > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'YIR 02 Basic and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921447,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Year in Review Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Year in Review Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'YIR 02 Basic and clinical immunology Armin Braun  Neuroimmunology and allergy  Inge   Kortekaas Krohn  Autoimmunity in atopic diseases  Gale Roberts  Precision medicine in immunodeficiency  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF99FF',\n",
       "  'type': 'Year in Review Sessions',\n",
       "  'category': 'Dermatology > Drug allergy > Basic and clinical immunology',\n",
       "  'session': 'YIR 03 Dermatology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921454,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Year in Review Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Year in Review Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'YIR 03 Dermatology Thomas Werfel  Atopic dermatitis - new treatments  Kathrin Scherer Hofmeier  Drug reactions of the skin or Novel mechanisms of drug reactions   Ana M Gimnez-Arnau  Chronic urticaria: Novel targeted treatments  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF99FF',\n",
       "  'type': 'Year in Review Sessions',\n",
       "  'category': 'ENT > Basic and clinical immunology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'YIR 04 ENT',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921461,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Year in Review Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Year in Review Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'YIR 04 ENT Bruce Tan  Impaired olfaction: diagnostics and its role in diseases  Wytske Fokkens  Management of CRS: Highlights of EPOS 2020  Banu Bozkurt  Ocular allergy   ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF99FF',\n",
       "  'type': 'Year in Review Sessions',\n",
       "  'category': 'Pediatrics > Food allergy > Allergen immunotherapy     ',\n",
       "  'session': 'YIR 05 Pediatrics',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921467,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Year in Review Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Year in Review Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'YIR 05 Pediatrics Nikolaos Papadopoulos  PEARL  Montserrat Alvaro Lozano  Allergen immunotherapy for food allergy  James E Gern  Prevention: lessons from birth cohorts  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCFF',\n",
       "  'type': 'Junior Members Assembly',\n",
       "  'category': 'Basic and clinical immunology > Allergy and clinical immunology',\n",
       "  'session': 'JMA Edu Useful tips when applying for a research grant',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921469,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Junior Members Assembly' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Junior Members Assembly</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"JMA Edu Useful tips when applying for a research grant Aurelie Najm  Setting up a multidisciplinary team: increasing the value of your ideas  Adam Byrne  Seeking European and international funding  Henry McSorley  Preparing a grant: Dos and Don'ts  \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCFF',\n",
       "  'type': 'Junior Members Assembly',\n",
       "  'category': 'Allergen immunotherapy      > Food allergy > Dermatology',\n",
       "  'session': 'JMA Sci Multidisciplinary approach and unmet needs in allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921468,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Junior Members Assembly' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCFF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Junior Members Assembly</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'JMA Sci Multidisciplinary approach and unmet needs in allergen immunotherapy Lennart Conemans  Immunotherapy for the treatment of allergic asthma: a new step in the GINA Guidelines  Pasquale Comberiati  Allergen immunotherapy for rhinitis phenotypes other than allergic rhinitis: mixed rhinitis and local allergic rhinitis  Deepti Deshpande  Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?  Mattia Giovannini  Is there room for immunotherapy for the treatment of atopic dermatitis?  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Food allergy > Allergy diagnosis and systems medicine > Pediatrics',\n",
       "  'session': 'IPGC 01 Non-IgE mediated food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921400,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 01 Non-IgE mediated food allergy Michael Ardern-Jones  Non-IgE mediated food allergies, epidemiology and clinical presentation  Mirna Chehade  Diagnostic approach to patients with gastrointestinal eosinophilic disorders  Antonella Cianferoni  Food elimination diet in eosinophilic esophagitis and other eosinophilic gastrointestinal disorders (Clinical cases)  Rosan Meyer  Management: multiple vs. single FPIES  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Food allergy > Allergy diagnosis and systems medicine > Pediatrics',\n",
       "  'session': 'IPGC 02 Practical management of IgE-mediated food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921401,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 02 Practical management of IgE-mediated food allergy Maeve M. Kelleher  Risk assessment and active management of food allergy  Nicolette Wilma de Jong  Allergen avoidance and precautionary allergen labelling  Carina Venter  Alternative free-from foods to reach a balanced diet  Simona Barni  Current and novel therapeutically approaches for food allergy  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Allergen immunotherapy      > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'IPGC 03 Allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921412,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 03 Allergen immunotherapy Stephen  Till  Allergen Immunotherapy: state of the art Update (clinical)  Lars Jacobsen  Evidence of immunotherapy on allergy prevention?  Adam M Chaker  Adherence: A challenge for Immunotherapy  Thomas Kndig  Novel approaches of allergen immunotherapy  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Allergy diagnosis and systems medicine > Drug allergy > Dermatology',\n",
       "  'session': 'IPGC 04 How to evaluate cutaneous manifestations of drug hypersensitivity',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921418,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 04 How to evaluate cutaneous manifestations of drug hypersensitivity Charlotte G. Mortz  Clinical manifestations  Maja Mockenhaupt  Danger signs    Differential diagnosis  Guy Scadding  Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Allergy diagnosis and systems medicine > Allergy and clinical immunology > Food allergy',\n",
       "  'session': 'IPGC 05 Implementing molecular allergology and cellular testing in allergy diagnostics 2020',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921419,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 05 Implementing molecular allergology and cellular testing in allergy diagnostics 2020 Jrg Kleine-Tebbe  Implementing component research diagnostics in allergy diagnosis  Paolo  Matricardi  Molecular profiling of allergic patients by multiplex testing  Edward Frank Knol  Cellular tests for the diagnosing and monitoring of allergy  Olga Luengo  Practical guide to using allergen micro array  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Pediatrics',\n",
       "  'session': 'IPGC 06 Asthma management: state of the art 2020',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921426,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 06 Asthma management: state of the art 2020 Christopher John Corrigan  Asthma: phenotypes to endotypes  Jasper Kappen  Targeted approaches for asthma  Matteo Bonini  Safety of   in asthma  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Basic and clinical immunology > Pediatrics > Allergen immunotherapy     ',\n",
       "  'session': 'IPGC 07 Understanding immunological pathways of the new biological therapies',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921439,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 07 Understanding immunological pathways of the new biological therapies Oscar Palomares   Biologicals: state of the art  Onur Boyman  What happens if you block IL-4/IL-13?  Thomas Eiwegger  Pregnancy and  : to stop or not to stop    Special considerations for the usage of   in childhood  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33CC',\n",
       "  'type': 'Interactive Postgraduate Courses',\n",
       "  'category': 'Drug allergy > Dermatology > Allergy diagnosis and systems medicine',\n",
       "  'session': 'IPGC 08 Management of drug hypersensitivity',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921455,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Interactive Postgraduate Courses' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33CC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Interactive Postgraduate Courses</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'IPGC 08 Management of drug hypersensitivity Maria J Torres  Skin test, drug provocation and laboratory tests: which ones and when?  Josefina Maria Rodrigues Cernadas  General principles of drug desensitization  Knut Brockow  A patient with an acute reaction: recognize, document and treat  ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Asthma > Basic and clinical immunology > Allergy and clinical immunology',\n",
       "  'session': 'OAS 01 Asthma mechanisms',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921244,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 01 Asthma mechanisms Stanislawa Bazan-Socha Bogdan Jakiela The &alpha;<sub>2</sub>&beta;<sub>1</sub> integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma 569 Stanislawa Bazan-Socha Jacek Zarychta The &alpha;<sub>2</sub>&beta;<sub>1</sub> integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma 569 Stanislawa Bazan-Socha Jerzy Soja The &alpha;<sub>2</sub>&beta;<sub>1</sub> integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma 569 Stanislawa Bazan-Socha Joanna Zuk The &alpha;<sub>2</sub>&beta;<sub>1</sub> integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma 569 Stanislawa Bazan-Socha Krzysztof Okon The &alpha;<sub>2</sub>&beta;<sub>1</sub> integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma 569 Stanislawa Bazan-Socha Lech Zareba The &alpha;<sub>2</sub>&beta;<sub>1</sub> integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma 569 Jos Manuel Rodrigo-Muoz Beatriz Sastre Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction 224 Jos Manuel Rodrigo-Muoz Joaqu\\xadn Sastre Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction 224 Jos Manuel Rodrigo-Muoz Jos Antonio Caas Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction 224 Jos Manuel Rodrigo-Muoz Manuel Jorge Rial Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction 224 Jos Manuel Rodrigo-Muoz Natalia Redondo Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction 224 Jos Manuel Rodrigo-Muoz Raquel Garc\\xada-Latorre Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction 224 Jos Manuel Rodrigo-Muoz Santiago Quirce Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction 224 Yong Chul Lee Hae Jin Park NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma 180 Yong Chul Lee Jae Seok Jeong NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma 180 Yong Chul Lee Kyeong Hwa Park NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma 180 Yong Chul Lee So Ri Kim NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma 180 Urszula Radzikowska Andrzej Eljaszewicz Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Anita Dreher Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Cezmi A Akdis Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska David J Jackson Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Ge Tan Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Juan Rodriguez-Coira Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Liam O` Mahoney Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Marcin Moniuszko Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Marek Jutel Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Mei Ding Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Michael R Edwards Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Michal Pirozynski Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Milena Sokolowska Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Paulina Wawrzyniak Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Pawel Gajdanowicz Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Richard A Williamson Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Sebastian L Johnston Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Sylwia Smolinska Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Urszula Radzikowska Tatiana Kebadze Combined rhinovirus and house-dust mite exposure induce activation of RIG-I inflammasome and metabolic reprogramming of bronchial epithelial cells in asthma 1048 Geertje Maria de Boer Esmee K Van Der Ploeg Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma 1059 Geertje Maria de Boer Gerdien Tramper Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma 1059 Geertje Maria de Boer Gert-Jan Braunstahl Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma 1059 Geertje Maria de Boer Marjolein De Bruijn Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma 1059 Geertje Maria de Boer Mees Dorleijn Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma 1059 Geertje Maria de Boer Menno Van Nimwegen Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma 1059 Geertje Maria de Boer Rudi W. Hendriks Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma 1059 Aleksandra Wardzynska Joanna Jamroz-Brzeska Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients 933 Aleksandra Wardzynska Joanna Rywaniak Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients 933 Aleksandra Wardzynska Joanna Samanta Makowska Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients 933 Aleksandra Wardzynska Malgorzata Pawelczyk Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients 933 Aleksandra Wardzynska Marek Leszek Kowalski Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients 933 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allergy and clinical immunology > ENT > Basic and clinical immunology',\n",
       "  'session': 'OAS 02 Biomarkers and drugs of allergic rhinitis',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921245,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 02 Biomarkers and drugs of allergic rhinitis Qing-Ling Fu Hongyu Zhang Plasma extracellular vesicles promote the development of type 2 T helper cells via transferring of mirnas in patients with allergic rhinitis 121 Qing-Ling Fu Shubin Fang Plasma extracellular vesicles promote the development of type 2 T helper cells via transferring of mirnas in patients with allergic rhinitis 121 Min-Gyu Kang Dong-Hyun Kim Probiotic NVP-1703 alleviates perennial allergic rhinitis by inducing IL-10 expression: A four-weeks, multi-center, double-blind, randomized, placebo-controlled clinical trial 583 Min-Gyu Kang Jeong-Hee Choi Probiotic NVP-1703 alleviates perennial allergic rhinitis by inducing IL-10 expression: A four-weeks, multi-center, double-blind, randomized, placebo-controlled clinical trial 583 Min-Gyu Kang Seung-Won Han Probiotic NVP-1703 alleviates perennial allergic rhinitis by inducing IL-10 expression: A four-weeks, multi-center, double-blind, randomized, placebo-controlled clinical trial 583 Petra U Zieglmayer Andreas Goessl Reformulating budesonide nasal spray (budesolv 10) multiplies clinical potency in grass pollen allergic patients 299 Petra U Zieglmayer Markus Savli Reformulating budesonide nasal spray (budesolv 10) multiplies clinical potency in grass pollen allergic patients 299 Petra U Zieglmayer Nicole Unger- Manhart Reformulating budesonide nasal spray (budesolv 10) multiplies clinical potency in grass pollen allergic patients 299 Petra U Zieglmayer Patrick Lemell Reformulating budesonide nasal spray (budesolv 10) multiplies clinical potency in grass pollen allergic patients 299 Petra U Zieglmayer Ren Schmutz Reformulating budesonide nasal spray (budesolv 10) multiplies clinical potency in grass pollen allergic patients 299 Petra U Zieglmayer Ren Zieglmayer Reformulating budesonide nasal spray (budesolv 10) multiplies clinical potency in grass pollen allergic patients 299 Petra U Zieglmayer Sabine Nakowitsch Reformulating budesonide nasal spray (budesolv 10) multiplies clinical potency in grass pollen allergic patients 299 Ranny Van Weissenbruch Arkady Koltun MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch David Price MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Duc Tung Nguyen MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Ferdinand Kopietz MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Gabriella Glffy MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Glenis Scadding MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Hans Christian Kuhl MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Joaquim Mullol MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Ludger Klimek MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Melanie Emmeluth MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Ranny Van Weissenbruch Wolfgang Pohl MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study 249 Hilda De Jong Claus Bachert Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong David Price Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Dermot Ryan Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Glenis Scadding Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Jose Antonio Castillo Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Pete Smith Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Ruth Murray Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Ulrich Wahn Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Victoria Carter Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Hilda De Jong Walter Canonica Evaluating the real-life effect of MP-AzeFlu on asthma control in patients with allergic rhinitis and asthma in UK primary care<br /> 689 Ludger Klimek Arkady Koltun MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek David Price MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Duc Tung Nguyen MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Ferdinand Kopietz MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Gabriella Galffy MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Glenis Scadding MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Hans Christian Kuhl MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Joaquim Mullol MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Melanie Emmeluth MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Ranny Van Weissenbruch MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 Ludger Klimek Wolfgang Pohl MP-AzeFlu improves allergic rhinitis severity regardless of disease phenotype &ndash; a real-life study 458 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'OAS 03 Mechanisms of gastrointestinal food allergy and its management',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921246,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 03 Mechanisms of gastrointestinal food allergy and its management Mirelle T. A. Kleuskens Albert J. Bredenoord Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment 303 Mirelle T. A. Kleuskens Bart Herpers Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment 303 Mirelle T. A. Kleuskens Betty C. A. M. Van Esch Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment 303 Mirelle T. A. Kleuskens Frank A. Redegeld Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment 303 Mirelle T. A. Kleuskens Johan Garssen Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment 303 Mirelle T. A. Kleuskens Mara A. P. Diks Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment 303 Mirelle T. A. Kleuskens Maria Louise Haasnoot Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment 303 Catherine Sonaly Ferreira Martins Ariana Campos Yang Is IgA a piece of the EoE puzzle? 1544 Catherine Sonaly Ferreira Martins Fabio Fernandes Morato Castro Is IgA a piece of the EoE puzzle? 1544 Catherine Sonaly Ferreira Martins Galina Grishina Is IgA a piece of the EoE puzzle? 1544 Catherine Sonaly Ferreira Martins Hugh A Sampson Is IgA a piece of the EoE puzzle? 1544 Catherine Sonaly Ferreira Martins Juliana Mendona Guimares Is IgA a piece of the EoE puzzle? 1544 Catherine Sonaly Ferreira Martins Keity Souza Santos Is IgA a piece of the EoE puzzle? 1544 Catherine Sonaly Ferreira Martins Maria Suprun Is IgA a piece of the EoE puzzle? 1544 Catherine Sonaly Ferreira Martins Patricia Salles Cunha Is IgA a piece of the EoE puzzle? 1544 Naoya Arakawa Hirokazu Arakawa Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 Naoya Arakawa Hisako Yagi Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 Naoya Arakawa Koichiro Sato Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 Naoya Arakawa Maiko Tatsuki Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 Naoya Arakawa Satoshi Yamada Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 Naoya Arakawa Takashi Ishige Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 Naoya Arakawa Takumi Takizawa Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 Naoya Arakawa Yutaka Nishida Serum levels of soluble interleukin-2 receptor and thymus and activation-regulated chemokine in non-IgE-mediated gastrointestinal food allergies 959 R. Sharon Chinthrajah Kari Nadeau Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Monali Manohar Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Natasha Purington Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Neeraja Kambham Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Nielsen Fernandez-Becker Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Scott Boyd Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Shu Cao Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Stephen Galli Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 R. Sharon Chinthrajah Wenming Zhang Eosinophilic gastrointestinal responses during peanut oral immunotherapy in a randomized controlled trial 1154 Jennifer D. Hamilton Allen Radin Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Evan S. Dellon Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Ikuo Hirano Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Leda P. Mannent Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Marc E. Rothenberg Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Marcella Ruddy Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Margaret H. Collins Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Matthew F. Wipperman Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Mirna Chehade Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Naimish Patel Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Neil M. H. Graham Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Sara Hamon Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Sivan Harel Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton Wei Keat Lim Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Jennifer D. Hamilton William Brian Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis 430 Mengshan Liu Atanaska Kostadinova Oral tolerance induction for cow&rsquo;s milk allergy prevention using polymeric nanoparticles loaded with beta-lactoglobulin derived peptides  334 Mengshan Liu Cornelus F. Van Nostrum Oral tolerance induction for cow&rsquo;s milk allergy prevention using polymeric nanoparticles loaded with beta-lactoglobulin derived peptides  334 Mengshan Liu Johan Garssen Oral tolerance induction for cow&rsquo;s milk allergy prevention using polymeric nanoparticles loaded with beta-lactoglobulin derived peptides  334 Mengshan Liu Linette E. Willemsen Oral tolerance induction for cow&rsquo;s milk allergy prevention using polymeric nanoparticles loaded with beta-lactoglobulin derived peptides  334 Mengshan Liu Suzan Thijssen Oral tolerance induction for cow&rsquo;s milk allergy prevention using polymeric nanoparticles loaded with beta-lactoglobulin derived peptides  334 Mengshan Liu Wim E. Hennink Oral tolerance induction for cow&rsquo;s milk allergy prevention using polymeric nanoparticles loaded with beta-lactoglobulin derived peptides  334 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Basic and clinical immunology > Allergy and clinical immunology > Food allergy',\n",
       "  'session': 'OAS 04 Microbiota as a regulator of immune responses',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921247,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 04 Microbiota as a regulator of immune responses Carole Brosseau Amandine Selle Modulation of the immune system in feto-maternal tissues by prebiotics supplementation during pregnancy: A future strategy for allergy prevention 170 Carole Brosseau Angeline Duval Modulation of the immune system in feto-maternal tissues by prebiotics supplementation during pregnancy: A future strategy for allergy prevention 170 Carole Brosseau Marie Bodinier Modulation of the immune system in feto-maternal tissues by prebiotics supplementation during pregnancy: A future strategy for allergy prevention 170 Riccardo Castagnoli Ai Ing Lim Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Anna Villa Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Cristina Corsino Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Danielle Fink Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Douglas B. Kuhns Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Elena Fontana Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Emilia L Falcone Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Francesca Pala Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Gian Luigi Marseglia Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Julie Segre Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Lisa M Ott De Bruin Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Luigi D Notarangelo Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Mariam Quinones Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Marita Bosticardo Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Michail Lionakis Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Ottavia Maria Delmonte Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Poorani Subramanian Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Rosita Rigoni Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Sean P. Conlan Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Vasileios Oikonomou Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Yasmine Belkaid Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Riccardo Castagnoli Yu Han Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 474 Marina  Prez Gord Carles Ubeda Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Domingo Barber Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Elisa Zubeldia-Varela Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Evangelina Lopez De Maturana Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Isabel Adoracin Martin-Antoniano Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Leticia Mera-Berriatua Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Mar\\xada Dolores Ibez Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Mar\\xada Pilar Francino Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Paula Cabrera-Freitag Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Marina  Prez Gord Raphalle Bazire Gut microbiota at the onset of food allergic milk-mediated reactions does not differentiate between allergic infants and non allergic controls 1072 Bettina Schmid Anke Fhnrich Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis 405 Bettina Schmid Axel Knstner Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis 405 Bettina Schmid Eugen Bersuch Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis 405 Bettina Schmid Hauke Busch Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis 405 Bettina Schmid Martin Glatz Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis 405 Bettina Schmid Philipp Bosshard Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis 405 Ana Lozano Dilia Mercado Modulation of T cell responses by a helminth immunomodulator from ascaris lumbricoides 1404 Ana Lozano Josefina Zakzuk Modulation of T cell responses by a helminth immunomodulator from ascaris lumbricoides 1404 Ana Lozano Luis Caraballo Modulation of T cell responses by a helminth immunomodulator from ascaris lumbricoides 1404 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Asthma > Allergy and clinical immunology > ENT',\n",
       "  'session': 'OAS 05  Targeted treatment in asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921248,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 05  Targeted treatment in asthma Claire Emson \\x85sa Hellqvist Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study 1175 Claire Emson Gene Colice Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study 1175 Claire Emson Jane R Parnes Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study 1175 Claire Emson Jonathan Corren Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study 1175 Claire Emson Kinga Salapa Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study 1175 Jonathan Corren Asa Hellqvist Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study 879 Jonathan Corren Jane R Parnes Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study 879 Jonathan Corren Martin Karpefors Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study 879 Ian Pavord Andrew Menzies-Gow Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study 1103 Ian Pavord Esther Garcia Gil Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study 1103 Ian Pavord Malin Fageras Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study 1103 Ian Pavord Stefan Peterson Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study 1103 Ian Pavord Thomas Bengtsson Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study 1103 Jorge F. Maspero Antonio Valero Santiago A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Asif H. Khan A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Benjamin Ortiz A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Linda B. Ford A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Nadia Daizadeh A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Nami Pandit-Abid A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Paul Rowe A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Piotr Kuna A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Siddhesh Kamat A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Jorge F. Maspero Yamo Deniz A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study 818 Bob Geng Benjamin Ortiz Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study 875 Bob Geng Paul Rowe Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study 875 Bob Geng William W. Busse Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study 875 Bob Geng Yamo Deniz Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study 875 Bob Geng Zhen Chen Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study 875 Jonathan Corren Gene Colice The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study 1105 Jonathan Corren Jean-Pierre Llanos-Ackert The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study 1105 Jonathan Corren Karen Bowen The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study 1105 Jonathan Corren Kinga Salapa The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study 1105 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allergy diagnosis and systems medicine > Food allergy > Allergy and clinical immunology',\n",
       "  'session': 'OAS 06  Component resolved diagnosis: new insights',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921249,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"OAS 06  Component resolved diagnosis: new insights Stephanie Dramburg Alessandro Travaglini Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Alfred Priftanji Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Ana M Pereira Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Andrea Barbalace Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Andrea Di Rienzo Businco Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Angel Mazon Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Anne Bourgoin Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Antonio Nieto Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Aydan Acar Sahin Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Aykut Gvensen Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Ayse \\x96ztrk Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Blerina Bregu Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Blerta Lame Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Cansin Sackensen Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Claire Dimier Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Dah Tay Jang Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Denis Charpin Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Dolores Hernandez Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Duygu Yazici Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Ekaterina Potapova Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Elisabetta Pellegrini Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Elsa Caeiro Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Eris Mesonjesi Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Fotis Psarros Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Fsun Kalpaklioglu Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Giovanni Pajno Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Ifigenia Sfika Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Ilenia Panasiti Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Joao A Fonseca Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Laurie Pahus Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Lucia Caminiti Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Luis Delgado Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Maria Antonia Brighetti Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Maria V Dimou Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Mariana Couto Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Mariana Pereira Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Michael Makris Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Michel Thibaudon Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Nikiolaos G Papadopoulos Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Nur Mnevver Pinar Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg \\x96zlem Gksel Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Paolo Maria Matricardi Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Paraskevi Xepapadaki Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Ruth Llusar Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Salvatore Tripodi Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Simone Pelosi Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Stefania Arasi Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Suarez Javier Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Sule Caglayan Sozmen Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Tara Maria Hoffmann Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Theresa Lipp Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Valentine Verdier Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Stephanie Dramburg Valeria Villella Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study 877 Laura  Vias Jenny Verdetoso Der p 23 sensitization and impact on immunotherapy choice 450 Laura  Vias Maite Sanz Der p 23 sensitization and impact on immunotherapy choice 450 Laura  Vias Maria Irene Gallego Der p 23 sensitization and impact on immunotherapy choice 450 Laura  Vias Moises Labrador Der p 23 sensitization and impact on immunotherapy choice 450 Laura  Vias Olga Luengo Der p 23 sensitization and impact on immunotherapy choice 450 Laura  Vias Victoria Cardona Der p 23 sensitization and impact on immunotherapy choice 450 Gabriele Gadermaier Angelika Hrschlger Expect the unexpected: Allergic reactions to horse chestnut are triggered by sensitization to Art v 1 from mugwort pollen 897 Gabriele Gadermaier Christine Kapfhammer Expect the unexpected: Allergic reactions to horse chestnut are triggered by sensitization to Art v 1 from mugwort pollen 897 Gabriele Gadermaier Eva Vejvar Expect the unexpected: Allergic reactions to horse chestnut are triggered by sensitization to Art v 1 from mugwort pollen 897 Gabriele Gadermaier Peter Briza Expect the unexpected: Allergic reactions to horse chestnut are triggered by sensitization to Art v 1 from mugwort pollen 897 Gabriele Gadermaier Stephanie Eichhorn Expect the unexpected: Allergic reactions to horse chestnut are triggered by sensitization to Art v 1 from mugwort pollen 897 Gabriele Gadermaier Wolfgang Hemmer Expect the unexpected: Allergic reactions to horse chestnut are triggered by sensitization to Art v 1 from mugwort pollen 897 Geoffrey Mueller Alexander Foo New allergens derived from Ara h 1 and Jug r 2: molecular characterization of the cross-reactivity between the N-terminal leader sequences 1075 Geoffrey Mueller Barry Hurlburt New allergens derived from Ara h 1 and Jug r 2: molecular characterization of the cross-reactivity between the N-terminal leader sequences 1075 Geoffrey Mueller Eugene Derose New allergens derived from Ara h 1 and Jug r 2: molecular characterization of the cross-reactivity between the N-terminal leader sequences 1075 Geoffrey Mueller Hsiaopo Cheng New allergens derived from Ara h 1 and Jug r 2: molecular characterization of the cross-reactivity between the N-terminal leader sequences 1075 Geoffrey Mueller Jacqueline Nesbit New allergens derived from Ara h 1 and Jug r 2: molecular characterization of the cross-reactivity between the N-terminal leader sequences 1075 Geoffrey Mueller Soheila Maleki New allergens derived from Ara h 1 and Jug r 2: molecular characterization of the cross-reactivity between the N-terminal leader sequences 1075 Andreas Ludwig Lopata Aya C Taki Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Dianne Campbell Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Elecia Johnston Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Heimo Breiteneder Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Jennifer Rolland Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Robyn O'Hehir Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Roni Nugraha Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Sandip D Kamath Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Shaymaviswanathan Karnaneedi Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Tanja Kalic Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Thimo Ruethers Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 Andreas Ludwig Lopata Thu T. K Le Seafood allergy in the Asia-Pacific &ndash; current advances in diagnosis and management 1280 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Asthma > Environmental and occupational allergy > Allergy diagnosis and systems medicine',\n",
       "  'session': 'OAS 07  Functional genomics in respiratory diseases: allergy and beyond',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921250,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 07  Functional genomics in respiratory diseases: allergy and beyond Pawel Kozlik Andzelika Siwiec Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis 1537 Pawel Kozlik Joanna Zuk Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis 1537 Pawel Kozlik Stanislawa Bazan-Socha Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis 1537 Pawel Kozlik Sylwia Czuma Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis 1537 Anand Kumar Andiappan Bernett Lee FCER1A promoter variants confers susceptibility to allergic asthma by modulating immune subsets classical monocytes and pDC 901 Anand Kumar Andiappan De Yun Wang FCER1A promoter variants confers susceptibility to allergic asthma by modulating immune subsets classical monocytes and pDC 901 Anand Kumar Andiappan Erik Meln FCER1A promoter variants confers susceptibility to allergic asthma by modulating immune subsets classical monocytes and pDC 901 Anand Kumar Andiappan Josephine Lum FCER1A promoter variants confers susceptibility to allergic asthma by modulating immune subsets classical monocytes and pDC 901 Anand Kumar Andiappan Kia Joo Puan FCER1A promoter variants confers susceptibility to allergic asthma by modulating immune subsets classical monocytes and pDC 901 Anand Kumar Andiappan Olaf Rotzschke FCER1A promoter variants confers susceptibility to allergic asthma by modulating immune subsets classical monocytes and pDC 901 Anand Kumar Andiappan Simon Kebede Merid FCER1A promoter variants confers susceptibility to allergic asthma by modulating immune subsets classical monocytes and pDC 901 Kavita Reginald Fook Tim Chew Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis 108 Kavita Reginald Keng Foo Teh Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis 108 Kavita Reginald Sri Anusha Matta Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis 108 Kavita Reginald Sze Lei Pang Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis 108 Kavita Reginald Yang Yie Sio Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis 108 Kavita Reginald Yi Ying Lim Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis 108 Kavita Reginald Yu Ting Ng Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis 108 JI WON LEE Claus Bachert Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Ha Kyeong Won Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Hee Bom Moon Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Hyouk Soo Kwon Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Ji Hyang Lee Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Jun Pyo Choi Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Kyung Gon Kim Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Tae Bum Kim Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE Woo Jung Song Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 JI WON LEE You Sook Cho Effects of cigarette smoke extract exposure on the secretion of pro-allergic proteins from&nbsp;Staphylococcus aureus 1201 Jolanda Van Bilsen Anne Staudt Kvistgaard Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Geert Houben Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Jossie Garthoff Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Karen Knipping Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Lars Verschuren Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Lon Knippels Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Lotte Neergaard Jacobsen Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Marie Meima Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Maril Van Stee Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Marjolein Meijerink Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Remon Dulos Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Shaji Krishnan Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Jolanda Van Bilsen Tanja Rouhani Rankouhi Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life 301 Anya C Jones Anthony Bosco Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Barbara J Holt Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Deborah H Strickland Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Denise Anderson Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Diana Gutierrez Cardenas Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Emmanuelle Fantino Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones James F Read Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Michael Serralha Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Patrick G Holt Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Peter D Sly Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 Anya C Jones Sally Galbraith Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis. 1122 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Dermatology > Pediatrics > Allergy and clinical immunology',\n",
       "  'session': 'OAS 08  Atopic dermatitis: new insights',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921251,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 08  Atopic dermatitis: new insights Stephan Weidinger Ana B Rossi Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Eric L Simpson Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Grece Saba Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Isabelle Guillemin Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Jonathan I Silverberg Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Laurent Eckert Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Lysel Brignoli Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Miriam C Fenton Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Paola Mina-Osorio Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Sebastien Auziere Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Sebastien Barbarot Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Stephan Weidinger Susan H Boklage Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents 1115 Emine Gulsah Torun Aysegul Ertugrul Sleep patterns and development of children with atopic dermatitis 277 Emine Gulsah Torun Doga Ceren Tekguc Sleep patterns and development of children with atopic dermatitis 277 Emine Gulsah Torun Ilknur Bostanci Sleep patterns and development of children with atopic dermatitis 277 Su Chen Dan Jones Maternal serum lipids at birth are associated with eczema at age 1, 4, 10 and 18 years in offsprings 1477 Su Chen Hasan Arshad Maternal serum lipids at birth are associated with eczema at age 1, 4, 10 and 18 years in offsprings 1477 Su Chen Thilina Anthony Maternal serum lipids at birth are associated with eczema at age 1, 4, 10 and 18 years in offsprings 1477 Su Chen Wilfried Joachim Jurgen Karmaus (karmaus1) Maternal serum lipids at birth are associated with eczema at age 1, 4, 10 and 18 years in offsprings 1477 Yuriy Bisyuk L M Dubuske Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis 1127 Yuriy Bisyuk N Derkach Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis 1127 Yuriy Bisyuk O Litus Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis 1127 Yuriy Bisyuk V Litus Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis 1127 Chun Kwok Wong Kam Lun Hon Anti-inflammatory activities of IL-37b on atopic dermatitis via regulating AMPK-mTOR and intestinal metabolites-dependent autophagy 379 Chun Kwok Wong Miranda Sin Man Tsang Anti-inflammatory activities of IL-37b on atopic dermatitis via regulating AMPK-mTOR and intestinal metabolites-dependent autophagy 379 Chun Kwok Wong Peiyong Jiang Anti-inflammatory activities of IL-37b on atopic dermatitis via regulating AMPK-mTOR and intestinal metabolites-dependent autophagy 379 Chun Kwok Wong Tiangheng Hou Anti-inflammatory activities of IL-37b on atopic dermatitis via regulating AMPK-mTOR and intestinal metabolites-dependent autophagy 379 Lisa A. Beck Ana B. Rossi Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis 429 Lisa A. Beck Brad Shumel Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis 429 Lisa A. Beck Diamant Thai Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis 429 Lisa A. Beck Mette Deleuran Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis 429 Lisa A. Beck Robert Bissonnette Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis 429 Lisa A. Beck Sivan Harel Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis 429 Lisa A. Beck Zhen Chen Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis 429 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Asthma > Allergy and clinical immunology > Food allergy',\n",
       "  'session': 'OAS 09 Asthma biomarkers',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921252,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 09 Asthma biomarkers David Obeso Alma Villaseor Metabolic biomarkers from a severe food-pollen allergy model classify uncontrolled asthmatic patients 428 David Obeso Coral Barbas Metabolic biomarkers from a severe food-pollen allergy model classify uncontrolled asthmatic patients 428 David Obeso Domingo Barber Metabolic biomarkers from a severe food-pollen allergy model classify uncontrolled asthmatic patients 428 David Obeso Maria Escribese Metabolic biomarkers from a severe food-pollen allergy model classify uncontrolled asthmatic patients 428 Han-Kyul Kim Bermseok Oh A phenome-wide association study of asthma genetic variants identified shared genetic risk in respiratory diseases 783 Han-Kyul Kim Hae Un Jung A phenome-wide association study of asthma genetic variants identified shared genetic risk in respiratory diseases 783 Han-Kyul Kim Ji Eun Lim A phenome-wide association study of asthma genetic variants identified shared genetic risk in respiratory diseases 783 Han-Kyul Kim Ji-One Kang A phenome-wide association study of asthma genetic variants identified shared genetic risk in respiratory diseases 783 Han-Kyul Kim Tae-Woong Ha A phenome-wide association study of asthma genetic variants identified shared genetic risk in respiratory diseases 783 Han-Kyul Kim Won Jun Lee A phenome-wide association study of asthma genetic variants identified shared genetic risk in respiratory diseases 783 Takeshi Nabe Kazuyuki Kitatani Involvement of IL-5/eosinophils in acquisition of steroid resistance in a severe asthma model 83 Takeshi Nabe Masaya Matsuda Involvement of IL-5/eosinophils in acquisition of steroid resistance in a severe asthma model 83 Takeshi Nabe Miku Nomura Involvement of IL-5/eosinophils in acquisition of steroid resistance in a severe asthma model 83 Takeshi Nabe Naoki Takemoto Involvement of IL-5/eosinophils in acquisition of steroid resistance in a severe asthma model 83 Takeshi Nabe Ryogo Terakawa Involvement of IL-5/eosinophils in acquisition of steroid resistance in a severe asthma model 83 Linda S. Mansfield Alexander D. Ethridge Does shifting from a risk to a protective gut microbiome provide protection against allergic airway disease after house dust mite (HDM) challenge? 672 Linda S. Mansfield Hinako Terauchi Does shifting from a risk to a protective gut microbiome provide protection against allergic airway disease after house dust mite (HDM) challenge? 672 Linda S. Mansfield Ivon Moya Uribe Does shifting from a risk to a protective gut microbiome provide protection against allergic airway disease after house dust mite (HDM) challenge? 672 Linda S. Mansfield Julia A. Bell Does shifting from a risk to a protective gut microbiome provide protection against allergic airway disease after house dust mite (HDM) challenge? 672 Linda S. Mansfield S. Hasan Arshad Does shifting from a risk to a protective gut microbiome provide protection against allergic airway disease after house dust mite (HDM) challenge? 672 Linda S. Mansfield Susan L. Ewart Does shifting from a risk to a protective gut microbiome provide protection against allergic airway disease after house dust mite (HDM) challenge? 672 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Drug allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'OAS 10 Clinical aspects and mechanisms of drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921253,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 10 Clinical aspects and mechanisms of drug allergy Raymond Mak Chelsea Elwood Proactive penicillin de-labeling in pregnant patients: Safety and outcomes 1349 Raymond Mak Elisabeth Mcclymont Proactive penicillin de-labeling in pregnant patients: Safety and outcomes 1349 Raymond Mak Ethan Zhang Proactive penicillin de-labeling in pregnant patients: Safety and outcomes 1349 Raymond Mak Melissa Watt Proactive penicillin de-labeling in pregnant patients: Safety and outcomes 1349 Raymond Mak Vanessa Paquette Proactive penicillin de-labeling in pregnant patients: Safety and outcomes 1349 Amene Tesfaye Ayane Alba Rodriguez-Nogales Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy 1526 Amene Tesfaye Ayane Mar\\xada I Montaez Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy 1526 Amene Tesfaye Ayane Mar\\xada J Torres Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy 1526 Amene Tesfaye Ayane Mar\\xada J. Rodr\\xadguez Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy 1526 Amene Tesfaye Ayane Patricia Malagn Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy 1526 Amene Tesfaye Ayane Sara Bened Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy 1526 Amene Tesfaye Ayane Tah\\xada D. Fernndez Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy 1526 Young Il Koh Da Woon Sim Higher occurrence of multiple drug allergy syndrome to first-line anti-tuberculosis drugs 53 Young Il Koh Hye Su You Higher occurrence of multiple drug allergy syndrome to first-line anti-tuberculosis drugs 53 Young Il Koh Ji Eun Yu Higher occurrence of multiple drug allergy syndrome to first-line anti-tuberculosis drugs 53 Lourdes Elizabeth Palomino Beln De La Hoz Profile of a case series of patients with adverse reactions to iron at a tertiary hospital in Madrid, Spain 620 Lourdes Elizabeth Palomino Dar\\xado Antol\\xadn Profile of a case series of patients with adverse reactions to iron at a tertiary hospital in Madrid, Spain 620 Lourdes Elizabeth Palomino Emilio Solano Profile of a case series of patients with adverse reactions to iron at a tertiary hospital in Madrid, Spain 620 Lourdes Elizabeth Palomino Pilar Berges Profile of a case series of patients with adverse reactions to iron at a tertiary hospital in Madrid, Spain 620 Lourdes Elizabeth Palomino Raquel Cabrera Profile of a case series of patients with adverse reactions to iron at a tertiary hospital in Madrid, Spain 620 Lourdes Elizabeth Palomino Vanessa Chica Profile of a case series of patients with adverse reactions to iron at a tertiary hospital in Madrid, Spain 620 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allergy and clinical immunology > Basic and clinical immunology > Allergen immunotherapy     ',\n",
       "  'session': 'OAS 11 Trends in insect venom hypersensitivity',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921254,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 11 Trends in insect venom hypersensitivity Wojciech Francuzik . Nora Network Members Venom-induced anaphylaxis&nbsp;&ndash; phenotype and risk factors &ndash; data from the European Anaphylaxis Registry 1304 Wojciech Francuzik Margitta Worm Venom-induced anaphylaxis&nbsp;&ndash; phenotype and risk factors &ndash; data from the European Anaphylaxis Registry 1304 Wojciech Francuzik Roberta Scarpone Venom-induced anaphylaxis&nbsp;&ndash; phenotype and risk factors &ndash; data from the European Anaphylaxis Registry 1304 Wojciech Francuzik Sabine Dlle-Bierke Venom-induced anaphylaxis&nbsp;&ndash; phenotype and risk factors &ndash; data from the European Anaphylaxis Registry 1304 Asta Makaraviciute \\x85sa Marknell Dewitt Development of a specific IgE immunoassay for Asian hornet venom (Vespa velutina) 1136 Asta Makaraviciute Celina Marklund Development of a specific IgE immunoassay for Asian hornet venom (Vespa velutina) 1136 Asta Makaraviciute Luis Arenas Development of a specific IgE immunoassay for Asian hornet venom (Vespa velutina) 1136 Asta Makaraviciute Svante Bohman Development of a specific IgE immunoassay for Asian hornet venom (Vespa velutina) 1136 Lukasz Szymanski Aleksander Zakrzewski The effect of specific Hymenoptera venom immunotherapy using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes and serum cytokine concentration. 939 Lukasz Szymanski Andrzej Chcialowski The effect of specific Hymenoptera venom immunotherapy using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes and serum cytokine concentration. 939 Lukasz Szymanski Ciepielak Martyna The effect of specific Hymenoptera venom immunotherapy using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes and serum cytokine concentration. 939 Lukasz Szymanski Jerzy Kruszewski The effect of specific Hymenoptera venom immunotherapy using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes and serum cytokine concentration. 939 Lukasz Szymanski Wanda Stankiewicz The effect of specific Hymenoptera venom immunotherapy using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes and serum cytokine concentration. 939 Lukasz Szymanski Weronika Urbanska The effect of specific Hymenoptera venom immunotherapy using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes and serum cytokine concentration. 939 Nina Frelih Tea Mocnik Systemic reactions to honey-bee stings in beekeepers receiving venom immunotherapy (VIT) and quality of life of beekeepers on VIT 1288 Manuela Fragner Christine Hafner Adherence to hymenoptera venom immunotherapy: Real-life data from Austria 601 Manuela Fragner Franz Trautinger Adherence to hymenoptera venom immunotherapy: Real-life data from Austria 601 Manuela Fragner Julia Moser Adherence to hymenoptera venom immunotherapy: Real-life data from Austria 601 Arantza Vega Castro David Rodr\\xadguez Gil Venom immunotherapy in predominant Api m 10 sensitization: Does it work? 647 Arantza Vega Castro Juan Maria Beitia Venom immunotherapy in predominant Api m 10 sensitization: Does it work? 647 Arantza Vega Castro M Beln Mateo Borrega Venom immunotherapy in predominant Api m 10 sensitization: Does it work? 647 Arantza Vega Castro Maria Isabel Pea Venom immunotherapy in predominant Api m 10 sensitization: Does it work? 647 Arantza Vega Castro Montserrat Mart\\xadnez Venom immunotherapy in predominant Api m 10 sensitization: Does it work? 647 Arantza Vega Castro Remedios Crdenas Venom immunotherapy in predominant Api m 10 sensitization: Does it work? 647 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Pediatrics > Food allergy > Allergen immunotherapy     ',\n",
       "  'session': 'OAS 12 Food allergy: recent research from birth to adolescence',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921255,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"OAS 12 Food allergy: recent research from birth to adolescence Ekaterina Khaleva Alessandro Fiocchi Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Aline B Sprikkelman Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Ana Fiandor Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Ana A Schoemaker Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Andreas Reich Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Clare E.n Mills Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Graham Roberts Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Indra Butiene Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Jose Ignacio Larco Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Kate E.c. Grimshaw Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Kirsten Beyer Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Leonard Rosenfeld Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Linus B Grabenhenrich Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Marek L. Kowalski Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Michael Clausen Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Nikolaos G. Papadopoulos Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Odilija Rudzeviciene Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Paraskevi Xepapadaki Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Ruta Dubakiene Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Sigurveig Th Sigurdardottir Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Ekaterina Khaleva Thomas Keil Risk factors for cow&rsquo;s milk allergy in Europe: EuroPrevall birth cohort 148 Aysylu Gamirova Anna Berbenyuk Food proteins in human milk and likelihood of allergic reactions in children: A systematic review 1296 Aysylu Gamirova Daniel Munblit Food proteins in human milk and likelihood of allergic reactions in children: A systematic review 1296 Aysylu Gamirova Daria Levina Food proteins in human milk and likelihood of allergic reactions in children: A systematic review 1296 Aysylu Gamirova Dmitrii Peshko Food proteins in human milk and likelihood of allergic reactions in children: A systematic review 1296 Aysylu Gamirova Robert J Boyle Food proteins in human milk and likelihood of allergic reactions in children: A systematic review 1296 Anna Berbenyuk Aysylu Gamirova Maternal diet during lactation and allergy in infants and children: Pilot data from the systematic review and meta-analysis 1427 Anna Berbenyuk Daniel Munblit Maternal diet during lactation and allergy in infants and children: Pilot data from the systematic review and meta-analysis 1427 Anna Berbenyuk Daria Levina Maternal diet during lactation and allergy in infants and children: Pilot data from the systematic review and meta-analysis 1427 Anna Berbenyuk Dmitrii Peshko Maternal diet during lactation and allergy in infants and children: Pilot data from the systematic review and meta-analysis 1427 Vibha Sharma Aideen Byrne Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Antoine Deschildre Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Antonella Muraro Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Caroline Nilsson Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Christine Delebarre Sauvage Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Daniel C Adelman Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma David Norval Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Franck Boralevi Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Frederic De Blay Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma George Du Toit Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma John Chapman Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Jonathan O'B Hourihane Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Jos Manuel Zubeldia Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Katharina Blumchen Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Kirsten Beyer Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma M. Dolores Ibez Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Michel Erlewyn-Lajeunesse Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Montserrat Fernndez-Rivas Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Vibha Sharma Paul J Turner Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population 1230 Maria Giovanna Puoti Antony Aston Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Edward Peter Gaynor Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Jenny Epstein Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Joseph Machta Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Leanne Goh Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Lucy Jackman Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Marco Gasparetto Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Mark Furman Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Nandinee Patel Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Osvaldo Borrelli Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Paul Turner Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Sharon Hall Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Suzanne Dowling Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Maria Giovanna Puoti Tom Marrs Current practice in the diagnosis and management of paediatric eosinophilic oesophagitis in a multi-centre cohort in London 1467 Negisa Seyed Toutounchi Aletta D Kraneveld Exposure to the mycotoxin deoxynivalenol during pregnancy and lactation enhances the ovalbumin-specific allergic response in the offspring 790 Negisa Seyed Toutounchi Astrid Hogenkamp Exposure to the mycotoxin deoxynivalenol during pregnancy and lactation enhances the ovalbumin-specific allergic response in the offspring 790 Negisa Seyed Toutounchi Belinda Van\\x80\\x98t Land Exposure to the mycotoxin deoxynivalenol during pregnancy and lactation enhances the ovalbumin-specific allergic response in the offspring 790 Negisa Seyed Toutounchi Gert Folkerts Exposure to the mycotoxin deoxynivalenol during pregnancy and lactation enhances the ovalbumin-specific allergic response in the offspring 790 Negisa Seyed Toutounchi Johan Garssen Exposure to the mycotoxin deoxynivalenol during pregnancy and lactation enhances the ovalbumin-specific allergic response in the offspring 790 Negisa Seyed Toutounchi Saskia Braber Exposure to the mycotoxin deoxynivalenol during pregnancy and lactation enhances the ovalbumin-specific allergic response in the offspring 790 Negisa Seyed Toutounchi Suzan Thijssen Exposure to the mycotoxin deoxynivalenol during pregnancy and lactation enhances the ovalbumin-specific allergic response in the offspring 790 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Asthma > Environmental and occupational allergy > Pediatrics',\n",
       "  'session': 'OAS 13 Epidemiology: clinical trials - real life',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921256,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"OAS 13 Epidemiology: clinical trials - real life Matea Deliu Adnan Custovic Patterns of wheeze severity from early childhood to late adolescence: Longitudinal transition analysis in a birth cohort study 1250 Matea Deliu Sara Fontanella Patterns of wheeze severity from early childhood to late adolescence: Longitudinal transition analysis in a birth cohort study 1250 Francis Thien Alan Young Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance 719 Francis Thien Naomi Sarah Cohen Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance 719 Francis Thien Sonali Rochelle Bridget Fernando Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance 719 Jonathan Corren Benjamin Ortiz Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 Jonathan Corren David J. Jackson Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 Jonathan Corren Michel Djandji Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 Jonathan Corren Nadia Daizadeh Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 Jonathan Corren Paul Rowe Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 Jonathan Corren Thomas O'Riordan Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 Jonathan Corren Thomas B. Casale Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 Jonathan Corren Yamo Deniz Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST 444 David J Jackson Hassan Burhan Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab 698 David J Jackson Paul Pfeffer Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab 698 David J Jackson Sabada Dube Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab 698 David J Jackson Tamsin Morris Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab 698 Marko Simunovic Bircan Erbas Spatiotemporal characteristics of asthma emergency department presentations in diverse biogeographical and climatic regions 348 Marko Simunovic Janet Davies Spatiotemporal characteristics of asthma emergency department presentations in diverse biogeographical and climatic regions 348 Marko Simunovic Justin Boyle Spatiotemporal characteristics of asthma emergency department presentations in diverse biogeographical and climatic regions 348 Marko Simunovic Philip Baker Spatiotemporal characteristics of asthma emergency department presentations in diverse biogeographical and climatic regions 348 Diego Bagnasco Giovanni Passalacqua Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 1036 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Basic and clinical immunology > Allergy and clinical immunology > Dermatology',\n",
       "  'session': 'OAS 14 Novel mechanisms of inflammation',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921257,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 14 Novel mechanisms of inflammation Gesa J Albers Adam J Byrne IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Gesa J Albers Clare M Lloyd IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Gesa J Albers Irina A Udalova IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Gesa J Albers Jua Iwasaki IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Gesa J Albers Patricia P Ogger IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Gesa J Albers Peter Mcerlean IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Gesa J Albers Poonam Ghai IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Gesa J Albers Tariq E Khoyratty IRF5 regulates airway macrophage metabolic responses to viral challenge 1130 Naruhito Iwasaki Fuminori Tokunaga Macrophages produce histamine through the interaction with antigen-specific Th2 cells  46 Naruhito Iwasaki Hirokazu Sakamoto Macrophages produce histamine through the interaction with antigen-specific Th2 cells  46 Naruhito Iwasaki Kishiko Sunami Macrophages produce histamine through the interaction with antigen-specific Th2 cells  46 Naruhito Iwasaki Seigo Terawaki Macrophages produce histamine through the interaction with antigen-specific Th2 cells  46 Hanna Siiskonen Irene Castellano Pellicena Human skin mast cells express photoreceptors, and blue light inhibits their degranulation 1277 Hanna Siiskonen Jie Shen Fok Human skin mast cells express photoreceptors, and blue light inhibits their degranulation 1277 Hanna Siiskonen Jrg Scheffel Human skin mast cells express photoreceptors, and blue light inhibits their degranulation 1277 Hanna Siiskonen Marcus Maurer Human skin mast cells express photoreceptors, and blue light inhibits their degranulation 1277 Hanna Siiskonen Natallia Uzunbajakava Human skin mast cells express photoreceptors, and blue light inhibits their degranulation 1277 Hanna Siiskonen Natasha Botchkareva Human skin mast cells express photoreceptors, and blue light inhibits their degranulation 1277 Hanna Siiskonen Serena Buscone Human skin mast cells express photoreceptors, and blue light inhibits their degranulation 1277 Dmitry Borisovich Chudakov Daria Sergeevna Tsaregorotseva Low antigen doses trigger B-cell igE class switching in tissue associated lymphoid structures but not in regional lymph nodes 70 Dmitry Borisovich Chudakov Elena Victorovna Svirshchevskaya Low antigen doses trigger B-cell igE class switching in tissue associated lymphoid structures but not in regional lymph nodes 70 Dmitry Borisovich Chudakov Gulnar Vaisovna Fattakhova Low antigen doses trigger B-cell igE class switching in tissue associated lymphoid structures but not in regional lymph nodes 70 Javier Sanchez Solares Carmela Pablo-Torres Celiac disease causes epithelial disruption of the oral mucosa 521 Javier Sanchez Solares Celso Diaz-Fernandez Celiac disease causes epithelial disruption of the oral mucosa 521 Javier Sanchez Solares Cristina Gomez-Casado Celiac disease causes epithelial disruption of the oral mucosa 521 Javier Sanchez Solares Domingo Barber Celiac disease causes epithelial disruption of the oral mucosa 521 Javier Sanchez Solares Gustavo Perez-Alvarez Celiac disease causes epithelial disruption of the oral mucosa 521 Javier Sanchez Solares Leire Parapar Celiac disease causes epithelial disruption of the oral mucosa 521 Javier Sanchez Solares Luis Sanchez Celiac disease causes epithelial disruption of the oral mucosa 521 Javier Sanchez Solares Poul Srensen Celiac disease causes epithelial disruption of the oral mucosa 521 Guanjun Dong Chuanping Si Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus 509 Guanjun Dong Huabao Xiong Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus 509 Guanjun Dong Hui Zhang Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus 509 Guanjun Dong Xuehui Li Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus 509 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allergen immunotherapy      > Allergy and clinical immunology > Food allergy',\n",
       "  'session': 'OAS 15 Cutting edge insights into allergen immunotherapy mechanisms',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921258,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 15 Cutting edge insights into allergen immunotherapy mechanisms Janice Anastasia Layhadi Anke H Maitland-Van Der Zee Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Chung Yan Rachael Li Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Cornelis M Van Drunen Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Esther H Steveling-Klein Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Gemma Vil\\xa0-Nadal Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Hergen Spits Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Korneliusz Golebski Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Madison M Lenormand Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Mohamed H Shamji Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Mongkol Lao-Araya Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Oleksandra Fedina Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Stephen R Durham Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Susanne J Vijverberg Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Suzanne M Bal Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Umit Sahiner Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Janice Anastasia Layhadi Wytske J Fokkens Grass pollen sublingual immunotherapy drives the generation of functional IL-10-producing innate lymphoid cells that are associated with clinical benefit: An RDBPC study 1206 Verena Katarina Khler Christina L Pranger Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Erika Jensen-Jarolim Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Gabriel Osborn Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Gerhard Hofer Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Heather J Bax Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Judit F Singer Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Judith Wortmann Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Mano Nakamura Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Silvia Crescioli Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Sophia N Karagiannis Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Verena Katarina Khler Walter Keller Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays 438 Xuxin Lai Deyu Zhao Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Xuxin Lai Guodong Hao Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Xuxin Lai Haifeng Zhong Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Xuxin Lai Jinling Liu Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Xuxin Lai Siu Fu Hui Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Xuxin Lai Suqing Zhang Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Xuxin Lai Yong He Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Xuxin Lai Yuemei Sun Dermatophagoides pteronyssinus subcutaneous immunotherapy induced allergen specific IgG4 can be detected in saliva and strongly correlated with serological IgG4 743 Hanisah Sharif David Fear IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Gemma Vila Nadal IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Guy Scadding IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Jing Zhang IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Mohamed H Shamji IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Oleksandra Fedina IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Rebecca Parkin IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Stephen R Durham IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Wannada Laisuan IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Hanisah Sharif Yi Yi IL-10+ T follicular helper cells (CXCR5+PD-1+CD4+ TFH10) promote immune tolerance and regulate b cell function following allergen immunotherapy: A proof-of-concept cross-sectional study 1330 Cristina Benito Villalvilla Jos Luis Subiza Allergoids conjugated to mannan drive monocyte differentiation into tolerogenic dendritic cells by promoting metabolic reprogramming 371 Cristina Benito Villalvilla Mario Prez-Diego Allergoids conjugated to mannan drive monocyte differentiation into tolerogenic dendritic cells by promoting metabolic reprogramming 371 Cristina Benito Villalvilla Oscar Palomares Allergoids conjugated to mannan drive monocyte differentiation into tolerogenic dendritic cells by promoting metabolic reprogramming 371 Leticia Mera-Berriatua Alma Villaseor Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Carlos Blanco Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Coral Barbas Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua David Obeso Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Domingo Barber Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Mar\\xada Marta Escribese Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Montserrat Fernndez-Rivas Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Pilar Rico Nieto Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Raphalle Bazire Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 Leticia Mera-Berriatua Toms Clive Barker-Tejeda Grass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes over time 806 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Pediatrics > Dermatology > Environmental and occupational allergy',\n",
       "  'session': 'OAS 16 Atopic dermatitis: pathogeneseis and treatment',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921259,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 16 Atopic dermatitis: pathogeneseis and treatment Tom Marrs Gideon Lack Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg 1545 Tom Marrs Joanne Craven Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg 1545 Tom Marrs Kirsty Logan Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg 1545 Tom Marrs Michael Perkin Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg 1545 Tom Marrs Suzanne Radulovic Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg 1545 Olga Semernik Alexander Lebedenko The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children 501 Ting Fan Leung Agnes Sze Yin Leung Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Amy Mei Kam Chang Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Apple Chung Man Yeung Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Cecily Woon Wa Leung Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Jennifer Wing Ki Yau Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Kate Ching Ching Chan Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Nam Sze Cheng Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Paul Kay Sheung Chan Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Shuk Man Li Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Wing Hung Tam Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Ting Fan Leung Ye Hao Chen Evolution of skin microbiota and its relationship to eczema development in Chinese infants 84 Kun Baek Song Eun Sang Rhee The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study 511 Kun Baek Song Jinho Yu The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study 511 Kun Baek Song Min Ju Kim The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study 511 Kun Baek Song Minji Park The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study 511 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Food allergy > Pediatrics > Allergen immunotherapy     ',\n",
       "  'session': 'OAS 17 Novel perspectives on diagnosis and management of food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921260,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 17 Novel perspectives on diagnosis and management of food allergy Angelika Miriam Gabler Bernadette Eberlein Characterization of individual sensitization profiles in patients with WDEIA using the BAT with different&nbsp;gliadins, glutenin subunits and hydrolyzed wheat proteins 793 Angelika Miriam Gabler Julia Winkler Characterization of individual sensitization profiles in patients with WDEIA using the BAT with different&nbsp;gliadins, glutenin subunits and hydrolyzed wheat proteins 793 Angelika Miriam Gabler Katharina Anne Scherf Characterization of individual sensitization profiles in patients with WDEIA using the BAT with different&nbsp;gliadins, glutenin subunits and hydrolyzed wheat proteins 793 Angelika Miriam Gabler Knut Brockow Characterization of individual sensitization profiles in patients with WDEIA using the BAT with different&nbsp;gliadins, glutenin subunits and hydrolyzed wheat proteins 793 Angelika Miriam Gabler Tilo Biedermann Characterization of individual sensitization profiles in patients with WDEIA using the BAT with different&nbsp;gliadins, glutenin subunits and hydrolyzed wheat proteins 793 Marta Paolucci Chiara Arena Allergen-blocking antibodies: A novel concept of peanut-allergy immunotherapy 190 Marta Paolucci Dimitri Bieli Allergen-blocking antibodies: A novel concept of peanut-allergy immunotherapy 190 Marta Paolucci Natascha Wuillemin Allergen-blocking antibodies: A novel concept of peanut-allergy immunotherapy 190 Marta Paolucci Thomas M. Kndig Allergen-blocking antibodies: A novel concept of peanut-allergy immunotherapy 190 Marta Paolucci Tiziana Sonati Allergen-blocking antibodies: A novel concept of peanut-allergy immunotherapy 190 Marta Paolucci Ying Wckerle-Men Allergen-blocking antibodies: A novel concept of peanut-allergy immunotherapy 190 Philippe  Bgin David M. Fleischer Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Dianne E. Campbell Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Gordon Sussman Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Kirsten Beyer Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Lara Ford Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Robin Mukherjee Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Roxanne C. Oriel Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Todd D. Green Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Philippe  Bgin Wayne Shreffler Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies 1362 Paul J Turner Alexander Y.g. Yip Need for more than one dose of adrenaline to treat anaphylaxis: A systematic review and meta-analysis 372 Paul J Turner Despo Ierodiakonou Need for more than one dose of adrenaline to treat anaphylaxis: A systematic review and meta-analysis 372 Paul J Turner Joan Bartra Need for more than one dose of adrenaline to treat anaphylaxis: A systematic review and meta-analysis 372 Paul J Turner Kok Wee Chong Need for more than one dose of adrenaline to treat anaphylaxis: A systematic review and meta-analysis 372 Paul J Turner Nandinee Patel Need for more than one dose of adrenaline to treat anaphylaxis: A systematic review and meta-analysis 372 Paul J Turner Robert J Boyle Need for more than one dose of adrenaline to treat anaphylaxis: A systematic review and meta-analysis 372 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'ENT > Allergen immunotherapy      > Allergy and clinical immunology',\n",
       "  'session': 'OAS 18 Diagnosis and management of ocular allergy and allergic rhinitis',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921261,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 18 Diagnosis and management of ocular allergy and allergic rhinitis Xenophon Aggelides Alexis Fourlis Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Andreas Bardoutsos Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Athanasia Karanasiou Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Gregory Stainhaouer Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Ioannis Dologlou Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Konstantinos Romanidis Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Nikolaos Gavogiannakis Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Nikolaos G Papadopoulos Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Nikoletta Rovina Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Pantelis Angelidis Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Pantelis Tzamalis Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Paraskevi Xepapadaki Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Pavlos Vidalis Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Sotiria Antaranian Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Sotiris Nikoletseas Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Stylianos Bakamidis Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Xenophon Aggelides Thomas Sounapoglou Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis. Can mobile technology improve control? 1202 Sowmya Arudi Nagarajan Arka Subhra Ghosh Underdiagnosed and growing epidemic of ocular allergy (OA) - diagnostic tools and role of allergen immunotherapy in severe OA 539 Sowmya Arudi Nagarajan Rohit Shetty Underdiagnosed and growing epidemic of ocular allergy (OA) - diagnostic tools and role of allergen immunotherapy in severe OA 539 Sowmya Arudi Nagarajan Sharon D Souza Underdiagnosed and growing epidemic of ocular allergy (OA) - diagnostic tools and role of allergen immunotherapy in severe OA 539 Sowmya Arudi Nagarajan Swaminathan Sethu Underdiagnosed and growing epidemic of ocular allergy (OA) - diagnostic tools and role of allergen immunotherapy in severe OA 539 Anne Marie Salapatek Basma Ismail A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC) 522 Anne Marie Salapatek David Clark A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC) 522 Anne Marie Salapatek Ola Soliman A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC) 522 Anne Marie Salapatek Peter Couroux A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC) 522 Maria Joo Vasconcelos Ana Margarida Mesquita Efficacy of allergen immunotherapy for allergic rhinoconjunctivitis assessed by conjunctival allergen provocation&ndash; a real-life study 663 Maria Joo Vasconcelos Diana Silva Efficacy of allergen immunotherapy for allergic rhinoconjunctivitis assessed by conjunctival allergen provocation&ndash; a real-life study 663 Maria Joo Vasconcelos Joana Miranda Efficacy of allergen immunotherapy for allergic rhinoconjunctivitis assessed by conjunctival allergen provocation&ndash; a real-life study 663 Maria Joo Vasconcelos Jos Lu\\xads Plcido Efficacy of allergen immunotherapy for allergic rhinoconjunctivitis assessed by conjunctival allergen provocation&ndash; a real-life study 663 Maria Joo Vasconcelos Ricardo Moo Coutinho Efficacy of allergen immunotherapy for allergic rhinoconjunctivitis assessed by conjunctival allergen provocation&ndash; a real-life study 663 Maria Joo Vasconcelos Tiago Rama Efficacy of allergen immunotherapy for allergic rhinoconjunctivitis assessed by conjunctival allergen provocation&ndash; a real-life study 663 Andrea Leonardi Alan T. Chang Treatment of severe allergic conjunctivitis with antolimab indicated improvement of ocular signs and symptoms and reduction of severity of comorbid atopic diseases in a phase 1b open-label study 594 Andrea Leonardi Andrea K. Kantor Treatment of severe allergic conjunctivitis with antolimab indicated improvement of ocular signs and symptoms and reduction of severity of comorbid atopic diseases in a phase 1b open-label study 594 Andrea Leonardi Henrik S. Rasmussen Treatment of severe allergic conjunctivitis with antolimab indicated improvement of ocular signs and symptoms and reduction of severity of comorbid atopic diseases in a phase 1b open-label study 594 Andrea Leonardi Peter Y. Chang Treatment of severe allergic conjunctivitis with antolimab indicated improvement of ocular signs and symptoms and reduction of severity of comorbid atopic diseases in a phase 1b open-label study 594 Andrea Leonardi Stephen C. Foster Treatment of severe allergic conjunctivitis with antolimab indicated improvement of ocular signs and symptoms and reduction of severity of comorbid atopic diseases in a phase 1b open-label study 594 Andrea Leonardi Stephen D. Anesi Treatment of severe allergic conjunctivitis with antolimab indicated improvement of ocular signs and symptoms and reduction of severity of comorbid atopic diseases in a phase 1b open-label study 594 Vladyslav Tsaryk A Kurchenko Molecular sensitization predictors of allergen-specific immunotherapy efficacy in patients with perennial allergic rhinitis with sensitization to house dust mites<br />&nbsp; 900 Vladyslav Tsaryk L M Dubuske Molecular sensitization predictors of allergen-specific immunotherapy efficacy in patients with perennial allergic rhinitis with sensitization to house dust mites<br />&nbsp; 900 Vladyslav Tsaryk O Akhtemiichuk Molecular sensitization predictors of allergen-specific immunotherapy efficacy in patients with perennial allergic rhinitis with sensitization to house dust mites<br />&nbsp; 900 Vladyslav Tsaryk S Yuriev Molecular sensitization predictors of allergen-specific immunotherapy efficacy in patients with perennial allergic rhinitis with sensitization to house dust mites<br />&nbsp; 900 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Basic and clinical immunology > Asthma > ENT',\n",
       "  'session': 'OAS 19 Novel innate immune mechanisms',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921262,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 19 Novel innate immune mechanisms Somaye Sadeghi Mohammad Mehdi Naghizadeh Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard 321 Somaye Sadeghi Nariman Mosaffa Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard 321 Somaye Sadeghi Seyed Mahmoud Hashemi Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard 321 Somaye Sadeghi Tooba Ghazanfari Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard 321 Chuanping  Si Guanjun Dong Leukadherin-1-mediated activation of CD11b promotes the gathering of MDSCs and inhibits LPS-induced pro-inflammatory response 718 Chuanping  Si Huabao xiong Leukadherin-1-mediated activation of CD11b promotes the gathering of MDSCs and inhibits LPS-induced pro-inflammatory response 718 Chuanping  Si Hui Zhang Leukadherin-1-mediated activation of CD11b promotes the gathering of MDSCs and inhibits LPS-induced pro-inflammatory response 718 Chuanping  Si Xiaoying Yao Leukadherin-1-mediated activation of CD11b promotes the gathering of MDSCs and inhibits LPS-induced pro-inflammatory response 718 Mario Prez-Diego Alba Angelina Metabolic reprogramming and autophagy mediate the tolerogenic effects induced by the synthetic cannabinoid WIN55,212-2 in human dendritic cells 841 Mario Prez-Diego Beate Rckert Metabolic reprogramming and autophagy mediate the tolerogenic effects induced by the synthetic cannabinoid WIN55,212-2 in human dendritic cells 841 Mario Prez-Diego Cezmi A. Akdis Metabolic reprogramming and autophagy mediate the tolerogenic effects induced by the synthetic cannabinoid WIN55,212-2 in human dendritic cells 841 Mario Prez-Diego Jacobo Lpez-Abente Metabolic reprogramming and autophagy mediate the tolerogenic effects induced by the synthetic cannabinoid WIN55,212-2 in human dendritic cells 841 Mario Prez-Diego Mar Mart\\xadn-Fontecha Metabolic reprogramming and autophagy mediate the tolerogenic effects induced by the synthetic cannabinoid WIN55,212-2 in human dendritic cells 841 Mario Prez-Diego Mbeccel Akdis Metabolic reprogramming and autophagy mediate the tolerogenic effects induced by the synthetic cannabinoid WIN55,212-2 in human dendritic cells 841 Mario Prez-Diego \\x93scar Palomares Metabolic reprogramming and autophagy mediate the tolerogenic effects induced by the synthetic cannabinoid WIN55,212-2 in human dendritic cells 841 Milad Moloudizargari Esmaeil Mortaz Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids 258 Milad Moloudizargari Mohammad Hossein Asghari Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids 258 Khaleda Rahman Qazi Eva Sverremark-Ekstrm Extreme prematurity strongly imprints circulating Natural Killer- and &gamma;&delta; T cells, which are further influenced by sepsis 796 Khaleda Rahman Qazi Georg Bach Jensen Extreme prematurity strongly imprints circulating Natural Killer- and &gamma;&delta; T cells, which are further influenced by sepsis 796 Khaleda Rahman Qazi Giovanna Marchini Extreme prematurity strongly imprints circulating Natural Killer- and &gamma;&delta; T cells, which are further influenced by sepsis 796 Khaleda Rahman Qazi Maria C Jenmalm Extreme prematurity strongly imprints circulating Natural Killer- and &gamma;&delta; T cells, which are further influenced by sepsis 796 Khaleda Rahman Qazi Marieke Van Der Heiden Extreme prematurity strongly imprints circulating Natural Killer- and &gamma;&delta; T cells, which are further influenced by sepsis 796 Khaleda Rahman Qazi Sophia Bjrkander Extreme prematurity strongly imprints circulating Natural Killer- and &gamma;&delta; T cells, which are further influenced by sepsis 796 Khaleda Rahman Qazi Thomas Abrahamsson Extreme prematurity strongly imprints circulating Natural Killer- and &gamma;&delta; T cells, which are further influenced by sepsis 796 Esmee Kelly van der Ploeg G A Tramper CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg G J Braunstahl CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg G. De Boer CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg H Spits CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg K Golebski CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg M Van Nimwegen CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg R. Stadhouders CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg R. W. Hendriks CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 Esmee Kelly van der Ploeg S. M. Bal CD45RO marks activated corticostero&iuml;d resistant ILC2s as present in severe asthma and chronic rhinosinusitis with nasal polyps 1456 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'OAS 20 Novel allergens and mechanisms of food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921263,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 20 Novel allergens and mechanisms of food allergy Oliver Hemmings Alexandra Figueira Santos Functional differences in peanut-specific IgE can explain discrepancies between IgE titres and allergic reactions to peanut 880 Oliver Hemmings Umar Niazi Functional differences in peanut-specific IgE can explain discrepancies between IgE titres and allergic reactions to peanut 880 Stef J Koppelman Adrie Westphal Peanut 2S albumin Ara h 7: Purification from peanut, and initial biochemical and immunochemical characterization 172 Stef J Koppelman Danijela Apostolovic Peanut 2S albumin Ara h 7: Purification from peanut, and initial biochemical and immunochemical characterization 172 Stef J Koppelman Govardus De Jong Peanut 2S albumin Ara h 7: Purification from peanut, and initial biochemical and immunochemical characterization 172 Stef J Koppelman Joseph Baumert Peanut 2S albumin Ara h 7: Purification from peanut, and initial biochemical and immunochemical characterization 172 Stef J Koppelman Justin Marsh Peanut 2S albumin Ara h 7: Purification from peanut, and initial biochemical and immunochemical characterization 172 Stef J Koppelman Philip Johnson Peanut 2S albumin Ara h 7: Purification from peanut, and initial biochemical and immunochemical characterization 172 Beatriz Cabanillas Carmen Cuadrado Epitope mapping of the major allergen 2S albumin from pine nut 134 Beatriz Cabanillas Cristina Bueno Epitope mapping of the major allergen 2S albumin from pine nut 134 Beatriz Cabanillas Jesus F Crespo Epitope mapping of the major allergen 2S albumin from pine nut 134 Beatriz Cabanillas Linda Monaci Epitope mapping of the major allergen 2S albumin from pine nut 134 Beatriz Cabanillas Mayte Villalba Epitope mapping of the major allergen 2S albumin from pine nut 134 Beatriz Cabanillas Natalija Novak Epitope mapping of the major allergen 2S albumin from pine nut 134 Cristina Bueno-D\\xadaz Eva Batanero Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Cristina Bueno-D\\xadaz Johan Garssen Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Cristina Bueno-D\\xadaz Laura Mart\\xadn-Pedraza Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Cristina Bueno-D\\xadaz Linette E. M. Willemsen Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Cristina Bueno-D\\xadaz Mayte Villalba Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Cristina Bueno-D\\xadaz Sandra G. P. J Korsten Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Cristina Bueno-D\\xadaz Suzan Thijssen Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Cristina Bueno-D\\xadaz Vernica Ayechu-Muruzabal Mustard seed allergen Sin a 1 provokes epithelial inflammation and IL-33 release and may affect moDC activation 974 Diego Pazos-Castro Alma Yuste-Montalvo The skin acts as the preferential sensitizing pathway in an in vivo model of anaphylaxis 962 Diego Pazos-Castro Araceli D\\xadaz-Perales The skin acts as the preferential sensitizing pathway in an in vivo model of anaphylaxis 962 Diego Pazos-Castro Jaime Tome-Amat The skin acts as the preferential sensitizing pathway in an in vivo model of anaphylaxis 962 Diego Pazos-Castro Maria Garrido-Arandia The skin acts as the preferential sensitizing pathway in an in vivo model of anaphylaxis 962 Diego Pazos-Castro Vanesa Esteban The skin acts as the preferential sensitizing pathway in an in vivo model of anaphylaxis 962 Diego Pazos-Castro Zulema Gonzalez-Klein The skin acts as the preferential sensitizing pathway in an in vivo model of anaphylaxis 962 Pattraporn Satitsuksanoa Ge Tan B cells responses during immunotherapy in allergic children compared to natural tolerance 1217 Pattraporn Satitsuksanoa Irish Chang B cells responses during immunotherapy in allergic children compared to natural tolerance 1217 Pattraporn Satitsuksanoa Kari Nadeau B cells responses during immunotherapy in allergic children compared to natural tolerance 1217 Pattraporn Satitsuksanoa Milena Sokolowska B cells responses during immunotherapy in allergic children compared to natural tolerance 1217 Pattraporn Satitsuksanoa Mbeccel Akdis B cells responses during immunotherapy in allergic children compared to natural tolerance 1217 Pattraporn Satitsuksanoa Oliver Wirz B cells responses during immunotherapy in allergic children compared to natural tolerance 1217 Pattraporn Satitsuksanoa Willem Van De Veen B cells responses during immunotherapy in allergic children compared to natural tolerance 1217 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Dermatology > Basic and clinical immunology > Dermatology',\n",
       "  'session': 'OAS 21 Hereditary angioedema: quo vadis?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921264,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 21 Hereditary angioedema: quo vadis? Krzysztof Kuziemski Ali Dursun Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Claudia Cozma Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski David Lowe Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Donatello Crocetta Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Giorgio Giannattasio Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Koksal Ozgul Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Matt Reed Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Selen Zlbahar Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Toni M Foerster Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Krzysztof Kuziemski Volha Skrahina Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology &ndash; the international EHA study  1475 Timothy Craig Anver Reshef Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Bruce Ritchie Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Don S. Levy Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Emel Aygren-Prsn Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Henrike Feuersenger Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Ingo Pragst Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Inmaculada Martinez-Saguer Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Iris Jacobs Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Joshua S. Jacobs Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Markus Magerl Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Paul K. Keith Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig Paula Busse Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig William H. Yang Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Timothy Craig William L. Lumry Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE 1451 Marcus Maurer Aleena Banerji Lanadelumab is well-tolerated and effective across patient subgroups: Findings from the HELP open-label extension study 1287 Marcus Maurer Daniel Soteres Lanadelumab is well-tolerated and effective across patient subgroups: Findings from the HELP open-label extension study 1287 Marcus Maurer H. Henry Li Lanadelumab is well-tolerated and effective across patient subgroups: Findings from the HELP open-label extension study 1287 Marcus Maurer James Hao Lanadelumab is well-tolerated and effective across patient subgroups: Findings from the HELP open-label extension study 1287 Marcus Maurer Joshua Jacobs Lanadelumab is well-tolerated and effective across patient subgroups: Findings from the HELP open-label extension study 1287 Marcus Maurer Peng Lu Lanadelumab is well-tolerated and effective across patient subgroups: Findings from the HELP open-label extension study 1287 Marcus Maurer William R Lumry Lanadelumab is well-tolerated and effective across patient subgroups: Findings from the HELP open-label extension study 1287 Sorena Kiani-Alikhan Emel Aygren-Prsn Efficacy of lanadelumab is durable over time: Findings from the HELP Study and HELP OLE 1096 Sorena Kiani-Alikhan Hong Ren Efficacy of lanadelumab is durable over time: Findings from the HELP Study and HELP OLE 1096 Sorena Kiani-Alikhan John Anderson Efficacy of lanadelumab is durable over time: Findings from the HELP Study and HELP OLE 1096 Sorena Kiani-Alikhan Jonathan A Bernstein Efficacy of lanadelumab is durable over time: Findings from the HELP Study and HELP OLE 1096 Sorena Kiani-Alikhan Marc Riedl Efficacy of lanadelumab is durable over time: Findings from the HELP Study and HELP OLE 1096 Sorena Kiani-Alikhan Peng Lu Efficacy of lanadelumab is durable over time: Findings from the HELP Study and HELP OLE 1096 Sorena Kiani-Alikhan Raffi Tachdjian Efficacy of lanadelumab is durable over time: Findings from the HELP Study and HELP OLE 1096 Henriette Farkas Adrian Young Wu Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Avner Reshef Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Daniel Dix Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Emel Aygoren-Pursun Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Heather Iocca Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Jonathan Peter Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Marcin Stobiecki Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Marcus Maurer Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Sharon Murray Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Sorena Kiani Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Sylvia Dobo Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas Tamar Kinaciyan Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Henriette Farkas William P Sheridan Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results 484 Marcus Maurer Anete S Grumach Long-term effectiveness and safety of icatibant for the on-demand treatment&nbsp;of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey 1118 Marcus Maurer Hilary J Longhurst Long-term effectiveness and safety of icatibant for the on-demand treatment&nbsp;of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey 1118 Marcus Maurer Irmgard Andresen Long-term effectiveness and safety of icatibant for the on-demand treatment&nbsp;of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey 1118 Marcus Maurer Jaco Botha Long-term effectiveness and safety of icatibant for the on-demand treatment&nbsp;of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey 1118 Marcus Maurer Laurence Bouillet Long-term effectiveness and safety of icatibant for the on-demand treatment&nbsp;of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey 1118 Marcus Maurer Teresa Caballero Long-term effectiveness and safety of icatibant for the on-demand treatment&nbsp;of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey 1118 Marcus Maurer Werner Aberer Long-term effectiveness and safety of icatibant for the on-demand treatment&nbsp;of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey 1118 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Pediatrics > Asthma > Dermatology',\n",
       "  'session': 'OAS 22 Prediction, development and natural course of allergic diseases',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921265,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 22 Prediction, development and natural course of allergic diseases Alyssa Ylescupidez George Du Toit Longitudinal trajectories of eczema severity, duration, and affected body-region predict risk of food allergy in combination with filaggrin gene mutations 1412 Alyssa Ylescupidez Gideon Lack Longitudinal trajectories of eczema severity, duration, and affected body-region predict risk of food allergy in combination with filaggrin gene mutations 1412 Alyssa Ylescupidez Helen Brough Longitudinal trajectories of eczema severity, duration, and affected body-region predict risk of food allergy in combination with filaggrin gene mutations 1412 Alyssa Ylescupidez Henry T Bahnson Longitudinal trajectories of eczema severity, duration, and affected body-region predict risk of food allergy in combination with filaggrin gene mutations 1412 Alyssa Ylescupidez Katerina Salavoura Longitudinal trajectories of eczema severity, duration, and affected body-region predict risk of food allergy in combination with filaggrin gene mutations 1412 Alyssa Ylescupidez Suzana Radulovic Longitudinal trajectories of eczema severity, duration, and affected body-region predict risk of food allergy in combination with filaggrin gene mutations 1412 Kenji Toyokuni Fumi Ishikawa Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Hiroya Ogita Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Ichiro Nomura Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Kiwako Yamamoto-Hanada Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Koji Nishimura Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Makoto Irahara Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Mayako Saito-Abe Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Miori Sato Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Shigenori Kabashima Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Tatsuki Fukuie Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Tomoyuki Kiguchi Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Yoshitsune Miyagi Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Yukihiro Ohya Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Yumiko Miyaji Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Kenji Toyokuni Yusuke Inuzuka Household pet exposure in prenatal and early childhood and allergic diseases: A general population birth cohort study 283 Dilini M Kothalawala Faisal I Rezwan Development of a childhood asthma prediction model using machine learning approaches 1101 Dilini M Kothalawala John W Holloway Development of a childhood asthma prediction model using machine learning approaches 1101 Dilini M Kothalawala S Hasan Arshad Development of a childhood asthma prediction model using machine learning approaches 1101 Shu-Li Julie  Wang Hui-Ju Wen Prediction of childhood allergic disease occurrence by adoptions of machine learning methods 41 Shu-Li Julie  Wang Vincent S. Tseng Prediction of childhood allergic disease occurrence by adoptions of machine learning methods 41 Shu-Li Julie  Wang Yu Huang Prediction of childhood allergic disease occurrence by adoptions of machine learning methods 41 Shu-Li Julie  Wang Yue Leon Guo Prediction of childhood allergic disease occurrence by adoptions of machine learning methods 41 Charlotte E Rutter David P Strachan Comparison of risk factors for childhood rhinoconjunctivitis, asthma and eczema in affluent and non-affluent countries: ISAAC Phase Three 988 Charlotte E Rutter Luis Garcia-Marcos Comparison of risk factors for childhood rhinoconjunctivitis, asthma and eczema in affluent and non-affluent countries: ISAAC Phase Three 988 Charlotte E Rutter M Innes Asher Comparison of risk factors for childhood rhinoconjunctivitis, asthma and eczema in affluent and non-affluent countries: ISAAC Phase Three 988 Charlotte E Rutter Neil Pearce Comparison of risk factors for childhood rhinoconjunctivitis, asthma and eczema in affluent and non-affluent countries: ISAAC Phase Three 988 Charlotte E Rutter Philippa Ellwood Comparison of risk factors for childhood rhinoconjunctivitis, asthma and eczema in affluent and non-affluent countries: ISAAC Phase Three 988 Charlotte E Rutter Richard J Silverwood Comparison of risk factors for childhood rhinoconjunctivitis, asthma and eczema in affluent and non-affluent countries: ISAAC Phase Three 988 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Basic and clinical immunology > Asthma > Allergy and clinical immunology',\n",
       "  'session': 'OAS 23 Biologicals and DARPins: new mechanisitic insights and novel applications',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921266,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 23 Biologicals and DARPins: new mechanisitic insights and novel applications Jonathan Corren Allen Radin Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Benjamin Ortiz Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Brad Shumel Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren G. Walter Canonica Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Jennifer D. Hamilton Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Leda P. Mannent Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Marcella Ruddy Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Marius Ardeleanu Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Megan S. Rice Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Michel Djandji Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Naimish Patel Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Neil M. H. Graham Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Nikhil Amin Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Paul Rowe Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Sivan Harel Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren William Brian Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Yamo Deniz Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Jonathan Corren Zhen Chen Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases 941 Tamara Quint Christine Bangert Effects of omalizumab on ASS intolerance in patients with aspirin-exacerbated respiratory disease (AERD)&nbsp; 1022 Tamara Quint Dariga Ramazanova Effects of omalizumab on ASS intolerance in patients with aspirin-exacerbated respiratory disease (AERD)&nbsp; 1022 Tamara Quint Robin Ristl Effects of omalizumab on ASS intolerance in patients with aspirin-exacerbated respiratory disease (AERD)&nbsp; 1022 Tamara Quint Stefan Janik Effects of omalizumab on ASS intolerance in patients with aspirin-exacerbated respiratory disease (AERD)&nbsp; 1022 Tamara Quint Sven Schneider Effects of omalizumab on ASS intolerance in patients with aspirin-exacerbated respiratory disease (AERD)&nbsp; 1022 Tamara Quint Valerie Dahm Effects of omalizumab on ASS intolerance in patients with aspirin-exacerbated respiratory disease (AERD)&nbsp; 1022 Alexander Eggel Daniel Brigger Disruptive anti-IgE inhibitors for the treatment of allergic lung inflammation 1332 Alexander Eggel Mario Noti Disruptive anti-IgE inhibitors for the treatment of allergic lung inflammation 1332 Alexander Eggel Noemi Zbren Disruptive anti-IgE inhibitors for the treatment of allergic lung inflammation 1332 Alexander Eggel Pascal Gasser Disruptive anti-IgE inhibitors for the treatment of allergic lung inflammation 1332 Alexander Eggel Pascal Guntern Disruptive anti-IgE inhibitors for the treatment of allergic lung inflammation 1332 Pascal Guntern Alexander Eggel The role of IgE glycosylation patterns on its biological activity 1172 Pascal Guntern Daniel Brigger The role of IgE glycosylation patterns on its biological activity 1172 Pascal Guntern Luke Pennington The role of IgE glycosylation patterns on its biological activity 1172 Pascal Guntern Noemi Zbren The role of IgE glycosylation patterns on its biological activity 1172 Pascal Guntern Pascal Gasser The role of IgE glycosylation patterns on its biological activity 1172 Pascal Guntern Rahel Ruppli The role of IgE glycosylation patterns on its biological activity 1172 Pascal Guntern Theodore Jardetzky The role of IgE glycosylation patterns on its biological activity 1172 Anna Aalbers Maud Hermans Benralizumab in refractory hypereosinophilic syndrome effectively reduces eosinophil counts but does not always resolve all clinical symptoms 1163 Anna Aalbers Pim Mutsaers Benralizumab in refractory hypereosinophilic syndrome effectively reduces eosinophil counts but does not always resolve all clinical symptoms 1163 Simon Gebremeskel Alan Wong A Siglec-8 antibody reduces substance P-induced inflammation by inhibiting MRGPR-mediated mast cell activation 1374 Simon Gebremeskel Bradford A Youngblood A Siglec-8 antibody reduces substance P-induced inflammation by inhibiting MRGPR-mediated mast cell activation 1374 Simon Gebremeskel Emily C Brock A Siglec-8 antibody reduces substance P-induced inflammation by inhibiting MRGPR-mediated mast cell activation 1374 Simon Gebremeskel John Leung A Siglec-8 antibody reduces substance P-induced inflammation by inhibiting MRGPR-mediated mast cell activation 1374 Simon Gebremeskel Julia Schanin A Siglec-8 antibody reduces substance P-induced inflammation by inhibiting MRGPR-mediated mast cell activation 1374 Simon Gebremeskel Tina Davis A Siglec-8 antibody reduces substance P-induced inflammation by inhibiting MRGPR-mediated mast cell activation 1374 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Pediatrics > Asthma > ENT',\n",
       "  'session': 'OAS 24  From early wheeze to rhinitis and asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921267,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 24  From early wheeze to rhinitis and asthma Idun Holmdahl Anastasia Filiou Early life wheeze - risk factors for asthma in school age 389 Idun Holmdahl Anna Asarnoj Early life wheeze - risk factors for asthma in school age 389 Idun Holmdahl Cilla Sderhll* Early life wheeze - risk factors for asthma in school age 389 Idun Holmdahl Gunilla Hedlin Early life wheeze - risk factors for asthma in school age 389 Idun Holmdahl Jon Roald Konradsen* Early life wheeze - risk factors for asthma in school age 389 Idun Holmdahl Katarina Stenberg Hammar Early life wheeze - risk factors for asthma in school age 389 Idun Holmdahl Magnus Persson Borres Early life wheeze - risk factors for asthma in school age 389 Idun Holmdahl Marianne Van Hage Early life wheeze - risk factors for asthma in school age 389 Nagaraju Kuravi Karthik Nagaraju Clinical profile of children with preschool recurrent wheeze from South India 1283 Nagaraju Kuravi Sathya Srivatsav Clinical profile of children with preschool recurrent wheeze from South India 1283 Nagaraju Kuravi Venkata Kasyapi Voorakaranam Clinical profile of children with preschool recurrent wheeze from South India 1283 Jelena ivkovic Boro Nogalo Effect of exercise on FENO levels in climate specific environment, in children with mild to moderate persistent asthma 993 Jelena ivkovic Davor Plavec Effect of exercise on FENO levels in climate specific environment, in children with mild to moderate persistent asthma 993 Jelena ivkovic Marcel Lipej Effect of exercise on FENO levels in climate specific environment, in children with mild to moderate persistent asthma 993 Jelena ivkovic Mirjana Turkalj Effect of exercise on FENO levels in climate specific environment, in children with mild to moderate persistent asthma 993 Jelena ivkovic Olga Malev Effect of exercise on FENO levels in climate specific environment, in children with mild to moderate persistent asthma 993 Aleksander Adamiec Bo Chawes FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review 816 Aleksander Adamiec Leo Pekka Malmberg FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review 816 Aleksander Adamiec Marek Ruszczynski FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review 816 Aleksander Adamiec Tuomas Jartti FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review 816 Aleksander Adamiec Varpu Elenius FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review 816 Aleksander Adamiec Wojciech Feleszko FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review 816 Perdita Permaul Carter R. Petty Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens 1344 Perdita Permaul Wanda Phipatanakul Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens 1344 Perdita Permaul William J. Sheehan Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens 1344 Lilijana Besednjak-Kocijancic  Does probiotic microorganism lactobacillus reuteri prevents allergic rhinitis and rhinoconjunctivitis development in children 310 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allergy diagnosis and systems medicine > Food allergy > ENT',\n",
       "  'session': 'OAS 25 New methodological insights for allergy diagnosis',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921268,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 25 New methodological insights for allergy diagnosis Stefanie   Schmalz Alexandra Shosherova Bet v 1 specific IgG4 from birch pollen allergic patients shows a more diverse repertoire than specific IgE 1150 Stefanie   Schmalz Christian Radauer Bet v 1 specific IgG4 from birch pollen allergic patients shows a more diverse repertoire than specific IgE 1150 Stefanie   Schmalz Christof Ebner Bet v 1 specific IgG4 from birch pollen allergic patients shows a more diverse repertoire than specific IgE 1150 Stefanie   Schmalz Gunter Sturm Bet v 1 specific IgG4 from birch pollen allergic patients shows a more diverse repertoire than specific IgE 1150 Stefanie   Schmalz Vanessa Mayr Bet v 1 specific IgG4 from birch pollen allergic patients shows a more diverse repertoire than specific IgE 1150 POL ANDRE APOIL Audrey Martin-Blondel Cow&rsquo;s milk allergy can be monitored through the degree of competition between specific IgE and IgG 1290 POL ANDRE APOIL Ghislaine Chamayou Cow&rsquo;s milk allergy can be monitored through the degree of competition between specific IgE and IgG 1290 POL ANDRE APOIL Joana Vitte Cow&rsquo;s milk allergy can be monitored through the degree of competition between specific IgE and IgG 1290 POL ANDRE APOIL Natacha Casanovas Cow&rsquo;s milk allergy can be monitored through the degree of competition between specific IgE and IgG 1290 POL ANDRE APOIL Simon Pinchemel Cow&rsquo;s milk allergy can be monitored through the degree of competition between specific IgE and IgG 1290 Nils Scheib Carsten Bindslev-Jensen Biotin interference can cause false-negative IgE test results in patients with anaphylaxis 929 Nils Scheib Charlotte Mara Heinrich Biotin interference can cause false-negative IgE test results in patients with anaphylaxis 929 Nils Scheib Chrysanthi Skevaki Biotin interference can cause false-negative IgE test results in patients with anaphylaxis 929 Nils Scheib Daniel Bauersachs Biotin interference can cause false-negative IgE test results in patients with anaphylaxis 929 Nils Scheib Dmitrii Pogorelov Biotin interference can cause false-negative IgE test results in patients with anaphylaxis 929 Nils Scheib Feng He Biotin interference can cause false-negative IgE test results in patients with anaphylaxis 929 Nils Scheib Markus Ollert Biotin interference can cause false-negative IgE test results in patients with anaphylaxis 929 Anna Kosowska Marek Jutel Environmental exposure chamber is a useful tool for better selection of AIT patients with HDM triggered rhinoconjuctivitis for assessment of potential biomarkers of allergen tolerance 1445 Anna Kosowska Pawel Gajdanowicz Environmental exposure chamber is a useful tool for better selection of AIT patients with HDM triggered rhinoconjuctivitis for assessment of potential biomarkers of allergen tolerance 1445 Anna Kosowska Sylwia Smolinska Environmental exposure chamber is a useful tool for better selection of AIT patients with HDM triggered rhinoconjuctivitis for assessment of potential biomarkers of allergen tolerance 1445 Ibon Eguiluz-Gracia Almudena Testera-Montes Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge 946 Ibon Eguiluz-Gracia Carmen Rondon Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge 946 Ibon Eguiluz-Gracia Maria Jos Torres Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge 946 Ibon Eguiluz-Gracia Natalia Perez-Sanchez Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge 946 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Drug allergy > Allergy and clinical immunology > Allergy and clinical immunology',\n",
       "  'session': 'OAS 26  In vitro diagnosis of drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921269,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 26  In vitro diagnosis of drug allergy Tahia D Fernandez Alaba Rodriguez-Nogales The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Ana Molina The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Cristobalina Mayorga The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Francisca Palomares The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Gador Bogas The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Maria Salas The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Maria I Montaez The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Maria J Rodriguez-Sanchez The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Maria J Torres The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 Tahia D Fernandez Ruben Fernandez-Santamaria The type of antigen presenting cells employed in the lymphocyte transformation test affects its effectivity in immediate allergic reactions to betalactams 835 sengl beyaz Abdullah Yilmaz Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 sengl beyaz Asli Gelincik Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 sengl beyaz Bahauddin Colakoglu Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 sengl beyaz Gunnur Deniz Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 sengl beyaz Nida Oztop Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 sengl beyaz Nilgun Akdeniz Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 sengl beyaz Semra Demir Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 sengl beyaz Suna Buyukozturk Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as rare antibiotic elicitors 894 Rubn Fernndez Santamar\\xada Alba Rodriguez-Nogales Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to betalactams using lymphocyte transformation test 999 Rubn Fernndez Santamar\\xada Cristobalina Mayorga Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to betalactams using lymphocyte transformation test 999 Rubn Fernndez Santamar\\xada Ezequiel Perez-Inestrosa Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to betalactams using lymphocyte transformation test 999 Rubn Fernndez Santamar\\xada Maria Isabel Montaez Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to betalactams using lymphocyte transformation test 999 Rubn Fernndez Santamar\\xada Maria Jose Torres Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to betalactams using lymphocyte transformation test 999 Rubn Fernndez Santamar\\xada Patricia Malagon Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to betalactams using lymphocyte transformation test 999 Rubn Fernndez Santamar\\xada Tahia Diana Fernandez Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to betalactams using lymphocyte transformation test 999 Catarina Pereira Coutinho Manuel Pereira Barbosa Basophil activation test in anaphylaxis to non-steroidal anti-inflammatory drugs &ndash; is it useful? 1194 Catarina Pereira Coutinho Maria Conceio Pereira Santos Basophil activation test in anaphylaxis to non-steroidal anti-inflammatory drugs &ndash; is it useful? 1194 Catarina Pereira Coutinho Marta Neto Basophil activation test in anaphylaxis to non-steroidal anti-inflammatory drugs &ndash; is it useful? 1194 Mar\\xada Jos Jurez \\x81ngel Maquieira Highly improved sensitive in vitro drug allergy test using an collection of new &szlig;-lactam-protein antigens 829 Mar\\xada Jos Jurez Pedro Quintero-Campos Highly improved sensitive in vitro drug allergy test using an collection of new &szlig;-lactam-protein antigens 829 Mar\\xada Jos Jurez Sergi Morais Highly improved sensitive in vitro drug allergy test using an collection of new &szlig;-lactam-protein antigens 829 Sergio  Fernndez Bravo Carlos Pastor-Vargas Anaphylaxis-derived extracellular vesicles induce vascular permeability 1047 Sergio  Fernndez Bravo Emilio Nez-Borque Anaphylaxis-derived extracellular vesicles induce vascular permeability 1047 Sergio  Fernndez Bravo Javier Cuesta-Herranz Anaphylaxis-derived extracellular vesicles induce vascular permeability 1047 Sergio  Fernndez Bravo Tamara Oliva Anaphylaxis-derived extracellular vesicles induce vascular permeability 1047 Sergio  Fernndez Bravo Vanesa Esteban Anaphylaxis-derived extracellular vesicles induce vascular permeability 1047 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allergen immunotherapy      > Allergy and clinical immunology > Food allergy',\n",
       "  'session': 'OAS 27  Clinical perspectives in allergen immunotherapy: where are we now?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921270,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"OAS 27  Clinical perspectives in allergen immunotherapy: where are we now? Sofia Andreevna  Arkhipova Darya Aleksandrovna Volkova Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma 612 Sofia Andreevna  Arkhipova Olesya Valeryevna Skorokhodkina Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma 612 David I Bernstein Anne K Ellis Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis  239 David I Bernstein Harold S. Nelson Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis  239 David I Bernstein Hendrik Nolte Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis  239 David I Bernstein Jrg Kleine-Tebbe Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis  239 Oksana Ereshko Karine Avetisyn Food allergies in children with birch pollen allergy and various profiles of sensitization to pollen components 1352 Oksana Ereshko Marina Snovskaya Food allergies in children with birch pollen allergy and various profiles of sensitization to pollen components 1352 Oksana Ereshko Svetlana Makarova Food allergies in children with birch pollen allergy and various profiles of sensitization to pollen components 1352 Yoshitaka Okamoto Kimihiro Okubo Disease modifying effect of sublingual immunotherapy tablets in patients with Japanese cedar pollinosis. A double-blind, randomised, parallel-group, placebo-controlled study 350 Yoshitaka Okamoto Minoru Gotoh Disease modifying effect of sublingual immunotherapy tablets in patients with Japanese cedar pollinosis. A double-blind, randomised, parallel-group, placebo-controlled study 350 Yoshitaka Okamoto Shinya Kaneko Disease modifying effect of sublingual immunotherapy tablets in patients with Japanese cedar pollinosis. A double-blind, randomised, parallel-group, placebo-controlled study 350 Yoshitaka Okamoto Syuji Yonekura Disease modifying effect of sublingual immunotherapy tablets in patients with Japanese cedar pollinosis. A double-blind, randomised, parallel-group, placebo-controlled study 350 Yoshitaka Okamoto Yuriko Maekawa Disease modifying effect of sublingual immunotherapy tablets in patients with Japanese cedar pollinosis. A double-blind, randomised, parallel-group, placebo-controlled study 350 Andrzej Bozek Jerzy Jarzab Long-term effects of allergen immunotherapy to grass pollen 89 Andrzej Bozek Renata Kozlowska Long-term effects of allergen immunotherapy to grass pollen 89 Jonathan Corren Claire Wang Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Elinore S Chung Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Elizabeth Laws Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Gordon Sussman Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Jennifer D Hamilton Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Joshua Jacobs Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Marcella Ruddy Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Mark H Moss Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Meagan P O'Brien Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Remi Gagnon Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Sarbjit Saini Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Tatiana Constant Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 Jonathan Corren Yiping Sun Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy 506 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Environmental and occupational allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'OAS 28 Pollution, aeroallergens and allergy risk',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921271,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 28 Pollution, aeroallergens and allergy risk Celia Maria Antunes Ana Galveias Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments 1120 Celia Maria Antunes Ana Rodrigues Costa Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments 1120 Celia Maria Antunes Beatriz Lara Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments 1120 Celia Maria Antunes Jesus Rojo Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments 1120 Celia Maria Antunes Maria Joo Costa Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments 1120 Celia Maria Antunes Marta Ot\\xadlio Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments 1120 Celia Maria Antunes Rosa Perez-Badia Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments 1120 Dorota Myszkowska Andrzej Skoczowski Can the birch pollen be more aggressive in the polluted environments? 756 Dorota Myszkowska Ewa Czarnobilska Can the birch pollen be more aggressive in the polluted environments? 756 Dorota Myszkowska Jacek Waga Can the birch pollen be more aggressive in the polluted environments? 756 Dorota Myszkowska Monika Ziemianin Can the birch pollen be more aggressive in the polluted environments? 756 Paolo Marraccini Emanuele Conforti Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Jacopo Mariani Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Laura Cantone Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Luca Ferrari Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Maria Stella Lombardi Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Pallav Bulsara Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Raymond Ignar Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Robert Howlin Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Simona Iodice Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Paolo Marraccini Valentina Bollati Air pollution exposure and allergic rhinitis exacerbation: The role of nasal microbiota and extracellular vesicle communication 1058 Izabele Juskiene Algirdas Valiulis Occasional sources and level of indoor pollution in primary schools of relative low polluted region of Eastern Europe<br /> 765 Izabele Juskiene Arunas Valiulis Occasional sources and level of indoor pollution in primary schools of relative low polluted region of Eastern Europe<br /> 765 Izabele Juskiene Kestutis Staras Occasional sources and level of indoor pollution in primary schools of relative low polluted region of Eastern Europe<br /> 765 Izabele Juskiene Nikolaj Tarasiuk Occasional sources and level of indoor pollution in primary schools of relative low polluted region of Eastern Europe<br /> 765 Izabele Juskiene Nina Prokopciuk Occasional sources and level of indoor pollution in primary schools of relative low polluted region of Eastern Europe<br /> 765 Izabele Juskiene Ulrich Franck Occasional sources and level of indoor pollution in primary schools of relative low polluted region of Eastern Europe<br /> 765 Izabele Juskiene Vadimas Dudoitis Occasional sources and level of indoor pollution in primary schools of relative low polluted region of Eastern Europe<br /> 765 Joo Cavaleiro Rufo Andr Moreira Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren 400 Joo Cavaleiro Rufo Ins Pacincia Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren 400 Joo Cavaleiro Rufo Isabella Annesi-Maesano Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren 400 Joo Cavaleiro Rufo Lu\\xads Delgado Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren 400 Joo Cavaleiro Rufo Mariana Farraia Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren 400 Magdalena Paplinska-Goryca Katarzyna Gorska The expression of inflammatory mediators in macrophages, epithelium and dendritic cells after urban particulate matter stimulation in triple co-culture scheme 276 Magdalena Paplinska-Goryca Paulina Misiukiewicz-Stepien Paulina The expression of inflammatory mediators in macrophages, epithelium and dendritic cells after urban particulate matter stimulation in triple co-culture scheme 276 Magdalena Paplinska-Goryca Rafal Krenke The expression of inflammatory mediators in macrophages, epithelium and dendritic cells after urban particulate matter stimulation in triple co-culture scheme 276 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Dermatology > Basic and clinical immunology > Pediatrics',\n",
       "  'session': 'OAS 29 What is new in urticaria and angioedema?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921272,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 29 What is new in urticaria and angioedema? Pavel Kolkhir Emek Kocatrk Diagnosis and treatment of urticarial vasculitis: An international survey 186 Pavel Kolkhir Hanna Bonnekoh Diagnosis and treatment of urticarial vasculitis: An international survey 186 Pavel Kolkhir Karoline Krause Diagnosis and treatment of urticarial vasculitis: An international survey 186 Pavel Kolkhir Marcus Maurer Diagnosis and treatment of urticarial vasculitis: An international survey 186 Pavel Kolkhir Mario Sanchez Borges Diagnosis and treatment of urticarial vasculitis: An international survey 186 Pavel Kolkhir Martin Metz Diagnosis and treatment of urticarial vasculitis: An international survey 186 Pavel Kolkhir Michihiro Hide Diagnosis and treatment of urticarial vasculitis: An international survey 186 Emek Kocatrk Alexander Marsland Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Alicja Kasperska-Zajac Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Ana Gimenez-Arnau Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Andrea Bauer Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Asli Gelincik Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Daria Fomina Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Ece Nur Degirmentepe Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Ekin savk Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Inna Danilycheva Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Iris Medina Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Karoline Krause Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Kiran Godse Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Laurence Boulliet Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Luis Felipe Ensina Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Marcus Maurer Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Maryam Khoshkhui Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Michael Rudenko Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Mona Al-Ahmad Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Niall Conlon Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Petra Staubach Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Roberta Criado Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Semra Ertan Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Simon Francis Thomsen Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Solange Valle Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 Emek Kocatrk Zuotao Zhao Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project 635 ilan asher Firas basha Emergency room&nbsp;visits of children&nbsp;and adults with Urticaria - prevalence, characterization and outcome 610 ilan asher Zev Sthoeger Emergency room&nbsp;visits of children&nbsp;and adults with Urticaria - prevalence, characterization and outcome 610 Jonathan A Bernstein Ana Gimnez-Arnau Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Avantika Barve Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Bobby Lanier Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Eva Hua Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Gordon Sussman Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Karl Sitz Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Marcus Maurer Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Martin Metz Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Michihiro Hide Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Reinhold Janocha Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Thomas Severin Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Jonathan A Bernstein Weily Soong Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria 716 Marcus Maurer Ana Maria Gimnez-Arnau Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Avantika Barve Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Bobby Lanier Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Eva Hua Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Gordon Sussman Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Jonathan A Bernstein Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Karl Sitz Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Martin Metz Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Michihiro Hide Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Reinhold Janocha Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Thomas Severin Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Marcus Maurer Weily Soong Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab 907 Young-Min Ye Hae-Sim Park A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria 758 Young-Min Ye Jeong-Hee Choi A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria 758 Young-Min Ye Mi-Ae Kim A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria 758 Young-Min Ye Yooseob Shin A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria 758 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allied health and primary care   > Food allergy > Allergy diagnosis and systems medicine',\n",
       "  'session': 'OAS 30 Allergy management in the 21st century: optimisation, knowledge and education',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921273,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 30 Allergy management in the 21st century: optimisation, knowledge and education Gert-Jan Braunstahl Floor Verhagen Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Jan Willem Arendse Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Jasper H Kappen Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Lei Man Chow Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Maurits S Van Maaren Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Patrick J E Bindels Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Richard H L Paping Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Roy Gerth Van Wijk Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Gert-Jan Braunstahl Sanne Ruikes-Mertens Optimization of allergen immunotherapy care using an integrated eHealth environment 1364 Michael Golding Elinor Simons Impact of food allergy on household expenditures among Manitoba families 1054 Michael Golding Jennifer Protudjer Impact of food allergy on household expenditures among Manitoba families 1054 Michal Deutch Diti Machnes-Maayan Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Michal Deutch Eti Elbaz Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Michal Deutch Irena Vekster-Offengenden Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Michal Deutch Mona Kidon Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Michal Deutch Nancy Agmon\\x80\\x93levin Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Michal Deutch Ramit Maoz-Segal Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Michal Deutch Shirly Frizinsky Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Michal Deutch Soad Haj Yahia Knowledge and awareness usage of an Epipen syringe among patients who suffer from life-threatening allergies 1104 Sophie Scheire An De Sutter The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Christophe Delaey The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Els Mehuys The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Inge Van Tongelen The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Jean-Paul Remon The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Koen Boussery The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Luc Van Bortel The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Philippe Gevaert The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Sophie Demarche The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Sophie Germonpr The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Thierry Christiaens The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Sophie Scheire Thierry Van Hees The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies 1134 Natalia Spolak-Bobryk Ewa Jassem Quality of life in mastocytosis scale (QLMS) - the construction of the disease-specific questionnaire 1376 Natalia Spolak-Bobryk Judyta Borchet Quality of life in mastocytosis scale (QLMS) - the construction of the disease-specific questionnaire 1376 Natalia Spolak-Bobryk Marek Niedoszytko Quality of life in mastocytosis scale (QLMS) - the construction of the disease-specific questionnaire 1376 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Food allergy > Allergy and clinical immunology > Pediatrics',\n",
       "  'session': 'OAS 31 Epidemiological and interventional studies of food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921274,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"OAS 31 Epidemiological and interventional studies of food allergy Sarah A Lyons Andr C Knulst Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Barbara K Ballmer-Weber Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Christian Bieli Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Cristina Fernandez-Perez Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons E. N. C. Mills Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Ischa Kmmeling Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons James Potts Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Laura Barreales Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Marek L. Kowalski Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Michael Clausen Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Monika Jedrzejczak-Czechowicz Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Montserrat Fernandez-Rivas Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Nikolaos G Papadopoulos Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Paco M. J. Welsing Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Paraskevi Xepapadaki Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Peter G.j. Burney Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Ronald Van Ree Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Ruta Dubakiene Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Tanya Kralimarkova Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Thuy-My T. M. Le Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Tihomir B. Mustakov Prevalence of food sensitisation and food allergy in children across Europe 991 Sarah A Lyons Todor A Popov Prevalence of food sensitisation and food allergy in children across Europe 991 Sandra Tedner Anna Asarnoj Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Anna Bergstrm Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Caroline Nilsson Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Catarina Almqvist Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Erik Meln Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Inger Kull Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Jon Konradsen Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Magnus P Borres Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Marianne Van Hage Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Marit Westman Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Natalia Ballardini Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Sandra Tedner Niklas Andersson Development of IgE-sensitization and symptoms to peanut over time: A 24 year follow up 1002 Elinor Simons Allan B Becker Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Elinor Simons Keely Loewen Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Elinor Simons Malcolm R Sears Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Elinor Simons Meghan B Azad Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Elinor Simons Padmaja Subbarao Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Elinor Simons Piush J Mandhane Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Elinor Simons Stuart E Turvey Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Elinor Simons Theo J Moraes Prenatal egg consumption and infant sensitization to egg and peanut in the CHILD cohort 1531 Wanyi Fu Charles Wang Lifestyle and helminth infection associated with taxonomic and functional shifts in gut microbiota in children with food allergy: The europrevall-INCO study 52 Wanyi Fu Gary W.k. Wong Lifestyle and helminth infection associated with taxonomic and functional shifts in gut microbiota in children with food allergy: The europrevall-INCO study 52 Wanyi Fu Jing Li Lifestyle and helminth infection associated with taxonomic and functional shifts in gut microbiota in children with food allergy: The europrevall-INCO study 52 Wanyi Fu Zhaowei Yang Lifestyle and helminth infection associated with taxonomic and functional shifts in gut microbiota in children with food allergy: The europrevall-INCO study 52 Jialing Jiang Aame Andy-Nweye Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Adam Robinson Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Alexandria Bozen Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Amal Assa'Ad Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Amaziah Coleman Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Annika Chura Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Avneet Chadha Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Christopher Warren Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Dannielle Brown Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Hemant Sharma Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Iman Abdikarim Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Isabel Galic Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Jacqueline Pongracic Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Jamie Fierstein Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Lucy Bilaver Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Mahboobeh Mahdavinia Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Mary C Tobin Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Olivia Negris Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Pamela Newmark Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Perry Catlin Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Ruchi Gupta Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Jialing Jiang Susan Fox Early introduction of peanut, egg, and milk among black and white food-allergic children in the forward study 1497 Rachel L Peters Adrian Lowe No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Anne-Louise Ponsonby No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Danny Ye Barrett No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Jennifer J Koplin No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Kirsten P Perrett No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Mimi Tang No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Shyamali C Dharmage No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Vicki Mcwilliam No cashew allergy in children introduced to cashew by age 1 year 1563 Rachel L Peters Victoria Soriano No cashew allergy in children introduced to cashew by age 1 year 1563 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Drug allergy > Allergy and clinical immunology > Dermatology',\n",
       "  'session': 'OAS 32 Diagnosis and management of drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921275,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 32 Diagnosis and management of drug allergy Vincent R. van Cuilenborg Elke M.e. Bos A cohort study into intravenous drug provocation tests in perioperative allergy 1139 Vincent R. van Cuilenborg Fabian O. Kooij A cohort study into intravenous drug provocation tests in perioperative allergy 1139 Vincent R. van Cuilenborg Ingrid Terreehorst A cohort study into intravenous drug provocation tests in perioperative allergy 1139 Vincent R. van Cuilenborg Jeroen Hermanides A cohort study into intravenous drug provocation tests in perioperative allergy 1139 Vincent R. van Cuilenborg Markus W. Hollmann A cohort study into intravenous drug provocation tests in perioperative allergy 1139 Ins Machado Cunha Eva Gomes Drug provocation test in non-immediate beta lactam hypersensitivity workup: One-day&nbsp;vs&nbsp;prolonged protocol in pediatric patients 1329 Ins Machado Cunha Joana Gouveia Drug provocation test in non-immediate beta lactam hypersensitivity workup: One-day&nbsp;vs&nbsp;prolonged protocol in pediatric patients 1329 Ins Machado Cunha Maria Lu\\xads Marques Drug provocation test in non-immediate beta lactam hypersensitivity workup: One-day&nbsp;vs&nbsp;prolonged protocol in pediatric patients 1329 Oyindamola Stephanie Kayode Krzysztof Rutkowski Teicoplanin hypersensitivity in peri-operative anaphylaxis 623 Oyindamola Stephanie Kayode Leonard Qc Siew Teicoplanin hypersensitivity in peri-operative anaphylaxis 623 Oyindamola Stephanie Kayode Rubaiyat Haque Teicoplanin hypersensitivity in peri-operative anaphylaxis 623 Oyindamola Stephanie Kayode Stephen Till Teicoplanin hypersensitivity in peri-operative anaphylaxis 623 Olga Branicka Barbara Rogala Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs. 846 Olga Branicka Grazyna Stryjewska-Makuch Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs. 846 Olga Branicka Joanna Glck Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs. 846 Olga Branicka Marcelina Niemiec-Urbanczyk Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs. 846 ANNA RADICE Donatella Macchia Hypersensitivity reactions to iodinated contrast media: Still a matter of debate 1214 ANNA RADICE Elisa Meucci Hypersensitivity reactions to iodinated contrast media: Still a matter of debate 1214 ANNA RADICE Filippo Fassio Hypersensitivity reactions to iodinated contrast media: Still a matter of debate 1214 ANNA RADICE Maria Loredana Chiara Iorno Hypersensitivity reactions to iodinated contrast media: Still a matter of debate 1214 ANNA RADICE Mariangela Sibilio Hypersensitivity reactions to iodinated contrast media: Still a matter of debate 1214 Leyla Pur Ozyigit Ayse Bilge Ozturk Title: Treating Through in Drug Allergy: What do the allergists think about? 514 Leyla Pur Ozyigit Ozge Soyer Title: Treating Through in Drug Allergy: What do the allergists think about? 514 Leyla Pur Ozyigit Sevim Bavbek Title: Treating Through in Drug Allergy: What do the allergists think about? 514 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Environmental and occupational allergy > Allergy and clinical immunology > Asthma',\n",
       "  'session': 'OAS 33 Environment, aeroallergen and health',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921276,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 33 Environment, aeroallergen and health Charlotte Sindt Gilles Oliver Phenological phases of pollination and climate change 766 Charlotte Sindt Jean-Pierre Besancenot Phenological phases of pollination and climate change 766 Charlotte Sindt Michel Thibaudon Phenological phases of pollination and climate change 766 Charlotte Sindt Samuel Monnier Phenological phases of pollination and climate change 766 Celia Maria Antunes Ana Galveias Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in &Eacute;vora (Portugal) 1079 Celia Maria Antunes Ana Mar\\xada Burgos-Montero Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in &Eacute;vora (Portugal) 1079 Celia Maria Antunes Ana R. Costa Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in &Eacute;vora (Portugal) 1079 Celia Maria Antunes Beatriz Lara Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in &Eacute;vora (Portugal) 1079 Celia Maria Antunes Jess Rojo Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in &Eacute;vora (Portugal) 1079 Celia Maria Antunes Jorge Romero-Morte Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in &Eacute;vora (Portugal) 1079 Celia Maria Antunes Rosa Prez-Badia Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in &Eacute;vora (Portugal) 1079 Anne Kathleen Ellis Claire Wang Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Dan Adams Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Divya Ramesh Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Jenny Thiele Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Lisa Steacy Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Meagan P. O\\x80\\x99brien Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Michelle Deveaux Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Ryan Pennington Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Shaun Langdon Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Anne Kathleen Ellis Terry Walker Allergic symptoms are highly associated between environmental exposure unit exposures and a natural seasonal exposure to birch pollen but the magnitude of the maximum change is different 1234 Carsten Ambelas Skjoth Alexander Kurganskiy Ragweed pollen concentrations on local and regional scale on the Pannonia Plain and beyond 1384 Carsten Ambelas Skjoth Barbara Stjepanovic Ragweed pollen concentrations on local and regional scale on the Pannonia Plain and beyond 1384 Carsten Ambelas Skjoth Branko Sikoparija Ragweed pollen concentrations on local and regional scale on the Pannonia Plain and beyond 1384 Carsten Ambelas Skjoth Donat Magyar Ragweed pollen concentrations on local and regional scale on the Pannonia Plain and beyond 1384 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FFFF00',\n",
       "  'type': 'Oral Abstract Sessions',\n",
       "  'category': 'Allergen immunotherapy      > Asthma > Allergy and clinical immunology',\n",
       "  'session': 'OAS 34  Allergen immunotherapy: new decade, new approaches',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921277,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FFFF00;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'OAS 34  Allergen immunotherapy: new decade, new approaches Alexander Heldner Adam Chaker House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Carsten B. Schmidt-Weber House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Dennis Russkamp House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Francesca Alessandrini House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Matthew D. Heath House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Matthias F. Kramer House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Murray A. Skinner House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Simon Blank House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Sonja Heine House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Alexander Heldner Ulrich Zissler House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma 223 Guillem Montamat Caroline Davril Successful CpG/Fel d 1-based immunotherapy reduces Th2 effector and memory cell compartments in a mouse model of allergic asthma<br /> 595 Guillem Montamat Cathy Leonard Successful CpG/Fel d 1-based immunotherapy reduces Th2 effector and memory cell compartments in a mouse model of allergic asthma<br /> 595 Guillem Montamat Markus Ollert Successful CpG/Fel d 1-based immunotherapy reduces Th2 effector and memory cell compartments in a mouse model of allergic asthma<br /> 595 Guillem Montamat Olivia Domingues Successful CpG/Fel d 1-based immunotherapy reduces Th2 effector and memory cell compartments in a mouse model of allergic asthma<br /> 595 Max Kirtland Daphne Tsitoura Effects of toll-like receptor 7 on dendritic cells and B cells in inducing tolerogenic responses during allergic inflammation: A proof of concept study 1148 Max Kirtland Gemma Vila-Nadal Effects of toll-like receptor 7 on dendritic cells and B cells in inducing tolerogenic responses during allergic inflammation: A proof of concept study 1148 Max Kirtland Mohamed H Shamji Effects of toll-like receptor 7 on dendritic cells and B cells in inducing tolerogenic responses during allergic inflammation: A proof of concept study 1148 Max Kirtland Stephen Reginald Durham Effects of toll-like receptor 7 on dendritic cells and B cells in inducing tolerogenic responses during allergic inflammation: A proof of concept study 1148 Yu Kuwabara Fumio Kamiyama Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Mio Saito Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Mizuho Nagao Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Naofumi Suzuki Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Naoki Okada Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Ryo Imakiire Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Sayami Ito Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Shinsaku Nakagawa Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Taiga Kobori Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Takao Fujisawa Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Yu Kuwabara Ying-Shu Quan Epicutaneous immunotherapy for severe egg allergy utilizing a novel antigen delivery device: A double-blind placebo-controlled pilot study 763 Madison Lenormand Gemma Vila Nadal Targeting IL-10-producing regulatory B cells with a novel hypoallergenic depigmented and polymerized phleum pratense candidate for allergen immunotherapy in seasonal allergic rhinitis 1129 Madison Lenormand Hanisah Sharif Targeting IL-10-producing regulatory B cells with a novel hypoallergenic depigmented and polymerized phleum pratense candidate for allergen immunotherapy in seasonal allergic rhinitis 1129 Madison Lenormand Janice Layhadi Targeting IL-10-producing regulatory B cells with a novel hypoallergenic depigmented and polymerized phleum pratense candidate for allergen immunotherapy in seasonal allergic rhinitis 1129 Madison Lenormand Jeronimo Carnes Targeting IL-10-producing regulatory B cells with a novel hypoallergenic depigmented and polymerized phleum pratense candidate for allergen immunotherapy in seasonal allergic rhinitis 1129 Madison Lenormand Mohamed Shamji Targeting IL-10-producing regulatory B cells with a novel hypoallergenic depigmented and polymerized phleum pratense candidate for allergen immunotherapy in seasonal allergic rhinitis 1129 Madison Lenormand Raquel Moya Targeting IL-10-producing regulatory B cells with a novel hypoallergenic depigmented and polymerized phleum pratense candidate for allergen immunotherapy in seasonal allergic rhinitis 1129 Madison Lenormand Rebecca Parkin Targeting IL-10-producing regulatory B cells with a novel hypoallergenic depigmented and polymerized phleum pratense candidate for allergen immunotherapy in seasonal allergic rhinitis 1129 Laura Hesse Arjen H Petersen Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma 813 Laura Hesse Hakan Kalay Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma 813 Laura Hesse Henk Vietor Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma 813 Laura Hesse Martijn C Nawijn Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma 813 Laura Hesse Martino Ambrosini Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma 813 Laura Hesse Roy Feenstra Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma 813 Laura Hesse Yvette Van Kooyk Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma 813 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC9933',\n",
       "  'type': 'Late Breaking Oral Abstract Sessions',\n",
       "  'category': 'Allergen immunotherapy      > Food allergy > Basic and clinical immunology',\n",
       "  'session': 'LB OAS 01  Immunotherapy: from bench to bedside ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921377,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB OAS 01  Immunotherapy: from bench to bedside  Dianne Campbell Alexander Porter Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Clive Hayward Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Hugh Sampson Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Kari C Nadeau Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Paul Kearney Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Paul J. Turner Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Robert Getts Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Sharon Chinthrajah Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Dianne Campbell Stephen J. Galli Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations 1776 Oliver Pfaar Carmen Vidal Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Efstrathios Karagiannis Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Frdric De Blay Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Giovanni Passalacqua Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Krzysztof Kowal Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Ludger Klimek Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Margitta Worm Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Martine Le Gall Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Miguel Tortajada-Girbs Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Natalia Nenasheva Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Pascal Demoly Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Peter Creticos Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Philippe Gevaert Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Oliver Pfaar Thomas Casale Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet 1866 Margitta Worm Karl-Christian Bergmann Safety review of 300IR house dust mite tablet from pooled data of clinical trials and post marketing experience 1869 Margitta Worm Katia Daghildjian Safety review of 300IR house dust mite tablet from pooled data of clinical trials and post marketing experience 1869 Margitta Worm Kwok Yan Safety review of 300IR house dust mite tablet from pooled data of clinical trials and post marketing experience 1869 Vincent Dioszeghy Camille Plaquet Epicutaneous immunotherapy in murine model modulates humoral immunity through regulation of IL-13+ T follicular helper cells 1739 Vincent Dioszeghy Fabrice Porcheray Epicutaneous immunotherapy in murine model modulates humoral immunity through regulation of IL-13+ T follicular helper cells 1739 Vincent Dioszeghy Hugh Sampson Epicutaneous immunotherapy in murine model modulates humoral immunity through regulation of IL-13+ T follicular helper cells 1739 Leo Laoubi Hugh Sampson Distinct contribution of skin dendritic cell subsets to the efficacy of epicutaneous immunotherapy in murine models of food allergy 1747 Leo Laoubi Jean-Franois Nicolas Distinct contribution of skin dendritic cell subsets to the efficacy of epicutaneous immunotherapy in murine models of food allergy 1747 Leo Laoubi Marc Vocanson Distinct contribution of skin dendritic cell subsets to the efficacy of epicutaneous immunotherapy in murine models of food allergy 1747 Leo Laoubi Vincent Dioszeghy Distinct contribution of skin dendritic cell subsets to the efficacy of epicutaneous immunotherapy in murine models of food allergy 1747 Joana Barradas Lopes Ctia Santa Safety of ultra-rush protocol on venom immunotherapy: Evaluation of risk factors for adverse events 1778 Joana Barradas Lopes Cristiana Ferreira Safety of ultra-rush protocol on venom immunotherapy: Evaluation of risk factors for adverse events 1778 Joana Barradas Lopes Ins Lopes Safety of ultra-rush protocol on venom immunotherapy: Evaluation of risk factors for adverse events 1778 Joana Barradas Lopes Mrcio Mesquita Safety of ultra-rush protocol on venom immunotherapy: Evaluation of risk factors for adverse events 1778 Joana Barradas Lopes Patr\\xadcia Barreira Safety of ultra-rush protocol on venom immunotherapy: Evaluation of risk factors for adverse events 1778 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC9933',\n",
       "  'type': 'Late Breaking Oral Abstract Sessions',\n",
       "  'category': 'Food allergy > Allergy diagnosis and systems medicine',\n",
       "  'session': 'LB OAS 02 Food allergy: state of the art',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921378,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB OAS 02 Food allergy: state of the art Lucy Duan Adelle Roberta Atkinson Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Ahuva Magder Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Alireza Berenjy Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Alper Celik Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Arun Ramani Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Chiara Palladino Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Christina Maria Ditlof Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan David Hummel Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Delvin So Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Heimo Breiteneder Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Jean-Soo Lee Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Jennifer Anh Hoang Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Julia Elizabeth Mainwaring Upton Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Klara Schmidthaler Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Lisa Hung Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Mara Alexanian-Farr Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Maria Asper Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Marta Ponce Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Samantha Wong Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Thomas Eiwegger Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Vy Hong-Diep Kim Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Xiaojun Yin Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Lucy Duan Zslot Szepfalusi Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy in Canadian and Central European children and adolescents: The markers of nut allergy study (MONAS) 1746 Katharina Blmchen C. Jones Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen K. Beyer Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen K. Oluwayi Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen M. A. Skinner Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen M. D. Heath Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen M. F. Bachmann Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen M. F. Kramer Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen M. H. Shamji Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen P. J. De Kam Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Katharina Blmchen T. M. Kndig Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy 1825 Mayte Suarez-Farinas George Dutoit Expansion of humoral antibody repertoire is associated with eczema status and development of peanut allergy at 5 years in children enrolled in the LEAP trail 1643 Mayte Suarez-Farinas Gideon Lack Expansion of humoral antibody repertoire is associated with eczema status and development of peanut allergy at 5 years in children enrolled in the LEAP trail 1643 Mayte Suarez-Farinas Henry T Bahnson Expansion of humoral antibody repertoire is associated with eczema status and development of peanut allergy at 5 years in children enrolled in the LEAP trail 1643 Mayte Suarez-Farinas Hugh A Sampson Expansion of humoral antibody repertoire is associated with eczema status and development of peanut allergy at 5 years in children enrolled in the LEAP trail 1643 Mayte Suarez-Farinas Maria Suprun Expansion of humoral antibody repertoire is associated with eczema status and development of peanut allergy at 5 years in children enrolled in the LEAP trail 1643 Mayte Suarez-Farinas Robert Getts Expansion of humoral antibody repertoire is associated with eczema status and development of peanut allergy at 5 years in children enrolled in the LEAP trail 1643 Mayte Suarez-Farinas Rohit Raghunathan Expansion of humoral antibody repertoire is associated with eczema status and development of peanut allergy at 5 years in children enrolled in the LEAP trail 1643 Maria Suprun Alice Henning Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Donald Y Leung Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Galina Grishina Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Hugh A Sampson Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Marc Witmer Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Mayte Suarez-Farinas Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Peter Dawson Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Robert Getts Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Robert Wood Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Scott Sicherer Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Stacie Jones Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Maria Suprun Wesley Burks Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients    1658 Ahla Ghauri Ingo Marenholz Cryopreservation of human immune cells for prospective single-cell transcriptome profiling in food allergy 1757 Ahla Ghauri Norbert Hbner Cryopreservation of human immune cells for prospective single-cell transcriptome profiling in food allergy 1757 Ahla Ghauri Young Ae Lee Cryopreservation of human immune cells for prospective single-cell transcriptome profiling in food allergy 1757 Svetlana Denisova Lydia Ilyenko Metabolic activity of intestinal microflora and artificial feeding 1708 Svetlana Denisova Olga Kachalova Metabolic activity of intestinal microflora and artificial feeding 1708 Svetlana Denisova Olga Tarasova Metabolic activity of intestinal microflora and artificial feeding 1708 Svetlana Denisova Tatyana Sentsova Metabolic activity of intestinal microflora and artificial feeding 1708 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC9933',\n",
       "  'type': 'Late Breaking Oral Abstract Sessions',\n",
       "  'category': 'Food allergy > Pediatrics > Allergy and clinical immunology',\n",
       "  'session': 'LB OAS 03 Pediatric food allergy: what is new?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921379,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB OAS 03 Pediatric food allergy: what is new? Bright Nwaru Emma Goksr Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age 1637 Bright Nwaru Gran Wennergren Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age 1637 Kirsty Logan Campbell Dianne Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Craven Joanna Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan E N Mills Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan George Du Toit Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Gideon Lack Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Graham Roberts Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Henry T Bahnson Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Johanna Bellach Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Kirsten Beyer Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Michael R Perkin Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Ronald Van Ree Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Kirsty Logan Ylescupidez Alyssa Early introduction of peanut reduces peanut allergy across different risk groups: Results from pooled and causal inference analyses 1867 Lavanya Diwakar Carole Cummins Understanding parent preferences for paediatric allergy services 1795 Lavanya Diwakar Tracy Roberts Understanding parent preferences for paediatric allergy services 1795 Stefania Arasi Alessandro Giovanni Fiocchi Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Arianna Cafarotti Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Carla Riccardi Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Lamia Dahdah Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Maria Carolina Colucci Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Maria Cristina Artesani Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Maurizio Mennini Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Rocco Valluzzi Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Valentina Pecora Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Veronica Calandrelli Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Stefania Arasi Vincenzo Fierro Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience  1650 Riccardo Scarpa Carlo Agostini Granulomatous-lymphocytic interstitial lung disease (GLILD) in CVID: A case-control retrospective study 1852 Riccardo Scarpa Francesco Cinetto Granulomatous-lymphocytic interstitial lung disease (GLILD) in CVID: A case-control retrospective study 1852 Riccardo Scarpa Raffaella Neri Granulomatous-lymphocytic interstitial lung disease (GLILD) in CVID: A case-control retrospective study 1852 Riccardo Scarpa Sabrina Gianese Granulomatous-lymphocytic interstitial lung disease (GLILD) in CVID: A case-control retrospective study 1852 Niamh Troy Barbara Holt Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 Niamh Troy Bosco Anthony Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 Niamh Troy Deborah Strickland Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 Niamh Troy Michael Serralha Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 Niamh Troy Patrick Holt Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 Niamh Troy Sally Galbraith Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 Niamh Troy Sly Peter Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 Niamh Troy Zahir Islam Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator 1801 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC9933',\n",
       "  'type': 'Late Breaking Oral Abstract Sessions',\n",
       "  'category': 'Allergy and clinical immunology > Allergy diagnosis and systems medicine > Food allergy',\n",
       "  'session': 'LB OAS 04 Skin diseases: what is new?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921380,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB OAS 04 Skin diseases: what is new? Arturo Rinaldi Angelica Korsfeldt Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Anita Dreher Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Britta Stolpe Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Cezmi A. Akdis Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Daniel Burla Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi David Melin Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Ellen D. Renner Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Eugen Bersuch Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Kristina Tsekova Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Marja Gautschi Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Matthias Mhrenschlager Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Nima Askary Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Per Svedenhag Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Simon Grant Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Arturo Rinaldi Siobhan Ward Electrical impedance spectroscopy as an efficient tool for the characterization of epithelial barrier in patients with atopic dermatitis 1731 Karin Hartmann Andrew Morrison Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Brenton Mar Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Cem Akin Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Daniel J. Deangelo Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Deepti H. Radia Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Frank Siebenhaar Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Hanneke Oude Elberink Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Hui-Min Lin Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Jason Gotlib Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Marcus Maurer Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Mariana Castells Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Mark L. Heaney Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Massimo Triggiani Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Michael W. Deininger Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Oleg Schmidt-Kittler Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Paul Van Daele Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Sigurd Broesby-Olsen Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Tracy I. George Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Karin Hartmann Vito Sabato Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study 1832 Marina Sabat Bresc Anna Sala-Cunill A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Beatriz Veleiro-Perez A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Carmen Diaz-Donado A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Julin Azofra A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Mar Guilarte A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Maria Luisa Baeza A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Marta Ferrer A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Moiss Labrador-Horrillo A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Nria Rodriguez-Garijo A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Pere Gaig A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Pilar Gil A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Marina Sabat Bresc Valeria Herrera-Lasso A tale of nobody\\x80\\x99s land: Histaminergic angioedema 1856 Martin Metz Anastasia Teterina Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz D James Haddon Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Gordon Sussman Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Jeremy J Lim Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Joshua Galanter Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Leslie Chinn Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Marcus Maurer Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Petra Staubach Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Remi Gagnon Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Timothy T Lu Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Tom Chu Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Tonny Tanus Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz Tracy Burgess Fenebrutinib in refractory chronic spontaneous urticaria 1692 Martin Metz William H Yang Fenebrutinib in refractory chronic spontaneous urticaria 1692 Ana Rostaher Adrian Urwyler Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers 1792 Ana Rostaher Cezmi Akdis Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers 1792 Ana Rostaher Claude Favrot Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers 1792 Ana Rostaher Lena Zwickl Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers 1792 Ana Rostaher Nina Fischer Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers 1792 Ana Rostaher Sabrina Audergon Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers 1792 Ana Rostaher Sabrina Rodriguez-Campos Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers 1792 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC9933',\n",
       "  'type': 'Late Breaking Oral Abstract Sessions',\n",
       "  'category': 'Drug allergy > Pediatrics',\n",
       "  'session': 'LB OAS 05 Drug allergy: state of the art',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921381,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB OAS 05 Drug allergy: state of the art Ricardo  Madrigal-Burgaleta Jaume Mart\\xad-Garrido Implementing drug provocation testing in the assessment and management pathways of reactions to chemotherapy and biological agents 1648 Ricardo  Madrigal-Burgaleta Kevin Molina Mata Implementing drug provocation testing in the assessment and management pathways of reactions to chemotherapy and biological agents 1648 Ricardo  Madrigal-Burgaleta Maria Teresa Dordal Implementing drug provocation testing in the assessment and management pathways of reactions to chemotherapy and biological agents 1648 Ricardo  Madrigal-Burgaleta Paula Vazquez-Revuelta Implementing drug provocation testing in the assessment and management pathways of reactions to chemotherapy and biological agents 1648 Ricardo  Madrigal-Burgaleta Ramon Lleonart Implementing drug provocation testing in the assessment and management pathways of reactions to chemotherapy and biological agents 1648 Annabelle Arnold Britta Von Ungern-Sternberg The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics 1729 Annabelle Arnold Kevin Murray The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics 1729 Annabelle Arnold Kristina Rueter The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics 1729 Annabelle Arnold Michaela Lucas The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics 1729 Annabelle Arnold Michelle Trevenen The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics 1729 Annabelle Arnold Zaheerah Haywood The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics 1729 Maria Rosario Caballero Iason Thomas Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort 1699 Maria Rosario Caballero Mike Weale Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort 1699 Maria Rosario Caballero Sevil Badin Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort 1699 Jessy Elst Athina L. Van Gasse MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Chris H. Bridts MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Christel Mertens MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Diana Campillo-Davo MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Didier G. Ebo MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Jean-Pierre Timmermans MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Marcus Maurer MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Margaretha A. Faber MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Margo M. Hagendorens MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Michel Van Houdt MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Viggo Van Tendeloo MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 Jessy Elst Vito Sabato MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing 1831 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC9933',\n",
       "  'type': 'Late Breaking Oral Abstract Sessions',\n",
       "  'category': 'Asthma > Allergy diagnosis and systems medicine > Food allergy',\n",
       "  'session': 'LB OAS 06 Allergy diagonosis and asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921382,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB OAS 06 Allergy diagonosis and asthma Hans Jrgen Hoffmann Alexandra Santos Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Anna Nopp Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Bernadette Eberlein Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Christian Mbs Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Christobalina Mayorga Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Didier Ebo Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Edward Knol Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Mariona Pascal Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Mohammed H Shamji Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Sanna Edelman Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Sarita U Patil Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Hans Jrgen Hoffmann Wolf-Jochen Geilenkeuser Building confidence in the basophil activation test: Standardization and external quality assurance - an EAACI task force 1844 Christoph Nagl Carla Mastrorilli Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Carlo Caffarelli Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Francesca Cipriani Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Giampaolo Ricci Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Karin Hoffmann-Sommergruber Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Merima Bublin Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Paolo Matricardi Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Roberto Bernadini Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Salvatore Tripodi Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Christoph Nagl Sebastian Kleinfercher Purification and characterization of a novel kiwifruit allergen from the gibberellin-regulated protein (GRP) family 1725 Maciej Chalubinski Adrian Gajewski Transmission of the rhinovirus HRV16 from rhinovirus-infected human airway epithelium to the human pulmonary vascular endothelium 1759 Maciej Chalubinski Magdalena Chmiela Transmission of the rhinovirus HRV16 from rhinovirus-infected human airway epithelium to the human pulmonary vascular endothelium 1759 Maciej Chalubinski Marek L. Kowalski Transmission of the rhinovirus HRV16 from rhinovirus-infected human airway epithelium to the human pulmonary vascular endothelium 1759 Maciej Chalubinski Mateusz Gawrysiak Transmission of the rhinovirus HRV16 from rhinovirus-infected human airway epithelium to the human pulmonary vascular endothelium 1759 Maciej Chalubinski Robert Szewczyk Transmission of the rhinovirus HRV16 from rhinovirus-infected human airway epithelium to the human pulmonary vascular endothelium 1759 Giorgio Walter Canonica Annie Burden Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Arjun Mohan Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Borja G. Cosio Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Esther Garcia Gil Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Francesco Menzella Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica James G. Zangrilli Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Lawrence Mcdermott Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Nijira L. Lugogo Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Pascal Chanez Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Renaud Louis Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Giorgio Walter Canonica Tim W. Harrison Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial 1647 Fabiana Furci Annarita Dama Unmasking the true asthma control: Results from a pharmacy population based survey 1663 Fabiana Furci Bianca Olivieri Unmasking the true asthma control: Results from a pharmacy population based survey 1663 Fabiana Furci Chiara Bovo Unmasking the true asthma control: Results from a pharmacy population based survey 1663 Fabiana Furci Gianenrico Senna Unmasking the true asthma control: Results from a pharmacy population based survey 1663 Fabiana Furci Marco Caminati Unmasking the true asthma control: Results from a pharmacy population based survey 1663 Lavinia Davidescu _ On Behalf Of The Ab07015 Study Group Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Eduard Khodosh Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Elliot Israel Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Gilles Devouassoux Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Grigoriy Ursol Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Lesia Kuryk Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Monja-Marie Nortje Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Oleksii Korzh Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Olga Godlevska Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Olivier Hermine Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Pascal Chanez Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 Lavinia Davidescu Vikranth Deshmukh Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015 1874 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC9933',\n",
       "  'type': 'Late Breaking Oral Abstract Sessions',\n",
       "  'category': 'Food allergy > Asthma > Environmental and occupational allergy',\n",
       "  'session': 'LB OAS 07 Food allergy and environmental allergies: what is new?',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921383,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Oral Abstract Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Oral Abstract Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB OAS 07 Food allergy and environmental allergies: what is new? Andrew Clark Elizabeth Powell Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting 1727 Andrew Clark Pamela Ewan Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting 1727 Andrew Clark Quiza Zolkipli Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting 1727 Richard E. Goodman Philip E Johnson Should we use partial allergen sequence information for food allergy risk assessment?  1781 Yvan Vandenplas Ana Moreno \\x81lvarez Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Anne Goh Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Maria Laura Gosoniu Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Marta Zolnowska Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Monika Tadi Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Ralf G Heine Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Roberto Berni Canani Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Sin Ludman Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Yvan Vandenplas Zsuzsanna Tengelyi Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow\\x80\\x99s milk allergy 1885 Denise Rauer Athanasios Damialis A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Claudia Traidl-Hoffmann A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Fiona Skottke A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Franziska Kolek A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Mar\\xada Plaza A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Selina Herrmann A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Stefanie Gilles A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Vera Schwierzeck A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 Denise Rauer Vivien Leier-Wirtz A walk in the park: Exposure to fungal spores increases nasal inflammatory responses to grass pollen and changes the nasal mycobiome 1686 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Allergen immunotherapy     ',\n",
       "  'session': 'PDS 01 Allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921278,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 01 Allergen immunotherapy Evgeniia Korotchenko David Calzada Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Evgeniia Korotchenko Isabella Anna Joubert Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Evgeniia Korotchenko Jernimo Carns Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Evgeniia Korotchenko Jutta Horejs-Hoeck Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Evgeniia Korotchenko Michael Hauser Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Evgeniia Korotchenko Raquel Moya Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Evgeniia Korotchenko Richard Weiss Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Evgeniia Korotchenko Sandra Scheiblhofer Therapeutic efficacy of depigmented house dust mite extract cutaneous immunizations 1141 Xenia Bovermann Christian Vogelberg Accelerated dose escalation schedule with 3 injections of a 6-grasses allergoid preparation is safe in children and adolescents 1186 Xenia Bovermann Ludger Klimek Accelerated dose escalation schedule with 3 injections of a 6-grasses allergoid preparation is safe in children and adolescents 1186 Xenia Bovermann Matthias Kopp Accelerated dose escalation schedule with 3 injections of a 6-grasses allergoid preparation is safe in children and adolescents 1186 Albert Roger Ana Tabar Safety and tolerability of a subcutaneously administered tyrosine adsorbed modified mites allergen MIX + MPL 289 Albert Roger Clara Estany Safety and tolerability of a subcutaneously administered tyrosine adsorbed modified mites allergen MIX + MPL 289 Albert Roger Clara Padr Safety and tolerability of a subcutaneously administered tyrosine adsorbed modified mites allergen MIX + MPL 289 Albert Roger Dolores Hernndez Safety and tolerability of a subcutaneously administered tyrosine adsorbed modified mites allergen MIX + MPL 289 Albert Roger Jos Luis Justicia Safety and tolerability of a subcutaneously administered tyrosine adsorbed modified mites allergen MIX + MPL 289 Albert Roger Pieter Jan De Kam Safety and tolerability of a subcutaneously administered tyrosine adsorbed modified mites allergen MIX + MPL 289 Thalia L. Carreo Matthew D. Heath Conventional immunotherapy vs nano-vaccination in high risk allergy 244 Thalia L. Carreo Matthias F. Kramer Conventional immunotherapy vs nano-vaccination in high risk allergy 244 Thalia L. Carreo Murray A. Skinner Conventional immunotherapy vs nano-vaccination in high risk allergy 244 Alicia Chenoweth Andrew Tutt Glyco-engineering and IgG-Fc mutations to improve efficacy of monoclonal antibody therapy for breast cancer 1074 Alicia Chenoweth Anita Grigoriadis Glyco-engineering and IgG-Fc mutations to improve efficacy of monoclonal antibody therapy for breast cancer 1074 Alicia Chenoweth Anthony Cheung Glyco-engineering and IgG-Fc mutations to improve efficacy of monoclonal antibody therapy for breast cancer 1074 Alicia Chenoweth Kristina Ilieva Glyco-engineering and IgG-Fc mutations to improve efficacy of monoclonal antibody therapy for breast cancer 1074 Alicia Chenoweth Rebecca Marlow Glyco-engineering and IgG-Fc mutations to improve efficacy of monoclonal antibody therapy for breast cancer 1074 Alicia Chenoweth Sophia Karagiannis Glyco-engineering and IgG-Fc mutations to improve efficacy of monoclonal antibody therapy for breast cancer 1074 Jos Fernando Florido Lpez Carmelo Escudero Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Carmen Andreu Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Dorimar Brugaletta Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Leticia Herrero Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Lluis A. Navarro Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Marta Seoane Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Mercedes Hernndez Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Miguel Torrecilla Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Jos Fernando Florido Lpez Mnica Antn Effectiveness and safety of immunotherapy with an allergoid adjuvanted with a TLR-4 agonist in asthmatic patients allergic to olive pollen: Results of a controlled retrospective study 285 Mnica Ru\\xadz Garc\\xada Jaime Sanchez-Lopez Sustained long-term clinical effectiveness of subcutaneous allergen immunotherapy to house dust mites 776 Mnica Ru\\xadz Garc\\xada Jose Carlos Garcia-Robaina Sustained long-term clinical effectiveness of subcutaneous allergen immunotherapy to house dust mites 776 Mnica Ru\\xadz Garc\\xada Carmen Vidal Safety and efficacy of subcutaneous immunotherapy with undiluted mixture of two different depigmented-polymerized mite extracts 1043 Mnica Ru\\xadz Garc\\xada Francisco Carballada-Gonzalez Safety and efficacy of subcutaneous immunotherapy with undiluted mixture of two different depigmented-polymerized mite extracts 1043 Mnica Ru\\xadz Garc\\xada Jaime Sanchez-Lopez Safety and efficacy of subcutaneous immunotherapy with undiluted mixture of two different depigmented-polymerized mite extracts 1043 Mnica Ru\\xadz Garc\\xada Jose Carlos Garcia-Robaina Safety and efficacy of subcutaneous immunotherapy with undiluted mixture of two different depigmented-polymerized mite extracts 1043 Mnica Ru\\xadz Garc\\xada Sara Lopez-Freire Safety and efficacy of subcutaneous immunotherapy with undiluted mixture of two different depigmented-polymerized mite extracts 1043 Stefania Arasi Ifigenia Sfika A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Marco Di Fraia A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Maria Antonia Brighetti A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Paolo Maria Matricardi A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Pierluigi Verardo A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Salvatore Tripodi A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Serena Perna A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Stephanie Dramburg A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Sveva Castelli A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Travaglini Alessandro A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Valeria Villella A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Stefania Arasi Villalta Danilo A multiparametric approach to allergen immunotherapy prescription in children and adults with seasonal allergic rhinitis 1431 Patricia Vanessa Rostan Andrea Wangorsch Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Patricia Vanessa Rostan Benno Weigmann Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Patricia Vanessa Rostan Edith Graulich Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Patricia Vanessa Rostan Iris Bellinghausen Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Patricia Vanessa Rostan Joachim Saloga Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Patricia Vanessa Rostan Kerstin Steinbrink Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Patricia Vanessa Rostan Robert Ose Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Patricia Vanessa Rostan Stephan Scheurer Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies 306 Anna Ntalli Bernhard Meineke Allergenic activity determination of therapeutic house dust mites allergen preparations adsorbed to aluminum hydroxide by ImmunoCAP inhibition assay 1014 Anna Ntalli Christoph Willers Allergenic activity determination of therapeutic house dust mites allergen preparations adsorbed to aluminum hydroxide by ImmunoCAP inhibition assay 1014 Anna Ntalli Gerald Reese Allergenic activity determination of therapeutic house dust mites allergen preparations adsorbed to aluminum hydroxide by ImmunoCAP inhibition assay 1014 Anna Ntalli Katja Tonn Allergenic activity determination of therapeutic house dust mites allergen preparations adsorbed to aluminum hydroxide by ImmunoCAP inhibition assay 1014 Anna Ntalli Kerstin Bauermeister Allergenic activity determination of therapeutic house dust mites allergen preparations adsorbed to aluminum hydroxide by ImmunoCAP inhibition assay 1014 Anna Ntalli Nadine Muchow Allergenic activity determination of therapeutic house dust mites allergen preparations adsorbed to aluminum hydroxide by ImmunoCAP inhibition assay 1014 Anna Ntalli Steffen Augustin Allergenic activity determination of therapeutic house dust mites allergen preparations adsorbed to aluminum hydroxide by ImmunoCAP inhibition assay 1014 Mulin Feng Jing Li Allergen immunotherapy-induced igG4 reduces basophil activation in house dust mite allergic asthma patients 96 Mulin Feng Mo Xian Allergen immunotherapy-induced igG4 reduces basophil activation in house dust mite allergic asthma patients 96 Mulin Feng Qiujuan Su Allergen immunotherapy-induced igG4 reduces basophil activation in house dust mite allergic asthma patients 96 Mulin Feng Rundong Qin Allergen immunotherapy-induced igG4 reduces basophil activation in house dust mite allergic asthma patients 96 Mulin Feng Xiaohui Zeng Allergen immunotherapy-induced igG4 reduces basophil activation in house dust mite allergic asthma patients 96 Mulin Feng Xu Shi Allergen immunotherapy-induced igG4 reduces basophil activation in house dust mite allergic asthma patients 96 Olatz Zenarruzabeitia Agurtzane Bilbao Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Olatz Zenarruzabeitia Ane Orrantia Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Olatz Zenarruzabeitia Francisco Borrego Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Olatz Zenarruzabeitia Ignacio Jauregui Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Olatz Zenarruzabeitia Iigo Terrn Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Olatz Zenarruzabeitia Joana Vitall Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Olatz Zenarruzabeitia M Dolores Martinez Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Olatz Zenarruzabeitia Pedro M. Gamboa Immunological changes, including CD300 molecules expression, during allergen desensitization immunotherapy 741 Rongfei Zhu Fedina Oleksandra Establishing a Th2 and Tfh cell exhaustion in vitro model using TCR Signaling to test T cell anergy during immunotherapy 1236 Rongfei Zhu Hanisah Sharif Establishing a Th2 and Tfh cell exhaustion in vitro model using TCR Signaling to test T cell anergy during immunotherapy 1236 Rongfei Zhu Janice A Layhadi Establishing a Th2 and Tfh cell exhaustion in vitro model using TCR Signaling to test T cell anergy during immunotherapy 1236 Rongfei Zhu Mohamed H Shamji Establishing a Th2 and Tfh cell exhaustion in vitro model using TCR Signaling to test T cell anergy during immunotherapy 1236 Rongfei Zhu Stephen R Durham Establishing a Th2 and Tfh cell exhaustion in vitro model using TCR Signaling to test T cell anergy during immunotherapy 1236 Rongfei Zhu Wannada Laisuan Establishing a Th2 and Tfh cell exhaustion in vitro model using TCR Signaling to test T cell anergy during immunotherapy 1236 Rongfei Zhu Zheng Liu Establishing a Th2 and Tfh cell exhaustion in vitro model using TCR Signaling to test T cell anergy during immunotherapy 1236 Loredana Della Valle Alessia Gatta Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Anila Rita Farinelli Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Arianna Lumaca Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Claudia Petrarca Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Enrico Cavallucci Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Gilda Scarano Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Mario Di Gioacchino Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Pietro Del Biondo Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Loredana Della Valle Roberto Paganelli Mite immunotherapy induces maturation of highly differentiated (activated and secreting) T regulatory cells 1353 Maria Regina Strobl Andrea Wangorsch Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet&nbsp;v&nbsp;1 or Mal&nbsp;d&nbsp;1 1138 Maria Regina Strobl Barbara Bohle Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet&nbsp;v&nbsp;1 or Mal&nbsp;d&nbsp;1 1138 Maria Regina Strobl Christian Lupinek Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet&nbsp;v&nbsp;1 or Mal&nbsp;d&nbsp;1 1138 Maria Regina Strobl Claudia Kitzmller Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet&nbsp;v&nbsp;1 or Mal&nbsp;d&nbsp;1 1138 Maria Regina Strobl Gabriela Snchez Acosta Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet&nbsp;v&nbsp;1 or Mal&nbsp;d&nbsp;1 1138 Maria Regina Strobl Tamar Kinaciyan Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet&nbsp;v&nbsp;1 or Mal&nbsp;d&nbsp;1 1138 Ting Fan Leung Christine Yee Yan Wai Durable curative effects of hypoallergen nanoplasmid vaccine in a mouse model of shrimp hypersensitivity 559 Ting Fan Leung Ka Hou Chu Durable curative effects of hypoallergen nanoplasmid vaccine in a mouse model of shrimp hypersensitivity 559 Ting Fan Leung Patrick S C Leung Durable curative effects of hypoallergen nanoplasmid vaccine in a mouse model of shrimp hypersensitivity 559 Maja Zabel Bernhard Kratzer Chimeric antigen receptor (CAR) T cells for the treatment of allergy 1038 Maja Zabel Doris Trapin Chimeric antigen receptor (CAR) T cells for the treatment of allergy 1038 Maja Zabel Peter Steinberger Chimeric antigen receptor (CAR) T cells for the treatment of allergy 1038 Maja Zabel Winfried Pickl Chimeric antigen receptor (CAR) T cells for the treatment of allergy 1038 anila rita farinelli Alessia Gatta Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 anila rita farinelli Arianna Lumaca Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 anila rita farinelli Claudia Petrarca Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 anila rita farinelli Gilda Scarano Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 anila rita farinelli Loredana Della Valle Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 anila rita farinelli Mario Di Gioacchino Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 anila rita farinelli Pietro Del Biondo Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 anila rita farinelli Roberto Paganelli Vitamin D supplementation enhances the efficacy of mite sublingual immunotherapy with monomeric allergoid 1324 Sara Bjrk Stefnsdttir Antonia Fettelschoss-Gabriel Development of immunotherapy against equine insect bite hypersensitivity 1455 Sara Bjrk Stefnsdttir Eliane Marti Development of immunotherapy against equine insect bite hypersensitivity 1455 Sara Bjrk Stefnsdttir Elisa Bach Development of immunotherapy against equine insect bite hypersensitivity 1455 Sara Bjrk Stefnsdttir Holmfridur Kristjansdottir Development of immunotherapy against equine insect bite hypersensitivity 1455 Sara Bjrk Stefnsdttir Sigridur Jonsdottir Development of immunotherapy against equine insect bite hypersensitivity 1455 Sara Bjrk Stefnsdttir Sigurbjorg Torsteinsdottir Development of immunotherapy against equine insect bite hypersensitivity 1455 Sara Bjrk Stefnsdttir Vilhjalmur Svansson Development of immunotherapy against equine insect bite hypersensitivity 1455 Francisco Moreno Albert Roger Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Francisco Moreno Alfons Malet Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Francisco Moreno Antonio Parra Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Francisco Moreno Antonio Valero Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Francisco Moreno Carla Torn Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Francisco Moreno Clara Padr Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Francisco Moreno Jos L. Justicia Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Francisco Moreno Victoria Moreno Immunologic profile of patients allergic to dermatophagoides pteronyssinus as a biomarker of response to allergen immunotherapy 234 Anna Sala Carla Torn Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Fernando Rodr\\xadguez Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Gemma Biarns Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Jos A. \\x81lvarez Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Jos L. Justicia Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Jos R. Lav\\xadn Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Juan A. Mart\\xadnez Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Juan J. Liana Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Marta Barquero Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Sof\\xada Lain Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Snia Gelis Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Tefilo Lobera Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Anna Sala Valentina Gutirrez Effectiveness and safety of a glutaraldehyde-modified microcrystalline tyrosine (MCT)-associated extract of mites in patients with allergic rhinitis: Results of a retrospective study 240 Yuriko Maekawa Chiyoko Kunishima Post-marketing survey evaluating the safety and efficacy of the SQ house dust mite (HDM) sublingual immunotherapy-tablet in Japanese patients with HDM-induced allergic rhinitis (2016-19 Analysis) 286 Yuriko Maekawa Keiichi Taniguchi Post-marketing survey evaluating the safety and efficacy of the SQ house dust mite (HDM) sublingual immunotherapy-tablet in Japanese patients with HDM-induced allergic rhinitis (2016-19 Analysis) 286 Yuriko Maekawa Noriaki Nishino Post-marketing survey evaluating the safety and efficacy of the SQ house dust mite (HDM) sublingual immunotherapy-tablet in Japanese patients with HDM-induced allergic rhinitis (2016-19 Analysis) 286 Yuriko Maekawa Remi Hashimoto Post-marketing survey evaluating the safety and efficacy of the SQ house dust mite (HDM) sublingual immunotherapy-tablet in Japanese patients with HDM-induced allergic rhinitis (2016-19 Analysis) 286 Mrcio Andr Mesquita Ana Reis Ferreira Allergen immunotherapy compliance: Risk factors for early interruption 1200 Mrcio Andr Mesquita Ana Rita Presa Allergen immunotherapy compliance: Risk factors for early interruption 1200 Mrcio Andr Mesquita Cristina Valente Allergen immunotherapy compliance: Risk factors for early interruption 1200 Mrcio Andr Mesquita Ins Lopes Allergen immunotherapy compliance: Risk factors for early interruption 1200 Mrcio Andr Mesquita Joana Gomes Allergen immunotherapy compliance: Risk factors for early interruption 1200 Julie Willekens Lara Moons Using virtual reality during immunotherapy in children: Pilot study 1006 Julie Willekens Patricia Oosterlinck Using virtual reality during immunotherapy in children: Pilot study 1006 Julie Willekens Peter Vermeir Using virtual reality during immunotherapy in children: Pilot study 1006 Julie Willekens Philippe Gevaert Using virtual reality during immunotherapy in children: Pilot study 1006 Julie Willekens Ruben Vermeir Using virtual reality during immunotherapy in children: Pilot study 1006 Julie Willekens Tiffany Verhaeghe Using virtual reality during immunotherapy in children: Pilot study 1006 Martin Wald Anne Coss Formallergoids are more resistant against aggregation induced by thermal stress than native allergen extracts 886 Martin Wald Anton Roemer Formallergoids are more resistant against aggregation induced by thermal stress than native allergen extracts 886 Martin Wald Christoph Willers Formallergoids are more resistant against aggregation induced by thermal stress than native allergen extracts 886 Martin Wald Kerstin Bauermeister Formallergoids are more resistant against aggregation induced by thermal stress than native allergen extracts 886 Martin Wald Steffen Augustin Formallergoids are more resistant against aggregation induced by thermal stress than native allergen extracts 886 Steffen Augustin Christoph Willers Matching the allergen composition of diagnostic and therapeutic pollen allergen products with the allergome of the respective species 1076 Steffen Augustin Frank Fischer Matching the allergen composition of diagnostic and therapeutic pollen allergen products with the allergome of the respective species 1076 Steffen Augustin Thomas Eichhorn Matching the allergen composition of diagnostic and therapeutic pollen allergen products with the allergome of the respective species 1076 Kerstin Bauermeister Christoph Willers Identification and quantification of Der p 23 across the manufacturing process of a therapeutic mite allergen product 1268 Kerstin Bauermeister Frank Fischer Identification and quantification of Der p 23 across the manufacturing process of a therapeutic mite allergen product 1268 Kerstin Bauermeister Kornelia Engler Identification and quantification of Der p 23 across the manufacturing process of a therapeutic mite allergen product 1268 Kerstin Bauermeister Steffen Augustin Identification and quantification of Der p 23 across the manufacturing process of a therapeutic mite allergen product 1268 Kerstin Bauermeister Thomas Eichhorn Identification and quantification of Der p 23 across the manufacturing process of a therapeutic mite allergen product 1268 Jing Li Renbin Huang Effect of dermatophagoides pteronyssinus immunotherapy on upper and lower airway inflammatory response to nasal allergen challenge 90 Jing Li Rundong Qin Effect of dermatophagoides pteronyssinus immunotherapy on upper and lower airway inflammatory response to nasal allergen challenge 90 Mohammad Farazuddin Chang H Kim Intranasal adjuvant nanoemulsion requires retinoic acid receptor signaling in dendritic cells to induce T cell responses 97 Mohammad Farazuddin James R Baker Jr* Intranasal adjuvant nanoemulsion requires retinoic acid receptor signaling in dendritic cells to induce T cell responses 97 Mohammad Farazuddin Leon Friesen Intranasal adjuvant nanoemulsion requires retinoic acid receptor signaling in dendritic cells to induce T cell responses 97 Mohammad Farazuddin Nicholas Ludka Intranasal adjuvant nanoemulsion requires retinoic acid receptor signaling in dendritic cells to induce T cell responses 97 Ignacio Garc\\xada Nez Anna Boronat Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Ignacio Garc\\xada Nez Dolores Martos Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Ignacio Garc\\xada Nez Jos L. Justicia Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Ignacio Garc\\xada Nez Jos L. Prez-Formoso Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Ignacio Garc\\xada Nez Mercedes Ram\\xadrez Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Ignacio Garc\\xada Nez Ramn Nez Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Ignacio Garc\\xada Nez Sandra Vicario Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Ignacio Garc\\xada Nez Zulay Almeida Immunotherapy with a microcrystalline tyrosine (MCT)-associated mites allergoid reduces severity of disease and emergency visits in asthmatic patients 229 Maria Ins Silva Clia Costa Pru p 3 sublingual immunotherapy - rush protocol versus ultra- rush protocol: Comparing safety 1257 Maria Ins Silva Ftima Cabral Duarte Pru p 3 sublingual immunotherapy - rush protocol versus ultra- rush protocol: Comparing safety 1257 Maria Ins Silva Manuel Pereira Barbosa Pru p 3 sublingual immunotherapy - rush protocol versus ultra- rush protocol: Comparing safety 1257 Maria Ins Silva Marisa Paulino Pru p 3 sublingual immunotherapy - rush protocol versus ultra- rush protocol: Comparing safety 1257 Leticia Herrero Lifona Carmelo Escudero Immunotherapy with a microcrystalline tyrosine-adjuvanted allergoid combined with a TLR-4 agonist reduces emergency room admissions and improves asthma severity in children allergic to olive pollen 288 Leticia Herrero Lifona Fernando Florido Immunotherapy with a microcrystalline tyrosine-adjuvanted allergoid combined with a TLR-4 agonist reduces emergency room admissions and improves asthma severity in children allergic to olive pollen 288 Leticia Herrero Lifona Jess Mac\\xadas Immunotherapy with a microcrystalline tyrosine-adjuvanted allergoid combined with a TLR-4 agonist reduces emergency room admissions and improves asthma severity in children allergic to olive pollen 288 Leticia Herrero Lifona Marta Seoane Immunotherapy with a microcrystalline tyrosine-adjuvanted allergoid combined with a TLR-4 agonist reduces emergency room admissions and improves asthma severity in children allergic to olive pollen 288 Leticia Herrero Lifona Mercedes Hernndez Immunotherapy with a microcrystalline tyrosine-adjuvanted allergoid combined with a TLR-4 agonist reduces emergency room admissions and improves asthma severity in children allergic to olive pollen 288 Leticia Herrero Lifona Miguel Torrecilla Immunotherapy with a microcrystalline tyrosine-adjuvanted allergoid combined with a TLR-4 agonist reduces emergency room admissions and improves asthma severity in children allergic to olive pollen 288 Leticia Herrero Lifona Rafael Pineda Immunotherapy with a microcrystalline tyrosine-adjuvanted allergoid combined with a TLR-4 agonist reduces emergency room admissions and improves asthma severity in children allergic to olive pollen 288 Natalia G. Antonevich A Filatava Method of olfactory epithelium-derived mesenchymal stem cells pooling for application in cell therapy 1294 Natalia G. Antonevich A Hancharou Method of olfactory epithelium-derived mesenchymal stem cells pooling for application in cell therapy 1294 Natalia G. Antonevich A Rynda Method of olfactory epithelium-derived mesenchymal stem cells pooling for application in cell therapy 1294 Natalia G. Antonevich L M Dubuske Method of olfactory epithelium-derived mesenchymal stem cells pooling for application in cell therapy 1294 Haifeng Zhong Jing Li Cell free facilitated allergen binding (ELIFAB) in autologous serum enables direct competition between allergen specific IgE and non-IgE 782 Haifeng Zhong Peter A. Wrtzen Cell free facilitated allergen binding (ELIFAB) in autologous serum enables direct competition between allergen specific IgE and non-IgE 782 Haifeng Zhong Shi Chen Cell free facilitated allergen binding (ELIFAB) in autologous serum enables direct competition between allergen specific IgE and non-IgE 782 Haifeng Zhong Xiaoxiong Xiao Cell free facilitated allergen binding (ELIFAB) in autologous serum enables direct competition between allergen specific IgE and non-IgE 782 Haifeng Zhong Xuxin Lai Cell free facilitated allergen binding (ELIFAB) in autologous serum enables direct competition between allergen specific IgE and non-IgE 782 Hui Gan Guanghui Liu Omalizumab improves safety, compliance, and symptom control in mites SCIT in Chinese children<br /> 490 Hui Gan Xiang Dong Omalizumab improves safety, compliance, and symptom control in mites SCIT in Chinese children<br /> 490 Vronique Gomord Anne-Catherine Fitchette Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Elizabeth Fixman Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Guillaume Beauverger Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Guy Tropper Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Loic Faye Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Lorna Garnier Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Louis-P Vezina Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Rjean Desgagnes Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Ronald Van Ree Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Sbastien Viel Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Stefanie Busold Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Vronique Gomord Virginie Stordeur Engineering&nbsp;eBioparticles for allergen immunotherapy 1097 Shigeki Katoh Hiroki Matsuhara Hyaluronan enhances the effect of allergen-specific sublingual immunotherapy in a dermatophagoides farinae-induced mouse model of chronic asthma 47 Shigeki Katoh Hitomi Tanaka Hyaluronan enhances the effect of allergen-specific sublingual immunotherapy in a dermatophagoides farinae-induced mouse model of chronic asthma 47 Shigeki Katoh Katsuyo Ohashi-Doi Hyaluronan enhances the effect of allergen-specific sublingual immunotherapy in a dermatophagoides farinae-induced mouse model of chronic asthma 47 Shigeki Katoh Toru Oga Hyaluronan enhances the effect of allergen-specific sublingual immunotherapy in a dermatophagoides farinae-induced mouse model of chronic asthma 47 Rebecca V Parkin David Larson Evaluating a method validation to deplete, purify and determine the function of IgG4, IgA1 and IgA2 antibodies induced following sublingual immunotherapy in patients with allergic rhinitis 1160 Rebecca V Parkin Didem Sanver Evaluating a method validation to deplete, purify and determine the function of IgG4, IgA1 and IgA2 antibodies induced following sublingual immunotherapy in patients with allergic rhinitis 1160 Rebecca V Parkin Guy W Scadding Evaluating a method validation to deplete, purify and determine the function of IgG4, IgA1 and IgA2 antibodies induced following sublingual immunotherapy in patients with allergic rhinitis 1160 Rebecca V Parkin Mohamed H Shamji Evaluating a method validation to deplete, purify and determine the function of IgG4, IgA1 and IgA2 antibodies induced following sublingual immunotherapy in patients with allergic rhinitis 1160 Rebecca V Parkin Stephen R Durham Evaluating a method validation to deplete, purify and determine the function of IgG4, IgA1 and IgA2 antibodies induced following sublingual immunotherapy in patients with allergic rhinitis 1160 Rebecca V Parkin Wannada Laisuan Evaluating a method validation to deplete, purify and determine the function of IgG4, IgA1 and IgA2 antibodies induced following sublingual immunotherapy in patients with allergic rhinitis 1160 Saurabh Bhargava Vishal Bhargava Topical delivery of aceclofenac by novel nanostructured carrier 1341 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Allergy and clinical immunology',\n",
       "  'session': 'PDS 02 Allergy and clinical immunology ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921285,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 02 Allergy and clinical immunology  Ella Vitalievna Churyukina Angela Vladimirovna Moskovkina The hyperandrogenic syndrome as a promoting factor for allergic diseases in pubertal girls 524 Ella Vitalievna Churyukina Olesya Zinovievna Puzikova The hyperandrogenic syndrome as a promoting factor for allergic diseases in pubertal girls 524 Ella Vitalievna Churyukina Victoria Alexandrovna Popova The hyperandrogenic syndrome as a promoting factor for allergic diseases in pubertal girls 524 Ekaterina Kozlova Irina Guseva Characteristics of growth in children with severe atopic dermatitis 513 Ekaterina Kozlova Irina Zakharova Characteristics of growth in children with severe atopic dermatitis 513 Ekaterina Kozlova Mariam Zakharian Characteristics of growth in children with severe atopic dermatitis 513 Ekaterina Kozlova Natalia Zvonkova Characteristics of growth in children with severe atopic dermatitis 513 Ekaterina Kozlova Nikolay Murashkin Characteristics of growth in children with severe atopic dermatitis 513 Ekaterina Kozlova Tatiana Borovik Characteristics of growth in children with severe atopic dermatitis 513 Elisa Marziali Cinzia De Libero Tacrolimus 0.1% eye drops for severe vernal keratoconjunctivitis in a pediatric population: Long-term efficacy and safety 1320 Elisa Marziali Gioia Danti Tacrolimus 0.1% eye drops for severe vernal keratoconjunctivitis in a pediatric population: Long-term efficacy and safety 1320 Elisa Marziali Laura Di Grande Tacrolimus 0.1% eye drops for severe vernal keratoconjunctivitis in a pediatric population: Long-term efficacy and safety 1320 Elisa Marziali Neri Pucci Tacrolimus 0.1% eye drops for severe vernal keratoconjunctivitis in a pediatric population: Long-term efficacy and safety 1320 Elisa Marziali Roberto Caputo Tacrolimus 0.1% eye drops for severe vernal keratoconjunctivitis in a pediatric population: Long-term efficacy and safety 1320 Myriam Mamodaly Bertine Flokstra De Blok EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Clara Gaudin EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Elizabeth Angier EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Jantina Van Der Velde EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Janwillen Kocks EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Kerstin Romberg EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Luciana Kase Tanno EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Pascal Demoly EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Radek Gawlik EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Myriam Mamodaly Ryan Dermot EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care 987 Tiago Azenha Rama Alberto \\x93rfo Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Ana Filipa Henriques Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Andrea Mayado Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Andrs Garc\\xada-Montero Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Carolina Caldas Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Ins Torrado Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Ivn Alvarez-Twose Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Javier Ignacio Muoz-Gonzlez Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Laura Sanchez-Muoz Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Tiago Azenha Rama Mar\\xada Jara-Acevedo Mast cell activation syndromes presenting as anaphylaxis: A comparison study between two predictive scores for mast cell clonality<br /> 1220 Marek Niedoszytko Aleksandra Grska Grska Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Boguslaw Nedoszytko Nedoszytko Nedoszytko Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Dominik Strapagiel Strapagiel Strapagiel Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Hanneke OudeElberink Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Jasper Van Doormaal van Doormaal Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Leszek Kalinowski Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Magdalena Lange Lange Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Marta Gruchala-Niedoszytko Gruchala-Niedoszytko Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Marta Sobalska-Kwapis Sobalska-Kwapis Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Peter Valent Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Marek Niedoszytko Roman Nowicki Results from a genome-wide association study&nbsp;(GWAS) in mastocytosis reveal new gene polymorphisms associated with WHO subgroups 1350 Ali H Ziyab Yaser M Ali Association of psoriasis with allergic multimorbidity of asthma, rhinitis, and eczema among schoolchildren: A cross-sectional study 360 Isabella Pali-Schll Anneliese Kasper-Giebl Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Donata Vercelli Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Erika Jensen-Jarolim Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Erika Von Mutius Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Franziska Roth-Walter Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Gerlinde Hofstetter Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Karin Hufnagl Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Luis Fernandez Pacios Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Rodolfo Bianchini Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Sheriene Moussa Afify Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Simona Winkler Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Stella Ahlers Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Stephan Hann Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Theresa Altemeier Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Isabella Pali-Schll Thomas Wittek Secretory beta-lactoglobulin associated with zinc in stable dust causes a Th1 immune bias in vitro and may contribute to the allergy protective effect of cattle farms 834 Anna Danica Josepha Korath Erika Jensen-Jarolim Qualitative and quantitative comparison of pollen allergen exposure between horses and human - a collaborative study with the Austrian pollen information service 1398 Anna Danica Josepha Korath Gerlinde Hofstetter Qualitative and quantitative comparison of pollen allergen exposure between horses and human - a collaborative study with the Austrian pollen information service 1398 Anna Danica Josepha Korath Karin Hufnagl Qualitative and quantitative comparison of pollen allergen exposure between horses and human - a collaborative study with the Austrian pollen information service 1398 Anna Danica Josepha Korath Katharina Bastl Qualitative and quantitative comparison of pollen allergen exposure between horses and human - a collaborative study with the Austrian pollen information service 1398 Anna Danica Josepha Korath Maximilian Bastl Qualitative and quantitative comparison of pollen allergen exposure between horses and human - a collaborative study with the Austrian pollen information service 1398 Anna Danica Josepha Korath Uwe E. Berger Qualitative and quantitative comparison of pollen allergen exposure between horses and human - a collaborative study with the Austrian pollen information service 1398 Ebenezer Satyaraj Peichuan Sun Specific anti-Fel d 1 IgY neutralizes Fel d 1, the major cat allergen, and reduces basophil degranulation 1083 Ebenezer Satyaraj Scott Sherrill Specific anti-Fel d 1 IgY neutralizes Fel d 1, the major cat allergen, and reduces basophil degranulation 1083 Mojca  Bizjak Dorothea Terhorst-Molawi Features of cold urticaria linked to cold-induced anaphylaxis 1482 Mojca  Bizjak Marcus Maurer Features of cold urticaria linked to cold-induced anaphylaxis 1482 Mojca  Bizjak Mitja Konik Features of cold urticaria linked to cold-induced anaphylaxis 1482 Clare Oni Chris Rutkowski Predicting systemic mastocytosis in patients with severe anaphylaxis &ndash; a UK single centre experience 1187 Clare Oni Clive E Grattan Predicting systemic mastocytosis in patients with severe anaphylaxis &ndash; a UK single centre experience 1187 Clare Oni Deepto Radia Predicting systemic mastocytosis in patients with severe anaphylaxis &ndash; a UK single centre experience 1187 Clare Oni Nicholas C. P. Cross Predicting systemic mastocytosis in patients with severe anaphylaxis &ndash; a UK single centre experience 1187 Hiroya Ogita Fumi Ishikawa &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Hirohisa Saito &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Ichiro Nomura &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Kenji Toyokuni &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Kiwako Yamamoto-Hanada &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Koji Nishimura &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Makoto Irahara &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Mayako Saito-Abe &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Miori Sato &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Shigenori Kabashima &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Tatsuki Fukuie &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Tomoyuki Kiguchi &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Yoshitsune Miyagi &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Yukihiro Ohya &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Yumiko Miyaji &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Hiroya Ogita Yusuke Inuzuka &ldquo;Tiny amount of egg&rdquo; for safe introduction into infants sensitized with egg-white 385 Theresa Lipp Alessandro Travaglini Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Alfred Priftanji Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Ana M Pereira Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Andrea Barbalace Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Andrea Di Rienzo Businco Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Angel Mazon Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Anne Bourgoin Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Antonio Nieto Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Aydan Acar Sahin Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Aykut Guvensen Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Ayse \\x96ztrk Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Blerina Bregu Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Blerta Lame Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Cansin Sackesen Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Claire Dimier Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Dah Tay Jang Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Denis Charpin Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Dolores Hernandez Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Duygu Yazici Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Ekaterina Potapova Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Elisabetta Pellegrini Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Elsa Caeiro Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Eris Mesonjesi Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Fotis Psarros Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Fusun Kalpaklioglu Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Giovanni Pajno Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Ifigenia Sfika Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Ilenia Panasiti Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Javier Suarez Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Joao A Fonseca Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Laurie Pahus Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Lucia Caminiti Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Luis Delgado Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Maria Antonia Brighetti Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Maria V Dimou Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Mariana Couto Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Mariana Pereira Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Michael Makris Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Michel Thibaudon Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Nikolaos G Papadopoulos Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Nur Munevver Pinar Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Ozlem Goksel Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Paolo M Matricardi Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Paraskevi Xepapadaki Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Ruth Llusar Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Salvatore Tripodi Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Simone Pelosi Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Stefania Arasi Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Stephanie Dramburg Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Sule Caglayan Sozmen Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Tara Maria Hoffmann Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Valentine Verdier Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Valeria Villella Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Theresa Lipp Xenophon Aggelides Pollen food allergy syndrome in seven southern European countries: Results from the @IT.2020 multicenter study 1125 Magdalena Kraft Johannes Gebauer Grading of anaphylaxis severity on the numeric rating scale: The use of an artificial neural network to evaluate data from the European Anaphylaxis Registry 642 Magdalena Kraft Margitta Worm Grading of anaphylaxis severity on the numeric rating scale: The use of an artificial neural network to evaluate data from the European Anaphylaxis Registry 642 Magdalena Kraft Sabine Dlle-Bierke Grading of anaphylaxis severity on the numeric rating scale: The use of an artificial neural network to evaluate data from the European Anaphylaxis Registry 642 Lu\\xads Gustavo Romani Fernandes Isabela Oliveira Sandrini Assugeni Recombinant antigen 5 from Polybia paulista wasp venom (Hymenoptera, Vespidae): Antigen specific antibody production and functional profile of CD4<sup>+</sup> T cells in the immune response 432 Lu\\xads Gustavo Romani Fernandes Mrcia Regina Brochetto-Braga Recombinant antigen 5 from Polybia paulista wasp venom (Hymenoptera, Vespidae): Antigen specific antibody production and functional profile of CD4<sup>+</sup> T cells in the immune response 432 Lu\\xads Gustavo Romani Fernandes Murilo Luiz Bazon Recombinant antigen 5 from Polybia paulista wasp venom (Hymenoptera, Vespidae): Antigen specific antibody production and functional profile of CD4<sup>+</sup> T cells in the immune response 432 Lu\\xads Gustavo Romani Fernandes Patr\\xadcia Ucelli Simioni Recombinant antigen 5 from Polybia paulista wasp venom (Hymenoptera, Vespidae): Antigen specific antibody production and functional profile of CD4<sup>+</sup> T cells in the immune response 432 Lu\\xads Gustavo Romani Fernandes Ricardo Lima Zollner Recombinant antigen 5 from Polybia paulista wasp venom (Hymenoptera, Vespidae): Antigen specific antibody production and functional profile of CD4<sup>+</sup> T cells in the immune response 432 Tiago Azenha Rama Alberto \\x93rfo Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Almudena Matito Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Ana Filipa Henriques Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Andrea Mayado Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Andrs Garc\\xada-Montero Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Carolina Caldas Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Ivan Alvarez-Twose Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Javier Ignacio Muoz-Gonzlez Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Laura Sanchez-Muoz Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Tiago Azenha Rama Maria Jara-Acevedo Plasma cytokine profile in patients with systemic mastocytosis and bone involvement 503 Mateusz Gawrysiak Adrian Gajewski The effect of human rhinovirus HRV-16 on the barrier properties and regeneration of human pulmonary endothelium 850 Mateusz Gawrysiak Aleksandra Likonska The effect of human rhinovirus HRV-16 on the barrier properties and regeneration of human pulmonary endothelium 850 Mateusz Gawrysiak Maciej Chalubinski The effect of human rhinovirus HRV-16 on the barrier properties and regeneration of human pulmonary endothelium 850 Mateusz Gawrysiak Magdalena Chmiela The effect of human rhinovirus HRV-16 on the barrier properties and regeneration of human pulmonary endothelium 850 Mateusz Gawrysiak Marek L. Kowalski The effect of human rhinovirus HRV-16 on the barrier properties and regeneration of human pulmonary endothelium 850 Mateusz Gawrysiak Robert Szewczyk The effect of human rhinovirus HRV-16 on the barrier properties and regeneration of human pulmonary endothelium 850 Igor Petrovich  Shilovskiy Alexander Arkadievich Nikolskii Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Igor Petrovich  Shilovskiy Dmitrii Anatolievich Kudlay Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Igor Petrovich  Shilovskiy Ekaterina Draganovna Barvinskaia Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Igor Petrovich  Shilovskiy Kseniya Vadimovna Kozhihova Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Igor Petrovich  Shilovskiy Ludmila Ivanovna Vishnyakova Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Igor Petrovich  Shilovskiy Musa Rakhimovich Khaitov Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Igor Petrovich  Shilovskiy Sergei Mikhailovich Andreev Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Igor Petrovich  Shilovskiy Valerii Valerievich Smirnov Dendrimeric form of the peptide from antigenic zero-site of F protein exhibit antiviral effect against respiratory syncytial virus 471 Miranda Sin Man Tsang Chun Kwok Wong Interaction of eosinophils and dermal fibroblasts/keratinocytes in fungal-infection-related atopic dermatitis 696 Miranda Sin Man Tsang Tianheng Hou Interaction of eosinophils and dermal fibroblasts/keratinocytes in fungal-infection-related atopic dermatitis 696 Miranda Sin Man Tsang Xun Gao Interaction of eosinophils and dermal fibroblasts/keratinocytes in fungal-infection-related atopic dermatitis 696 Cristine Secco Rosario Carlos Antonio Riedi Prevalence of allergic conjunctivitis and multimorbidities in adolescents according to gender 169 Cristine Secco Rosario Cristina Alves Cardozo Prevalence of allergic conjunctivitis and multimorbidities in adolescents according to gender 169 Cristine Secco Rosario Debora Carla Chong Silva Prevalence of allergic conjunctivitis and multimorbidities in adolescents according to gender 169 Cristine Secco Rosario Herberto Jose Chong Neto Prevalence of allergic conjunctivitis and multimorbidities in adolescents according to gender 169 Cristine Secco Rosario Monica Nunes Lima Prevalence of allergic conjunctivitis and multimorbidities in adolescents according to gender 169 Cristine Secco Rosario Nelson Augusto Rosario Prevalence of allergic conjunctivitis and multimorbidities in adolescents according to gender 169 KALLIOPI PANAGIOTOPOULOU  Stress as a risk factor in the onset of allergic asthma  149 Taras Petrovych Baranovskyi  A personalized approach to the prevention of perennial allergic rhinitis based on SNP and allergen sensitization in the population of Ukraine 576 Ju Hee Kim Dong Keon Yon Type of water added to powdered formula associates with asthma exacerbation: A national cohort study 723 Ju Hee Kim Eun Kyo Ha Type of water added to powdered formula associates with asthma exacerbation: A national cohort study 723 Ju Hee Kim Man Yong Han Type of water added to powdered formula associates with asthma exacerbation: A national cohort study 723 Ju Hee Kim Seung Won Lee Type of water added to powdered formula associates with asthma exacerbation: A national cohort study 723 Ju Hee Kim Youn Ho Shin Type of water added to powdered formula associates with asthma exacerbation: A national cohort study 723 Linda Borgonovo Alessandro Toscano Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Andrea Toniato Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Angela Daniela Macellaio Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Carlo Maria Rossi Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Eleonora Brusamolino Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Elide Anna Pastorello Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Jan Walter Volk Schroeder Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Joseph Scibilia Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Laura Farioli Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Linda Borgonovo Selene Nicolosi Comparison of the main clinical characteristics in subjects with mastocytosis with and without allergy to hymenoptera venom 891 Danielle Fehr Peter Schmid-Grendelmeier A short latency time and the absence of skin symptoms are indicators for severe systemic sting reactions in Hymenoptera venom allergy 317 Danielle Fehr Sara Micaletto A short latency time and the absence of skin symptoms are indicators for severe systemic sting reactions in Hymenoptera venom allergy 317 Danielle Fehr Thomas Mhr A short latency time and the absence of skin symptoms are indicators for severe systemic sting reactions in Hymenoptera venom allergy 317 Mnica Ru\\xadz Garc\\xada Jaime Sanchez-Lopez Overlapping of pollen seasons, importance of pollen monitoring stations and its impact on clinical studies 779 Mnica Ru\\xadz Garc\\xada Neus Jimenez-Salles Overlapping of pollen seasons, importance of pollen monitoring stations and its impact on clinical studies 779 HyeJeong Kim Chun Kim Lysophosphatidylseine induces eosinophil extracellular trap and degranulation by lytic cell death 272 HyeJeong Kim Il Yup Chung Lysophosphatidylseine induces eosinophil extracellular trap and degranulation by lytic cell death 272 HyeJeong Kim Myeong Seong Sim Lysophosphatidylseine induces eosinophil extracellular trap and degranulation by lytic cell death 272 Ebenezer Satyaraj Cari Gardner Cat diet coated with egg ingredient containing anti-Fel d 1 antibodies reduces active Fel d 1 levels in cats&rsquo; saliva and on their hair and dander 1092 Ebenezer Satyaraj Ivan Filipi Cat diet coated with egg ingredient containing anti-Fel d 1 antibodies reduces active Fel d 1 levels in cats&rsquo; saliva and on their hair and dander 1092 Ebenezer Satyaraj Scott Sherrill Cat diet coated with egg ingredient containing anti-Fel d 1 antibodies reduces active Fel d 1 levels in cats&rsquo; saliva and on their hair and dander 1092 david calzada Ana Renshaw-Caldern Characterization and stability studies of mixtures of depigmented-polymerized extracts with Alternaria alternata 764 david calzada Cristina Osuna Characterization and stability studies of mixtures of depigmented-polymerized extracts with Alternaria alternata 764 david calzada Jernimo Carns Characterization and stability studies of mixtures of depigmented-polymerized extracts with Alternaria alternata 764 david calzada Nuria Parody Characterization and stability studies of mixtures of depigmented-polymerized extracts with Alternaria alternata 764 Adrian Lukasz Gajewski Aleksandra Likonska The modulatory effect of IL-33, IL-25 and IL-5 on human rhinovirus-induced anti-viral, inflammatory and Th2-type cytokine response by human pulmonary endothelium 926 Adrian Lukasz Gajewski Maciej Chalubinski The modulatory effect of IL-33, IL-25 and IL-5 on human rhinovirus-induced anti-viral, inflammatory and Th2-type cytokine response by human pulmonary endothelium 926 Adrian Lukasz Gajewski Magdalena Chmiela The modulatory effect of IL-33, IL-25 and IL-5 on human rhinovirus-induced anti-viral, inflammatory and Th2-type cytokine response by human pulmonary endothelium 926 Adrian Lukasz Gajewski Marek L. Kowalski The modulatory effect of IL-33, IL-25 and IL-5 on human rhinovirus-induced anti-viral, inflammatory and Th2-type cytokine response by human pulmonary endothelium 926 Adrian Lukasz Gajewski Mateusz Gawrysiak The modulatory effect of IL-33, IL-25 and IL-5 on human rhinovirus-induced anti-viral, inflammatory and Th2-type cytokine response by human pulmonary endothelium 926 Adrian Lukasz Gajewski Robert Szewczyk The modulatory effect of IL-33, IL-25 and IL-5 on human rhinovirus-induced anti-viral, inflammatory and Th2-type cytokine response by human pulmonary endothelium 926 Pavel Nesmiyanov Andrey Strygin Mycobacterium vaccae lysate promotes IL-10 secreting dendritic cells development 111 Pavel Nesmiyanov Boris Tolkachev Mycobacterium vaccae lysate promotes IL-10 secreting dendritic cells development 111 Pavel Nesmiyanov Evgeniy Morkovin Mycobacterium vaccae lysate promotes IL-10 secreting dendritic cells development 111 Amilcar Perez-Riverol Alexis Musacchio-Lasa Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Amilcar Perez-Riverol Gabriel Hideki Izuka Moraes Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Amilcar Perez-Riverol Jose Roberto Aparecido Dos Santos-Pinto Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Amilcar Perez-Riverol Lu\\xads Gustavo Romani-Fernandes Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Amilcar Perez-Riverol Maria Beatrice Bil Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Amilcar Perez-Riverol Mario Sergio Palma Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Amilcar Perez-Riverol Ricardo De Lima-Zollner Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Amilcar Perez-Riverol Thilo Jakob Identification and molecular characterization of the phospholipase A1 from Apoica pallens wasp venom 591 Urban Cerpes Gunter Johannes Sturm Is the sensitivity of multiplex testing sufficient to diagnose bee and vespid venom allergy? 1243 Urban Cerpes Karin Laipold Is the sensitivity of multiplex testing sufficient to diagnose bee and vespid venom allergy? 1243 Urban Cerpes Lisa Arzt-Gradwohl Is the sensitivity of multiplex testing sufficient to diagnose bee and vespid venom allergy? 1243 Urban Cerpes Lukas Koch Is the sensitivity of multiplex testing sufficient to diagnose bee and vespid venom allergy? 1243 Urban Cerpes Patrik Tripolt Is the sensitivity of multiplex testing sufficient to diagnose bee and vespid venom allergy? 1243 Marcin Stobiecki Ewa Czarnobilska Sensitization to venom components and sIgG4 production during venom immunotherapy in honeybee venom and vespula venom allergic patients 1442 Marcin Stobiecki Wojciech Dyga Sensitization to venom components and sIgG4 production during venom immunotherapy in honeybee venom and vespula venom allergic patients 1442 Berenice C Bastien Ebenezer Satyaraj Fel d 1 levels vary between cats and within the same cat over the course of the year 1065 Berenice C Bastien Gardner Gardner Fel d 1 levels vary between cats and within the same cat over the course of the year 1065 Scott Sherrill Berenice C Bastien Correlation of salivary and hair Fel d 1 levels in domestic shorthair cats 1069 Scott Sherrill Cari Gardner Correlation of salivary and hair Fel d 1 levels in domestic shorthair cats 1069 Scott Sherrill Ebenezer Satyaraj Correlation of salivary and hair Fel d 1 levels in domestic shorthair cats 1069 Luo Wenting Baoqing Sun A new trend in sensitization to cockroach allergen: A cross-sectional study of indoor allergens and food allergens in the inland region of southwest china 181 Maria Joo Vasconcelos Ana Margarida Mesquita Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Daniela Brando Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Diana Silva Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Joana Miranda Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Jos Lu\\xads Plcido Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Leonor Carneiro-Leo Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Lu\\xads Amaral Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Ricardo Moo Coutinho Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Maria Joo Vasconcelos Tiago Rama Clinical relevance of aeroallergen sensitization in an allergy centre in the North of Portugal 670 Sung-Woo Cho Chae-Seo Rhee Changing in sensitization pattern and prevalence of allergic airway disease to common aeroallergens in 10 year time interval in Korea: A single center study 1156 M. Angeles Lopez-Matas Azahara Gonzlez-Ruiz Allergy to crickets 193 M. Angeles Lopez-Matas Cristina Martorell Allergy to crickets 193 M. Angeles Lopez-Matas Jernimo Carns Allergy to crickets 193 M. Angeles Lopez-Matas Juan Carlos Cerd Mir Allergy to crickets 193 M. Angeles Lopez-Matas M. Dolores De Las Marinas Allergy to crickets 193 Max Becker Jens-Oliver Stei\\x9f Safety of modified ultra-rush venom immunotherapy with lyophilized extracts in children - a retrospective and prospective analysis 844 Carmen Bermdez Hormigo Anabel Pelez Vargas Sting challenge with hymenoptera: Our experience 1488 Carmen Bermdez Hormigo Berta Ruiz Len Sting challenge with hymenoptera: Our experience 1488 Carmen Bermdez Hormigo Carmen Moreno Aguilar Sting challenge with hymenoptera: Our experience 1488 Carmen Bermdez Hormigo M\\xadriam Bermdez Bejarano Sting challenge with hymenoptera: Our experience 1488 Carmen Bermdez Hormigo Nadine Blanco Toledano Sting challenge with hymenoptera: Our experience 1488 Carmen Bermdez Hormigo Pilar Serrano Delgado Sting challenge with hymenoptera: Our experience 1488 Valeriy Valerievich Smirnov Alexandr Igorevich Martynov The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Valeriy Valerievich Smirnov Andrey Yurievich Toptygin The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Valeriy Valerievich Smirnov Dmitry Anatolievich Kudlay The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Valeriy Valerievich Smirnov Evgenii Andreevich Egorenkov The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Valeriy Valerievich Smirnov Gayane Emmanuilovna Avoyan The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Valeriy Valerievich Smirnov Igor Vladimirovich Andreev The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Valeriy Valerievich Smirnov Musa Rakhimovich Khaitov The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Valeriy Valerievich Smirnov Olga Sergeevna Kulaga The study of qualitative and quantitative composition of allergen and allergoids from birch pollen 1405 Adeyinka Odebode Adedotun Adekunle Inflammatory responses in mice after intranasal instillation of spores of some aspergillus and penicillium spp monitored in Southwest Nigeria 79 Adeyinka Odebode Ebenezer Farombi Inflammatory responses in mice after intranasal instillation of spores of some aspergillus and penicillium spp monitored in Southwest Nigeria 79 Hsiao Hui Ong De Yun Wang Human rhinovirus persistence reduces viral load of secondary H3N2 infection in in vitro human nasal epithelium 1049 Hsiao Hui Ong Kai Sen Tan Human rhinovirus persistence reduces viral load of secondary H3N2 infection in in vitro human nasal epithelium 1049 Hsiao Hui Ong Mark Thong Human rhinovirus persistence reduces viral load of secondary H3N2 infection in in vitro human nasal epithelium 1049 Hsiao Hui Ong Vincent Tk Chow Human rhinovirus persistence reduces viral load of secondary H3N2 infection in in vitro human nasal epithelium 1049 Hsiao Hui Ong Yew Kwang Ong Human rhinovirus persistence reduces viral load of secondary H3N2 infection in in vitro human nasal epithelium 1049 Marcos  Pealver Mellado Angel Blasco Sarramian Allergy to millet in an atopic bird keeper 398 Marcos  Pealver Mellado Elena Bravo Hernndez Allergy to millet in an atopic bird keeper 398 Marcos  Pealver Mellado Idoia Gonzlez Mahave Allergy to millet in an atopic bird keeper 398 Marcos  Pealver Mellado Irene Vidal Oribe Allergy to millet in an atopic bird keeper 398 Marcos  Pealver Mellado Pilar Hernndez Alfonso Allergy to millet in an atopic bird keeper 398 Marcos  Pealver Mellado Tefilo Lobera Labairu Allergy to millet in an atopic bird keeper 398 Cristiana  Cancela Ferreira Arminda Guilherme Corkworker&#39;s lung: Case report 1142 Cristiana  Cancela Ferreira Sofia Neves Corkworker&#39;s lung: Case report 1142 Michael Dittmar Carsten B. Schmidt-Weber Natural induction of tolerance to honeybee-venom in non-allergic beekeepers 367 Michael Dittmar Knut Brockow Natural induction of tolerance to honeybee-venom in non-allergic beekeepers 367 Michael Dittmar Peter Seiringer Natural induction of tolerance to honeybee-venom in non-allergic beekeepers 367 Michael Dittmar Simon Blank Natural induction of tolerance to honeybee-venom in non-allergic beekeepers 367 Michael Dittmar Tilo Biedermann Natural induction of tolerance to honeybee-venom in non-allergic beekeepers 367 Michael Dittmar Ulf Darsow Natural induction of tolerance to honeybee-venom in non-allergic beekeepers 367 david calzada Beatriz Rojas Heterogenicity of the allergen content in male dog urine and dander 752 david calzada Jernimo Carns Heterogenicity of the allergen content in male dog urine and dander 752 david calzada Mayte Gallego Heterogenicity of the allergen content in male dog urine and dander 752 david calzada V\\xadctor Iraola Heterogenicity of the allergen content in male dog urine and dander 752 Hyouk-Soo Kwon Chan Sun Park High absorbance ratio of toxocara ELISA is associated with eosinophilia and prolonged persistence of lung infiltration<br /> 464 Hyouk-Soo Kwon Hee Bom Moon High absorbance ratio of toxocara ELISA is associated with eosinophilia and prolonged persistence of lung infiltration<br /> 464 Hyouk-Soo Kwon Jin An High absorbance ratio of toxocara ELISA is associated with eosinophilia and prolonged persistence of lung infiltration<br /> 464 Hyouk-Soo Kwon Tae Bum Kim High absorbance ratio of toxocara ELISA is associated with eosinophilia and prolonged persistence of lung infiltration<br /> 464 Hyouk-Soo Kwon Woo Jung Song High absorbance ratio of toxocara ELISA is associated with eosinophilia and prolonged persistence of lung infiltration<br /> 464 Hyouk-Soo Kwon You Sook Cho High absorbance ratio of toxocara ELISA is associated with eosinophilia and prolonged persistence of lung infiltration<br /> 464 virginie doyen Carine Truyens Specific IgE produced during helminths infections target mainly cross-reactive carbohydrate determinants 1109 virginie doyen Francis Corazza Specific IgE produced during helminths infections target mainly cross-reactive carbohydrate determinants 1109 virginie doyen Hiep Tran Thi Mong Specific IgE produced during helminths infections target mainly cross-reactive carbohydrate determinants 1109 virginie doyen Hoa Nhu Thi Specific IgE produced during helminths infections target mainly cross-reactive carbohydrate determinants 1109 virginie doyen Olivier Michel Specific IgE produced during helminths infections target mainly cross-reactive carbohydrate determinants 1109 virginie doyen Phuongh Ngoc Huynh Specific IgE produced during helminths infections target mainly cross-reactive carbohydrate determinants 1109 virginie doyen Thanh Le Chi Specific IgE produced during helminths infections target mainly cross-reactive carbohydrate determinants 1109 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Allergy diagnosis and systems medicine',\n",
       "  'session': 'PDS 03 Allergy diagnosis and systems medicine',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921279,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 03 Allergy diagnosis and systems medicine Mason Xue Bao Qing Sun Evaluation of the diagnostic efficacies of serological markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in idiopathic interstitial pneumonia 208 Mason Xue Lu Qian Zhou Evaluation of the diagnostic efficacies of serological markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in idiopathic interstitial pneumonia 208 Hannah M Kansen Andr C Knulst A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Cornelis K Van Der Ent A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Dianne Mw Gorissen A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Francine C Van Erp A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Geert Wj Frederix A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Maartje F Van Velzen A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Marike Stadermann A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Thuy-My Le A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Willem R Keusters A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Hannah M Kansen Yolanda Meijer A diagnostic flowchart for peanut allergy based on Ara h 2 is accurate, safe and reduces costs in children in secondary and tertiary care 827 Christian Radauer Heimo Breiteneder YoaJ, an expansin-like protein from Bacillus subtilis, is a non-allergenic structural homologue of the major grass pollen allergen Phl p 1 968 Christian Radauer Jaana Schneider YoaJ, an expansin-like protein from Bacillus subtilis, is a non-allergenic structural homologue of the major grass pollen allergen Phl p 1 968 Christian Radauer Jiaqian Tang YoaJ, an expansin-like protein from Bacillus subtilis, is a non-allergenic structural homologue of the major grass pollen allergen Phl p 1 968 Christian Radauer Mohamed H Shamji YoaJ, an expansin-like protein from Bacillus subtilis, is a non-allergenic structural homologue of the major grass pollen allergen Phl p 1 968 Christian Radauer Rebecca V Parkin YoaJ, an expansin-like protein from Bacillus subtilis, is a non-allergenic structural homologue of the major grass pollen allergen Phl p 1 968 Christian Radauer Stephen R Durham YoaJ, an expansin-like protein from Bacillus subtilis, is a non-allergenic structural homologue of the major grass pollen allergen Phl p 1 968 Iryna Shchurok A Ishchanka Nasal and oral low dose provocative tests for the diagnosis of phenotypes and endotypes of allergic rhinitis and asthma 1001 Iryna Shchurok D Novicau Nasal and oral low dose provocative tests for the diagnosis of phenotypes and endotypes of allergic rhinitis and asthma 1001 Iryna Shchurok I Semenova Nasal and oral low dose provocative tests for the diagnosis of phenotypes and endotypes of allergic rhinitis and asthma 1001 Iryna Shchurok L M Dubuske Nasal and oral low dose provocative tests for the diagnosis of phenotypes and endotypes of allergic rhinitis and asthma 1001 Erik Meln Anna Asarnoj Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Anna Bergstrm Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Antonis Georgelis Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Catarina Almqvist Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Gran Pershagen Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Inger Kull Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Magnus P Borres Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Marianne Van Hage Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Marit Westman Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Natalia Ballardini Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Erik Meln Niklas Andersson Male sex is strongly associated with IgE-sensitization to aeroallergens but not food allergens: Results up to age 24 years from the BAMSE birth cohort 1437 Lukas Koch Eva Maria Sturm IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing 930 Lukas Koch Gunter Josef Sturm IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing 930 Lukas Koch Karin Laipold IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing 930 Lukas Koch Lisa Arzt-Gradwohl IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing 930 Lukas Koch Urban Cerpes IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing 930 Lukas Koch Werner Aberer IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing 930 Catherine King Fionnuala Cox The integration and utility of a multiplex allergy panel in routine clinical practice 1190 Catherine King Karen Jones The integration and utility of a multiplex allergy panel in routine clinical practice 1190 Catherine King Niall Conlon The integration and utility of a multiplex allergy panel in routine clinical practice 1190 Dong-Chull Choi Byung-Jae Lee Blood eosinophil and exhaled NO as a predictive biomarker for sputum eosinophil level  349 Dong-Chull Choi Eun-Sil Koh Blood eosinophil and exhaled NO as a predictive biomarker for sputum eosinophil level  349 Dong-Chull Choi Jin-Young Lee Blood eosinophil and exhaled NO as a predictive biomarker for sputum eosinophil level  349 Tamar Kinaciyan Amanda Zbyszewski Prevalence of latex-fruit syndrome among latex allergic/sensitized patients 113 Tamar Kinaciyan Renate Schoepke Prevalence of latex-fruit syndrome among latex allergic/sensitized patients 113 Tamar Kinaciyan Violetta Zbyszewski Prevalence of latex-fruit syndrome among latex allergic/sensitized patients 113 Hannah M Kansen Andr C Knulst Peanut allergy is accurately predicted in one third of adults with suspected peanut allergy using specific IgE to Ara h 2 and Ara h 6&nbsp; 833 Hannah M Kansen Cornelis K Van Der Ent Peanut allergy is accurately predicted in one third of adults with suspected peanut allergy using specific IgE to Ara h 2 and Ara h 6&nbsp; 833 Hannah M Kansen Edward F Knol Peanut allergy is accurately predicted in one third of adults with suspected peanut allergy using specific IgE to Ara h 2 and Ara h 6&nbsp; 833 Hannah M Kansen Francine C Van Erp Peanut allergy is accurately predicted in one third of adults with suspected peanut allergy using specific IgE to Ara h 2 and Ara h 6&nbsp; 833 Hannah M Kansen Henny G Otten Peanut allergy is accurately predicted in one third of adults with suspected peanut allergy using specific IgE to Ara h 2 and Ara h 6&nbsp; 833 Hannah M Kansen Thuy-My M Le Peanut allergy is accurately predicted in one third of adults with suspected peanut allergy using specific IgE to Ara h 2 and Ara h 6&nbsp; 833 Hannah M Kansen Yolanda Meijer Peanut allergy is accurately predicted in one third of adults with suspected peanut allergy using specific IgE to Ara h 2 and Ara h 6&nbsp; 833 Peiyan Zheng Baoqing Sun Diagnostic value of basophilic granulocyte activation test in sensitizing dust mites 77 Tamar Kinaciyan Amanda Zbyszewski Prevalence of latex allergy and latex sensitization among patients of a tertiary allergy referral center in 2012 112 Tamar Kinaciyan Renate Schoepke Prevalence of latex allergy and latex sensitization among patients of a tertiary allergy referral center in 2012 112 Tamar Kinaciyan Violetta Zbyszewski Prevalence of latex allergy and latex sensitization among patients of a tertiary allergy referral center in 2012 112 Mose Michel Eva Serrano Analysis of tryptase prescription in a teaching hospital 598 Mose Michel Farid Mankouri Analysis of tryptase prescription in a teaching hospital 598 Mose Michel Jean-Louis Mge Analysis of tryptase prescription in a teaching hospital 598 Mose Michel Joana Vitte Analysis of tryptase prescription in a teaching hospital 598 ANKUR AMIT SARIN Jushya Bhatia Allergic contact sensitization in patients with venous leg ulcer: A multi-centric study 48 ANKUR AMIT SARIN Kailash Bhatia Allergic contact sensitization in patients with venous leg ulcer: A multi-centric study 48 Maarten J. Van Dinther Douwe De Boer Complexity of allergy in-vitro diagnostics: comparison of the new IDS Specific IgE assay and the conventional ImmunoCAP assay for inhalation allergens 1239 Maarten J. Van Dinther Judith A. Bons Complexity of allergy in-vitro diagnostics: comparison of the new IDS Specific IgE assay and the conventional ImmunoCAP assay for inhalation allergens 1239 Maarten J. Van Dinther Paul P. Menheere Complexity of allergy in-vitro diagnostics: comparison of the new IDS Specific IgE assay and the conventional ImmunoCAP assay for inhalation allergens 1239 Rubi Salgado Ailan Wang Analytical performance of the NOVEOS immunoassay for detection of allergen-specific IgE to M006 (alternaria alternata) to aid in the diagnosis of allergic diseases 204 Rubi Salgado Andrea Cruz-Campos Analytical performance of the NOVEOS immunoassay for detection of allergen-specific IgE to M006 (alternaria alternata) to aid in the diagnosis of allergic diseases 204 Rubi Salgado Brittany Braddock Analytical performance of the NOVEOS immunoassay for detection of allergen-specific IgE to M006 (alternaria alternata) to aid in the diagnosis of allergic diseases 204 Rubi Salgado Eva Kieu Analytical performance of the NOVEOS immunoassay for detection of allergen-specific IgE to M006 (alternaria alternata) to aid in the diagnosis of allergic diseases 204 Rubi Salgado Seak Yith Analytical performance of the NOVEOS immunoassay for detection of allergen-specific IgE to M006 (alternaria alternata) to aid in the diagnosis of allergic diseases 204 Rubi Salgado Shane Bryant Analytical performance of the NOVEOS immunoassay for detection of allergen-specific IgE to M006 (alternaria alternata) to aid in the diagnosis of allergic diseases 204 Ainara Vlez Del Burgo Del Hoyo David Rodr\\xadguez Gil Improving the Alt a 1 harvest using solid culture media 830 Ainara Vlez Del Burgo Del Hoyo Idoia Postigo Resa Improving the Alt a 1 harvest using solid culture media 830 Ainara Vlez Del Burgo Del Hoyo Jorge Mart\\xadnez Quesada Improving the Alt a 1 harvest using solid culture media 830 Ainara Vlez Del Burgo Del Hoyo Patricia Snchez Hernndez Improving the Alt a 1 harvest using solid culture media 830 Ainara Vlez Del Burgo Del Hoyo Ricardo Palacios Pelaez Improving the Alt a 1 harvest using solid culture media 830 Anna Kosowska Magdalena Zemelka-Wiacek Validation of environmental exposure chamber (EEC) for controlled human inhalation studies in patients with timothy grass pollen - triggered allergic rhinoconjunctivitis 393 Anna Kosowska Marek Jutel Validation of environmental exposure chamber (EEC) for controlled human inhalation studies in patients with timothy grass pollen - triggered allergic rhinoconjunctivitis 393 Anna Kosowska Sylwia Smolinska Validation of environmental exposure chamber (EEC) for controlled human inhalation studies in patients with timothy grass pollen - triggered allergic rhinoconjunctivitis 393 Ekaterina Potapova Chrysanthi Skevaki Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients 1212 Ekaterina Potapova Daniel Bauersachs Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients 1212 Ekaterina Potapova Harald Renz Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients 1212 Ekaterina Potapova Paolo Maria Matricardi Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients 1212 Cindy Liao Edsel Sinson Grass and tree allergen components specific IgE assay on the NOVEOS immunoanalyzer: Evaluation of inter-method comparison 1144 Cindy Liao Kelline Rodems Grass and tree allergen components specific IgE assay on the NOVEOS immunoanalyzer: Evaluation of inter-method comparison 1144 Cindy Liao Michael Raymundo Grass and tree allergen components specific IgE assay on the NOVEOS immunoanalyzer: Evaluation of inter-method comparison 1144 Cindy Liao Morkoah Blay Grass and tree allergen components specific IgE assay on the NOVEOS immunoanalyzer: Evaluation of inter-method comparison 1144 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Asthma',\n",
       "  'session': 'PDS 04 Asthma ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921280,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 04 Asthma  B Lugachov K Maliy Polymorphism of the TNFAIP3 gene (T380G) and expression of TNFAIP3 in patients with bronchial asthma 1334 B Lugachov L M Dubuske Polymorphism of the TNFAIP3 gene (T380G) and expression of TNFAIP3 in patients with bronchial asthma 1334 B Lugachov V Beloglazov Polymorphism of the TNFAIP3 gene (T380G) and expression of TNFAIP3 in patients with bronchial asthma 1334 Young-Ho Kim Chang-Keun Kim A randomized, single-blind, placebo-controlled study on the efficacy of the tulobuterol patch (TP-LABA) in treating acute exacerbation of asthmatic bronchitis in children 314 Young-Ho Kim Eunmi Kwon A randomized, single-blind, placebo-controlled study on the efficacy of the tulobuterol patch (TP-LABA) in treating acute exacerbation of asthmatic bronchitis in children 314 Young-Ho Kim Zak Callaway A randomized, single-blind, placebo-controlled study on the efficacy of the tulobuterol patch (TP-LABA) in treating acute exacerbation of asthmatic bronchitis in children 314 Jonathan Corren Benjamin Ortiz Dupilumab reduces the percentage of patients experiencing severe exacerbations each calendar month throughout the year in patients with type 2 inflammatory, uncontrolled, moderate-to-severe asthma 1089 Jonathan Corren Christian Domingo Dupilumab reduces the percentage of patients experiencing severe exacerbations each calendar month throughout the year in patients with type 2 inflammatory, uncontrolled, moderate-to-severe asthma 1089 Jonathan Corren Michel Djandji Dupilumab reduces the percentage of patients experiencing severe exacerbations each calendar month throughout the year in patients with type 2 inflammatory, uncontrolled, moderate-to-severe asthma 1089 Jonathan Corren Nadia Daizadeh Dupilumab reduces the percentage of patients experiencing severe exacerbations each calendar month throughout the year in patients with type 2 inflammatory, uncontrolled, moderate-to-severe asthma 1089 Jonathan Corren Nora Crikelair Dupilumab reduces the percentage of patients experiencing severe exacerbations each calendar month throughout the year in patients with type 2 inflammatory, uncontrolled, moderate-to-severe asthma 1089 Jonathan Corren Paul Rowe Dupilumab reduces the percentage of patients experiencing severe exacerbations each calendar month throughout the year in patients with type 2 inflammatory, uncontrolled, moderate-to-severe asthma 1089 Jonathan Corren Yamo Deniz Dupilumab reduces the percentage of patients experiencing severe exacerbations each calendar month throughout the year in patients with type 2 inflammatory, uncontrolled, moderate-to-severe asthma 1089 Gerdien Tramper Cathelijne Van Zelst Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 Gerdien Tramper Geertje De Boer Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 Gerdien Tramper Gert Verhoeven Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 Gerdien Tramper Gert-Jan Braunstahl Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 Gerdien Tramper Guido Epping Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 Gerdien Tramper Marjolein De Bruijn Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 Gerdien Tramper Mees Dorleijn Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 Gerdien Tramper Rudi Hendriks Prevention of exacerbations in moderate-severe asthma by bacterial lysate add-on therapy: A randomised controlled trial 1380 virginie doyen Anh Poirot Treg response in mite asthma after allergen exposure 983 virginie doyen Audrey Jacob Treg response in mite asthma after allergen exposure 983 virginie doyen Francis Corraza Treg response in mite asthma after allergen exposure 983 virginie doyen Frederic De Blay Treg response in mite asthma after allergen exposure 983 virginie doyen Myriam Maumy-Bertrand Treg response in mite asthma after allergen exposure 983 virginie doyen Naji Khayath Treg response in mite asthma after allergen exposure 983 virginie doyen Nathalie Domis Treg response in mite asthma after allergen exposure 983 Hui-Ju Tsai Shun-Yu Tsai Increased childhood fractional exhaled nitric oxide predicts of new-onset asthma in adolescence and young adulthood 720 Hui-Ju Tsai Tsung-Chieh Yao Increased childhood fractional exhaled nitric oxide predicts of new-onset asthma in adolescence and young adulthood 720 Gwang-Cheon Jang Joo Hyun Jin Relative risk of asthma and pneumonia in prematurity: Using big data of South Korean health-care records 706 Gwang-Cheon Jang Shin Won Yoon Relative risk of asthma and pneumonia in prematurity: Using big data of South Korean health-care records 706 Mariana Paula Rezelj Anja Simonic Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Mariana Paula Rezelj Irena Pocvavek Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Mariana Paula Rezelj Jana Trsan Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Mariana Paula Rezelj Peter Kopac Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Mariana Paula Rezelj Sabina krgat Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Mariana Paula Rezelj Tea Mocnik Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Mariana Paula Rezelj Tina Morgan Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Mariana Paula Rezelj Tina Remkar Comparing results of the asthma control test and severe asthma quality of life questionary in patients with severe asthma on biologic therapy 1453 Nelly Cataln Cceres Cristina Stein Coronado Concordance between Impulse Oscillometry parameters and Asthma Control Test score 629 Nelly Cataln Cceres Ethel Ibez Echevarr\\xada Concordance between Impulse Oscillometry parameters and Asthma Control Test score 629 Nelly Cataln Cceres Inmaculada Ibarra Calabuig Concordance between Impulse Oscillometry parameters and Asthma Control Test score 629 Nelly Cataln Cceres Leah Landaveri Snchez Concordance between Impulse Oscillometry parameters and Asthma Control Test score 629 Nelly Cataln Cceres Miguel D\\xadaz Palacios Concordance between Impulse Oscillometry parameters and Asthma Control Test score 629 Nelly Cataln Cceres Remedios Alamar Mart\\xadnez Concordance between Impulse Oscillometry parameters and Asthma Control Test score 629 Julia Klle Alexander Kiefer The role of interleukin 3 (IL3) in allergic asthma 275 Julia Klle Nikolaos G. Papadopoulos The role of interleukin 3 (IL3) in allergic asthma 275 Julia Klle Paraskevi Xepapadaki The role of interleukin 3 (IL3) in allergic asthma 275 Julia Klle Ralf Rieker The role of interleukin 3 (IL3) in allergic asthma 275 Julia Klle Susetta Finotto The role of interleukin 3 (IL3) in allergic asthma 275 Julia Klle Theodor Zimmermann The role of interleukin 3 (IL3) in allergic asthma 275 Julia Klle Tytti Vuorinen The role of interleukin 3 (IL3) in allergic asthma 275 Leyla Pur Ozyigit Ayse Bilge Ozturk NK cells in the pathogenesis of obese asthma phenotypes 655 Leyla Pur Ozyigit Bilun Gemicioglu NK cells in the pathogenesis of obese asthma phenotypes 655 Leyla Pur Ozyigit Esin Cetin Aktas NK cells in the pathogenesis of obese asthma phenotypes 655 Leyla Pur Ozyigit Gunnur Deniz NK cells in the pathogenesis of obese asthma phenotypes 655 Leyla Pur Ozyigit Yusuf Metin Gelmez NK cells in the pathogenesis of obese asthma phenotypes 655 Wilfried Karmaus A. Daniel Jones Maternal serum lipids at birth are associated with lung development of their offspring from age 10 to 26 years 721 Wilfried Karmaus Hongmei Zhang Maternal serum lipids at birth are associated with lung development of their offspring from age 10 to 26 years 721 Wilfried Karmaus Su Chen Maternal serum lipids at birth are associated with lung development of their offspring from age 10 to 26 years 721 Wilfried Karmaus Syed Hasan Arshad Maternal serum lipids at birth are associated with lung development of their offspring from age 10 to 26 years 721 Wilfried Karmaus Thilani Anthony Maternal serum lipids at birth are associated with lung development of their offspring from age 10 to 26 years 721 Masaya Matsuda Hiro Tomita Suppressive effect of intratracheal administration of IL-10 on steroid-resistant asthmatic responses in mice 337 Masaya Matsuda Junpei Hamaguchi Suppressive effect of intratracheal administration of IL-10 on steroid-resistant asthmatic responses in mice 337 Masaya Matsuda Kazuyuki Kitatani Suppressive effect of intratracheal administration of IL-10 on steroid-resistant asthmatic responses in mice 337 Masaya Matsuda Mari Minakawa Suppressive effect of intratracheal administration of IL-10 on steroid-resistant asthmatic responses in mice 337 Masaya Matsuda Miki Inaba Suppressive effect of intratracheal administration of IL-10 on steroid-resistant asthmatic responses in mice 337 Masaya Matsuda Takeshi Nabe Suppressive effect of intratracheal administration of IL-10 on steroid-resistant asthmatic responses in mice 337 Masaya Matsuda Yuma Takagi Suppressive effect of intratracheal administration of IL-10 on steroid-resistant asthmatic responses in mice 337 Sharon R. Van Nevel Claus Bachert Differential response of C57BL/6 and BALB/c mice in Alternaria alternata-induced allergic airway inflammation. 951 Sharon R. Van Nevel Gabriele Holtappels Differential response of C57BL/6 and BALB/c mice in Alternaria alternata-induced allergic airway inflammation. 951 Sharon R. Van Nevel Natalie De Ruyck Differential response of C57BL/6 and BALB/c mice in Alternaria alternata-induced allergic airway inflammation. 951 Sharon R. Van Nevel Olga Krysko Differential response of C57BL/6 and BALB/c mice in Alternaria alternata-induced allergic airway inflammation. 951 Kathrin Balz Chrysanthi Skevaki A systems immunoinformatics approach for identification of cross-reactive respiratory virus-and allergen-derived T cell epitopes 963 Kathrin Balz Franz Cemic A systems immunoinformatics approach for identification of cross-reactive respiratory virus-and allergen-derived T cell epitopes 963 Kathrin Balz Harald Renz A systems immunoinformatics approach for identification of cross-reactive respiratory virus-and allergen-derived T cell epitopes 963 Kathrin Balz Max Schulthei\\x9f A systems immunoinformatics approach for identification of cross-reactive respiratory virus-and allergen-derived T cell epitopes 963 Olga Krysko Andrea Teufelberger Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Olga Krysko Barbara M Brker Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Olga Krysko Claus Bachert Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Olga Krysko Dmitri Krysko Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Olga Krysko Maria Nordengrn Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Olga Krysko Paco Hulpiau Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Olga Krysko Sarah De Graeve Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Olga Krysko Sharon Van Nevel Identification of a novel pathway in immune response towards S.aureus protease like protein D<br /> 1221 Enrico Heffler Francesco Blasi Chronic rhinosinusitis with nasal polyps impacts in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 794 Enrico Heffler Gianenrico Senna Chronic rhinosinusitis with nasal polyps impacts in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 794 Enrico Heffler Giorgio Walter Canonica Chronic rhinosinusitis with nasal polyps impacts in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 794 Enrico Heffler Luca Malvezzi Chronic rhinosinusitis with nasal polyps impacts in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 794 Enrico Heffler Marco Caminati Chronic rhinosinusitis with nasal polyps impacts in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 794 Enrico Heffler Marco Mantero Chronic rhinosinusitis with nasal polyps impacts in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 794 Enrico Heffler Pierluigi Paggiaro Chronic rhinosinusitis with nasal polyps impacts in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 794 Enrico Heffler Francesca Puggioni Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: Data from the Severe Asthma Network in Italy (SANI) registry 804 Enrico Heffler Francesco Blasi Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: Data from the Severe Asthma Network in Italy (SANI) registry 804 Enrico Heffler Gianenrico Senna Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: Data from the Severe Asthma Network in Italy (SANI) registry 804 Enrico Heffler Giorgio Walter Canonica Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: Data from the Severe Asthma Network in Italy (SANI) registry 804 Enrico Heffler Marco Caminati Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: Data from the Severe Asthma Network in Italy (SANI) registry 804 Enrico Heffler Pierluigi Paggiaro Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: Data from the Severe Asthma Network in Italy (SANI) registry 804 Mariana Lobato Joo Gaspar-Marques Secondary adrenal insufficiency related to high doses of inhaled corticosteroids in severe asthma patients 676 Mariana Lobato Paula Leiria Pinto Secondary adrenal insufficiency related to high doses of inhaled corticosteroids in severe asthma patients 676 Mariana Lobato Pedro Carreiro-Martins Secondary adrenal insufficiency related to high doses of inhaled corticosteroids in severe asthma patients 676 Lucas Demey Alain Michils Exhaled nitric oxide as a marker of asthma control in severe eosinophilic asthma: Airway calibre matters 1091 Lucas Demey Alain Van Muylem Exhaled nitric oxide as a marker of asthma control in severe eosinophilic asthma: Airway calibre matters 1091 Lucas Demey Amaryllis Haccuria Exhaled nitric oxide as a marker of asthma control in severe eosinophilic asthma: Airway calibre matters 1091 Lucas Demey Florence Schleich Exhaled nitric oxide as a marker of asthma control in severe eosinophilic asthma: Airway calibre matters 1091 Lucas Demey Monique Henquet Exhaled nitric oxide as a marker of asthma control in severe eosinophilic asthma: Airway calibre matters 1091 Lucas Demey Renaud Louis Exhaled nitric oxide as a marker of asthma control in severe eosinophilic asthma: Airway calibre matters 1091 Lise Melscoet Frederic De Blay Effects of omalizumab in allergic bronchopulmonary aspergillosis in 10 asthmatic patients 1246 Lise Melscoet Naji Khayath Effects of omalizumab in allergic bronchopulmonary aspergillosis in 10 asthmatic patients 1246 Akio Mori Akemi Ohtomo-Abe Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Chiemi Kumitani Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Hiroaki Hayashi Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Kai Ryu Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Kentaro Watai Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Kisako Nagayama Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Kiyoshi Sekiya Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Maki Iwata Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Masami Taniguchi Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Miyako Yamaguchi Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Norihiko Fujita Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Osamu Kaminuma Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Satoshi Kouyama Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Takayuki Ohtomo Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Yosuke Kamide Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Yuma Fukutomi Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Yuto Hamada Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Akio Mori Yuto Nakamura Pharmacological analysis of helper T cell-dependent, steroid-resistant asthma 16 Nina Li Alexander Kiefer The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Anna Lewandowska-Polak The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Claus Bachert The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Heikki Lukkarinen The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Julia Koelle The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Marek L. Kowalski The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Mbeccel Akdis The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Nan Zhang The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Nikolaos G Papadopoulos The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Paraskevi Xepapadaki The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Susetta Finotto The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Theodor Zimmermann The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Tuomas Jartti The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Nina Li Tytti Vuorinen The role of regulated on activation, normal T cell expressed and secreted (RANTES) in allergic asthma 381 Saba Al Heialy Bassam Mahboub Involvement of IL-17 in steroid hyporesponsiveness in obese asthmatics through dysregulation of GR-alpha/ GR beta expression 745 Saba Al Heialy Laila Salameh Involvement of IL-17 in steroid hyporesponsiveness in obese asthmatics through dysregulation of GR-alpha/ GR beta expression 745 Saba Al Heialy Mellissa Gaudet Involvement of IL-17 in steroid hyporesponsiveness in obese asthmatics through dysregulation of GR-alpha/ GR beta expression 745 Saba Al Heialy Qutayba Hamid Involvement of IL-17 in steroid hyporesponsiveness in obese asthmatics through dysregulation of GR-alpha/ GR beta expression 745 Basak Ezgi Sarac Cagatay Karaaslan The effect of SERPINB3 on mucus expression in airway epithelial cells 772 Basak Ezgi Sarac Dilara Karaguzel The effect of SERPINB3 on mucus expression in airway epithelial cells 772 Basak Ezgi Sarac Esra Birben The effect of SERPINB3 on mucus expression in airway epithelial cells 772 Basak Ezgi Sarac Hayriye Akel Bilgic The effect of SERPINB3 on mucus expression in airway epithelial cells 772 Basak Ezgi Sarac Omer Kalayci The effect of SERPINB3 on mucus expression in airway epithelial cells 772 Hayriye Akel  Bilgic Aysun Kilic Suloglu Oxidative stress and antioxidant responses in airway inflammatory and resident cells experimentally simulated by cigarette smoke condensate (CSC) 789 Hayriye Akel  Bilgic Cagatay Karaaslan Oxidative stress and antioxidant responses in airway inflammatory and resident cells experimentally simulated by cigarette smoke condensate (CSC) 789 Hayriye Akel  Bilgic Omer Kalayci Oxidative stress and antioxidant responses in airway inflammatory and resident cells experimentally simulated by cigarette smoke condensate (CSC) 789 So Ri Kim Hae Jin Park An inhaled formulation of IGFBP-3 attenuates endoplasmic reticulum stress and severe neutrophilic asthmatic manifestations in mice 179 So Ri Kim Kyeong Hwa Park An inhaled formulation of IGFBP-3 attenuates endoplasmic reticulum stress and severe neutrophilic asthmatic manifestations in mice 179 So Ri Kim Yong Chul Lee An inhaled formulation of IGFBP-3 attenuates endoplasmic reticulum stress and severe neutrophilic asthmatic manifestations in mice 179 Lawrence Shih-Hsin Wu Jiu-Yao Wang Early-life EV-A71 infection augments allergen-induced airway inflammation in asthma through trained immunity of macrophage 1000 Lawrence Shih-Hsin Wu Pei-Chi Chen Early-life EV-A71 infection augments allergen-induced airway inflammation in asthma through trained immunity of macrophage 1000 Lawrence Shih-Hsin Wu Yung-I Hou Early-life EV-A71 infection augments allergen-induced airway inflammation in asthma through trained immunity of macrophage 1000 Karina Stein Carsten B. Schmidt-Weber How airway epithelial cells direct dendritic cells in asthma: A search for master regulators 938 Karina Stein Holger Heine How airway epithelial cells direct dendritic cells in asthma: A search for master regulators 938 Karina Stein Ulrich M. Zissler How airway epithelial cells direct dendritic cells in asthma: A search for master regulators 938 Johann Sieverding Holger Heine Microbial asthma protection mediated by TLR8 1027 Johann Sieverding Karina Stein Microbial asthma protection mediated by TLR8 1027 Thomas James Aidan Maguire Elena Ortiz-Zapater Sphingosine-1-phosphate induces constriction and hyperresponsiveness in ex vivo human airways 1123 Thomas James Aidan Maguire Gregory Knock Sphingosine-1-phosphate induces constriction and hyperresponsiveness in ex vivo human airways 1123 Thomas James Aidan Maguire Grzegorz Woszczek Sphingosine-1-phosphate induces constriction and hyperresponsiveness in ex vivo human airways 1123 Sun Young Yoon Jae-Hyung Roh Association between the fatty liver index and the incidence of newly onset adult asthma incidence: Result from the national health insurance service-national sample cohort database in Korea 82 Sun Young Yoon song-I Lee Association between the fatty liver index and the incidence of newly onset adult asthma incidence: Result from the national health insurance service-national sample cohort database in Korea 82 Yoshiki Shiraishi Asako Kitahara Thymic stromal lymphopoietin may induce interferon resistance on group 2 innate lymphoid cell-dependnent eosinophilic airway inflammation 158 Yoshiki Shiraishi Jun Tanaka Thymic stromal lymphopoietin may induce interferon resistance on group 2 innate lymphoid cell-dependnent eosinophilic airway inflammation 158 Yoshiki Shiraishi Koichiro Asano Thymic stromal lymphopoietin may induce interferon resistance on group 2 innate lymphoid cell-dependnent eosinophilic airway inflammation 158 Yoshiki Shiraishi Naoki Okada Thymic stromal lymphopoietin may induce interferon resistance on group 2 innate lymphoid cell-dependnent eosinophilic airway inflammation 158 Yoshiki Shiraishi Tsuyoshi Oguma Thymic stromal lymphopoietin may induce interferon resistance on group 2 innate lymphoid cell-dependnent eosinophilic airway inflammation 158 Francesca Losa Aran Singanayagam Differences in induction of asthma-relevant pro-inflammatory mediators by &beta;2-agonists and muscarinic antagonists in human bronchial epithelial cells  332 Francesca Losa Kartik Kumar Differences in induction of asthma-relevant pro-inflammatory mediators by &beta;2-agonists and muscarinic antagonists in human bronchial epithelial cells  332 Francesca Losa Michael R Edwards Differences in induction of asthma-relevant pro-inflammatory mediators by &beta;2-agonists and muscarinic antagonists in human bronchial epithelial cells  332 Francesca Losa Patrick Mallia Differences in induction of asthma-relevant pro-inflammatory mediators by &beta;2-agonists and muscarinic antagonists in human bronchial epithelial cells  332 Francesca Losa Sebastian L Johnston Differences in induction of asthma-relevant pro-inflammatory mediators by &beta;2-agonists and muscarinic antagonists in human bronchial epithelial cells  332 Francesca Losa Stefano Del Giacco Differences in induction of asthma-relevant pro-inflammatory mediators by &beta;2-agonists and muscarinic antagonists in human bronchial epithelial cells  332 Francesca Losa Tatiana Kebadze Differences in induction of asthma-relevant pro-inflammatory mediators by &beta;2-agonists and muscarinic antagonists in human bronchial epithelial cells  332 Sarah Miethe Daniel Piotr Potaczek Inflammatory phenotype of HDM-induced allergic airway inflammation is altered in obese C57BL/6 mice 1012 Sarah Miethe Felix Picard Inflammatory phenotype of HDM-induced allergic airway inflammation is altered in obese C57BL/6 mice 1012 Sarah Miethe Harald Renz Inflammatory phenotype of HDM-induced allergic airway inflammation is altered in obese C57BL/6 mice 1012 Sarah Miethe Hartmann Raifer Inflammatory phenotype of HDM-induced allergic airway inflammation is altered in obese C57BL/6 mice 1012 Sarah Miethe Holger Garn Inflammatory phenotype of HDM-induced allergic airway inflammation is altered in obese C57BL/6 mice 1012 Sarah Miethe Kim Pauck Inflammatory phenotype of HDM-induced allergic airway inflammation is altered in obese C57BL/6 mice 1012 Sarah Miethe Stefanie Hagner-Benes Inflammatory phenotype of HDM-induced allergic airway inflammation is altered in obese C57BL/6 mice 1012 Mar\\xada Garrido-Arandia Alejandro Romero-Sahagun Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 Mar\\xada Garrido-Arandia Alma Yuste-Montalvo Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 Mar\\xada Garrido-Arandia Araceli D\\xadaz-Perales Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 Mar\\xada Garrido-Arandia Diego Pazos-Castro Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 Mar\\xada Garrido-Arandia Guadalupe Hernandez-Ramirez Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 Mar\\xada Garrido-Arandia Jaime Tome-Amat Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 Mar\\xada Garrido-Arandia Vanesa Esteban Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 Mar\\xada Garrido-Arandia Zulema Gonzalez-Klein Phl p 1 homologues from straw might be responsible for allergic phenotypes among pollinic patients in autumn 1051 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Basic and clinical immunology',\n",
       "  'session': 'PDS 05 Basic and clinical immunology ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921281,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"PDS 05 Basic and clinical immunology  Roxana Lucia Sfrent Cornateanu Ana Maria Gheorghiu Cellular adhesion molecules and IL-6 as disease activity markers for systemic sclerosis 563 Roxana Lucia Sfrent Cornateanu Carina Mihai Cellular adhesion molecules and IL-6 as disease activity markers for systemic sclerosis 563 Roxana Lucia Sfrent Cornateanu Daciana Marta Cellular adhesion molecules and IL-6 as disease activity markers for systemic sclerosis 563 Roxana Lucia Sfrent Cornateanu ileana Constantinescu Cellular adhesion molecules and IL-6 as disease activity markers for systemic sclerosis 563 Roxana Lucia Sfrent Cornateanu Iolanda Panaitiu Cellular adhesion molecules and IL-6 as disease activity markers for systemic sclerosis 563 Roxana Lucia Sfrent Cornateanu Mihai Bojinca Cellular adhesion molecules and IL-6 as disease activity markers for systemic sclerosis 563 Mounira Benidir Djenette Hakem Relevance of the measurement of anti-phosphatidyl-serine / prothrombin autoantibodies in the diagnosis of anti-phospholipid syndrome 1386 Mounira Benidir Ghania Hamadi Relevance of the measurement of anti-phosphatidyl-serine / prothrombin autoantibodies in the diagnosis of anti-phospholipid syndrome 1386 Mounira Benidir Nabila Attal Relevance of the measurement of anti-phosphatidyl-serine / prothrombin autoantibodies in the diagnosis of anti-phospholipid syndrome 1386 Mounira Benidir Samira Kebbab Relevance of the measurement of anti-phosphatidyl-serine / prothrombin autoantibodies in the diagnosis of anti-phospholipid syndrome 1386 Mounira Benidir Sofiane Samir Salah Relevance of the measurement of anti-phosphatidyl-serine / prothrombin autoantibodies in the diagnosis of anti-phospholipid syndrome 1386 Mani Bhargava Saurabh Bhargava Dendritic nanoarchitectures for the treatment of psoriasis 1363 Myrthes Toledo Barros Ana Karolina B B Marinho Mortality in a cohort of common variable immunodeficiency (CVID) patients from 1980 to 2019 1325 Myrthes Toledo Barros Bruno Sini Mortality in a cohort of common variable immunodeficiency (CVID) patients from 1980 to 2019 1325 Myrthes Toledo Barros Cristina Maria Kokron Mortality in a cohort of common variable immunodeficiency (CVID) patients from 1980 to 2019 1325 Myrthes Toledo Barros Jorge Kalil Mortality in a cohort of common variable immunodeficiency (CVID) patients from 1980 to 2019 1325 Myrthes Toledo Barros Octavio Grecco Mortality in a cohort of common variable immunodeficiency (CVID) patients from 1980 to 2019 1325 Ella Vitalievna Churyukina Vera Olegovna Andreeva The role of autoimmunity in the pathogenesis of ovarian insufficient in adolescent girls 519 Rodolfo Bianchini Alina Groschopf AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Rodolfo Bianchini Daniel Reichhold AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Rodolfo Bianchini Erika Jensen-Jarolim AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Rodolfo Bianchini Galateja Jordakieva AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Rodolfo Bianchini Gerhard J Zlabinger AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Rodolfo Bianchini Jakob Piehslinger AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Rodolfo Bianchini Klaus Alexander AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Rodolfo Bianchini Sebastian A. F Jensen AllergoOncology&ndash;IgG4 in cancer drives macrophages towards M2b-like regulatory phenotype and negatively influences antibody-dependent effector functions with implications for disease progression 1016 Willem van de Veen Alex Straumann A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Alexandra Walliman A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Barbara Stanic A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Beate Rueckert A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Cezmi Akdis A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Christina Fassnacht A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Daan Huntjens A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Danielle Verschoor A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Desislava Ignatova A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Emmanuella Guenova A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Francesc Castro-Giner A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Ge Tan A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Globinska Anna A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Hergen Spits A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Jansen Kirstin A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Lukas Flatz A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Mariette Herrmann A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Marloes Van Splunter A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Mbeccel Akdis A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Oliver Wirz A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Rodney Fonseca Guevara A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Terufumi Kubo A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Urs Ochsner A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Willem van de Veen Yun-Tsan Chang A novel pro-angiogenic B cell subset is increased in cancer and chronic inflammation 253 Swati Sharma Naveen Arora Cockroach allergen exposure alters redox homeostasis and mediates airway inflammation 375 Karin Hufnagl Erika Jensen-Jarolim The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Karin Hufnagl Frank Redegeld The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Karin Hufnagl Franziska Roth-Walter The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Karin Hufnagl Gerlinde Hofstetter The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Karin Hufnagl Livia Kromp The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Karin Hufnagl Luis Pacios The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Karin Hufnagl Markus Wiederstein The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Karin Hufnagl Rodolfo Bianchini The allergenic capacity of the major birch pollen allergen Bet v 1 can be impaired by vitamin D3 binding 984 Wannada Laisuan Pintip Ngamjanyaporn The prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-&gamma; autoantibodies 295 Wannada Laisuan Porpon Rotjanapan The prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-&gamma; autoantibodies 295 Wannada Laisuan Prapaporn Pisitkun The prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-&gamma; autoantibodies 295 Wannada Laisuan Supa Oncham The prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-&gamma; autoantibodies 295 Wannada Laisuan Thanitta Suangtamai The prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-&gamma; autoantibodies 295 Tamiris Amanda Julio Ana Maria Roselino Bullous pemphigoid and dementia association: Is there any molecular mimicry between BP antigens in skin and brain? 80 Tamiris Amanda Julio Julio Csar Moriguti Bullous pemphigoid and dementia association: Is there any molecular mimicry between BP antigens in skin and brain? 80 Mani Bhargava Saurabh Bhargava Folate conjugated nanoparticulate drug delivery system for the effective management of rheumatoid arthritis 1378 Jing Jin Heng Xu Discovery of a potential highly selective inhibitor of PI3-Kiase Delta D128 in the treatment of adjuvant induced arthritis 784 Jing Jin Huimin Jiang Discovery of a potential highly selective inhibitor of PI3-Kiase Delta D128 in the treatment of adjuvant induced arthritis 784 Jing Jin Mingjin Wang Discovery of a potential highly selective inhibitor of PI3-Kiase Delta D128 in the treatment of adjuvant induced arthritis 784 Jing Jin Rong Fu Discovery of a potential highly selective inhibitor of PI3-Kiase Delta D128 in the treatment of adjuvant induced arthritis 784 Jing Jin Songwen Lin Discovery of a potential highly selective inhibitor of PI3-Kiase Delta D128 in the treatment of adjuvant induced arthritis 784 Jing Jin Xiaoguang Chen Discovery of a potential highly selective inhibitor of PI3-Kiase Delta D128 in the treatment of adjuvant induced arthritis 784 Marielena Jakobi Alexander Kiefer Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Marielena Jakobi Benjamin A Raby Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Marielena Jakobi Hooman Mirzakahni Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Marielena Jakobi Manfred Rauh Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Marielena Jakobi Nikolaos G Papadopoulos Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Marielena Jakobi Scott T Weiss Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Marielena Jakobi Susetta Finotto Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Marielena Jakobi Theodor Zimmermann Role of&nbsp; Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma 866 Jun Wang Jing Ye Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 138 Jun Wang Meng-Yue Li Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 138 Jun Wang Xue Kang Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 138 Jun Wang Zhi-Qun Huang Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 138 Anette Teo Hansen Seln Vadim V Sumbayev Biochemical regulation of the Tim-3-galectin-9 immunosuppressive pathway 1055 Heather J Bax Alexandra Robinson AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Ana Montes AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Anna Winship AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Atousa Khiabany AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Chara Stavraka AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Charleen Chan Wah Hak AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Cheryl Gillett AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Christopher J Corrigan AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Claire Barton AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Cristina Naceur-Lombardelli AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Debra H Josephs AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Giulia Pellizzari AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Hannah J Gould AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax James F Spicer AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Jitesh Chauhan AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Kristina M Ilieva AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Natalie Woodman AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Sarah Pinder AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Sharmistha Ghosh AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Sidath Katugampola AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Sophia N Karagiannis AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Heather J Bax Stephen J Till AllergoOncology: Study of potential hypersensitivity to an anti-tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test 1372 Menno van Zelm Emily S Edwards Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Menno van Zelm Fiona Hore-Lacy Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Menno van Zelm Josh Chatelier Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Menno van Zelm Julian J Bosco Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Menno van Zelm Paul U Cameron Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Menno van Zelm Pei M Aui Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Menno van Zelm Robert G Stirling Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Menno van Zelm Robyn E O'Hehir Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells 817 Marisa Paulino Claudia Varandas Merging quality of life and clinical severity in CVID 1512 Marisa Paulino Filipe Barbosa Merging quality of life and clinical severity in CVID 1512 Marisa Paulino Manuel Pereira-Barbosa Merging quality of life and clinical severity in CVID 1512 Marisa Paulino Sara Silva Merging quality of life and clinical severity in CVID 1512 Marisa Paulino Susana Lopes Da Silva Merging quality of life and clinical severity in CVID 1512 Rafaela Rla Leite Guimares Carolina Sanchez Aranda Bacillus Calmette-Guerin (BCG) complications in children with Severe Combined immunodeficiency (SCID) - what is the best therapy?&nbsp; 1553 Rafaela Rla Leite Guimares Dirceu Sol Bacillus Calmette-Guerin (BCG) complications in children with Severe Combined immunodeficiency (SCID) - what is the best therapy?&nbsp; 1553 Rafaela Rla Leite Guimares Maria Candida Faria Varanda Rizzo Bacillus Calmette-Guerin (BCG) complications in children with Severe Combined immunodeficiency (SCID) - what is the best therapy?&nbsp; 1553 Rafaela Rla Leite Guimares Maria Isabel De Moraes Pinto Bacillus Calmette-Guerin (BCG) complications in children with Severe Combined immunodeficiency (SCID) - what is the best therapy?&nbsp; 1553 Rafaela Rla Leite Guimares Mariana Gouveia Pereira Bacillus Calmette-Guerin (BCG) complications in children with Severe Combined immunodeficiency (SCID) - what is the best therapy?&nbsp; 1553 Ryuta Kamekura Hayato Yabe Cytotoxic peripheral T helper cells are involved in the pathogenesis of IgG4-related disease 462 Ryuta Kamekura Hiroki Takahashi Cytotoxic peripheral T helper cells are involved in the pathogenesis of IgG4-related disease 462 Ryuta Kamekura Kenichi Takano Cytotoxic peripheral T helper cells are involved in the pathogenesis of IgG4-related disease 462 Ryuta Kamekura Motohisa Yamamoto Cytotoxic peripheral T helper cells are involved in the pathogenesis of IgG4-related disease 462 Ryuta Kamekura Shingo Ichimiya Cytotoxic peripheral T helper cells are involved in the pathogenesis of IgG4-related disease 462 Hung Yi Lu Jung Sheng Chen Comorbidities of systemic lupus erythematosus prior to and following diagnosis - comparative data of childhood, adult and late-onset disease 541 Hung Yi Lu Kuo Wei Yeh Comorbidities of systemic lupus erythematosus prior to and following diagnosis - comparative data of childhood, adult and late-onset disease 541 Marieke van der Heiden Caroline Nilsson Retinoic acid suppresses&nbsp;S. aureus-induced T helper 9 cells&nbsp;in vitro, both in healthy and atopic individuals 1037 Marieke van der Heiden Eva Sverremark-Ekstrm Retinoic acid suppresses&nbsp;S. aureus-induced T helper 9 cells&nbsp;in vitro, both in healthy and atopic individuals 1037 Marieke van der Heiden Isabella Badolati Retinoic acid suppresses&nbsp;S. aureus-induced T helper 9 cells&nbsp;in vitro, both in healthy and atopic individuals 1037 Marieke van der Heiden Sophia Bjrkander Retinoic acid suppresses&nbsp;S. aureus-induced T helper 9 cells&nbsp;in vitro, both in healthy and atopic individuals 1037 Marieke van der Heiden Ulrika Hellberg Retinoic acid suppresses&nbsp;S. aureus-induced T helper 9 cells&nbsp;in vitro, both in healthy and atopic individuals 1037 Ivan V Zvyagin Artem I Mikelov In- and off-season peripheral blood T cell repertoire profiling of patients with birch pollen allergy 1486 Ivan V Zvyagin Ekaterina A Komech In- and off-season peripheral blood T cell repertoire profiling of patients with birch pollen allergy 1486 Ivan V Zvyagin Yuri B Lebedev In- and off-season peripheral blood T cell repertoire profiling of patients with birch pollen allergy 1486 Nicole F Brackett Anna Poms CRISPR gene editing of the major Cat Allergen, Fel d 1 470 Nicole F Brackett Julia C Riedy CRISPR gene editing of the major Cat Allergen, Fel d 1 470 Nicole F Brackett Martin D Chapman CRISPR gene editing of the major Cat Allergen, Fel d 1 470 Nicole F Brackett Mazhar Adli CRISPR gene editing of the major Cat Allergen, Fel d 1 470 Chuang Li Hao Jia Qi Huang The function and mechansim of cbl-b in RSV infection 154 Chuang Li Hao Yu Ma The function and mechansim of cbl-b in RSV infection 154 Giulia Costanzo Alessandra Olianas The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Barbara Manconi The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Cristina Contini The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Davide Firinu The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Francesco Cinetto The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Irene Messana The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Maria Rita Messina The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Maria Teresa Sanna The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Massimo Castagnola The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Simone Serrao The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Stefano Del Giacco The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Giulia Costanzo Tiziana Cabras The salivary proteomic profile of predominantly antibody deficiencies: Preliminary results 531 Anna A. Barilo Marina V. Smolnikova Immunological parameters in psoriasis depending on the disease severity in Eastern Siberia of Russia 560 Anna A. Barilo Svetlana V. Smirnova Immunological parameters in psoriasis depending on the disease severity in Eastern Siberia of Russia 560 Oxana A. Svitich A. Vinnitskaya Effect of CXCL12 and TLR ligands on tumor cell migration and expression of innate immunity factors 1491 Oxana A. Svitich Vitaliy Zverev Effect of CXCL12 and TLR ligands on tumor cell migration and expression of innate immunity factors 1491 Oxana A. Svitich Yulia Ammour Effect of CXCL12 and TLR ligands on tumor cell migration and expression of innate immunity factors 1491 Chuang Li Hao Jiaqi Huang DTX3L mediated regulation of TBK1 positively regulates type I IFN signaling pathway and cellular antiviral response 178 Chuang Li Hao Yu Ma DTX3L mediated regulation of TBK1 positively regulates type I IFN signaling pathway and cellular antiviral response 178 Jir\\xad Litzman Eva Hlavackova Ivemark syndrome - three case reports 460 Jir\\xad Litzman Marcela Vlkova Ivemark syndrome - three case reports 460 Cristina Mezzanotte Armando Gabrielli Neoplasia in common variable immunodeficiency: A case series 949 Cristina Mezzanotte Denise Menghini Neoplasia in common variable immunodeficiency: A case series 949 Cristina Mezzanotte Federico Guidotti Neoplasia in common variable immunodeficiency: A case series 949 Cristina Mezzanotte Maria Giovanna Danieli Neoplasia in common variable immunodeficiency: A case series 949 Cristina Mezzanotte Veronica Pedini Neoplasia in common variable immunodeficiency: A case series 949 Svetlana Sciuca Cristina Tomacinschi Thymus manifestations in an autopsy-based series of primary immunodeficiencies diseases 1007 Svetlana Sciuca Lilia Sinitina Thymus manifestations in an autopsy-based series of primary immunodeficiencies diseases 1007 Svetlana Sciuca Rodica Selevestru Thymus manifestations in an autopsy-based series of primary immunodeficiencies diseases 1007 Svetlana Sciuca Vergil Petrovici Thymus manifestations in an autopsy-based series of primary immunodeficiencies diseases 1007 Brindusa Ruxandra Capilna Reka Borka Balas X-linked hyper-IgM syndrome (XHIGM): Case report from Romania with novel mutation of CD40LG 1457 Brindusa Ruxandra Capilna Reka Toth X-linked hyper-IgM syndrome (XHIGM): Case report from Romania with novel mutation of CD40LG 1457 Brindusa Ruxandra Capilna Tudor Emil Capilna X-linked hyper-IgM syndrome (XHIGM): Case report from Romania with novel mutation of CD40LG 1457 Cristina Mezzanotte Alberto Paladini Oral health status in patients affected by Common Variable Immunodeficiency 958 Cristina Mezzanotte Angelo Putignano Oral health status in patients affected by Common Variable Immunodeficiency 958 Cristina Mezzanotte Denise Menghini Oral health status in patients affected by Common Variable Immunodeficiency 958 Cristina Mezzanotte Scilla Sparabombe Oral health status in patients affected by Common Variable Immunodeficiency 958 Cristina Mezzanotte Veronica Pedini Oral health status in patients affected by Common Variable Immunodeficiency 958 Cristina M Kokron Alex F Prado Antimicrobial prophylaxis in common variable immunodeficiency patients: Data collected from a Brazilian tertiary hospital 1501 Cristina M Kokron Ana Karolina B B Marinho Antimicrobial prophylaxis in common variable immunodeficiency patients: Data collected from a Brazilian tertiary hospital 1501 Cristina M Kokron Jorge Kalil Antimicrobial prophylaxis in common variable immunodeficiency patients: Data collected from a Brazilian tertiary hospital 1501 Cristina M Kokron Myrthes Toledo Barros Antimicrobial prophylaxis in common variable immunodeficiency patients: Data collected from a Brazilian tertiary hospital 1501 Cristina M Kokron Octavio Grecco Antimicrobial prophylaxis in common variable immunodeficiency patients: Data collected from a Brazilian tertiary hospital 1501 Youssouf Sereme Anne Filleron Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Cline Chartier Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Joana Vitte Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Mose Michel Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Patricia Blanchard Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Pierre Corbeau Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Simon Pinchemel Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Soraya Mezouar Non-invasive immunological exploration of the premature newborn infant 1311 Youssouf Sereme Tu Anh Tran Non-invasive immunological exploration of the premature newborn infant 1311 Saba Al Heialy Abiola Senok Upregulation of GATA-3 expression in response to simulated microgravity 792 Saba Al Heialy Bassam Mahboub Upregulation of GATA-3 expression in response to simulated microgravity 792 Saba Al Heialy Mahmood Yaseen Hachim Upregulation of GATA-3 expression in response to simulated microgravity 792 Saba Al Heialy Noha Mousaad Elemam Upregulation of GATA-3 expression in response to simulated microgravity 792 Saba Al Heialy Qutayba Hamid Upregulation of GATA-3 expression in response to simulated microgravity 792 Chunwei Li Jun Cui Epithelial NLRP3 inflammasome contribute inflammation, pyroptosis and mucin production in human airway epithelium in response to rhinovirus<br />&nbsp; 561 Chunwei Li Li Yue Li Epithelial NLRP3 inflammasome contribute inflammation, pyroptosis and mucin production in human airway epithelium in response to rhinovirus<br />&nbsp; 561 Chunwei Li Tao Liu Epithelial NLRP3 inflammasome contribute inflammation, pyroptosis and mucin production in human airway epithelium in response to rhinovirus<br />&nbsp; 561 Cristina Tomacinschii Mihaela Bataneant The serum immunoglobulins changes in respiratory infections of children with primary immunodeficiencies 969 Cristina Tomacinschii Rodica Selevestru The serum immunoglobulins changes in respiratory infections of children with primary immunodeficiencies 969 Cristina Tomacinschii Svetlana Sciuca The serum immunoglobulins changes in respiratory infections of children with primary immunodeficiencies 969 Patricia Maria O Farrill Diana Andrea Herrera MonoMAC syndrome in a patient with a GATA2 mutation: Case report 1524 Patricia Maria O Farrill Fanny Rubi Vargas MonoMAC syndrome in a patient with a GATA2 mutation: Case report 1524 Patricia Maria O Farrill Laura Berron MonoMAC syndrome in a patient with a GATA2 mutation: Case report 1524 Patricia Maria O Farrill Nora Hilda Segura MonoMAC syndrome in a patient with a GATA2 mutation: Case report 1524 Osamu Kaminuma Akio Mori Antigen-specific T cells confer nasal hyperresponsiveness in murine models of allergic rhinitis 26 Osamu Kaminuma Norimasa Yamasaki Antigen-specific T cells confer nasal hyperresponsiveness in murine models of allergic rhinitis 26 Osamu Kaminuma Sawako Ogata Antigen-specific T cells confer nasal hyperresponsiveness in murine models of allergic rhinitis 26 Osamu Kaminuma Takachika Hiroi Antigen-specific T cells confer nasal hyperresponsiveness in murine models of allergic rhinitis 26 Osamu Kaminuma Tomoe Nishimura Antigen-specific T cells confer nasal hyperresponsiveness in murine models of allergic rhinitis 26 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Dermatology',\n",
       "  'session': 'PDS 06 Dermatology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921282,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"PDS 06 Dermatology Matthew J Ridd Alison R G Shaw What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Anna Gilbertson What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Claire Clement What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Deb Marriage What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Douglas Webb What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Elizabeth Angier What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Ingrid Muller What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Joanna Coast What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Joanne R Chalmers What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Jodi Taylor What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Joe Kai What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Kirsty Garfield What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Kirsty Roberts What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Lisa Waddell What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Lucy Selman What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Miriam Santer What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Nicholas L Turner What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Peter S Blair What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Matthew J Ridd Robert J Boyle What is the value of test-guided dietary advice for children with eczema? Trial of eczema allergy screening tests (TEST) feasibility randomised controlled trial (RCT) with nested qualitative study 410 Jane R Parnes Janet Griffiths Key learnings and the informed design of a randomized, placebo-controlled, dose-ranging phase 2b study to evaluate the efficacy of tezepelumab in moderate-to-severe Atopic Dermatitis 457 Jane R Parnes Steven Komjathy Key learnings and the informed design of a randomized, placebo-controlled, dose-ranging phase 2b study to evaluate the efficacy of tezepelumab in moderate-to-severe Atopic Dermatitis 457 Marcus Maurer Ana Gimnez-Arnau Pooled analysis of the AWARE, laCAN and AMAC studies: CSU management and best practice insights 440 Marcus Maurer Chia-Yu Chu Pooled analysis of the AWARE, laCAN and AMAC studies: CSU management and best practice insights 440 Marcus Maurer Luis Felipe Ensina Pooled analysis of the AWARE, laCAN and AMAC studies: CSU management and best practice insights 440 Marcus Maurer Paolo Tassinari Pooled analysis of the AWARE, laCAN and AMAC studies: CSU management and best practice insights 440 Marcus Maurer Xavier Jaumont Pooled analysis of the AWARE, laCAN and AMAC studies: CSU management and best practice insights 440 Sinem Ayse \\x96rnek Cihan Orcen Remission rates and detailed evaluation of second line treatments in chronic urticaria patients with respect to clinical and laboratory parameters: Experience from a UCARE Center 1112 Sinem Ayse \\x96rnek Emek Kocaturk Remission rates and detailed evaluation of second line treatments in chronic urticaria patients with respect to clinical and laboratory parameters: Experience from a UCARE Center 1112 Joan Mendivil Giovanna Devercelli The relationship between treatment with long-term prophylaxis and attack rate in hereditary angioedema (HAE): A multinational chart review study 1216 Joan Mendivil Maral Dersarkissian The relationship between treatment with long-term prophylaxis and attack rate in hereditary angioedema (HAE): A multinational chart review study 1216 Joan Mendivil Mei Sheng Duh The relationship between treatment with long-term prophylaxis and attack rate in hereditary angioedema (HAE): A multinational chart review study 1216 Joan Mendivil Mu Cheng The relationship between treatment with long-term prophylaxis and attack rate in hereditary angioedema (HAE): A multinational chart review study 1216 Joan Mendivil Rose Chang The relationship between treatment with long-term prophylaxis and attack rate in hereditary angioedema (HAE): A multinational chart review study 1216 Joan Mendivil Sujata P Sarda The relationship between treatment with long-term prophylaxis and attack rate in hereditary angioedema (HAE): A multinational chart review study 1216 Tatsuya Ogawa Manabu Fujimoto The KEAP1/NRF2 system is an initiator of atopic sensitization 839 Tatsuya Ogawa Yasushi Suga The KEAP1/NRF2 system is an initiator of atopic sensitization 839 Tatsuya Ogawa Yosuke Ishitsuka The KEAP1/NRF2 system is an initiator of atopic sensitization 839 Eva Maria Rehbinder Alexis Rapin Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Anne Cathrine Staff Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Benjamin Marsland Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Bjrn Nordlund Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Cline Pattaroni Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Chistine Monceyron Jonassen Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Cilla Sderhll Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Gunilla Hedlin Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Hvard Ove Skjerven Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Julie Pernot Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Kai-Hkon Carlsen Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Karin Cecilie Ldrup Carlsen Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Knut Rudi Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Linn Landr Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Louis Mercier Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Nicola Harris Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Niki Ubags Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Eva Maria Rehbinder Riyas Vettukattil Skin microbiome, skin barrier, and atopic dermatitis in the first year of life 1322 Mariana Albertinazzi de Souza Pachani Ariana Campos Yang Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Mariana Albertinazzi de Souza Pachani Carolina Reis Sgarbi Martins Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Mariana Albertinazzi de Souza Pachani Daniel Bialowas Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Mariana Albertinazzi de Souza Pachani Fabio Fernandes Morato Castro Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Mariana Albertinazzi de Souza Pachani Francine Albino Zanetti Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Mariana Albertinazzi de Souza Pachani Jorge Kalil Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Mariana Albertinazzi de Souza Pachani Mariele Morandin Lopes Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Mariana Albertinazzi de Souza Pachani Sarah Aguiar Nunes Clinical evolution of Kaposi&#39;s varicelliform eruption using Immunosupressive drugs as treatment for atopic dermatitis 1276 Andreas Wollenberg Ana B. Rossi Long-term dupilumab treatment up to 100 weeks has no impact on serum lipids in patients with moderate-to-severe atopic dermatitis 409 Andreas Wollenberg Brad Shumel Long-term dupilumab treatment up to 100 weeks has no impact on serum lipids in patients with moderate-to-severe atopic dermatitis 409 Andreas Wollenberg Faisal A. Khokhar Long-term dupilumab treatment up to 100 weeks has no impact on serum lipids in patients with moderate-to-severe atopic dermatitis 409 Andreas Wollenberg Thomas Bieber Long-term dupilumab treatment up to 100 weeks has no impact on serum lipids in patients with moderate-to-severe atopic dermatitis 409 Andreas Wollenberg Zhen Chen Long-term dupilumab treatment up to 100 weeks has no impact on serum lipids in patients with moderate-to-severe atopic dermatitis 409 Pelin Kuteyla  Can Emek Kocaturk The prevalence of metabolic syndrome and the risk of coronary artery disease development in chronic spontaneous urticaria assessed by the framingham risk score 203 Pelin Kuteyla  Can \\x96mer \\x96zdemir The prevalence of metabolic syndrome and the risk of coronary artery disease development in chronic spontaneous urticaria assessed by the framingham risk score 203 Jie Shen Fok Marcus Maurer Predictors of response to treatment in chronic spontaneous urticaria &ndash; results of a systematic review 742 Jie Shen Fok Martin K Church Predictors of response to treatment in chronic spontaneous urticaria &ndash; results of a systematic review 742 Jie Shen Fok Pavel Kolkhir Predictors of response to treatment in chronic spontaneous urticaria &ndash; results of a systematic review 742 Allyne  Moura F E Sousa Arajo Amanda Brolio De Souza Presence of angioedema in patients with chronic urticaria and montelukast response 975 Allyne  Moura F E Sousa Arajo Antonio Abilio Motta Presence of angioedema in patients with chronic urticaria and montelukast response 975 Allyne  Moura F E Sousa Arajo Grazielly De Ftima Pereira Presence of angioedema in patients with chronic urticaria and montelukast response 975 Allyne  Moura F E Sousa Arajo Iandra Leite Perez Presence of angioedema in patients with chronic urticaria and montelukast response 975 Allyne  Moura F E Sousa Arajo Jorge Kalil Presence of angioedema in patients with chronic urticaria and montelukast response 975 Allyne  Moura F E Sousa Arajo La\\xads Souza Gomes Presence of angioedema in patients with chronic urticaria and montelukast response 975 Allyne  Moura F E Sousa Arajo Larissa De Queiroz Mamede Presence of angioedema in patients with chronic urticaria and montelukast response 975 Allyne  Moura F E Sousa Arajo Rosana Camara Agondi Presence of angioedema in patients with chronic urticaria and montelukast response 975 Ana M Gimnez-Arnau Avantika Barve Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Bobby Lanier Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Eva Hua Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Gordon Sussman Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Jonathan A Bernstein Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Karl Sitz Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Marcus Maurer Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Maria Magdalena Balp Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Martin Metz Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Michihiro Hide Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Pritam Gupta Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Reinhold Reinhold Janocha Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Thomas Severin Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Ana M Gimnez-Arnau Weily Soong Disease control correlates with improvement of dermatology quality of life in CSU patients with angioedema treated with ligelizumab 1019 Anna Valerieva Andrea Zanichelli Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Anurag Relan Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Henriette Farkas Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Katarina Hrubiskova Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Kinga Viktria Kohalmi Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Luca Bellizzi Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Maria T Staevska Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Milos Jesenak Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Roman Hakl Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Anna Valerieva Vesna Grivcheva-Panovska Treatment of hereditary angioedema attacks: A European registry of recombinant human C1 esterase inhibitor 1210 Neil Inhaber Dan Sexton Treatment-specific normalization of plasma kallikrein activity observed in patients with Hereditary Angioedema (HAE) 708 Neil Inhaber Jonathan A. Bernstein Treatment-specific normalization of plasma kallikrein activity observed in patients with Hereditary Angioedema (HAE) 708 Neil Inhaber Peng Lu Treatment-specific normalization of plasma kallikrein activity observed in patients with Hereditary Angioedema (HAE) 708 Neil Inhaber Priya S Chockalingam Treatment-specific normalization of plasma kallikrein activity observed in patients with Hereditary Angioedema (HAE) 708 Neil Inhaber Zhiwei Zhou Treatment-specific normalization of plasma kallikrein activity observed in patients with Hereditary Angioedema (HAE) 708 Konrad Bork Guenther Witzke Review of hereditary angioedema with normal C1 inhibitor: Pathology, genetics, symptoms, and treatment 1158 Konrad Bork Jochen Hardt Review of hereditary angioedema with normal C1 inhibitor: Pathology, genetics, symptoms, and treatment 1158 Konrad Bork Karin Wulff Review of hereditary angioedema with normal C1 inhibitor: Pathology, genetics, symptoms, and treatment 1158 Konrad Bork Subhransu Prusty Review of hereditary angioedema with normal C1 inhibitor: Pathology, genetics, symptoms, and treatment 1158 Konrad Bork Thomas Machnig Review of hereditary angioedema with normal C1 inhibitor: Pathology, genetics, symptoms, and treatment 1158 Hilary J. Longhurst Anete S Grumach Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey 1333 Hilary J. Longhurst Irmgard Andresen Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey 1333 Hilary J. Longhurst Jaco Botha Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey 1333 Hilary J. Longhurst Laurence Bouillet Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey 1333 Hilary J. Longhurst Marcus Maurer Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey 1333 Hilary J. Longhurst Teresa Caballero Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey 1333 Hilary J. Longhurst Werner Aberer Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey 1333 Teresa Caballero Anete S Grumach Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice 1300 Teresa Caballero Hilary J Longhurst Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice 1300 Teresa Caballero Irmgard Andresen Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice 1300 Teresa Caballero Jaco Botha Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice 1300 Teresa Caballero Laurence Bouillet Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice 1300 Teresa Caballero Marcus Maurer Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice 1300 Teresa Caballero Werner Aberer Effectiveness of icatibant to control symptoms of HAE attacks in real-world clinical practice 1300 Laurence Bouillet Aurelie Du-Thanh Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Laurence Bouillet Christina Lenkei Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Laurence Bouillet David Launay Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Laurence Bouillet Delphine Gobert Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Laurence Bouillet Isabelle Boccon-Gibod Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Laurence Bouillet Karima Boudjemia Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Laurence Bouillet Olivier Fain Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Laurence Bouillet Sophie Debord-Peguet Effectiveness of lanadelumab in the real-world setting: findings from a temporary authorization of use (ATU) in France for the treatment of hereditary angioedema type 1/2 1285 Inmaculada Martinez Saguer Giorgio Giannattasio Evaluation of long-term effectiveness of lanadelumab for hereditary angioedema in real-world clinical practice: Design of the ENABLE study 1126 Inmaculada Martinez Saguer Joan Mendivil Evaluation of long-term effectiveness of lanadelumab for hereditary angioedema in real-world clinical practice: Design of the ENABLE study 1126 Inmaculada Martinez Saguer Marcus Maurer Evaluation of long-term effectiveness of lanadelumab for hereditary angioedema in real-world clinical practice: Design of the ENABLE study 1126 Inmaculada Martinez Saguer Markus Magerl Evaluation of long-term effectiveness of lanadelumab for hereditary angioedema in real-world clinical practice: Design of the ENABLE study 1126 Inmaculada Martinez Saguer Tamar Kinaciyan Evaluation of long-term effectiveness of lanadelumab for hereditary angioedema in real-world clinical practice: Design of the ENABLE study 1126 Inmaculada Martinez Saguer Walter A Wuillemin Evaluation of long-term effectiveness of lanadelumab for hereditary angioedema in real-world clinical practice: Design of the ENABLE study 1126 Avner Reshef Adrian Y Wu Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Emel Aygoren-Pursun Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Eniko Nagy Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Henriette Farkas Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Jonathan Peter Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Marcin Stobiecki Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Marcus Maurer Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Melanie Cornpropst Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Phil Collis Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Sharon Murray Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Sorena Kiani Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Avner Reshef Tamar Kinaciyan Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study 1406 Theo Gulen Jesper Jarkvist Food hypersensitivity in clonal mast cell disorders &ndash; prevalence and clinical features of reactions&nbsp; &nbsp; 614 Theo Gulen Knut Brockow Food hypersensitivity in clonal mast cell disorders &ndash; prevalence and clinical features of reactions&nbsp; &nbsp; 614 Marlena Magdalena Sztormowska Ewa Jassem The pulmonary manifestation of mastocytosis 811 Marlena Magdalena Sztormowska Marek Niedoszytko The pulmonary manifestation of mastocytosis 811 Nida Oztop Akif Selim Yavuz Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Asli Gelincik Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Bahauddin Colakoglu Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Belkis Ertek Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Glkan Ozkan Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Meliha Nalcaci Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Osman Ozan Yegit Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Semra Demir Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Sengl Beyaz Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Suna Buyukozturk Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Nida Oztop Tarik Onur Tiryaki Assessment of potential risk factors for anaphylaxis in patients with mastocytosis 1233 Leonor Esteves Caldeira Catarina Coutinho Clinical experience of a specialized urticaria consultation from a Ucare center 667 Leonor Esteves Caldeira Clia Costa Clinical experience of a specialized urticaria consultation from a Ucare center 667 Leonor Esteves Caldeira Manuel Pereira Barbosa Clinical experience of a specialized urticaria consultation from a Ucare center 667 Leonor Esteves Caldeira Marisa Paulino Clinical experience of a specialized urticaria consultation from a Ucare center 667 Leonor Esteves Caldeira Marta Neto Clinical experience of a specialized urticaria consultation from a Ucare center 667 Luis Felipe Chiaverini Ensina Fabian Dabove Treatment impact on quality of life of patients with chronic urticaria refractory to at least one course of H1 antihistamine therapy: Real-world evidence from AWARE-LACan study 775 Luis Felipe Chiaverini Ensina Felicia Berroa Treatment impact on quality of life of patients with chronic urticaria refractory to at least one course of H1 antihistamine therapy: Real-world evidence from AWARE-LACan study 775 Luis Felipe Chiaverini Ensina Fernanda Di Tata Treatment impact on quality of life of patients with chronic urticaria refractory to at least one course of H1 antihistamine therapy: Real-world evidence from AWARE-LACan study 775 Luis Felipe Chiaverini Ensina Liliana Mar\\xada Tamayo Quijano Treatment impact on quality of life of patients with chronic urticaria refractory to at least one course of H1 antihistamine therapy: Real-world evidence from AWARE-LACan study 775 Luis Felipe Chiaverini Ensina Margarita Velsquez-Lopera Treatment impact on quality of life of patients with chronic urticaria refractory to at least one course of H1 antihistamine therapy: Real-world evidence from AWARE-LACan study 775 Luis Felipe Chiaverini Ensina Paolo Tassinari Treatment impact on quality of life of patients with chronic urticaria refractory to at least one course of H1 antihistamine therapy: Real-world evidence from AWARE-LACan study 775 ilan asher Eli magen Long term (&gt;1 year) treatment of chronic spontaneous urticaria with Omalizumab - a real life study 616 ilan asher Elias tubi Long term (&gt;1 year) treatment of chronic spontaneous urticaria with Omalizumab - a real life study 616 ilan asher Keren mahlab Guri Long term (&gt;1 year) treatment of chronic spontaneous urticaria with Omalizumab - a real life study 616 ilan asher zehava vaddas Long term (&gt;1 year) treatment of chronic spontaneous urticaria with Omalizumab - a real life study 616 ilan asher Zev Sthoeger Long term (&gt;1 year) treatment of chronic spontaneous urticaria with Omalizumab - a real life study 616 Zsuzsanna Erika Balla Henriette Farkas The importance of complement testing in acquired angioedema due to angiotensin-converting enzyme inhibitors 242 Zsuzsanna Erika Balla Kinga Viktria Kohalmi The importance of complement testing in acquired angioedema due to angiotensin-converting enzyme inhibitors 242 Zsuzsanna Erika Balla Lilian Varga The importance of complement testing in acquired angioedema due to angiotensin-converting enzyme inhibitors 242 Zsuzsanna Erika Balla Nomi Andrsi The importance of complement testing in acquired angioedema due to angiotensin-converting enzyme inhibitors 242 Zsuzsanna Erika Balla Zsuzsanna Zsilinszky The importance of complement testing in acquired angioedema due to angiotensin-converting enzyme inhibitors 242 Markus Magerl Claudia Cozma Study to evaluate metabolomic profiling of hereditary angioedem and identify candidate biomarkers for disease monitoring (HAEKA Study) 1360 Markus Magerl Donatello Crocetta Study to evaluate metabolomic profiling of hereditary angioedem and identify candidate biomarkers for disease monitoring (HAEKA Study) 1360 Markus Magerl Giorgio Giannattasio Study to evaluate metabolomic profiling of hereditary angioedem and identify candidate biomarkers for disease monitoring (HAEKA Study) 1360 Markus Magerl Marcus Maurer Study to evaluate metabolomic profiling of hereditary angioedem and identify candidate biomarkers for disease monitoring (HAEKA Study) 1360 Markus Magerl Neil Inhaber Study to evaluate metabolomic profiling of hereditary angioedem and identify candidate biomarkers for disease monitoring (HAEKA Study) 1360 Markus Magerl Toni M Frster Study to evaluate metabolomic profiling of hereditary angioedem and identify candidate biomarkers for disease monitoring (HAEKA Study) 1360 Markus Magerl Volha Skrahina Study to evaluate metabolomic profiling of hereditary angioedem and identify candidate biomarkers for disease monitoring (HAEKA Study) 1360 Dhanis Lad Alan D Irvine Neonatal natural moisturising factor concentrations in a high-risk cohort with parental history of atopy compared to a reference cohort 1392 Dhanis Lad Carol N\\xad Chaoimh Neonatal natural moisturising factor concentrations in a high-risk cohort with parental history of atopy compared to a reference cohort 1392 Dhanis Lad Claudio Nico Neonatal natural moisturising factor concentrations in a high-risk cohort with parental history of atopy compared to a reference cohort 1392 Dhanis Lad Gerwin J Puppels Neonatal natural moisturising factor concentrations in a high-risk cohort with parental history of atopy compared to a reference cohort 1392 Dhanis Lad Jonathan O'B Hourihane Neonatal natural moisturising factor concentrations in a high-risk cohort with parental history of atopy compared to a reference cohort 1392 Dhanis Lad Peter J Caspers Neonatal natural moisturising factor concentrations in a high-risk cohort with parental history of atopy compared to a reference cohort 1392 Jonathan I Silverberg Ana B Rossi Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Eric L Simpson Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Grece Saba Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Isabelle Guillemin Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Laurent Eckert Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Lysel Brignoli Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Miriam C Fenton Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Paola Mina-Osorio Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Sebastien Auziere Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Sebastien Barbarot Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Stephan Weidinger Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Jonathan I Silverberg Susan H Boklage Worldwide survey in 18 countries assessing prevalence of atopic dermatitis among adolescents 1068 Paula Kage Jan Chirstoph Simon Mental comorbidities in atopic eczema: Patient oriented scores are more helpful than EASI 133 Paula Kage Laura Poblotzki Mental comorbidities in atopic eczema: Patient oriented scores are more helpful than EASI 133 Paula Kage Regina Treudler Mental comorbidities in atopic eczema: Patient oriented scores are more helpful than EASI 133 Paula Kage Samira Zeynalova Mental comorbidities in atopic eczema: Patient oriented scores are more helpful than EASI 133 Nina Elliot Bethan James Assessing the management of Eczema Herpeticum in children with Atopic Dermatitis 507 Nina Elliot Sian Ludman Assessing the management of Eczema Herpeticum in children with Atopic Dermatitis 507 Nina Elliot Vineela Thotapalli Assessing the management of Eczema Herpeticum in children with Atopic Dermatitis 507 Mayumi Matsunaga Mizuho Nagao Predictive factors for treatment outcome in children with moderate or severe atopic dermatitis 280 Mayumi Matsunaga Takao Fujisawa Predictive factors for treatment outcome in children with moderate or severe atopic dermatitis 280 Anna Sergeevna Rusanova Alexandra Yurievna Nikitina Clinical and immunological effectiveness of immunotherapy for atopic dermatitis on house dust mites 151 Anna Sergeevna Rusanova Tatiana Alexandrovna Slavyanskaya Clinical and immunological effectiveness of immunotherapy for atopic dermatitis on house dust mites 151 Anna Sergeevna Rusanova Vladislava Vitalievna Derkach Clinical and immunological effectiveness of immunotherapy for atopic dermatitis on house dust mites 151 Roohi Rasool Wani Qurteeba Qadiri Potential role of&nbsp;LELP1 SNP (rs7534334)&nbsp;as&nbsp;pre disposing factor as well as an indicator&nbsp;for immunological&nbsp;interventions in moderate to severe atopic dermatitis 759 Sabine Altrichter Marcus Maurer Acethylcholine-induced whealing is associated with enhanced skin reactions in cholinergic urticaria patients 404 Sabine Altrichter Yiyu Wang Acethylcholine-induced whealing is associated with enhanced skin reactions in cholinergic urticaria patients 404 Nida Oztop Akif Selim Yavuz Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Asli Gelincik Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Bahauddin Colakoglu Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Glkan Ozkan Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Mehmet Aydogan Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Meliha Nalcaci Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Pelin Karaca Ozer Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Semra Demir Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Sengl Beyaz Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Suna Buyukozturk Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Tarik Onur Tiryaki Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Nida Oztop Zehra Bugra Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis 1100 Roberta Parente Chiara Cardamone Mastocytosis in children: Correlation between severity of mediator related symptoms and clinical and laboratory parameters of disease  1527 Roberta Parente Daniela Masci Mastocytosis in children: Correlation between severity of mediator related symptoms and clinical and laboratory parameters of disease  1527 Roberta Parente Domenico Ciotta Mastocytosis in children: Correlation between severity of mediator related symptoms and clinical and laboratory parameters of disease  1527 Roberta Parente Giulia De Feo Mastocytosis in children: Correlation between severity of mediator related symptoms and clinical and laboratory parameters of disease  1527 Roberta Parente Massimo Triggiani Mastocytosis in children: Correlation between severity of mediator related symptoms and clinical and laboratory parameters of disease  1527 Aliya Rafailovna Klyucharova Olesya Valeryevna Skorohodkina Significance of provocative tests in the diagnosis of cold urticaria for patients from different climatic zones 661 Ozdemir Can Tzer Asli Gelincik The presence of intestinal Blastocystis in chronic urticaria: Is eradication helpful for clinical improvement? 1319 Ozdemir Can Tzer Bahauddin Colakoglu The presence of intestinal Blastocystis in chronic urticaria: Is eradication helpful for clinical improvement? 1319 Ozdemir Can Tzer Nese Sonmez The presence of intestinal Blastocystis in chronic urticaria: Is eradication helpful for clinical improvement? 1319 Ozdemir Can Tzer Ozan Yegit The presence of intestinal Blastocystis in chronic urticaria: Is eradication helpful for clinical improvement? 1319 Ozdemir Can Tzer Ozden Boral The presence of intestinal Blastocystis in chronic urticaria: Is eradication helpful for clinical improvement? 1319 Ozdemir Can Tzer Semra Demir The presence of intestinal Blastocystis in chronic urticaria: Is eradication helpful for clinical improvement? 1319 Ozdemir Can Tzer Suna Buyukozturk The presence of intestinal Blastocystis in chronic urticaria: Is eradication helpful for clinical improvement? 1319 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Drug allergy',\n",
       "  'session': 'PDS 07 Drug allergy ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921283,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 07 Drug allergy  Jacqueline Loprete Adrienne Torda De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Alisa Kane De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Andrew Carr De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Ari Murad De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Brendan Mcmullan De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Brynn Wainstein De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Catherine Toong De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Constance Katelaris De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Dianne Campbell De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Jeffrey Post De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Louise Evans De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Melanie Wong De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Jacqueline Loprete Robyn Richardson De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals- towards standardisation and improved patient outcomes 658 Hilary I Allen Andrew W Murphy DE-labelling beta-lactam allergy using telemedicine and single dose oral challenge in a low risk paediatric cohort: Outcome of DE-labelling process one year later 1208 Hilary I Allen Edina M Moylett DE-labelling beta-lactam allergy using telemedicine and single dose oral challenge in a low risk paediatric cohort: Outcome of DE-labelling process one year later 1208 Hilary I Allen Marta Vazquez-Ortiz DE-labelling beta-lactam allergy using telemedicine and single dose oral challenge in a low risk paediatric cohort: Outcome of DE-labelling process one year later 1208 Jose Cornejo-Garc\\xada Gador Bogas Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 Jose Cornejo-Garc\\xada Inmaculada Doa Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 Jose Cornejo-Garc\\xada Joan Bartra Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 Jose Cornejo-Garc\\xada Jos Julio Laguna Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 Jose Cornejo-Garc\\xada Mar\\xada Isidoro-Garcia Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 Jose Cornejo-Garc\\xada Mar\\xada Jos Torres Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 Jose Cornejo-Garc\\xada Natalia Prez-Snchez Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 Jose Cornejo-Garc\\xada Raquel Jurado-Escobar Variants in the cytosolic phospholipase A2 gene (PLA2G4A) associate with NSAIDs-induced acute urticaria/angioedema 890 witchaya srisuwatchari Anca Mirela Chiriac Diagnostic performance of serial serum total tryptase measurement to differentiate allergic from non-allergic reaction among patients with perioperative hypersensitivity reaction 668 witchaya srisuwatchari Anna Borushko Diagnostic performance of serial serum total tryptase measurement to differentiate allergic from non-allergic reaction among patients with perioperative hypersensitivity reaction 668 witchaya srisuwatchari Jean Luc Bourrain Diagnostic performance of serial serum total tryptase measurement to differentiate allergic from non-allergic reaction among patients with perioperative hypersensitivity reaction 668 witchaya srisuwatchari Pascal Demoly Diagnostic performance of serial serum total tryptase measurement to differentiate allergic from non-allergic reaction among patients with perioperative hypersensitivity reaction 668 witchaya srisuwatchari Yoann Ehrhard Diagnostic performance of serial serum total tryptase measurement to differentiate allergic from non-allergic reaction among patients with perioperative hypersensitivity reaction 668 Maria Tsami Anastasia Geka Evaluation of patients with reported penicillin allergy: A prospective study of penicillin skin testing 646 Maria Tsami Dimitra Grapsa Evaluation of patients with reported penicillin allergy: A prospective study of penicillin skin testing 646 Maria Tsami Ekaterini Syrigou Evaluation of patients with reported penicillin allergy: A prospective study of penicillin skin testing 646 Maria Tsami Fotis Psarros Evaluation of patients with reported penicillin allergy: A prospective study of penicillin skin testing 646 Maria Tsami Nikolaos Syrigos Evaluation of patients with reported penicillin allergy: A prospective study of penicillin skin testing 646 Maria Tsami Stavros Tzelepis Evaluation of patients with reported penicillin allergy: A prospective study of penicillin skin testing 646 Daniel W Neu Amanda R Gillion Impact of beta lactam allergies on selection of antimicrobials in an inpatient setting 115 Daniel W Neu Debendra N Pattanaik Impact of beta lactam allergies on selection of antimicrobials in an inpatient setting 115 Daniel W Neu Tommie Jo Guidry Impact of beta lactam allergies on selection of antimicrobials in an inpatient setting 115 Karolina Frachowicz Aleksandra Wardzynska Clinical phenotypes of non-steroidal anti-inflammatory drug (NSAID) hypersensitivity among patients referred to allergy outpatient clinic 738 Karolina Frachowicz Marek Kowalski Clinical phenotypes of non-steroidal anti-inflammatory drug (NSAID) hypersensitivity among patients referred to allergy outpatient clinic 738 Kyung Hee Park Jae-Hyun Lee Predicting anaphylaxis before the first exposure of cetuximab using serum specific IgE measurement 769 Kyung Hee Park Jongsun Lee Predicting anaphylaxis before the first exposure of cetuximab using serum specific IgE measurement 769 Kyung Hee Park Jung-Won Park Predicting anaphylaxis before the first exposure of cetuximab using serum specific IgE measurement 769 Kyung Hee Park Sung-Ryeol Kim Predicting anaphylaxis before the first exposure of cetuximab using serum specific IgE measurement 769 Jni Costa Carvalho Ana Todo Bom Specific IgE to cefaclor in the diagnosis of type I hypersensitivity to cephalosporins and aminopenicillins 1539 Jni Costa Carvalho Carlos Loureiro Specific IgE to cefaclor in the diagnosis of type I hypersensitivity to cephalosporins and aminopenicillins 1539 Jni Costa Carvalho Emilia Far\\xada Specific IgE to cefaclor in the diagnosis of type I hypersensitivity to cephalosporins and aminopenicillins 1539 Jni Costa Carvalho Frederico S. Regateiro Specific IgE to cefaclor in the diagnosis of type I hypersensitivity to cephalosporins and aminopenicillins 1539 Jni Costa Carvalho Ins Nunes Specific IgE to cefaclor in the diagnosis of type I hypersensitivity to cephalosporins and aminopenicillins 1539 Jni Costa Carvalho Iolanda Alen Coutinho Specific IgE to cefaclor in the diagnosis of type I hypersensitivity to cephalosporins and aminopenicillins 1539 Jni Costa Carvalho Rosrio Cunha Specific IgE to cefaclor in the diagnosis of type I hypersensitivity to cephalosporins and aminopenicillins 1539 BEGUM GORGULU Guldane Cengiz Seval Rapid drug desensitization with rituximab in 24 cases: A single-center experience  72 BEGUM GORGULU Muhit Ozcan Rapid drug desensitization with rituximab in 24 cases: A single-center experience  72 BEGUM GORGULU Resat Kendirlinan Rapid drug desensitization with rituximab in 24 cases: A single-center experience  72 BEGUM GORGULU Selami Kocak Toprak Rapid drug desensitization with rituximab in 24 cases: A single-center experience  72 BEGUM GORGULU Sevim Bavbek Rapid drug desensitization with rituximab in 24 cases: A single-center experience  72 Alex Lacerda Cristina Frias Sartorelli Tolledo Piza Evaluation of the safety profile of selective COX-2 inhibitors in patients with Non-Steroidal Anti-Inflammatory Drugs (NSAID) reactions in Brazil 555 Alex Lacerda Fernanda Casares Marcelino Evaluation of the safety profile of selective COX-2 inhibitors in patients with Non-Steroidal Anti-Inflammatory Drugs (NSAID) reactions in Brazil 555 Alex Lacerda Ines Cristina Camelo-Nunes Evaluation of the safety profile of selective COX-2 inhibitors in patients with Non-Steroidal Anti-Inflammatory Drugs (NSAID) reactions in Brazil 555 Alex Lacerda Luis Felipe Ensina Evaluation of the safety profile of selective COX-2 inhibitors in patients with Non-Steroidal Anti-Inflammatory Drugs (NSAID) reactions in Brazil 555 Estefan\\xada Alexandra Montenegro Echeverr\\xada Aurora Gutierrez Gonzalez May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Carlos Rodriguez De La Vega May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Eva M Morchon Miguel May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Fernando Rodriguez Fernandez May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Laura Ferreira Freire May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Laura Zurbano Azqueta May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Leticia De Las Vecillas Snchez May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Maria Soledad Duque Gmez May I receive my first-line treatment although I&#39;m allergic? 957 Estefan\\xada Alexandra Montenegro Echeverr\\xada Marta Sotelo Garcia May I receive my first-line treatment although I&#39;m allergic? 957 Irem Turgay Yagmur Aynur Kucukcongar Yavas Evaluation of hypersensitivity reactions in patients receiving enzyme replacement therapy 1222 Irem Turgay Yagmur Emine Dibek Misirlioglu Evaluation of hypersensitivity reactions in patients receiving enzyme replacement therapy 1222 Irem Turgay Yagmur Ersoy Civelek Evaluation of hypersensitivity reactions in patients receiving enzyme replacement therapy 1222 Irem Turgay Yagmur Ilknur Kulhas Celik Evaluation of hypersensitivity reactions in patients receiving enzyme replacement therapy 1222 Irem Turgay Yagmur Mehmet Gunduz Evaluation of hypersensitivity reactions in patients receiving enzyme replacement therapy 1222 Irem Turgay Yagmur Muge Toyran Evaluation of hypersensitivity reactions in patients receiving enzyme replacement therapy 1222 Irem Turgay Yagmur Ozlem Unal Uzun Evaluation of hypersensitivity reactions in patients receiving enzyme replacement therapy 1222 Pedro Quintero Campos \\x81ngel Maquieira In vitro detection of amoxicillin alergy by luminescent immunoassay 1018 Pedro Quintero Campos Mar\\xada Jos Jurez In vitro detection of amoxicillin alergy by luminescent immunoassay 1018 Pedro Quintero Campos Sergi Morais In vitro detection of amoxicillin alergy by luminescent immunoassay 1018 Patricia Romero Leyla Pur Ozyigit Has NAP 6 caught us napping?: Anaesthetist&rsquo;s perspective for drug hypersensitivity reactions 1266 Patricia Romero Nasreen Khan Has NAP 6 caught us napping?: Anaesthetist&rsquo;s perspective for drug hypersensitivity reactions 1266 Ins Gonalves Nunes Ana Todo-Bom Anaphylaxis induced by specific challenge tests 1494 Ins Gonalves Nunes Beatriz Tavares Anaphylaxis induced by specific challenge tests 1494 Ins Gonalves Nunes Carmelita Ribeiro Anaphylaxis induced by specific challenge tests 1494 Ins Gonalves Nunes Em\\xadlia Faria Anaphylaxis induced by specific challenge tests 1494 Ins Gonalves Nunes Frederico Regateiro Anaphylaxis induced by specific challenge tests 1494 Ins Gonalves Nunes Graa Loureiro Anaphylaxis induced by specific challenge tests 1494 Ins Gonalves Nunes Isabel Carrapatoso Anaphylaxis induced by specific challenge tests 1494 Ins Gonalves Nunes Jni Carvalho Anaphylaxis induced by specific challenge tests 1494 Aiwen Wang Stephanie Li Hui Lee Cross-reactivity of cephalosporins in patients with IgE-mediated allergy to penicillins: A systematic review 33 Eralda Lekli Albana Gjeli Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Amarilda Zyli Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Denisa Spahiu Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Dorela Luku Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Dorina Oga Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Edina Zhabjaku Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Enkeleida Kryeziu Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Erald Topciu Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Eris Mesonjesi Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Etleva Qirko Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Jonida Vladi Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Julijana Asllani Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Klaudia Lekli Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Klea Xhelilaj Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Lorilda Budo Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Mehmet Hoxha Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Eralda Lekli Viola Nushi Clinical and epidemiological patterns of NSAIDs allergic reactions as single drug orally administered among emergency presenters 557 Jettanong Klaewsongkram Hiroshi Chantaphakul NSAID-induced blended reactions are not uncommon and aspirin desensitization could also be helpful 156 Jettanong Klaewsongkram Pungjai Mongkolpathumrat NSAID-induced blended reactions are not uncommon and aspirin desensitization could also be helpful 156 Jettanong Klaewsongkram Sirinoot Palapinyo NSAID-induced blended reactions are not uncommon and aspirin desensitization could also be helpful 156 Jettanong Klaewsongkram Supranee Buranapraditkun NSAID-induced blended reactions are not uncommon and aspirin desensitization could also be helpful 156 Goria  Andriollo Alessandro Buonomo Hypersensitivity reactions to platinum drugs and taxanes 954 Goria  Andriollo Arianna Aruanno Hypersensitivity reactions to platinum drugs and taxanes 954 Goria  Andriollo Eleonora Nucera Hypersensitivity reactions to platinum drugs and taxanes 954 Teodorikez Wilfox Jimenez-Rodriguez Javier Fernandez Desensitization to monoclonal antibodies 1169 Teodorikez Wilfox Jimenez-Rodriguez Maria Ruano-Zaragoza Desensitization to monoclonal antibodies 1169 Teodorikez Wilfox Jimenez-Rodriguez Mariela Lindo-Gutarra Desensitization to monoclonal antibodies 1169 Teodorikez Wilfox Jimenez-Rodriguez Purificacion Gonzalez-Delgado Desensitization to monoclonal antibodies 1169 Teodorikez Wilfox Jimenez-Rodriguez Victor Soriano-Gomis Desensitization to monoclonal antibodies 1169 \\x96zge Can Bostan Ali Fuat Kalyoncu Premedication should be given regardless of skin test results in radiocontrast media hypersensitivity 413 \\x96zge Can Bostan Ebru \\x87elebioglu Premedication should be given regardless of skin test results in radiocontrast media hypersensitivity 413 \\x96zge Can Bostan Gl Karakaya Premedication should be given regardless of skin test results in radiocontrast media hypersensitivity 413 \\x96zge Can Bostan Mehmet Erdem \\x87akmak Premedication should be given regardless of skin test results in radiocontrast media hypersensitivity 413 \\x96zge Can Bostan Saltuk Bugra Kaya Premedication should be given regardless of skin test results in radiocontrast media hypersensitivity 413 Tihomir Mustakov Georgy D. Christov Comparison of two different approaches to register anaphylatic and severe allergic reactions 1536 Tihomir Mustakov Nikolay N. Houbanov Comparison of two different approaches to register anaphylatic and severe allergic reactions 1536 Tihomir Mustakov Todor A. Popov Comparison of two different approaches to register anaphylatic and severe allergic reactions 1536 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'ENT',\n",
       "  'session': 'PDS 08 ENT ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921284,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 08 ENT  Zhi Qun Huang De Yun Wang Interleukin-13 exacerbates the effects of rhinoviruses on the nasal epithelial structure and immune response 157 Zhi Qun Huang Hsiao Hui Ong Interleukin-13 exacerbates the effects of rhinoviruses on the nasal epithelial structure and immune response 157 Zhi Qun Huang Jing Liu Interleukin-13 exacerbates the effects of rhinoviruses on the nasal epithelial structure and immune response 157 Zhi Qun Huang Jing Ye Interleukin-13 exacerbates the effects of rhinoviruses on the nasal epithelial structure and immune response 157 Tim Delemarre Claus Bachert An underestimated predictive role for Type 2 inflammation in CRSsNP 653 Tim Delemarre Elien Gevaert An underestimated predictive role for Type 2 inflammation in CRSsNP 653 Tim Delemarre Gabriele Holtappels An underestimated predictive role for Type 2 inflammation in CRSsNP 653 Tim Delemarre Natalie De Ruyck An underestimated predictive role for Type 2 inflammation in CRSsNP 653 Joaquim Mullol Miret Asif H. Khan Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Claus Bachert Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Joseph K. Han Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Leda P. Mannent Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Martin Desrosiers Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Nadia Daizadeh Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Nikhil Amin Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Roger Jankowski Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Joaquim Mullol Miret Siddhesh Kamat Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies 443 Philippe Gevaert Joaquim Mullol Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Joseph K. Han Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Lutaf Islam Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Peter W. Hellings Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Petter Olsson Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Randall Ow Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Rebecca Saenz Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Rui Zhao Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Philippe Gevaert Theodore Omachi Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 695 Claus Bachert Benjamin Ortiz Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Leda P. Mannent Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Nami Pandit-Abid Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Nikhil Amin Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Niranjan Kanesa-Thasan Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Philippe Gevaert Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Stella E. Lee Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Suzanne Green Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Xin Lu Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Claus Bachert Zhen Chen Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps &ndash; safety analysis from the SINUS-52 phase 3 trial 420 Femke Robays An Mariman The impact of nasal disorders on sleep 1180 Femke Robays Hannelore Van Mullem The impact of nasal disorders on sleep 1180 Femke Robays Peter Vermeir The impact of nasal disorders on sleep 1180 Femke Robays Philippe Gevaert The impact of nasal disorders on sleep 1180 xin luo Jianbo Shi The changes of clinical and histological characteristics of chronic rhinosinusitis with nasal polyps in China 922 xin luo Yinyan Lai The changes of clinical and histological characteristics of chronic rhinosinusitis with nasal polyps in China 922 xin luo Zhaofeng Xu The changes of clinical and histological characteristics of chronic rhinosinusitis with nasal polyps in China 922 Bing YAN Chengshuo Wang Predictive significance of Charcot-Leyden Crystal mRNA levels in nasal brushing for nasal polyp recurrence 679 Bing YAN Luo Zhang Predictive significance of Charcot-Leyden Crystal mRNA levels in nasal brushing for nasal polyp recurrence 679 JING LIU De Yun Wang IL-13 regulates cilia loss and localization of Cp110 in human nasal epithelium 751 JING LIU Hsiao Hui Ong IL-13 regulates cilia loss and localization of Cp110 in human nasal epithelium 751 JING LIU Kai Sen Tan IL-13 regulates cilia loss and localization of Cp110 in human nasal epithelium 751 JING LIU Kim Thye Thong IL-13 regulates cilia loss and localization of Cp110 in human nasal epithelium 751 JING LIU Ting Ting He IL-13 regulates cilia loss and localization of Cp110 in human nasal epithelium 751 JING LIU Yew Kwang Ong IL-13 regulates cilia loss and localization of Cp110 in human nasal epithelium 751 Heung-Man Lee Joo-Hoo Park Heat shock protein 47 regulates myofibroblast differentiation and extracellular matrix accumulation via smad2/3 signaling pathways in nasal fibroblasts 20 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Environmental and occupational allergy',\n",
       "  'session': 'PDS 09 Environmental and occupational allergy ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921286,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 09 Environmental and occupational allergy  Paola Mason Anna Chiara Frigo Outcome of isocyanate asthma is predicted by cluster allocation 976 Paola Mason Filippo Liviero Outcome of isocyanate asthma is predicted by cluster allocation 976 Paola Mason Gabriella Guarnieri Outcome of isocyanate asthma is predicted by cluster allocation 976 Paola Mason Piero Maestrelli Outcome of isocyanate asthma is predicted by cluster allocation 976 Nandini Ghosh  Purification and immuno-biochemical characterization of a novel pectate lyase allergen Hel a 6 and in silico multi-epitope vaccine designing 1146 Feng Lan Hai Bo Zhang Allergenicity of mugwort for induction of Th1 response in house dust mite sensitized allergic rhinitis patients&nbsp;&nbsp; 572 Feng Lan Li Min Zhao Allergenicity of mugwort for induction of Th1 response in house dust mite sensitized allergic rhinitis patients&nbsp;&nbsp; 572 Feng Lan Luo Zhang Allergenicity of mugwort for induction of Th1 response in house dust mite sensitized allergic rhinitis patients&nbsp;&nbsp; 572 Sandra Pfeiffer Ebrahim Razzazi-Fazeli Paecilomyces variotii - a novel fungal allergen source 231 Sandra Pfeiffer Ines Swoboda Paecilomyces variotii - a novel fungal allergen source 231 Sandra Pfeiffer Katharina Nbauer Paecilomyces variotii - a novel fungal allergen source 231 Sandra Pfeiffer Katja Sterflinger Paecilomyces variotii - a novel fungal allergen source 231 Sandra Pfeiffer Mariona Pascal Paecilomyces variotii - a novel fungal allergen source 231 Sandra Pfeiffer Santiago Quirce Paecilomyces variotii - a novel fungal allergen source 231 Markus Berger Hanns Moshammer Impact of air pollution on pollen allergy symptom data in a metropolis (Vienna, Austria): Unravelling the importance of ozone during three pollen seasons from 2010-2018 1565 Markus Berger Hans-Peter Hutter Impact of air pollution on pollen allergy symptom data in a metropolis (Vienna, Austria): Unravelling the importance of ozone during three pollen seasons from 2010-2018 1565 Markus Berger Katharina Bastl Impact of air pollution on pollen allergy symptom data in a metropolis (Vienna, Austria): Unravelling the importance of ozone during three pollen seasons from 2010-2018 1565 Markus Berger Lukas Dirr Impact of air pollution on pollen allergy symptom data in a metropolis (Vienna, Austria): Unravelling the importance of ozone during three pollen seasons from 2010-2018 1565 Markus Berger Maximilian Bastl Impact of air pollution on pollen allergy symptom data in a metropolis (Vienna, Austria): Unravelling the importance of ozone during three pollen seasons from 2010-2018 1565 Markus Berger Wolfgang Gstttner Impact of air pollution on pollen allergy symptom data in a metropolis (Vienna, Austria): Unravelling the importance of ozone during three pollen seasons from 2010-2018 1565 Ins Ribeiro Pacincia Andr Moreira Flying with indoor and airborne food allergens: An important source of exposure 238 Ins Ribeiro Pacincia Diana Silva Flying with indoor and airborne food allergens: An important source of exposure 238 Ins Ribeiro Pacincia Francisca Mendes Flying with indoor and airborne food allergens: An important source of exposure 238 Ins Ribeiro Pacincia Joo Cavaleiro Rufo Flying with indoor and airborne food allergens: An important source of exposure 238 Ins Ribeiro Pacincia Lu\\xads Delgado Flying with indoor and airborne food allergens: An important source of exposure 238 Ins Ribeiro Pacincia Mariana Farraia Flying with indoor and airborne food allergens: An important source of exposure 238 Ins Ribeiro Pacincia Mariana Leal Flying with indoor and airborne food allergens: An important source of exposure 238 Sanjoy Podder Goutam Kumar Saha House dust mite induced allergy among West Bengal population, India- prediction by logistic regression model 32 Sanjoy Podder Saibal Moitra House dust mite induced allergy among West Bengal population, India- prediction by logistic regression model 32 Sanjoy Podder Srijit Bhattacharya House dust mite induced allergy among West Bengal population, India- prediction by logistic regression model 32 Hussein H Mwanga Mohamed F Jeebhay Occupational risk factors for work-related asthma outcomes in health workers exposed to diverse cleaning agents 461 Hussein H Mwanga Roslynn Baatjies Occupational risk factors for work-related asthma outcomes in health workers exposed to diverse cleaning agents 461 Hussein H Mwanga Tanusha Singh Occupational risk factors for work-related asthma outcomes in health workers exposed to diverse cleaning agents 461 Mar\\xada Karina Magdalena Bethencourt Antonio Nieto Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Borja Bartolom Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Inmaculada Mar\\xada Snchez-Guerrero Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Jos Meseguer Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Jos Damin Lpez Snchez Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Juan Jos Corts Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Mar\\xada Pilar Lpez Sez Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Mariola Navarro Allergic occupational asthma because of almond shell dust 1308 Mar\\xada Karina Magdalena Bethencourt Mnica Snchez Prez Allergic occupational asthma because of almond shell dust 1308 Marcel Mazur Daniel Bulanda The effect of air pollution on basophil activity of birch pollen sensitive allergic rhinitis patients 1473 Marcel Mazur Ewa Czarnobilska The effect of air pollution on basophil activity of birch pollen sensitive allergic rhinitis patients 1473 Marcel Mazur Malgorzata Bulanda The effect of air pollution on basophil activity of birch pollen sensitive allergic rhinitis patients 1473 Marcel Mazur Wojciech Dyga The effect of air pollution on basophil activity of birch pollen sensitive allergic rhinitis patients 1473 Olga Branicka Lesia Rozlucka Case report of anaphylactic reaction oyster mushrooms (Pleurotus ostreatus) 1166 Olga Branicka Radoslaw Gawlik Case report of anaphylactic reaction oyster mushrooms (Pleurotus ostreatus) 1166 Lluis Marques Diana Garnica Occupational allergy due to pig seme 102 Lluis Marques Eva Alcoceba Occupational allergy due to pig seme 102 Lluis Marques Fernando Pineda Occupational allergy due to pig seme 102 Lluis Marques Miriam Castillo Occupational allergy due to pig seme 102 Lluis Marques Silvia Lara Occupational allergy due to pig seme 102 Irene Bartha de las Peas Azahara Lopez-Raigada Influence of aeroallergen sensitization profile in clinical exacerbations of patients with cystic fibrosis 1113 Irene Bartha de las Peas Carlos Blanco Influence of aeroallergen sensitization profile in clinical exacerbations of patients with cystic fibrosis 1113 Irene Bartha de las Peas Francisco Vega Influence of aeroallergen sensitization profile in clinical exacerbations of patients with cystic fibrosis 1113 Irene Bartha de las Peas Paloma Las-Heras Influence of aeroallergen sensitization profile in clinical exacerbations of patients with cystic fibrosis 1113 Irene Bartha de las Peas Tania Ramos Influence of aeroallergen sensitization profile in clinical exacerbations of patients with cystic fibrosis 1113 Siyuan Ma Chengshuo Wang The impairment of the barrier integrity of nasal eos-CRSwNP epithelial cells by PM2.5 can be partially repaired by budisonide<br /> 1561 Siyuan Ma Luo Zhang The impairment of the barrier integrity of nasal eos-CRSwNP epithelial cells by PM2.5 can be partially repaired by budisonide<br /> 1561 Siyuan Ma Mu Xian The impairment of the barrier integrity of nasal eos-CRSwNP epithelial cells by PM2.5 can be partially repaired by budisonide<br /> 1561 Rocco Luigi Valluzzi Alessandro Giovanni Fiocchi Air fresheners, bactericide cleaners and sensitization to indoor allergens among Italian children 1078 Rocco Luigi Valluzzi Mariacristina Artesani Air fresheners, bactericide cleaners and sensitization to indoor allergens among Italian children 1078 Rocco Luigi Valluzzi Maurizio Mennini Air fresheners, bactericide cleaners and sensitization to indoor allergens among Italian children 1078 Rocco Luigi Valluzzi Veronica Calandrelli Air fresheners, bactericide cleaners and sensitization to indoor allergens among Italian children 1078 Rocco Luigi Valluzzi Vincenzo Fierro Air fresheners, bactericide cleaners and sensitization to indoor allergens among Italian children 1078 Yoshiyuki Adachi Daisuke Yamanaka 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 Yoshiyuki Adachi Hiroki Matsuhara 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 Yoshiyuki Adachi Katsuyo Ohashi-Doi 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 Yoshiyuki Adachi Ken-Ichi Ishibashi 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 Yoshiyuki Adachi Naohito Ohno 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 Yoshiyuki Adachi Rie Hiratsuka 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 Yoshiyuki Adachi Takashi Kanno 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 Yoshiyuki Adachi Yoichiro Iwakura 1,3-&beta;-glucan in the Japanese cedar pollen activates innate immune response via dectin-1 724 manar farouk mohamed Eman Al Sayed Ahmed Pollen allergy among Egyptian patients with respiratory allergy 352 manar farouk mohamed Maged Mohamed Refaat Pollen allergy among Egyptian patients with respiratory allergy 352 manar farouk mohamed Nada Mohamed Nour- Al Din Pollen allergy among Egyptian patients with respiratory allergy 352 manar farouk mohamed Nermine Abd El - Nour Malaak Pollen allergy among Egyptian patients with respiratory allergy 352 manar farouk mohamed Osama Mohamed Abdel Latif Pollen allergy among Egyptian patients with respiratory allergy 352 Ella Vitalievna Churyukina Alexandr Alexeevich Kozhin ?icroelementosis as predictors of pubertal period delay in adolescent boys 534 Ella Vitalievna Churyukina Olesya Zinovievna Puzikova ?icroelementosis as predictors of pubertal period delay in adolescent boys 534 Ella Vitalievna Churyukina Victoria Alexandrovna Popova ?icroelementosis as predictors of pubertal period delay in adolescent boys 534 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Food allergy',\n",
       "  'session': 'PDS 10 Food allergy ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921287,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"PDS 10 Food allergy  Hisako Yagi Hirokazu Arakawa Novel whole blood allergen stimulation test for Non-IgE-mediated gastrointestinal food allergies in neonates and infants 822 Hisako Yagi Koichiro Sato Novel whole blood allergen stimulation test for Non-IgE-mediated gastrointestinal food allergies in neonates and infants 822 Hisako Yagi Naoya Arakawa Novel whole blood allergen stimulation test for Non-IgE-mediated gastrointestinal food allergies in neonates and infants 822 Hisako Yagi Satoshi Yamada Novel whole blood allergen stimulation test for Non-IgE-mediated gastrointestinal food allergies in neonates and infants 822 Hisako Yagi Takumi Takizawa Novel whole blood allergen stimulation test for Non-IgE-mediated gastrointestinal food allergies in neonates and infants 822 Hisako Yagi Yutaka Nishida Novel whole blood allergen stimulation test for Non-IgE-mediated gastrointestinal food allergies in neonates and infants 822 Jos Antonio Caas Ana Tabares Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 Jos Antonio Caas Carolina Gutirrez-Junquera Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 Jos Antonio Caas Claudia Barbero Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 Jos Antonio Caas Jos Manuel Rodrigo-Muoz Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 Jos Antonio Caas Natalia Redondo Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 Jos Antonio Caas Raquel Garc\\xada Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 Jos Antonio Caas Sonia Fernndez-Fernndez Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 Jos Antonio Caas Victoria Del Pozo Esophageal micrornas could be used as useful tool to discriminate between responder from non-responder children to proton pump inhibitor therapy in eosinophilic esophagitis pathology 189 LIAT NACHSHON Lior Tsviban Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy 637 LIAT NACHSHON Michael B Levy Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy 637 LIAT NACHSHON Michael R Goldberg Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy 637 LIAT NACHSHON Naama Epstein-Rigby Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy 637 LIAT NACHSHON Naama Schwartz Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy 637 LIAT NACHSHON Yitzhak Katz Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy 637 Montserrat Fernndez-Rivas Alex Smith PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Aline Sprikkelman PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Antonella Muraro PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Brian P Vickery PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Caroline Nilsson PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Daniel C Adelman PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas George Du Toit PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Jonathan O'B Hourihane PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Katharina Blumchen PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Kirsten Beyer PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Stacie M Jones PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 Montserrat Fernndez-Rivas Wayne G Shreffler PALISADE follow-on study&nbsp;(ARC004):&nbsp;Longer-term outcomes&nbsp;with&nbsp;AR101 oral immunotherapy&nbsp;for peanut allergy&nbsp; 1393 R. Sharon Chinthrajah Andrew J Long Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Holden Maecker Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Kari Nadeau Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Manisha Desai Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Mindy Tsai Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Monali Manohar Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Natasha Purington Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Robert Tibshirani Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Sayantani Sindher Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Scott Boyd Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Shu Cao Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Shu-Chen Lyu Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 R. Sharon Chinthrajah Stephen J Galli Decrease in dose-related allergic reactions over time during peanut oral immunotherapy in a randomized phase 2 study 1167 Erik R Wambre Allen R. Radin Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Claire Q. Wang Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Daniel C. Adelman Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Hannah Deberg Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Jennifer D. Hamilton Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Laura Winters Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Leda P. Mannett Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Marcella Ruddy Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Veronique Bajzik Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Erik R Wambre Vinh Nuce Baseline characteristics of peanut-allergic individuals during the dupilumab as adjunct to AR101 clinical trial 1343 Stephanie Erdle Edmond S Chan First real-world safety analysis of preschool tree nut oral immunotherapy 624 Stephanie Erdle Lianne Soller First real-world safety analysis of preschool tree nut oral immunotherapy 624 Stephanie Erdle Mary Mchenry First real-world safety analysis of preschool tree nut oral immunotherapy 624 Stephanie Erdle Raymond Mak First real-world safety analysis of preschool tree nut oral immunotherapy 624 Stephanie Erdle Tiffany Wong First real-world safety analysis of preschool tree nut oral immunotherapy 624 Stephanie Erdle Victoria E Cook First real-world safety analysis of preschool tree nut oral immunotherapy 624 Sarah A Lyons Andr C Knulst Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Barbara K. Ballmer-Weber Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Christian Bieli Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Cristina Fernndez-Perez Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons E. N. Clare Mills Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Harmieke Van Os - Medendorp Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Ischa Kmmeling Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons James Potts Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Laura Barreales Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Marek L Kowalski Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Michael Clausen Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Monika Jedrzejczak-Czechowicz Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Montserrat Fernndez-Rivas Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Nikolaos G. Papadopoulos Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Paco M. J. Welsing Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Paraskevi Xepapadaki Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Peter G. J. Burney Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Ronald Van Ree Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Ruta Dubakiene Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Thuy-My T. M. Le Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Tihomir B Mustakov Predictors of food sensitisation in European children and adults 1021 Sarah A Lyons Todor A Popov Predictors of food sensitisation in European children and adults 1021 Victoria Soriano Anne- Louise Ponsonby Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Victoria Soriano Jennifer J Koplin Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Victoria Soriano Martin O\\x80\\x99hely Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Victoria Soriano Mike Forrester Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Victoria Soriano Peter Vuillerman Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Victoria Soriano Rachel L Peters Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Victoria Soriano Rosemary Wright Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Victoria Soriano Shyamali C Dharmage Chemical sterilisation of pacifiers is associated with infant food allergy: The barwon infant study 69 Amy L Parrish Cathy Leonard Mucus barrier erosion by the commensal gut microbiome leads to exacerbated food allergy sensitization 1095 Amy L Parrish Mahesh Desai Mucus barrier erosion by the commensal gut microbiome leads to exacerbated food allergy sensitization 1095 Amy L Parrish Mareike Neumann Mucus barrier erosion by the commensal gut microbiome leads to exacerbated food allergy sensitization 1095 Amy L Parrish Markus Ollert Mucus barrier erosion by the commensal gut microbiome leads to exacerbated food allergy sensitization 1095 Amy L Parrish Stephanie Willieme Mucus barrier erosion by the commensal gut microbiome leads to exacerbated food allergy sensitization 1095 Amandine Selle Angline Duval Impact of prebiotics supplementation during pregnancy on food allergy development in offspring 185 Amandine Selle Carole Brosseau Impact of prebiotics supplementation during pregnancy on food allergy development in offspring 185 Amandine Selle Marie Bodinier Impact of prebiotics supplementation during pregnancy on food allergy development in offspring 185 Leticia Prez Rodr\\xadguez Daniel Lozano Ojalvo Triglycerides and phospholipids from egg yolk act as adjuvants at intestinal and lymphoid levels activating type-2 responses to egg white allergens in balb/c mice 1008 Leticia Prez Rodr\\xadguez Elena Molina Triglycerides and phospholipids from egg yolk act as adjuvants at intestinal and lymphoid levels activating type-2 responses to egg white allergens in balb/c mice 1008 Leticia Prez Rodr\\xadguez Monica Mart\\xadnez Blanco Triglycerides and phospholipids from egg yolk act as adjuvants at intestinal and lymphoid levels activating type-2 responses to egg white allergens in balb/c mice 1008 Leticia Prez Rodr\\xadguez Rosina Lpez Fandio Triglycerides and phospholipids from egg yolk act as adjuvants at intestinal and lymphoid levels activating type-2 responses to egg white allergens in balb/c mice 1008 Leticia Prez Rodr\\xadguez Sara Bend Triglycerides and phospholipids from egg yolk act as adjuvants at intestinal and lymphoid levels activating type-2 responses to egg white allergens in balb/c mice 1008 Carolina Perales Chorda Alma Villaseor Metabolic changes in a food allergy anaphylaxis model allow predicting IgE or non-IgE-mediated drug anaphylaxis patients 456 Carolina Perales Chorda Coral Barbas Metabolic changes in a food allergy anaphylaxis model allow predicting IgE or non-IgE-mediated drug anaphylaxis patients 456 Carolina Perales Chorda David Obeso Metabolic changes in a food allergy anaphylaxis model allow predicting IgE or non-IgE-mediated drug anaphylaxis patients 456 Carolina Perales Chorda Dolores Hernndez Fernndez De Rojas Metabolic changes in a food allergy anaphylaxis model allow predicting IgE or non-IgE-mediated drug anaphylaxis patients 456 Carolina Perales Chorda Domingo Barber Metabolic changes in a food allergy anaphylaxis model allow predicting IgE or non-IgE-mediated drug anaphylaxis patients 456 Carolina Perales Chorda Laura Twomey Metabolic changes in a food allergy anaphylaxis model allow predicting IgE or non-IgE-mediated drug anaphylaxis patients 456 Carolina Perales Chorda Marta Roca Metabolic changes in a food allergy anaphylaxis model allow predicting IgE or non-IgE-mediated drug anaphylaxis patients 456 Emilio Nez-Borque Diana Betancor Next generation sequencing for microRNA profile of human anaphylaxis serum samples and evaluation of serum-endothelium in vitro systems 995 Emilio Nez-Borque Jose Julio Laguna Next generation sequencing for microRNA profile of human anaphylaxis serum samples and evaluation of serum-endothelium in vitro systems 995 Emilio Nez-Borque Paloma Mar\\xada Dolores Ibaez Next generation sequencing for microRNA profile of human anaphylaxis serum samples and evaluation of serum-endothelium in vitro systems 995 Emilio Nez-Borque Sergio Fernandez-Bravo Next generation sequencing for microRNA profile of human anaphylaxis serum samples and evaluation of serum-endothelium in vitro systems 995 Emilio Nez-Borque Vanesa Esteban Next generation sequencing for microRNA profile of human anaphylaxis serum samples and evaluation of serum-endothelium in vitro systems 995 Casey G Cohen Bertrand J Jean-Claude Evaluating new processing methods and their effects on peanut allergenicity 328 Casey G Cohen Bruce D Mazer Evaluating new processing methods and their effects on peanut allergenicity 328 Casey G Cohen Wei Zhao Evaluating new processing methods and their effects on peanut allergenicity 328 Anna Maria Ehlers Andr C Knulst Vicilin-like antimicrobial peptides from macadamia nut are clinically relevant allergens 1041 Anna Maria Ehlers Bettina Brix Vicilin-like antimicrobial peptides from macadamia nut are clinically relevant allergens 1041 Anna Maria Ehlers Henny G Otten Vicilin-like antimicrobial peptides from macadamia nut are clinically relevant allergens 1041 Anna Maria Ehlers Stefanie Rohwer Vicilin-like antimicrobial peptides from macadamia nut are clinically relevant allergens 1041 Anna Maria Ehlers Thuy-My Le Vicilin-like antimicrobial peptides from macadamia nut are clinically relevant allergens 1041 Anna Maria Ehlers Waltraud Suer Vicilin-like antimicrobial peptides from macadamia nut are clinically relevant allergens 1041 Mar\\xada Pedrosa Ana Umpirrez Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Mar\\xada Pedrosa David Loli Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Mar\\xada Pedrosa Jess Jorr\\xadn Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Mar\\xada Pedrosa M Angeles Castillejo-Snchez Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Mar\\xada Pedrosa Natalia Canales-Bueno Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Mar\\xada Pedrosa Rosa Rodr\\xadguez-Prez Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Mar\\xada Pedrosa Santiago Quirce Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Mar\\xada Pedrosa Victor Guerrero-Snchez Que i 1, a new member of PR-10 family, related to oral allergy syndrome in holm oak sensitized patients. 1252 Caroline Klingebiel Agnes Aferiat-Derome Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Alain Poisson Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Anca Mirela Chiriac Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Angelica E. Ehrenberg Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Chantal Agabriel Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Eva Serrano Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Franoise Porri Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Joana Vitte Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Jolle Birnbaum Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Jonas Lidholm Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Jonas \\x96stling Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Marion Gouitaa Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Mose Michel Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Mylene Vivinus Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Pascal Demoly Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Sylvie Leroy Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Caroline Klingebiel Valrie Liabeuf Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients 1286 Tanja Kalic Andreas L. Lopata Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Aya C. Taki Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Diamond Hira Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Dianne Campbell Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Heimo Breiteneder Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Jennifer M. Rolland Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Nicholas A. Williamson Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Piotr Humeniuk Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Robyn E. O\\x80\\x99 Hehir Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Roni Nugraha Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Sandip D. Kamath Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Thimo Ruethers Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Tanja Kalic Thu T. K. Le Collagen is an important fish allergen which may be overlooked in current fish allergy diagnosis 1203 Kana Hamada Hiroshi Kido Combination of total binding of specific IgE, IgE avidity and specific IgG4 well predicts anaphylaxis induced by oral food challenge in young children with egg allergy 284 Kana Hamada Hitomi Tada Combination of total binding of specific IgE, IgE avidity and specific IgG4 well predicts anaphylaxis induced by oral food challenge in young children with egg allergy 284 Kana Hamada Mizuho Nagao Combination of total binding of specific IgE, IgE avidity and specific IgG4 well predicts anaphylaxis induced by oral food challenge in young children with egg allergy 284 Kana Hamada Takao Fujisawa Combination of total binding of specific IgE, IgE avidity and specific IgG4 well predicts anaphylaxis induced by oral food challenge in young children with egg allergy 284 Kana Hamada Wakako Shinahara Combination of total binding of specific IgE, IgE avidity and specific IgG4 well predicts anaphylaxis induced by oral food challenge in young children with egg allergy 284 Svetlana Makarova Andrey Fisenko IgE sensitization to food allergens in vegetarian children 836 Svetlana Makarova Dmitry Yasakov IgE sensitization to food allergens in vegetarian children 836 Svetlana Makarova Marina Snovskaya IgE sensitization to food allergens in vegetarian children 836 Jeongmin Lee Kyunguk Jeong Thermal effect on hen&rsquo;s egg white and quail egg white proteins and in vitro analysis of cross-reactivity in young children 863 Jeongmin Lee Purevsan Gantulga Thermal effect on hen&rsquo;s egg white and quail egg white proteins and in vitro analysis of cross-reactivity in young children 863 Jeongmin Lee Se-Ah Jeon Thermal effect on hen&rsquo;s egg white and quail egg white proteins and in vitro analysis of cross-reactivity in young children 863 Jeongmin Lee Sooyoung Lee Thermal effect on hen&rsquo;s egg white and quail egg white proteins and in vitro analysis of cross-reactivity in young children 863 Masatoshi Mitomori Makoto Nishino Most infants sensitized to egg can eat more than 1/2 heated whole egg 262 Masatoshi Mitomori Motohiro Ebisawa Most infants sensitized to egg can eat more than 1/2 heated whole egg 262 Masatoshi Mitomori Noriyuki Yanagida Most infants sensitized to egg can eat more than 1/2 heated whole egg 262 Masatoshi Mitomori Sakura Sato Most infants sensitized to egg can eat more than 1/2 heated whole egg 262 Leyla Pur Ozyigit Andrew J. Wardlaw Adult-onset cow&rsquo;s milk allergy: New challenges with atypical presentations 1248 Leyla Pur Ozyigit Heena Nandha Adult-onset cow&rsquo;s milk allergy: New challenges with atypical presentations 1248 Leyla Pur Ozyigit Nasreen Khan Adult-onset cow&rsquo;s milk allergy: New challenges with atypical presentations 1248 Humberto Sanchez Ana Entrala Usefulness of the lymphocyte transformation test to diagnose fish FPIES in adults 992 Humberto Sanchez Javier Dom\\xadnguez Ortega Usefulness of the lymphocyte transformation test to diagnose fish FPIES in adults 992 Humberto Sanchez Magdalena Lluch Usefulness of the lymphocyte transformation test to diagnose fish FPIES in adults 992 Humberto Sanchez Natalia Canales Usefulness of the lymphocyte transformation test to diagnose fish FPIES in adults 992 Humberto Sanchez Rosa Rodr\\xadguez Perez Usefulness of the lymphocyte transformation test to diagnose fish FPIES in adults 992 Humberto Sanchez Santiago Quirce Usefulness of the lymphocyte transformation test to diagnose fish FPIES in adults 992 Yusuke Inuzuka Fumi Ishikawa Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Hiroya Ogita Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Ichiro Nomura Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Kenji Toyokuni Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Kiwako Yamamoto-Hanada Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Koji Nishimura Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Makiko Miyata Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Makoto Irahara Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Masami Narita Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Mayako Saito-Abe Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Miori Sato Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Shigenori Kabashima Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Shinichiro Inagaki Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Takahisa Murata Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Tatsuki Fukuie Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Tatsuo Shimosawa Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Tatsuro Nakamura Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Tomoyuki Kiguchi Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Yoshitsune Miyagi Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Yukihiro Ohya Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Yusuke Inuzuka Yumiko Miyaji Diagnostic performance of urinary prostaglandin D2 metabolite for food allergy proven by double blind placebo control food challenge 282 Alena Frantsevna Matsko Dmitry Novicau Relation between saliva myeloperoxidase activity increasing after apple juice provocation and skin prick test 1226 Alena Frantsevna Matsko Natalia Aliakhnovich Relation between saliva myeloperoxidase activity increasing after apple juice provocation and skin prick test 1226 Na'ama Epstein-Rigbi Arnon Elizur Medical clowning positively impacts the quality of life of food allergic children starting oral immunotherapy for food allergy 252 Na'ama Epstein-Rigbi Liat Nachshon Medical clowning positively impacts the quality of life of food allergic children starting oral immunotherapy for food allergy 252 Na'ama Epstein-Rigbi Michael B Levy Medical clowning positively impacts the quality of life of food allergic children starting oral immunotherapy for food allergy 252 Na'ama Epstein-Rigbi Michael R Goldberg Medical clowning positively impacts the quality of life of food allergic children starting oral immunotherapy for food allergy 252 Na'ama Epstein-Rigbi Yael Koren Medical clowning positively impacts the quality of life of food allergic children starting oral immunotherapy for food allergy 252 Sarah Acaster Andrea Vereda Peanut allergy impact on productivity and quality of life (PAPRIQUA): The psychosocial impact of peanut allergy in children and caregivers 243 Sarah Acaster Anne Marciniak Peanut allergy impact on productivity and quality of life (PAPRIQUA): The psychosocial impact of peanut allergy in children and caregivers 243 Sarah Acaster Jane De Vries Peanut allergy impact on productivity and quality of life (PAPRIQUA): The psychosocial impact of peanut allergy in children and caregivers 243 Sarah Acaster Katy Gallop Peanut allergy impact on productivity and quality of life (PAPRIQUA): The psychosocial impact of peanut allergy in children and caregivers 243 Sarah Acaster Rebecca Knibb Peanut allergy impact on productivity and quality of life (PAPRIQUA): The psychosocial impact of peanut allergy in children and caregivers 243 Sarah Acaster Robert Ryan Peanut allergy impact on productivity and quality of life (PAPRIQUA): The psychosocial impact of peanut allergy in children and caregivers 243 Paul J Turner Isabel Skypala Intravenous fluids are effective for managing cardiovascular changes and gastrointestinal symptoms during food-related anaphylaxis 247 Paul J Turner Monica Ruiz-Garcia Intravenous fluids are effective for managing cardiovascular changes and gastrointestinal symptoms during food-related anaphylaxis 247 Paul J Turner Robert J Boyle Intravenous fluids are effective for managing cardiovascular changes and gastrointestinal symptoms during food-related anaphylaxis 247 Paul J Turner Stephen Durham Intravenous fluids are effective for managing cardiovascular changes and gastrointestinal symptoms during food-related anaphylaxis 247 Benjamin Remington Stef Koppelman Safety benefits of an increased threshold in milk-allergic patients: A quantitative risk assessment study 1192 Benjamin Remington Tanja Krone Safety benefits of an increased threshold in milk-allergic patients: A quantitative risk assessment study 1192 Nagaraju Kuravi Karthik Nagaraju Safety and efficacy of sublingual immunotherapy in IgE mediated Cow&rsquo;s Milk Protein Allergy 1275 Nagaraju Kuravi Sathya Srivatsav Safety and efficacy of sublingual immunotherapy in IgE mediated Cow&rsquo;s Milk Protein Allergy 1275 Nagaraju Kuravi Venkata Kasyapi Voorakaranam Safety and efficacy of sublingual immunotherapy in IgE mediated Cow&rsquo;s Milk Protein Allergy 1275 Lorna Garnier Claire Bulteau Oral immunotherapy in peanut allergic children: How to predict its effectiveness? 1179 Lorna Garnier Florence Villard Truc Oral immunotherapy in peanut allergic children: How to predict its effectiveness? 1179 Lorna Garnier Rmi Pescarmona Oral immunotherapy in peanut allergic children: How to predict its effectiveness? 1179 Lorna Garnier Sbastien Viel Oral immunotherapy in peanut allergic children: How to predict its effectiveness? 1179 Lorna Garnier Sylvie-Anne Andre Gomez Oral immunotherapy in peanut allergic children: How to predict its effectiveness? 1179 Katherine Anagnostou Andrea C Blackman Insights from a real-world peanut oral immunotherapy quality improvement program in a tertiary pediatric academic center in the United States  85 Katherine Anagnostou Carla M Davis Insights from a real-world peanut oral immunotherapy quality improvement program in a tertiary pediatric academic center in the United States  85 Katherine Anagnostou Kristen A Staggers Insights from a real-world peanut oral immunotherapy quality improvement program in a tertiary pediatric academic center in the United States  85 Katherine Anagnostou Lauren Kronisch Insights from a real-world peanut oral immunotherapy quality improvement program in a tertiary pediatric academic center in the United States  85 Koki Sasamoto Ken-Ichi Nagakura Three cases of low-dose oral immunotherapy for severe walnut allergy 361 Koki Sasamoto Motohiro Ebisawa Three cases of low-dose oral immunotherapy for severe walnut allergy 361 Koki Sasamoto Noriyuki Yanagida Three cases of low-dose oral immunotherapy for severe walnut allergy 361 Koki Sasamoto Sakura Sato Three cases of low-dose oral immunotherapy for severe walnut allergy 361 Sasawan Chinratanapisit Narissara Suratannon A cross-sectional, population-based study on the prevalence of food allergies among children in two different age groups in Bangkok area 717 Sasawan Chinratanapisit Pakit Vichyanond A cross-sectional, population-based study on the prevalence of food allergies among children in two different age groups in Bangkok area 717 Luana Voto Carmela Bravaccio Higher prevalence of food allergy in Italian children with autism spectrum disorder 1085 Luana Voto Giusy Della Gatta Higher prevalence of food allergy in Italian children with autism spectrum disorder 1085 Luana Voto Lucia Bianco Higher prevalence of food allergy in Italian children with autism spectrum disorder 1085 Luana Voto Ludovica Verde Higher prevalence of food allergy in Italian children with autism spectrum disorder 1085 Luana Voto Maria Pia Riccio Higher prevalence of food allergy in Italian children with autism spectrum disorder 1085 Luana Voto Rita Nocerino Higher prevalence of food allergy in Italian children with autism spectrum disorder 1085 Luana Voto Roberto Berni Canani Higher prevalence of food allergy in Italian children with autism spectrum disorder 1085 Yichao Wang Adrian J. Lowe Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Yichao Wang Anne-Louise Ponsonby Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Yichao Wang Jennifer J. Koplin Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Yichao Wang Kirsten P. Perrett Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Yichao Wang Mimi L.k. Tang Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Yichao Wang Rachel L. Peters Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Yichao Wang Shyamali C. Dharmage Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Yichao Wang Vicki L. Mcwilliam Community-based adverse food reactions and anaphylaxis in children with IgE-mediated food allergy at age 6 years: A population-based study 682 Mar\\xada Ruano-Zaragoza Iris Espinosa Hidalgo Lipid transfer protein sensitization: Clinical pattern and profile of molecular allergens in a population from the South of Spain 17 Mar\\xada Ruano-Zaragoza Javier Fernndez Snchez Lipid transfer protein sensitization: Clinical pattern and profile of molecular allergens in a population from the South of Spain 17 Mar\\xada Ruano-Zaragoza Norma Guerra Solis Lipid transfer protein sensitization: Clinical pattern and profile of molecular allergens in a population from the South of Spain 17 Mar\\xada Ruano-Zaragoza Purificacion Gonzlez Delgado Lipid transfer protein sensitization: Clinical pattern and profile of molecular allergens in a population from the South of Spain 17 Mar\\xada Ruano-Zaragoza Teodorikez Wilfox Jimnez-Rodr\\xadguez Lipid transfer protein sensitization: Clinical pattern and profile of molecular allergens in a population from the South of Spain 17 Mar\\xada Ruano-Zaragoza Victor Soriano Gomis Lipid transfer protein sensitization: Clinical pattern and profile of molecular allergens in a population from the South of Spain 17 M. B. Gea Kiewiet Carl Hamsten High prevalence of wasp sensitization in AGS patients from Sweden 882 M. B. Gea Kiewiet Danijela Apostolovic High prevalence of wasp sensitization in AGS patients from Sweden 882 M. B. Gea Kiewiet Jeanette Grundstrm High prevalence of wasp sensitization in AGS patients from Sweden 882 M. B. Gea Kiewiet Maria Starkhammar High prevalence of wasp sensitization in AGS patients from Sweden 882 M. B. Gea Kiewiet Marianne van Hage High prevalence of wasp sensitization in AGS patients from Sweden 882 Jeppe Madura Larsen Anniek Van De Velde Skin sensitisation potential of intact and acid hydrolysed gluten proteins formulated in different skin care products and applied to wheat-na&iuml;ve or wheat-tolerant Brown Norway rats 832 Jeppe Madura Larsen Charlotte Bernhard Madsen Skin sensitisation potential of intact and acid hydrolysed gluten proteins formulated in different skin care products and applied to wheat-na&iuml;ve or wheat-tolerant Brown Norway rats 832 Jeppe Madura Larsen Katrine Lindholm Bgh Skin sensitisation potential of intact and acid hydrolysed gluten proteins formulated in different skin care products and applied to wheat-na&iuml;ve or wheat-tolerant Brown Norway rats 832 Haerin Jang Jung Yeon Hong Integrated analysis of genomics and metabolomics in childhood food allergy resolution 712 Haerin Jang Kyung Won Kim Integrated analysis of genomics and metabolomics in childhood food allergy resolution 712 Haerin Jang Mina Kim Integrated analysis of genomics and metabolomics in childhood food allergy resolution 712 Haerin Jang Myung Hyun Sohn Integrated analysis of genomics and metabolomics in childhood food allergy resolution 712 Haerin Jang Yoon Hee Kim Integrated analysis of genomics and metabolomics in childhood food allergy resolution 712 M\\x93NICA MART\\x8dNEZ BLANCO Daniel Lozano-Ojalvo Albumin-derived peptides activate retinoic acid signalling pathways and induce regulatory responses through toll-like receptor interactions 781 M\\x93NICA MART\\x8dNEZ BLANCO Elena Molina Albumin-derived peptides activate retinoic acid signalling pathways and induce regulatory responses through toll-like receptor interactions 781 M\\x93NICA MART\\x8dNEZ BLANCO Leticia Prez-Rodr\\xadguez Albumin-derived peptides activate retinoic acid signalling pathways and induce regulatory responses through toll-like receptor interactions 781 M\\x93NICA MART\\x8dNEZ BLANCO Rosina Lpez-Fandio Albumin-derived peptides activate retinoic acid signalling pathways and induce regulatory responses through toll-like receptor interactions 781 Jeanette Grundstrm Carl Hamsten B cells from patients with &alpha;-Gal syndrome upregulate CD23 and proliferate in response to tick proteins 878 Jeanette Grundstrm Danijela Apostolovic B cells from patients with &alpha;-Gal syndrome upregulate CD23 and proliferate in response to tick proteins 878 Jeanette Grundstrm Gea M B Kiewiet B cells from patients with &alpha;-Gal syndrome upregulate CD23 and proliferate in response to tick proteins 878 Jeanette Grundstrm Maria Starkhammar B cells from patients with &alpha;-Gal syndrome upregulate CD23 and proliferate in response to tick proteins 878 Jeanette Grundstrm Marianne Van Hage B cells from patients with &alpha;-Gal syndrome upregulate CD23 and proliferate in response to tick proteins 878 Jeanette Grundstrm Neda Bigdeli B cells from patients with &alpha;-Gal syndrome upregulate CD23 and proliferate in response to tick proteins 878 Sandip D Kamath Andreas L Lopata Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Aya Taki Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Chris Johnson Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Fatima Ferreira Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Heidi Hofer Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Isabella Joubert Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Jennifer Rolland Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Josef Thalhamer Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Michael Wallner Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Paul Ramsland Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Peter Briza Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Richard Weiss Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Robyn O'Hehir Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Sandra Scheiblhofer Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Swati Iyer Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 Sandip D Kamath Thomas Mclean Effect of structural stability on endolysosomal degradation and T-cell reactivity of the invertebrate pan-allergen, tropomyosin 1199 \\x96yk \\x9czlmez Heimo Breiteneder Dissecting the post-translational modifications of ara h 2 produced in nicotiana benthamina plants 423 \\x96yk \\x9czlmez Nina Lengger Dissecting the post-translational modifications of ara h 2 produced in nicotiana benthamina plants 423 \\x96yk \\x9czlmez Vanessa Mayr Dissecting the post-translational modifications of ara h 2 produced in nicotiana benthamina plants 423 Alessandro Toscano Andrea Toniato Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Camilla Rosa Gentile Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Clizia Gagliardi Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Eleonora Brusamolino Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Elide Anna Pastorello Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Jan Walter Schroeder Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Joseph Scibilia Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Laura Farioli Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Laura Michelina Losappio Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Alessandro Toscano Linda Borgonovo Food allergy to toasted hazelnuts: Correlation between symptoms and positivity to the major allergens rCor a1, rCor a8 and rCor a9 459 Melike Kahveci Bulent Enis Sekerel IgE mediated food allergies differ in East Mediterranean children aged 0-2 years 1444 Melike Kahveci Gizem Koken IgE mediated food allergies differ in East Mediterranean children aged 0-2 years 1444 Melike Kahveci Ozge Soyer IgE mediated food allergies differ in East Mediterranean children aged 0-2 years 1444 Melike Kahveci Umit Murat Sahiner IgE mediated food allergies differ in East Mediterranean children aged 0-2 years 1444 Sakura Sato Chizuko Sugizaki Nationwide questionnaire-based survey of anaphylaxis related to oral food challenges in Japan 686 Sakura Sato Motohiro Ebisawa Nationwide questionnaire-based survey of anaphylaxis related to oral food challenges in Japan 686 Sakura Sato Noriyuki Yanagida Nationwide questionnaire-based survey of anaphylaxis related to oral food challenges in Japan 686 Maira Mastrocola De Campos  Leite Ana Paula Beltran Moschione Castro Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Maira Mastrocola De Campos  Leite Andre Augusto Simes Manso Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Maira Mastrocola De Campos  Leite Andrea Solferini Moraes Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Maira Mastrocola De Campos  Leite Antonio Carlos Pastorino Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Maira Mastrocola De Campos  Leite Bruna Pultrini Aquilante Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Maira Mastrocola De Campos  Leite Glauce Hiromi Yonamine Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Maira Mastrocola De Campos  Leite Lais Ferreira Lopes Brum Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Maira Mastrocola De Campos  Leite Mayra De Barros Dorna Natural history of cow&rsquo;s milk allergy in a tertiary healthcare centre 699 Renata Rodrigues Cocco Angela Teixeira Paes Peanuts and tree nuts allergies: A new concern among Brazilian children 1554 Renata Rodrigues Cocco Julia Souza Bittar Peanuts and tree nuts allergies: A new concern among Brazilian children 1554 Renata Rodrigues Cocco Mariana Curto Pasin Peanuts and tree nuts allergies: A new concern among Brazilian children 1554 Alessandro Toscano Camilla Rosa Gentile WDEIA: clinical features that differentiate patients sensitised to Tri a19 from those sensitised to Tri a14 1057 Alessandro Toscano Carlo Maria Rossi WDEIA: clinical features that differentiate patients sensitised to Tri a19 from those sensitised to Tri a14 1057 Alessandro Toscano Chrys Stafylaraki WDEIA: clinical features that differentiate patients sensitised to Tri a19 from those sensitised to Tri a14 1057 Alessandro Toscano Corrado Mirone WDEIA: clinical features that differentiate patients sensitised to Tri a19 from those sensitised to Tri a14 1057 Alessandro Toscano Elide Anna Pastorello WDEIA: clinical features that differentiate patients sensitised to Tri a19 from those sensitised to Tri a14 1057 Alessandro Toscano Joseph Scibilia WDEIA: clinical features that differentiate patients sensitised to Tri a19 from those sensitised to Tri a14 1057 Alessandro Toscano Laura Farioli WDEIA: clinical features that differentiate patients sensitised to Tri a19 from those sensitised to Tri a14 1057 Ana Prieto-Moreno Pfeifer Diana Prez-Alzte Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Elisa Haroun-D\\xadaz Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Francisco Javier Ruano Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Gabriela Canto Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Isabel Torres-Rojas Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Maria Vazquez De La Torre Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Maria Desamparados Cervera Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Maria Luisa Somoza Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Natalia Blanca-Lpez Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Ana Prieto-Moreno Pfeifer Paula Lpez-Gonzlez Sensitization to profilin from infancy to elderly in a well-defined area of Madrid (Spain) 1073 Keren Mahlab-Guri Daniel Elbirt The natural history of sesame allergy 31 Keren Mahlab-Guri Ilan Asher The natural history of sesame allergy 31 Keren Mahlab-Guri Laliv Kadar The natural history of sesame allergy 31 Keren Mahlab-Guri Shira Rosenberg-Bezalel The natural history of sesame allergy 31 Keren Mahlab-Guri Zev M Sthoeger The natural history of sesame allergy 31 Christina L Pranger Alessandro Fiocchi PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Erika Jensen-Jarolim PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Francisco Borrego PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Isabella Pali-Schll PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Judit F Singer PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Kristina M Ilieva PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Olatz Zenarruzabeitia PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Sophia N Karagiannis PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Christina L Pranger Verena K Khler PIPE-cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta-lactoglobulin in basophil activation tests (BAT) 396 Gulden Pasaoglu Karakis Adile Berna Dursun Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Asli Gelincik Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Ayse Baccioglu Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Can Tuzer Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Dilsad Mungan Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Ebru Celebioglu Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Emel Atayik Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Emel Kurt Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Ferda Oner Erkekol Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Fuat Kalyoncu Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Fusun Kalpaklioglu Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Gozde Koycu Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Gul Karakaya Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Ilkay Koca Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Omur Aydin Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Ozlem Goksel Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 Gulden Pasaoglu Karakis Reyhan Gumusburun Epidemiology of adult food allergies in turkey: A multicenter study<br /> 1556 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF9933',\n",
       "  'type': 'Poster Discussion Sessions',\n",
       "  'category': 'Pediatrics',\n",
       "  'session': 'PDS 11 Pediatric',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921288,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF9933;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'PDS 11 Pediatric May Ping (Samantha) Lee Anne Goh Utility of component specific-IgE to Ara h2 in the diagnosis of peanut allergy in Singaporean children 527 May Ping (Samantha) Lee Kok Wee Chong Utility of component specific-IgE to Ara h2 in the diagnosis of peanut allergy in Singaporean children 527 May Ping (Samantha) Lee Si Hui Goh Utility of component specific-IgE to Ara h2 in the diagnosis of peanut allergy in Singaporean children 527 May Ping (Samantha) Lee Wenyin Loh Utility of component specific-IgE to Ara h2 in the diagnosis of peanut allergy in Singaporean children 527 Catherine Baker Nandinee Patel Supervised feeds: A review of local practice 23 Marnie Robinson Dean Tey Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Eelyn Su Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Joanna Simmons Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Kirsten Perrett Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Mark Taranto Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Paxton Loke Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Sabeena Selvarajah Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Time Brettig Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Marnie Robinson Vicki Mcwilliam Should consideration be given to oral food challenge in children with a high positive&nbsp; (&ge;8mm) peanut skin prick test ? 1326 Nelli Prikhodchenko Ekaterina Zernova Clinical and immunological features of the different phenotypes of cow&#39;s milk allergy in infants&nbsp;<br /> 1533 Nelli Prikhodchenko Lamara Grigoryan Clinical and immunological features of the different phenotypes of cow&#39;s milk allergy in infants&nbsp;<br /> 1533 Nelli Prikhodchenko Tatyana Shumatova Clinical and immunological features of the different phenotypes of cow&#39;s milk allergy in infants&nbsp;<br /> 1533 Ga Eun Kim Jae Hwa Jung Usefulness of exhaled extended nitric oxide in children with allergic rhinitis 387 Ga Eun Kim Kyung Won Kim Usefulness of exhaled extended nitric oxide in children with allergic rhinitis 387 Ga Eun Kim Min Jung Kim Usefulness of exhaled extended nitric oxide in children with allergic rhinitis 387 Ga Eun Kim Myung Hyun Sohn Usefulness of exhaled extended nitric oxide in children with allergic rhinitis 387 Ga Eun Kim Soo Yeon Kim Usefulness of exhaled extended nitric oxide in children with allergic rhinitis 387 Ga Eun Kim Yoon Hee Kim Usefulness of exhaled extended nitric oxide in children with allergic rhinitis 387 Pavel Berezhanskiy Juilia Berezhanskaya Changes in the microcirculation system in children with asthma, depending on the burden of an allergic history 584 Natalia Shakhova Elena Kamaltynova Serum periostin levels in children with positive or negative asthma predictive index and healthy age-matched subjects 702 Natalia Shakhova Tatyana Kashinskaya Serum periostin levels in children with positive or negative asthma predictive index and healthy age-matched subjects 702 Luan Manh Chu Donald W Cockcroft Prevalence and factors associated with asthma and asthma phenotypes among farm and rural non-farm children  611 Luan Manh Chu Donna C Rennie Prevalence and factors associated with asthma and asthma phenotypes among farm and rural non-farm children  611 Luan Manh Chu James Dosman Prevalence and factors associated with asthma and asthma phenotypes among farm and rural non-farm children  611 Luan Manh Chu Joshua A Lawson Prevalence and factors associated with asthma and asthma phenotypes among farm and rural non-farm children  611 Luan Manh Chu Shelley Kirychuk Prevalence and factors associated with asthma and asthma phenotypes among farm and rural non-farm children  611 Leandra   Forchert Christian Lupinek Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Daniela Posa Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Ekaterina Potapova Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Laura Hatzler Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Paolo Maria Matricardi Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Rudolf Valenta Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Serena Perna Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Stephanie Dramburg Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Susanne Lau Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Susanne Vrtala Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Thomas Keil Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Ulrich Wahn Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Leandra   Forchert Yvonne Resch-Marat Evolution of the sensitisation against Der p 23 and its clinical implications: A MAS birth cohort study<br />&nbsp; 625 Seung-Won Lee Dong Keon Yon Effect of breast milk feeding on risk of future autoimmune diseases: a national birth cohort study with propensity score matching 837 Seung-Won Lee Hyun Yong Koh Effect of breast milk feeding on risk of future autoimmune diseases: a national birth cohort study with propensity score matching 837 Seung-Won Lee Ju Hee Kim Effect of breast milk feeding on risk of future autoimmune diseases: a national birth cohort study with propensity score matching 837 Seung-Won Lee Man Yong Han Effect of breast milk feeding on risk of future autoimmune diseases: a national birth cohort study with propensity score matching 837 Seung-Won Lee Youn Ho Shin Effect of breast milk feeding on risk of future autoimmune diseases: a national birth cohort study with propensity score matching 837 Fiona Frances Halton Amrit Dhesi Recognition and treatment of paediatric anaphylaxis: Would you know what to do? 688 Fiona Frances Halton Anusha Pachala Recognition and treatment of paediatric anaphylaxis: Would you know what to do? 688 Fiona Frances Halton Jessamy Grace Reece Recognition and treatment of paediatric anaphylaxis: Would you know what to do? 688 Fiona Frances Halton Mica Kathryn Skilton Recognition and treatment of paediatric anaphylaxis: Would you know what to do? 688 Fiona Frances Halton Niten Makwana Recognition and treatment of paediatric anaphylaxis: Would you know what to do? 688 Fiona Frances Halton Yuen Yee Chan Recognition and treatment of paediatric anaphylaxis: Would you know what to do? 688 Yu Ping SONG Christine Kit Ching Tung Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yu Ping SONG Gary Wing Kin Wong Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yu Ping SONG Jin Pao Hou Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yu Ping SONG Kin Pong Tao Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yu Ping SONG Man Fung Tang Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yu Ping SONG Renee Wan Yi Chan Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yu Ping SONG Stephen Kwok Wing Tsui Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yu Ping SONG Ting Fan Leung Dynamic changes of nasopharyngeal microbiome during asthma exacerbations in Hong Kong schoolchildren 101 Yuqing Wang Chuangli Hao Follow up and risk factors analysis of recurrent wheezing after bronchiolitis in infants, a 2-year study from China 145 Yuqing Wang Min Wu Follow up and risk factors analysis of recurrent wheezing after bronchiolitis in infants, a 2-year study from China 145 Yuqing Wang Sainan Chen Follow up and risk factors analysis of recurrent wheezing after bronchiolitis in infants, a 2-year study from China 145 Yuqing Wang Wenjing Gu Follow up and risk factors analysis of recurrent wheezing after bronchiolitis in infants, a 2-year study from China 145 Yuqing Wang Wujun Jiang Follow up and risk factors analysis of recurrent wheezing after bronchiolitis in infants, a 2-year study from China 145 Zoia Nesterenko  Connective tissue disorders vs asthma: Phenotypes in children 468 Tetiana Umanets Alla Nakonechna Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Tetiana Umanets Anton Kostyuchyk Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Tetiana Umanets Antonina Buratynska Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Tetiana Umanets Mykola Umanets Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Tetiana Umanets Olexandr Rudnev Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Tetiana Umanets Victoria Khomenko Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Tetiana Umanets Volodymyr Lapshyn Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Tetiana Umanets Yuri Antipkin Relationship between house dust mites sensitization profiles and type and severity of respiratory allergic diseases in children 632 Athina Papadopoulou Despoina-Zoe Mermiri Does the use of systemic steroids during infancy influence the BMI and the lipid profile of children in schoolage or adolescence? 1273 Athina Papadopoulou Stavroula Lampidi Does the use of systemic steroids during infancy influence the BMI and the lipid profile of children in schoolage or adolescence? 1273 Athina Papadopoulou Thalia Lampidi Does the use of systemic steroids during infancy influence the BMI and the lipid profile of children in schoolage or adolescence? 1273 Athina Papadopoulou Theodora Lappa Does the use of systemic steroids during infancy influence the BMI and the lipid profile of children in schoolage or adolescence? 1273 Joana Queirs Gomes Ana Rita Presa Acute bronchiolitis first episode and its impact on asthma: A comparison of etiologies 1397 Joana Queirs Gomes Conceio Costa Acute bronchiolitis first episode and its impact on asthma: A comparison of etiologies 1397 Joana Queirs Gomes Ivana Cardoso Acute bronchiolitis first episode and its impact on asthma: A comparison of etiologies 1397 Joana Queirs Gomes Joana Pinho Acute bronchiolitis first episode and its impact on asthma: A comparison of etiologies 1397 Joana Queirs Gomes Jos Alberto Ferreira Acute bronchiolitis first episode and its impact on asthma: A comparison of etiologies 1397 Paraskevi Korovessi Athina Papadopoulou Local Allergy Rhinitis: 5 years follow up of 73 cases 1418 Paraskevi Korovessi Despoina-Zoe Mermiri Local Allergy Rhinitis: 5 years follow up of 73 cases 1418 Paraskevi Korovessi Martha Charisi Local Allergy Rhinitis: 5 years follow up of 73 cases 1418 Paraskevi Korovessi Stavroula Kostaridou Local Allergy Rhinitis: 5 years follow up of 73 cases 1418 Paraskevi Korovessi Stavroula Lampidi Local Allergy Rhinitis: 5 years follow up of 73 cases 1418 Kiwako Yamamoto-Hanada Eiryo Kawakami Cytokines/chemokines clustering by AI technique in pilot study of Japan environment and children&rsquo;s study (JECS)  37 Kiwako Yamamoto-Hanada Hirohisa Saito Cytokines/chemokines clustering by AI technique in pilot study of Japan environment and children&rsquo;s study (JECS)  37 Kiwako Yamamoto-Hanada Kenji Matsumoto Cytokines/chemokines clustering by AI technique in pilot study of Japan environment and children&rsquo;s study (JECS)  37 Kiwako Yamamoto-Hanada Mayako Saito-Abe Cytokines/chemokines clustering by AI technique in pilot study of Japan environment and children&rsquo;s study (JECS)  37 Kiwako Yamamoto-Hanada Yukihiro Ohya Cytokines/chemokines clustering by AI technique in pilot study of Japan environment and children&rsquo;s study (JECS)  37 Katariina Koivusaari Essi Syrjl Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Jorma Ilonen Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Jorma Toppari Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Mikael Knip Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Minna Kaila Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Riitta Veijola Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Sari Niinist Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Suvi Mirjami Virtanen Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Katariina Koivusaari Tapani Alatossava Consumption of differently processed milk products and risk of asthma in children<br />&nbsp; 871 Joshua A Lawson David Blackburn Mental health conditions among children with asthma and their association with asthma health care utilization and medication use 1282 Joshua A Lawson Declan Quinn Mental health conditions among children with asthma and their association with asthma health care utilization and medication use 1282 Joshua A Lawson Donna Goodridge Mental health conditions among children with asthma and their association with asthma health care utilization and medication use 1282 Joshua A Lawson Donna Rennie Mental health conditions among children with asthma and their association with asthma health care utilization and medication use 1282 Joshua A Lawson Lloyd Balbuena Mental health conditions among children with asthma and their association with asthma health care utilization and medication use 1282 Joshua A Lawson Luan Chu Mental health conditions among children with asthma and their association with asthma health care utilization and medication use 1282 Joshua A Lawson Trent Litzenberger Mental health conditions among children with asthma and their association with asthma health care utilization and medication use 1282 Pamela Cekola Aimee Henrikson Prospective surveillance of an amino acid-based infant formula in infants with cow&#39;s milk protein allergy, in a routine clinical practice setting 257 Pamela Cekola Heidi Reichert Prospective surveillance of an amino acid-based infant formula in infants with cow&#39;s milk protein allergy, in a routine clinical practice setting 257 Pamela Cekola Krysmaru Araujo Torres Prospective surveillance of an amino acid-based infant formula in infants with cow&#39;s milk protein allergy, in a routine clinical practice setting 257 Pamela Cekola Maureen Huhmann Prospective surveillance of an amino acid-based infant formula in infants with cow&#39;s milk protein allergy, in a routine clinical practice setting 257 Pamela Cekola Sarah Cohen Prospective surveillance of an amino acid-based infant formula in infants with cow&#39;s milk protein allergy, in a routine clinical practice setting 257 Viktorija Kaminskaite David Bartle A case controlled retrospective study on the effect of neonatal probiotic supplementation on the incidence and tolerance to Cow&#39;s Milk Protein Allergy&nbsp; 504 Viktorija Kaminskaite Emily Chesshyre A case controlled retrospective study on the effect of neonatal probiotic supplementation on the incidence and tolerance to Cow&#39;s Milk Protein Allergy&nbsp; 504 Viktorija Kaminskaite Emily Lloyd A case controlled retrospective study on the effect of neonatal probiotic supplementation on the incidence and tolerance to Cow&#39;s Milk Protein Allergy&nbsp; 504 Viktorija Kaminskaite Heledd Williams A case controlled retrospective study on the effect of neonatal probiotic supplementation on the incidence and tolerance to Cow&#39;s Milk Protein Allergy&nbsp; 504 Viktorija Kaminskaite Kathleen Sim A case controlled retrospective study on the effect of neonatal probiotic supplementation on the incidence and tolerance to Cow&#39;s Milk Protein Allergy&nbsp; 504 Viktorija Kaminskaite Sian Ludman A case controlled retrospective study on the effect of neonatal probiotic supplementation on the incidence and tolerance to Cow&#39;s Milk Protein Allergy&nbsp; 504 Skander Anis  Larakeb Carine Larue Billard Does food oral immunotherapy impact the Body mass index of allergic children? &nbsp; 533 Skander Anis  Larakeb Patricia Tom Does food oral immunotherapy impact the Body mass index of allergic children? &nbsp; 533 Raphalle Bazire Carmelo Escudero Characteristics of a Spanish pediatric sample sensitized to peanut LTP (Ara h 9) 1309 Raphalle Bazire Maria Dolores Ibez Characteristics of a Spanish pediatric sample sensitized to peanut LTP (Ara h 9) 1309 Raphalle Bazire Olaya \\x81lvarez Characteristics of a Spanish pediatric sample sensitized to peanut LTP (Ara h 9) 1309 Raphalle Bazire Pablo Rodr\\xadguez Del R\\xado Characteristics of a Spanish pediatric sample sensitized to peanut LTP (Ara h 9) 1309 Raphalle Bazire Silvia Snchez-Garc\\xada Characteristics of a Spanish pediatric sample sensitized to peanut LTP (Ara h 9) 1309 Olga Semernik Alexander Afonin The blood serum proteome of children suffering from atopic diseases 798 Olga Semernik Alexander Lebedenko The blood serum proteome of children suffering from atopic diseases 798 Olga Semernik Andrey larichkin The blood serum proteome of children suffering from atopic diseases 798 Olga Semernik Ilya Alliluev The blood serum proteome of children suffering from atopic diseases 798 Olga Semernik Irina Loginova The blood serum proteome of children suffering from atopic diseases 798 Olga Semernik Victoria Gunko The blood serum proteome of children suffering from atopic diseases 798 Mingjun Shao Chuanhe Liu Investigation of young children with wheezing 748 Mingjun Shao Chunyu Tian Investigation of young children with wheezing 748 Mingjun Shao Li Sha Investigation of young children with wheezing 748 Mingjun Shao Mengya Zhao Investigation of young children with wheezing 748 Mingjun Shao Wenjing Zhu Investigation of young children with wheezing 748 Mingjun Shao Yuzhi Chen Investigation of young children with wheezing 748 Grzegorz Marek Brozek Agnieszka Jarosinska Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Bartlomiej Nowak Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Jan Eugeniusz Zejda Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Joanna Lenart Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Justyna Gawlewicz Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Krzysztof Kocot Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Maciej Nowak Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Mateusz Jankowski Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Grzegorz Marek Brozek Wojciech Mrowicki Real increase in the frequency of allergic diseases and symptoms in children aged 7-10 years in Katowice (Poland) 803 Tomoki Takahashi Fumiya Yamaide Comparison of cytokine levels in breast milk collected from different generations  368 Tomoki Takahashi Hiroshi M Ueno Comparison of cytokine levels in breast milk collected from different generations  368 Tomoki Takahashi Naoki Shimojo Comparison of cytokine levels in breast milk collected from different generations  368 Tomoki Takahashi Taiji Nakano Comparison of cytokine levels in breast milk collected from different generations  368 Tomoki Takahashi Yohei Kawasaki Comparison of cytokine levels in breast milk collected from different generations  368 Tomoki Takahashi Yuki Shiko Comparison of cytokine levels in breast milk collected from different generations  368 Anna Bodajko-Grochowska Andrzej Emeryk Costs of outpatient treatment of childhood asthma in Poland 1099 Anna Bodajko-Grochowska Anna Bednarek Costs of outpatient treatment of childhood asthma in Poland 1099 Anna Bodajko-Grochowska Ewa Markut-Miotla Costs of outpatient treatment of childhood asthma in Poland 1099 Rodica Selevestru Angela Cazacu-Stratu Relative and attributable risk of occupational hygiene factors for bronchial asthma in pupils 1354 Rodica Selevestru Cristina Tomacinschii Relative and attributable risk of occupational hygiene factors for bronchial asthma in pupils 1354 Rodica Selevestru Grigore Friptuleac Relative and attributable risk of occupational hygiene factors for bronchial asthma in pupils 1354 Rodica Selevestru Svetlana Sciuca Relative and attributable risk of occupational hygiene factors for bronchial asthma in pupils 1354 Hanna Kasianenko Serheii Goncharuk Analysis of the results of multicomponent diagnostics in children of different ages with allergic diseases in the Southern region of Ukraine 452 Nicola Jay Farhat Javed South asian mothers&rsquo; views and experiences of accessing paediatric allergy services in sheffield for their babies and/or young children 197 Nicola Jay Jo Cooke South asian mothers&rsquo; views and experiences of accessing paediatric allergy services in sheffield for their babies and/or young children 197 Nicola Jay Naheeda Rehman South asian mothers&rsquo; views and experiences of accessing paediatric allergy services in sheffield for their babies and/or young children 197 Nicola Jay Punita Chowbey South asian mothers&rsquo; views and experiences of accessing paediatric allergy services in sheffield for their babies and/or young children 197 Nicola Jay Sue Peckover South asian mothers&rsquo; views and experiences of accessing paediatric allergy services in sheffield for their babies and/or young children 197 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Allergen immunotherapy     ',\n",
       "  'session': 'LB PDS 01 Allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921335,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 01 Allergen immunotherapy Inna Tulaeva Carolin Cornelius PreS-based grass pollen allergy vaccine BM32 may protect against hepatitis B 1752 Inna Tulaeva Margarete Focke-Tejkl PreS-based grass pollen allergy vaccine BM32 may protect against hepatitis B 1752 Inna Tulaeva Milena Weber PreS-based grass pollen allergy vaccine BM32 may protect against hepatitis B 1752 Inna Tulaeva Petra Zieglmayer PreS-based grass pollen allergy vaccine BM32 may protect against hepatitis B 1752 Inna Tulaeva Rainer Henning PreS-based grass pollen allergy vaccine BM32 may protect against hepatitis B 1752 Inna Tulaeva Rudolf Valenta PreS-based grass pollen allergy vaccine BM32 may protect against hepatitis B 1752 Ralph Msges Cengiz Acikel Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Esther Raskopf Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Esther Steveling Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Filippo Fassio Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Gabriela Canto Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Patrick Yong Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Petra Zieglmayer Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Silke Allekotte Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Ralph Msges Sven Becker Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids \\x80\\x93 a meta-analysis 1726 Monica Gonzalez Medina Adriana Izquierdo Dominguez An observational study on the use of topic corticosteroids in patients with local side effects during subcutaneous immunotherapy in respiratory allergies 1808 Monica Gonzalez Medina Johana Gil Serrano An observational study on the use of topic corticosteroids in patients with local side effects during subcutaneous immunotherapy in respiratory allergies 1808 Carmen Vidal Efstrathios. Karagiannis Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Frdric De Blay Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Giovanni Passalacqua Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Krzysztof Kowal Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Ludger Klimek Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Margitta Worm Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Martine Le Gall Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Miguel Tortajada-Girbs Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Natalia Nenasheva Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Oliver Pfaar Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Pascal Demoly Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Peter Creticos Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Philippe Gevaert Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 Carmen Vidal Thomas Casale Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet 1870 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Allergy and clinical immunology',\n",
       "  'session': 'LB PDS 02 Allergy and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921336,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 02 Allergy and clinical immunology Marcus Maurer Diane Young CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Diego Alvarado CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Elizabeth Crowley CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Elsa Paradise CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Eric Forsberg CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Lawrence J Thomas CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Linda Crew CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Lynn Aneiro CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Margo Heath-Chiozzi CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Martin Kankam CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Michael Murphy CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Pamela Ann Morani CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Thomas Hawthorne CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Marcus Maurer Tibor Keler CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in serum tryptase and a favorable safety profile in a phase 1a healthy volunteer study 1829 Carine Blanchard Antje Krner Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Carine Blanchard Francis Foata Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Carine Blanchard Lnack Dupuis Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Carine Blanchard Mandy Vogel Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Carine Blanchard Norbert Sprenger Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Carine Blanchard Sbastien holvoet Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Carine Blanchard Sophie Nutten Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Carine Blanchard Wieland Kiess Association of 2\\x80\\x99FL and lnnt with the decreased risk to develop allergic sensitization  1728 Natacha Santos Ana Margarida Pereira Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos \\x82ngela Gaspar Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Elisa Pedro Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Em\\xadlia Faria Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Eva Gomes Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Isabel Carrapatoso Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Leonor Carneiro-Leo Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Lu\\xads Delgado Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Manuel Branco-Ferreira Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Mrio Morais-Almeida Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Rita Cmara Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Natacha Santos Rodrigo Rodrigues-Alves Anaphylaxis in Portugal: Results from a decade of an allergy society registry 1842 Sonja Kopanja Dubravka Smiljkovic Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Klara Schmidthaler Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Konrad Hoetzenecker Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Peter Jaksch Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Peter Valent Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Sherezade Moino-Romero Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Sophia Grosshauser Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Walter Klepetko Soluble fceRI may modulate human lung mast cell activation  1843 Sonja Kopanja Zsolt Szpfalusi Soluble fceRI may modulate human lung mast cell activation  1843 Rachel S. Simpson Jason K. Lee Dupilumab as a novel steroid-sparing treatment for IgG4-related disease 1790 Susetta Finotto Alexander Kiefer The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Barbara Stanic The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Jasmin Krug The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Julia Koelle The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Mircea Chiriac The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Mbeccel Akdis The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Nikolaos G Papadopoulos The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Paraskevi Xepapadaki The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Theodor Zimmermann The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Susetta Finotto Tytti Vuorinen The role of interferon type I and type III receptors in rhinovirus induced allergic asthma 1657 Amilcar Perez-Riverol Alexis Musacchio-Lasa Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Amilcar Perez-Riverol Britta Dorn Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Amilcar Perez-Riverol Jose Roberto Aparecido dos Santos-Pinto Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Amilcar Perez-Riverol Lu\\xads Romani Romani-Fernandes Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Amilcar Perez-Riverol Maria Beatrice Bil Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Amilcar Perez-Riverol Mario Sergio Palma Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Amilcar Perez-Riverol Ricardo De Lima-Zollner Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Amilcar Perez-Riverol Thilo Jakob Characterization of a conserved B-cell linear epitope on antigen 5 venom allergen as a putative molecular basis for peptide-based cross-reactivity among clinically relevant insects  1624 Maria Angiola Crivellaro Pietro Maculan Efficacy and safety of hymenoptera venom allergy immunotherapy (VIT) and the longer maintenance schedule (12 months)  in occupational exposed (OE) patients  1775 Emma Goksr Bo Lundbck Clusters of IgE levels of food allergens and risk of asthma and rhinitis in adults 1767 Emma Goksr Bright Nwaru Clusters of IgE levels of food allergens and risk of asthma and rhinitis in adults 1767 Emma Goksr Magnus Borres Clusters of IgE levels of food allergens and risk of asthma and rhinitis in adults 1767 Emma Goksr Rani Basna Clusters of IgE levels of food allergens and risk of asthma and rhinitis in adults 1767 Sofiya Portuhay Ijaz Ahmad Ogeer Going the distance: Assessing efficacy of prolonged injection intervals in CSU patients receiving monthly omalizumab 1859 Sofiya Portuhay Jason Abraham Ohayon Going the distance: Assessing efficacy of prolonged injection intervals in CSU patients receiving monthly omalizumab 1859 Sofiya Portuhay Khadijah Brouillette Going the distance: Assessing efficacy of prolonged injection intervals in CSU patients receiving monthly omalizumab 1859 Sofiya Portuhay Moni Tarin Going the distance: Assessing efficacy of prolonged injection intervals in CSU patients receiving monthly omalizumab 1859 Sofiya Portuhay Vaidehi Bhatt Going the distance: Assessing efficacy of prolonged injection intervals in CSU patients receiving monthly omalizumab 1859 Sofiya Portuhay Vince Wu Going the distance: Assessing efficacy of prolonged injection intervals in CSU patients receiving monthly omalizumab 1859 Sofiya Portuhay Wardha Wardha Going the distance: Assessing efficacy of prolonged injection intervals in CSU patients receiving monthly omalizumab 1859 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Allergy diagnosis and systems medicine',\n",
       "  'session': 'LB PDS 03 Allergy diagnosis and systems medicine',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921337,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 03 Allergy diagnosis and systems medicine Polat Goktas Ali Fuat Kalyoncu Development of a novel skin prick test evaluation methodology using a low-cost, smartphone-based thermographic imaging: A feasibility study 1840 Polat Goktas Duygu Gulseren Development of a novel skin prick test evaluation methodology using a low-cost, smartphone-based thermographic imaging: A feasibility study 1840 Polat Goktas Ebru Celebioglu Development of a novel skin prick test evaluation methodology using a low-cost, smartphone-based thermographic imaging: A feasibility study 1840 Polat Goktas Gul Karakaya Development of a novel skin prick test evaluation methodology using a low-cost, smartphone-based thermographic imaging: A feasibility study 1840 Polat Goktas Mehmet Erdem Cakmak Development of a novel skin prick test evaluation methodology using a low-cost, smartphone-based thermographic imaging: A feasibility study 1840 Polat Goktas Ozge Can Bostan Development of a novel skin prick test evaluation methodology using a low-cost, smartphone-based thermographic imaging: A feasibility study 1840 Polat Goktas Saltuk Bugra Kaya Development of a novel skin prick test evaluation methodology using a low-cost, smartphone-based thermographic imaging: A feasibility study 1840 Uta Jappe Askin Guelsen Tackling challenges in diagnosis and prognosis of house dust mite allergic patients 1653 Uta Jappe Christian Schwager Tackling challenges in diagnosis and prognosis of house dust mite allergic patients 1653 Uta Jappe Daniel Rosero Tackling challenges in diagnosis and prognosis of house dust mite allergic patients 1653 Uta Jappe Marisa Boettger Tackling challenges in diagnosis and prognosis of house dust mite allergic patients 1653 Uta Jappe Skadi Kull Tackling challenges in diagnosis and prognosis of house dust mite allergic patients 1653 Uta Jappe Theresa Walsemann Tackling challenges in diagnosis and prognosis of house dust mite allergic patients 1653 Azize Pinar metbulut Betl Karaatmaca Evaluation of skin patch test results with contact allergens in children 1766 Azize Pinar metbulut Emine Dibek Misirlioglu Evaluation of skin patch test results with contact allergens in children 1766 Azize Pinar metbulut Ersoy Civelek Evaluation of skin patch test results with contact allergens in children 1766 Azize Pinar metbulut Ilknur Klhas \\x87elik Evaluation of skin patch test results with contact allergens in children 1766 Azize Pinar metbulut Irem Turgay Yagmur Evaluation of skin patch test results with contact allergens in children 1766 Azize Pinar metbulut Mge Toyran Evaluation of skin patch test results with contact allergens in children 1766 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Asthma',\n",
       "  'session': 'LB PDS 04 Asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921338,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 04 Asthma Angela Simpson Clare Murray Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Gina Kerry Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Joanne Mitchell Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Laura Healy Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Lesley Lowe Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Lisa Wilmore Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Michael Porter Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Ran Wang Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Rhys Tudge Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Robyn Campbell Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Sarah Drake Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Angela Simpson Stephen Fowler Diagnosing asthma in adults\\x80\\x93 prospective testing of the UK national guideline 1691 Clare Murray Angela Simpson Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Gina Kerry Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Joanne Mitchell Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Laura Healy Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Lesley Lowe Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Lisa Wilmore Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Michael Porter Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Ran Wang Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Rhys Tudge Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Robyn Campbell Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Sarah Drake Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Clare Murray Stephen Fowler Diagnosing asthma in children \\x80\\x93 prospective testing of the UK national guideline 1693 Li Shao HanBing zou Variation of IL-9,IL-17 and IFN-7 in bronchoalveolar lavage fluid and peripheral blood in asthmatic mice with mycoplasma pneumonia infection 1594 Li Shao LanFang Cao Variation of IL-9,IL-17 and IFN-7 in bronchoalveolar lavage fluid and peripheral blood in asthmatic mice with mycoplasma pneumonia infection 1594 Li Shao YinShi Guo Variation of IL-9,IL-17 and IFN-7 in bronchoalveolar lavage fluid and peripheral blood in asthmatic mice with mycoplasma pneumonia infection 1594 Andrea McDowell Juwon Kang Intelligent asthma diagnosis using serum and urine microbial extracellular vesicle metagenomics 1722 Andrea McDowell Tae-Seop Shin Intelligent asthma diagnosis using serum and urine microbial extracellular vesicle metagenomics 1722 Andrea McDowell Yoon-Keun Kim Intelligent asthma diagnosis using serum and urine microbial extracellular vesicle metagenomics 1722 Andrea McDowell Young-Koo Jee Intelligent asthma diagnosis using serum and urine microbial extracellular vesicle metagenomics 1722 sarah drake Clare Murray UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Gina Kerry UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Joanne Mitchell UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Laura Healy UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Lesley Lowe UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Lisa Wilmore UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Michael Porter UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Ran Wang UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Rhys Tudge UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Robyn Campbell UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 sarah drake Stephen Fowler UK guidance for the diagnosis of asthma in children \\x80\\x93 are they able to complete the required tests? 1871 Sabina Illi Bianca Schaub 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Dominik Thiele 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Erika Von Mutius 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Gesine Hansen 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Jimmy Omony 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Klaus Rabe 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Matthias V. Kopp 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Nicole Maison 17q21 and phenotypes of wheeze and asthma in children and adults 1659 Sabina Illi Thomas Bahmer 17q21 and phenotypes of wheeze and asthma in children and adults 1659 George Konstantinou Emmanouel Manousakis Fraction of exhaled nitric oxide fluctuations predict viral-induced wheezing episodes in preschool children 1799 George Konstantinou Nikolaos G Papadopoulos Fraction of exhaled nitric oxide fluctuations predict viral-induced wheezing episodes in preschool children 1799 George Konstantinou Paraskevi Xepapadaki Fraction of exhaled nitric oxide fluctuations predict viral-induced wheezing episodes in preschool children 1799 Manuel Soto-Mart\\xadnez Adriana Yock-Corrales Current prevalence of asthma and allergic diseases related symptoms in adults in Costa Rica 1720 Manuel Soto-Mart\\xadnez Fiorella Agglietti Current prevalence of asthma and allergic diseases related symptoms in adults in Costa Rica 1720 Manuel Soto-Mart\\xadnez Gloriana Villalobos Current prevalence of asthma and allergic diseases related symptoms in adults in Costa Rica 1720 Manuel Soto-Mart\\xadnez Lydiana Avila Current prevalence of asthma and allergic diseases related symptoms in adults in Costa Rica 1720 Manuel Soto-Mart\\xadnez Manuel Soto-Quiros Current prevalence of asthma and allergic diseases related symptoms in adults in Costa Rica 1720 Manuel Soto-Mart\\xadnez Mariana Pacheco Current prevalence of asthma and allergic diseases related symptoms in adults in Costa Rica 1720 Roman Yatsyshyn Bohdana Doskaliuk Analysis of indicators of bronchial asthma control under combined therapy with the use of allergen-specific immunotherapy with household allergens 1644 Roman Yatsyshyn Natalia Cherniuk Analysis of indicators of bronchial asthma control under combined therapy with the use of allergen-specific immunotherapy with household allergens 1644 Roman Yatsyshyn Petro Gerych Analysis of indicators of bronchial asthma control under combined therapy with the use of allergen-specific immunotherapy with household allergens 1644 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Basic and clinical immunology',\n",
       "  'session': 'LB PDS 05 Basic and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921339,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB PDS 05 Basic and clinical immunology Jessica Jane O'Konek James R Baker Jr Early-life immunization with aluminium adjuvant results in th2-biased immunity and allergic sensitization to antigens encountered later in life 1678 Jessica Jane O'Konek Jeffrey J Landers Early-life immunization with aluminium adjuvant results in th2-biased immunity and allergic sensitization to antigens encountered later in life 1678 Jessica Jane O'Konek Katarzyna W Janczak Early-life immunization with aluminium adjuvant results in th2-biased immunity and allergic sensitization to antigens encountered later in life 1678 Alaz \\x96zcan Antonios Kolios Neutrophil recruitment to local and systemic lymph nodes is differentially guided in inflammation 1628 Alaz \\x96zcan Cornelia Halin Neutrophil recruitment to local and systemic lymph nodes is differentially guided in inflammation 1628 Alaz \\x96zcan Onur Boyman Neutrophil recruitment to local and systemic lymph nodes is differentially guided in inflammation 1628 Alaz \\x96zcan Victor Collado-Diaz Neutrophil recruitment to local and systemic lymph nodes is differentially guided in inflammation 1628 Ilia Vorozhko Lydia Ilyenko The immunological monitoring of infants with cow's milk allergy 1716 Ilia Vorozhko Olga Kachalova The immunological monitoring of infants with cow's milk allergy 1716 Ilia Vorozhko Svetlana Denisova The immunological monitoring of infants with cow's milk allergy 1716 Sabelo Hadebe  Optimal TH2 allergic airway response requires IL-4Ra signalling by B cells at low dose of HDM 1785 Adam Klocperk Anna Sediva Atopy in 22q11.2 deletion syndrome patients 1681 Cristiana  Cancela Ferreira Antonio Marinho Hyper-IgE syndrome: Retrospective analysis of seven cases  1711 Cristiana  Cancela Ferreira Catarina Neves Hyper-IgE syndrome: Retrospective analysis of seven cases  1711 Cristiana  Cancela Ferreira Esmeralda Neves Hyper-IgE syndrome: Retrospective analysis of seven cases  1711 Cristiana  Cancela Ferreira Julia Vasconcelos Hyper-IgE syndrome: Retrospective analysis of seven cases  1711 Cristiana  Cancela Ferreira Laura Marques Hyper-IgE syndrome: Retrospective analysis of seven cases  1711 Adebanke Akinfenwa Huey-Jy Huang A murine model of birch pollen allergy 1605 Adebanke Akinfenwa Margarete Focke-Tejkl A murine model of birch pollen allergy 1605 Adebanke Akinfenwa Raffaela Campana A murine model of birch pollen allergy 1605 Adebanke Akinfenwa Rudolf Valenta A murine model of birch pollen allergy 1605 Adebanke Akinfenwa Susanne Vrtala A murine model of birch pollen allergy 1605 Marlene Quach Hans Jrgen Hoffmann Mast cells of severe asthmatics are more reactive at low IgE affinity whereas those of healthy controls are not 1847 Marlene Quach Johannes Martin Schmid Mast cells of severe asthmatics are more reactive at low IgE affinity whereas those of healthy controls are not 1847 Marlene Quach Lars Harder Christensen Mast cells of severe asthmatics are more reactive at low IgE affinity whereas those of healthy controls are not 1847 Marlene Quach Madeleine Emilie Salzer Mast cells of severe asthmatics are more reactive at low IgE affinity whereas those of healthy controls are not 1847 ODED SHAMRIZ Yuval Tal Whole exome sequencing in adults with polyautoimmunity: A useful tool in the service of the clinical immunologist 1576 Aysen Bingol Dilara Kocacik Uygun Low levels of IgE: Immune deficiency? 1791 Melanie Neeland Jennifer J Koplin Mass cytometry reveals multi-parametric immune signatures that govern allergy over tolerance in peanut sensitised infants 1575 Melanie Neeland Kari C Nadeau Mass cytometry reveals multi-parametric immune signatures that govern allergy over tolerance in peanut sensitised infants 1575 Melanie Neeland Kirsten P Perrett Mass cytometry reveals multi-parametric immune signatures that govern allergy over tolerance in peanut sensitised infants 1575 Melanie Neeland Monali Manohar Mass cytometry reveals multi-parametric immune signatures that govern allergy over tolerance in peanut sensitised infants 1575 Melanie Neeland Richard Saffery Mass cytometry reveals multi-parametric immune signatures that govern allergy over tolerance in peanut sensitised infants 1575 Melanie Neeland Sandra Andorf Mass cytometry reveals multi-parametric immune signatures that govern allergy over tolerance in peanut sensitised infants 1575 Melanie Neeland Thanh D Dang Mass cytometry reveals multi-parametric immune signatures that govern allergy over tolerance in peanut sensitised infants 1575 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Dermatology',\n",
       "  'session': 'LB PDS 06 Dermatology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921340,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 06 Dermatology Nam Sze Cheng Hoi Shan Suzanne Lo Is parental self-efficacy the key to managing childhood eczema? 1796 Nam Sze Cheng Kai Chow Choi Is parental self-efficacy the key to managing childhood eczema? 1796 Nam Sze Cheng Kam Lun Ellis Hon Is parental self-efficacy the key to managing childhood eczema? 1796 Nam Sze Cheng Pak Chun Janita Chau Is parental self-efficacy the key to managing childhood eczema? 1796 Nam Sze Cheng Pok Hong Lam Is parental self-efficacy the key to managing childhood eczema? 1796 Nam Sze Cheng Ting Fan Leung Is parental self-efficacy the key to managing childhood eczema? 1796 Arturo Rinaldi Angelica Korsfeldt Household laundry detergents disrupt epidermal barrier integrity in mice 1733 Arturo Rinaldi Cezmi A. Akdis Household laundry detergents disrupt epidermal barrier integrity in mice 1733 Arturo Rinaldi David Burla Household laundry detergents disrupt epidermal barrier integrity in mice 1733 Arturo Rinaldi Ge Tan Household laundry detergents disrupt epidermal barrier integrity in mice 1733 Arturo Rinaldi Per Svedenhag Household laundry detergents disrupt epidermal barrier integrity in mice 1733 Arturo Rinaldi Simon Grant Household laundry detergents disrupt epidermal barrier integrity in mice 1733 Arturo Rinaldi Siobhan Ward Household laundry detergents disrupt epidermal barrier integrity in mice 1733 Benjamin Adam Delphine Staumont-Sall Management of chronic urticaria in primary care by general practitioners in North of France 1636 Benjamin Adam Emeline Pape Management of chronic urticaria in primary care by general practitioners in North of France 1636 Benjamin Adam Frdric Dezoteux Management of chronic urticaria in primary care by general practitioners in North of France 1636 Benjamin Adam Selma Azib Management of chronic urticaria in primary care by general practitioners in North of France 1636 Weily Soong Ana Gimnez-Arnau Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Avantika Barve Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Bobby Lanier Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Eva Hua Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Gordon Sussman Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Jonathan A Bernstein Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Karl Sitz Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Marcus Maurer Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Martin Metz Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Reinhold Janocha Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Weily Soong Thomas Severin Long-term treatment with ligelizumab achieves prolonged symptom control in patients with chronic spontaneous urticaria during the post-treatment follow-up 1828 Chiara Tontini Alice Corsi Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Andrea Costantini Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Anna Zawistowska-Deniziak Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Anna Maria Offidani Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Arifa Ozir-Fazalalikhan Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Astrid L. Voskamp Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Elena Marinelli Busilacchi Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Emanuela Martina Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Hermelijn H. Smits Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Leonardo Antonicelli Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Maria Beatrice Bil Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Tamar Tak Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 Chiara Tontini Yvonne C.M. Kruize Immunological differences among chronic spontaneous urticaria patient subgroups according to omalizumab end-treatment outcome 1845 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Drug allergy',\n",
       "  'session': 'LB PDS 07 Drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921341,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 07 Drug allergy Giulia . Carli Alessandro Farsi Work-up of non-immediate cutaneous reactions to direct oral anticoagulants 1709 Giulia . Carli Antonino Romano Work-up of non-immediate cutaneous reactions to direct oral anticoagulants 1709 Giulia . Carli Domenico Lippolis Work-up of non-immediate cutaneous reactions to direct oral anticoagulants 1709 Giulia . Carli Gabriele Cortellini Work-up of non-immediate cutaneous reactions to direct oral anticoagulants 1709 Giulia . Carli Laura Franceschini Work-up of non-immediate cutaneous reactions to direct oral anticoagulants 1709 Catarina Pereira Coutinho Manuel Pereira Barbosa Drug provocation tests with nonsteroidal anti-inflammatory drugs - are they safe in 3 steps? 1823 Catarina Pereira Coutinho Marta Neto Drug provocation tests with nonsteroidal anti-inflammatory drugs - are they safe in 3 steps? 1823 Jessy Elst Athina L. Van Gasse Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Chris H. Bridts Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Christel Mertens Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Didier G. Ebo Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Leander P. De Puysseleyr Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Lene H. Garvey Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Margaretha A. Faber Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Margo M. Hagendorens Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Marie-Line M. Van Der Poorten Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Jessy Elst Vito Sabato Mast cell activation tests: A new asset in the exploration and diagnosis of immediate drug hypersensitivity 1862 Gustavo Jorge Molina-Molina Anna Sala Cunill One-solution protocol for desensitization to chemotherapeutics and biological agents, A non-inferior approach respect to three-solution protocols 1793 Gustavo Jorge Molina-Molina Jenny Verdesoto One-solution protocol for desensitization to chemotherapeutics and biological agents, A non-inferior approach respect to three-solution protocols 1793 Gustavo Jorge Molina-Molina Mar Guilarte One-solution protocol for desensitization to chemotherapeutics and biological agents, A non-inferior approach respect to three-solution protocols 1793 Gustavo Jorge Molina-Molina Moiss Labrador Horrillo One-solution protocol for desensitization to chemotherapeutics and biological agents, A non-inferior approach respect to three-solution protocols 1793 Gustavo Jorge Molina-Molina Olga Luengo One-solution protocol for desensitization to chemotherapeutics and biological agents, A non-inferior approach respect to three-solution protocols 1793 Gustavo Jorge Molina-Molina Victoria Cardona One-solution protocol for desensitization to chemotherapeutics and biological agents, A non-inferior approach respect to three-solution protocols 1793 Ing Ni Lu Alla Nakonecha Polyethylene glycol is the major allergen in depot medroxyprogesterone acetate (DMPA) 1600 Ing Ni Lu Annette Wagner Polyethylene glycol is the major allergen in depot medroxyprogesterone acetate (DMPA) 1600 Ing Ni Lu Krzysztof Rutkowski Polyethylene glycol is the major allergen in depot medroxyprogesterone acetate (DMPA) 1600 Ing Ni Lu Lucinda Kennard Polyethylene glycol is the major allergen in depot medroxyprogesterone acetate (DMPA) 1600 Ing Ni Lu Rita Mirakian Polyethylene glycol is the major allergen in depot medroxyprogesterone acetate (DMPA) 1600 Maria Lu\\xads Marques Eva Rebelo Gomes Clinical features and diagnostic approach in fixed drug eruptions  1669 Maria Lu\\xads Marques Ins Lobo Clinical features and diagnostic approach in fixed drug eruptions  1669 Maria Lu\\xads Marques Ins Machado Cunha Clinical features and diagnostic approach in fixed drug eruptions  1669 Maria Lu\\xads Marques Joana Gouveia Clinical features and diagnostic approach in fixed drug eruptions  1669 Maria Lu\\xads Marques Joel Reis Clinical features and diagnostic approach in fixed drug eruptions  1669 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'ENT',\n",
       "  'session': 'LB PDS 08 ENT',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921342,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 08 ENT yuan zhang  Impact of O3 and autumn pollens on new allergic rhinitis sensitization and outpatient visits  1599 Stephanie Dramburg Alessandro Travaglini High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Anna Maria Zicari High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Danilo Villalta High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Ekaterina Potapova High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Francesca Buzzulini High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Ifigenia Sfika High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Marco Di Fraia High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Maria Antonia Brighetti High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Paolo Maria Matricardi High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Pierluigi Verardo High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Salvatore Tripodi High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Serena Perna High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Simone Pelosi High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Stefanie Arasi High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Sveva Castelli High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 Stephanie Dramburg Valeria Villella High adherence to prescribed ediary recording by patients with seasonal allergic rhinitis: The @IT.2020 project  1574 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Environmental and occupational allergy',\n",
       "  'session': 'LB PDS 09 Environmental and occupational allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921343,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB PDS 09 Environmental and occupational allergy Catherine Pashley Abbie Fairs A fungal spore calendar for england: Analysis of 13 years of daily counts at Leicester, UK 1854 Catherine Pashley Andrew J. Wardlaw A fungal spore calendar for england: Analysis of 13 years of daily counts at Leicester, UK 1854 Catherine Pashley Awab Amin A fungal spore calendar for england: Analysis of 13 years of daily counts at Leicester, UK 1854 Catherine Pashley Fiona A. Symon A fungal spore calendar for england: Analysis of 13 years of daily counts at Leicester, UK 1854 Catherine Pashley Jack Satchwell A fungal spore calendar for england: Analysis of 13 years of daily counts at Leicester, UK 1854 Catherine Pashley Richard Edwards A fungal spore calendar for england: Analysis of 13 years of daily counts at Leicester, UK 1854 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Food allergy',\n",
       "  'session': 'LB PDS 10 Food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921344,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB PDS 10 Food allergy Davide P Caimmi Elena Carboni Is pistachio authorized in patients with negative allergy work-up for cashew? 1690 Davide P Caimmi Enrica Manca Is pistachio authorized in patients with negative allergy work-up for cashew? 1690 Davide P Caimmi Maria De Filippo Is pistachio authorized in patients with negative allergy work-up for cashew? 1690 Davide P Caimmi Nidhal Touati Is pistachio authorized in patients with negative allergy work-up for cashew? 1690 Xiang Gao Jia Yin Associations of functional LYST polymorphisms with susceptibility to wheat-dependent exercise-induced anaphylaxis in the han chinese population 1879 Tamazoust GUIDDIR Ariane Nemni Risk and evolution of igE-mediated food allergies before and after liver transplantation in a pediatric cohort 1588 Tamazoust GUIDDIR Carine Billard Risk and evolution of igE-mediated food allergies before and after liver transplantation in a pediatric cohort 1588 Tamazoust GUIDDIR Christele Kyheng Risk and evolution of igE-mediated food allergies before and after liver transplantation in a pediatric cohort 1588 Tamazoust GUIDDIR Emmanuel Jacquemin Risk and evolution of igE-mediated food allergies before and after liver transplantation in a pediatric cohort 1588 Tamazoust GUIDDIR Joseph Cohen Risk and evolution of igE-mediated food allergies before and after liver transplantation in a pediatric cohort 1588 Tamazoust GUIDDIR Kzrysiek Roman Risk and evolution of igE-mediated food allergies before and after liver transplantation in a pediatric cohort 1588 Tamazoust GUIDDIR Oanez Ackermann Risk and evolution of igE-mediated food allergies before and after liver transplantation in a pediatric cohort 1588 Erika Lee Adelle Atkinson Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee David Hummel Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Jennifer Hoang Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Julia Upton Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Klara Schmidthaler Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Lucy Duan Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Maria Asper Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Sam Wong Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Thomas Eiwegger Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Erika Lee Zsolt Szepfalusi Patterns of tree nut co-sensitization in a central European and Canadian cohort of children with peanut allergy 1602 Stefan Kabasser Christine Hafner Pru du 6 is a useful marker allergen for the diagnosis of almond allergy 1649 Stefan Kabasser Heimo Breiteneder Pru du 6 is a useful marker allergen for the diagnosis of almond allergy 1649 Stefan Kabasser Iris Chang Pru du 6 is a useful marker allergen for the diagnosis of almond allergy 1649 Stefan Kabasser Kari Christine Nadeau Pru du 6 is a useful marker allergen for the diagnosis of almond allergy 1649 Stefan Kabasser Merim Bublin Pru du 6 is a useful marker allergen for the diagnosis of almond allergy 1649 Bettina Duca Haadiya Mohammed Predicting challenge outcome in young people with persistent cow\\x80\\x99s milk allergy  1702 Bettina Duca Kok Wee Chong Predicting challenge outcome in young people with persistent cow\\x80\\x99s milk allergy  1702 Bettina Duca Marta Vazquez-Ortiz Predicting challenge outcome in young people with persistent cow\\x80\\x99s milk allergy  1702 Bettina Duca Paul Justin Turner Predicting challenge outcome in young people with persistent cow\\x80\\x99s milk allergy  1702 Bettina Duca Victoria Villalobos Violn Predicting challenge outcome in young people with persistent cow\\x80\\x99s milk allergy  1702 Mongkol Lao-Araya Pisuttikan Rangkakulnuwat No increase in prevalence of food allergy among preschool children in Northern Thailand: 2011-2019 1578 Meenakshi Krishnan Kate Swan The correlation between outcomes of 'supervised feeds' and immunological cut-off values in food allergic children 1665 Meenakshi Krishnan Katherine Knight The correlation between outcomes of 'supervised feeds' and immunological cut-off values in food allergic children 1665 Meenakshi Krishnan Susan Chan The correlation between outcomes of 'supervised feeds' and immunological cut-off values in food allergic children 1665 Danijela Apostolovic Anna Nopp Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Danijela Apostolovic Carl Hamsten Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Danijela Apostolovic Gea M.B. Kiewiet Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Danijela Apostolovic Jeanette Grundstrm Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Danijela Apostolovic Maria Starkhammar Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Danijela Apostolovic Marianne Van Hage Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Danijela Apostolovic Marija Perusko Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Danijela Apostolovic Neda Bigdeli Do basophil activation and a-gal specific antibodies reflect clinical phenotypes of red meat allergic patients? 1751 Kosei Yamashita Takanori Imai Sustained unresponsiveness and quality of life in post oral immunotherapy children 1676 Kosei Yamashita Toshinori Nakamura Sustained unresponsiveness and quality of life in post oral immunotherapy children 1676 Gang Chen Audrey Dunn Galvin Quality of life of children and adolescents with food allergy: Mapping FAQLQ-PF onto paediatric-specific health state utility scores 1719 Gang Chen Dianne E. Campbell Quality of life of children and adolescents with food allergy: Mapping FAQLQ-PF onto paediatric-specific health state utility scores 1719 Gang Chen Matthew Greenhawt Quality of life of children and adolescents with food allergy: Mapping FAQLQ-PF onto paediatric-specific health state utility scores 1719 Hannah Hunter Ching Ching Yung Preliminary results of a phase II trial of peanut oral immunotherapy in adults 1760 Hannah Hunter Iason Thomas Preliminary results of a phase II trial of peanut oral immunotherapy in adults 1760 Hannah Hunter Kok Loong Ue Preliminary results of a phase II trial of peanut oral immunotherapy in adults 1760 Hannah Hunter Leonard Siew Preliminary results of a phase II trial of peanut oral immunotherapy in adults 1760 Hannah Hunter Olympia Tsilochristou Preliminary results of a phase II trial of peanut oral immunotherapy in adults 1760 Hannah Hunter Stephen Till Preliminary results of a phase II trial of peanut oral immunotherapy in adults 1760 Hannah Hunter Victoria Cornelius Preliminary results of a phase II trial of peanut oral immunotherapy in adults 1760 Delara Babaie Fariborz Zandieh 2-year follow up of patients with wheat anaphylaxis after wheat oral immunotherapy 1824 Delara Babaie Habib Soheili 2-year follow up of patients with wheat anaphylaxis after wheat oral immunotherapy 1824 Delara Babaie Hamideh Seifi 2-year follow up of patients with wheat anaphylaxis after wheat oral immunotherapy 1824 Delara Babaie Mehrnaz Mesdaghi 2-year follow up of patients with wheat anaphylaxis after wheat oral immunotherapy 1824 Delara Babaie Mitra Sahragard 2-year follow up of patients with wheat anaphylaxis after wheat oral immunotherapy 1824 Delara Babaie Motohiro Ebisawa 2-year follow up of patients with wheat anaphylaxis after wheat oral immunotherapy 1824 Delara Babaie Ramin Ghasemi 2-year follow up of patients with wheat anaphylaxis after wheat oral immunotherapy 1824 Peter Smith Carina Venter Infants and toddlers are dropping acid: Do commercial infant and toddler foods cause epithelial injury and predispose to the development of food allergy? 1782 Peter Smith Emma Oswald Infants and toddlers are dropping acid: Do commercial infant and toddler foods cause epithelial injury and predispose to the development of food allergy? 1782 Peter Smith Tayla Mary Knight Infants and toddlers are dropping acid: Do commercial infant and toddler foods cause epithelial injury and predispose to the development of food allergy? 1782 Peter Smith Velencia Soutter Infants and toddlers are dropping acid: Do commercial infant and toddler foods cause epithelial injury and predispose to the development of food allergy? 1782 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#FF6600',\n",
       "  'type': 'Late Breaking Poster Discussion Sessions',\n",
       "  'category': 'Pediatrics',\n",
       "  'session': 'LB PDS 11 Pediatric',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921345,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Poster Discussion Sessions' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#FF6600;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Poster Discussion Sessions</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB PDS 11 Pediatric Alina Murgu Alice Azoicai Evolutionary models of asthma in children treated with omalizumab 1889 Alina Murgu Aurica Rugina Evolutionary models of asthma in children treated with omalizumab 1889 Alina Murgu Bogdan Stana Evolutionary models of asthma in children treated with omalizumab 1889 Alina Murgu Ileana Ioniuc Evolutionary models of asthma in children treated with omalizumab 1889 Alina Murgu Irina Criscov Evolutionary models of asthma in children treated with omalizumab 1889 Alina Murgu Monica Alexoae Evolutionary models of asthma in children treated with omalizumab 1889 Alina Murgu Paula Popovici Evolutionary models of asthma in children treated with omalizumab 1889 Anjum Grewal Nicola Jay Implementation and evaluation of a novel antibiotic allergy diagnostic pathway in children 1715 Liselot De Vlieger Dominique Bullens Baked egg oral food challenge outcomes in a pediatric population of hen\\x80\\x99s egg allergic children  1680 Liselot De Vlieger Jasmine Leus Baked egg oral food challenge outcomes in a pediatric population of hen\\x80\\x99s egg allergic children  1680 Liselot De Vlieger Katrien Coppens Baked egg oral food challenge outcomes in a pediatric population of hen\\x80\\x99s egg allergic children  1680 Liselot De Vlieger Marc Raes Baked egg oral food challenge outcomes in a pediatric population of hen\\x80\\x99s egg allergic children  1680 Liselot De Vlieger Marianne Diels Baked egg oral food challenge outcomes in a pediatric population of hen\\x80\\x99s egg allergic children  1680 Suzana Radulovic Katherine Knight Coconut oral food challenge outcomes in a tertiary children\\x80\\x99s allergy service 1700 Lydia Ilyenko Olga Kachalova Postnatal risk factors for allergies to cow's milk in infant 1712 Lydia Ilyenko Svetlana Denisova Postnatal risk factors for allergies to cow's milk in infant 1712 Hlne Amazouz Isabelle Momas Mediterranean diet at 8 years and lung function, sensitisation and allergy in french schoolchildren: The PARIS birth cohort 1723 Hlne Amazouz Rancire Fanny Mediterranean diet at 8 years and lung function, sensitisation and allergy in french schoolchildren: The PARIS birth cohort 1723 Maria Kostara Anna Challa Studying the association among food allergic children, 25OH vitamin D and VDBP levels 1664 Maria Kostara Dimitrios Rallis Studying the association among food allergic children, 25OH vitamin D and VDBP levels 1664 Maria Kostara Sophia Tsabouri Studying the association among food allergic children, 25OH vitamin D and VDBP levels 1664 Maria Kostara Vasileios Giapros Studying the association among food allergic children, 25OH vitamin D and VDBP levels 1664 Sofia Tsampouri Burkin Beken The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Carlo Caffarelli The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Carsten Flohr The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Charlotte Gotthard Mortz The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Chris. A Rutkowski The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri George. N Konstantinou The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Giovanni. B Pajno The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Helena Pite The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Lauri-Ann Van Der Poel The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Martin. K Church The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Montserrat Alvaro- Lozano The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Petra Staubach The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Sebastian Lefvre The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Sherief. R Janmohamed The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Stefania Arasi The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Sussane Lau The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Tabi Anika Leslie The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 Sofia Tsampouri Torsten Zuberbier The EAACI task force on chronic urticaria in children - research and clinical network (CU-kids) 1780 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Allergen immunotherapy     ',\n",
       "  'session': 'TPS 01 Allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921291,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 01 Allergen immunotherapy Rajica Stosovic Vesna Tomic Spiric Efficacy and safety of sublingual immunotherapy in local allergic rhinitis 1466 Manuel Jorge Rial Albert Roger Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Manuel Jorge Rial Alfons Malet Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Manuel Jorge Rial Anna Boronat Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Manuel Jorge Rial Antonio Parra Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Manuel Jorge Rial Begoa Navarro Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Manuel Jorge Rial Diego Gutirrez Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Manuel Jorge Rial Jos L. Justicia Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Manuel Jorge Rial Victoria Moreno Effectiveness of a glutaraldehyde-modified microcrystalline tyrosine (mct)-associated extract of house dust mites in allergic patients not sensitised to Der p 1 NOR Der p 2 241 Ana Margarida Mesquita Alice Coimbra Is subcutaneous immunotherapy safe for children? 1044 Ana Margarida Mesquita Jose Luis Plcido Is subcutaneous immunotherapy safe for children? 1044 Ana Margarida Mesquita Ricardo Moo Coutinho Is subcutaneous immunotherapy safe for children? 1044 \\x96zge Can Bostan Ali Fuat Kalyoncu Evaluation of clinical effectiveness of hymenoptera venom immunotherapy in patients who received venom immunotherapy for at least five years or discontinued 422 \\x96zge Can Bostan Ebru \\x87elebioglu Evaluation of clinical effectiveness of hymenoptera venom immunotherapy in patients who received venom immunotherapy for at least five years or discontinued 422 \\x96zge Can Bostan Gl Karakaya Evaluation of clinical effectiveness of hymenoptera venom immunotherapy in patients who received venom immunotherapy for at least five years or discontinued 422 \\x96zge Can Bostan Mehmet Erdem \\x87akmak Evaluation of clinical effectiveness of hymenoptera venom immunotherapy in patients who received venom immunotherapy for at least five years or discontinued 422 \\x96zge Can Bostan Saltuk Bugra Kaya Evaluation of clinical effectiveness of hymenoptera venom immunotherapy in patients who received venom immunotherapy for at least five years or discontinued 422 Vita Zakurskaya Ludmila Siziakina Features of innate and adaptive immunity in patients with varying degrees of ASIT effectiveness 873 Ryohei Suzuki Akiko Aota Examination of the long-term effect of oral immunotherapy in children with cow&rsquo;s milk allergy 407 Ryohei Suzuki Kenichi Akashi Examination of the long-term effect of oral immunotherapy in children with cow&rsquo;s milk allergy 407 Ryohei Suzuki Nagatoshi Sagara Examination of the long-term effect of oral immunotherapy in children with cow&rsquo;s milk allergy 407 Ryohei Suzuki Toshio Katsunuma Examination of the long-term effect of oral immunotherapy in children with cow&rsquo;s milk allergy 407 Ryohei Suzuki Yuriko Sekiguchi Examination of the long-term effect of oral immunotherapy in children with cow&rsquo;s milk allergy 407 Laura Schiavi Anna Maria Zicari Improvement in nasal reactivity after grass pollen immunotherapy in persistent allergic rhinitis  411 Laura Schiavi Giovanna De Castro Improvement in nasal reactivity after grass pollen immunotherapy in persistent allergic rhinitis  411 Laura Schiavi Giulia Brindisi Improvement in nasal reactivity after grass pollen immunotherapy in persistent allergic rhinitis  411 Laura Schiavi Lorenzo Loffredo Improvement in nasal reactivity after grass pollen immunotherapy in persistent allergic rhinitis  411 Laura Schiavi Marzia Duse Improvement in nasal reactivity after grass pollen immunotherapy in persistent allergic rhinitis  411 Laura Schiavi Valentina De Vittori Improvement in nasal reactivity after grass pollen immunotherapy in persistent allergic rhinitis  411 Besim Prnjavorac Adlija cauevic Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Besim Prnjavorac Edin Jusufovic Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Besim Prnjavorac Enes Hodic Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Besim Prnjavorac Lejla Prnjavorac Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Besim Prnjavorac Lejla aranovic Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Besim Prnjavorac Maja Malenica Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Besim Prnjavorac Tamer Bego Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Besim Prnjavorac Tanja Dujic Long term follow up of effects of subcutaneous immunotherapy for dermatophagoides allergy 1483 Y Minich A Hancharou Comparison of in vitro methods for generation of tolerogenic dendritic cells 1301 Y Minich L M Dubuske Comparison of in vitro methods for generation of tolerogenic dendritic cells 1301 Y Minich N Antonevich Comparison of in vitro methods for generation of tolerogenic dendritic cells 1301 Sheriene Moussa Afify Andreas Regner Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly-sensitization BALB/c model 1414 Sheriene Moussa Afify Erika Jensen-Jarolim Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly-sensitization BALB/c model 1414 Sheriene Moussa Afify Franziska Roth-Walter Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly-sensitization BALB/c model 1414 Sheriene Moussa Afify Isabella Pali-Schll Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly-sensitization BALB/c model 1414 Sheriene Moussa Afify Karin Hufnagl Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly-sensitization BALB/c model 1414 Sheriene Moussa Afify Lisa Marie Petje Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly-sensitization BALB/c model 1414 Sheriene Moussa Afify Sonja guethoff Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly-sensitization BALB/c model 1414 Dmitriy Sergeevich Smirnov Alexandr Nicolaevich Mitin Effects of allergen-specific immunotherapy on FOXP3 isoforms expression by regulatory T-cells in patients with seasonal allergic rhinitis 1071 Dmitriy Sergeevich Smirnov Almira Dmitrievna Donetskova Effects of allergen-specific immunotherapy on FOXP3 isoforms expression by regulatory T-cells in patients with seasonal allergic rhinitis 1071 Dmitriy Sergeevich Smirnov Marina Mikchaylovna Litvina Effects of allergen-specific immunotherapy on FOXP3 isoforms expression by regulatory T-cells in patients with seasonal allergic rhinitis 1071 Dmitriy Sergeevich Smirnov Oksana Mikchailovna Kurbacheva Effects of allergen-specific immunotherapy on FOXP3 isoforms expression by regulatory T-cells in patients with seasonal allergic rhinitis 1071 Andrei Hancharou A Prokhorov Immune impact of programmed dendritic cell immunotherapy in pancreatic cancer patients 1284 Andrei Hancharou L M Dubuske Immune impact of programmed dendritic cell immunotherapy in pancreatic cancer patients 1284 Andrei Hancharou N Antonevich Immune impact of programmed dendritic cell immunotherapy in pancreatic cancer patients 1284 Andrei Hancharou O Timohina Immune impact of programmed dendritic cell immunotherapy in pancreatic cancer patients 1284 Andrei Hancharou S Romanovskaya Immune impact of programmed dendritic cell immunotherapy in pancreatic cancer patients 1284 Mariana Pereira Ana Morete Control of allergic disease in patients under treatment with subcutaneous allergen immunotherapy 415 Mariana Pereira Ana Margarida Pereira Control of allergic disease in patients under treatment with subcutaneous allergen immunotherapy 415 Mariana Pereira Joo Almeida Fonseca Control of allergic disease in patients under treatment with subcutaneous allergen immunotherapy 415 Mariana Pereira Lu\\xads Miguel Arajo Control of allergic disease in patients under treatment with subcutaneous allergen immunotherapy 415 Mariana Pereira Maria-Graa Castel-Branco Control of allergic disease in patients under treatment with subcutaneous allergen immunotherapy 415 Plamena Ivanova Novakova Jose Luis Justicia Patients&#39; satisfaction with five-grass sublingual immunotherapy 492 Plamena Ivanova Novakova Mariya Toncheva Staevska Patients&#39; satisfaction with five-grass sublingual immunotherapy 492 Plamena Ivanova Novakova Silviya Mihaylova Novakova Patients&#39; satisfaction with five-grass sublingual immunotherapy 492 Alfons Malet Angel Javier Moral Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Angel Julio Huertas Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet David Baquero Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Inma Buendia Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Isabel Ojeda Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Jaime Ayguade Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Joan Serra Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Juan Carlos Miralles Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Luis Mario Tubella Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Mar Jimenez Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Marcos Pealver Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Maria Matas Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Alfons Malet Sandra Yago Real-life safety study with a polymerized extract of Alternaria alternata in patients with allergic rhinoconjunctivitis or asthma 885 Merve Poyraz Ayse Baccioglu Evaluation of adherence and safety of subcutaneous immunotherapy with aeroallergens in real life 906 Merve Poyraz Ayse Fusun Kalpaklioglu Evaluation of adherence and safety of subcutaneous immunotherapy with aeroallergens in real life 906 Merve Poyraz Betl Dumanoglu Evaluation of adherence and safety of subcutaneous immunotherapy with aeroallergens in real life 906 Merve Poyraz Dilek Oksuzer Cimsir Evaluation of adherence and safety of subcutaneous immunotherapy with aeroallergens in real life 906 ALESSIA GATTA Anila Farinelli Mite immunotherapy with high-dose monomeric allergen administered every 8 weeks is safe and effective 1149 ALESSIA GATTA Arianna Lumaca Mite immunotherapy with high-dose monomeric allergen administered every 8 weeks is safe and effective 1149 ALESSIA GATTA Gilda Scarano Mite immunotherapy with high-dose monomeric allergen administered every 8 weeks is safe and effective 1149 ALESSIA GATTA Loredana Della Valle Mite immunotherapy with high-dose monomeric allergen administered every 8 weeks is safe and effective 1149 ALESSIA GATTA Mario Di Gioacchino Mite immunotherapy with high-dose monomeric allergen administered every 8 weeks is safe and effective 1149 ALESSIA GATTA Pietro Del Biondo Mite immunotherapy with high-dose monomeric allergen administered every 8 weeks is safe and effective 1149 ALESSIA GATTA Roberto Paganelli Mite immunotherapy with high-dose monomeric allergen administered every 8 weeks is safe and effective 1149 Sren Helbo Skaarup Hans Jrgen Hoffmann Regression analysis of combined symptom and medication score. A better way to use data and exclude annual pollen fluctuations 970 Sren Helbo Skaarup Johannes Schmid Regression analysis of combined symptom and medication score. A better way to use data and exclude annual pollen fluctuations 970 Sren Helbo Skaarup Tina Skjold Regression analysis of combined symptom and medication score. A better way to use data and exclude annual pollen fluctuations 970 \\x81ngel Luis Villaln Garc\\xada Alfredo Iglesias Cadarso Immunotherapy to hymenopters, hospital or primary care centers administration? 674 \\x81ngel Luis Villaln Garc\\xada Antonio Prez Pimiento Immunotherapy to hymenopters, hospital or primary care centers administration? 674 \\x81ngel Luis Villaln Garc\\xada Luc\\xada Indira Melgar Gonzalez Immunotherapy to hymenopters, hospital or primary care centers administration? 674 \\x81ngel Luis Villaln Garc\\xada Marta Gema Lpez San Mart\\xadn Immunotherapy to hymenopters, hospital or primary care centers administration? 674 \\x81ngel Luis Villaln Garc\\xada Miriam Barrios Albajar Immunotherapy to hymenopters, hospital or primary care centers administration? 674 Richa Mishra Naveen Arora Immunomodulation by TLR-5 ligand conjugated with cockroach allergenic components for allergy therapeutics 508 Virginie Stordeur Anne-Catherine Fitchette Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Guillaume Beauverger Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Guy Tropper Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Jean Auger Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Loic Faye Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Louis-P Vezina Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Lydia Auger Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Rjean Desgagnes Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Ronald Van Ree Bioparticle-potentiated immunotherapy for cat allergy 1124 Virginie Stordeur Veronique Gomord Bioparticle-potentiated immunotherapy for cat allergy 1124 Svetlana Guryanova Irina Andreeva Effect of glucosaminyl muramyl dipeptide on the immune system of patients with secondary variable immune deficiency and agammaglobulinemia 1505 Svetlana Guryanova Ludmila Sizyakina Effect of glucosaminyl muramyl dipeptide on the immune system of patients with secondary variable immune deficiency and agammaglobulinemia 1505 Svetlana Guryanova Tatyana Andronova Effect of glucosaminyl muramyl dipeptide on the immune system of patients with secondary variable immune deficiency and agammaglobulinemia 1505 Kyohei Morita Chie Yoshimura Dose reduction in inhaled corticosteroids of sublingual immunotherapy for Japanese cedar pollen-associated allergic rhinitis and asthma 261 Kyohei Morita Toshitaka Morishima Dose reduction in inhaled corticosteroids of sublingual immunotherapy for Japanese cedar pollen-associated allergic rhinitis and asthma 261 Kyohei Morita Yasuo Nishizaka Dose reduction in inhaled corticosteroids of sublingual immunotherapy for Japanese cedar pollen-associated allergic rhinitis and asthma 261 Jung Yeon Shim Aram Yang Clinical and immunological response to subcutaneous immunotherapy in children with allergic rhinitis 884 Jung Yeon Shim Deok Soo Kim Clinical and immunological response to subcutaneous immunotherapy in children with allergic rhinitis 884 Jung Yeon Shim Hye Lim Jung Clinical and immunological response to subcutaneous immunotherapy in children with allergic rhinitis 884 Jung Yeon Shim Jae Won Shim Clinical and immunological response to subcutaneous immunotherapy in children with allergic rhinitis 884 Jung Yeon Shim Ji Hee Kwak Clinical and immunological response to subcutaneous immunotherapy in children with allergic rhinitis 884 Jung Yeon Shim Young Joo Han Clinical and immunological response to subcutaneous immunotherapy in children with allergic rhinitis 884 Dsire Erlinda Sophia Larenas-Linnemann Fernanda Anglica Rodr\\xadguez Monroy Allergen extract potency as measured in SPT is maintained in a sublingual maintenance vial with a mix of three non-homologous allergens of pollens and mites 1519 Katsuyo Ohashi-Doi Hiroki Matsuhara Allergen stability and immunological reactivity following dissolution and co-incubation of house dust mite and japanese cedar pollen SLIT-tablets 865 Katsuyo Ohashi-Doi Kaare Lund Allergen stability and immunological reactivity following dissolution and co-incubation of house dust mite and japanese cedar pollen SLIT-tablets 865 Katsuyo Ohashi-Doi Takashi Yamamoto Allergen stability and immunological reactivity following dissolution and co-incubation of house dust mite and japanese cedar pollen SLIT-tablets 865 Inkyu Hwang Hyun-Ah Park The mast cell stabilizing activity and anti-asthmatic effect of inotodiol, a natural oxysterol from chaga mushroom, via perturbation of mast cell-specific transcriptional network 1189 Inkyu Hwang Jihoon Yu The mast cell stabilizing activity and anti-asthmatic effect of inotodiol, a natural oxysterol from chaga mushroom, via perturbation of mast cell-specific transcriptional network 1189 Inkyu Hwang Jongtae Park The mast cell stabilizing activity and anti-asthmatic effect of inotodiol, a natural oxysterol from chaga mushroom, via perturbation of mast cell-specific transcriptional network 1189 Inkyu Hwang Le Hong Son The mast cell stabilizing activity and anti-asthmatic effect of inotodiol, a natural oxysterol from chaga mushroom, via perturbation of mast cell-specific transcriptional network 1189 Inkyu Hwang Thi Minh Nguyet Nguyen The mast cell stabilizing activity and anti-asthmatic effect of inotodiol, a natural oxysterol from chaga mushroom, via perturbation of mast cell-specific transcriptional network 1189 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Allergy and clinical immunology',\n",
       "  'session': 'TPS 02 Allergy and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921293,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"TPS 02 Allergy and clinical immunology Lesia Rozlucka Barbara Rogala The&nbsp;prevalence&nbsp;of atopy in keratoconus (KC) 1361 Lesia Rozlucka Dorota Wygledowska-Promienska The&nbsp;prevalence&nbsp;of atopy in keratoconus (KC) 1361 Lesia Rozlucka Joanna Glck The&nbsp;prevalence&nbsp;of atopy in keratoconus (KC) 1361 Lesia Rozlucka Piotr Gosciniewicz The&nbsp;prevalence&nbsp;of atopy in keratoconus (KC) 1361 Aleksandra Joanna Likonska Adrian Gajewski The effect of human rhinovirus HRV-16 on angiogenesis and remodeling in 3D cultures of human pulmonary endothelium 815 Aleksandra Joanna Likonska Kinga Klimczak The effect of human rhinovirus HRV-16 on angiogenesis and remodeling in 3D cultures of human pulmonary endothelium 815 Aleksandra Joanna Likonska Maciej Chalubinski The effect of human rhinovirus HRV-16 on angiogenesis and remodeling in 3D cultures of human pulmonary endothelium 815 Aleksandra Joanna Likonska Marek L. Kowalski The effect of human rhinovirus HRV-16 on angiogenesis and remodeling in 3D cultures of human pulmonary endothelium 815 Aleksandra Joanna Likonska Mateusz Gawrysiak The effect of human rhinovirus HRV-16 on angiogenesis and remodeling in 3D cultures of human pulmonary endothelium 815 Skr \\x87eki Fatih Cicek Knowledge of mothers of asthmatic children about asthma 1450 Skr \\x87eki Hakan Kucuker Knowledge of mothers of asthmatic children about asthma 1450 Skr \\x87eki Nihat Sapan Knowledge of mothers of asthmatic children about asthma 1450 Skr \\x87eki Yakup Canitez Knowledge of mothers of asthmatic children about asthma 1450 Skr \\x87eki Yasin Karali Knowledge of mothers of asthmatic children about asthma 1450 Franoise  Brignole-Baudouin Alfred Kobal Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Christophe Baudouin Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Hong Liang Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Karima Kessal Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Lilia Merabet Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Nouara Harfouche Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Samir Bouhadiba Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Serge Doan Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Franoise  Brignole-Baudouin Thierry Bury Interest of ocular surface biological explorations in patients presenting with ocular allergic manifestations 1359 Ekaterina  Barvinskaia Alexandr Nikolskii RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Alina Sokolova RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Dmitrii Kudlay RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Igor Shilovskiy RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Kseniya Kozhikhova RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Ludmila Vishniakova RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Musa Khaitov RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Sergei Andreev RNA interference technology as a new approache for allergic rhinitis therapy 535 Ekaterina  Barvinskaia Valeriia Kovchina RNA interference technology as a new approache for allergic rhinitis therapy 535 Joana Miranda Ana Rodolfo The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Joana Miranda Ana Margarida Mesquita The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Joana Miranda Eunice Dias De Castro The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Joana Miranda Jos Lu\\xads Plcido The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Joana Miranda Josefina Rodrigues Cernadas The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Joana Miranda Leonor Carneiro-Leo The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Joana Miranda Maria Joo Vasconcelos The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Joana Miranda Tiago Azenha Rama The&nbsp;role of an Allergy and Clinical Immunology department in the care of hospitalized patients in a Portuguese University Hospital 1116 Suhana binti Ahmad Jit Kang Lim Profile of TNFR2<sup>+</sup> Tregs and CD103<sup>+</sup> DCs in the exposure of gold nanoparticles and etanercept in PBMCs of asthma patients 691 Suhana binti Ahmad Nor Azrini Azid Profile of TNFR2<sup>+</sup> Tregs and CD103<sup>+</sup> DCs in the exposure of gold nanoparticles and etanercept in PBMCs of asthma patients 691 Suhana binti Ahmad Ramlah Kadir Profile of TNFR2<sup>+</sup> Tregs and CD103<sup>+</sup> DCs in the exposure of gold nanoparticles and etanercept in PBMCs of asthma patients 691 Suhana binti Ahmad Rohimah Mohamud Profile of TNFR2<sup>+</sup> Tregs and CD103<sup>+</sup> DCs in the exposure of gold nanoparticles and etanercept in PBMCs of asthma patients 691 Annick Barbaud Anne-Claire Fougerousse Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Audrey Lamirand Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Brigitte Milpied Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Delphine Staumont-Salle Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Eric Vicaut Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Florence Tetart Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Frederic Berard Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Heloise Cartiaux Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Karine Benjamin Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Laurence Bouillet Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Nicolas Bruno Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 Annick Barbaud Selma Azib-Meftah Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in france: One-year final results of LUCIOL study 447 David Gonzlez De Olano Beln De-La-Hoz-Caballer Successful treatment of allergic bronchopulmonary aspergillosis with benralizumab after no response to omalizumab 1448 David Gonzlez De Olano Carlos Almonacid-Snchez Successful treatment of allergic bronchopulmonary aspergillosis with benralizumab after no response to omalizumab 1448 David Gonzlez De Olano Gonzalo De-Los-Santos-Granados Successful treatment of allergic bronchopulmonary aspergillosis with benralizumab after no response to omalizumab 1448 David Gonzlez De Olano Lorena Bernal-Rubio Successful treatment of allergic bronchopulmonary aspergillosis with benralizumab after no response to omalizumab 1448 David Gonzlez De Olano P\\xada De-Calzada-Bustingorri Successful treatment of allergic bronchopulmonary aspergillosis with benralizumab after no response to omalizumab 1448 Colin O'Rourke Alexandra Santos Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke David Larson Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Ekaterina Khaleva Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke George Du Toit Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Gideon Lack Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Graham Roberts Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Henry Tee Bahnson Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Kristina Harris Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Monica Basting Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Natalia Becares Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Natalia Couto-Francisco Practical prediction of reaction severity by suite of biomarkers 1535 Colin O'Rourke Suzana Radulovic Practical prediction of reaction severity by suite of biomarkers 1535 Debbi Stockhammer Constance Helen Katelaris Getting the food allergy message across 182 Debbi Stockhammer Maree Donna Simpson Getting the food allergy message across 182 Debbi Stockhammer Thiru Vanniasinkam Getting the food allergy message across 182 Marianne Raith Ines Swoboda Thermal and enzymatic stability of inhalant and food allergens of the Bet v 1 protein family 1155 Marianne Raith Melanie Wallner Thermal and enzymatic stability of inhalant and food allergens of the Bet v 1 protein family 1155 Teresa De Aramburu Mera Borja Bartolome Royal jelly allergy 1377 Teresa De Aramburu Mera Krasimira Baynova Royal jelly allergy 1377 Teresa De Aramburu Mera Marta Ochando Diez-Canseco Royal jelly allergy 1377 Teresa De Aramburu Mera Robledo Avila Castellano Royal jelly allergy 1377 Eugene Egorenkov Alexandr Igorevich Martynov Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 Eugene Egorenkov Andrei Yurievich Toptygin Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 Eugene Egorenkov Dmitriy Anatolievich Kudlay Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 Eugene Egorenkov Gayane Emmanuilovna Avoyan Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 Eugene Egorenkov Igor Vladimirovich Andreev Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 Eugene Egorenkov Musa Rakhimovich Khaitov Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 Eugene Egorenkov Olga Sergeevna Kulaga Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 Eugene Egorenkov Valery Valerievich Smirnov Obtaining and characterization of allergen and allergoid from bee venom for immunotherapy 1291 David Muccino Alyn Morice Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Carmen La Rosa Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Christopher Assaid Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Eduardo Urdaneta Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Ian D Pavord Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Jacyln A Smith Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Lorcan Mcgarvey Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Peter V Dicpinigaitis Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 David Muccino Surinder S Birring Baseline characteristics from a phase 3, randomized controlled trial (COUGH-1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 1295 ROBERT BABELA Jana Ivanova Total costs associated with allergic rhinitis diagnosis (J30): Analysis of direct and indirect costs in single EU jurisdiction in 201 130 ROBERT BABELA Lubica Hlinkova Total costs associated with allergic rhinitis diagnosis (J30): Analysis of direct and indirect costs in single EU jurisdiction in 201 130 ROBERT BABELA Milos Jesenak Total costs associated with allergic rhinitis diagnosis (J30): Analysis of direct and indirect costs in single EU jurisdiction in 201 130 ROBERT BABELA Vladimir Uraz Total costs associated with allergic rhinitis diagnosis (J30): Analysis of direct and indirect costs in single EU jurisdiction in 201 130 ROBERT BABELA Zuzana Rennerova Total costs associated with allergic rhinitis diagnosis (J30): Analysis of direct and indirect costs in single EU jurisdiction in 201 130 NITCHANAN ACHARARIT Orapan Poachanukoon Effect of zingiber cassumunar (PLAI capsule) on nasal eosinophils and cytokine productions in allergic rhinitis 1117 NITCHANAN ACHARARIT Paskorn Sritipsukho Effect of zingiber cassumunar (PLAI capsule) on nasal eosinophils and cytokine productions in allergic rhinitis 1117 NITCHANAN ACHARARIT Phuntila Tharabenjasin Effect of zingiber cassumunar (PLAI capsule) on nasal eosinophils and cytokine productions in allergic rhinitis 1117 NITCHANAN ACHARARIT Prapasri Kulalert Effect of zingiber cassumunar (PLAI capsule) on nasal eosinophils and cytokine productions in allergic rhinitis 1117 NITCHANAN ACHARARIT Sira Nanthapisal Effect of zingiber cassumunar (PLAI capsule) on nasal eosinophils and cytokine productions in allergic rhinitis 1117 Sung Won Kim Chun Kim Anaphylaxis and epinephrine autoinjector prescription at a single hospital 476 Sung Won Kim Yoon Ha Hwang Anaphylaxis and epinephrine autoinjector prescription at a single hospital 476 Zhirong Du Jia Yin Follow-up of 121 patients with wheat-dependent exercise-induced anaphylaxis in China 132 Myeong Seong Sim Chun Kim Lysophosphatidylserine induces MUC5AC in airway epithelial cells via an GPCR-EGFR-ERK signaling axis 271 Myeong Seong Sim Hye Jeong Kim Lysophosphatidylserine induces MUC5AC in airway epithelial cells via an GPCR-EGFR-ERK signaling axis 271 Myeong Seong Sim Il Yup Chung Lysophosphatidylserine induces MUC5AC in airway epithelial cells via an GPCR-EGFR-ERK signaling axis 271 Dhanis Lad Alan Irvine Can more be done to implement translational weaning advice for mothers? 1173 Dhanis Lad Carol Ni Chaoimh Can more be done to implement translational weaning advice for mothers? 1173 Dhanis Lad Geraldine Roche Can more be done to implement translational weaning advice for mothers? 1173 Dhanis Lad Ita Herlihy Can more be done to implement translational weaning advice for mothers? 1173 Dhanis Lad Jonathan Hourihane Can more be done to implement translational weaning advice for mothers? 1173 Franziska Roth-Walter Christian A Mller Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Elisa Einwallner Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Erich Vyscocil Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Erika Jensen-Jarolim Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Karin Hufnagl Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Lisa-Marie Petje Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Maximilian Bastl Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Sheriene M Afify Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Sonja Guethoff Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Tina Bartosik Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Franziska Roth-Walter Uwe Berger Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B-cell numbers yet with higher intracellular iron 1213 Elena Tonti Mark Larch Geographic variability of house dust mite sensitization profiles: Der p 7 and Der p 23 are major allergens among South African allergic patients 1318 Elena Tonti Pascal Hickey Geographic variability of house dust mite sensitization profiles: Der p 7 and Der p 23 are major allergens among South African allergic patients 1318 Elena Tonti Rudolf Valenta Geographic variability of house dust mite sensitization profiles: Der p 7 and Der p 23 are major allergens among South African allergic patients 1318 Elena Tonti Susanne Vrtala Geographic variability of house dust mite sensitization profiles: Der p 7 and Der p 23 are major allergens among South African allergic patients 1318 Elena Tonti Thomas Schlederer Geographic variability of house dust mite sensitization profiles: Der p 7 and Der p 23 are major allergens among South African allergic patients 1318 Elena Tonti Varun Muddaluru Geographic variability of house dust mite sensitization profiles: Der p 7 and Der p 23 are major allergens among South African allergic patients 1318 Anastasiia Levchenko Liliia Romaniuk Allergic diseases in&nbsp;patients with&nbsp;irritable bowel syndrome&nbsp; 1489 Serge Doan Angele Soria Demodex palpebral infestation in dupilumab-related blepharoconjunctivitis 768 Serge Doan Isabelle Cochereau Demodex palpebral infestation in dupilumab-related blepharoconjunctivitis 768 Serge Doan Jean David Bouaziz Demodex palpebral infestation in dupilumab-related blepharoconjunctivitis 768 Serge Doan Marie Jachiet Demodex palpebral infestation in dupilumab-related blepharoconjunctivitis 768 Serge Doan Marie Noelle Crepy Demodex palpebral infestation in dupilumab-related blepharoconjunctivitis 768 Serge Doan Vincent Descamps Demodex palpebral infestation in dupilumab-related blepharoconjunctivitis 768 Rita Limo Amlia Sp\\xadnola Santos Vernal keratoconjunctivitis successfully treated with omalizumab: 2 case reports 1429 Rita Limo Ana Mendes Vernal keratoconjunctivitis successfully treated with omalizumab: 2 case reports 1429 Rita Limo Anabela Lopes Vernal keratoconjunctivitis successfully treated with omalizumab: 2 case reports 1429 Rita Limo Manuel Pereira Barbosa Vernal keratoconjunctivitis successfully treated with omalizumab: 2 case reports 1429 Rita Limo Maria Elisa Pedro Vernal keratoconjunctivitis successfully treated with omalizumab: 2 case reports 1429 Pia Allegri Chiara Ciurlo Evaluation of the efficacy and safety on allergic conjunctivitis of 0.001% Hydrocortisone &ndash; 0.2% Hyaluronic Acid ophthalmic solution 643 Pia Allegri Federico Rissotto Evaluation of the efficacy and safety on allergic conjunctivitis of 0.001% Hydrocortisone &ndash; 0.2% Hyaluronic Acid ophthalmic solution 643 Pia Allegri Laura Bergamino Evaluation of the efficacy and safety on allergic conjunctivitis of 0.001% Hydrocortisone &ndash; 0.2% Hyaluronic Acid ophthalmic solution 643 Pia Allegri Roberta Rissotto Evaluation of the efficacy and safety on allergic conjunctivitis of 0.001% Hydrocortisone &ndash; 0.2% Hyaluronic Acid ophthalmic solution 643 Keith Sacco Lawrence Dubuske Dupilumab administration prior to aspirin desensitization in a patient with samter\\x80\\x99s triad with severe aspirin-exacerbated respiratory disease  297 Christos Fokoloros Evangelia Papadavid Data of patients with mastocytosis from the Hellenic ECNM center of excellence 1056 Christos Fokoloros Michael Makris Data of patients with mastocytosis from the Hellenic ECNM center of excellence 1056 Christos Fokoloros Pericles G Foukas Data of patients with mastocytosis from the Hellenic ECNM center of excellence 1056 Christos Fokoloros Sotirios G Papageorgiou Data of patients with mastocytosis from the Hellenic ECNM center of excellence 1056 Christos Fokoloros Vasilliki Pappa Data of patients with mastocytosis from the Hellenic ECNM center of excellence 1056 Laura Rami Lluch Anna Puigdemont Safety and efficacy of two accelerated schedules of subcutaneous allergen immunotherapy in canine atopic dermatitis 990 Marilyn Urrutia Pereira Dirceu Sol Prevalence of allergic rhinitis and atopic dermatitis and associated factors in uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 311 Marilyn Urrutia Pereira Herberto Chong Neto Prevalence of allergic rhinitis and atopic dermatitis and associated factors in uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 311 Marilyn Urrutia Pereira Laura Simon Prevalence of allergic rhinitis and atopic dermatitis and associated factors in uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 311 Marilyn Urrutia Pereira Luis Garc\\xada-Marcos Prevalence of allergic rhinitis and atopic dermatitis and associated factors in uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 311 Marilyn Urrutia Pereira Philippa Ellwood Prevalence of allergic rhinitis and atopic dermatitis and associated factors in uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 311 Marilyn Urrutia Pereira Pietro Nunes Rinelli Prevalence of allergic rhinitis and atopic dermatitis and associated factors in uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 311 Zhifeng Huang Baoqing Sun Sensitization to furry animals and clinical relevance of house dust mite-induced allergic rhinitis in a Guangzhou, China 710 Natalia Begievna Migacheva Alexander Viktorovich Zhestkov Staphylococcus aureus colonization of the skin: Can it be a risk factor for atopic dermatitis development in high risk infants? 736 Natalia Begievna Migacheva Artem Viktorovich Lyamin Staphylococcus aureus colonization of the skin: Can it be a risk factor for atopic dermatitis development in high risk infants? 736 Natalia Begievna Migacheva Yury Solomonovich Smolkin Staphylococcus aureus colonization of the skin: Can it be a risk factor for atopic dermatitis development in high risk infants? 736 Jordina Belmonte Carlos Pedemonte Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Clara Padr-Casas Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Concepcion De Linares Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Irina Bobolea Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Joan Bartra Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Laia Farraons Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Laia Ferr-Ybarz Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Mar\\xada Basagaa-Torrento Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Mar\\xada Del Mar San Miguel Monc\\xadn Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Marta Vias Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Miguel Angel Baltasar-Drag Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Moiss Labrador-Horrillo Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Nria Campa-Falcon Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Nria Corts Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Olga Esteso-Hontoria Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Oscar Asensio Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Rosa Muoz-Cano Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Sira Miquel-Marc Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Teresa Garriga-Baraut Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Jordina Belmonte Vanessa Gzquez-Garcia Allergy risk period to Phl p 1 and Phl p 5 in Catalonia in view of the airborne levels of Poaceae pollen and Phl p 5 1081 Woo Kyung Kim  The relation between vitamin D levels and respiratory virus infection in children with recurrent wheezing  119 Joana Miranda Afonso Caires Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Ana Rodolfo Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Ana Margarida Mesquita Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Daniela Abreu Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Jos Torres Costa Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Jos Lu\\xads Plcido Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Maria Joo Vasconcelos Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Ricardo Moo Coutinho Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Joana Miranda Tiago Azenha Rama Characterization of elderly population&rsquo;s referrals to an Allergy and Clinical Immunology department outpatient clinic 1229 Albertina Varandas Capelo Camila Chieza Oral aspirin provocation test and clinical characteristics of patients with chronic rhinosinusitis, nasal polyps and asthma 1543 Albertina Varandas Capelo Eliane Miranda Oral aspirin provocation test and clinical characteristics of patients with chronic rhinosinusitis, nasal polyps and asthma 1543 Albertina Varandas Capelo Gabriela Monteiro Oral aspirin provocation test and clinical characteristics of patients with chronic rhinosinusitis, nasal polyps and asthma 1543 Albertina Varandas Capelo Livia Nascimento Oral aspirin provocation test and clinical characteristics of patients with chronic rhinosinusitis, nasal polyps and asthma 1543 Albertina Varandas Capelo Mariana Paulsen Oral aspirin provocation test and clinical characteristics of patients with chronic rhinosinusitis, nasal polyps and asthma 1543 Albertina Varandas Capelo Roberta Meireles Oral aspirin provocation test and clinical characteristics of patients with chronic rhinosinusitis, nasal polyps and asthma 1543 Albertina Varandas Capelo Walter Eyer Oral aspirin provocation test and clinical characteristics of patients with chronic rhinosinusitis, nasal polyps and asthma 1543 elizaveta rybnikova Tatyana Fedoskova The epidemiological of insect allergy in pediatri? practice in Moscow 788 Christos Fokoloros Caterina Chliva Clinical features of patients with severe anaphylactic reactions to hymenoptera stings and clinical efficacy of venom immunotherapy: Experience of a Mediterranean Center 1088 Christos Fokoloros Evangelia Papadavid Clinical features of patients with severe anaphylactic reactions to hymenoptera stings and clinical efficacy of venom immunotherapy: Experience of a Mediterranean Center 1088 Christos Fokoloros Ioanna Kanavarou Clinical features of patients with severe anaphylactic reactions to hymenoptera stings and clinical efficacy of venom immunotherapy: Experience of a Mediterranean Center 1088 Christos Fokoloros Maria Ntakoula Clinical features of patients with severe anaphylactic reactions to hymenoptera stings and clinical efficacy of venom immunotherapy: Experience of a Mediterranean Center 1088 Christos Fokoloros Maria Vrana Clinical features of patients with severe anaphylactic reactions to hymenoptera stings and clinical efficacy of venom immunotherapy: Experience of a Mediterranean Center 1088 Christos Fokoloros Michael Makris Clinical features of patients with severe anaphylactic reactions to hymenoptera stings and clinical efficacy of venom immunotherapy: Experience of a Mediterranean Center 1088 Christos Fokoloros Xenophon Aggelides Clinical features of patients with severe anaphylactic reactions to hymenoptera stings and clinical efficacy of venom immunotherapy: Experience of a Mediterranean Center 1088 Tiago Azenha Rama Almudena Matito Systemic mastocytosis presenting as anaphylaxis to hymenoptera venom: Not just wasps and bees 250 Tiago Azenha Rama Ana Filipa Henriques Systemic mastocytosis presenting as anaphylaxis to hymenoptera venom: Not just wasps and bees 250 Tiago Azenha Rama Ivn Alvarez-Twose Systemic mastocytosis presenting as anaphylaxis to hymenoptera venom: Not just wasps and bees 250 Tiago Azenha Rama Laura Sanchez-Muoz Systemic mastocytosis presenting as anaphylaxis to hymenoptera venom: Not just wasps and bees 250 Tiago Azenha Rama Torrado Ines Systemic mastocytosis presenting as anaphylaxis to hymenoptera venom: Not just wasps and bees 250 Leah Landaveri Sanchez Ana Giner Valero Correlation between the results of hymenoptera venom multiplex assays and single-parameter assays: Utility in the clinical practice 103 Leah Landaveri Sanchez Ramn Lopez Salgueiro Correlation between the results of hymenoptera venom multiplex assays and single-parameter assays: Utility in the clinical practice 103 Leah Landaveri Sanchez Remedios Alamar Martinez Correlation between the results of hymenoptera venom multiplex assays and single-parameter assays: Utility in the clinical practice 103 Marisa Paulino Clia Costa Bumblebee alergy: Double sensitization or cross reactivity? 1365 Marisa Paulino Elisa Pedro Bumblebee alergy: Double sensitization or cross reactivity? 1365 Marisa Paulino Fernando Pineda Bumblebee alergy: Double sensitization or cross reactivity? 1365 Marisa Paulino M. Conceio Pereira-Santos Bumblebee alergy: Double sensitization or cross reactivity? 1365 Marisa Paulino Manuel Pereira-Barbosa Bumblebee alergy: Double sensitization or cross reactivity? 1365 Marisa Paulino Miriam Castillo Bumblebee alergy: Double sensitization or cross reactivity? 1365 Marisa Paulino Ruben Ferreira Bumblebee alergy: Double sensitization or cross reactivity? 1365 Jasper Alexander Willey Mogg Catherine Stroud Patient selection for venom immunotherapy improves after introduction of a clinical checklist 1111 Ewa Cichocka-Jarosz Grzegorz Lis Qualification properties of the diagnostic tests in children with Hymenoptera venom allergy 909 Ewa Cichocka-Jarosz Nina Ml Qualification properties of the diagnostic tests in children with Hymenoptera venom allergy 909 Ewa Cichocka-Jarosz Piotr Brzyski Qualification properties of the diagnostic tests in children with Hymenoptera venom allergy 909 Ewa Cichocka-Jarosz Urszula Jedynak-Wasowicz Qualification properties of the diagnostic tests in children with Hymenoptera venom allergy 909 Ewa Cichocka-Jarosz Zofia Mazurek-Durlak Qualification properties of the diagnostic tests in children with Hymenoptera venom allergy 909 MARIA RITA MESSINA Davide Firinu Anakinra as a diagnostic and therapeutic trial for Undifferentiated Autoinflammatory Syndromes. Management of three clinical cases 529 MARIA RITA MESSINA Giulia Anna Maria Luigia Costanzo Anakinra as a diagnostic and therapeutic trial for Undifferentiated Autoinflammatory Syndromes. Management of three clinical cases 529 MARIA RITA MESSINA Maria Pina Barca Anakinra as a diagnostic and therapeutic trial for Undifferentiated Autoinflammatory Syndromes. Management of three clinical cases 529 MARIA RITA MESSINA Stefano Del Giacco Anakinra as a diagnostic and therapeutic trial for Undifferentiated Autoinflammatory Syndromes. Management of three clinical cases 529 Iolanda Alen Coutinho Ana Todo Bom Hypereosinophilic syndrome with severe dermatological clinical presentation: Off-lable therapy with benralizumab 319 Iolanda Alen Coutinho Carlos Loureiro Hypereosinophilic syndrome with severe dermatological clinical presentation: Off-lable therapy with benralizumab 319 Iolanda Alen Coutinho Joana Pita Hypereosinophilic syndrome with severe dermatological clinical presentation: Off-lable therapy with benralizumab 319 Iolanda Alen Coutinho Joni Carvalho Hypereosinophilic syndrome with severe dermatological clinical presentation: Off-lable therapy with benralizumab 319 Iolanda Alen Coutinho Marta Alves Hypereosinophilic syndrome with severe dermatological clinical presentation: Off-lable therapy with benralizumab 319 Ingrida Sauliene Laura Sukiene Is the mobile tool changing monitoring of influence of pollen load on personal health? 544 Andrea Enfedaque Merino Antoni Mart\\xadnez-Ballest AlerGo project: Development of an app and website for the management and supervision of patients undergoing oral food immunotherapy 876 Andrea Enfedaque Merino Edgar Batista De Frutos AlerGo project: Development of an app and website for the management and supervision of patients undergoing oral food immunotherapy 876 Andrea Enfedaque Merino Gaspar Dalmau Duch AlerGo project: Development of an app and website for the management and supervision of patients undergoing oral food immunotherapy 876 Andrea Enfedaque Merino Olga Esteso Hontoria AlerGo project: Development of an app and website for the management and supervision of patients undergoing oral food immunotherapy 876 Andrea Enfedaque Merino Pere Gaig Jan AlerGo project: Development of an app and website for the management and supervision of patients undergoing oral food immunotherapy 876 Andrea Enfedaque Merino Vanessa Gzquez Garc\\xada AlerGo project: Development of an app and website for the management and supervision of patients undergoing oral food immunotherapy 876 Charlotte Goss Athanasius Ishak Lactation anaphylaxis: A case presentation<br /> 934 Charlotte Goss Prathap Pillai Lactation anaphylaxis: A case presentation<br /> 934 Marta Pires Alves Ana Todo Bom Mastocytosis in adults: 11-year retrospective study in a terciary hospital 1508 Marta Pires Alves Carmelita Ribeiro Mastocytosis in adults: 11-year retrospective study in a terciary hospital 1508 Marta Pires Alves Francisca Cunha Mastocytosis in adults: 11-year retrospective study in a terciary hospital 1508 Marta Pires Alves Iolanda Alen Mastocytosis in adults: 11-year retrospective study in a terciary hospital 1508 Venkata Kasyapi Voorakaranam Karthik Nagaraju Rare manifestation of endogenous hormone hypersensitivity &ndash; 5 cases of progesterone hypersensitivity from india 1231 Venkata Kasyapi Voorakaranam Nagaraju Kuravi Rare manifestation of endogenous hormone hypersensitivity &ndash; 5 cases of progesterone hypersensitivity from india 1231 Luo Wenting Baoqing Sun Standardization construction of polycentric NCRC allergy disease biobank 125 Ayse Bilge Ozturk A. Fuat Kalyoncu Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Adile Berna Dursun Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Asli Gelincik Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Betl Byktiryaki Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Blent Sekerel Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Cansin Sakesen Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Dilber Taylan Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Ebru \\x87elebioglu Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Francesko Hela Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Gl Karakaya Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Halil Snmez Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Osman Ozan Yigit Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Ozge Soyer Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk \\x96zgr Albayrak Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Sinem Firtina Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk Tuba Erdogan Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ayse Bilge Ozturk \\x9cmit Murat Sahiner Prevalence of Apis, Vespula and Polistes sensitivity in venom allergic patients in Turkey 554 Ins Gonalves Nunes Ana Todo-Bom Hymenoptera venom immunotherapy induced anaphylaxis: 1 year of conventional VIT 1367 Ins Gonalves Nunes Beatriz Tavares Hymenoptera venom immunotherapy induced anaphylaxis: 1 year of conventional VIT 1367 Ins Gonalves Nunes Graa Loureiro Hymenoptera venom immunotherapy induced anaphylaxis: 1 year of conventional VIT 1367 Seong bae Ahn Eun Kyo Ha Influence of type and level of residence on lung function, FeNO and allergic status in children in a urban area 905 Seong bae Ahn Hye Mi Jee Influence of type and level of residence on lung function, FeNO and allergic status in children in a urban area 905 Seong bae Ahn Ju Hee Kim Influence of type and level of residence on lung function, FeNO and allergic status in children in a urban area 905 Seong bae Ahn Man Yong Han Influence of type and level of residence on lung function, FeNO and allergic status in children in a urban area 905 Seong bae Ahn Seung Won Lee Influence of type and level of residence on lung function, FeNO and allergic status in children in a urban area 905 Seong bae Ahn Youn Ho Shin Influence of type and level of residence on lung function, FeNO and allergic status in children in a urban area 905 Grzegorz Porebski Mirella Brzozowska Alpha-gal syndrome after a tick bite &ndash; the first report from Poland<br /> 580 Grzegorz Porebski Natalia Mokrzycka Alpha-gal syndrome after a tick bite &ndash; the first report from Poland<br /> 580 Svitlana Zubchenko Valentyna Chopyak Pathogenic correlations of miR-146a and miR-155 levels with concentration of cytokines in patients with allergopathy in chronic persistence of Epstein-Barr virus infection 510 Hsueh-Chun Wang  AhR controlled-lipid droplets biogenesis buffers against ER lipid imbalance in Club cells in vitro 408 Isabel Gonzlez-Mart\\xadn Maria Teresa Palomeque-Rodr\\xadguez Should we always treat with immunotherapy hymenoptera venom anaphylaxis? 1267 Isabel Gonzlez-Mart\\xadn Marina Lluncor-Salazar Should we always treat with immunotherapy hymenoptera venom anaphylaxis? 1267 Isabel Gonzlez-Mart\\xadn Marta Rodr\\xadguez-Lantarn Should we always treat with immunotherapy hymenoptera venom anaphylaxis? 1267 Mge Olga  Assessment of the demographic and clinical features of the geriatric patients admitted to allergy clinic 1347 Jimena Laiseca Garc\\xada Ana Rosado Ingelmo A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain 587 Jimena Laiseca Garc\\xada Elia Prez Fernndez A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain 587 Jimena Laiseca Garc\\xada Luc\\xada Gonzlez Bravo A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain 587 Jimena Laiseca Garc\\xada Marianela Managua Brandoni Petrone A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain 587 Jimena Laiseca Garc\\xada Martina Privitera Torres A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain 587 Jimena Laiseca Garc\\xada Miguel Angel Tejedor Alonso A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain 587 Jimena Laiseca Garc\\xada Sabela Prez Codesido A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain 587 \\x96zge Can Bostan Ali Fuat Kalyoncu Kounis syndrome: Evaluation of seven cases 417 \\x96zge Can Bostan Ebru \\x87elebioglu Kounis syndrome: Evaluation of seven cases 417 \\x96zge Can Bostan Gl Karakaya Kounis syndrome: Evaluation of seven cases 417 \\x96zge Can Bostan Mehmet Erdem \\x87akmak Kounis syndrome: Evaluation of seven cases 417 \\x96zge Can Bostan Saltuk Bugra Kaya Kounis syndrome: Evaluation of seven cases 417 Ilaria Bertozzi Alessandro Parmigiani A case of eosinophilic cystitis successfully treated with anti -IL5 monoclonal antibody 1224 Ilaria Bertozzi Carlo Agostini A case of eosinophilic cystitis successfully treated with anti -IL5 monoclonal antibody 1224 Ilaria Bertozzi Cesarina Facchini A case of eosinophilic cystitis successfully treated with anti -IL5 monoclonal antibody 1224 Ilaria Bertozzi Elisabetta Favero A case of eosinophilic cystitis successfully treated with anti -IL5 monoclonal antibody 1224 Ilaria Bertozzi Francesco Cinetto A case of eosinophilic cystitis successfully treated with anti -IL5 monoclonal antibody 1224 Ratchaneewan Sinitkul Emma Marczylo Assessment of atopic status in Thai pregnant women, a pilot birth cohort study 1336 Ratchaneewan Sinitkul Richard J. Maude Assessment of atopic status in Thai pregnant women, a pilot birth cohort study 1336 Ratchaneewan Sinitkul Timothy W. Gant Assessment of atopic status in Thai pregnant women, a pilot birth cohort study 1336 Ratchaneewan Sinitkul Wiparat Manuyakorn Assessment of atopic status in Thai pregnant women, a pilot birth cohort study 1336 Maria Valle Campanon-Toro Alicia Gallardo Higueras Epidemiological profile of patients with honey bee allergy in a West-Central region in Spain 1522 Maria Valle Campanon-Toro Esther Moreno Rodilla Epidemiological profile of patients with honey bee allergy in a West-Central region in Spain 1522 Maria Valle Campanon-Toro Ignacio Dvila Gonzlez Epidemiological profile of patients with honey bee allergy in a West-Central region in Spain 1522 Maria Valle Campanon-Toro Miriam Sobrino Garc\\xada Epidemiological profile of patients with honey bee allergy in a West-Central region in Spain 1522 Maria Valle Campanon-Toro Paloma Jaqueti Epidemiological profile of patients with honey bee allergy in a West-Central region in Spain 1522 Enrique Fern&aacute;ndez-Caldas Eugenio Fernandez Moya Variability of Can f 1 production among 74 dog hair samples 1132 Enrique Fern&aacute;ndez-Caldas Eva Abel Fernandez Variability of Can f 1 production among 74 dog hair samples 1132 Enrique Fern&aacute;ndez-Caldas Miriam Moran Variability of Can f 1 production among 74 dog hair samples 1132 Enrique Fern&aacute;ndez-Caldas Sandra Sivill Variability of Can f 1 production among 74 dog hair samples 1132 Rita Brs Ana Mendes Omalizumab in immunotherapy with hymenoptera venom &ndash; experience of a portuguese tertiary centre 851 Rita Brs Anabela Lopes Omalizumab in immunotherapy with hymenoptera venom &ndash; experience of a portuguese tertiary centre 851 Rita Brs Elisa Pedro Omalizumab in immunotherapy with hymenoptera venom &ndash; experience of a portuguese tertiary centre 851 Rita Brs Joana Caiado Omalizumab in immunotherapy with hymenoptera venom &ndash; experience of a portuguese tertiary centre 851 Rita Brs Manuel Pereira-Barbosa Omalizumab in immunotherapy with hymenoptera venom &ndash; experience of a portuguese tertiary centre 851 Rita Brs Maria Conceio Pereira Dos Santos Omalizumab in immunotherapy with hymenoptera venom &ndash; experience of a portuguese tertiary centre 851 R M Paulauskas-Vasaitis A M Montoro-De Francisco Permanent birth control devices and Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). A case report 1265 R M Paulauskas-Vasaitis Enrique Gabriel Gomez-Gonzalez Permanent birth control devices and Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). A case report 1265 R M Paulauskas-Vasaitis Jenaro Jose Hernandez-Pena Permanent birth control devices and Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). A case report 1265 R M Paulauskas-Vasaitis Jose Maria Mateos-Galvan Permanent birth control devices and Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). A case report 1265 R M Paulauskas-Vasaitis M Angeles Nunez-Hernandez Permanent birth control devices and Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). A case report 1265 R M Paulauskas-Vasaitis M Belen De Mateo-Hernandez Permanent birth control devices and Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). A case report 1265 Olesya O. Koloskova Anastasiia Nosova Influence of pegilation on the pharmacokinetics of RNA/liposomal complexes 920 Olesya O. Koloskova Musa Khaitov Influence of pegilation on the pharmacokinetics of RNA/liposomal complexes 920 Olesya O. Koloskova Valerii Smirnov Influence of pegilation on the pharmacokinetics of RNA/liposomal complexes 920 Victoria Rodinkova A Voronkina Changes of antihistamine sales patterns in central Ukraine shows the impacts of both global warming and increased ragweed sensitization 812 Victoria Rodinkova L M Dubuske Changes of antihistamine sales patterns in central Ukraine shows the impacts of both global warming and increased ragweed sensitization 812 Victoria Rodinkova M Yasniuk Changes of antihistamine sales patterns in central Ukraine shows the impacts of both global warming and increased ragweed sensitization 812 Victoria Rodinkova O Kryvoviaz Changes of antihistamine sales patterns in central Ukraine shows the impacts of both global warming and increased ragweed sensitization 812 Victoria Rodinkova S Yuriev Changes of antihistamine sales patterns in central Ukraine shows the impacts of both global warming and increased ragweed sensitization 812 Victoria Rodinkova Ya Resnik Changes of antihistamine sales patterns in central Ukraine shows the impacts of both global warming and increased ragweed sensitization 812 Valeriia  Kovchina Dmitry Kudlay Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Evgenii Egorenkov Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Galina Ramenskaya Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Igor Shilovskiy Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Musa Khaitov Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Olesya Koloskova Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Valery Smirnov Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Vladislav Turenko Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Valeriia  Kovchina Yuri Sebyakin Liposomal nanoparticles with siRNA : Promising approach of targeted delivery to liver 945 Radovan Mijanovic Dimitrije Dimitrijev Increased values of D-dimer in anaphylaxis: Case series 787 Yury Vladimirovich Zhernov Kirill Mokhniuk Case report of a Paederus dermatitis in international humanitarian medical mission in Nicaragua 549 Mohamed Abuzakouk Deepa Grandon The use of biologic therapies in a large tertiary hospital in the United Arab Emirates &ndash; a retrospective study 551 Mohamed Abuzakouk Fulvio Salvo The use of biologic therapies in a large tertiary hospital in the United Arab Emirates &ndash; a retrospective study 551 Mohamed Abuzakouk Mohsen Nasir The use of biologic therapies in a large tertiary hospital in the United Arab Emirates &ndash; a retrospective study 551 Mohamed Abuzakouk Omar Ghorab The use of biologic therapies in a large tertiary hospital in the United Arab Emirates &ndash; a retrospective study 551 Julia Levina Anna Alekseeva A successful treatment with omalizumab of severe chronic spontaneous urticaria associated with autoimmune thyroiditis in children: A ?ase report 1060 Julia Levina Elena Vishneva A successful treatment with omalizumab of severe chronic spontaneous urticaria associated with autoimmune thyroiditis in children: A ?ase report 1060 Julia Levina Kamilla Efendieva A successful treatment with omalizumab of severe chronic spontaneous urticaria associated with autoimmune thyroiditis in children: A ?ase report 1060 Julia Levina Leila Namazova-Baranova A successful treatment with omalizumab of severe chronic spontaneous urticaria associated with autoimmune thyroiditis in children: A ?ase report 1060 Julia Levina Polina Arimova A successful treatment with omalizumab of severe chronic spontaneous urticaria associated with autoimmune thyroiditis in children: A ?ase report 1060 Julia Levina Vera Kalugina A successful treatment with omalizumab of severe chronic spontaneous urticaria associated with autoimmune thyroiditis in children: A ?ase report 1060 Jens Christian  Richter  Respiratory health in a small cohort of disadvantaged immigrants to Sweden was not improved by an intervention only addressing their poor housing conditions 475 Anna Sergeevna Rusanova Alexandra Yurievna Nikitina Allergic diseases in the CIS-countries: Reality and official statistics 155 Anna Sergeevna Rusanova Tatiana Alexandrovna Slavyanskaya Allergic diseases in the CIS-countries: Reality and official statistics 155 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Allergy diagnosis and systems medicine',\n",
       "  'session': 'TPS 03 Allergy diagnosis and systems medicine',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921294,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 03 Allergy diagnosis and systems medicine Patarin Joavisidha Anon Srikiatkhachorn Contributions of global geographic origins and age to aeroallergen sensitivities 273 Patarin Joavisidha Nichapat Pourpongpan Contributions of global geographic origins and age to aeroallergen sensitivities 273 Patarin Joavisidha Patchrapa Siriyotha Contributions of global geographic origins and age to aeroallergen sensitivities 273 Patarin Joavisidha Sirada Khottip Contributions of global geographic origins and age to aeroallergen sensitivities 273 Patarin Joavisidha Supalak Kamyan Contributions of global geographic origins and age to aeroallergen sensitivities 273 Patarin Joavisidha Suphaneewan Joavisidha Contributions of global geographic origins and age to aeroallergen sensitivities 273 Behnam Keshavarz Jeffrey M Wilson Effect of hygiene on IgE responses to house dust mite: An investigation of children from rural Ecuador and urban Costa Rica 1496 Behnam Keshavarz Jonas Lidholm Effect of hygiene on IgE responses to house dust mite: An investigation of children from rural Ecuador and urban Costa Rica 1496 Behnam Keshavarz Peter W Heymann Effect of hygiene on IgE responses to house dust mite: An investigation of children from rural Ecuador and urban Costa Rica 1496 Behnam Keshavarz Philip J Cooper Effect of hygiene on IgE responses to house dust mite: An investigation of children from rural Ecuador and urban Costa Rica 1496 Behnam Keshavarz Thomas A. E. Platts-Mills Effect of hygiene on IgE responses to house dust mite: An investigation of children from rural Ecuador and urban Costa Rica 1496 Sviatlana Starchenka Anna M. Kuklinska-Pijanka Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Sviatlana Starchenka Kerry L. Knox Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Sviatlana Starchenka Matthew D. Heath Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Sviatlana Starchenka Max Bermingham Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Sviatlana Starchenka Murray A. Skinner Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Sviatlana Starchenka Petra Visic Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Sviatlana Starchenka Simon J. Hewings Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Sviatlana Starchenka Trevor D. Wilson Analytical platform development for standartisation and quality control of major grass allergen content - Lol p1 in grass allergoid vaccine 226 Ksenia Kozhikhova Anastasiia Timofeeva Enhanced transfection of oligonucleotides by modified peptide dendrimer vectors 1503 Ksenia Kozhikhova Artem Shatilov Enhanced transfection of oligonucleotides by modified peptide dendrimer vectors 1503 Ksenia Kozhikhova Diana Uspenskaya Enhanced transfection of oligonucleotides by modified peptide dendrimer vectors 1503 Ksenia Kozhikhova Igor Shilovskiy Enhanced transfection of oligonucleotides by modified peptide dendrimer vectors 1503 Ksenia Kozhikhova Liudmila Vishniakova Enhanced transfection of oligonucleotides by modified peptide dendrimer vectors 1503 Ksenia Kozhikhova Musa Khaitov Enhanced transfection of oligonucleotides by modified peptide dendrimer vectors 1503 Ksenia Kozhikhova Sergey Andreev Enhanced transfection of oligonucleotides by modified peptide dendrimer vectors 1503 Mason Xue Bao Qing Sun The role of N-6/N-3 ratio and N-9 metabolites in assessing chronic obstructive pulmonary diseases progression 210 Mason Xue Lu Qian Zhou The role of N-6/N-3 ratio and N-9 metabolites in assessing chronic obstructive pulmonary diseases progression 210 Mason Xue Yi Feng Zeng The role of N-6/N-3 ratio and N-9 metabolites in assessing chronic obstructive pulmonary diseases progression 210 Maria Joo Vasconcelos Artur Vilela Does a successful spirometry in preschool children is dependent on training? 862 Maria Joo Vasconcelos Carla Martins Does a successful spirometry in preschool children is dependent on training? 862 Maria Joo Vasconcelos Diana Silva Does a successful spirometry in preschool children is dependent on training? 862 Maria Joo Vasconcelos Jos Lu\\xads Plcido Does a successful spirometry in preschool children is dependent on training? 862 Nurat Ajidagba Jennifer Ball Compliance with UK tryptase requesting guidelines for assessment of anaphylaxis in a large NHS trust 1395 Nurat Ajidagba Michael Stevens Compliance with UK tryptase requesting guidelines for assessment of anaphylaxis in a large NHS trust 1395 Evgeni Stanev Georgi Nikolov Comparison between thermal imaging and standard reading of intradermal tests 445 Evgeni Stanev Maria Dencheva Comparison between thermal imaging and standard reading of intradermal tests 445 Sofia Martins Farinha Brbara Kong Cardoso Diagnostic efficiency of skin prick tests to&nbsp;Dermatophagoides pteronyssinus&nbsp;and&nbsp;Lepidoglyphus destructor&nbsp;&ndash; comparing two commercial extracts<br /> 597 Sofia Martins Farinha Elza Tomaz Diagnostic efficiency of skin prick tests to&nbsp;Dermatophagoides pteronyssinus&nbsp;and&nbsp;Lepidoglyphus destructor&nbsp;&ndash; comparing two commercial extracts<br /> 597 Sofia Martins Farinha Filipa Semedo Diagnostic efficiency of skin prick tests to&nbsp;Dermatophagoides pteronyssinus&nbsp;and&nbsp;Lepidoglyphus destructor&nbsp;&ndash; comparing two commercial extracts<br /> 597 Sofia Martins Farinha Marta Martins Diagnostic efficiency of skin prick tests to&nbsp;Dermatophagoides pteronyssinus&nbsp;and&nbsp;Lepidoglyphus destructor&nbsp;&ndash; comparing two commercial extracts<br /> 597 Laura  Vias Gustavo Jorge Molina Correlation of specific IgE determined by an immunoblotting assay with skin prick tests 1094 Laura  Vias Jenny Verdetoso Correlation of specific IgE determined by an immunoblotting assay with skin prick tests 1094 Laura  Vias Moiss Labrador Correlation of specific IgE determined by an immunoblotting assay with skin prick tests 1094 Laura  Vias Olga Luengo Correlation of specific IgE determined by an immunoblotting assay with skin prick tests 1094 Laura  Vias Victoria Cardona Correlation of specific IgE determined by an immunoblotting assay with skin prick tests 1094 Carmen Panaitescu Kuan-Wei Chen <br />Molecular features in ragweed pollen -sensitized patients of Western Romania 1306 Carmen Panaitescu Rudolf Valenta <br />Molecular features in ragweed pollen -sensitized patients of Western Romania 1306 Carmen Panaitescu Tudor Paul Tamas <br />Molecular features in ragweed pollen -sensitized patients of Western Romania 1306 Tamar Abramidze Amiran Gamkrelidze Cypress sensitization among allergic patients in georgia: Clinical and diagnostics features 364 Tamar Abramidze Ekaterine Bochorishvili Cypress sensitization among allergic patients in georgia: Clinical and diagnostics features 364 Tamar Abramidze Maia Gotua Cypress sensitization among allergic patients in georgia: Clinical and diagnostics features 364 Tamar Abramidze Nana Dolidze Cypress sensitization among allergic patients in georgia: Clinical and diagnostics features 364 Tamar Abramidze Natela Melikidze Cypress sensitization among allergic patients in georgia: Clinical and diagnostics features 364 Zhirong Du Jia Yin Characteristics of patients with wheat-dependent exercise-induced urticaria 131 Zhirong Du Junda Li Characteristics of patients with wheat-dependent exercise-induced urticaria 131 Zhirong Du Yingyang Xu Characteristics of patients with wheat-dependent exercise-induced urticaria 131 Sowmya Arudi Nagarajan Harsha N S Skin prick test sensitisation pattern in children and adults presenting with allergy symptoms in Bangalore, India - a retrospective ananlysis 159 Manoj Kumar Anil Kumar Mavi Evaluate the cockroach exposure and sensitization in asthma patients 526 Manoj Kumar Kamal Singh Evaluate the cockroach exposure and sensitization in asthma patients 526 Manoj Kumar Raj Kumar Evaluate the cockroach exposure and sensitization in asthma patients 526 Manoj Kumar Rajesh Kumar Gupta Evaluate the cockroach exposure and sensitization in asthma patients 526 Arti Dhawal  Shah Amrita Swati Fungal sensitivity in bronchial asthma and allergic rhinitis: A search beyond aspergillus fumigatus 390 Arti Dhawal  Shah Dhawal Niranjan Shah Fungal sensitivity in bronchial asthma and allergic rhinitis: A search beyond aspergillus fumigatus 390 Arti Dhawal  Shah Swati Malani Fungal sensitivity in bronchial asthma and allergic rhinitis: A search beyond aspergillus fumigatus 390 Justin T Marsh Abigail S Burrows Occurrence of hydroxyproline in peanut and possible relevance to food allergy 1345 Justin T Marsh Fulei Luan Occurrence of hydroxyproline in peanut and possible relevance to food allergy 1345 Justin T Marsh Philip E Johnson Occurrence of hydroxyproline in peanut and possible relevance to food allergy 1345 Justin T Marsh Richard E Goodman Occurrence of hydroxyproline in peanut and possible relevance to food allergy 1345 Justin T Marsh Stef J Koppelman Occurrence of hydroxyproline in peanut and possible relevance to food allergy 1345 Elise Slob Alen Faiz Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Antonio Espuela Ortiz Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Colin Palmer Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Cristina Longo Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Cyrielle Maroteau Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Esteban G. Burchard Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Esther Herrera-Luis Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Fook Tim Chew Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Gerard H. Koppelman Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Katia Verhamme Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Leila Karimi Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Maarten Van Den Berge Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Maria Pino-Yanes Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Marille Pijnenburg Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Merve Kutlu Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Patricia Soares Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Pieter Hiemstra Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Somnath Mukhopadhyay Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Steve Turner Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Susanne J.h. Vijverberg Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Uro Potocnik Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Elise Slob Wim Timens Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma 967 Sergii Zaikov Aleksandr Nazarenko Comparison of the determination of sensitization to the dust-mite allergens in patients with respiratory allergies using the multiplex microarray test and western-blot test 1388 Sergii Zaikov Artemii Bogomolov Comparison of the determination of sensitization to the dust-mite allergens in patients with respiratory allergies using the multiplex microarray test and western-blot test 1388 Marine-Alexia LEFEVRE Anne Hermann Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Audrey Nosbaum Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Aurore Rozires Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Charles Dzviga Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Florence Hacard Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Jean-Fraois Nicolas Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Marc Vocanson Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Marie Baeck Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Marie-Christine Ferrier-Lebouedec Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Pauline Pralong Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Marine-Alexia LEFEVRE Vanina Lenief Unique molecular signatures distinguish skin inflammatory reactions induced by chemical allergens and irritants 63 Cristiana  Cancela Ferreira Ana Paula Cruz Patients with extremely elevated IgE levels: A descriptive study 1174 Cristiana  Cancela Ferreira Arminda Guilherme Patients with extremely elevated IgE levels: A descriptive study 1174 Cristiana  Cancela Ferreira Maria Figueiredo Patients with extremely elevated IgE levels: A descriptive study 1174 Leticia De las Vecillas Snchez Fernando Rodr\\xadguez Fernandez Evaluation of anisakis simplex diagnosis tests: Clinically relevant sensitization and identification of high-risk allergic patients 302 Leticia De las Vecillas Snchez Florencio M. Ubeira Evaluation of anisakis simplex diagnosis tests: Clinically relevant sensitization and identification of high-risk allergic patients 302 Leticia De las Vecillas Snchez Marcos Lpez Hoyos Evaluation of anisakis simplex diagnosis tests: Clinically relevant sensitization and identification of high-risk allergic patients 302 Leticia De las Vecillas Snchez Pedro Muoz Cacho Evaluation of anisakis simplex diagnosis tests: Clinically relevant sensitization and identification of high-risk allergic patients 302 Leticia De las Vecillas Snchez Raquel Hondal-Garcia Evaluation of anisakis simplex diagnosis tests: Clinically relevant sensitization and identification of high-risk allergic patients 302 Leticia De las Vecillas Snchez Victoria Mart\\xadnez-Sernndez Evaluation of anisakis simplex diagnosis tests: Clinically relevant sensitization and identification of high-risk allergic patients 302 Leticia De las Vecillas Snchez Vittoria Montecchiani Evaluation of anisakis simplex diagnosis tests: Clinically relevant sensitization and identification of high-risk allergic patients 302 Serhii  Dmitrievich Yuriev A Kurchenko Diagnostic Features of House Dust Mite Sensitization 802 Serhii  Dmitrievich Yuriev L M Dubuske Diagnostic Features of House Dust Mite Sensitization 802 Serhii  Dmitrievich Yuriev S Zubchenko Diagnostic Features of House Dust Mite Sensitization 802 Serhii  Dmitrievich Yuriev V Tsaryk Diagnostic Features of House Dust Mite Sensitization 802 Monica Gonzalez Medina Clara Padr Map of molecular diagnostic availability in Catalonia (Spain) (m&agrave;gic.cat project) 1415 Monica Gonzalez Medina Concepcin De Linares Map of molecular diagnostic availability in Catalonia (Spain) (m&agrave;gic.cat project) 1415 Monica Gonzalez Medina Mar\\xada Del Mar San Miguel Monc\\xadn. Map of molecular diagnostic availability in Catalonia (Spain) (m&agrave;gic.cat project) 1415 Monica Gonzalez Medina Sira Miquel Map of molecular diagnostic availability in Catalonia (Spain) (m&agrave;gic.cat project) 1415 Monica Gonzalez Medina Teresa Garriga Map of molecular diagnostic availability in Catalonia (Spain) (m&agrave;gic.cat project) 1415 Justin T Marsh Ellenor Sell Proteomic analysis of allergens in salmon and trout 1460 Justin T Marsh Laura M Braden Proteomic analysis of allergens in salmon and trout 1460 Justin T Marsh Mark Walton Proteomic analysis of allergens in salmon and trout 1460 Justin T Marsh Philip E Johnson Proteomic analysis of allergens in salmon and trout 1460 Ling-sai Chang Ho-Chang Kuo Low FCMR expression in kawasaki disease six months after disease onset 43 Natalia Ewa Ukleja-Sokolowska Ewa Barbara Gawronska-Ukleja Analysis of the allergen profile of shrimp-sensitized patients based on ImmunoCap ISAC results 1315 Natalia Ewa Ukleja-Sokolowska Kinga Lis Analysis of the allergen profile of shrimp-sensitized patients based on ImmunoCap ISAC results 1315 Natalia Ewa Ukleja-Sokolowska Lukasz Sokolowski Analysis of the allergen profile of shrimp-sensitized patients based on ImmunoCap ISAC results 1315 Natalia Ewa Ukleja-Sokolowska Magdalena Zbikowska-Gotz Analysis of the allergen profile of shrimp-sensitized patients based on ImmunoCap ISAC results 1315 Natalia Ewa Ukleja-Sokolowska Rafal Adamczak Analysis of the allergen profile of shrimp-sensitized patients based on ImmunoCap ISAC results 1315 Natalia Ewa Ukleja-Sokolowska Zbigniew Bartuzi Analysis of the allergen profile of shrimp-sensitized patients based on ImmunoCap ISAC results 1315 Ella Vitalievna Churyukina Irina Ivanovna Krukier The role of immunogenetic factors in premature birth 472 Ella Vitalievna Churyukina Marina Arcadievna Levkovich The role of immunogenetic factors in premature birth 472 Oxana A. Svitich A. Avagyan Association of the NOS3 gene polymorphism with the risk of open-angle glaucoma development 1479 Oxana A. Svitich Alia Kinkulkina Association of the NOS3 gene polymorphism with the risk of open-angle glaucoma development 1479 Oxana A. Svitich Tatiana Gavrilova Association of the NOS3 gene polymorphism with the risk of open-angle glaucoma development 1479 Oxana A. Svitich Vitaliy Zverev Association of the NOS3 gene polymorphism with the risk of open-angle glaucoma development 1479 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Allied health and primary care  ',\n",
       "  'session': 'TPS 04 Allied health and primary care',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921295,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 04 Allied health and primary care Evangline CLARK Bertine Flokstra-De Blok Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Elizabeth Angier Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Jean Willem Kocks Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Kerstin Romberg Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Luciana Tanno Kase Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Pascal Demoly Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Radek Gawlik Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Ryan Dermot Urticaria logogram: Optimization of management in primary care 439 Evangline CLARK Tina Van Der Velde Urticaria logogram: Optimization of management in primary care 439 Bertine Margaretha Janine Flokstra - de Blok Clara Gaudin EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Dermot Ryan EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Elizabeth Angier EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Evangeline Clark EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Jantina Van Der Velde EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Janwillem Willem H Kocks EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Kerstin Romberg EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Luciana Tanno EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Myriam Mamodaly EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Pascal Demoly EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Bertine Margaretha Janine Flokstra - de Blok Radek Gawlik EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care 1270 Martha Cabrera Bertine Flokstra \\x80\\x93 De Blok Current allergy educational needs in primary care. Preliminary results of the EAACI working group on primary care survey 304 Martha Cabrera Dan Purushotam Current allergy educational needs in primary care. Preliminary results of the EAACI working group on primary care survey 304 Martha Cabrera Dermot Ryan Current allergy educational needs in primary care. Preliminary results of the EAACI working group on primary care survey 304 Martha Cabrera Elizabeth Angier Current allergy educational needs in primary care. Preliminary results of the EAACI working group on primary care survey 304 Martha Cabrera Laura Losappio Current allergy educational needs in primary care. Preliminary results of the EAACI working group on primary care survey 304 Martha Cabrera Radoslaw Gawlik Current allergy educational needs in primary care. Preliminary results of the EAACI working group on primary care survey 304 Martha Cabrera Sinthia Bosnic-Anticevich Current allergy educational needs in primary care. Preliminary results of the EAACI working group on primary care survey 304 Vilte Kritopaityte Brigita Sitkauskiene Evaluation of sleep quality and its link with nasal symptoms in chronic rhinitis 416 Vilte Kritopaityte Laura Tamasauskiene Evaluation of sleep quality and its link with nasal symptoms in chronic rhinitis 416 Ricardo Moo Coutinho Alice Coimbra Quality of life assessment in allergic and non-allergic individuals to hymenoptera venom 1245 Ricardo Moo Coutinho Ana Margarida Mesquita Quality of life assessment in allergic and non-allergic individuals to hymenoptera venom 1245 Ricardo Moo Coutinho Jos Lu\\xads Plcido Quality of life assessment in allergic and non-allergic individuals to hymenoptera venom 1245 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Asthma',\n",
       "  'session': 'TPS 05  Asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921296,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 05  Asthma Valeriy Kuznetsov Alexandra Uchevatkina Basophil activation test in the diagnosis of fungal sensitization in in severe asthma patients 60 Valeriy Kuznetsov Ekaterina Frolova Basophil activation test in the diagnosis of fungal sensitization in in severe asthma patients 60 Valeriy Kuznetsov Larisa Filippova Basophil activation test in the diagnosis of fungal sensitization in in severe asthma patients 60 Valeriy Kuznetsov Natalya Vasilyeva Basophil activation test in the diagnosis of fungal sensitization in in severe asthma patients 60 Valeriy Kuznetsov Nikolay Klimko Basophil activation test in the diagnosis of fungal sensitization in in severe asthma patients 60 Valeriy Kuznetsov Oleg Aak Basophil activation test in the diagnosis of fungal sensitization in in severe asthma patients 60 Valeriy Kuznetsov Yana Kozlova Basophil activation test in the diagnosis of fungal sensitization in in severe asthma patients 60 luca perfetti Antonio Meriggi Bronchodilation tests with ipratropium-bromide vs salbutamol in asthmatic adults: Differences in 24-hour holter ECG monitoring and in the response to skin prick tests 313 luca perfetti Carlo Biale Bronchodilation tests with ipratropium-bromide vs salbutamol in asthmatic adults: Differences in 24-hour holter ECG monitoring and in the response to skin prick tests 313 luca perfetti Margherita Carotenuto Bronchodilation tests with ipratropium-bromide vs salbutamol in asthmatic adults: Differences in 24-hour holter ECG monitoring and in the response to skin prick tests 313 luca perfetti Maria Gabriella Calcagno Bronchodilation tests with ipratropium-bromide vs salbutamol in asthmatic adults: Differences in 24-hour holter ECG monitoring and in the response to skin prick tests 313 Vladimir Beloglazov A Gordienko Lipopolysaccharide-binding systems and systemic inflammation in patients of asthma with various inflammation bio phenotypes 996 Vladimir Beloglazov L M Dubuske Lipopolysaccharide-binding systems and systemic inflammation in patients of asthma with various inflammation bio phenotypes 996 Vladimir Beloglazov N Shadchneva Lipopolysaccharide-binding systems and systemic inflammation in patients of asthma with various inflammation bio phenotypes 996 Vladimir Beloglazov Y Popenko Lipopolysaccharide-binding systems and systemic inflammation in patients of asthma with various inflammation bio phenotypes 996 Olga Savelieva Alexandra Karunas Genetic and epigenetic markers of the efficacy of beta-2-agonits therapy in asthma patients 919 Olga Savelieva Elza Khusnutdinova Genetic and epigenetic markers of the efficacy of beta-2-agonits therapy in asthma patients 919 Olga Savelieva Esfir Etkina Genetic and epigenetic markers of the efficacy of beta-2-agonits therapy in asthma patients 919 Olga Savelieva Radik Gatiyatullin Genetic and epigenetic markers of the efficacy of beta-2-agonits therapy in asthma patients 919 Olga Savelieva Regina Murzina Genetic and epigenetic markers of the efficacy of beta-2-agonits therapy in asthma patients 919 Olga Savelieva Yuliya Fedorova Genetic and epigenetic markers of the efficacy of beta-2-agonits therapy in asthma patients 919 Miramgul Dyneva Alexander Nikolskii Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 Miramgul Dyneva Alina Sokolova Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 Miramgul Dyneva Dmitriy Kudlay Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 Miramgul Dyneva Elena Savlevich Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 Miramgul Dyneva Igor Shilovskiy Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 Miramgul Dyneva Musa Khaitov Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 Miramgul Dyneva Oksana Kurbacheva Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 Miramgul Dyneva Valeriia Kovchina Characteristic of systemic and local inflammation in nasal polyps comorbid with asthma 1034 O Rosenberg A Seiliev Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg A Shulga Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg E Akulova Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg Ju Kirillov Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg K Shapovalov Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg L M Dubuske Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg O Lovacheva Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg O Stepanova Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg R Khanferyan Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 O Rosenberg V Volchkov Influence of natural lung surfactant inhalations on clinical symptoms, pulmonary function parameters and quantity of surfactant associated hydrophilic proteins in patients with bronchial asthma 874 Andrey Evgenievich Lintsov Irina Mikhailovna Spivak Analysis of cytogenetic effects of corticosteroids in asthmatic patients 1546 Andrey Evgenievich Lintsov Nadezhda Mikhailovna Pleskach Analysis of cytogenetic effects of corticosteroids in asthmatic patients 1546 Andrey Evgenievich Lintsov Pavel Alekseevich Slizhov Analysis of cytogenetic effects of corticosteroids in asthmatic patients 1546 Andrey Evgenievich Lintsov Sergei Eduardovich Shevelev Analysis of cytogenetic effects of corticosteroids in asthmatic patients 1546 Andrey Evgenievich Lintsov Vasiliy Ivanovich Trofimov Analysis of cytogenetic effects of corticosteroids in asthmatic patients 1546 Andrey Evgenievich Lintsov Viktor Mikhailovich Mikhelson Analysis of cytogenetic effects of corticosteroids in asthmatic patients 1546 Yoo Seob Shin Hae-Sim Park The blocking effect of glycoprotein IIb/IIIa receptor in the mouse model of asthma  212 Yoo Seob Shin Hoang Kim Tu Trinh The blocking effect of glycoprotein IIb/IIIa receptor in the mouse model of asthma  212 Yoo Seob Shin Seo-Hee Kim The blocking effect of glycoprotein IIb/IIIa receptor in the mouse model of asthma  212 Nestor Gonzlez Roldn Andrzej Gamian Non-pathogenic airway microbiota can favor asthma development: A dimannosyl glycerolipid from -Rothia aeria - leads to IL-13 production by Natural Killer T cells 936 Nestor Gonzlez Roldn Kamila Mackiewicz Non-pathogenic airway microbiota can favor asthma development: A dimannosyl glycerolipid from -Rothia aeria - leads to IL-13 production by Natural Killer T cells 936 Nestor Gonzlez Roldn Katarzyna Anna Duda Non-pathogenic airway microbiota can favor asthma development: A dimannosyl glycerolipid from -Rothia aeria - leads to IL-13 production by Natural Killer T cells 936 Nestor Gonzlez Roldn Mariola Pasciak Non-pathogenic airway microbiota can favor asthma development: A dimannosyl glycerolipid from -Rothia aeria - leads to IL-13 production by Natural Killer T cells 936 Nestor Gonzlez Roldn Sylvia Dpow Non-pathogenic airway microbiota can favor asthma development: A dimannosyl glycerolipid from -Rothia aeria - leads to IL-13 production by Natural Killer T cells 936 Yosuke Fukuda Akihiko Tanaka Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Hideki Inoue Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Hironori Sagara Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Kaho Akimoto Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Kuniaki Hirai Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Mayumi Yamamoto Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Shin Ohta Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Shintaro Suzuki Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Tetsuya Homma Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Tomoki Uno Late addition of budesonide inhibits virus-induced cytokine production 479 Yosuke Fukuda Yoshitaka Uchida Late addition of budesonide inhibits virus-induced cytokine production 479 Andrey Evgenievich Lintsov Alisher Kadirovich Soliev Investigation of DNA repair synthesis in peripheral blood lymphocytes of asthmatic patients with different phenotypes and severity 1520 Andrey Evgenievich Lintsov Boris Mikhailivich Uslontsev Investigation of DNA repair synthesis in peripheral blood lymphocytes of asthmatic patients with different phenotypes and severity 1520 Andrey Evgenievich Lintsov Nadezhda Mikhailovna Pleskach Investigation of DNA repair synthesis in peripheral blood lymphocytes of asthmatic patients with different phenotypes and severity 1520 Andrey Evgenievich Lintsov Pavel Alekseevich Slizhov Investigation of DNA repair synthesis in peripheral blood lymphocytes of asthmatic patients with different phenotypes and severity 1520 Andrey Evgenievich Lintsov Vasili Ivanovich Trofimov Investigation of DNA repair synthesis in peripheral blood lymphocytes of asthmatic patients with different phenotypes and severity 1520 Andrey Evgenievich Lintsov Viktor Mikhailovich Mikhelson Investigation of DNA repair synthesis in peripheral blood lymphocytes of asthmatic patients with different phenotypes and severity 1520 Mariana Valente Farraia Andr Moreira Volatilome analysis to identify subjects with asthma in need of therapy optimization 386 Mariana Valente Farraia Francisca Mendes Volatilome analysis to identify subjects with asthma in need of therapy optimization 386 Mariana Valente Farraia Ins Pacincia Volatilome analysis to identify subjects with asthma in need of therapy optimization 386 Mariana Valente Farraia Joo Cavaleiro Rufo Volatilome analysis to identify subjects with asthma in need of therapy optimization 386 Mariana Valente Farraia Lu\\xads Delgado Volatilome analysis to identify subjects with asthma in need of therapy optimization 386 Miriam Bennett Angela Simpson Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test 603 Miriam Bennett Clare Murray Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test 603 Miriam Bennett Gail Gauvreau Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test 603 Miriam Bennett Jiakai Wu Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test 603 Miriam Bennett Ruth Cusack Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test 603 Miriam Bennett Silvia Bulfone-Paus Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test 603 ANA ROSA CRISTINA NIN VALENCIA Alberto Luna Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 ANA ROSA CRISTINA NIN VALENCIA David Romero Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 ANA ROSA CRISTINA NIN VALENCIA Humberto Snchez Ocando Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 ANA ROSA CRISTINA NIN VALENCIA Javier Dom\\xadnguez Ortega Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 ANA ROSA CRISTINA NIN VALENCIA Mar\\xada Luisa Caballero Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 ANA ROSA CRISTINA NIN VALENCIA Pilar Barranco Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 ANA ROSA CRISTINA NIN VALENCIA Santiago Quirce Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 ANA ROSA CRISTINA NIN VALENCIA Valent\\xadn Lpez Carrasco Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma 1215 Margarida Cortez E Castro Anoop Chauhan IL-6 and Ykl-40 in severe asthma 1474 Margarida Cortez E Castro Clair Barber IL-6 and Ykl-40 in severe asthma 1474 Margarida Cortez E Castro Gabrielle Lockett IL-6 and Ykl-40 in severe asthma 1474 Margarida Cortez E Castro John Holloway IL-6 and Ykl-40 in severe asthma 1474 Margarida Cortez E Castro Laurie Lau IL-6 and Ykl-40 in severe asthma 1474 Margarida Cortez E Castro Peter Howarth IL-6 and Ykl-40 in severe asthma 1474 Margarida Cortez E Castro Scott Elliott IL-6 and Ykl-40 in severe asthma 1474 Margarida Cortez E Castro Thomas Brown IL-6 and Ykl-40 in severe asthma 1474 Mar\\xada Isabel Delgado Dolset Alma Villaseor Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset Ana Cabrera Santana Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset Coral Barbas Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset David Obeso Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset Domingo Barber Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset Jose Angel Cumplido Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset Juan Rodriguez-Coira Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset Mar\\xada M Escribese Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Mar\\xada Isabel Delgado Dolset Teresa Carrillo Identification of biomarkers for patient stratification in HDM-allergic asthma 441 Maria \\x96dling Anna Bergstrm Asthma-related healthcare and pharmacological consumption from adolescence to young adulthood 943 Maria \\x96dling Catarina Almqvist Asthma-related healthcare and pharmacological consumption from adolescence to young adulthood 943 Maria \\x96dling Christer Janson Asthma-related healthcare and pharmacological consumption from adolescence to young adulthood 943 Maria \\x96dling Erik Meln Asthma-related healthcare and pharmacological consumption from adolescence to young adulthood 943 Maria \\x96dling Inger Kull Asthma-related healthcare and pharmacological consumption from adolescence to young adulthood 943 Maria \\x96dling Jenny Hallberg Asthma-related healthcare and pharmacological consumption from adolescence to young adulthood 943 Maria \\x96dling Niklas Andersson Asthma-related healthcare and pharmacological consumption from adolescence to young adulthood 943 Lise Melscoet Frederic De Blay Retrospective study showing Omalizumab effectiveness in non-atopic severe asthma compared to atopic severe asthma 1307 Lise Melscoet Naji Khayath Retrospective study showing Omalizumab effectiveness in non-atopic severe asthma compared to atopic severe asthma 1307 Alexandra Kothra Christina Michopoulou Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra Emmanouil Manousakis Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra John Lakoumentas Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra Maria Galani Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra Maria Kritikou Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra Maria Passioti Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra Nikolaos Douladiris Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra Nikolaos G Papadopoulos Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Alexandra Kothra Paraskevi Xepapadaki Lung function as assessed by impulse oscillometry and spirometry in relation to different asthma phenotypes and allergic sensitization in asthmatic children 1470 Manali Mukherjee Ali Ashkar Suboptimal response to benralizumab is not associated with inadequate eosinophil suppression&nbsp;&nbsp; 1480 Manali Mukherjee Chynna M Huang Suboptimal response to benralizumab is not associated with inadequate eosinophil suppression&nbsp;&nbsp; 1480 Manali Mukherjee Katherine Radford Suboptimal response to benralizumab is not associated with inadequate eosinophil suppression&nbsp;&nbsp; 1480 Manali Mukherjee Nan Zhao Suboptimal response to benralizumab is not associated with inadequate eosinophil suppression&nbsp;&nbsp; 1480 Manali Mukherjee Parameswaran K Nair Suboptimal response to benralizumab is not associated with inadequate eosinophil suppression&nbsp;&nbsp; 1480 Manali Mukherjee Sophie Poznanski Suboptimal response to benralizumab is not associated with inadequate eosinophil suppression&nbsp;&nbsp; 1480 Sylvie Caron Harry Heijerman The dosage of salbutamol in spirometric reversibility testing. do-re-mi- study 433 Sylvie Caron Jeroen Van Exsel The dosage of salbutamol in spirometric reversibility testing. do-re-mi- study 433 Sylvie Caron Marlous Nagtegaal The dosage of salbutamol in spirometric reversibility testing. do-re-mi- study 433 Sylvie Caron Saar Bendien The dosage of salbutamol in spirometric reversibility testing. do-re-mi- study 433 Jae-Woo Jung Chang Hyun Lee Monitoring of serial dynamic imaging changes corresponding to airway hyperresponsiveness in murine asthma model using ultra-high-resolution CT 740 Jae-Woo Jung Hye-Ryun Kang Monitoring of serial dynamic imaging changes corresponding to airway hyperresponsiveness in murine asthma model using ultra-high-resolution CT 740 Jae-Woo Jung Jung Suk Oh Monitoring of serial dynamic imaging changes corresponding to airway hyperresponsiveness in murine asthma model using ultra-high-resolution CT 740 Joanna Matysiak Agnieszka Klupczynska Usefulness of serum free amino acid profiling in asthmatic children 558 Joanna Matysiak Anna Breborowicz Usefulness of serum free amino acid profiling in asthmatic children 558 Joanna Matysiak Anna Mackowiak Usefulness of serum free amino acid profiling in asthmatic children 558 Joanna Matysiak Jan Matysiak Usefulness of serum free amino acid profiling in asthmatic children 558 Joanna Matysiak Katarzyna Olejniczak Usefulness of serum free amino acid profiling in asthmatic children 558 Joanna Matysiak Olga Pawlicka Usefulness of serum free amino acid profiling in asthmatic children 558 Joanna Matysiak Zenon J Kokot Usefulness of serum free amino acid profiling in asthmatic children 558 Eleftheria Pertsinidou Anders Sjlander Fully automated, precise measurement of EDN in nasal mucosal lining fluid 1046 Eleftheria Pertsinidou Magnus Molin Fully automated, precise measurement of EDN in nasal mucosal lining fluid 1046 Eleftheria Pertsinidou Nehmat Singh Fully automated, precise measurement of EDN in nasal mucosal lining fluid 1046 Eleftheria Pertsinidou Ryan Thwaites Fully automated, precise measurement of EDN in nasal mucosal lining fluid 1046 Eleftheria Pertsinidou Trevor T Hansel Fully automated, precise measurement of EDN in nasal mucosal lining fluid 1046 Eleftheria Pertsinidou Anders Sjlander Automated measurement of MPO and NGAL in nasal mucosal lining fluid 1278 Eleftheria Pertsinidou Magnus Molin Automated measurement of MPO and NGAL in nasal mucosal lining fluid 1278 Eleftheria Pertsinidou Nehmat Singh Automated measurement of MPO and NGAL in nasal mucosal lining fluid 1278 Eleftheria Pertsinidou Ryan Thwaites Automated measurement of MPO and NGAL in nasal mucosal lining fluid 1278 Eleftheria Pertsinidou Trevor T Hansel Automated measurement of MPO and NGAL in nasal mucosal lining fluid 1278 Janwillem Kocks Bertine Flokstra-De Blok EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Clara Gaudin EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Dermot Ryan EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Evangeline Clark EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Kerstin Romberg EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Liz Angier EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Luciana Tanno EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Pascal Demoly EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Radek Gawlik EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Janwillem Kocks Tina Van Der Velde EAACI task force logograms: Asthma logogram to facilitate the diagnosis of asthma in primary care 1086 Ksenia Pavlova Daria Mdinaradze The variability of response to the standard pharmacotherapy in asthma patients 1102 Ksenia Pavlova Natalia Ilyna The variability of response to the standard pharmacotherapy in asthma patients 1102 Ksenia Pavlova Oksana Kurbacheva The variability of response to the standard pharmacotherapy in asthma patients 1102 Todor A. Popov Diana Hristova Powder methylcellulose improves asthma control and cough in uncontrolled asthma patients during the winter season 1207 Todor A. Popov Georgi Christoff Powder methylcellulose improves asthma control and cough in uncontrolled asthma patients during the winter season 1207 Todor A. Popov Lawrence Dubuske Powder methylcellulose improves asthma control and cough in uncontrolled asthma patients during the winter season 1207 Todor A. Popov Tanya Z. Kralimarkova Powder methylcellulose improves asthma control and cough in uncontrolled asthma patients during the winter season 1207 Todor A. Popov Tihomir B. Mustakov Powder methylcellulose improves asthma control and cough in uncontrolled asthma patients during the winter season 1207 Nadezda Shershakova Alexander A Babakhin Effect of allergen specific immunotherapy with monomeric allergoid in murine model of bronchial asthma 853 Nadezda Shershakova Anastasiia A Galkina Effect of allergen specific immunotherapy with monomeric allergoid in murine model of bronchial asthma 853 Nadezda Shershakova Ekaterina D Barvinskaya Effect of allergen specific immunotherapy with monomeric allergoid in murine model of bronchial asthma 853 Nadezda Shershakova Musa R Khaitov Effect of allergen specific immunotherapy with monomeric allergoid in murine model of bronchial asthma 853 Nadezda Shershakova Oleg Y Kamishnikov Effect of allergen specific immunotherapy with monomeric allergoid in murine model of bronchial asthma 853 Nadezda Shershakova Rakhim M Khaitov Effect of allergen specific immunotherapy with monomeric allergoid in murine model of bronchial asthma 853 Nadezda Shershakova Sergey M Andreev Effect of allergen specific immunotherapy with monomeric allergoid in murine model of bronchial asthma 853 Chang-Keun Kim Eunmi Kwon Montelukast reduces serum levels of eosinophil-derived neurotoxin (EDN) in preschool asthma 308 Chang-Keun Kim Hisashi Nishimori Montelukast reduces serum levels of eosinophil-derived neurotoxin (EDN) in preschool asthma 308 Chang-Keun Kim Jin-Sung Park Montelukast reduces serum levels of eosinophil-derived neurotoxin (EDN) in preschool asthma 308 Chang-Keun Kim Mizuho Nagao Montelukast reduces serum levels of eosinophil-derived neurotoxin (EDN) in preschool asthma 308 Chang-Keun Kim Takao Fujisawa Montelukast reduces serum levels of eosinophil-derived neurotoxin (EDN) in preschool asthma 308 Chang-Keun Kim Tikatoshi Ogino Montelukast reduces serum levels of eosinophil-derived neurotoxin (EDN) in preschool asthma 308 Chang-Keun Kim Zak Callaway Montelukast reduces serum levels of eosinophil-derived neurotoxin (EDN) in preschool asthma 308 Galina Sergeeva Alexander Emelyanov Biomarkers of airways inflammation in patients with severe asthma and concomitant COPD in a real clinical practice 467 Galina Sergeeva Antonina Znakhurenko Biomarkers of airways inflammation in patients with severe asthma and concomitant COPD in a real clinical practice 467 Galina Sergeeva Eugenia Leshenkova Biomarkers of airways inflammation in patients with severe asthma and concomitant COPD in a real clinical practice 467 Mette Northman  Hermansen Bo Lundsgaard Chawes Predictors of completion and outcome of exercise challenge tests in childhood asthma 454 Mette Northman  Hermansen Christina Lykke Jacobsen Predictors of completion and outcome of exercise challenge tests in childhood asthma 454 Mette Northman  Hermansen Johan Dagnegaard Predictors of completion and outcome of exercise challenge tests in childhood asthma 454 Mette Northman  Hermansen Kirsten Skamstrup Hansen Predictors of completion and outcome of exercise challenge tests in childhood asthma 454 Mette Northman  Hermansen Susanne Larsen Predictors of completion and outcome of exercise challenge tests in childhood asthma 454 Betl Dumanoglu Ayse Baioglu Effect of internet addiction on asthma control and medication adherence 1178 Betl Dumanoglu Ayse Fsun Kalpaklioglu Effect of internet addiction on asthma control and medication adherence 1178 Betl Dumanoglu Dilek \\x96kszer \\x87imsir Effect of internet addiction on asthma control and medication adherence 1178 Betl Dumanoglu Merve Poyraz Effect of internet addiction on asthma control and medication adherence 1178 Galina Ignatova Elena Blinova Comparison of targeted therapy effectiveness for the treatment of severe eosinophilic bronchial asthma 904 Galina Ignatova Irina Grebneva Comparison of targeted therapy effectiveness for the treatment of severe eosinophilic bronchial asthma 904 Galina Ignatova Olga Rodionova Comparison of targeted therapy effectiveness for the treatment of severe eosinophilic bronchial asthma 904 Galina Ignatova Vladimir Antonov Comparison of targeted therapy effectiveness for the treatment of severe eosinophilic bronchial asthma 904 Veronika Denisova Anita Denisova Microcirculation disorders in Children with bronchial asthma 654 Veronika Denisova Natalia Geppe Microcirculation disorders in Children with bronchial asthma 654 Veronika Denisova Natalia Kolosova Microcirculation disorders in Children with bronchial asthma 654 Kostiantyn Dmytriiev Andrii Sidorov Smoking cessation in patients with asthma: How big difference will it make? 733 Kostiantyn Dmytriiev Nataliia Slepchenko Smoking cessation in patients with asthma: How big difference will it make? 733 Kostiantyn Dmytriiev Nataliia Tsymbaliuk Smoking cessation in patients with asthma: How big difference will it make? 733 Kostiantyn Dmytriiev Yuriy Mostovoy Smoking cessation in patients with asthma: How big difference will it make? 733 Manuel Jorge Rial Aida Gmez-Cardeosa Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Javier Pinillos Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Joaqu\\xadn Sastre Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Jose Manuel Rodrigo-Muoz Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Jos Antonio Caas Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Mar Fernndez-Nieto Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Marcela Valverde-Monge Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Maria Jess Rodr\\xadguez-Nieto Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Nicols Gonzlez-Mangado Changes of serum microRNAs after biological treatment in severe asthma 1185 Manuel Jorge Rial Victoria Del Pozo Changes of serum microRNAs after biological treatment in severe asthma 1185 Dilara Karaguzel Basak Ezgi Sarac Effects of HDM derived protease allergens on matrix metalloproteases and cytokine profiles in airway epithelial cells 1040 Dilara Karaguzel Cagatay Karaaslan Effects of HDM derived protease allergens on matrix metalloproteases and cytokine profiles in airway epithelial cells 1040 Dilara Karaguzel Hayriye Akel Bilgic Effects of HDM derived protease allergens on matrix metalloproteases and cytokine profiles in airway epithelial cells 1040 Nicole Monica Dawn van der Burg Ellen Tufvesson Could multiple flow rate FeNO and associated biomarkers assist in identifying dual responders in the allergic asthma population? 940 Nicole Monica Dawn van der Burg Henning Stenberg Could multiple flow rate FeNO and associated biomarkers assist in identifying dual responders in the allergic asthma population? 940 Nicole Monica Dawn van der Burg Leif Bjermer Could multiple flow rate FeNO and associated biomarkers assist in identifying dual responders in the allergic asthma population? 940 Nicole Monica Dawn van der Burg Zuzana Diamant Could multiple flow rate FeNO and associated biomarkers assist in identifying dual responders in the allergic asthma population? 940 Gabriella Melo Fontes Silva Dias Jorge Kalil Are N-ERD really a non atopic disease? Comparative between the phenotype allergic and nonallergic in N-ERD in a Brasilian cohort 1181 Gabriella Melo Fontes Silva Dias Pedro Giavina-Bianchi Are N-ERD really a non atopic disease? Comparative between the phenotype allergic and nonallergic in N-ERD in a Brasilian cohort 1181 Gabriella Melo Fontes Silva Dias Rosana Cmara Agondi Are N-ERD really a non atopic disease? Comparative between the phenotype allergic and nonallergic in N-ERD in a Brasilian cohort 1181 Yuka Kashitani Hajime Yoshisue Long-term safety and efficacy of omalizumab in japanese paediatric patients with severe allergic asthma: A post-marketing surveillance 153 Yuka Kashitani Makoto Nagasaki Long-term safety and efficacy of omalizumab in japanese paediatric patients with severe allergic asthma: A post-marketing surveillance 153 Yuka Kashitani Noriko Nakamura Long-term safety and efficacy of omalizumab in japanese paediatric patients with severe allergic asthma: A post-marketing surveillance 153 Yuka Kashitani Takayoshi sasajima Long-term safety and efficacy of omalizumab in japanese paediatric patients with severe allergic asthma: A post-marketing surveillance 153 Bashir Omarjee Jean Franois Vellin Predictors of accelerated FEV1 decline in patients with rhinitis 566 Bashir Omarjee Suren Budhan Predictors of accelerated FEV1 decline in patients with rhinitis 566 Panagiotis Sakkatos Natalia Pavlovskaia Daily peak expiratory flow (PEF) recordings obtained by a digital self-monitoring device can predict asthma patients&rsquo; PEF zones of the next day 786 Panagiotis Sakkatos Thomas Antalffy Daily peak expiratory flow (PEF) recordings obtained by a digital self-monitoring device can predict asthma patients&rsquo; PEF zones of the next day 786 Marcelina Kocwin Elena Maria Parazzini Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Marcelina Kocwin Fabiano Di Marco Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Marcelina Kocwin Fulvia Ribolla Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Marcelina Kocwin Mirta Cavallini Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Marcelina Kocwin Rocco Francesco Rinaldo Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Marcelina Kocwin Silvia Ruggeri Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Marcelina Kocwin Silvia Terraneo Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Marcelina Kocwin Stefano Centanni Use of combination biologic therapy in uncontrolled severe asthma: Case report 571 Krasimira Zheleva Baynova Francisco Javier Alvarez Gutirres Analysis of the presence of immunodeficiencies in an asthmatic population with recurrent respiratory infections 1357 Krasimira Zheleva Baynova Jose Manuel Lucena Soto Analysis of the presence of immunodeficiencies in an asthmatic population with recurrent respiratory infections 1357 Krasimira Zheleva Baynova Juan Francisco Medina Gallardo Analysis of the presence of immunodeficiencies in an asthmatic population with recurrent respiratory infections 1357 Krasimira Zheleva Baynova Mar\\xada Auxiliadora Romero Falcn Analysis of the presence of immunodeficiencies in an asthmatic population with recurrent respiratory infections 1357 Paraskevi Korovessi Anna Lewandowska-Polak Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Claus Bachert Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Heikki Lukkarinen Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi John Lakoumentas Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Marek L. Kowalski Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Nan Zhang Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Nikolaos G Papadopoulos Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Paraskevi Xepapadaki Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Susetta Finotto Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Theodor Zimmermann Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Paraskevi Korovessi Tuomas Jartti Evolution of airway inflammation in preschoolers with asthma&mdash;results of a two-year longitudinal study 1271 Birgitte Carbuhn  Larsen Anne Sofie Bjerrum Comparison of flow cytometry and light microscopy in identification of leukocyte populations in induced sputum in patients with severe asthma 517 Birgitte Carbuhn  Larsen Emilie Rytter Olesen Comparison of flow cytometry and light microscopy in identification of leukocyte populations in induced sputum in patients with severe asthma 517 Birgitte Carbuhn  Larsen Hans Jrgen Hoffmann Comparison of flow cytometry and light microscopy in identification of leukocyte populations in induced sputum in patients with severe asthma 517 Birgitte Carbuhn  Larsen Johannes Martin Schmid Comparison of flow cytometry and light microscopy in identification of leukocyte populations in induced sputum in patients with severe asthma 517 Birgitte Carbuhn  Larsen Tina Skjold Comparison of flow cytometry and light microscopy in identification of leukocyte populations in induced sputum in patients with severe asthma 517 Robert Movrare Andrei Malinovschi Serum eosinophil derived neurotoxin (EDN)&nbsp;levels are elevated in asthma subjects as measured using a new EDN research assay 994 Robert Movrare Christer Janson Serum eosinophil derived neurotoxin (EDN)&nbsp;levels are elevated in asthma subjects as measured using a new EDN research assay 994 Robert Movrare Eleftheria Pertsinidou Serum eosinophil derived neurotoxin (EDN)&nbsp;levels are elevated in asthma subjects as measured using a new EDN research assay 994 Robert Movrare Magnus Molin Serum eosinophil derived neurotoxin (EDN)&nbsp;levels are elevated in asthma subjects as measured using a new EDN research assay 994 Cristina Jcome Adelaide Alves Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Alberto Costa Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Alicia Barra Castro Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Ana Arrobas Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Ana Mendes Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Ana Todo Bom Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Ana Margarida Pereira Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Ana Sofia moreira Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Beln De La Hoz Caballer Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Carlos Alves Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Carlos Lozoya Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Carmen Vidal Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Cludia Chaves Loureiro Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Cristina Lopes Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Dar\\xado Antol\\xadn-Amrigo Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome David Gonzalez De Olano Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Diana Bordalo Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Diana Silva Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Didina Coelho Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Fernando Menezes Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Filipa Todo Bom Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Georgeta Oliveira Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Joana Carvalho Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Joo Almeida Fonseca Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Joo Azevedo Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Joo Cardoso Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Jos Alberto Ferreira Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Jos Carlos Cidrais Rodrigues Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Lilia Maia Santos Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Lu\\xads Taborda-Barata Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Madalena Emiliano Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Margarida Valrio Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Maria Fernanda Teixeira Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Maria Joo Vasconcelos Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Maria Jos Clix Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Natacha Santos Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Nuno Neuparth Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Paula Leiria Pinto Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Paula Mndez Brea Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Ricardo Gomes Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Rita Amaral Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Rita Cmara Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Rita Gerardo Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Rodrigo Rodrigues Alves Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Rute Almeida Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Cristina Jcome Sara Lpez Freire Feasibility of a mobile app to improve inhaler adherence in real-world patients with asthma: A multicentre observational study in Portugal and Spain 431 Margarida Cortez E Castro Andreia Matos Endothelial dysfunction in asthmatics- genetic models 22 Margarida Cortez E Castro Joana Ferreira Endothelial dysfunction in asthmatics- genetic models 22 Margarida Cortez E Castro Manuel Bicho Endothelial dysfunction in asthmatics- genetic models 22 Roohi Rasool Wani Afaq Hameed Beigh Analysis of immuno modulating gene expression in Allergic asthmatics 739 Roohi Rasool Wani Qurteeba Qadiri Analysis of immuno modulating gene expression in Allergic asthmatics 739 Alina Olegovna Makeeva Darya Vladimirovna Demina Phenotypic characteristics of type 2 Innate lymphoid cells (ILC2s) in peripheral blood of patients with T2-driven bronchial asthma compared with healthy donors. 956 Alina Olegovna Makeeva Ekaterina Alexandrovna Pashkina Phenotypic characteristics of type 2 Innate lymphoid cells (ILC2s) in peripheral blood of patients with T2-driven bronchial asthma compared with healthy donors. 956 Alina Olegovna Makeeva Elena Andreevna Blinova Phenotypic characteristics of type 2 Innate lymphoid cells (ILC2s) in peripheral blood of patients with T2-driven bronchial asthma compared with healthy donors. 956 Alina Olegovna Makeeva Vladimir Alexandrovich Kozlov Phenotypic characteristics of type 2 Innate lymphoid cells (ILC2s) in peripheral blood of patients with T2-driven bronchial asthma compared with healthy donors. 956 William H Yang B Santone Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang D Ramesh Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang F Shawki Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang J Yang Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang L Haya Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang M. P. O\\x80\\x99brien Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang P Meier Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang R Mehri Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang S Kelly Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 William H Yang S Narula Reproducibility of the early asthmatic response to cat allergen in a Naturalistic Exposure Chamber:&nbsp; Methodology 986 \\x96zge Can Bostan Ali Fuat Kalyoncu Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results 421 \\x96zge Can Bostan Ebru \\x87elebioglu Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results 421 \\x96zge Can Bostan Gl Karakaya Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results 421 \\x96zge Can Bostan Mehmet Erdem \\x87akmak Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results 421 \\x96zge Can Bostan Saltuk Bugra Kaya Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results 421 Michael Gerstlauer Claudia Mailaender Prevalence of repeated systemic corticosteroid prescriptions in children and adolescents with asthma diagnosis in Germany 463 Michael Gerstlauer Inessa Schwab Sauerbeck Prevalence of repeated systemic corticosteroid prescriptions in children and adolescents with asthma diagnosis in Germany 463 Roxana silvia Bumbacea Carmen Panaitescu Short-acting beta<sub>2</sub>-agonists (SABA) usage patterns from asthma control level perspective. Results from an asthma patients survey 1403 Roxana silvia Bumbacea Dragos Bumbacea Short-acting beta<sub>2</sub>-agonists (SABA) usage patterns from asthma control level perspective. Results from an asthma patients survey 1403 Oliver J Price Emil S Walsted Physical in-activity: Lacking inspiration to exercise?&nbsp; 1530 ROBERT BABELA Milos Jesenak Total costs associated with asthma: Analysis of direct and indirect costs in single EU jurisdiction 129 ROBERT BABELA Robert Mamrilla Total costs associated with asthma: Analysis of direct and indirect costs in single EU jurisdiction 129 ROBERT BABELA Vladimir Uraz Total costs associated with asthma: Analysis of direct and indirect costs in single EU jurisdiction 129 ROBERT BABELA Zuzana Rennerova Total costs associated with asthma: Analysis of direct and indirect costs in single EU jurisdiction 129 Nataliia Slepchenko Andrii Sidorov Budesonide/formoterol efficacy&nbsp; in &ldquo;obese&rdquo; asthma 730 Nataliia Slepchenko Kostiantyn Dmytriiev Budesonide/formoterol efficacy&nbsp; in &ldquo;obese&rdquo; asthma 730 Nataliia Slepchenko Nataliia Tsymbaliuk Budesonide/formoterol efficacy&nbsp; in &ldquo;obese&rdquo; asthma 730 Nataliia Slepchenko Yuriy Mostovoy Budesonide/formoterol efficacy&nbsp; in &ldquo;obese&rdquo; asthma 730 Maria De filippo Amelia Licari Biomarkers in childhood allergic asthma 1259 Maria De filippo Gianluigi Marseglia Biomarkers in childhood allergic asthma 1259 Maria De filippo Giorgio Ciprandi Biomarkers in childhood allergic asthma 1259 Maria De filippo Ilaria Brambilla Biomarkers in childhood allergic asthma 1259 Maria De filippo Lucia Sacchi Biomarkers in childhood allergic asthma 1259 Paula Galvn Blasco David Ramos Clinical and inflammatory phenotypic profile of the moderate and severe persistent asthma in a tertiary hospital of Barcelona 1487 Paula Galvn Blasco Eder Fredy Mateus-Medina Clinical and inflammatory phenotypic profile of the moderate and severe persistent asthma in a tertiary hospital of Barcelona 1487 Paula Galvn Blasco Lorena Soto-Retes Clinical and inflammatory phenotypic profile of the moderate and severe persistent asthma in a tertiary hospital of Barcelona 1487 Paula Galvn Blasco Vicente Plaza Clinical and inflammatory phenotypic profile of the moderate and severe persistent asthma in a tertiary hospital of Barcelona 1487 Shu-Bin Fang Hong-Yu Zhang Anion exchange chromatographic isolation of small extracellular vesicles derived from iPSC-MSC ameliorated allergic asthma in mice 122 Shu-Bin Fang Qing-Ling Fu Anion exchange chromatographic isolation of small extracellular vesicles derived from iPSC-MSC ameliorated allergic asthma in mice 122 Marina V. Smolnikova Nina Gorbacheva Polymorphism of IL13, IL31 and IL33 genes in the pathogenesis of moderate-to-severe asthma in Siberian children 264 Marina V. Smolnikova Olga Konopleva Polymorphism of IL13, IL31 and IL33 genes in the pathogenesis of moderate-to-severe asthma in Siberian children 264 Marina V. Smolnikova Sergey Tereshchenko Polymorphism of IL13, IL31 and IL33 genes in the pathogenesis of moderate-to-severe asthma in Siberian children 264 Elena Blinova Anna E. Makarova Expression of PD-1 and activation markers on T-cells in patients with asthma 391 Elena Blinova Ekaterina A. Pashkina Expression of PD-1 and activation markers on T-cells in patients with asthma 391 Elena Blinova Vladimir Alexandrovich Kozlov Expression of PD-1 and activation markers on T-cells in patients with asthma 391 David Gonzlez De Olano Alejandro Lpez-Neyra Quantifying patients referred to a severe uncontrolled asthma unit with a final diagnosis of true severe uncontrolled asthma 1510 David Gonzlez De Olano Carlos Almonacid-Snchez Quantifying patients referred to a severe uncontrolled asthma unit with a final diagnosis of true severe uncontrolled asthma 1510 David Gonzlez De Olano Carmen Rodr\\xadguez-Calle Quantifying patients referred to a severe uncontrolled asthma unit with a final diagnosis of true severe uncontrolled asthma 1510 David Gonzlez De Olano Diana Paulina Chiluiza-Reyes Quantifying patients referred to a severe uncontrolled asthma unit with a final diagnosis of true severe uncontrolled asthma 1510 David Gonzlez De Olano Diurbis Velasco-Alvarez Quantifying patients referred to a severe uncontrolled asthma unit with a final diagnosis of true severe uncontrolled asthma 1510 stefania colantuono Antonella Pentassuglia Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 stefania colantuono Antonio Gasbarrini Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 stefania colantuono Antonio Romano Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 stefania colantuono Barbara Tolusso Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 stefania colantuono Clara Di Mario Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 stefania colantuono Cristiano Caruso Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 stefania colantuono Elisa Gremese Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 stefania colantuono Gabriele Rumi Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs 1254 Hwa Young Lee Ji Young Kang Clinical characteristics of overweight asthma patients in systemic inflammation and airflow obstruction 14 Hwa Young Lee Sook Young Lee Clinical characteristics of overweight asthma patients in systemic inflammation and airflow obstruction 14 Hwa Young Lee Young Kyoon Kim Clinical characteristics of overweight asthma patients in systemic inflammation and airflow obstruction 14 Zuqin Yang Julia Koelle The role of interleukin-10 in asthma 384 Zuqin Yang Nina Li The role of interleukin-10 in asthma 384 Zuqin Yang Ralf Joachim Rieker The role of interleukin-10 in asthma 384 Zuqin Yang Susetta Finotto The role of interleukin-10 in asthma 384 Yeong Ho Rha Hey Sung Baik The role of small airway on persistent bronchial hyper-reactivity in school children with asthma 542 Yeong Ho Rha Man Young Han The role of small airway on persistent bronchial hyper-reactivity in school children with asthma 542 Yeong Ho Rha Sun Hee Choi The role of small airway on persistent bronchial hyper-reactivity in school children with asthma 542 Yeong Ho Rha Young Ho Sheen The role of small airway on persistent bronchial hyper-reactivity in school children with asthma 542 Kyung Soo Hong Jung Eun Park Predictors and characteristics of exercise-induced asthma in young adult 823 Ella Vitalievna Churyukina Maria Vasilievna Dudareva Immunological markers of the phenotype of bronchial asthma with obesity 424 Galyna Vladymirovna Yeryomenko Oksana Mykolaivna Khokhuda Metabolic disturbances in patients with asthma 599 Galyna Vladymirovna Yeryomenko Tetyana Vasylivna Bezditko Metabolic disturbances in patients with asthma 599 Hasibe Artac Arzu Ay The association between asthma and atopy with central obesity in children 140 Hasibe Artac Ayca Emsen The association between asthma and atopy with central obesity in children 140 Hasibe Artac Hulya Ucaryilmaz The association between asthma and atopy with central obesity in children 140 Marilyn Urrutia Pereira Dirceu Sol Factors associated with asthma in parents of uruguaiana&rsquo;s teenagers: Global asthma network (GAN) 309 Marilyn Urrutia Pereira Herberto Chong Neto Factors associated with asthma in parents of uruguaiana&rsquo;s teenagers: Global asthma network (GAN) 309 Marilyn Urrutia Pereira Laura Simon Factors associated with asthma in parents of uruguaiana&rsquo;s teenagers: Global asthma network (GAN) 309 Marilyn Urrutia Pereira Luis Garc\\xada-Marcos Factors associated with asthma in parents of uruguaiana&rsquo;s teenagers: Global asthma network (GAN) 309 Marilyn Urrutia Pereira Philippa Ellwood Factors associated with asthma in parents of uruguaiana&rsquo;s teenagers: Global asthma network (GAN) 309 Marilyn Urrutia Pereira Pietro Nunes Rinelli Factors associated with asthma in parents of uruguaiana&rsquo;s teenagers: Global asthma network (GAN) 309 Sergey Sergeevich Masalskiy Angelina Stanislavovna Kalmykova The heterogeneity of the causal allergens of asthma in children  579 Sergey Sergeevich Masalskiy Olga Petrovna Uhanova The heterogeneity of the causal allergens of asthma in children  579 Sergey Sergeevich Masalskiy Yuriy Solomonovich Smolkin The heterogeneity of the causal allergens of asthma in children  579 Selime Ozen Canan Sule Karkiner Viral etiology of acute asthma exacerbation 645 Selime Ozen Demet Can Viral etiology of acute asthma exacerbation 645 Selime Ozen Esra Toprak Kanik Viral etiology of acute asthma exacerbation 645 Selime Ozen Idil Akay Haci Viral etiology of acute asthma exacerbation 645 Selime Ozen Ilke Taskirdi Viral etiology of acute asthma exacerbation 645 Selime Ozen Mehmet Sirin Kaya Viral etiology of acute asthma exacerbation 645 Selime Ozen Omer Akcal Viral etiology of acute asthma exacerbation 645 Kostiantyn Dmytriiev Nataliia Slepchenko &ldquo;Smoking&rdquo; asthma and non-smoking asthma: What is difference? 731 Kostiantyn Dmytriiev Nataliia Tsymbaliuk &ldquo;Smoking&rdquo; asthma and non-smoking asthma: What is difference? 731 Kostiantyn Dmytriiev Sidorov Andrii &ldquo;Smoking&rdquo; asthma and non-smoking asthma: What is difference? 731 Kostiantyn Dmytriiev Yuriy Mostovoy &ldquo;Smoking&rdquo; asthma and non-smoking asthma: What is difference? 731 elena tagliabue Diego Bagnasco Severe asthma: One disease many definitions 1030 elena tagliabue Enrico Heffler Severe asthma: One disease many definitions 1030 elena tagliabue Francesco Blasi Severe asthma: One disease many definitions 1030 elena tagliabue Francesco Menzella Severe asthma: One disease many definitions 1030 elena tagliabue Giorgio Walter Canonica Severe asthma: One disease many definitions 1030 elena tagliabue Giovanni Passalacqua Severe asthma: One disease many definitions 1030 elena tagliabue Marco Caminati Severe asthma: One disease many definitions 1030 elena tagliabue Pierluigi Paggiaro Severe asthma: One disease many definitions 1030 Aikaterini Brinia Aliki Korkontzelou Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Georgios Boulbasakos Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Ioannis Kalomenidis Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Marios Ioannou Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Nikolaos Athanasiou Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Nikolaos Vichos Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Paraskevi Katsaounou Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Sofia Pappa Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Sophia Gida Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Sotirios Kakavas Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Timoleon Giannakas Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Vasileios Giannakoulis Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Vasiliki Saltagianni Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Aikaterini Brinia Zafeiria Barmparessou Characteristics of patients admitted with asthma attacks in the emergency department of a University Hospital 1523 Hui-Fang Kao Hsiu-Ying Tseng Study of early-life enterovirus infection in the development of eczema, allergic rhinitis, and asthma in childhood 838 Hui-Fang Kao Hui-Ju Tsai Study of early-life enterovirus infection in the development of eczema, allergic rhinitis, and asthma in childhood 838 Hui-Fang Kao Jiu-Yao Wang Study of early-life enterovirus infection in the development of eczema, allergic rhinitis, and asthma in childhood 838 Mria Zelieskov Dagmar Trubacova Potential diagnostic value of serum periostin as a biomarker in pediatric bronchial asthma 1171 Mria Zelieskov Milos Jesenak Potential diagnostic value of serum periostin as a biomarker in pediatric bronchial asthma 1171 Mria Zelieskov Peter Banovcin Potential diagnostic value of serum periostin as a biomarker in pediatric bronchial asthma 1171 Mria Zelieskov Peter Durdik Potential diagnostic value of serum periostin as a biomarker in pediatric bronchial asthma 1171 Marina V. Smolnikova Eduard Kasparov IL-4, IL-5, IL-13, and TNF-&alpha; plasma levels in moderate-to-severe asthmatic children with different asthma control: A magnetic multiplex assay 363 Marina V. Smolnikova Sergey Tereshchenko IL-4, IL-5, IL-13, and TNF-&alpha; plasma levels in moderate-to-severe asthmatic children with different asthma control: A magnetic multiplex assay 363 Marina V. Smolnikova Svetlana Zobova IL-4, IL-5, IL-13, and TNF-&alpha; plasma levels in moderate-to-severe asthmatic children with different asthma control: A magnetic multiplex assay 363 Mohamed Abuzakouk Omar Ghorab Are GINA guidelines used correctly by clinicians to assess asthma severity? 552 Mohamed Abuzakouk Sonya Jacob Are GINA guidelines used correctly by clinicians to assess asthma severity? 552 Elena Vishneva Anna Alekseeva The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Elena Vishneva Elena Dobrynina The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Elena Vishneva Julia Levina The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Elena Vishneva Kamilla Efendieva The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Elena Vishneva Leyla Namazova-Baranova The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Elena Vishneva Lilia Selimzianova The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Elena Vishneva Polina Arimova The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Elena Vishneva Vera Kalugina The assessment of therapy with omalizumab in children and adults with severe asthma according to the patient registry 581 Dominika Ambrozej Gunilla Hedlin Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Heidi Makrinioti Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Jon R Konradsen Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Jrgen Schwarze Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Marek Ruszczynski Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Nikolaos Papadopoulos Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Tuomas Jartti Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Varpu Elenius Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Dominika Ambrozej Wojciech Feleszko Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses 965 Marufjon Salokhiddinov Elisabeth Stamou Efficiency of therapeutic and preventive measures in patients with bronchial asthma against the background metabolic syndrome  65 Marufjon Salokhiddinov Faxriddin Umarov Efficiency of therapeutic and preventive measures in patients with bronchial asthma against the background metabolic syndrome  65 Grazielly De Ftima Pereira Allyne Moura F E Sousa Arajo Inhaled corticosteroid use and its implication in peripheral eosinophil level 596 Grazielly De Ftima Pereira Iandra Leite Perez Inhaled corticosteroid use and its implication in peripheral eosinophil level 596 Grazielly De Ftima Pereira La\\xads Souza Gomes Inhaled corticosteroid use and its implication in peripheral eosinophil level 596 Grazielly De Ftima Pereira Larissa De Queiroz Mamede Inhaled corticosteroid use and its implication in peripheral eosinophil level 596 Grazielly De Ftima Pereira Pedro Giavina Bianchi Inhaled corticosteroid use and its implication in peripheral eosinophil level 596 Grazielly De Ftima Pereira Priscila De Abreu Franco Inhaled corticosteroid use and its implication in peripheral eosinophil level 596 Grazielly De Ftima Pereira Rosana Cmara Agondi Inhaled corticosteroid use and its implication in peripheral eosinophil level 596 Marina Bantul\\xa0 Fonts Antonio Valero Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Marina Bantul\\xa0 Fonts Csar Picado Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Marina Bantul\\xa0 Fonts Ebymar Arismendi Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Marina Bantul\\xa0 Fonts Irina Bobolea Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Marina Bantul\\xa0 Fonts Joan Bartra Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Marina Bantul\\xa0 Fonts Joaquim Mullol Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Marina Bantul\\xa0 Fonts Jordi Roca Ferrer Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Marina Bantul\\xa0 Fonts Valeria Tubita Vitamin D effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery 1087 Carole  Ederle Alain Meyer Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Carole  Ederle Anh Poirot Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Carole  Ederle Anne-Laure Charles Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Carole  Ederle Bernard Geny Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Carole  Ederle Emmanuel Andres Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Carole  Ederle Frdric De Blay Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Carole  Ederle Naji Khayath Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Carole  Ederle Raphal Clere-Jehl Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation 36 Lucas Morel Jacques Zimmer Effects of the neurotrophic factor Neurturin on epithelial barrier disruption in the context of asthma 916 Lucas Morel Olivia Domingues Effects of the neurotrophic factor Neurturin on epithelial barrier disruption in the context of asthma 916 Lucas Morel Tatiana Michel Effects of the neurotrophic factor Neurturin on epithelial barrier disruption in the context of asthma 916 Li Li Yue Binlin Chen Tetrahydrocurcumin ameliorates allergic airway inflammation by attenuating Th2 responses and Th2 signaling pathways in asthmatic mice 126 Li Li Yue Chunwei Li Tetrahydrocurcumin ameliorates allergic airway inflammation by attenuating Th2 responses and Th2 signaling pathways in asthmatic mice 126 Li Li Yue Xiaoyan Ye Tetrahydrocurcumin ameliorates allergic airway inflammation by attenuating Th2 responses and Th2 signaling pathways in asthmatic mice 126 Li Li Yue Yan Yang Tetrahydrocurcumin ameliorates allergic airway inflammation by attenuating Th2 responses and Th2 signaling pathways in asthmatic mice 126 Mariya Yurevna Smirnova-Saprytskaya1 Galina Alexekseevna Danilina Microbiological features of the indicators of bronchial asthma BA) and chronic obstructive pulmonary disease (COPD) during remissio 29 Mariya Yurevna Smirnova-Saprytskaya1 Galina Leonidovna Osipova Microbiological features of the indicators of bronchial asthma BA) and chronic obstructive pulmonary disease (COPD) during remissio 29 Mariya Yurevna Smirnova-Saprytskaya1 Kirill Alekseevich Zycov Microbiological features of the indicators of bronchial asthma BA) and chronic obstructive pulmonary disease (COPD) during remissio 29 Mariya Yurevna Smirnova-Saprytskaya1 Tatyana Petrovna Ospelnikova Microbiological features of the indicators of bronchial asthma BA) and chronic obstructive pulmonary disease (COPD) during remissio 29 Marilyn Urrutia Pereira Dirceu Sol Factors associated with asthma in Uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 307 Marilyn Urrutia Pereira Herberto Chong Neto Factors associated with asthma in Uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 307 Marilyn Urrutia Pereira Laura Simon Factors associated with asthma in Uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 307 Marilyn Urrutia Pereira Luis Garc\\xada-Marcos Factors associated with asthma in Uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 307 Marilyn Urrutia Pereira Phillipa Ellwood Factors associated with asthma in Uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 307 Marilyn Urrutia Pereira Pietro Nunes Rinelli Factors associated with asthma in Uruguaiana&rsquo;s adolescents: Global asthma network (GAN) 307 Irina Vladimirovna Demko Angelina Kraposhina Features of the immune status in various phenotypes of severe bronchial asthma 915 Irina Vladimirovna Demko Elena Sobko Features of the immune status in various phenotypes of severe bronchial asthma 915 Irina Vladimirovna Demko Irina Soloveva Features of the immune status in various phenotypes of severe bronchial asthma 915 Irina Vladimirovna Demko Marina Mamaeva Features of the immune status in various phenotypes of severe bronchial asthma 915 Irina Vladimirovna Demko Natalia Gordeeva Features of the immune status in various phenotypes of severe bronchial asthma 915 Viiu Blndal Andrei Malinovschi Atopic multimorbidity in asthma, association to allergy, inflammatory markers and other factors, results from the Swedish GA<sup>2</sup>LEN study<br /> 1026 Viiu Blndal Christer Janson Atopic multimorbidity in asthma, association to allergy, inflammatory markers and other factors, results from the Swedish GA<sup>2</sup>LEN study<br /> 1026 Viiu Blndal Fredrik Sundbom Atopic multimorbidity in asthma, association to allergy, inflammatory markers and other factors, results from the Swedish GA<sup>2</sup>LEN study<br /> 1026 Daniel Bialowas Francine Albino Zanetti Correlation between total serum IgE levels and sensibilization to aeroallergens 1292 Daniel Bialowas Jorge Kalil Correlation between total serum IgE levels and sensibilization to aeroallergens 1292 Daniel Bialowas Mariana Albertinazzi De Souza Pachani Correlation between total serum IgE levels and sensibilization to aeroallergens 1292 Daniel Bialowas Pedro Francisco Giavina-Bianchi Junior Correlation between total serum IgE levels and sensibilization to aeroallergens 1292 Daniel Bialowas Rosana Camara Agondi Correlation between total serum IgE levels and sensibilization to aeroallergens 1292 Christophe Pierre Marcot Frederic De Blay Retrospective analysis of the phenotypes of asthmatics patients followed in the Strasbourg Hospital and based on the sputum analysis 1313 Christophe Pierre Marcot Naji Khayath Retrospective analysis of the phenotypes of asthmatics patients followed in the Strasbourg Hospital and based on the sputum analysis 1313 Revaz Sepiashvili Darejan Khachapuridze Influenza seasonal vaccination decreased asthma and heart failure hospitalization rate in Georgia  1025 Revaz Sepiashvili Elene Khurtsidze Influenza seasonal vaccination decreased asthma and heart failure hospitalization rate in Georgia  1025 Revaz Sepiashvili Manana Chikhladze Influenza seasonal vaccination decreased asthma and heart failure hospitalization rate in Georgia  1025 Yousser Mohammad  Asthma and the war 808 Ins Sangalho Paula Leiria Pinto Differences on the perception of asthma control on a paediatric population 1465 Ins Sangalho Susana Palma-Carlos Differences on the perception of asthma control on a paediatric population 1465 \\x8eRCA SIMONA Mihaltan Florin Dumitru Mihaltan A clinical study of the relationship between anxiety and pulmonary function in patients with allergic asthma. Long term patient compliance 1366 Georgia Papapostolou Alf Tunster Nordic patient perspective on living with severe asthma 608 Georgia Papapostolou Gunilla Telg Nordic patient perspective on living with severe asthma 608 Georgia Papapostolou Jonas Binnmyr Nordic patient perspective on living with severe asthma 608 Georgia Papapostolou Klaus Roslind Nordic patient perspective on living with severe asthma 608 Oda Cecilie Ldrup Carlsen Anne Cathrine Staff Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Berit Granum Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Bjrn Nordlund Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Cecilie Svanes Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Christine M. Jonassen Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Cilla Sderhll Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Eva Maria Rehbinder Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Gunilla Hedlin Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Guttorm Haugen Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Hvard O. Skjerven Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Hrefna K Gudmundsdttir Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Kai-Hkon Carlsen Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Karin C. L. Carlsen Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Katrine Sjborg Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Linn Landr Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Randi Bertelsen Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Oda Cecilie Ldrup Carlsen Riyas Vettukattil Physical activity in pregnancy and association to allergic diseases; a Norwegian-Swedish mother-child birth cohort study 515 Caroline Reilly Antonios Stavropoulos-Kalinoglou Evaluating the validity of a smartphone step-counter in adults with asthma: A proof-of-concept study 1514 Caroline Reilly Ian J. Clifton Evaluating the validity of a smartphone step-counter in adults with asthma: A proof-of-concept study 1514 Caroline Reilly Oliver J. Price Evaluating the validity of a smartphone step-counter in adults with asthma: A proof-of-concept study 1514 Dermot Ryan Ben Noble Exploiting the EMR as a tool to facilitate asthma reviews. 227 Mariana Lobato Ana Brito Comparing two different hand-held FeNO analysers 845 Mariana Lobato Nuno Neuparth Comparing two different hand-held FeNO analysers 845 Mariana Lobato Paula Leiria Pinto Comparing two different hand-held FeNO analysers 845 Mariana Lobato Pedro Carreiro-Martins Comparing two different hand-held FeNO analysers 845 Mariana Lobato Sandra Santos Comparing two different hand-held FeNO analysers 845 Mariana Lobato Sara Serranho Comparing two different hand-held FeNO analysers 845 DZMITRY Y. RUZANAU Elena I. Davidovskaya Comparative efficacy of antileukotrienes and corticosteroids for the treatment of patients with comorbid uncontrolled asthma and allergic rhinitis  255 DZMITRY Y. RUZANAU Irina V. Buynevich Comparative efficacy of antileukotrienes and corticosteroids for the treatment of patients with comorbid uncontrolled asthma and allergic rhinitis  255 DZMITRY Y. RUZANAU Ludmila S. Bogush Comparative efficacy of antileukotrienes and corticosteroids for the treatment of patients with comorbid uncontrolled asthma and allergic rhinitis  255 DZMITRY Y. RUZANAU Oskar M. Gecht Comparative efficacy of antileukotrienes and corticosteroids for the treatment of patients with comorbid uncontrolled asthma and allergic rhinitis  255 DZMITRY Y. RUZANAU Tatyana T. Shebusheva Comparative efficacy of antileukotrienes and corticosteroids for the treatment of patients with comorbid uncontrolled asthma and allergic rhinitis  255 DZMITRY Y. RUZANAU Tatyana V. Baranovskaya Comparative efficacy of antileukotrienes and corticosteroids for the treatment of patients with comorbid uncontrolled asthma and allergic rhinitis  255 DZMITRY Y. RUZANAU Zinaida V. Lavor Comparative efficacy of antileukotrienes and corticosteroids for the treatment of patients with comorbid uncontrolled asthma and allergic rhinitis  255 Marina Peredelskaya Galina Sakharova Improvement in diagnosis of bronchial asthma in the russian federation in regard to the introduction of the next-generation clinical recommendations 316 Marina Peredelskaya Igor Demidov Improvement in diagnosis of bronchial asthma in the russian federation in regard to the introduction of the next-generation clinical recommendations 316 Marina Peredelskaya Natalia Nenasheva Improvement in diagnosis of bronchial asthma in the russian federation in regard to the introduction of the next-generation clinical recommendations 316 Marina Peredelskaya Nicolay Antonov Improvement in diagnosis of bronchial asthma in the russian federation in regard to the introduction of the next-generation clinical recommendations 316 Luc\\xada Cremades-Jimeno Blanca Crdaba Macrophage scavenger receptor 1 (MSR1) as a biomarker of different respiratory diseases 1042 Luc\\xada Cremades-Jimeno Germn Peces-Barba Macrophage scavenger receptor 1 (MSR1) as a biomarker of different respiratory diseases 1042 Luc\\xada Cremades-Jimeno Joaqu\\xadn Sastre Macrophage scavenger receptor 1 (MSR1) as a biomarker of different respiratory diseases 1042 Luc\\xada Cremades-Jimeno Maria \\x81ngeles De Pedro Macrophage scavenger receptor 1 (MSR1) as a biomarker of different respiratory diseases 1042 Luc\\xada Cremades-Jimeno Nicols Gonzlez-Mangado Macrophage scavenger receptor 1 (MSR1) as a biomarker of different respiratory diseases 1042 Luc\\xada Cremades-Jimeno Selene Baos Macrophage scavenger receptor 1 (MSR1) as a biomarker of different respiratory diseases 1042 Maria De filippo Amelia Licari Anxiety and depression in adolescents with severe asthma and in their caregivers 1462 Maria De filippo Gianluigi Marseglia Anxiety and depression in adolescents with severe asthma and in their caregivers 1462 Maria De filippo Giorgio Ciprandi Anxiety and depression in adolescents with severe asthma and in their caregivers 1462 Maria De filippo Martina Votto Anxiety and depression in adolescents with severe asthma and in their caregivers 1462 Maria De filippo Riccardo Ciprandi Anxiety and depression in adolescents with severe asthma and in their caregivers 1462 Hongmei Zhang Aniruddha Rathod Interweaving between genetic and epigenetic studies on asthma 268 Hongmei Zhang Hasan Arshad Interweaving between genetic and epigenetic studies on asthma 268 Hongmei Zhang Jiasong Duan Interweaving between genetic and epigenetic studies on asthma 268 Hongmei Zhang John W Holloway Interweaving between genetic and epigenetic studies on asthma 268 Hongmei Zhang Susan Ewart Interweaving between genetic and epigenetic studies on asthma 268 Hongmei Zhang Wilfried Karmaus Interweaving between genetic and epigenetic studies on asthma 268 Naofumi Suzuki Kana Hamada Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Kazutaka Nogami Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Keigo Kainuma Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Mayumi Matsunaga Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Miyuki Hoshi Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Mizuho Nagao Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Shingo Yamada Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Taiga Kobori Lung function trajectory of childhood and early adulthood asthma patients 359 Naofumi Suzuki Takao Fujisawa Lung function trajectory of childhood and early adulthood asthma patients 359 Norma  Susana De Barayazarra Andrea Zanacchi Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Norma  Susana De Barayazarra Claudia Sotomayor Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Norma  Susana De Barayazarra Juan Carlos Muio Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Norma  Susana De Barayazarra Mailen Mores Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Norma  Susana De Barayazarra Marcela Sabagh Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Norma  Susana De Barayazarra Romina Defanti Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Norma  Susana De Barayazarra Silvana Corelli Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Norma  Susana De Barayazarra Valeria Pedano Serum levels of interleukin 33 /sST2 in the inflammatory response in asthmatic patients 128 Ruperto Gonzlez-Prez Cristina Alava-Cruz House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Elena Mederos-Lu\\xads House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Fernando Pineda House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Inmaculada Snchez-Mach\\xadn House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Martina Aumayr House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Miriam Castillo House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Paloma Poza-Guedes House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Peter Forstenlechner House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Ruperto Gonzlez-Prez Victor Matheu House dust mite molecular profile in children with moderate-severe persistent asthma phenotype 499 Evgeny Beltyukov Tatyana Lepeshkova Prevalence of severe bronchial asthma phenotypes in the middle urals 195 Evgeny Beltyukov Veronika Naumova Prevalence of severe bronchial asthma phenotypes in the middle urals 195 Evgeny Beltyukov Vugar Abdullaev Prevalence of severe bronchial asthma phenotypes in the middle urals 195 PRITI MONDAL Sanjoy Podder Role of IL-18 -656(G/T) and -607(C/A) polymorphisms in aeroallergy in the atopic population of West Bengal, India 370 Ken Qin Gu  Asthma prevalence and its related factors in macao adult 220 Ramona Elena Nedelcu Florin Dumitru Mihaltan Clinical outcomes of awareness campaigns on the world asthma day 1358 Ramona Elena Nedelcu Roxana Maria Nemes Clinical outcomes of awareness campaigns on the world asthma day 1358 Ramona Elena Nedelcu Ruxandra Ulmeanu Clinical outcomes of awareness campaigns on the world asthma day 1358 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Basic and clinical immunology',\n",
       "  'session': 'TPS 06 Basic and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921298,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 06 Basic and clinical immunology Irina Vadimovna Nesterova Galina A. Chudilova Recombinant interferon alfa-2b in vitro corrects the altered phenotype of ?D64+CD16+CD32+CD11b+ and ?D64-CD16+CD32+CD11b+ subsets neutrophilic granulocytes of children with small purulent infection 92 Irina Vadimovna Nesterova Svetlana V. Kovaleva Recombinant interferon alfa-2b in vitro corrects the altered phenotype of ?D64+CD16+CD32+CD11b+ and ?D64-CD16+CD32+CD11b+ subsets neutrophilic granulocytes of children with small purulent infection 92 Irina Vadimovna Nesterova Tatiana V. Rusinova Recombinant interferon alfa-2b in vitro corrects the altered phenotype of ?D64+CD16+CD32+CD11b+ and ?D64-CD16+CD32+CD11b+ subsets neutrophilic granulocytes of children with small purulent infection 92 Irina Vadimovna Nesterova Valentina V. Malinovskaya Recombinant interferon alfa-2b in vitro corrects the altered phenotype of ?D64+CD16+CD32+CD11b+ and ?D64-CD16+CD32+CD11b+ subsets neutrophilic granulocytes of children with small purulent infection 92 Irina Vadimovna Nesterova Victor A Tarakanov Recombinant interferon alfa-2b in vitro corrects the altered phenotype of ?D64+CD16+CD32+CD11b+ and ?D64-CD16+CD32+CD11b+ subsets neutrophilic granulocytes of children with small purulent infection 92 Maja Stojanovic Aleksandra Peric-Popadic Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Maja Stojanovic Dragana Jovanovic Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Maja Stojanovic Ivan Rankovic Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Maja Stojanovic Rada Miskovic Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Maja Stojanovic Sanja Stankovic Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Maja Stojanovic Sanvila Raskovic Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Maja Stojanovic Vesna Tomic-Spiric Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Maja Stojanovic Vladimir Milivojevic Elevated Enhanced Liver Fibrosis (ELF) score in patients with takayasu arteritis and its relationship with some clinical characteristics 913 Irina Vadimovna Nesterova Alexandr N Shuvalov Experimental reprogramming in vitro of negatively transformed phenotype of four neutrophilic granulocytes functionally significant subsets in children with purulent bacterial infection 93 Irina Vadimovna Nesterova Galina A. Chudilova Experimental reprogramming in vitro of negatively transformed phenotype of four neutrophilic granulocytes functionally significant subsets in children with purulent bacterial infection 93 Irina Vadimovna Nesterova Natusia K. Barova Experimental reprogramming in vitro of negatively transformed phenotype of four neutrophilic granulocytes functionally significant subsets in children with purulent bacterial infection 93 Irina Vadimovna Nesterova Tatiana V. Rusinova Experimental reprogramming in vitro of negatively transformed phenotype of four neutrophilic granulocytes functionally significant subsets in children with purulent bacterial infection 93 Irina Vadimovna Nesterova Valeria N. Pavlenko Experimental reprogramming in vitro of negatively transformed phenotype of four neutrophilic granulocytes functionally significant subsets in children with purulent bacterial infection 93 Irina Vadimovna Nesterova Victor A. Tarakanov Experimental reprogramming in vitro of negatively transformed phenotype of four neutrophilic granulocytes functionally significant subsets in children with purulent bacterial infection 93 Sara Sebnem Kilic Sukru Cekic Evaluation of a patient with IKAROS gene deficiency 1370 Halyna Koval Aleksandr Eremenko Expression of TLR2 and TLR4 in myocardial tissue in patients with dilated cardiomyopathy 641 Halyna Koval Aleksandr Kamyshnyi Expression of TLR2 and TLR4 in myocardial tissue in patients with dilated cardiomyopathy 641 Halyna Koval Lawrence Dubuske Expression of TLR2 and TLR4 in myocardial tissue in patients with dilated cardiomyopathy 641 Halyna Koval Lubov Rizun Expression of TLR2 and TLR4 in myocardial tissue in patients with dilated cardiomyopathy 641 Halyna Koval Rostyslav Koval Expression of TLR2 and TLR4 in myocardial tissue in patients with dilated cardiomyopathy 641 Mounira Benidir Adila Hamdi Immunological diagnosis of cholangitis Biliary Primitive: Comparison of two anti-mitochondrial antibody assay tests 1327 Mounira Benidir Djenette Hakem Immunological diagnosis of cholangitis Biliary Primitive: Comparison of two anti-mitochondrial antibody assay tests 1327 Mounira Benidir Nabila Attal Immunological diagnosis of cholangitis Biliary Primitive: Comparison of two anti-mitochondrial antibody assay tests 1327 Mounira Benidir Saadi Berkane Immunological diagnosis of cholangitis Biliary Primitive: Comparison of two anti-mitochondrial antibody assay tests 1327 Mounira Benidir Samira Kebbab Immunological diagnosis of cholangitis Biliary Primitive: Comparison of two anti-mitochondrial antibody assay tests 1327 Mounira Benidir Sofiane Samir Salah Immunological diagnosis of cholangitis Biliary Primitive: Comparison of two anti-mitochondrial antibody assay tests 1327 Saurabh Bhargava  Solid lipid nanoparticles for effective management of psoriasis 91 Maysoun Al Rushood Amal Al-Eisa Interleukin-13 gene polymorphisms in idiopathic nephrotic syndrome in Kuwaiti arab children 278 Maysoun Al Rushood Mohammad Haider Interleukin-13 gene polymorphisms in idiopathic nephrotic syndrome in Kuwaiti arab children 278 Natalia Sergeevna  Zaitseva Dmitryi Petrovich Osipov The efficiency of physical rehabilitation in combatants with secondary immune dysfunction syndrome 1159 Natalia Sergeevna  Zaitseva Ludmila Petrovna Syziakina The efficiency of physical rehabilitation in combatants with secondary immune dysfunction syndrome 1159 Hui Zhang Chuanping Si Atractylenolide I ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via inhibiting inflammation and oxidative stress 685 Hui Zhang Guanjun Dong Atractylenolide I ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via inhibiting inflammation and oxidative stress 685 Hui Zhang Haiyan Wang Atractylenolide I ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via inhibiting inflammation and oxidative stress 685 Hui Zhang Huabao Xiong Atractylenolide I ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via inhibiting inflammation and oxidative stress 685 Svetlana Guryanova Ivan Kozlov Regulation by muramyl peptide GMDPA effector functions of NK cells from peripheral blood of healthy donors 1566 Svetlana Guryanova Olga Yurievna Borisova Regulation by muramyl peptide GMDPA effector functions of NK cells from peripheral blood of healthy donors 1566 Svetlana Guryanova Tatyana Andronova Regulation by muramyl peptide GMDPA effector functions of NK cells from peripheral blood of healthy donors 1566 Anastasiia Kolerova Elena Blinova The effect of IL-7 receptor blockade on the production of interleukin-4 and interferon-gamma by central and effector CD4 (+) memory cells under normal and inflammatory conditions in vitro 478 Anastasiia Kolerova Vladimir Balyasnikov The effect of IL-7 receptor blockade on the production of interleukin-4 and interferon-gamma by central and effector CD4 (+) memory cells under normal and inflammatory conditions in vitro 478 Anastasiia Kolerova Vladimir Kozlov The effect of IL-7 receptor blockade on the production of interleukin-4 and interferon-gamma by central and effector CD4 (+) memory cells under normal and inflammatory conditions in vitro 478 Natalia Aliakhnovich Alena Matsko Dose-dependent influence of titanium dioxide on the blood leukocytes phenotype 1387 Natalia Aliakhnovich Dmitriy Novicau Dose-dependent influence of titanium dioxide on the blood leukocytes phenotype 1387 Natalia Aliakhnovich Vladimir Janchanka Dose-dependent influence of titanium dioxide on the blood leukocytes phenotype 1387 Mounira Benidir Habiba Amroun Involvement of VEGF Polymorphisms in genetic susceptibility to develop rheumatoid arthritis among Algerian patients 1297 Mounira Benidir Hachemi Djoudi Involvement of VEGF Polymorphisms in genetic susceptibility to develop rheumatoid arthritis among Algerian patients 1297 Mounira Benidir Malik Djennane Involvement of VEGF Polymorphisms in genetic susceptibility to develop rheumatoid arthritis among Algerian patients 1297 Mounira Benidir Nabila Attal Involvement of VEGF Polymorphisms in genetic susceptibility to develop rheumatoid arthritis among Algerian patients 1297 Mounira Benidir Ryad Tamouza Involvement of VEGF Polymorphisms in genetic susceptibility to develop rheumatoid arthritis among Algerian patients 1297 Mounira Benidir Sofiane Samir Salah Involvement of VEGF Polymorphisms in genetic susceptibility to develop rheumatoid arthritis among Algerian patients 1297 Priscila Abreu Franco Alessandra Pontillo In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Alice Grossi In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Anete Sevciovic Grumach In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Fabio Fernandes Morato Castro In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Francesco Caroli In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Gecilmara Salviato Pileggi In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Isabella Ceccherini In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Jorge Elias Kalil In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Jos Antonio Sanches Junior In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Leonardo Oliveira Mendonca In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Marco Gattorno In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Maria Cecilia Rivitti In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Myrthes Anna Maragna Toledo-Barros In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Pedro Francisco Giavina-Bianchi Junior In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Priscila Abreu Franco Teresa Robazzi In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy 1389 Ikram Mezghiche Habiba Amroun Association of IL6R, FCGR2A, STAT4 and PTPN22 genes polymorphisms with rheumatoid arthritis; a case control study 604 Ikram Mezghiche Hachemi Djoudi Association of IL6R, FCGR2A, STAT4 and PTPN22 genes polymorphisms with rheumatoid arthritis; a case control study 604 Ikram Mezghiche Malik Djennane Association of IL6R, FCGR2A, STAT4 and PTPN22 genes polymorphisms with rheumatoid arthritis; a case control study 604 Ikram Mezghiche Mounira Benidir Association of IL6R, FCGR2A, STAT4 and PTPN22 genes polymorphisms with rheumatoid arthritis; a case control study 604 Ikram Mezghiche Nabila Attal Association of IL6R, FCGR2A, STAT4 and PTPN22 genes polymorphisms with rheumatoid arthritis; a case control study 604 Ikram Mezghiche Ryad Tamouza Association of IL6R, FCGR2A, STAT4 and PTPN22 genes polymorphisms with rheumatoid arthritis; a case control study 604 Ikram Mezghiche Sofiane Samir Salah Association of IL6R, FCGR2A, STAT4 and PTPN22 genes polymorphisms with rheumatoid arthritis; a case control study 604 Marta Lomikovska Halyna Potomkina Cytokine profile in patients with reactive arthritis caused by epstein-barr viral and chlamydial infections  251 Marta Lomikovska Iryna Kril Cytokine profile in patients with reactive arthritis caused by epstein-barr viral and chlamydial infections  251 Marta Lomikovska Natalya Horbal Cytokine profile in patients with reactive arthritis caused by epstein-barr viral and chlamydial infections  251 Marta Lomikovska Valentyna Chopyak Cytokine profile in patients with reactive arthritis caused by epstein-barr viral and chlamydial infections  251 Zana Brkic Faiz Karim Chronic spontaneous urticaria as auto-immune feature in common variable immunodeficiency 1145 Zana Brkic Martin Van Hagen Chronic spontaneous urticaria as auto-immune feature in common variable immunodeficiency 1145 Zana Brkic Maurits Van Maaren Chronic spontaneous urticaria as auto-immune feature in common variable immunodeficiency 1145 Zana Brkic Virgil Dalm Chronic spontaneous urticaria as auto-immune feature in common variable immunodeficiency 1145 Irina Vadimovna Nesterova Alexandr N. Shuvalov Recombinant IFN&alpha;2b &nbsp;restore defective subset&nbsp; IFN&alpha;/&beta;R1<sup>+</sup>IFN&gamma;R<sup>+</sup>TLR4<sup>+</sup> neutrophilic granulocyte and lead to a good clinical efficacy in active chronic herpes-viral infections 982 Irina Vadimovna Nesterova Eugenia J. Khalturina Recombinant IFN&alpha;2b &nbsp;restore defective subset&nbsp; IFN&alpha;/&beta;R1<sup>+</sup>IFN&gamma;R<sup>+</sup>TLR4<sup>+</sup> neutrophilic granulocyte and lead to a good clinical efficacy in active chronic herpes-viral infections 982 Irina Vadimovna Nesterova T.z.l. Nguyen Recombinant IFN&alpha;2b &nbsp;restore defective subset&nbsp; IFN&alpha;/&beta;R1<sup>+</sup>IFN&gamma;R<sup>+</sup>TLR4<sup>+</sup> neutrophilic granulocyte and lead to a good clinical efficacy in active chronic herpes-viral infections 982 Irina Vadimovna Nesterova Valentina V. Malinovskaya Recombinant IFN&alpha;2b &nbsp;restore defective subset&nbsp; IFN&alpha;/&beta;R1<sup>+</sup>IFN&gamma;R<sup>+</sup>TLR4<sup>+</sup> neutrophilic granulocyte and lead to a good clinical efficacy in active chronic herpes-viral infections 982 Skr \\x87eki Erdal Eren The evaluation of patients with TACI mutation 1153 Skr \\x87eki Fatih Cicek The evaluation of patients with TACI mutation 1153 Skr \\x87eki Orhan Gorukmez The evaluation of patients with TACI mutation 1153 Skr \\x87eki Sara Sebnem Kilic The evaluation of patients with TACI mutation 1153 Skr \\x87eki Sehime Gulsun Temel The evaluation of patients with TACI mutation 1153 Skr \\x87eki Yasin Karali The evaluation of patients with TACI mutation 1153 Claudia Alejandra Del Carmen Renteria Valdiviezo Juan Carlos Aldave Becerra Severe infections due to anti granulocyte macrophage colony stimulating factor autoantibodies: A case series 1493 Skr \\x87eki Candan Demiroz Abakay The evaluation of radiosensitivity in primary immunodeficiency 1436 Skr \\x87eki Huzeyfe Huriyet The evaluation of radiosensitivity in primary immunodeficiency 1436 Skr \\x87eki Melika Bektas Hortoglu The evaluation of radiosensitivity in primary immunodeficiency 1436 Skr \\x87eki Sara Sebnem Kilic The evaluation of radiosensitivity in primary immunodeficiency 1436 Skr \\x87eki Tolga Cavas The evaluation of radiosensitivity in primary immunodeficiency 1436 Albertina Varandas Capelo Eliane Miranda IgG4-related disease with lymphopenia and enlarged bone marrow mast cells 1516 Albertina Varandas Capelo Gabriela Monteiro IgG4-related disease with lymphopenia and enlarged bone marrow mast cells 1516 Albertina Varandas Capelo Livia Nascimento IgG4-related disease with lymphopenia and enlarged bone marrow mast cells 1516 Albertina Varandas Capelo Mariana Paulsen IgG4-related disease with lymphopenia and enlarged bone marrow mast cells 1516 Albertina Varandas Capelo Roberta Meireles IgG4-related disease with lymphopenia and enlarged bone marrow mast cells 1516 Albertina Varandas Capelo Rogerio Neves IgG4-related disease with lymphopenia and enlarged bone marrow mast cells 1516 Albertina Varandas Capelo Vivian Arteaga IgG4-related disease with lymphopenia and enlarged bone marrow mast cells 1516 Francine Albino Zanetti Ana Karolina Barreto Berselli Marinho Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Francine Albino Zanetti Cristina Maria Kokron Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Francine Albino Zanetti Daniel Bialowas Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Francine Albino Zanetti Jorge Kalil Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Francine Albino Zanetti Mariana Albertinazzi De Souza Pachani Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Francine Albino Zanetti Myrthes Toledo Barros Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Francine Albino Zanetti Octavio Grecco Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Francine Albino Zanetti Thais Santos De Souza Delay in diagnosis in adults patients with variable common immunodeficiency 1416 Lenka Kapustova Eva Malicherova Serum calprotectin in PFAPA syndrome- results from cohort of patients from Martin, Slovakia 1084 Lenka Kapustova Milos Jesenak Serum calprotectin in PFAPA syndrome- results from cohort of patients from Martin, Slovakia 1084 Lenka Kapustova Otilia Petrovicova Serum calprotectin in PFAPA syndrome- results from cohort of patients from Martin, Slovakia 1084 Lenka Kapustova Peter Banovcin Serum calprotectin in PFAPA syndrome- results from cohort of patients from Martin, Slovakia 1084 Ana-Maria Bosonea Anne Kathleen Ellis A 59-year-old male of French-Canadian background with disseminated mycobacterium avium complex secondary to anti-interferon gamma autoantibodies 489 Ana-Maria Bosonea Raymond Mak A 59-year-old male of French-Canadian background with disseminated mycobacterium avium complex secondary to anti-interferon gamma autoantibodies 489 O Yanovich L Titov Association of TLR4 gene polymorphisms with gastroduodenal diseases among patients with helicobacteriosis 860 O Yanovich L M Dubuske Association of TLR4 gene polymorphisms with gastroduodenal diseases among patients with helicobacteriosis 860 O Yanovich M Doroshko Association of TLR4 gene polymorphisms with gastroduodenal diseases among patients with helicobacteriosis 860 M Trusevich L Titov Assessment of inflammatory and immunosupressive biomarkers in sepsis patients 1137 M Trusevich L M Dubuske Assessment of inflammatory and immunosupressive biomarkers in sepsis patients 1137 M Trusevich Y Gorbich Assessment of inflammatory and immunosupressive biomarkers in sepsis patients 1137 Natalya Horbal Marta Lomikoska Recurrent herpes simplex virus infection: The IFN-&Alpha; synthesis monitoring on local and general levels 414 Marina V. Smolnikova Anna Lazareva Characteristics of nasal microflora in patients with polypous&nbsp;rhinosinusitis and asthmatic triad 727 Marina V. Smolnikova Liudmila Lapteva Characteristics of nasal microflora in patients with polypous&nbsp;rhinosinusitis and asthmatic triad 727 Marina V. Smolnikova Oksana Kolenchukova Characteristics of nasal microflora in patients with polypous&nbsp;rhinosinusitis and asthmatic triad 727 Marina V. Smolnikova Svetlana Smirnova Characteristics of nasal microflora in patients with polypous&nbsp;rhinosinusitis and asthmatic triad 727 Marina V. Smolnikova Elena Anisimova Genetic mannose binding lectin and L-ficolin deficiencies are associated with a higher risk of cagA positive chronic helicobacter pylori infection in adolescents 99 Marina V. Smolnikova Nina Gorbacheva Genetic mannose binding lectin and L-ficolin deficiencies are associated with a higher risk of cagA positive chronic helicobacter pylori infection in adolescents 99 Marina V. Smolnikova Sergey Tereshchenko Genetic mannose binding lectin and L-ficolin deficiencies are associated with a higher risk of cagA positive chronic helicobacter pylori infection in adolescents 99 Marina V. Smolnikova Svetlana Zobova Genetic mannose binding lectin and L-ficolin deficiencies are associated with a higher risk of cagA positive chronic helicobacter pylori infection in adolescents 99 Cludia Viseu Varandas Manuel Pereira-Barbosa The complexity of assessing clinical severity in CVID 1509 Cludia Viseu Varandas Marisa Paulino The complexity of assessing clinical severity in CVID 1509 Cludia Viseu Varandas Sara Silva The complexity of assessing clinical severity in CVID 1509 Cludia Viseu Varandas Susana Lopes Da Silva The complexity of assessing clinical severity in CVID 1509 Liz E Veramendi Espinoza Juan C Aldave Becerra Amino acid based-formula non-responsive cow&#39;s milk allergy?: A Peruvian case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome 683 Revaz Sepiashvili Darejan Khachapuridze Indicators of immune markers in patients with vitamin D deficiency 961 Revaz Sepiashvili Manana V Chikhladze Indicators of immune markers in patients with vitamin D deficiency 961 Revaz Sepiashvili Sofi Gamkrelidze Indicators of immune markers in patients with vitamin D deficiency 961 Marina V. Smolnikova Anna Lazareva Features of immunoreactivity in polypous rhinosinusitis and asthmatic triad 847 Marina V. Smolnikova Liudmila Lapteva Features of immunoreactivity in polypous rhinosinusitis and asthmatic triad 847 Marina V. Smolnikova Oksana Kolenchukova Features of immunoreactivity in polypous rhinosinusitis and asthmatic triad 847 Marina V. Smolnikova Svetlana Smirnova Features of immunoreactivity in polypous rhinosinusitis and asthmatic triad 847 Marina V. Smolnikova Eduard Kasparov Association of cytokine indicators with gastritis activity in age groups of children of Mongoloid and Caucasoid population in Central Asia region 494 Marina V. Smolnikova Tamara Polivanova Association of cytokine indicators with gastritis activity in age groups of children of Mongoloid and Caucasoid population in Central Asia region 494 Marina V. Smolnikova Vitaliy Vshivkov Association of cytokine indicators with gastritis activity in age groups of children of Mongoloid and Caucasoid population in Central Asia region 494 I Gorpynchenko G Drannik Assessment of diagnostic equivalence of biological secretions in men with chronic prostatitis /chronic pelvic pain 840 I Gorpynchenko K Nurimanov Assessment of diagnostic equivalence of biological secretions in men with chronic prostatitis /chronic pelvic pain 840 I Gorpynchenko L M Dubuske Assessment of diagnostic equivalence of biological secretions in men with chronic prostatitis /chronic pelvic pain 840 I Gorpynchenko T Poroshina Assessment of diagnostic equivalence of biological secretions in men with chronic prostatitis /chronic pelvic pain 840 I Gorpynchenko V Savchenko Assessment of diagnostic equivalence of biological secretions in men with chronic prostatitis /chronic pelvic pain 840 R Khanferyan E Savchenko Impact of endurance exercise in trained athletes on synthesis of chemokines 848 R Khanferyan L M Dubuske Impact of endurance exercise in trained athletes on synthesis of chemokines 848 R Khanferyan N Rieger Impact of endurance exercise in trained athletes on synthesis of chemokines 848 Ella Vitalievna Churyukina Irina Ivanovna Krukier Prognostic value of amynotic liquid cytokines in the assessment of development of complications in women with gestational diabetes mellitus 887 Ella Vitalievna Churyukina Marina Arcadievna Levkovich Prognostic value of amynotic liquid cytokines in the assessment of development of complications in women with gestational diabetes mellitus 887 Ella Vitalievna Churyukina Valeria Victorovna Avrutskaya Prognostic value of amynotic liquid cytokines in the assessment of development of complications in women with gestational diabetes mellitus 887 Marina V. Smolnikova Alexander Sinyakov The role of the humoral immunity in chronic atrophic gastritis 340 Marina V. Smolnikova Olga Smirnova The role of the humoral immunity in chronic atrophic gastritis 340 Aleksandr Nikolskii Alina Sokolova Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Aleksandr Nikolskii Dmitriy Kudlay Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Aleksandr Nikolskii Ekaterina Barvinskaia Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Aleksandr Nikolskii Igor Shilovskiy Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Aleksandr Nikolskii Liudmila Vishniakova Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Aleksandr Nikolskii Musa Khaitov Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Aleksandr Nikolskii Svetlana Bolotova Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Aleksandr Nikolskii Valeria Kovchina Using of lipopolysaccharide to increase neutrophilic inflammation in bronchial asthma murine model 895 Marina V. Smolnikova Irina Litvinova Activity of pro- and antioxidants as markers for assessment of physical status of athletes for determination performance level 780 Marina V. Smolnikova Oksana Kolenchukova Activity of pro- and antioxidants as markers for assessment of physical status of athletes for determination performance level 780 Marina V. Smolnikova Oleg Sutormin Activity of pro- and antioxidants as markers for assessment of physical status of athletes for determination performance level 780 Sara Sebnem Kilic Sukru Cekic Immunological evaluation of the patients with CAPS&nbsp; 1168 Natalya Horbal Marta Lomikovska Detection of HSV &frac12; in patients with systemic connective tissue diseases 1020 Alison Lanciarotta Andrea Frigato A rare complication of thrombotic microangiopathy (TMA) 1447 Alison Lanciarotta Carlo Agostini A rare complication of thrombotic microangiopathy (TMA) 1447 Alison Lanciarotta Federico Delle Vedove A rare complication of thrombotic microangiopathy (TMA) 1447 Alison Lanciarotta Francesco Cinetto A rare complication of thrombotic microangiopathy (TMA) 1447 Alison Lanciarotta Leonardo Tartaglia A rare complication of thrombotic microangiopathy (TMA) 1447 Alison Lanciarotta Sabrina Gianese A rare complication of thrombotic microangiopathy (TMA) 1447 Maria Ins Silva Blanca Polo Cutaneous mastocytosis and selective IgM deficiency &ndash; case report 1328 Maria Ins Silva Manuel Pereira Barbosa Cutaneous mastocytosis and selective IgM deficiency &ndash; case report 1328 Maria Ins Silva Mart\\xadn Perez Y Andrs Cutaneous mastocytosis and selective IgM deficiency &ndash; case report 1328 Maria Ins Silva Natlia Pris Fernandes Cutaneous mastocytosis and selective IgM deficiency &ndash; case report 1328 Maria Ins Silva Susana Lopes Da Silva Cutaneous mastocytosis and selective IgM deficiency &ndash; case report 1328 Catherine Sonaly Ferreira Martins Ana Paula Moschione Castro Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Catherine Sonaly Ferreira Martins Gabriela Araujo Toscano Henriques Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Catherine Sonaly Ferreira Martins Luizabel De Paula Gomes Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Catherine Sonaly Ferreira Martins Maira Mastrocola De Campos Leite Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Catherine Sonaly Ferreira Martins Marina Mendes Cavalcanti Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Catherine Sonaly Ferreira Martins Mayra De Barros Dorna Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Catherine Sonaly Ferreira Martins Pedro Henrique Borges Sousa Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Catherine Sonaly Ferreira Martins Tarcisio Rubens Da Silva Innate defect of the IL-12/IFN-&gamma; axis: A case report 1549 Tomas Milota  The prevalence and clinical significance of autoantibodies in patients with common variable immunodeficiency 55 Ramit Maoz-Segal Dity Machnes-Maayan Prevalence of infections, autoimmunity and malignancy in adult onset immunodeficiency: CD4 lymphopenia, common variable immunodeficiency and combined immunodeficiency&nbsp;&nbsp;  1385 Ramit Maoz-Segal Irena Offengenden Prevalence of infections, autoimmunity and malignancy in adult onset immunodeficiency: CD4 lymphopenia, common variable immunodeficiency and combined immunodeficiency&nbsp;&nbsp;  1385 Ramit Maoz-Segal Mona Kidon Prevalence of infections, autoimmunity and malignancy in adult onset immunodeficiency: CD4 lymphopenia, common variable immunodeficiency and combined immunodeficiency&nbsp;&nbsp;  1385 Ramit Maoz-Segal Nancy Agmon-Levin Prevalence of infections, autoimmunity and malignancy in adult onset immunodeficiency: CD4 lymphopenia, common variable immunodeficiency and combined immunodeficiency&nbsp;&nbsp;  1385 Ramit Maoz-Segal Ronen Shavit Prevalence of infections, autoimmunity and malignancy in adult onset immunodeficiency: CD4 lymphopenia, common variable immunodeficiency and combined immunodeficiency&nbsp;&nbsp;  1385 Ramit Maoz-Segal Shirly Frizinsky Prevalence of infections, autoimmunity and malignancy in adult onset immunodeficiency: CD4 lymphopenia, common variable immunodeficiency and combined immunodeficiency&nbsp;&nbsp;  1385 Ramit Maoz-Segal Soad Hajyahia Prevalence of infections, autoimmunity and malignancy in adult onset immunodeficiency: CD4 lymphopenia, common variable immunodeficiency and combined immunodeficiency&nbsp;&nbsp;  1385 Marina V. Smolnikova Nina Elmanova The role of cytokines in the progression of obstructive jaundice of gallstone origin 341 Marina V. Smolnikova Olga Smirnova The role of cytokines in the progression of obstructive jaundice of gallstone origin 341 Theodoros Karampitsakos Anastasia Korba The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Argyrios Tzouvelekis The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Aris Anagnostopoulos The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Demosthenes Bouros The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Evangelia Koukaki The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Evangelos Bouros The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Evangelos Markozannes The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Kuriaki Cholidou The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Vassiliki Panou The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Theodoros Karampitsakos Vassilios Tzilas The role of increased red cell distribution width and increased absolute number of monocytes as negative prognostic markers in patients with idiopathic pulmonary fibrosis 1161 Kseniia Suska Katheryna Gashynova Immune status of patients with bronchiectasis in Dnipro region of Ukraine 1459 Kseniia Suska Valeriia Dmytrychenko Immune status of patients with bronchiectasis in Dnipro region of Ukraine 1459 Laura - Tamasauskiene Brigita Sitkauskiene Local and systemic IL-22 level in patients with persistent allergic rhinitis caused by house dust mite 106 Laura - Tamasauskiene Vilte Marija Gintauskiene Local and systemic IL-22 level in patients with persistent allergic rhinitis caused by house dust mite 106 Marina V. Smolnikova Catherine Alymova The role of humoral immunity in adenoma and prostate cancer 343 Marina V. Smolnikova Edward Kasparov The role of humoral immunity in adenoma and prostate cancer 343 Marina V. Smolnikova Olga Smirnova The role of humoral immunity in adenoma and prostate cancer 343 Artem Andreevich Shatilov Aleksandr Veniaminovich Khramtsov Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Anastasiia Vitalevna Timofeeva Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Elizaveta Aleksandrovna Stepanova Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Evgeny Aleksandrovich Turetskiy Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Ksenia Vadimovna Kozhikhova Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Musa Rakhimovich Khaitov Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Nadezhda Nikolaevna Shershakova Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Salma Cherni Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Sergey Mikhailovich Andreev Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Artem Andreevich Shatilov Valeriy Valerevich Smirnov Antibodies against cationic peptide dendrimers do not recognize their linear fragments, yet they bind other cationic dendrimers 948 Marina V. Smolnikova Sergey Tereshchenko Genetic mannose binding lectin deficiency prevalence among the arctic populations of East Siberia 98 Junehyuk Lee Aerin Baek Changes of MMP-9 and MMP12 in response of acute viral infection in virtual model of macrophages. 73 Junehyuk Lee An-Soo Jang Changes of MMP-9 and MMP12 in response of acute viral infection in virtual model of macrophages. 73 Junehyuk Lee Dojin Kim Changes of MMP-9 and MMP12 in response of acute viral infection in virtual model of macrophages. 73 Junehyuk Lee Sung-Woo Park Changes of MMP-9 and MMP12 in response of acute viral infection in virtual model of macrophages. 73 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Dermatology',\n",
       "  'session': 'TPS 07 Dermatology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921299,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 07 Dermatology Maria Lu\\xads Marques Ins Lobo The importance of patch testing in anogenital dermatitis 1540 Maria Lu\\xads Marques Joel Reis The importance of patch testing in anogenital dermatitis 1540 Maria Lu\\xads Marques Miguel Nogueira The importance of patch testing in anogenital dermatitis 1540 Henriette Farkas Christina Nurse An open-label, multicentre phase 3 study evaluating lanadelumab for the prevention of hereditary angioedema attacks in paediatric patients: SPRING study design 1490 Henriette Farkas Emel Aygren-Prsn An open-label, multicentre phase 3 study evaluating lanadelumab for the prevention of hereditary angioedema attacks in paediatric patients: SPRING study design 1490 Henriette Farkas H Henry Li An open-label, multicentre phase 3 study evaluating lanadelumab for the prevention of hereditary angioedema attacks in paediatric patients: SPRING study design 1490 Henriette Farkas Maria Pedrosa An open-label, multicentre phase 3 study evaluating lanadelumab for the prevention of hereditary angioedema attacks in paediatric patients: SPRING study design 1490 Henriette Farkas Peng Lu An open-label, multicentre phase 3 study evaluating lanadelumab for the prevention of hereditary angioedema attacks in paediatric patients: SPRING study design 1490 Henriette Farkas Raffi Tachdjian An open-label, multicentre phase 3 study evaluating lanadelumab for the prevention of hereditary angioedema attacks in paediatric patients: SPRING study design 1490 Henriette Farkas William R Lumry An open-label, multicentre phase 3 study evaluating lanadelumab for the prevention of hereditary angioedema attacks in paediatric patients: SPRING study design 1490 Marcus Maurer H. James Wedner Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Heather Iocca Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Jana Hanzlikova Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer John Anderson Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Marc Riedl Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Roman Hakl Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Sandra Christiansen Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Sharon Murray Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Sylvia Dobo Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer Tamar Kinaciyan Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer William Lumry Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Marcus Maurer William P Sheridan Berotralstat&nbsp; (BCX7353)&nbsp; treatment following 24-weeks of placebo results in rapid and sustained reduction in the rate of hereditary angioedema (HAE) attacks: APeX-2 study results<br /> 1219 Emel Aygren-Prsn Aleena Banerji Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Bruce Zuraw Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Don Mcneil Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Douglas Johnston Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Eniko Nagy Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Jonathan A Bernstein Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Melanie Cornpropst Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Phil Collis Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Sharon Murray Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Stephen Fritz Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn Timothy Craig Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Emel Aygren-Prsn William H Yang Berotralstat (BCX7353) treatment demonstrates robust and durable reduction in the rate of hereditary angioedema (HAE) attacks over 48 weeks of the phase 3 APeX-2 study 1241 Peter Schmid-Grendelmeier Claudia Lang Major differences in sensitization patterns of Atopic Dermatitis patients in Tanzania vs. Switzerland 1421 Peter Schmid-Grendelmeier Elisante John Masenga Major differences in sensitization patterns of Atopic Dermatitis patients in Tanzania vs. Switzerland 1421 Peter Schmid-Grendelmeier Emma Guttmann-Yasski Major differences in sensitization patterns of Atopic Dermatitis patients in Tanzania vs. Switzerland 1421 Peter Schmid-Grendelmeier George Semango Major differences in sensitization patterns of Atopic Dermatitis patients in Tanzania vs. Switzerland 1421 Peter Schmid-Grendelmeier Hashim Kaderbhai Major differences in sensitization patterns of Atopic Dermatitis patients in Tanzania vs. Switzerland 1421 Peter Schmid-Grendelmeier Marie-Charlotte Brueggen Major differences in sensitization patterns of Atopic Dermatitis patients in Tanzania vs. Switzerland 1421 Sebastien Barbarot Ana B Rossi Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Eric L Simpson Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Isabelle Guillemin Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Jonathan I Silverberg Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Laurent Eckert Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Lysel Brignoli Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Miriam C Fenton Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Paola Mina-Osorio Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Sebastien Auziere Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Stephan Weidinger Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Susan H Boklage Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Sebastien Barbarot Tarek Mnif Worldwide survey shows that atopic dermatitis in adolescents is also associated with a negative impact on their families 1165 Zaruhi Gevorg Kalikyan Mkrtich Norayr Avagyan Use of Armenian fermented milk product &laquo;Choratan&raquo; in the treatment of atopic dermatitis 1299 Niamh Mcguire Mili Shah Real world experience of using dupilumab to treat eczema endotypes 1548 Fernanda Leonel Nunes Adriana S. Moreno Reduction of acute attacks in patients with hereditary angioedema (HAE) undergoing a multidisciplinary intervention program 1513 Fernanda Leonel Nunes Davi C. Aragon Reduction of acute attacks in patients with hereditary angioedema (HAE) undergoing a multidisciplinary intervention program 1513 Fernanda Leonel Nunes L. Karla Paula Arruda Reduction of acute attacks in patients with hereditary angioedema (HAE) undergoing a multidisciplinary intervention program 1513 Fernanda Leonel Nunes Luana S. M. Maia Reduction of acute attacks in patients with hereditary angioedema (HAE) undergoing a multidisciplinary intervention program 1513 Fernanda Leonel Nunes Mariana P. L. Ferriani Reduction of acute attacks in patients with hereditary angioedema (HAE) undergoing a multidisciplinary intervention program 1513 Fernanda Leonel Nunes Sarah S. Langer Reduction of acute attacks in patients with hereditary angioedema (HAE) undergoing a multidisciplinary intervention program 1513 Fernanda Leonel Nunes Teresa Caballero Reduction of acute attacks in patients with hereditary angioedema (HAE) undergoing a multidisciplinary intervention program 1513 JUSHYA  KAILASH BHATIA Ankur Sarin Smoke containing urushiol: Suggested cause of allergic contact dermatitis&nbsp; 1080 Connie Katelaris David Tognarini The Australian hereditary angioedema (HAE) quality of life study &ndash; preliminary data<br /> 1562 Connie Katelaris Fiona Perram The Australian hereditary angioedema (HAE) quality of life study &ndash; preliminary data<br /> 1562 Connie Katelaris Katheryn Fenton The Australian hereditary angioedema (HAE) quality of life study &ndash; preliminary data<br /> 1562 Connie Katelaris Pamela Burton The Australian hereditary angioedema (HAE) quality of life study &ndash; preliminary data<br /> 1562 Connie Katelaris Sherif Youssef The Australian hereditary angioedema (HAE) quality of life study &ndash; preliminary data<br /> 1562 Alexander Monnickendam Annette Wagner Auto-immunity to C1q: A marker of a subset of idiopathic angioedema 150 Shang-Ian Tee Yisheng Wong Retrospective analysis of provocation testing of patients with chronic inducible urticaria in a tertiary dermatological centre in Singapore<br /> 673 Ekaterina Burygina Aleksandra Uchevatkina Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Ekaterina Burygina Ekaterina Frolova Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Ekaterina Burygina Larisa Filippova Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Ekaterina Burygina Margarita Zakhvatkina Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Ekaterina Burygina Natalya Vasilyeva Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Ekaterina Burygina Nikolay Klimko Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Ekaterina Burygina Oleg Aak Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Ekaterina Burygina Yana Kozlova Basophil activation test using CD203c marker in the diagnosis of autoimmune urticaria 631 Caroline-Claudia Erhart Andreas Neumayr Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Caroline-Claudia Erhart Esther Helen Steveling-Klein Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Caroline-Claudia Erhart Felicitas Bellutti Enders Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Caroline-Claudia Erhart Karin Hartmann Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Caroline-Claudia Erhart Ksenija Kocur Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Caroline-Claudia Erhart Rahel Wampfler Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Caroline-Claudia Erhart Sven Poppert Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Caroline-Claudia Erhart Therese Ruf Infestation with Blastocystis hominis is frequent in patients with chronic spontaneous urticaria 1013 Iris Leibovich-Nassi Avner Reshef Prodromes can predict oncoming attacks of Hereditary Angioedema 502 Iris Leibovich-Nassi Dov Har-Even Prodromes can predict oncoming attacks of Hereditary Angioedema 502 Iris Leibovich-Nassi Hava Golander Prodromes can predict oncoming attacks of Hereditary Angioedema 502 Iris Leibovich-Nassi Raz Somech Prodromes can predict oncoming attacks of Hereditary Angioedema 502 Livia Savarese Andrea Zanichelli Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Angelica Petraroli Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Assunta Maiello Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Giuseppe Spadaro Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Ilaria Mormile Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Maria Bova Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Maria Francesca Freda Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Mauro Cancian Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Livia Savarese Riccardo Senter Psychological stress, emotion regulation and health engagement in adults with Hereditary Angioedema with C1 inhibitor deficiency&nbsp; 872 Johan Mohd Sani Carol Rockett Hereditary angioedema patients in the United States report expanded use of prophylaxis, but continue to experience attacks 196 Johan Mohd Sani Jinky Rosselli Hereditary angioedema patients in the United States report expanded use of prophylaxis, but continue to experience attacks 196 Johan Mohd Sani Michaela Gascon Hereditary angioedema patients in the United States report expanded use of prophylaxis, but continue to experience attacks 196 Johan Mohd Sani Rebecca Hahn Hereditary angioedema patients in the United States report expanded use of prophylaxis, but continue to experience attacks 196 Joo Marcelino Amlia Sp\\xadnola Santos Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Anabela Lopes Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Antnio Martinho Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Cludia Varandas Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Joana Cosme Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Manuel Branco Ferreira Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Manuel Pereira Barbosa Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Maria Ins Silva Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Sara Carvalho Factor XII hereditary angioedema: Clinical characterization of four families 1260 Joo Marcelino Tatiana Loureno Factor XII hereditary angioedema: Clinical characterization of four families 1260 Inmaculada Martinez Saguer Carmen Escuriola Ettingshausen Prophylactic therapy with lanadelumab in patients with clinically severe HAE-C1-INH - real life data - 281 Inmaculada Martinez Saguer Richard Linde Prophylactic therapy with lanadelumab in patients with clinically severe HAE-C1-INH - real life data - 281 Inmaculada Martinez Saguer Zeynep Gutowski Prophylactic therapy with lanadelumab in patients with clinically severe HAE-C1-INH - real life data - 281 Jeong-Hee  Choi Hae-Sim Park Omalizumab treatment in patients with cholinergic urticaria: A real-world retrospective study in Korea  346 Jeong-Hee  Choi Hye-Ryun Kang Omalizumab treatment in patients with cholinergic urticaria: A real-world retrospective study in Korea  346 Jeong-Hee  Choi Ji Hye Kim Omalizumab treatment in patients with cholinergic urticaria: A real-world retrospective study in Korea  346 Jeong-Hee  Choi Soo Jie Chung Omalizumab treatment in patients with cholinergic urticaria: A real-world retrospective study in Korea  346 Jeong-Hee  Choi Yoo Seob Shin Omalizumab treatment in patients with cholinergic urticaria: A real-world retrospective study in Korea  346 Jeong-Hee  Choi Young-Min Ye Omalizumab treatment in patients with cholinergic urticaria: A real-world retrospective study in Korea  346 Indrashis Podder Swosti Mohanty A cross-sectional observational study to assess the clinic-demographic profile of patients with foot dermatitis and determining their causative agents using patch test 449 Evelina Bojarska Audra Blaziene Contact allergy to cosmetics: The 6 year experience from Vilnius University Hospital Santaros Klinikos 1232 Evelina Bojarska Kotryna Linauskiene Contact allergy to cosmetics: The 6 year experience from Vilnius University Hospital Santaros Klinikos 1232 Evelina Bojarska Laura Malinauskiene Contact allergy to cosmetics: The 6 year experience from Vilnius University Hospital Santaros Klinikos 1232 Maria Alexandra Rodrigues Ins Lobo Eyelid dermatitis. Experience in our Cutaneous Allergy Unit between 2014 and 2019 1396 Maria Alexandra Rodrigues Manuela Selores Eyelid dermatitis. Experience in our Cutaneous Allergy Unit between 2014 and 2019 1396 \\x93scar Marcelo Gonzlez Jimnez Alba Maria Extremera Ortega Allergic contact dermatitis to acrylates contained in hydrogel of electrocardiogram electrodes 1478 \\x93scar Marcelo Gonzlez Jimnez Elisa Gomez Torrijos Allergic contact dermatitis to acrylates contained in hydrogel of electrocardiogram electrodes 1478 \\x93scar Marcelo Gonzlez Jimnez Jesus Borja Segade Allergic contact dermatitis to acrylates contained in hydrogel of electrocardiogram electrodes 1478 \\x93scar Marcelo Gonzlez Jimnez Juana Bautista Joyanes Romo Allergic contact dermatitis to acrylates contained in hydrogel of electrocardiogram electrodes 1478 \\x93scar Marcelo Gonzlez Jimnez Lucia Moreno Lozano Allergic contact dermatitis to acrylates contained in hydrogel of electrocardiogram electrodes 1478 Leonor Esteves Caldeira Ana Coelho Gomes A case of contact dermatitis caused by isobornyl acrylate in a glucose monitoring sensor 662 Leonor Esteves Caldeira Catarina Queirs A case of contact dermatitis caused by isobornyl acrylate in a glucose monitoring sensor 662 Leonor Esteves Caldeira Manuel Pereira Barbosa A case of contact dermatitis caused by isobornyl acrylate in a glucose monitoring sensor 662 Leonor Esteves Caldeira Marta Neto A case of contact dermatitis caused by isobornyl acrylate in a glucose monitoring sensor 662 Leonor Esteves Caldeira Natlia Pris Fernandes A case of contact dermatitis caused by isobornyl acrylate in a glucose monitoring sensor 662 Leonor Esteves Caldeira Teresa Correia A case of contact dermatitis caused by isobornyl acrylate in a glucose monitoring sensor 662 Suzanne Kelly Anne Rowe Real world data of Canadians living with hereditary angioedema (HAE): Need for innovative, newer prophylactic and subcutaneous treatments 1342 Suzanne Kelly Daphne Dumbrille Real world data of Canadians living with hereditary angioedema (HAE): Need for innovative, newer prophylactic and subcutaneous treatments 1342 Suzanne Kelly Jacquie Badiou Real world data of Canadians living with hereditary angioedema (HAE): Need for innovative, newer prophylactic and subcutaneous treatments 1342 Suzanne Kelly Kristy Brosz Real world data of Canadians living with hereditary angioedema (HAE): Need for innovative, newer prophylactic and subcutaneous treatments 1342 Suzanne Kelly Michelle Cooper Real world data of Canadians living with hereditary angioedema (HAE): Need for innovative, newer prophylactic and subcutaneous treatments 1342 Suzanne Kelly Robert Bick Real world data of Canadians living with hereditary angioedema (HAE): Need for innovative, newer prophylactic and subcutaneous treatments 1342 Suzanne Kelly William H Yang Real world data of Canadians living with hereditary angioedema (HAE): Need for innovative, newer prophylactic and subcutaneous treatments 1342 Cludia Viseu Varandas Amlia Sp\\xadnola Santos Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Anabela Lopes Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Clia Costa Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Elisa Pedro Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Estrella Alonso Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Ftima Duarte Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Joana Caiado Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Joana Cosme Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Joo Marcelino Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Leonor Esteves Caldeira Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Manuel Branco Ferreira Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Manuel Pereira-Barbosa Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Maria Ins Silva Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Marta Neto Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Natlia Paris Fernandes Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Rita Limo Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Cludia Viseu Varandas Susana Lopes Da Silva Hereditary angioedema: 24 years of experience in a Portuguese reference centre 1064 Mariam Movsisyan Armine Hakobyan The first family report of hereditary angioedema in Armenia 1209 Mariam Movsisyan Raffi Tachdjian The first family report of hereditary angioedema in Armenia 1209 Mariam Movsisyan Sofie Garaqyan The first family report of hereditary angioedema in Armenia 1209 Francisca V\\xadlchez Snchez Alberto Lpez-Lera AAE-C1-INH in a female patient previously diagnosed with HAE-C1-INH with severe angioedema, normal C1q and poor response to plasma derived C1-INH 1298 Francisca V\\xadlchez Snchez Margarita Lpez-Trascasa AAE-C1-INH in a female patient previously diagnosed with HAE-C1-INH with severe angioedema, normal C1q and poor response to plasma derived C1-INH 1298 Francisca V\\xadlchez Snchez Pilar Nozal AAE-C1-INH in a female patient previously diagnosed with HAE-C1-INH with severe angioedema, normal C1q and poor response to plasma derived C1-INH 1298 Francisca V\\xadlchez Snchez Rosario Cabaas AAE-C1-INH in a female patient previously diagnosed with HAE-C1-INH with severe angioedema, normal C1q and poor response to plasma derived C1-INH 1298 Francisca V\\xadlchez Snchez Rosario Fatou AAE-C1-INH in a female patient previously diagnosed with HAE-C1-INH with severe angioedema, normal C1q and poor response to plasma derived C1-INH 1298 Francisca V\\xadlchez Snchez Teresa Caballero AAE-C1-INH in a female patient previously diagnosed with HAE-C1-INH with severe angioedema, normal C1q and poor response to plasma derived C1-INH 1298 Francisca V\\xadlchez Snchez Yolanda Cabello AAE-C1-INH in a female patient previously diagnosed with HAE-C1-INH with severe angioedema, normal C1q and poor response to plasma derived C1-INH 1298 Joo Afonso Gonzalez de Almeida Caires Eunice Dias De Castro Cold urticaria: Assessment of a Portuguese population 326 Joo Afonso Gonzalez de Almeida Caires Jos L. Plcido Cold urticaria: Assessment of a Portuguese population 326 Joo Afonso Gonzalez de Almeida Caires Leonor Carneiro-Leo Cold urticaria: Assessment of a Portuguese population 326 Oxana A. Svitich Asya Kudryavtseva Methylation of TLRs in atopic dermatitis: Epigenetic regulation 1463 Oxana A. Svitich Elizaveta Bystritskaia Methylation of TLRs in atopic dermatitis: Epigenetic regulation 1463 Oxana A. Svitich Vladimir Sobolev Methylation of TLRs in atopic dermatitis: Epigenetic regulation 1463 Yehao Chen Agnes Sze-Yin Leung Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Apple Chung-Man Yeung Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Cecily Woon-Wa Leung Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Jennifer Wing-Ki Yau Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Kate Ching-Ching Chan Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Mei Kam Chang Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Nam Sze Cheng Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Paul Kay-Sheung Chan Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Shuk Man Li Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Ting Fan Leung Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Yehao Chen Wing Hung Tam Perinatal factors for resolution of early-onset eczema by one year old: A Chinese birth cohort in Hong Kong 497 Ella Vitalievna Churyukina Alexandr Alexeevich Afonin The role of neuron-specific enolase in the pathogenesis of chronic gastroduodenitis associated with Helicobacter pylori in children with atopic dermatitis 577 Ella Vitalievna Churyukina Irina Vitalievna Panova The role of neuron-specific enolase in the pathogenesis of chronic gastroduodenitis associated with Helicobacter pylori in children with atopic dermatitis 577 Ella Vitalievna Churyukina Svetlana Christophorovna Dombayan The role of neuron-specific enolase in the pathogenesis of chronic gastroduodenitis associated with Helicobacter pylori in children with atopic dermatitis 577 Ella Vitalievna Churyukina Tamara Andreevna Afonina The role of neuron-specific enolase in the pathogenesis of chronic gastroduodenitis associated with Helicobacter pylori in children with atopic dermatitis 577 Sarah Sella Langer Adriana Santos Moreno IgE sensitization profiles of Brazilian patients with atopic dermatitis: Predominant role of perennial aeroallergens 1411 Sarah Sella Langer Janaina Michelle Lima Melo IgE sensitization profiles of Brazilian patients with atopic dermatitis: Predominant role of perennial aeroallergens 1411 Sarah Sella Langer Julianne Alves Machado IgE sensitization profiles of Brazilian patients with atopic dermatitis: Predominant role of perennial aeroallergens 1411 Sarah Sella Langer L. Karla Arruda IgE sensitization profiles of Brazilian patients with atopic dermatitis: Predominant role of perennial aeroallergens 1411 Sarah Sella Langer Mariana Paes Leme Ferriani IgE sensitization profiles of Brazilian patients with atopic dermatitis: Predominant role of perennial aeroallergens 1411 Sarah Sella Langer Marina Mendona Dias IgE sensitization profiles of Brazilian patients with atopic dermatitis: Predominant role of perennial aeroallergens 1411 Sarah Sella Langer Renata Nahas Cardili IgE sensitization profiles of Brazilian patients with atopic dermatitis: Predominant role of perennial aeroallergens 1411 Maria Judith Cavalcante Andr Moreira Indoor endocrine disrupting chemicals may adversely affect atopic dermatitis symptoms in school aged children 801 Maria Judith Cavalcante Francisca Mendes Indoor endocrine disrupting chemicals may adversely affect atopic dermatitis symptoms in school aged children 801 Maria Judith Cavalcante Ins Pacincia Indoor endocrine disrupting chemicals may adversely affect atopic dermatitis symptoms in school aged children 801 Maria Judith Cavalcante Joo Rufo Indoor endocrine disrupting chemicals may adversely affect atopic dermatitis symptoms in school aged children 801 Maria Judith Cavalcante Lu\\xads Delgado Indoor endocrine disrupting chemicals may adversely affect atopic dermatitis symptoms in school aged children 801 Maria Judith Cavalcante Maria Alexandra Rodrigues Indoor endocrine disrupting chemicals may adversely affect atopic dermatitis symptoms in school aged children 801 Maria Judith Cavalcante Mariana Farraia Indoor endocrine disrupting chemicals may adversely affect atopic dermatitis symptoms in school aged children 801 Carla Irani Candie Jammal Overview of atopic dermatitis in a Lebanese population: A cross-sectional study 664 Carla Irani Marilyn Karam Overview of atopic dermatitis in a Lebanese population: A cross-sectional study 664 Carla Irani Martine Kai Overview of atopic dermatitis in a Lebanese population: A cross-sectional study 664 Carla Irani Pascale Salameh Overview of atopic dermatitis in a Lebanese population: A cross-sectional study 664 Carla Irani Souheil Hallit Overview of atopic dermatitis in a Lebanese population: A cross-sectional study 664 Raffaele Brancaccio Giovanni Florio Dupilumab efficacy in different atopic dermatitis phenotypes 602 Raffaele Brancaccio Tiziana Peduto Dupilumab efficacy in different atopic dermatitis phenotypes 602 Raffaele Brancaccio Vincenzo Patella Dupilumab efficacy in different atopic dermatitis phenotypes 602 Rita Brs Amlia Sp\\xadnola-Santos Dupilumab for severe atopic dermatitis &ndash; real life experience in a portuguese terciary centre 1010 Rita Brs Ana Mendes Dupilumab for severe atopic dermatitis &ndash; real life experience in a portuguese terciary centre 1010 Rita Brs Anabela Lopes Dupilumab for severe atopic dermatitis &ndash; real life experience in a portuguese terciary centre 1010 Rita Brs Clia Costa Dupilumab for severe atopic dermatitis &ndash; real life experience in a portuguese terciary centre 1010 Rita Brs Elisa Pedro Dupilumab for severe atopic dermatitis &ndash; real life experience in a portuguese terciary centre 1010 Rita Brs Manuel Pereira-Barbosa Dupilumab for severe atopic dermatitis &ndash; real life experience in a portuguese terciary centre 1010 Rita Brs Marta Neto Dupilumab for severe atopic dermatitis &ndash; real life experience in a portuguese terciary centre 1010 Abdullah A Alangari Jonathan Barker Manuka honey activates the aryl hydrocarbon receptor and down-regulates IL4-induced CCL26 532 Abdullah A Alangari Paola Di Meglio Manuka honey activates the aryl hydrocarbon receptor and down-regulates IL4-induced CCL26 532 Abdullah A Alangari Wisam Alwan Manuka honey activates the aryl hydrocarbon receptor and down-regulates IL4-induced CCL26 532 Thais Santos De Sousa Ariana Yang Is methotrexate effective in severe atopic dermatitis? 1511 Thais Santos De Sousa Daniel Bialowas Is methotrexate effective in severe atopic dermatitis? 1511 Thais Santos De Sousa Francine Albino Zanetti Is methotrexate effective in severe atopic dermatitis? 1511 Thais Santos De Sousa Gabriella Melo Fontes Silva Dias Is methotrexate effective in severe atopic dermatitis? 1511 Thais Santos De Sousa Jorge Kalil Is methotrexate effective in severe atopic dermatitis? 1511 Thais Santos De Sousa Mariana Albertinazzi De Souza Pachani Is methotrexate effective in severe atopic dermatitis? 1511 Thais Santos De Sousa Sarah Sarah Nunes Is methotrexate effective in severe atopic dermatitis? 1511 Daisuke Honda Hisaki Rinno Evaluation for the measurement results of C1-inhibitor activity and suggestion in the diagnostic cut-off value of C1-inhibitor activity in patients with hereditary angioedema type I/II 488 Daisuke Honda Hisatsugu Takahara Evaluation for the measurement results of C1-inhibitor activity and suggestion in the diagnostic cut-off value of C1-inhibitor activity in patients with hereditary angioedema type I/II 488 Daisuke Honda Isao Ohsawa Evaluation for the measurement results of C1-inhibitor activity and suggestion in the diagnostic cut-off value of C1-inhibitor activity in patients with hereditary angioedema type I/II 488 Daisuke Honda Yasuhiko Tomino Evaluation for the measurement results of C1-inhibitor activity and suggestion in the diagnostic cut-off value of C1-inhibitor activity in patients with hereditary angioedema type I/II 488 Daisuke Honda Yusuke Suzuki Evaluation for the measurement results of C1-inhibitor activity and suggestion in the diagnostic cut-off value of C1-inhibitor activity in patients with hereditary angioedema type I/II 488 Deniz Eyice Karabacak Ali Can How do pregnancy and type of delivery affect the clinical course of hereditary angioedema? 605 Deniz Eyice Karabacak Asli Gelincik How do pregnancy and type of delivery affect the clinical course of hereditary angioedema? 605 Deniz Eyice Karabacak Bahauddin Colakoglu How do pregnancy and type of delivery affect the clinical course of hereditary angioedema? 605 Deniz Eyice Karabacak Osman Ozan Yegit How do pregnancy and type of delivery affect the clinical course of hereditary angioedema? 605 Deniz Eyice Karabacak Semra Demir How do pregnancy and type of delivery affect the clinical course of hereditary angioedema? 605 Deniz Eyice Karabacak Suna Buyukozturk How do pregnancy and type of delivery affect the clinical course of hereditary angioedema? 605 Gustavo Jorge Molina-Molina Anna Sala-Cunill Role of the triggers in Hereditary Angioedema with normal C1 inhibitor and mutations from the gene of FXII (HAE-FXII) 1151 Gustavo Jorge Molina-Molina Johana Gil-Serrano Role of the triggers in Hereditary Angioedema with normal C1 inhibitor and mutations from the gene of FXII (HAE-FXII) 1151 Gustavo Jorge Molina-Molina Mar Guilarte Role of the triggers in Hereditary Angioedema with normal C1 inhibitor and mutations from the gene of FXII (HAE-FXII) 1151 Gustavo Jorge Molina-Molina Moiss Labrador-Horrillo Role of the triggers in Hereditary Angioedema with normal C1 inhibitor and mutations from the gene of FXII (HAE-FXII) 1151 Gustavo Jorge Molina-Molina Olga Luengo Role of the triggers in Hereditary Angioedema with normal C1 inhibitor and mutations from the gene of FXII (HAE-FXII) 1151 Gustavo Jorge Molina-Molina Victoria Cardona Role of the triggers in Hereditary Angioedema with normal C1 inhibitor and mutations from the gene of FXII (HAE-FXII) 1151 Ramit Maoz-Segal Diti Machnes-Maayan Long term prevention of hereditary angioedema with C1E-INH concentrate 607 Ramit Maoz-Segal Irena Offengenden Long term prevention of hereditary angioedema with C1E-INH concentrate 607 Ramit Maoz-Segal Mona Kidon Long term prevention of hereditary angioedema with C1E-INH concentrate 607 Ramit Maoz-Segal Nancy Agmon- Levin Long term prevention of hereditary angioedema with C1E-INH concentrate 607 Ramit Maoz-Segal Shirley Frizinsky Long term prevention of hereditary angioedema with C1E-INH concentrate 607 Ramit Maoz-Segal Suad Hajyahia Long term prevention of hereditary angioedema with C1E-INH concentrate 607 Ramit Maoz-Segal Yulia Liphshitz Long term prevention of hereditary angioedema with C1E-INH concentrate 607 Thomas Severin Ana Maria Gimnez-Arnau Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Avantika Barve Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Eva Hua Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Gordon Sussman Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Isabelle Indermuehle Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Marcus Maurer Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Michihiro Hide Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Reinhold Janocha Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Thomas Severin Sarbjit Singh Saini Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria 729 Ot\\xadlia Petrovicov Lenka Kapustova Off-label use of omalizumab for chronic spontaneous urticaria in children younger than 12 years (experience of one centre) 205 Ot\\xadlia Petrovicov Milos Jesenak Off-label use of omalizumab for chronic spontaneous urticaria in children younger than 12 years (experience of one centre) 205 Ot\\xadlia Petrovicov Peter Banovcin Off-label use of omalizumab for chronic spontaneous urticaria in children younger than 12 years (experience of one centre) 205 Sabela Prez-Codesido Ana Rosado Ingelmo Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Sabela Prez-Codesido Elena Garc\\xada Garc\\xada Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Sabela Prez-Codesido Enrique Gmez De La Fuente Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Sabela Prez-Codesido Jimena Laiseca-Garc\\xada Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Sabela Prez-Codesido Luc\\xada Gonzlez-Bravo Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Sabela Prez-Codesido Marianela Managua Brandoni-Petroni Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Sabela Prez-Codesido Martina Privitera-Torres Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Sabela Prez-Codesido Miguel \\x81ngel Tejedor Alonso Successful treatment of hypocomplementemic urticarial vasculitis with omalizumab: A case report 377 Anca C Chiriac Cipriana Stefanescu Epidemiological study: Self-reported (work-related and occupational) hand eczema 1441 Anca C Chiriac Doina Azoicai Epidemiological study: Self-reported (work-related and occupational) hand eczema 1441 Anca C Chiriac Mioara Matei Epidemiological study: Self-reported (work-related and occupational) hand eczema 1441 Anca C Chiriac Tatiana Taranu Epidemiological study: Self-reported (work-related and occupational) hand eczema 1441 Pedro Filipe Botelho Alves Ana Todo-Bom Viola duet: A rare case of sensitization&nbsp;to multiple contact allergens in a professional musician 677 Pedro Filipe Botelho Alves Frederico Regateiro Viola duet: A rare case of sensitization&nbsp;to multiple contact allergens in a professional musician 677 Livia Savarese Andrea Zanichelli Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Angelica Petraroli Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Giuseppe Spadaro Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Ilaria Mormile Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Maria Bova Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Maria Domenica Guarino Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Maria Francesca Freda Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Matteo Zabotto Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Mauro Cancian Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Riccardo Senter Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Livia Savarese Roberto Perricone Guidelines for the doctor-parents dialogue in pediatric C1-INH hereditary angioedema 854 Krasimira Zheleva Baynova Mar\\xada Robledo Avila Castellano Comorbidities in the spectrum of SERPING 1- related hereditary angioedema 1425 Krasimira Zheleva Baynova Marta Reguero Capilla Comorbidities in the spectrum of SERPING 1- related hereditary angioedema 1425 Krasimira Zheleva Baynova Teresa De Aramburu Mera Comorbidities in the spectrum of SERPING 1- related hereditary angioedema 1425 Krasimira Zheleva Baynova Teresa Gonzlez-Quevedo Comorbidities in the spectrum of SERPING 1- related hereditary angioedema 1425 Tamar Kinaciyan  Lip swelling after intense kissing 117 Karthik   Nagaraju Nagaraju Kuravi Aeroallergen sensitization among patients with chronic urticaria in the absence of allergic airway disease - a study from a referral allergy centre in South India 1242 Karthik   Nagaraju Sathya Srivatsav Aeroallergen sensitization among patients with chronic urticaria in the absence of allergic airway disease - a study from a referral allergy centre in South India 1242 Karthik   Nagaraju Venkata Kasyapi Voorakaranam Aeroallergen sensitization among patients with chronic urticaria in the absence of allergic airway disease - a study from a referral allergy centre in South India 1242 La\\xads Souza Gomes Allyne Moura F Sousa Araujo Urticarial vasculitis simulating refractory chronic urticaria: Histological characterization 1433 La\\xads Souza Gomes Antonio Abilio Motta Urticarial vasculitis simulating refractory chronic urticaria: Histological characterization 1433 La\\xads Souza Gomes Grazielly Ftima Pereira Urticarial vasculitis simulating refractory chronic urticaria: Histological characterization 1433 La\\xads Souza Gomes Jorge Kalil Urticarial vasculitis simulating refractory chronic urticaria: Histological characterization 1433 La\\xads Souza Gomes Larissa Queiroz Mamede Urticarial vasculitis simulating refractory chronic urticaria: Histological characterization 1433 La\\xads Souza Gomes Mara Giavina Bianchi Urticarial vasculitis simulating refractory chronic urticaria: Histological characterization 1433 La\\xads Souza Gomes Rosana Camara Agondi Urticarial vasculitis simulating refractory chronic urticaria: Histological characterization 1433 Catarina Pereira Coutinho Costa Clia Autoimmunity and its clinical relevance in chronic urticaria - experience of a Portuguese UCARE center 1240 Catarina Pereira Coutinho Leonor Esteves Caldeira Autoimmunity and its clinical relevance in chronic urticaria - experience of a Portuguese UCARE center 1240 Catarina Pereira Coutinho Manuel Pereira Barbosa Autoimmunity and its clinical relevance in chronic urticaria - experience of a Portuguese UCARE center 1240 Catarina Pereira Coutinho Marisa Paulino Autoimmunity and its clinical relevance in chronic urticaria - experience of a Portuguese UCARE center 1240 Catarina Pereira Coutinho Marta Neto Autoimmunity and its clinical relevance in chronic urticaria - experience of a Portuguese UCARE center 1240 Marisa Paulino Catarina Coutinho The role of inflammatory parameters as biomarkers for chronic spontaneuous urticaria and helicobacter pylori eradication response in a Portuguese population 1383 Marisa Paulino Clia Costa The role of inflammatory parameters as biomarkers for chronic spontaneuous urticaria and helicobacter pylori eradication response in a Portuguese population 1383 Marisa Paulino Leonor Caldeira The role of inflammatory parameters as biomarkers for chronic spontaneuous urticaria and helicobacter pylori eradication response in a Portuguese population 1383 Marisa Paulino Manuel Pereira-Barbosa The role of inflammatory parameters as biomarkers for chronic spontaneuous urticaria and helicobacter pylori eradication response in a Portuguese population 1383 Marisa Paulino Marta Neto The role of inflammatory parameters as biomarkers for chronic spontaneuous urticaria and helicobacter pylori eradication response in a Portuguese population 1383 Jimena Laiseca Garc\\xada Ana Rosado Ingelmo Histological features of acuagenic salt dependant urticaria. Case report 592 Jimena Laiseca Garc\\xada Beln Tristan Martin Histological features of acuagenic salt dependant urticaria. Case report 592 Jimena Laiseca Garc\\xada Enrique Gmez De La Fuente Histological features of acuagenic salt dependant urticaria. Case report 592 Jimena Laiseca Garc\\xada Javier Fernando Pinedo Histological features of acuagenic salt dependant urticaria. Case report 592 Jimena Laiseca Garc\\xada Luc\\xada Gnzalez Bravo Histological features of acuagenic salt dependant urticaria. Case report 592 Jimena Laiseca Garc\\xada Marianela Managua Brandoni Petrone Histological features of acuagenic salt dependant urticaria. Case report 592 Jimena Laiseca Garc\\xada Martina Privitera Torres Histological features of acuagenic salt dependant urticaria. Case report 592 Jimena Laiseca Garc\\xada Sabela Prez Codesido Histological features of acuagenic salt dependant urticaria. Case report 592 Joana Queirs Gomes Ana Rita Presa Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Ctia Santa Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Cristiana Ferreira Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Cristina Lara Valente Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Ins Lopes Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Isabel Rosmaninho Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Joana Barradas Lopes Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Jos Alberto Ferreira Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Lise Brosseron Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Mrcio Mesquita Chronic urticaria - a 10 years overview 1382 Joana Queirs Gomes Maria Arminda Guilherme Chronic urticaria - a 10 years overview 1382 Allyne  Moura F E Sousa Arajo Amanda Brolio De Sousa Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Antonio Abilio Motta Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Grazielley De Ftima Pereira Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Iandra Leite Perez Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Jessica Bonfim Mendes Cosentino Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Jorge Kalil Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Lais Souza Gomes Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Larissa De Queiroz Mamede Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Allyne  Moura F E Sousa Arajo Rosana Cmara Agondi Influence of emotional stress on clinical presentation of chronic urticaria patient 1555 Iandra Leite Perez Allyne Moura Arajo Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Iandra Leite Perez Amanda Brolio Souza Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Iandra Leite Perez Antonio Abilio Motta Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Iandra Leite Perez Grazielly Ftima Pereira Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Iandra Leite Perez Jorge Kalil Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Iandra Leite Perez La\\xads Souza Gomes Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Iandra Leite Perez Larissa Queiroz Mamede Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Iandra Leite Perez Rosana Camara Agondi Biomarkers in pacients with refractory chronic spontaneous urticaria 1424 Cristina Lara Valente Arminda Guilherme Review of cold inducible urticaria patients: The experience of a Portuguese center 1023 Cristina Lara Valente Ins Lopes Review of cold inducible urticaria patients: The experience of a Portuguese center 1023 Cristina Lara Valente Isabel Rosmaninho Review of cold inducible urticaria patients: The experience of a Portuguese center 1023 Cristina Lara Valente Joana Barradas Lopes Review of cold inducible urticaria patients: The experience of a Portuguese center 1023 Cristina Lara Valente Jos Alberto Ferreira Review of cold inducible urticaria patients: The experience of a Portuguese center 1023 Giovanna Lucy Cortez Aliaga Antonio Abilio Motta Chronic urticaria and loratadine response: Daily dose and side effects 1492 Giovanna Lucy Cortez Aliaga Daniel Bialowas Chronic urticaria and loratadine response: Daily dose and side effects 1492 Giovanna Lucy Cortez Aliaga Jorge Elias Kalil Filho Chronic urticaria and loratadine response: Daily dose and side effects 1492 Giovanna Lucy Cortez Aliaga Rosana Cmara Agondi Chronic urticaria and loratadine response: Daily dose and side effects 1492 Young Yoo Dasarang Kim Moderate-intensity aerobic exercise reduces allergic inflammation in a mouse model of atopic dermatitis 767 Young Yoo Jaehoon Lim Moderate-intensity aerobic exercise reduces allergic inflammation in a mouse model of atopic dermatitis 767 Young Yoo Seunghyun Kim Moderate-intensity aerobic exercise reduces allergic inflammation in a mouse model of atopic dermatitis 767 Young Yoo Sung Jin Yoon Moderate-intensity aerobic exercise reduces allergic inflammation in a mouse model of atopic dermatitis 767 Young Yoo Wang Kuk Son Moderate-intensity aerobic exercise reduces allergic inflammation in a mouse model of atopic dermatitis 767 Young Yoo Wonsuck Yoon Moderate-intensity aerobic exercise reduces allergic inflammation in a mouse model of atopic dermatitis 767 JUHEE HAN Chul Hwan Bang Atopic dermatitis and ocular disorders: A nationwide population-based cohort study  344 JUHEE HAN Jae Woong Yoon Atopic dermatitis and ocular disorders: A nationwide population-based cohort study  344 JUHEE HAN Ji Hyun Lee Atopic dermatitis and ocular disorders: A nationwide population-based cohort study  344 JUHEE HAN Jun Young Lee Atopic dermatitis and ocular disorders: A nationwide population-based cohort study  344 JUHEE HAN Suk Jun Lee Atopic dermatitis and ocular disorders: A nationwide population-based cohort study  344 JUHEE HAN Young Min Park Atopic dermatitis and ocular disorders: A nationwide population-based cohort study  344 VIKTORIYA KHAN Tair Nurpeissov Effect of vitamin D deficiency on the severity of atopic dermatiti 322 Maria Alexandra Rodrigues Andr Moreira Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Maria Alexandra Rodrigues Francisca Mendes Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Maria Alexandra Rodrigues Ins Pacincia Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Maria Alexandra Rodrigues Joo Rufo Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Maria Alexandra Rodrigues Judith Cavalcante Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Maria Alexandra Rodrigues Lu\\xads Delgado Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Maria Alexandra Rodrigues Mariana Farraia Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Maria Alexandra Rodrigues Tiago Torres Atopic dermatitis symptoms are associated with autonomic dysautonomia in school aged children 1302 Revaz Sepiashvili Darejan Khachapuridze Analysis of the factors causing atopic dermatitis based on reality of Western Georgia 981 Revaz Sepiashvili Manana Chikhladze Analysis of the factors causing atopic dermatitis based on reality of Western Georgia 981 Revaz Sepiashvili Sofi Gamkrelidze Analysis of the factors causing atopic dermatitis based on reality of Western Georgia 981 Revaz Sepiashvili Tatiana Slavyanskaya Analysis of the factors causing atopic dermatitis based on reality of Western Georgia 981 Anna Borushko  Russian-speaking groups on atopic dermatitis in social media 1560 Inna A. Larkova Valeryi A. Mukhortykh Atopic dermatitis in children: Is there any correlation between the severity of atopic dermatitis and the level of vitamin D? 1176 Inna A. Larkova Vera A. Revyakina Atopic dermatitis in children: Is there any correlation between the severity of atopic dermatitis and the level of vitamin D? 1176 Sofiya Portuhay Jason Ohayon Is it helpful? Impact of allergy assessments in the management of pediatric moderate to severe atopic dermatitis 1504 Sofiya Portuhay Khadija Nicole Brouillette Is it helpful? Impact of allergy assessments in the management of pediatric moderate to severe atopic dermatitis 1504 Sofiya Portuhay Vaidehi Bhatt Is it helpful? Impact of allergy assessments in the management of pediatric moderate to severe atopic dermatitis 1504 Sofiya Portuhay Vince Wu Is it helpful? Impact of allergy assessments in the management of pediatric moderate to severe atopic dermatitis 1504 Sofiya Portuhay Wardha Wardha Is it helpful? Impact of allergy assessments in the management of pediatric moderate to severe atopic dermatitis 1504 Fiona Frances Halton Isabel Helen Cowling The Hidden Danger of &ldquo;Miracle&rdquo; Creams for Childhood Eczema 694 Fiona Frances Halton Lydia Jade Scrivens The Hidden Danger of &ldquo;Miracle&rdquo; Creams for Childhood Eczema 694 Fiona Frances Halton Niten Makwana The Hidden Danger of &ldquo;Miracle&rdquo; Creams for Childhood Eczema 694 Regina Treudler Jan C. Simon A case of atopic eczema treated safely with dupilumab during pregnancy and lactation 71 Regina Treudler Paula Kage A case of atopic eczema treated safely with dupilumab during pregnancy and lactation 71 Maria Alexandra Rodrigues Manuela Selores Atopic dermatitis treatment with dupilumab in real life - the experience of a center 1279 Maria Alexandra Rodrigues Tiago Torres Atopic dermatitis treatment with dupilumab in real life - the experience of a center 1279 VIKTORIYA KHAN Tair Nurpeissov The role of a complex of emollients in the treatment of atopic dermatitis in children 985 Aleksandra Plavsic Aleksandra Peric Popadic C-reactive protein in chronic spontaneous urticaria: Correlation with disease activity, duration and therapy 320 Aleksandra Plavsic Milan Dimitrijevic C-reactive protein in chronic spontaneous urticaria: Correlation with disease activity, duration and therapy 320 Aleksandra Plavsic Rada Miskovic C-reactive protein in chronic spontaneous urticaria: Correlation with disease activity, duration and therapy 320 Aleksandra Plavsic Snezana Arandjelovic C-reactive protein in chronic spontaneous urticaria: Correlation with disease activity, duration and therapy 320 Aleksandra Plavsic Vesna Tomic Spiric C-reactive protein in chronic spontaneous urticaria: Correlation with disease activity, duration and therapy 320 Manuel Barcel Ivars \\x81ngel Sastre Sastre Contact allergy to disperse blue 106 924 Manuel Barcel Ivars Celia Morales Rubio Contact allergy to disperse blue 106 924 Manuel Barcel Ivars Laurys Restrepo Tinoco Contact allergy to disperse blue 106 924 Manuel Barcel Ivars Marta Burchs Feliciano Contact allergy to disperse blue 106 924 Beatriz Hierro Maghfour Maghfour Maghfour Foot allergic contact dermatitis to mercaptobenzothiazole, dipotassium dichromate, tetramethylthiuram disulfide (tmtd) with widespread involvement in periods of exacerbation 1258 Anca C Chiriac Cipriana Stefanescu A study in Romania on allergic contact dermatitis: Occupational or work-related skin disease among health-care providers? 1390 Anca C Chiriac Doina Azoicai A study in Romania on allergic contact dermatitis: Occupational or work-related skin disease among health-care providers? 1390 Anca C Chiriac Mioara Matei A study in Romania on allergic contact dermatitis: Occupational or work-related skin disease among health-care providers? 1390 Anca C Chiriac Tatiana Taranu A study in Romania on allergic contact dermatitis: Occupational or work-related skin disease among health-care providers? 1390 Ijaz Ogeer Jason Ohayon Hypersensitivity reaction to metals in tattoo pigment and relief from laser therapy 1500 Ijaz Ogeer Vince Wu Hypersensitivity reaction to metals in tattoo pigment and relief from laser therapy 1500 Marilize Esgalha Santos Antnio Carlos Biel Exogenous estrogen sensitivity in patients with different types of hereditary angioedema: A sistematic review 556 Marilize Esgalha Santos Francisco Srgio Santos Exogenous estrogen sensitivity in patients with different types of hereditary angioedema: A sistematic review 556 Elisabetta Greco Maria Domenica Guarino Septic shock complicates a genital oedema with bladder globe in a patient with HAE type 3: A case report. 1147 Elisabetta Greco Roberto Perricone Septic shock complicates a genital oedema with bladder globe in a patient with HAE type 3: A case report. 1147 Elisabetta Greco Stella Modica Septic shock complicates a genital oedema with bladder globe in a patient with HAE type 3: A case report. 1147 Daniela Fernandes Carvalho Antero Palma-Carlos Quality of Life in Portuguese patients with urticaria 826 Daniela Fernandes Carvalho Joana Freitas Quality of Life in Portuguese patients with urticaria 826 Daniela Fernandes Carvalho Paulo Ferrinho Quality of Life in Portuguese patients with urticaria 826 Daniela Fernandes Carvalho Pedro Aguiar Quality of Life in Portuguese patients with urticaria 826 Daniela Fernandes Carvalho Pedro Mendes-Bastos Quality of Life in Portuguese patients with urticaria 826 Guacira Rovigatti Franco Alex Isidoro Ferreira Prado Vasculitis in patients with chronic urticaria or autoimmune diseases 1193 Guacira Rovigatti Franco Antnio Ab\\xadlio Motta Vasculitis in patients with chronic urticaria or autoimmune diseases 1193 Guacira Rovigatti Franco Jorge Kalil Vasculitis in patients with chronic urticaria or autoimmune diseases 1193 Guacira Rovigatti Franco Larissa Queiroz Mamede Vasculitis in patients with chronic urticaria or autoimmune diseases 1193 Guacira Rovigatti Franco Mara Giavina-Bianchi Vasculitis in patients with chronic urticaria or autoimmune diseases 1193 Guacira Rovigatti Franco Myrthes Toledo Barros Vasculitis in patients with chronic urticaria or autoimmune diseases 1193 Guacira Rovigatti Franco Rosana Cmara Agondi Vasculitis in patients with chronic urticaria or autoimmune diseases 1193 Tanja Deleva Jovanova Natasha Teovska Mitrevska Mast cell sarcoma &ndash; urticaria and oedema quinke case report  206 Saerrah Murryam Tak Chin Telangiectasia Macularis Eruptiva Perstans 528 Pierre-Yves Jeandel  Hereditary angioedema: Is it time to revisit longterm attenuated androgen therapy use? 1164 Iolanda Alen Coutinho Ana Todo-Bom Clinical and analytical characterization of chronic urticaria adult patients &ndash; a one-year study from a portuguese terciary hospital 143 Iolanda Alen Coutinho Frederico S Regateiro Clinical and analytical characterization of chronic urticaria adult patients &ndash; a one-year study from a portuguese terciary hospital 143 Iolanda Alen Coutinho Joana Sofia Pita Clinical and analytical characterization of chronic urticaria adult patients &ndash; a one-year study from a portuguese terciary hospital 143 Iolanda Alen Coutinho Raquel Gomes Clinical and analytical characterization of chronic urticaria adult patients &ndash; a one-year study from a portuguese terciary hospital 143 Iolanda Alen Coutinho Rosa Fernandes Clinical and analytical characterization of chronic urticaria adult patients &ndash; a one-year study from a portuguese terciary hospital 143 Luc\\xada Indira Melgar Gonzlez Angel Luis Villaln Garc\\xada Chronic urticaria exacerbated by nsaids with aspirin tolerance achieved with omalizumab: A case report 397 Luc\\xada Indira Melgar Gonzlez Antonio Jose Prez Pimiento Chronic urticaria exacerbated by nsaids with aspirin tolerance achieved with omalizumab: A case report 397 Luc\\xada Indira Melgar Gonzlez Mar\\xada Del Mar Reao Martos Chronic urticaria exacerbated by nsaids with aspirin tolerance achieved with omalizumab: A case report 397 Luc\\xada Indira Melgar Gonzlez Miriam Barrios Albajar Chronic urticaria exacerbated by nsaids with aspirin tolerance achieved with omalizumab: A case report 397 Luc\\xada Indira Melgar Gonzlez Paloma Ferrando   Anaut Chronic urticaria exacerbated by nsaids with aspirin tolerance achieved with omalizumab: A case report 397 Hong Oei  Aquagenic urticaria treat with propanolol 493 Aleksandra Bergant Suhodolcan Maja Benko Severe solar urticaria treated with omalizumab 1228 Maria Alexandra Rodrigues Glria Cunha Velho Refractory chronic spontaneous urticaria in melanoma patient under pembrolizumab successfully treated with omalizumab 1317 Maria Alexandra Rodrigues Ins Lobo Refractory chronic spontaneous urticaria in melanoma patient under pembrolizumab successfully treated with omalizumab 1317 Maria Alexandra Rodrigues Manuela Selores Refractory chronic spontaneous urticaria in melanoma patient under pembrolizumab successfully treated with omalizumab 1317 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Drug allergy',\n",
       "  'session': 'TPS 08 Drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921301,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 08 Drug allergy Giuseppe Guida Andrea Antonelli Immediate hypersensitivity to systemic corticosteroids: &ldquo;When the class isn&rsquo;t everything&rdquo;: A case series 1093 Giuseppe Guida Iuliana Badiu Immediate hypersensitivity to systemic corticosteroids: &ldquo;When the class isn&rsquo;t everything&rdquo;: A case series 1093 Giuseppe Guida Paolo Noceti Immediate hypersensitivity to systemic corticosteroids: &ldquo;When the class isn&rsquo;t everything&rdquo;: A case series 1093 Giuseppe Guida Roberta Bergia Immediate hypersensitivity to systemic corticosteroids: &ldquo;When the class isn&rsquo;t everything&rdquo;: A case series 1093 Alicia Gallardo Higueras Cristina Mart\\xadn Garc\\xada Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Elena Laffond Yges Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Esther Moreno Rodilla Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Eva Mar\\xada Mac\\xadas Iglesias Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Francisco Javier Muoz Bellido Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Ignacio Dvila Gonzlez Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Mar\\xada Del Valle Campann Toro Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Mar\\xada Teresa Gracia Bara Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Miriam Sobrino Garc\\xada Immediate hypersensitivity to gadolinium-based contrast agents 1274 Alicia Gallardo Higueras Sonia De Arriba Mndez Immediate hypersensitivity to gadolinium-based contrast agents 1274 Philip Hei Li Chak-Sing Lau Prevalence, incidence and sensitization patterns of beta-lactam allergy in Hong Kong 94 Philip Hei Li Elaine Au Prevalence, incidence and sensitization patterns of beta-lactam allergy in Hong Kong 94 Philip Hei Li Heather Yeung Prevalence, incidence and sensitization patterns of beta-lactam allergy in Hong Kong 94 Tatevik Aloyan Zaruhi Gevorg Kalikyan The incidence of systemic reactions to drug skin tests among patients with suspected drug allergy in Armenia 312 \\x81ngel Luis Villaln Garc\\xada Alfredo Iglesias Cadarso Allergy to lysine clonixinate with positive prick test 530 \\x81ngel Luis Villaln Garc\\xada Beatriz Torres Prez Allergy to lysine clonixinate with positive prick test 530 \\x81ngel Luis Villaln Garc\\xada Mar\\xada Anglica Gutirrez-Maturana Jimenez Allergy to lysine clonixinate with positive prick test 530 \\x81ngel Luis Villaln Garc\\xada Marta Gema Lpez San Mart\\xadn Allergy to lysine clonixinate with positive prick test 530 \\x81ngel Luis Villaln Garc\\xada Miriam Barrios Albajar Allergy to lysine clonixinate with positive prick test 530 Nikolaos Syrigos Anastasia Geka Evaluation of amoxicillin drug allergy: A prospective study of amoxicillin skin testing 634 Nikolaos Syrigos Dimitra Grapsa Evaluation of amoxicillin drug allergy: A prospective study of amoxicillin skin testing 634 Nikolaos Syrigos Ekaterini Syrigou Evaluation of amoxicillin drug allergy: A prospective study of amoxicillin skin testing 634 Nikolaos Syrigos Maria Tsami Evaluation of amoxicillin drug allergy: A prospective study of amoxicillin skin testing 634 Nikolaos Syrigos Stavros Tzelepis Evaluation of amoxicillin drug allergy: A prospective study of amoxicillin skin testing 634 Iris Espinosa Hidalgo Javier Fernandez Usefulness of skin tests in radiological contrast media reactions 1050 Iris Espinosa Hidalgo Maria Ruano-Zaragoza Usefulness of skin tests in radiological contrast media reactions 1050 Iris Espinosa Hidalgo Norma Guerra-Solis Usefulness of skin tests in radiological contrast media reactions 1050 Iris Espinosa Hidalgo Teodorikez Jimenez-Rodriguez Usefulness of skin tests in radiological contrast media reactions 1050 Ana Prieto-Moreno Pfeifer Diana Prez-Alzate Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Elisa Haroun-D\\xadaz Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Francisco Javier Ruano Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Gabriela Canto Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Isabel Torres-Rojas Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Maria Vzquez De La Torre Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Maria Desamparados Cervera Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Maria Luisa Somoza Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Natalia Blanca-Lpez Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Ana Prieto-Moreno Pfeifer Paula Lpez-Gonzlez Descriptive study of selective reactions to NSAIDs in a referral hospital 1062 Maria  Vanessa Chica Belen De La Hoz Utility of basotest in the perioperatory anaphilaxy our experience 1143 Maria  Vanessa Chica Emilio Solano Utility of basotest in the perioperatory anaphilaxy our experience 1143 Maria  Vanessa Chica Lourdes Palomino Utility of basotest in the perioperatory anaphilaxy our experience 1143 Maria  Vanessa Chica Raquel Cabrera Utility of basotest in the perioperatory anaphilaxy our experience 1143 Marta Ochando D\\xadez-Canseco Manuel Prados Castao Fixed exanthema to naproxen with tolerance to ibuprofen and dexketoprofen 1419 Marta Ochando D\\xadez-Canseco Marta Reguero Capilla Fixed exanthema to naproxen with tolerance to ibuprofen and dexketoprofen 1419 Marta Ochando D\\xadez-Canseco Teresa De Aramburu Mera Fixed exanthema to naproxen with tolerance to ibuprofen and dexketoprofen 1419 Laura Ortega Mart\\xadn Joaqu\\xadn Sastre 2 rare possibilities in one patient: Anaphylaxis due to intradermal skin test with amoxicillin 1439 Laura Ortega Mart\\xadn Mar Fernndez-Nieto 2 rare possibilities in one patient: Anaphylaxis due to intradermal skin test with amoxicillin 1439 Laura Ortega Mart\\xadn Marcela Valverde-Monge 2 rare possibilities in one patient: Anaphylaxis due to intradermal skin test with amoxicillin 1439 mihn-sook jue Eunjung park Use of angiotensin receptor antagonists and calcium channel blockers and the risk of skin cancers: A nationwide retrospective cohort study from Korea 380 mihn-sook jue Young Lee Use of angiotensin receptor antagonists and calcium channel blockers and the risk of skin cancers: A nationwide retrospective cohort study from Korea 380 Ignacio Garc\\xada Nez Lorena Moreno-Viedma Descriptive study of our patients with propionic acid hypersensitivity 800 Ignacio Garc\\xada Nez Luis-Manuel Entrenas-Costa Descriptive study of our patients with propionic acid hypersensitivity 800 Ignacio Garc\\xada Nez Maria-Angeles Algaba-Marmol Descriptive study of our patients with propionic acid hypersensitivity 800 Azahara Lpez Raigada A Vera Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex 1067 Azahara Lpez Raigada C Blanco Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex 1067 Azahara Lpez Raigada F Vega Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex 1067 Azahara Lpez Raigada I Bartha Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex 1067 Azahara Lpez Raigada J Mamula Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex 1067 Azahara Lpez Raigada M T Belver Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex 1067 Azahara Lpez Raigada M V Mgica Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex 1067 Albertina Varandas Capelo Clety Llerena Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Gabriela Monteiro Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Hanna Oliveira Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Livia Nascimento Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Mariana Paulsen Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Paula Aarestrup Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Roberta Meireles Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Vivian Arteaga Medical students&rsquo; knowledge about anaphylaxis 1446 Albertina Varandas Capelo Walter Eyer Medical students&rsquo; knowledge about anaphylaxis 1446 Luc\\xada Gonzlez Bravo Ana Nieto-Nieto Anaphylactic reactions with three non-related drugs 466 Luc\\xada Gonzlez Bravo Jimena Laiseca-Garcia Anaphylactic reactions with three non-related drugs 466 Luc\\xada Gonzlez Bravo Maria Dolores Alonso-Diaz De Durana Anaphylactic reactions with three non-related drugs 466 Luc\\xada Gonzlez Bravo Marianela Brandoni-Petrone Anaphylactic reactions with three non-related drugs 466 Luc\\xada Gonzlez Bravo Martina Privitera-Torres Anaphylactic reactions with three non-related drugs 466 Luc\\xada Gonzlez Bravo Miguel Angel Tejedor-Alonso Anaphylactic reactions with three non-related drugs 466 Luc\\xada Gonzlez Bravo Sabela Perez-Codesido Anaphylactic reactions with three non-related drugs 466 Young-Joo Cho Dong Yoon Kang Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Hye-Kyung Park Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Hye-Ryun Kang Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Ji-Su Shim Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Jung-Won Park Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Min-Hye Kim Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Sae-Hoon Kim Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Seoung Ju Park Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Sujeong Kim Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Young-Hee Nam Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Young-Il Koh Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Young-Joo Cho Young-Min Ye Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry 481 Rita Limo Amlia Sp\\xadnola Santos An unusual IgE mediated hypersensitivity &ndash; two case reports of acetaminophen allergy 1183 Rita Limo Anabela Lopes An unusual IgE mediated hypersensitivity &ndash; two case reports of acetaminophen allergy 1183 Rita Limo Manuel Pereira Barbosa An unusual IgE mediated hypersensitivity &ndash; two case reports of acetaminophen allergy 1183 Rita Limo Maria Conceio Pereira Santos An unusual IgE mediated hypersensitivity &ndash; two case reports of acetaminophen allergy 1183 Najah BEN FADHEL Amel Chaabane Hemophagocytic lymphohistiocytosis overlapping DRESS syndrome: A case series 1303 Najah BEN FADHEL Ferdaous Chahed Hemophagocytic lymphohistiocytosis overlapping DRESS syndrome: A case series 1303 Najah BEN FADHEL Haifa Ben Romdhane Hemophagocytic lymphohistiocytosis overlapping DRESS syndrome: A case series 1303 Najah BEN FADHEL Helmi Ammar Hemophagocytic lymphohistiocytosis overlapping DRESS syndrome: A case series 1303 Najah BEN FADHEL Karim Aouam Hemophagocytic lymphohistiocytosis overlapping DRESS syndrome: A case series 1303 Najah BEN FADHEL Nadia Ben Fredj Hemophagocytic lymphohistiocytosis overlapping DRESS syndrome: A case series 1303 Amelie Gauthier Anca Mirela Chiriac Immediate allergy to platinum based chemotherapy in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC) 1426 Amelie Gauthier Farid Mankouri Immediate allergy to platinum based chemotherapy in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC) 1426 Amelie Gauthier Olivia Sgarbura Immediate allergy to platinum based chemotherapy in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC) 1426 Amelie Gauthier Pascal Demoly Immediate allergy to platinum based chemotherapy in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC) 1426 \\x96zge Can Bostan Ali Fuat Kalyoncu Successful desensitization with chemotherapeutic drugs: A tertiary care center experience 425 \\x96zge Can Bostan Ebru \\x87elebioglu Successful desensitization with chemotherapeutic drugs: A tertiary care center experience 425 \\x96zge Can Bostan Gl Karakaya Successful desensitization with chemotherapeutic drugs: A tertiary care center experience 425 \\x96zge Can Bostan Mehmet Erdem \\x87akmak Successful desensitization with chemotherapeutic drugs: A tertiary care center experience 425 \\x96zge Can Bostan \\x96zge \\x96ztrk Aktas Successful desensitization with chemotherapeutic drugs: A tertiary care center experience 425 \\x96zge Can Bostan Saltuk Bugra Kaya Successful desensitization with chemotherapeutic drugs: A tertiary care center experience 425 Clara Gaudin Bertine Flokstra De Blok Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Dermot Ryan Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Elizabeth Angier Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Jan Willem Kocks Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Jantina Van Der Velde Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin K. Romberg Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Luciana Kase Tanno Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Myriam Mamodaly Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Pascal Demoly Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Clara Gaudin Radek Gawlik Drug hypersensitivity (DH) logograms: Diagnostic and management decision support tools in primary care to optimize health care pathways 1033 Marion Aline Rene RAMASSAMY Alain Didier Piperacillin-tazobactam-induced fever in chronic respiratory disease: safe provocation test under premedication 1375 Marion Aline Rene RAMASSAMY Claire Mailhol Piperacillin-tazobactam-induced fever in chronic respiratory disease: safe provocation test under premedication 1375 Marion Aline Rene RAMASSAMY Isabelle Recoche Piperacillin-tazobactam-induced fever in chronic respiratory disease: safe provocation test under premedication 1375 Marion Aline Rene RAMASSAMY Laurent Guilleminault Piperacillin-tazobactam-induced fever in chronic respiratory disease: safe provocation test under premedication 1375 Marion Aline Rene RAMASSAMY Marlne Murris Piperacillin-tazobactam-induced fever in chronic respiratory disease: safe provocation test under premedication 1375 Maria  Vanessa Chica Alicia Barra The utility of basophil activation test&nbsp; as a diagnostic tool in metamizol sensitization 1464 Maria  Vanessa Chica Belen De La Hoz The utility of basophil activation test&nbsp; as a diagnostic tool in metamizol sensitization 1464 Maria  Vanessa Chica Lourdes Palomino The utility of basophil activation test&nbsp; as a diagnostic tool in metamizol sensitization 1464 Maria  Vanessa Chica Pilar Berges The utility of basophil activation test&nbsp; as a diagnostic tool in metamizol sensitization 1464 Maria  Vanessa Chica Raquel Cabrera The utility of basophil activation test&nbsp; as a diagnostic tool in metamizol sensitization 1464 caroline boutelleau Alexis Bocquet Cross-reactivity between penicillins and carbapenems in a patient with a delayed hypersensitivity 136 caroline boutelleau Catharina Chatain Cross-reactivity between penicillins and carbapenems in a patient with a delayed hypersensitivity 136 caroline boutelleau Isabelle Boccon-Gibod Cross-reactivity between penicillins and carbapenems in a patient with a delayed hypersensitivity 136 caroline boutelleau Marie Thrse Leccia Cross-reactivity between penicillins and carbapenems in a patient with a delayed hypersensitivity 136 caroline boutelleau Pauline Pralong Cross-reactivity between penicillins and carbapenems in a patient with a delayed hypersensitivity 136 caroline boutelleau Valentina Zambelli Cross-reactivity between penicillins and carbapenems in a patient with a delayed hypersensitivity 136 Jana Vydlakova Darina Sediva Allergic reaction to L-thyroxine in a patient with poor response to thyroid hormone supplementation 215 Giuseppe Parrinello Alessandro Buonomo Metronidazole hypersensitivity in a patient with angioedema and systemic rash 446 Giuseppe Parrinello Angela Rizzi Metronidazole hypersensitivity in a patient with angioedema and systemic rash 446 Giuseppe Parrinello Arianna Aruanno Metronidazole hypersensitivity in a patient with angioedema and systemic rash 446 Giuseppe Parrinello Eleonora Nucera Metronidazole hypersensitivity in a patient with angioedema and systemic rash 446 Maria Ntakoula Caterina Chlica Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) 567 Maria Ntakoula Christos Fokoloros Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) 567 Maria Ntakoula Evangelia Chytiroglou Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) 567 Maria Ntakoula Evangelia Papadavid Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) 567 Maria Ntakoula Michael Makris Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) 567 Maria Ntakoula Xenophon Aggelides Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) 567 Giulia Costanzo Davide Firinu Accidental exposure to the JAK-inhibitor baricitinib during pregnancy in Rheumatoid Arthritis: A case report 582 Giulia Costanzo Francesca Losa Accidental exposure to the JAK-inhibitor baricitinib during pregnancy in Rheumatoid Arthritis: A case report 582 Giulia Costanzo Margherita Deidda Accidental exposure to the JAK-inhibitor baricitinib during pregnancy in Rheumatoid Arthritis: A case report 582 Giulia Costanzo Maria Pina Barca Accidental exposure to the JAK-inhibitor baricitinib during pregnancy in Rheumatoid Arthritis: A case report 582 Giulia Costanzo Maria Rita Messina Accidental exposure to the JAK-inhibitor baricitinib during pregnancy in Rheumatoid Arthritis: A case report 582 Giulia Costanzo Stefano Del Giacco Accidental exposure to the JAK-inhibitor baricitinib during pregnancy in Rheumatoid Arthritis: A case report 582 Chiara Jiamin Chong Adrian Kwok Wai Chan Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Chiara Jiamin Chong Chaw Su Naing Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Chiara Jiamin Chong Haur Yueh Lee Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Chiara Jiamin Chong Ibrahim Muhammad Hanif Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Chiara Jiamin Chong Janet Beng Neo Khoo Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Chiara Jiamin Chong Karen Jui Lin Choo Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Chiara Jiamin Chong Kavitha Garuna Murthee Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Chiara Jiamin Chong Kheng Yong Ong Outcomes of an outpatient drug allergy evaluation clinic in a tertiary hospital 852 Laura del Mar Vasquez Castillo Carlos Daniel Serrano Reyes Cross reaction anaphyilaxis to non-steroidal antiinflammatory drugs (NSAIDs) 1039 Laura del Mar Vasquez Castillo Diana Lucia Silva Espinosa Cross reaction anaphyilaxis to non-steroidal antiinflammatory drugs (NSAIDs) 1039 Laura del Mar Vasquez Castillo Luis Fernando Ramirez Zuluaga Cross reaction anaphyilaxis to non-steroidal antiinflammatory drugs (NSAIDs) 1039 Irene Bartha de las Peas Andrea Vera Hand-foot exfoliative dermatitis after administration of parenteral iodinated contrast media 1061 Irene Bartha de las Peas Azahara Lopez-Raigada Hand-foot exfoliative dermatitis after administration of parenteral iodinated contrast media 1061 Irene Bartha de las Peas Carlos Blanco Hand-foot exfoliative dermatitis after administration of parenteral iodinated contrast media 1061 Irene Bartha de las Peas Francisco Vega Hand-foot exfoliative dermatitis after administration of parenteral iodinated contrast media 1061 Irene Bartha de las Peas Victoria Mugica Hand-foot exfoliative dermatitis after administration of parenteral iodinated contrast media 1061 David Enrique Loli Ausejo Carmen Gmez-Traseira Delayed hypersensitivity reaction to metronidazole: A case report of a 11-year old patient 1128 David Enrique Loli Ausejo Mnica Rodr\\xadguez-Alvarez Delayed hypersensitivity reaction to metronidazole: A case report of a 11-year old patient 1128 Ilaria Bisconti Caroline Gilbert Pseudoephedrine induced baboon syndrome confirmed by oral provocation test 191 Ilaria Bisconti Raj K Rajakulasingam Pseudoephedrine induced baboon syndrome confirmed by oral provocation test 191 Ilaria Bisconti Sheena Barnett Pseudoephedrine induced baboon syndrome confirmed by oral provocation test 191 Ilaria Bisconti Thippeswamy Billahalli Pseudoephedrine induced baboon syndrome confirmed by oral provocation test 191 Ilaria Bisconti Timothy J Watts Pseudoephedrine induced baboon syndrome confirmed by oral provocation test 191 Jan Walter Schroeder Alessandro Toscano Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Andrea Toniato Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Chiara Gamba Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Daniela Angela Macellaio Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Eleonoro Brusamolino Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Elide Anna Pastorello Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Joseph Scibilia Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Luca Giuseppe Balossi Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Scarlet Bernal Ortiz Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Valentina Caputo Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Jan Walter Schroeder Valeria Fabbri Diagnostic role of HHV-6 reactivation in a study population of 27 Italian patients affected by DRESS 856 Temyrzhan Nurpeissov Tair Nurpeissov Preventing hypersensitivity reactions to local anesthetics 881 Beatriz Gonzlez-Cano Alicia Gmez-Lpez Subacute eczema after dexamethasone suppression test 964 Beatriz Gonzlez-Cano Diana Betancor-Prez Subacute eczema after dexamethasone suppression test 964 Beatriz Gonzlez-Cano Joaquin Sastre Subacute eczema after dexamethasone suppression test 964 Beatriz Gonzlez-Cano Marcela Valverde-Monge Subacute eczema after dexamethasone suppression test 964 Isabel Torres Rojas Ana Prieto-Moreno Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Diana Prez-Alzate Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Elisa Haroun-D\\xadaz Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Francisco Javier Ruano Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Gabriela Canto Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Maria Vzquez De La Torre Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Maria Desamparados Cervera Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Maria Luisa Somoza \\x81lvarez Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Natalia Blanca-Lpez Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Isabel Torres Rojas Paula Lpez-Gonzlez Allergological evaluation of hypersensitivity reactions to betalactams in children 1090 Sergii Zaikov Artemii Bogomolov The problem of hypersensitivity to drugs in patients with lung tuberculosis 1110 Nicola Giangrande Concepcion Cordobes Duran Delayed hypersensitivity reaction to Adalilumab diagnosed by in vivo study 1312 Nicola Giangrande Jesus Miguel Garc\\xada Menaya Delayed hypersensitivity reaction to Adalilumab diagnosed by in vivo study 1312 Nicola Giangrande Mariana Marcos Fernandez Delayed hypersensitivity reaction to Adalilumab diagnosed by in vivo study 1312 Nicola Giangrande Pedro Bobadilla Gonzalez Delayed hypersensitivity reaction to Adalilumab diagnosed by in vivo study 1312 Nevzat Baskaya Aysegul Ertugrul Drug provocation tests in children with reactions related to beta-lactam antibiotics 1323 Nevzat Baskaya Saliha Esenboga Drug provocation tests in children with reactions related to beta-lactam antibiotics 1323 Nevzat Baskaya Serap Ozmen Drug provocation tests in children with reactions related to beta-lactam antibiotics 1323 Osman Ozan Yegit Asli Gelincik Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Osman Ozan Yegit Bahattin \\x87olakoglu Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Osman Ozan Yegit Derya \\x9cnal Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Osman Ozan Yegit Mge Olga Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Osman Ozan Yegit Ramazan Ersoy Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Osman Ozan Yegit Sacide Rana isik Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Osman Ozan Yegit Semra Demir Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Osman Ozan Yegit Suna Bykztrk Is tetracycli?ne HCL treatment safe i?n pati?ents wi?th beta-lactam allergy? 870 Albertina Varandas Capelo Camila Martins Chieza Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Albertina Varandas Capelo Eliane Miranda Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Albertina Varandas Capelo Gabriela Monteiro Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Albertina Varandas Capelo Livia Nascimento Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Albertina Varandas Capelo Mariana Domingues Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Albertina Varandas Capelo Mariana Paulsen Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Albertina Varandas Capelo Norma Rubini Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Albertina Varandas Capelo Roberta Meireles Safety of oral desensitization to penicillin for the treatment of pregnant women with syfilis 1417 Selda Ali Alina Ivasciuc Profile of nonsteroidal anti-inflammatory drugs hypersensitive patients who underwent oral challenge test with alternative drug&nbsp; 1532 Selda Ali Larisa Ionela Stefanescu Profile of nonsteroidal anti-inflammatory drugs hypersensitive patients who underwent oral challenge test with alternative drug&nbsp; 1532 Selda Ali Roxana Silvia Bumbacea Profile of nonsteroidal anti-inflammatory drugs hypersensitive patients who underwent oral challenge test with alternative drug&nbsp; 1532 Selda Ali Sabina Loredana Corcea Profile of nonsteroidal anti-inflammatory drugs hypersensitive patients who underwent oral challenge test with alternative drug&nbsp; 1532 Zainab Ridha \\x89milie Proulx Mixed progestogen hypersensitivity in a patient using&nbsp;a combined contraceptive skin patch: A case report 1557 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'ENT',\n",
       "  'session': 'TPS 09 ENT ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921303,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 09 ENT  Takahisa Murata Tatsuro Nakamura 8-iso prostaglandin E2 causes nasal congestion in allergic rhinitis of mice 35 Takahisa Murata Yuri Tachibana 8-iso prostaglandin E2 causes nasal congestion in allergic rhinitis of mice 35 Sui-zi ZHOU  Long-term defects of nasal epithelium barrier functions in patients with nasopharyngeal carcinoma post chemo-radiotherapy 725 Jun Wang Jing Ye Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 144 Jun Wang Meng-Yue Li Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 144 Jun Wang Xue Kang Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 144 Jun Wang Zhi-Qun Huang Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis 144 Soo Whan Kim Do Hyun Kim Intranasal azelastine and mometasone exhibit a synergistic effect on a murine model of allergic rhinitis 831 Soo Whan Kim Il Hwan Lee Intranasal azelastine and mometasone exhibit a synergistic effect on a murine model of allergic rhinitis 831 Jing Ye Li Shen Clinical efficacy and mechanism of endoscopic vidian neurectomy for allergic rhinitis 163 Yaqi Peng Qing-Ling Fu Immunomodulatory effects of mesenchymal stem cells-derived small extracellular vesicles on dendritic cells via IL-10 in patients with allergic rhinitis 222 Yaqi Peng Zhi-Bin Xu Immunomodulatory effects of mesenchymal stem cells-derived small extracellular vesicles on dendritic cells via IL-10 in patients with allergic rhinitis 222 Rui Zheng Jianbo Shi Th2-response-amplifying function of dcs by combinatorial IL-17RB, ST2 and TSLPR signaling is associated with allergic rhinitis severity 51 Rui Zheng Qintai Yang Th2-response-amplifying function of dcs by combinatorial IL-17RB, ST2 and TSLPR signaling is associated with allergic rhinitis severity 51 Rui Zheng Yang Chen Th2-response-amplifying function of dcs by combinatorial IL-17RB, ST2 and TSLPR signaling is associated with allergic rhinitis severity 51 Rui Zheng Yueqi Sun Th2-response-amplifying function of dcs by combinatorial IL-17RB, ST2 and TSLPR signaling is associated with allergic rhinitis severity 51 Seung Min In Hong Geun An The effect of intermittent hypoxia on human airway mucosa 44 Seung Min In Ki-Il Lee The effect of intermittent hypoxia on human airway mucosa 44 Dong-Kyu Kim Dae Woo Kim Enhanced type 2 immune reaction by increased IL-22/IL-22ra1 signaling in chronic rhinosinusitis with nasal polyp 76 Dong-Kyu Kim Joon Kon Kim Enhanced type 2 immune reaction by increased IL-22/IL-22ra1 signaling in chronic rhinosinusitis with nasal polyp 76 CHEN - CAO Sifei - Yu Increase in IL-17-positive cells in sinonasal inverted papilloma 188 Jun Wang Jing Ye Comparison of buffered 2.3% and buffered 0.9% nasal saline sprays in eosinophilic chronic rhinosinusitis with polyposis in chinese adults after endoscopic sinus surgery 353 Jun Wang Meng-Yue Li Comparison of buffered 2.3% and buffered 0.9% nasal saline sprays in eosinophilic chronic rhinosinusitis with polyposis in chinese adults after endoscopic sinus surgery 353 Jun Wang Zhi-Qun Huang Comparison of buffered 2.3% and buffered 0.9% nasal saline sprays in eosinophilic chronic rhinosinusitis with polyposis in chinese adults after endoscopic sinus surgery 353 Teet Pullerits Bo Lundbck Incidence and remission of allergic rhinitis in a Swedish adult population<br /> 546 Teet Pullerits Bright I Nwaru Incidence and remission of allergic rhinitis in a Swedish adult population<br /> 546 Teet Pullerits Helena Backman Incidence and remission of allergic rhinitis in a Swedish adult population<br /> 546 Teet Pullerits Linda Ekerljung Incidence and remission of allergic rhinitis in a Swedish adult population<br /> 546 Teet Pullerits Madeleine Rdinger Incidence and remission of allergic rhinitis in a Swedish adult population<br /> 546 David Enrique Loli Ausejo Mar\\xada Pedrosa Prevalence of Quercus ilex sensitization in pollen allergic patients in Madrid, Spain 1170 David Enrique Loli Ausejo Rosa Rodr\\xadguez-Prez Prevalence of Quercus ilex sensitization in pollen allergic patients in Madrid, Spain 1170 David Enrique Loli Ausejo Santiago Quirce Prevalence of Quercus ilex sensitization in pollen allergic patients in Madrid, Spain 1170 Dina Sayed Sheha Amira Ramadan Elmahdi Association between Dyslipidemia and Allergic Rhinitis 1255 Dina Sayed Sheha Lobna Abdelaziz El-Korashi Association between Dyslipidemia and Allergic Rhinitis 1255 Dina Sayed Sheha Marwa Abdelazim Elbegermy Association between Dyslipidemia and Allergic Rhinitis 1255 Irina Nickolaevna Grigorieva Irina Vladimirovna Manina Local production of specific immunoglobulin E to molds in ecological environment of Moscow 498 Gabriella Glffy Arkady Koltun International cross-sectional survey on therapy decision for patients with allergic rhinitis during routine consultation 245 Gabriella Glffy Duc Tung Nguyen International cross-sectional survey on therapy decision for patients with allergic rhinitis during routine consultation 245 Gabriella Glffy Ferdinand Kopietz International cross-sectional survey on therapy decision for patients with allergic rhinitis during routine consultation 245 Gabriella Glffy Hans Christian Kuhl International cross-sectional survey on therapy decision for patients with allergic rhinitis during routine consultation 245 Gabriella Glffy Melanie Emmeluth International cross-sectional survey on therapy decision for patients with allergic rhinitis during routine consultation 245 Galateja Jordakieva Erika Jensen-Jarolim Impact of cetirizine on allergen-induced blood cell dynamics in male and female allergic rhinitis subjects 1024 Galateja Jordakieva Michael Kundi Impact of cetirizine on allergen-induced blood cell dynamics in male and female allergic rhinitis subjects 1024 Galateja Jordakieva Patrick Lemell Impact of cetirizine on allergen-induced blood cell dynamics in male and female allergic rhinitis subjects 1024 Galateja Jordakieva Petra Zieglmayer Impact of cetirizine on allergen-induced blood cell dynamics in male and female allergic rhinitis subjects 1024 Galateja Jordakieva Ren Zieglmayer Impact of cetirizine on allergen-induced blood cell dynamics in male and female allergic rhinitis subjects 1024 Galateja Jordakieva Richard Crevenna Impact of cetirizine on allergen-induced blood cell dynamics in male and female allergic rhinitis subjects 1024 Roxana Lucia Sfrent Cornateanu Catalin Tucureanu Chemokines associated with allergic rhinitis 1339 Roxana Lucia Sfrent Cornateanu Daciana Marta Chemokines associated with allergic rhinitis 1339 Roxana Lucia Sfrent Cornateanu Ileana Constantinescu Chemokines associated with allergic rhinitis 1339 Roxana Lucia Sfrent Cornateanu Nicolae Ovidiu Berghi Chemokines associated with allergic rhinitis 1339 Roxana Lucia Sfrent Cornateanu Ramona Caragheorgheopol Chemokines associated with allergic rhinitis 1339 Oxana Kurbacheva Olga Ostankova Real-world data on Chronic Rhinosinusitis with Nasal Polyps in Russia from open internet sources assessed by artificial intelligence 496 Oxana Kurbacheva Vladimir Bulatov Real-world data on Chronic Rhinosinusitis with Nasal Polyps in Russia from open internet sources assessed by artificial intelligence 496 Oxana Kurbacheva Vladimir Kozlov Real-world data on Chronic Rhinosinusitis with Nasal Polyps in Russia from open internet sources assessed by artificial intelligence 496 Oxana Kurbacheva Yuliya Solovkina Real-world data on Chronic Rhinosinusitis with Nasal Polyps in Russia from open internet sources assessed by artificial intelligence 496 Annina Lyly Anu Laulajainen-Hongisto Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Heikki Turpeinen Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Johanna Sahlman Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Juha Pekkanen Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Jura Numminen Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Jyri Myller Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Paula Kauppi Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Saara Sillanp Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Sanna Toppila-Salmi Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Annina Lyly Seija Vento Factors affecting upper airway control of NSAID-excacerbated respiratory disease 453 Almudena Testera-Montes Adriana Ariza Endophenotype of patients with local allergic rhinitis by Alternaria alternata 843 Almudena Testera-Montes Carmen Rondon Endophenotype of patients with local allergic rhinitis by Alternaria alternata 843 Almudena Testera-Montes Ibon Eguiluz-Gracia Endophenotype of patients with local allergic rhinitis by Alternaria alternata 843 Almudena Testera-Montes Maria Salas Cassinello Endophenotype of patients with local allergic rhinitis by Alternaria alternata 843 Almudena Testera-Montes Maria Jos Torres Endophenotype of patients with local allergic rhinitis by Alternaria alternata 843 Yong Li Zhiqi Ma Efficacy of active probiotics in allergic rhinitis in children: An observational study on 342 patients 543 Semah  Abdu Andrew Mckenzie IL-25R-expressing B cells in chronic rhinosinusitis with nasal polyps 1197 Semah  Abdu Claire Hopkins IL-25R-expressing B cells in chronic rhinosinusitis with nasal polyps 1197 Semah  Abdu Grzegorz Woszczek IL-25R-expressing B cells in chronic rhinosinusitis with nasal polyps 1197 Semah  Abdu Jane Xia IL-25R-expressing B cells in chronic rhinosinusitis with nasal polyps 1197 Semah  Abdu Stephen Till IL-25R-expressing B cells in chronic rhinosinusitis with nasal polyps 1197 Igor Kaidashev H Morokhovets Patterns in google trends terms reporting of rhinitis in the alternaria mold spore season in Ukraine 918 Igor Kaidashev J Bousquet Patterns in google trends terms reporting of rhinitis in the alternaria mold spore season in Ukraine 918 Igor Kaidashev L M Dubuske Patterns in google trends terms reporting of rhinitis in the alternaria mold spore season in Ukraine 918 Igor Kaidashev O Bilous Patterns in google trends terms reporting of rhinitis in the alternaria mold spore season in Ukraine 918 Igor Kaidashev V Rodinkova Patterns in google trends terms reporting of rhinitis in the alternaria mold spore season in Ukraine 918 Giovanni Paoletti Enrico Heffler Extended exhaled nitric oxide analysis and&nbsp;small lower airway functional impairment in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 512 Giovanni Paoletti Francesca Pirola Extended exhaled nitric oxide analysis and&nbsp;small lower airway functional impairment in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 512 Giovanni Paoletti Francesca Puggioni Extended exhaled nitric oxide analysis and&nbsp;small lower airway functional impairment in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 512 Giovanni Paoletti Francesca Racca Extended exhaled nitric oxide analysis and&nbsp;small lower airway functional impairment in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 512 Giovanni Paoletti Giorgio Walter Canonica Extended exhaled nitric oxide analysis and&nbsp;small lower airway functional impairment in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 512 Giovanni Paoletti Giulio Melone Extended exhaled nitric oxide analysis and&nbsp;small lower airway functional impairment in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 512 Giovanni Paoletti Luca Malvezzi Extended exhaled nitric oxide analysis and&nbsp;small lower airway functional impairment in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 512 Andrea Melis Adriana Pintus A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Davide Rizzo A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Fabio Sultani A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Francesco Bussu A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Francesco Tanda A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Laura Maria De Luca A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Paolo Castiglia A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Pietro Pirina A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Silvia Atzei A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Andrea Melis Susanna Casula A prospective study about effects of endoscopic sinus surgery on upper and lower airways performance 525 Jonathan Corren Claus Bachert Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Joaquim Mullol Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Lutaf Islam Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Peter H Wellings Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Philippe Gevaert Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Rebecca Saenz Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Rui Zhao Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Thoedore Omachi Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Jonathan Corren Xavier Jaumont Omalizumab responders analysis in nasal polyposis: A supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials 714 Doston Mirkomilovich Sultonov Ulugbek Saidakramovich Khasanov Histological examination of patients with nasal polyposis and features of chronic polypoid rhinosinusitis in Uzbekistan region. Analysis report of 50 cases with chronic polypoid rhinosinusitis 1289 Min Zhou Yan Ruan SERPINE1 affect the proliferation of human nasal epithelial cells through p53 signaling pathway 1264 Ana Vukicevic Milanovic Aleksandra Peric Popadic Incidence of atopic constitution in children with otitis media with effusion 1045 Ana Vukicevic Milanovic Ivan Djordjevic Incidence of atopic constitution in children with otitis media with effusion 1045 Ana Vukicevic Milanovic Miljan Milanovic Incidence of atopic constitution in children with otitis media with effusion 1045 Francesca Pirola Armando De Virgilio Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Francesca Pirola Enrico Heffler Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Francesca Pirola Fabio Ferreli Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Francesca Pirola Giorgio Walter Canonica Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Francesca Pirola Giovanni Paoletti Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Francesca Pirola Giuseppe Mercante Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Francesca Pirola Giuseppe Spriano Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Francesca Pirola Luca Malvezzi Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of &ldquo;reboot&rdquo; surgery 395 Zhao-Ni Wang De Yun Wang Upregulation of cell-surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection 755 Zhao-Ni Wang Kai Sen Tan Upregulation of cell-surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection 755 Zhao-Ni Wang Zhuang Gui Chen Upregulation of cell-surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection 755 Aspasia Karavelia  Otitis media with effusion in children with allergic rhinitis  201 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Environmental and occupational allergy',\n",
       "  'session': 'TPS 10 Environmental and occupational allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921305,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 10 Environmental and occupational allergy Charlotte Sindt Gilles Oliver Evolution of ragweed pollination in France 770 Charlotte Sindt Michel Thibaudon Evolution of ragweed pollination in France 770 Charlotte Sindt Samuel Monnier Evolution of ragweed pollination in France 770 Minyoung Jung Junyoung An Impact of parental urinary cotinine-verified smoking status on allergic diseases in children and adolescents: Analysis of population-based nationally representative data 516 Nadja Stru\\x9f Claudia Mattern An oil-based nasal gel for the treatment of seasonal allergic rhinitis 300 Nadja Stru\\x9f Jens M Hohlfeld An oil-based nasal gel for the treatment of seasonal allergic rhinitis 300 Nadja Stru\\x9f Philipp Badorrek An oil-based nasal gel for the treatment of seasonal allergic rhinitis 300 Nadja Stru\\x9f Udo Mattern An oil-based nasal gel for the treatment of seasonal allergic rhinitis 300 Ingrida Sauliene Gediminas Valiulis New opportunities for hay fever patients in Lithuania: Allergenic pollen load in real-time 573 Ingrida Sauliene Gintautas Daunys New opportunities for hay fever patients in Lithuania: Allergenic pollen load in real-time 573 Ingrida Sauliene Laura Sukiene New opportunities for hay fever patients in Lithuania: Allergenic pollen load in real-time 573 Ingrida Sauliene Lukas Vaitkevicius New opportunities for hay fever patients in Lithuania: Allergenic pollen load in real-time 573 Juan Rodriguez-Coira Alma Villaseor Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Carmen Moreno-Aguilar Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Cezmi A Akdis Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Cristina Gmez-Casado Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Domingo Barber Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Javier Snchez-Solares Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Milena Sokolowska Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Urszula Radzikowska Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Juan Rodriguez-Coira Vanesa Saiz Severe olive pollen allergic patients present a distinctive T cell and cytokine profile 383 Stefan Schaefer Joerg Haus The impact of deep learning algorithms on airborne pollen monitoring with the BAA500 1035 Stefan Schaefer Rouven Moeller The impact of deep learning algorithms on airborne pollen monitoring with the BAA500 1035 Stefan Schaefer Thomas Berlage The impact of deep learning algorithms on airborne pollen monitoring with the BAA500 1035 Danylo Oleksandrovych Tovstyk Iryna Vovk Alternaria and other fungal spores associated with Ambrosia pollen in Ukraine<br /> 1218 Danylo Oleksandrovych Tovstyk Maryna Yasniuk Alternaria and other fungal spores associated with Ambrosia pollen in Ukraine<br /> 1218 Danylo Oleksandrovych Tovstyk Olena Palamarchuk Alternaria and other fungal spores associated with Ambrosia pollen in Ukraine<br /> 1218 Danylo Oleksandrovych Tovstyk Olga Kaminska Alternaria and other fungal spores associated with Ambrosia pollen in Ukraine<br /> 1218 Danylo Oleksandrovych Tovstyk Victoria Rodinkova Alternaria and other fungal spores associated with Ambrosia pollen in Ukraine<br /> 1218 Dae Hyun Lim Dong Jun Ha Effect of PM10 exposure time on the clinic visits of allergic rhinitis in South Korea 74 Dae Hyun Lim Jeong Hee Kim Effect of PM10 exposure time on the clinic visits of allergic rhinitis in South Korea 74 Tsuyoshi Oguma Jun Tanaka Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune<br /> 692 Tsuyoshi Oguma Katsuhiko Kamei Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune<br /> 692 Tsuyoshi Oguma Katsuyoshi Tomomatsu Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune<br /> 692 Tsuyoshi Oguma Koichiro Asano Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune<br /> 692 Tsuyoshi Oguma Naoki Okada Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune<br /> 692 Tsuyoshi Oguma Takashi Ishiguro Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune<br /> 692 NARESH SINGH Naveen Arora Diesel exhaust exposure induced microRNA dysregulation leads to collagen deposition via TGF-&beta; signalling 495 Jae Won Oh Ju-Young Shin Allergenic pollen calendar in Korea based on probability distribution models and up-to-date observation 263 Jae Won Oh Kyu Rang Kim Allergenic pollen calendar in Korea based on probability distribution models and up-to-date observation 263 Jae Won Oh Young Jin Choi Allergenic pollen calendar in Korea based on probability distribution models and up-to-date observation 263 Caroline Brigido Paredes Isabel Fernandez De Alba Porcel Monosensitized Cypress pollen allergy patients: Is there an actual difference? 1281 Caroline Brigido Paredes Laura Manzanedo Ortega Monosensitized Cypress pollen allergy patients: Is there an actual difference? 1281 Caroline Brigido Paredes Patricia Alloza Gomez Monosensitized Cypress pollen allergy patients: Is there an actual difference? 1281 Caroline Brigido Paredes Pedro Carretero Anibarro Monosensitized Cypress pollen allergy patients: Is there an actual difference? 1281 Caroline Brigido Paredes Reyes Perez Gimenez Monosensitized Cypress pollen allergy patients: Is there an actual difference? 1281 Nimai Chandra Saha Sanjoy Podder* Association of CD14 C(-159)T polymorphism and aeroallergens induced asthma among Indians 40 Ezgi Ulusoy Sevracan Aysegul Ertugrul Characteristics of cat sensitivity in children living in Central Anatolia 1053 Ezgi Ulusoy Sevracan I?lknur Bostanci Characteristics of cat sensitivity in children living in Central Anatolia 1053 Ezgi Ulusoy Sevracan Nevzat Baskaya Characteristics of cat sensitivity in children living in Central Anatolia 1053 Ezgi Ulusoy Sevracan Zeynep Sengul Emeksiz Characteristics of cat sensitivity in children living in Central Anatolia 1053 Anne K Elis Christopher Carlsten Efficacy of fexofenadine HCL 180 mg vs placebo in seasonal allergic rhinitis aggravated in presence of air pollutants: Phase 3, sequential and parallel-group, double-blind, randomized study 1262 Anne K Elis Margarita Murrieta-Aguttes Efficacy of fexofenadine HCL 180 mg vs placebo in seasonal allergic rhinitis aggravated in presence of air pollutants: Phase 3, sequential and parallel-group, double-blind, randomized study 1262 Anne K Elis Sandy Furey Efficacy of fexofenadine HCL 180 mg vs placebo in seasonal allergic rhinitis aggravated in presence of air pollutants: Phase 3, sequential and parallel-group, double-blind, randomized study 1262 Tara Maria Hoffmann Alessandro Travaglini &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Alfred Priftanji &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Ana Maria Pereira &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Andrea Barbalace &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Andrea Di Rienzo Businco &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Angel Mazon &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Anne Bourgoin &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Antonio Nieto &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Ayce \\x96ztrk &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Aydan Acar Sahin &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Aykut Guvensen &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Blerina Bregu &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Blerta Lame &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Cansin Sackesen &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Claire Dimier &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Dah Tay Jang &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Denis Charpin &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Dolores Hernandez &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Duygu Yazici &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Ekaterina Potapova &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Elisabetta Pellegrini &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Elsa Caeiro &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Eris Mesonjesi &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Fotis Psarros &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Fusun Kalpaklioglu &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Giovanni Pajno &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Ifigenia Sfika &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Ilenia Panasiti &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Javier Suarez &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Joao A Fonseca &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Laurie Pahus &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Lucia Caminiti &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Luis Delgado &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Maria V Dimou &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Maria Antonia Brighetti &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Mariana Couto &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Mariana Pereira &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Michael Makris &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Michel Thibaudon &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Nikos G Papadopoulos &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Nur Munevver Pinar &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Oliver Pfaar &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Ozlem Goksel &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann P Xepapadaki &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Paolo M Matricardi &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Ruth Llusar &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Salvatore Tripodi &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Simone Pelosi &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Stefania Arasi &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Stephanie Dramburg &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Sule Caglayan Sozmen &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Valentina Panetta &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Valentine Verdier &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Valeria Villella &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Tara Maria Hoffmann Xenophon Aggelides &ldquo;whole&rdquo; vs. &ldquo;fragmented&rdquo; approach to EAACI pollen season definitions: A multicenter study in six Southern European cities 12 Takashi Kanno Daisuke Yamanaka Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Takashi Kanno Hiroki Matsuhara Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Takashi Kanno Katsuyo Ohashi-Doi Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Takashi Kanno Ken-Ichi Ishibashi Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Takashi Kanno Naohito Ohno Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Takashi Kanno Rie Hiratsuka Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Takashi Kanno Yoichiro Iwakura Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Takashi Kanno Yoshiyuki Adachi Latent 1,3-&beta;-D-glucan in Japanese cedar pollen facilitated allergen-specific IgE production 491 Hang Li Christopher Carlsten Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Hang Li Christopher F. Rider Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Hang Li Maria J. Aristizabal Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Hang Li Min Hyung Ryu Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Hang Li Rachel L. Clifford Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Hang Li Shuyu Fan Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Hang Li Wayne Tse Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Hang Li Weiping Wen Predominant DNMT and TET enzymes mediate environmental exposure effects in the bronchial epithelium in a controlled human exposure study 734 Paulina Misiukiewicz-Stepien Magdalena Paplinska-Goryca The response of healthy nasal epithelium to urban particulate matter stimulation in triple co-cultures of macrophages, epithelium and dendritic cells 291 Paulina Misiukiewicz-Stepien Michal Mierzejewski The response of healthy nasal epithelium to urban particulate matter stimulation in triple co-cultures of macrophages, epithelium and dendritic cells 291 Paulina Misiukiewicz-Stepien Rafal Krenke The response of healthy nasal epithelium to urban particulate matter stimulation in triple co-cultures of macrophages, epithelium and dendritic cells 291 Maria Luisa Somoza Eva Fernandez Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Francisco Javier Ruano Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Gabriela Canto Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Isabel Torres-Rojas Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Jose Damian Lopez-Sanchez Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Laura Martin-Pedraza Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Laura Victorio Puche Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza M Desamparados Cervera Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Maria Vazquez De La Torre Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Mayte Villalba Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Miguel Blanca Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Miriam Moran Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Natalia Blanca-Lopez Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Maria Luisa Somoza Sandra Sivil Pru p 9 is a new peach tree pollen allergen involved in rhinitis and occupational asthma 1198 Carmen Galn Ana Valle Is the cupressaceae pollen calendar representative of allergy risk period of cup a 1 allergen? 230 Carmen Galn Concepcin De Linares Is the cupressaceae pollen calendar representative of allergy risk period of cup a 1 allergen? 230 Carmen Galn Consuelo Diaz De La Guardia Is the cupressaceae pollen calendar representative of allergy risk period of cup a 1 allergen? 230 Carmen Galn Maria Pilar Plaza Is the cupressaceae pollen calendar representative of allergy risk period of cup a 1 allergen? 230 Carmen Galn Purificacin Alczar Is the cupressaceae pollen calendar representative of allergy risk period of cup a 1 allergen? 230 Joo Young Roh Jaelim Cho Effect of air pollutants on clinic visits&nbsp;of atopic dermatitis patients&nbsp;&nbsp; 697 Joo Young Roh Jin Ok Baek Effect of air pollutants on clinic visits&nbsp;of atopic dermatitis patients&nbsp;&nbsp; 697 Joo Young Roh Se Ha Park Effect of air pollutants on clinic visits&nbsp;of atopic dermatitis patients&nbsp;&nbsp; 697 Joo Young Roh Seul Ki Lee Effect of air pollutants on clinic visits&nbsp;of atopic dermatitis patients&nbsp;&nbsp; 697 Joo Young Roh Shin Young Song Effect of air pollutants on clinic visits&nbsp;of atopic dermatitis patients&nbsp;&nbsp; 697 Joo Young Roh Sunho Kee Effect of air pollutants on clinic visits&nbsp;of atopic dermatitis patients&nbsp;&nbsp; 697 Marina A Mokronosova Tatyana Zheltikova House dust mites and sensitization to indoor allergens in atopic patients in Moscow (1989-1991; 2015-2019) 997 Ana Prieto-Moreno Pfeifer Diana Perez Alzate Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Elisa Haroun-Diaz Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Francisco Feo Brito Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Francisco Javier Ruano Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Gabriela Canto Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Isabel Torres-Rojas Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Maria Vzquez De La Torre Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Maria Desamparados Cervera Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Maria Luisa Somoza Alvarez Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Natalia Blanca-Lopez Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Paula Lopez-Gonzalez Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Rosa Prez Bad\\xada Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Ana Prieto-Moreno Pfeifer Teresa Alfaya Arias Profile of airborne pollen concentrations in a new station in Madrid: Description of pollen levels during the last three years 1235 Laura Haya Bryan Santone Characterization of Der p 1 carrying particles: Ground dust mite and spent culture 1369 Laura Haya James Freihaut Characterization of Der p 1 carrying particles: Ground dust mite and spent culture 1369 Laura Haya Jimmy Yang Characterization of Der p 1 carrying particles: Ground dust mite and spent culture 1369 Laura Haya Karim Saad Characterization of Der p 1 carrying particles: Ground dust mite and spent culture 1369 Laura Haya Suzanne Kelly Characterization of Der p 1 carrying particles: Ground dust mite and spent culture 1369 Laura Haya William H Yang Characterization of Der p 1 carrying particles: Ground dust mite and spent culture 1369 Man Yong Han Eun Kyo Ha Phthalate associated with small airway lung function&nbsp;linked to the periostin 855 Man Yong Han Hey Sung Baek Phthalate associated with small airway lung function&nbsp;linked to the periostin 855 Man Yong Han Hye Mi Jee Phthalate associated with small airway lung function&nbsp;linked to the periostin 855 Man Yong Han Ju Hee Kim Phthalate associated with small airway lung function&nbsp;linked to the periostin 855 Man Yong Han Seung Won Lee Phthalate associated with small airway lung function&nbsp;linked to the periostin 855 Man Yong Han Youn Ho Shin Phthalate associated with small airway lung function&nbsp;linked to the periostin 855 Goutam Kumar Saha Debarati Dey Sensitization to aeroallergens among eastern indian population &ndash; a retrospective study 351 Goutam Kumar Saha Sanjoy Podder Sensitization to aeroallergens among eastern indian population &ndash; a retrospective study 351 Maria Luisa Somoza Ana Prieto-Moreno Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Diana Perez-Alzate Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Elisa Haroun-Diaz Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Eva Fernandez Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Gabriela Canto Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Jose Damian Lopez Sanchez Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Laura Martin-Pedraza Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Laura Victorio Puche Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Mayte Villalba Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Miguel Blanca Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Miriam Moran Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Natalia Blanca-Lopez Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Paula Lopez-Gonzalez Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 Maria Luisa Somoza Sandra Sivill Ole e 6-like allergen from peach tree pollen that can induce respiratory symptoms in children 1182 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Food allergy',\n",
       "  'session': 'TPS 11 Food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921306,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"TPS 11 Food allergy Cristina Bruno Anna Luzzetti Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Antonietta Sarracino Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Carmen Di Scala Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Gianluca Picariello Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Giusy Della Gatta Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Laura Carucci Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Laura Pisapia Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Linda Cosenza Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Lorella Paparo Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Luana Voto Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Rita Nocerino Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Roberto Berni Canani Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Serena Coppola Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Tommaso Cozzolino Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Valentina Canale Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Veronica Giglio Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Ylenia Maddalena Epigenetic immunomodulatory action on tregs activation elicited by protein fraction of different formulas for cow&rsquo;s milk allergy treatment  374 Cristina Bruno Anna Luzzetti A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Antonietta Sarracino A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Carmen Di Scala A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Claudio Pirozzi A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Giusy Della Gatta A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Laura Pisapia A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Lorella Paparo A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Luana Voto A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Roberto Russo A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Rosaria Meli A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Serena Coppola A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Cristina Bruno Valentina Canale A new butyrate releaser modulates tolerogenic mechanisms in a murine model of cow&rsquo;s milk allergy 378 Valeriy Mukhortykh Ilya Vorozhko Biomarker of eosinophilic inflammation in children suffering from food allergy 640 Valeriy Mukhortykh Inna Larkova Biomarker of eosinophilic inflammation in children suffering from food allergy 640 Valeriy Mukhortykh Vera Revyakina Biomarker of eosinophilic inflammation in children suffering from food allergy 640 Toms Clive Barker Tejeda Coral Barbas Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda David Rojo Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda Domingo Barber Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda Elisa Zubeldia-Varela Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda Maria Dolores Ibez Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda Mar\\xada Fernanda Rey-Stolle Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda Marina Perez-Gordo Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda Paula Cabrera-Freitag Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Toms Clive Barker Tejeda Raphalle Bazire Metabolomic analysis of a novel model of cow&rsquo;s milk allergy 859 Nelli Prikhodchenko Antonina Nee Urinary zonulin level as a marker of intestinal status in infants with gastrointestinal form of food allergy 1506 Nelli Prikhodchenko Ekaterina zernova E. Urinary zonulin level as a marker of intestinal status in infants with gastrointestinal form of food allergy 1506 Nelli Prikhodchenko Elina Katenkova Urinary zonulin level as a marker of intestinal status in infants with gastrointestinal form of food allergy 1506 Nelli Prikhodchenko Tatyana Shumatova Urinary zonulin level as a marker of intestinal status in infants with gastrointestinal form of food allergy 1506 Sanchiz  Africa Carmen Cuadrado Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Sanchiz  Africa Fatima Vicente Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Sanchiz  Africa Joseph Haddad Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Sanchiz  Africa Karim Allaf Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Sanchiz  Africa Mar\\xada Pedrosa Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Sanchiz  Africa Rosa Rodr\\xadguez Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Sanchiz  Africa Rosario Linacero Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Sanchiz  Africa Santiago Quirce Influence of Instant Controlled Pressure Drop (DIC) on allergenic potential of tree nuts 898 Jialing Jiang Aame Andy-Nweye Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Adam Robinson Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Alexandria Bozen Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Amal Assa\\x80\\x99ad Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Amaziah Coleman Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Annika Chura Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Avneet Chadha Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Christopher Warren Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Dannielle Brown Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Felix Araujo-Perez Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Hemant Sharma Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Iman Abdikarim Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Isabel Galic Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Jacqueline Pongracic Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Jamie Fierstein Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Lucy Bilaver Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Mahboobeh Mahdavinia Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Mary C Tobin Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Olivia Negris Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Pamela Newmark Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Patrick Seed Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Perry Catlin Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Ruchi Gupta Differences in gut microbiome composition between black and white food allergic children 1481 Jialing Jiang Susan Fox Differences in gut microbiome composition between black and white food allergic children 1481 Maria A Oliver Angharad Cullinane Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1 917 Maria A Oliver Bryan Smith Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1 917 Maria A Oliver Cathy Thorpe Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1 917 Maria A Oliver James P Hindley Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1 917 Maria A Oliver Kristina Reid Black Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1 917 Maria A Oliver Martin D Chapman Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1 917 Maria A Oliver Stephanie Filep Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1 917 Janne Burman Anna Pelkonen Bronchial hyperressponsiveness in children with persistent peanut and egg allergy 25 Janne Burman Kaarina Kukkonen Bronchial hyperressponsiveness in children with persistent peanut and egg allergy 25 Janne Burman Kati Palosuo Bronchial hyperressponsiveness in children with persistent peanut and egg allergy 25 Janne Burman Mika Mkel Bronchial hyperressponsiveness in children with persistent peanut and egg allergy 25 Janne Burman Pekka Malmberg Bronchial hyperressponsiveness in children with persistent peanut and egg allergy 25 Janne Burman Sami Remes Bronchial hyperressponsiveness in children with persistent peanut and egg allergy 25 Holly C. Y. Lam Deborah L. Jarvis Seasonal trend of food-related anaphylaxis hospital admissions in England 287 Holly C. Y. Lam Paul J. Turner Seasonal trend of food-related anaphylaxis hospital admissions in England 287 Lorraine Curran Khairy Gad Survey of young people and carers&#39; experience of undertaking pre-adolescent peanut or tree nuts oral food challenges in secondary care setting , NHS, northern Ireland, UK in 2019 908 Lorraine Curran Michaela Mcauley Survey of young people and carers&#39; experience of undertaking pre-adolescent peanut or tree nuts oral food challenges in secondary care setting , NHS, northern Ireland, UK in 2019 908 Soad Haj Yahia Diti Machnes-Maayan Diagnostic accuracy of &ldquo;pronut&rdquo;, for peanut allergy in children 202 Soad Haj Yahia Mona I Kidon Diagnostic accuracy of &ldquo;pronut&rdquo;, for peanut allergy in children 202 Soad Haj Yahia Nancy Agmon-Levin Diagnostic accuracy of &ldquo;pronut&rdquo;, for peanut allergy in children 202 Soad Haj Yahia Ramit Maoz-Segal Diagnostic accuracy of &ldquo;pronut&rdquo;, for peanut allergy in children 202 Soad Haj Yahia Ran hovav Diagnostic accuracy of &ldquo;pronut&rdquo;, for peanut allergy in children 202 Soad Haj Yahia Shirly Frizinsky Diagnostic accuracy of &ldquo;pronut&rdquo;, for peanut allergy in children 202 Soad Haj Yahia Yulia Lifshitz Diagnostic accuracy of &ldquo;pronut&rdquo;, for peanut allergy in children 202 Srishti Vashisht Naresh Singh Can in silico tools determine food\\x80\\x99s (lentinula edodes) allergenicity? 392 Srishti Vashisht Naveen Arora Can in silico tools determine food\\x80\\x99s (lentinula edodes) allergenicity? 392 Srishti Vashisht Rakshak Kumar Can in silico tools determine food\\x80\\x99s (lentinula edodes) allergenicity? 392 Srishti Vashisht Shakuntala Lavasa Can in silico tools determine food\\x80\\x99s (lentinula edodes) allergenicity? 392 Almudena Delgado Gonzlez Alfredo Iglesias Cadarso The achenes&rsquo; role in the strawberry allergy 628 Almudena Delgado Gonzlez Fernando Pineda De La Losa The achenes&rsquo; role in the strawberry allergy 628 Almudena Delgado Gonzlez Maria Anglica Gutierrez-Maturana Jimenez The achenes&rsquo; role in the strawberry allergy 628 Almudena Delgado Gonzlez Maria Mar Reao Martos The achenes&rsquo; role in the strawberry allergy 628 Almudena Delgado Gonzlez Marta Gema Lpez San Martin The achenes&rsquo; role in the strawberry allergy 628 Shaymaviswanathan Karnaneedi Andreas L Lopata Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Aya C Taki Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Dean Jerry Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Elecia B Johnston Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Nick M Wade Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Roger Huerlimann Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Roni Nugraha Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Sandip D Kamath Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Shaymaviswanathan Karnaneedi Thimo Ruethers Identifying undiscovered and novel allergens among the 5 most consumed shrimp species using advanced transcriptomic analysis 701 Paul Kearney Alex Porter Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney Clive Hayward Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney David Luta Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney Hugh A Sampson Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney Kari Nadeau Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney Marc Witmer Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney R. Sharon Chinthrajah Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney Robert Getts Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Paul Kearney Stephen J Galli Repeated validation of a high performing peanut allergy diagnostic on POISED trial subjects 711 Mark Smits Aard De Jong Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Andr Knulst Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Everton Souto Lima Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Geert Houben Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Gregory Ladics Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Kitty Verhoeckx Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Lilia Bab Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Marjolein Meijerink Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Martien Caspers Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Scott Mcclain Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Mark Smits Thuy-My Le Predicting the allergenicity of legume proteins using a PBMC gene expression assay 799 Rajia Bahri Paul Turner Mast cell activation test, a novel approach for egg and cow&rsquo;s milk food allergy diagnosis in children 893 Rajia Bahri Silvia Bulfone-Paus Mast cell activation test, a novel approach for egg and cow&rsquo;s milk food allergy diagnosis in children 893 Sooyoung Lee Kyunguk Jeong Perilla seed allergy II. development of diagnostic tests and partial identification of major IgE binding components 896 Sooyoung Lee Purevsan Gantulga Perilla seed allergy II. development of diagnostic tests and partial identification of major IgE binding components 896 Sooyoung Lee So Yeon Lee Perilla seed allergy II. development of diagnostic tests and partial identification of major IgE binding components 896 Sooyoung Lee Soo-Jong Hong Perilla seed allergy II. development of diagnostic tests and partial identification of major IgE binding components 896 Lucia Maltagliati Alessandro Farsi Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Donatella Macchia Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Elisa Meucci Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Enrico Scala Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Francesco Annunziato Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Francesco Liotta Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Giulia Carli Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Hlne Snchal Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Laura Maggi Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Lorenzo Cecchi Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Lorenzo Cosmi Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Lorenzo Salvati Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Paola Parronchi Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Lucia Maltagliati Pascal Poncet Clinical and allergological characterization of a group of Italian patients with suspected peamaclein allergy 1152 Rita Nocerino Elvira Verduci The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Giorgio Bedogni The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Laura Carucci The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Linda Cosenza The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Lorella Paparo The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Luca Riva The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Roberto Berni Canani The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Samuele Palazzo The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Serena Coppola The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Tommaso Cozzolino The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Rita Nocerino Ylenia Maddalena The effect of different formulas in children with cow&rsquo;s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study  327 Kazuyo Kuzume Koji Nishimura How to drink milk - eight years&rsquo; assessment of an intermittent step-up method of oral immunotherapy for severe cow&rsquo;s milk allergy patients 618 Kazuyo Kuzume Michiko Okamoto How to drink milk - eight years&rsquo; assessment of an intermittent step-up method of oral immunotherapy for severe cow&rsquo;s milk allergy patients 618 Kazuyo Kuzume Munemitsu Koizumi How to drink milk - eight years&rsquo; assessment of an intermittent step-up method of oral immunotherapy for severe cow&rsquo;s milk allergy patients 618 Kazuyo Kuzume Tsuneyuki Asami How to drink milk - eight years&rsquo; assessment of an intermittent step-up method of oral immunotherapy for severe cow&rsquo;s milk allergy patients 618 Kazuyo Kuzume Yu Kuwabara How to drink milk - eight years&rsquo; assessment of an intermittent step-up method of oral immunotherapy for severe cow&rsquo;s milk allergy patients 618 Kazuyo Kuzume Yuki Kagata How to drink milk - eight years&rsquo; assessment of an intermittent step-up method of oral immunotherapy for severe cow&rsquo;s milk allergy patients 618 Mar\\xada Jos Pealver Hernndez Beatriz Moya Oral immunotherapy with omalizumab in patients with severe persistent allergy to cow&#39;s milk proteins 619 Mar\\xada Jos Pealver Hernndez Jess Fernndez Crespo Oral immunotherapy with omalizumab in patients with severe persistent allergy to cow&#39;s milk proteins 619 Mar\\xada Jos Pealver Hernndez Laura Mar\\xadn Oral immunotherapy with omalizumab in patients with severe persistent allergy to cow&#39;s milk proteins 619 Mar\\xada Jos Pealver Hernndez Maria Carmen Diguez Oral immunotherapy with omalizumab in patients with severe persistent allergy to cow&#39;s milk proteins 619 Giovanni Battista Pajno Domenico Corica Maintenance feeding regimens after egg oral desensitization, a large randomized controlled study 761 Giovanni Battista Pajno Giuseppe Crisafulli Maintenance feeding regimens after egg oral desensitization, a large randomized controlled study 761 Giovanni Battista Pajno Lucia Caminiti Maintenance feeding regimens after egg oral desensitization, a large randomized controlled study 761 Giovanni Battista Pajno Mariella Valenzise Maintenance feeding regimens after egg oral desensitization, a large randomized controlled study 761 Giovanni Battista Pajno Stefania Arasi Maintenance feeding regimens after egg oral desensitization, a large randomized controlled study 761 Giovanni Battista Pajno Tommaso Aversa Maintenance feeding regimens after egg oral desensitization, a large randomized controlled study 761 Audrey DunnGalvin David M Fleischer Evaluation of psychometric parameters of food allergy quality-of-life questionnaires with item response theory for the assessment of health-related quality of life during food allergy treatments 1247 Audrey DunnGalvin Dianne E. Campbell Evaluation of psychometric parameters of food allergy quality-of-life questionnaires with item response theory for the assessment of health-related quality of life during food allergy treatments 1247 Audrey DunnGalvin Gabriel Coelho Evaluation of psychometric parameters of food allergy quality-of-life questionnaires with item response theory for the assessment of health-related quality of life during food allergy treatments 1247 Audrey DunnGalvin Jonathan Hourihane Evaluation of psychometric parameters of food allergy quality-of-life questionnaires with item response theory for the assessment of health-related quality of life during food allergy treatments 1247 Audrey DunnGalvin Phillipe Bgin Evaluation of psychometric parameters of food allergy quality-of-life questionnaires with item response theory for the assessment of health-related quality of life during food allergy treatments 1247 Audrey DunnGalvin Todd D. Green Evaluation of psychometric parameters of food allergy quality-of-life questionnaires with item response theory for the assessment of health-related quality of life during food allergy treatments 1247 Theodora  Dimaresi Christina Michopoulou Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Theodora  Dimaresi Emmanouil Manousakis Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Theodora  Dimaresi George Konstantinou Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Theodora  Dimaresi John Lakoumentas Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Theodora  Dimaresi Maria Galani Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Theodora  Dimaresi Nikolaos Douladiris Douladiris Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Theodora  Dimaresi Nikolaos G. Papadopoulos Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Theodora  Dimaresi Paraskevi Xepapadaki Prognostic factors linked to the tolerance in boiled eggs and baked in food eggs in children with allergies 1423 Vince Wu Diane Gwartz Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Ijaz Ogeer Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Jason Ohayon Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Khadija Brouillette Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Kristiina Frechette Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Portuhay Sofiya Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Tarin Moni Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Vaidehi Bhatt Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Vince Wu Wardha Wardha Peanut introduction in atopic infants, are we doing enough to educate non-allergists? 1485 Deniz Eyice Karabacak Asli Gelincik Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Deniz Eyice Karabacak Bahauddin Colakoglu Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Deniz Eyice Karabacak Derya \\x9cnal Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Deniz Eyice Karabacak Nida Oztop Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Deniz Eyice Karabacak Osman Ozan Yegit Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Deniz Eyice Karabacak Semra Demir Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Deniz Eyice Karabacak Sengul Beyaz Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Deniz Eyice Karabacak Suna Buyukozturk Successful red meat desensitization in patients with alpha-gal syndrome with various clinical manifestations<br /> 600 Sayantani Sindher Kari Nadeau Improved quality of life and burden of treatment in long-term follow up in food allergic participants treated with oral immunotherapy 1177 Sayantani Sindher Olivia Raeber Improved quality of life and burden of treatment in long-term follow up in food allergic participants treated with oral immunotherapy 1177 Sayantani Sindher R  Sharon Chinthrajah Improved quality of life and burden of treatment in long-term follow up in food allergic participants treated with oral immunotherapy 1177 Sayantani Sindher Shu Cao Improved quality of life and burden of treatment in long-term follow up in food allergic participants treated with oral immunotherapy 1177 Sayantani Sindher William J Collins Improved quality of life and burden of treatment in long-term follow up in food allergic participants treated with oral immunotherapy 1177 Ulrika Lindblom Andr Lauber Top 10 research questions in food allergy using a patient-priority setting partnership 1314 Ulrika Lindblom Jonas Binnmyr Top 10 research questions in food allergy using a patient-priority setting partnership 1314 Ulrika Lindblom Marina Jonsson Top 10 research questions in food allergy using a patient-priority setting partnership 1314 Grazielly De Ftima Pereira Allyne Allyne Moura F E Sousa Araujo Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Grazielly De Ftima Pereira Ariana Campos Yang Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Grazielly De Ftima Pereira Fbio Fernandes Morato Castro Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Grazielly De Ftima Pereira Iandra Leite Perez Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Grazielly De Ftima Pereira La\\xads Souza Gomes Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Grazielly De Ftima Pereira Larissa De Queiroz Mamede Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Grazielly De Ftima Pereira Pablo Torres Cordova Cordova Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Grazielly De Ftima Pereira Priscila De Abreu Franco Delayed diagnosis of eosinophilic esophagitis in patients with cow&rsquo;s milk allergy IgE mediated 615 Martina Votto Amelia Licari Eosinophilic esophagitis during allergen immunotherapy in children: Is slit a possible risk factor 176 Martina Votto Andreana Zecchini Eosinophilic esophagitis during allergen immunotherapy in children: Is slit a possible risk factor 176 Martina Votto Gian Luigi Marseglia Eosinophilic esophagitis during allergen immunotherapy in children: Is slit a possible risk factor 176 Martina Votto Maria De Filippo Eosinophilic esophagitis during allergen immunotherapy in children: Is slit a possible risk factor 176 Martina Votto Michela Caironi Eosinophilic esophagitis during allergen immunotherapy in children: Is slit a possible risk factor 176 Martina Votto Ursula Pia Ferrari Eosinophilic esophagitis during allergen immunotherapy in children: Is slit a possible risk factor 176 Laura Carucci Anna Luzzetti Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Antonella Sarracino Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Cristina Bruno Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Laura Pisapia Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Linda Cosenza Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Lorella Paparo Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Pasqualina Capasso Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Rita Nocerino Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Roberto Berni Canani Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Tommaso Cozzolino Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Laura Carucci Valentina Canale Immune mechanisms involved in the pathogenesis of gastrointestinal non-IgE-mediated food allergy 315 Ichiro Nomura Hideaki Morita Nation-wide survey in Japan reveals that half of non-IgE&ndash;mediated gastrointestinal food allergies developed during neonatal period 681 Ichiro Nomura Hirohisa Saito Nation-wide survey in Japan reveals that half of non-IgE&ndash;mediated gastrointestinal food allergies developed during neonatal period 681 Ichiro Nomura Hiroko Suzuki Nation-wide survey in Japan reveals that half of non-IgE&ndash;mediated gastrointestinal food allergies developed during neonatal period 681 Ichiro Nomura Kenji Matsumoto Nation-wide survey in Japan reveals that half of non-IgE&ndash;mediated gastrointestinal food allergies developed during neonatal period 681 Ichiro Nomura Mayu Yamamoto Nation-wide survey in Japan reveals that half of non-IgE&ndash;mediated gastrointestinal food allergies developed during neonatal period 681 Ichiro Nomura Saori Nagashima Nation-wide survey in Japan reveals that half of non-IgE&ndash;mediated gastrointestinal food allergies developed during neonatal period 681 Ichiro Nomura Yukaghir Ohya Nation-wide survey in Japan reveals that half of non-IgE&ndash;mediated gastrointestinal food allergies developed during neonatal period 681 Noriyuki Yanagida Ken-Ich Nagakura Time of initial symptom appearance during milk and egg oral food challenges: A multicenter prospective study 161 Noriyuki Yanagida Kiyotake Ogura Time of initial symptom appearance during milk and egg oral food challenges: A multicenter prospective study 161 Noriyuki Yanagida Kyohei Takahashi Time of initial symptom appearance during milk and egg oral food challenges: A multicenter prospective study 161 Noriyuki Yanagida Makoto Nishino Time of initial symptom appearance during milk and egg oral food challenges: A multicenter prospective study 161 Noriyuki Yanagida Motohiro Ebisawa Time of initial symptom appearance during milk and egg oral food challenges: A multicenter prospective study 161 Noriyuki Yanagida Sakura Sato Time of initial symptom appearance during milk and egg oral food challenges: A multicenter prospective study 161 Noriyuki Yanagida Tomoyuki Asaumi Time of initial symptom appearance during milk and egg oral food challenges: A multicenter prospective study 161 Ting Fan Leung Agnes Sy Leung Strong allergenicity of grass carp is related to high IgE-binding capacity of its major allergen cten i 1 356 Ting Fan Leung Christine Yy Wai Strong allergenicity of grass carp is related to high IgE-binding capacity of its major allergen cten i 1 356 Ting Fan Leung Gary Wk Wong Strong allergenicity of grass carp is related to high IgE-binding capacity of its major allergen cten i 1 356 Ting Fan Leung Kary Jy Xu Strong allergenicity of grass carp is related to high IgE-binding capacity of its major allergen cten i 1 356 Ting Fan Leung Maco Cy Lam Strong allergenicity of grass carp is related to high IgE-binding capacity of its major allergen cten i 1 356 Ting Fan Leung Nicki Yh Leung Strong allergenicity of grass carp is related to high IgE-binding capacity of its major allergen cten i 1 356 Carina Gabriela Uasuf Caterina Di Sano Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Carina Gabriela Uasuf Claudia D'Anna Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Carina Gabriela Uasuf Danilo Villalta Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Carina Gabriela Uasuf Elisabetta De Angelis Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Carina Gabriela Uasuf Ignazio Brusca Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Carina Gabriela Uasuf Linda Monaci Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Carina Gabriela Uasuf Maria Barrale Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Carina Gabriela Uasuf Rocco Guagnano Identification of immunoreactive protein bands in Goji berries superfood by proteomic analysis 548 Lan Zhao Fangmei Luo Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Hanbing Xie Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Hao Cheng Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Huimin Jia Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Huiying Wang Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Kejian Zhu Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Meiling Liu Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Ronald Van Ree Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Xiang Zhou Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Xianqi Zhang Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Lan Zhao Zhongshan Gao Identification of a chitinase as a major allergen in Chinese bayberry fruit 687 Julia Katharina Winkler Angelika Gabler Skin Prick test sensitization profiles to gluten fractions in patients with wheat-dependent exercise-induced anaphylaxis 953 Julia Katharina Winkler Claudia Kugler Skin Prick test sensitization profiles to gluten fractions in patients with wheat-dependent exercise-induced anaphylaxis 953 Julia Katharina Winkler Katharina Scherf Skin Prick test sensitization profiles to gluten fractions in patients with wheat-dependent exercise-induced anaphylaxis 953 Julia Katharina Winkler Knut Brockow Skin Prick test sensitization profiles to gluten fractions in patients with wheat-dependent exercise-induced anaphylaxis 953 Julia Katharina Winkler Tilo Biedermann Skin Prick test sensitization profiles to gluten fractions in patients with wheat-dependent exercise-induced anaphylaxis 953 Annalisa Matolo Davide Firinu The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Francesca Losa The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Giovanni Sotgiu The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Giulia Anna Maria Luigia Costanzo The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Laura Saderi The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Maria Luisa Di Martino The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Maria Pina Barca The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Maria Rita Messina The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Nicoletta Corso The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Paolo Serra The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Annalisa Matolo Stefano Del Giacco The role of cofactors in food allergy: A retrospective study in a cohort of patients sensitized to Lipid transfer proteins (LTPs) and/or &omega;-5-gliadin 1133 Andreas Ludwig Lopata Elecia Johnston Is tropomyosin a good indicator of crustacean and mollusc allergy?<br /> 1558 Andreas Ludwig Lopata Hieu Chi Chu Is tropomyosin a good indicator of crustacean and mollusc allergy?<br /> 1558 Andreas Ludwig Lopata Khanh Van Bui Is tropomyosin a good indicator of crustacean and mollusc allergy?<br /> 1558 Andreas Ludwig Lopata Sandip D Kamath Is tropomyosin a good indicator of crustacean and mollusc allergy?<br /> 1558 Andreas Ludwig Lopata Thu Thi Kieu Le Is tropomyosin a good indicator of crustacean and mollusc allergy?<br /> 1558 Andreas Ludwig Lopata Yen Thi Hai Pham Is tropomyosin a good indicator of crustacean and mollusc allergy?<br /> 1558 Jaume Mart\\xad Garrido Blanca Andrs-Lpez Shrimp and chicken allergy 1410 Jaume Mart\\xad Garrido Borja Bartolom-Zavala Shrimp and chicken allergy 1410 Jaume Mart\\xad Garrido Maria Teresa Dordal-Culla Shrimp and chicken allergy 1410 Jaume Mart\\xad Garrido Paula Vzquez-Revuelta Shrimp and chicken allergy 1410 Jaume Mart\\xad Garrido Ramon Lleonart-Bellfill Shrimp and chicken allergy 1410 Jaume Mart\\xad Garrido Valeria Herrera-Lasso Shrimp and chicken allergy 1410 Priyanka Dadha (Jain)  Evaluation and estimation of reported and IgE mediated food allergy in India 173 Inmaculada Ibarra Calabuig Alfonso Carreo Rojo Prevalence of lipid transfer protein allergy in a Southern Mediterranean population 401 Inmaculada Ibarra Calabuig Angel Abellan Aleman Prevalence of lipid transfer protein allergy in a Southern Mediterranean population 401 Inmaculada Ibarra Calabuig Angel Julio Huertas Amoros Prevalence of lipid transfer protein allergy in a Southern Mediterranean population 401 Inmaculada Ibarra Calabuig Manuel Jose Pajaron Fernandez Prevalence of lipid transfer protein allergy in a Southern Mediterranean population 401 Inmaculada Ibarra Calabuig Mercedes Ram\\xadrez Hernndez Prevalence of lipid transfer protein allergy in a Southern Mediterranean population 401 Inmaculada Ibarra Calabuig Alfonso Carreo Rojo Clinical profile of LTP and profilin sensitized patients in a southern mediterranean population 638 Inmaculada Ibarra Calabuig Angel Abellan Aleman Clinical profile of LTP and profilin sensitized patients in a southern mediterranean population 638 Inmaculada Ibarra Calabuig Angel Julio Huertas Amoros Clinical profile of LTP and profilin sensitized patients in a southern mediterranean population 638 Inmaculada Ibarra Calabuig Manuel Jose Pajaron Fernandez Clinical profile of LTP and profilin sensitized patients in a southern mediterranean population 638 Inmaculada Ibarra Calabuig Mercedes Ram\\xadrez Hernndez Clinical profile of LTP and profilin sensitized patients in a southern mediterranean population 638 Huimin  Huang Baoqing Sun Distribution characteristics of cow&rsquo;s milk-sIgE components in children with respiratory allergic diseases in southern China 709 Huimin  Huang Wenting Luo Distribution characteristics of cow&rsquo;s milk-sIgE components in children with respiratory allergic diseases in southern China 709 Isabel Torres Rojas Ana Prieto-Moreno Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Diana Prez-Alzate Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Elisa Haroun-D\\xadaz Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Francisco Javier Ruano Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Gabriela Canto D\\xadez Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Mar\\xada Vzquez De La Torre Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Mar\\xada Desamparados Cervera Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Maria Luisa Somoza Alvarez Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Natalia Blanca-Lopez Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Isabel Torres Rojas Paula Lpez-Gonzlez Lipid transfer protein sensitization in Madrid: Distribution by age 1003 Raquel Aguilera-Insunza Arturo Borzutzky Peanut allergy in Chilean population 1082 Raquel Aguilera-Insunza Carolina Iturriaga Peanut allergy in Chilean population 1082 Raquel Aguilera-Insunza Guillermo Prez-Mateluna Peanut allergy in Chilean population 1082 Raquel Aguilera-Insunza Luis Venegas Peanut allergy in Chilean population 1082 Raquel Aguilera-Insunza Sara Concha Peanut allergy in Chilean population 1082 Raquel Aguilera-Insunza Teresa Peralta Peanut allergy in Chilean population 1082 Marisa Paulino Clia Costa Molecular sensitization profile of patients with lipid transfer protein syndrome and associated clinical characteristics 1310 Marisa Paulino M. Conceio Pereira-Santos Molecular sensitization profile of patients with lipid transfer protein syndrome and associated clinical characteristics 1310 Marisa Paulino Manuel Pereira-Barbosa Molecular sensitization profile of patients with lipid transfer protein syndrome and associated clinical characteristics 1310 Enza Carmina  D'Auria Erica Pendezza Prevalence of food allergy in children with atopic dermatitis 1368 Enza Carmina  D'Auria Francesca Rella Prevalence of food allergy in children with atopic dermatitis 1368 Enza Carmina  D'Auria Gian Vincenzo Zuccotti Prevalence of food allergy in children with atopic dermatitis 1368 Enza Carmina  D'Auria Marco Ugo Andrea Sartorio Prevalence of food allergy in children with atopic dermatitis 1368 Enza Carmina  D'Auria Simone Pilloni Prevalence of food allergy in children with atopic dermatitis 1368 Cristina Isabel Stein Coronado Dolores Hernandez Fernandez De Rojas Altered intestinal permeability in patients with food allergy to lipid transfer proteins 773 Cristina Isabel Stein Coronado Ethel Ibaez Echevarr\\xada Altered intestinal permeability in patients with food allergy to lipid transfer proteins 773 Cristina Isabel Stein Coronado Mar\\xada Trelis Villanueva Altered intestinal permeability in patients with food allergy to lipid transfer proteins 773 Cristina Isabel Stein Coronado Paula Ruiz Mallol Altered intestinal permeability in patients with food allergy to lipid transfer proteins 773 Cristina Isabel Stein Coronado Susana Cifre Martinez Altered intestinal permeability in patients with food allergy to lipid transfer proteins 773 Thomas Holzhauser Andreas Reuter Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Bodo Niggemann Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Elke Vlker Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Jasmin Popp Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Jelena Spiric Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Kirsten Beyer Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Lisa-Marie Drner Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Lothar Vogel Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Stefanie Randow Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Thomas Holzhauser Valerie Trendelenburg Contribution of continuous IgE binding epitopes to the allergenicity of Pis&nbsp;s&nbsp;1, a major Pisum sativum allergen in pea allergic children 1098 Dorota Myszkowska Barbara Zapala Estimation of the genetic variations of filaggrine gene (FLG) in atopic and non-atopic patients with food dependent symptoms 857 Dorota Myszkowska Ewa Czarnobilska Estimation of the genetic variations of filaggrine gene (FLG) in atopic and non-atopic patients with food dependent symptoms 857 Allison Hicks Carina Venter Accidental ingestions to known food allergies in children vs. adolescents 448 Allison Hicks Claire Levek Accidental ingestions to known food allergies in children vs. adolescents 448 Allison Hicks David M Fleischer Accidental ingestions to known food allergies in children vs. adolescents 448 Ronna L Campbell Christine M Lohse Assessment of a symptom-based coding algorithm for identification of emergency department food-anaphylaxis patients 693 Ronna L Campbell James T Li Assessment of a symptom-based coding algorithm for identification of emergency department food-anaphylaxis patients 693 Ronna L Campbell John B Hagan Assessment of a symptom-based coding algorithm for identification of emergency department food-anaphylaxis patients 693 Ronna L Campbell Mollie L Alpern Assessment of a symptom-based coding algorithm for identification of emergency department food-anaphylaxis patients 693 Ronna L Campbell Molly M Jeffery Assessment of a symptom-based coding algorithm for identification of emergency department food-anaphylaxis patients 693 Ronna L Campbell Peter J Moore Assessment of a symptom-based coding algorithm for identification of emergency department food-anaphylaxis patients 693 M\\xadriam Arajo Elena Finelli Food allergy in siblings &ndash; doctor, is my younger child also going to be allergic? 1458 M\\xadriam Arajo Gonalo Martins-Dos-Santos Food allergy in siblings &ndash; doctor, is my younger child also going to be allergic? 1458 M\\xadriam Arajo Ins Sangalho Food allergy in siblings &ndash; doctor, is my younger child also going to be allergic? 1458 M\\xadriam Arajo Paula Leiria Pinto Food allergy in siblings &ndash; doctor, is my younger child also going to be allergic? 1458 M\\xadriam Arajo Sara Prates Food allergy in siblings &ndash; doctor, is my younger child also going to be allergic? 1458 M\\xadriam Arajo Sofia Ferrito Food allergy in siblings &ndash; doctor, is my younger child also going to be allergic? 1458 Jennifer L P Protudjer Nina V Gunnarsson Establishing perceived life status of children with food allergy, and their families by use of a visual analogue scale 64 Jennifer L P Protudjer Roelinde Middelveld Establishing perceived life status of children with food allergy, and their families by use of a visual analogue scale 64 Jennifer L P Protudjer Staffan Ahlstedt Establishing perceived life status of children with food allergy, and their families by use of a visual analogue scale 64 Futian Dong Jun Peng Rapid desensitization therapy for food allergies 260 Debbi Stockhammer Constance Helen Katelaris Managing a child with food allergy is not all bad 214 Debbi Stockhammer Maree Donna Simpson Managing a child with food allergy is not all bad 214 Debbi Stockhammer Thiru Vanniasinkam Managing a child with food allergy is not all bad 214 Maria Pasioti Christina Michopoulou Comparison of protocols for introducing tree nuts in patients with allergy to tree nuts (re-introducing nuts in allergic patients-ReINA study) - preliminary data 762 Maria Pasioti Emmanouil Manousakis Comparison of protocols for introducing tree nuts in patients with allergy to tree nuts (re-introducing nuts in allergic patients-ReINA study) - preliminary data 762 Maria Pasioti Maria Galani Comparison of protocols for introducing tree nuts in patients with allergy to tree nuts (re-introducing nuts in allergic patients-ReINA study) - preliminary data 762 Maria Pasioti Nikolaos Douladiris Comparison of protocols for introducing tree nuts in patients with allergy to tree nuts (re-introducing nuts in allergic patients-ReINA study) - preliminary data 762 Maria Pasioti Nikolaos Gavriil Papapadopoulos Comparison of protocols for introducing tree nuts in patients with allergy to tree nuts (re-introducing nuts in allergic patients-ReINA study) - preliminary data 762 Maria Pasioti Paraskevi Xepapadaki Comparison of protocols for introducing tree nuts in patients with allergy to tree nuts (re-introducing nuts in allergic patients-ReINA study) - preliminary data 762 Zeynep Parlak Aysegl Akarsu Plant-based milk alternative preference for children with cow milk protein allergy: Affecting factors and effect on nutritional status<br /> 947 Zeynep Parlak Betl Byktiryaki Plant-based milk alternative preference for children with cow milk protein allergy: Affecting factors and effect on nutritional status<br /> 947 Zeynep Parlak Blent Enis Sekerel Plant-based milk alternative preference for children with cow milk protein allergy: Affecting factors and effect on nutritional status<br /> 947 Zeynep Parlak Melike Kahveci Plant-based milk alternative preference for children with cow milk protein allergy: Affecting factors and effect on nutritional status<br /> 947 Zeynep Parlak \\x96zge Soyer Plant-based milk alternative preference for children with cow milk protein allergy: Affecting factors and effect on nutritional status<br /> 947 Zeynep Parlak \\x9cmit Murat Sahiner Plant-based milk alternative preference for children with cow milk protein allergy: Affecting factors and effect on nutritional status<br /> 947 Urszula Jedynak-Wasowicz Ewa Cichocka-Jarosz Tolerance of the cow&#39;s milk is related to 2-years earlier serum specific IgE levels and results of the oral food challenge 1195 Urszula Jedynak-Wasowicz Grzegorz Lis Tolerance of the cow&#39;s milk is related to 2-years earlier serum specific IgE levels and results of the oral food challenge 1195 Urszula Jedynak-Wasowicz Natalia Figura Tolerance of the cow&#39;s milk is related to 2-years earlier serum specific IgE levels and results of the oral food challenge 1195 Katrine Lindholm Bgh Ana Isabel Sancho Grass protein as a novel sustainable protein source - evaluation of the allergenicity 1263 Katrine Lindholm Bgh Claus Heiner Bang-Berthelsen Grass protein as a novel sustainable protein source - evaluation of the allergenicity 1263 Katrine Lindholm Bgh Hans Jrgen Hoffmann Grass protein as a novel sustainable protein source - evaluation of the allergenicity 1263 Katrine Lindholm Bgh Johannes Martin Schmid Grass protein as a novel sustainable protein source - evaluation of the allergenicity 1263 Katrine Lindholm Bgh Peter Ruhdal Jensen Grass protein as a novel sustainable protein source - evaluation of the allergenicity 1263 Faye Candice  Harrison Alexandra Figueira Santos Allergic reactions reported after negative double-blind placebo-controlled food challenges (DBPCFC) to milk and egg on the BAT 2 Study 1471 Faye Candice  Harrison Charlotte Stedman Allergic reactions reported after negative double-blind placebo-controlled food challenges (DBPCFC) to milk and egg on the BAT 2 Study 1471 Faye Candice  Harrison Marta Krawiec Allergic reactions reported after negative double-blind placebo-controlled food challenges (DBPCFC) to milk and egg on the BAT 2 Study 1471 Evgeny Beltyukov Sofya Tsarkova Food allergy to nuts and fruits in children with hay fever and oral allergy syndrome in the middle urals 246 Evgeny Beltyukov Tatyana Lepeshkova Food allergy to nuts and fruits in children with hay fever and oral allergy syndrome in the middle urals 246 Evgeny Beltyukov Veronika Naumova Food allergy to nuts and fruits in children with hay fever and oral allergy syndrome in the middle urals 246 Toshinori Nakamura Mayu Maeda Oral food challenges using multiple-dose steps for cow&rsquo;s milk allergy: Safety and efficiency 1015 Toshinori Nakamura Takanori Imai Oral food challenges using multiple-dose steps for cow&rsquo;s milk allergy: Safety and efficiency 1015 Toshinori Nakamura Taro Kamiya Oral food challenges using multiple-dose steps for cow&rsquo;s milk allergy: Safety and efficiency 1015 Toshinori Nakamura Yuki Okada Oral food challenges using multiple-dose steps for cow&rsquo;s milk allergy: Safety and efficiency 1015 Martina Votto Alessandro Raffaele Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 175 Martina Votto Amelia Licari Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 175 Martina Votto Francesca Oliverio Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 175 Martina Votto Gian Luigi Marseglia Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 175 Martina Votto Lilia Altieri Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 175 Martina Votto Paola Castelli Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 175 Martina Votto Riccardo Castagnoli Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 175 Giovanna Lucy Cortez Aliaga Ariana Campos Yang Tolerance to baked foods in patients with eosinophilic esophagitis associated with IgE mediated cow&acute;s milk allergy or egg allergy 1434 Giovanna Lucy Cortez Aliaga Fabio Morato Castro Tolerance to baked foods in patients with eosinophilic esophagitis associated with IgE mediated cow&acute;s milk allergy or egg allergy 1434 Giovanna Lucy Cortez Aliaga Pablo Torres Tolerance to baked foods in patients with eosinophilic esophagitis associated with IgE mediated cow&acute;s milk allergy or egg allergy 1434 Giovanna Lucy Cortez Aliaga Patricia Salles Cunha Tolerance to baked foods in patients with eosinophilic esophagitis associated with IgE mediated cow&acute;s milk allergy or egg allergy 1434 Ana Cristina Felicio Rios Miranda Ana Flavia Sousa Sousa Evaluation of endoscopic phenotype of Eosinophilic Esophagitis patients followed at a tertiary hospital 1552 Ana Cristina Felicio Rios Miranda Ariana Campos Yang Evaluation of endoscopic phenotype of Eosinophilic Esophagitis patients followed at a tertiary hospital 1552 Ana Cristina Felicio Rios Miranda Denise Leite Caldeira Evaluation of endoscopic phenotype of Eosinophilic Esophagitis patients followed at a tertiary hospital 1552 Mahboubeh Mansouri Kharaghani Arezoo - Shirzani Food protein-induced enterocolitis syndrome (FPIES) mimics Bartter syndrome-a case report 652 Mahboubeh Mansouri Kharaghani Sepideh - Darougar Food protein-induced enterocolitis syndrome (FPIES) mimics Bartter syndrome-a case report 652 chiho tatsumoto Mizuho Nagao Solid food protein-induced enterocolitis syndrome: A case series study in Japan 744 chiho tatsumoto Takao Fujisawa Solid food protein-induced enterocolitis syndrome: A case series study in Japan 744 Arghya Laha Goutam Kumar Saha Diagnosis of food allergy using artificial intelligence: A sample study from West Bengal, India 30 Arghya Laha Saibal Moitra Diagnosis of food allergy using artificial intelligence: A sample study from West Bengal, India 30 Arghya Laha Sanjoy Podder* Diagnosis of food allergy using artificial intelligence: A sample study from West Bengal, India 30 Arghya Laha Srijit Bhattacharya Diagnosis of food allergy using artificial intelligence: A sample study from West Bengal, India 30 AIDA BERMEJO BECERRO Jernimo Carns New peach allergens 109 AIDA BERMEJO BECERRO Mar\\xada \\x81ngeles Lopez-Matas New peach allergens 109 AIDA BERMEJO BECERRO Maria Gabriela Abreu Ramirez New peach allergens 109 AIDA BERMEJO BECERRO Maria Gabriela Zambrano Ibarra New peach allergens 109 AIDA BERMEJO BECERRO Roberto Pelta Fernndez New peach allergens 109 diti machnes maayan Eti Albaz Sesame oral food challenges 254 diti machnes maayan Frizinsky Shirli Sesame oral food challenges 254 diti machnes maayan Michal Deutch Sesame oral food challenges 254 diti machnes maayan Mona I. Kidon Sesame oral food challenges 254 diti machnes maayan Ramit Maoz-Segal Sesame oral food challenges 254 diti machnes maayan Soad Hajyahia Sesame oral food challenges 254 HIRONAGA YOSHIMOTO Kanako Ogura Risk factors for positive shrimp oral food challenge tests. 270 HIRONAGA YOSHIMOTO Kyohei Takahashi Risk factors for positive shrimp oral food challenge tests. 270 HIRONAGA YOSHIMOTO Motohiro Ebisawa Risk factors for positive shrimp oral food challenge tests. 270 HIRONAGA YOSHIMOTO Noriyuki Yanagida Risk factors for positive shrimp oral food challenge tests. 270 HIRONAGA YOSHIMOTO Sakura Sato Risk factors for positive shrimp oral food challenge tests. 270 Martina Privitera-Torres Ana Gonzlez-Moreno Molds as a source of food allergen 318 Martina Privitera-Torres Ana Nieto-Nieto Molds as a source of food allergen 318 Martina Privitera-Torres Borja Bartolom-Zabala Molds as a source of food allergen 318 Martina Privitera-Torres Jimena Laiseca-Garc\\xada Molds as a source of food allergen 318 Martina Privitera-Torres Luc\\xada Gonzlez-Bravo Molds as a source of food allergen 318 Martina Privitera-Torres Maria Dolores Alonso-D\\xadaz De Durana Molds as a source of food allergen 318 Martina Privitera-Torres Marianela Brandoni-Petrone Molds as a source of food allergen 318 Martina Privitera-Torres Sabela Prez-Codesido Molds as a source of food allergen 318 sira nanthapisal Orapan Poachanukoon Clinical characteristics of prawn allergy in Thai people 110 sira nanthapisal Paskorn Sritipsukho Clinical characteristics of prawn allergy in Thai people 110 sira nanthapisal Piyawut Kreetapirom Clinical characteristics of prawn allergy in Thai people 110 sira nanthapisal Prapasri Kulalert Clinical characteristics of prawn allergy in Thai people 110 Masako Abe  Effect of folic acid supplementation to pregnant women on food hypersensitivities in children in which neither parent had any allergies 737 Valeriy Mukhortykh Ilya Vorozhko Characteristics of cell &ndash; mediated immunity in children with food allerg? 636 Valeriy Mukhortykh Inna Larkova Characteristics of cell &ndash; mediated immunity in children with food allerg? 636 Valeriy Mukhortykh Vera Revyakina Characteristics of cell &ndash; mediated immunity in children with food allerg? 636 Barry K Hurlburt Hsiaopo Cheng Epitope Mapping Pathogenesis Class-10 Panallergens 1373 Barry K Hurlburt Soheila J Maleki Epitope Mapping Pathogenesis Class-10 Panallergens 1373 ADRIAN GERMAN SANCHEZ Ana Maria Alonso Llamazares Beer and wine allergy by sensitization to saccharomyces cerevisiae 1157 ADRIAN GERMAN SANCHEZ Bakai Matala Ahmed Beer and wine allergy by sensitization to saccharomyces cerevisiae 1157 ADRIAN GERMAN SANCHEZ Borja Bartolome Zavala Beer and wine allergy by sensitization to saccharomyces cerevisiae 1157 ADRIAN GERMAN SANCHEZ Fernando Garcia Gonzalez Beer and wine allergy by sensitization to saccharomyces cerevisiae 1157 ADRIAN GERMAN SANCHEZ Ignacio Antepara Ercoreca Beer and wine allergy by sensitization to saccharomyces cerevisiae 1157 Chandni Mathur Anand Bahadur Singh Emphasizing complete consideration of clinical history and immunoserological parameters for complete diagnosis: An Indian Food Allergic Case Study 1432 Chandni Mathur Pooran Chand Kathuria Emphasizing complete consideration of clinical history and immunoserological parameters for complete diagnosis: An Indian Food Allergic Case Study 1432 Chandni Mathur Pushpa Dahiya Emphasizing complete consideration of clinical history and immunoserological parameters for complete diagnosis: An Indian Food Allergic Case Study 1432 Elena Mederos Luis Cristina \\x81lava Cruz Clinical profile of limpet allergy: A preliminary report 1461 Elena Mederos Luis Inmaculada Snchez Mach\\xadn Clinical profile of limpet allergy: A preliminary report 1461 Elena Mederos Luis Paloma Poza Guedes Clinical profile of limpet allergy: A preliminary report 1461 Elena Mederos Luis Ruperto Gonzlez Clinical profile of limpet allergy: A preliminary report 1461 Elena Mederos Luis V\\xadctor Matheu Clinical profile of limpet allergy: A preliminary report 1461 Lydia Wong Amelia Santosa Pink &amp; purple - a clue to diagnosis in recurrent angioedema 266 Lydia Wong Chun Xian Serene Xu Pink &amp; purple - a clue to diagnosis in recurrent angioedema 266 Lydia Wong Mei Yu Ng Pink &amp; purple - a clue to diagnosis in recurrent angioedema 266 Elba Redondo Vegas Andrea Alejandra Garbn Camero Andean Maca: A superfood as a new source of food allergy 903 Elba Redondo Vegas Carlos Pastor Vargas Andean Maca: A superfood as a new source of food allergy 903 Elba Redondo Vegas Leticia Uriarte Vega Andean Maca: A superfood as a new source of food allergy 903 Elba Redondo Vegas Montserrat Fernndez Rivas Andean Maca: A superfood as a new source of food allergy 903 Elba Redondo Vegas Sonia Vzquez Corts Andean Maca: A superfood as a new source of food allergy 903 Mnica Snchez Prez Antonio Nieto Snchez Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Borja Bartolom Zavala Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Inmaculada Mar\\xada Snchez-Guerrero Villajos Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Jos Meseguer Arce Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Jos Damin Lpez Snchez Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Juan Jos Corts Collado Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Mar\\xada Karina Magdalena Bethencourt Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Mar\\xada Pilar Lpez Sez Complex diagnosis in food allergy. Beyond the panallergens 1351 Mnica Snchez Prez Mariola Navarro Guerrero Complex diagnosis in food allergy. Beyond the panallergens 1351 Bushra Javed Syed Usman Shaukat TDA toolkit: Oral food challenges Threshold Data Analysis suite, a web-based application to derive threshold dose distribution and eliciting doses 621 Hikmet Tekin Nacaroglu Fatma Nur Ayman Garlic allergy: A rare cause of anaphylaxis in infants 225 Hikmet Tekin Nacaroglu Mahmut Celebi Garlic allergy: A rare cause of anaphylaxis in infants 225 Benjamin Kilkelly Lyn Ventilacion A survey of perceived challenges faced by schools in East and North Hertfordshire regarding the management of anaphylaxis 1472 Benjamin Kilkelly Michael Ha A survey of perceived challenges faced by schools in East and North Hertfordshire regarding the management of anaphylaxis 1472 Michael Ha Benjamin Kilkelly A re-audit of East and North Hertfordshire Schools&rsquo; policy on the management of anaphylaxis 1547 Michael Ha Lyn Ventilacion A re-audit of East and North Hertfordshire Schools&rsquo; policy on the management of anaphylaxis 1547 Eduardo Garc\\xada-Lirio Borja Bartolome Efficacy of sublingual immunotherapy in three patients with peanut allergy 565 Eduardo Garc\\xada-Lirio Cristina Galn Efficacy of sublingual immunotherapy in three patients with peanut allergy 565 Eduardo Garc\\xada-Lirio Javier Snchez Efficacy of sublingual immunotherapy in three patients with peanut allergy 565 Eduardo Garc\\xada-Lirio Pedro Manuel Gamboa Efficacy of sublingual immunotherapy in three patients with peanut allergy 565 Janina Sauer  Testing of nutritional symptom diary mobile applications 972 Dragan Mijakoski Aneta Atanasovska Food allergy in a random children population in RN Macedonia: A need for national guidelines and core outcomes for food allergy treatments 1108 Dragan Mijakoski Dragana Bislimovska Food allergy in a random children population in RN Macedonia: A need for national guidelines and core outcomes for food allergy treatments 1108 Dragan Mijakoski Jordan Minov Food allergy in a random children population in RN Macedonia: A need for national guidelines and core outcomes for food allergy treatments 1108 Dragan Mijakoski Jovanka Karadzinska-Bislimovska Food allergy in a random children population in RN Macedonia: A need for national guidelines and core outcomes for food allergy treatments 1108 Dragan Mijakoski Sasho Stoleski Food allergy in a random children population in RN Macedonia: A need for national guidelines and core outcomes for food allergy treatments 1108 Raquel Montserrat Cabrera Hernndez Alicia Barra Castro Clinical and immunological evolution of egg allergic patients after the introduction of baked egg 1272 Raquel Montserrat Cabrera Hernndez Beln De La Hoz Caballer Clinical and immunological evolution of egg allergic patients after the introduction of baked egg 1272 Raquel Montserrat Cabrera Hernndez Jonnathan Andrs Acevedo Galvis Clinical and immunological evolution of egg allergic patients after the introduction of baked egg 1272 Raquel Montserrat Cabrera Hernndez Soledad Terrados Cepeda Clinical and immunological evolution of egg allergic patients after the introduction of baked egg 1272 Inna A. Larkova Tatiana N. Korotkova Multi-strain probiotic as an adjuvant in oral tolerance in children with food allergy 1422 Inna A. Larkova Valeryi A Mukhortykh Multi-strain probiotic as an adjuvant in oral tolerance in children with food allergy 1422 Inna A. Larkova Vera A. Revyakina Multi-strain probiotic as an adjuvant in oral tolerance in children with food allergy 1422 Giovanna Lucy Cortez Aliaga Ariana Campos Yang Treatment with high temperature processed foods &quot;baked protocol&quot; in patients with IgE mediated cow&acute;s milk allergy and egg allergy 1449 Giovanna Lucy Cortez Aliaga Fabio Morato Castro Treatment with high temperature processed foods &quot;baked protocol&quot; in patients with IgE mediated cow&acute;s milk allergy and egg allergy 1449 Giovanna Lucy Cortez Aliaga Juliana Guimares Treatment with high temperature processed foods &quot;baked protocol&quot; in patients with IgE mediated cow&acute;s milk allergy and egg allergy 1449 Giovanna Lucy Cortez Aliaga Pablo Torres Treatment with high temperature processed foods &quot;baked protocol&quot; in patients with IgE mediated cow&acute;s milk allergy and egg allergy 1449 Giovanna Lucy Cortez Aliaga Patricia Salles Cunha Treatment with high temperature processed foods &quot;baked protocol&quot; in patients with IgE mediated cow&acute;s milk allergy and egg allergy 1449 Jssica Bonfim Mendes  Cosentino Allyne Moura Arajo Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino Ariana Campos Yang Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino Fbio Morato Castro Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino Giovana Cortez Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino Henrikki Gomes Antila Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino Jorge Kalil Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino L\\xadvia Gomes Fonseca Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino Pablo Torres Cordova Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 Jssica Bonfim Mendes  Cosentino Patr\\xadcia Salles Cunha Treatment of cow&#39;s milk protein allergy with foods processed at high temperatures 1499 BARBARA CANCADO Carolina Sanchez Aranda Egg allergy patients and yellow fever vaccine: How should i vaccinate them? 1507 BARBARA CANCADO Dirceu Sol Egg allergy patients and yellow fever vaccine: How should i vaccinate them? 1507 BARBARA CANCADO Marcia Carvalho Mallozi Egg allergy patients and yellow fever vaccine: How should i vaccinate them? 1507 Wardha Wardha Jason Abraham Ohayon Is it worth the effort?: Assessing tree nut uptake and impact on quality of life of families following an in-office oral food challenge 1528 Wardha Wardha Khadija Khan Is it worth the effort?: Assessing tree nut uptake and impact on quality of life of families following an in-office oral food challenge 1528 Wardha Wardha Sofiya Portuhay Is it worth the effort?: Assessing tree nut uptake and impact on quality of life of families following an in-office oral food challenge 1528 Wardha Wardha Tarin Moni Is it worth the effort?: Assessing tree nut uptake and impact on quality of life of families following an in-office oral food challenge 1528 Wardha Wardha Vidi Bhatt Is it worth the effort?: Assessing tree nut uptake and impact on quality of life of families following an in-office oral food challenge 1528 Wardha Wardha Vince Wu Is it worth the effort?: Assessing tree nut uptake and impact on quality of life of families following an in-office oral food challenge 1528 Ctia Santa Ana Reis Ferreira Positive egg specific IgE&nbsp;antibodies in adults 1550 Ctia Santa Cristina Lara Valente Positive egg specific IgE&nbsp;antibodies in adults 1550 Ctia Santa Ins Lopes Positive egg specific IgE&nbsp;antibodies in adults 1550 Agnes Sze Yin Leung Christine Yee Yan Wai Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Gary Wing Kin Wong Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Gilbert Chua Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Jaime Sou Da Rosa Duque Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Kary Jia Ying Xu Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Maco Cheuk Yin Lam Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Marco Hok Kung Ho Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Nicki Yat Hin Leung Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Polly Po Ki Ho Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Tak Hong Lee Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Ting Fan Leung Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Wai Hung Chan Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Yat Sun Yau Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Agnes Sze Yin Leung Yuki Yuk Shum Characteristics of chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges 339 Iason Thomas Ching Ching Yung Quinoa allergy: A case series 622 Iason Thomas Leonard Q.c. Siew Quinoa allergy: A case series 622 Iason Thomas Maria Rosa Caballero Quinoa allergy: A case series 622 Iason Thomas Rubaiyat Haque Quinoa allergy: A case series 622 Iason Thomas Stephen James Till Quinoa allergy: A case series 622 Andrea Alejandra  Fernndez Bol\\xadvar Jesus Miguel Garc\\xada Menaya Hypersensitivity systemic reaction to fig (ficus carica) 626 Andrea Alejandra  Fernndez Bol\\xadvar Luis Fernndez Moya Hypersensitivity systemic reaction to fig (ficus carica) 626 Andrea Alejandra  Fernndez Bol\\xadvar Maria Dotor Lavado Hypersensitivity systemic reaction to fig (ficus carica) 626 Andrea Alejandra  Fernndez Bol\\xadvar Pedro Bobadilla Gonzlez Hypersensitivity systemic reaction to fig (ficus carica) 626 Joan Domnech Witek Isabel Maria Ontaon Timn Study and follow-up of patients with allergic eosinophilic esophagitis phenotype 39 Joan Domnech Witek Marian Sells Cutillas. Study and follow-up of patients with allergic eosinophilic esophagitis phenotype 39 Joan Domnech Witek Ramn Rodr\\xadguez Pacheco Study and follow-up of patients with allergic eosinophilic esophagitis phenotype 39 Joan Domnech Witek Teresa Colomina Colomina Study and follow-up of patients with allergic eosinophilic esophagitis phenotype 39 Joan Domnech Witek Vicente Jover Cerda Study and follow-up of patients with allergic eosinophilic esophagitis phenotype 39 Joan Domnech Witek Zahira Maria Franzn Laz Study and follow-up of patients with allergic eosinophilic esophagitis phenotype 39 Adi Ovadia Ilan Dalal Sesame allergic patients can tolerate non-crashed sesame seeds food challenge 219 Dominique Dano Maya Yassine Food allergy therapeutic patient education in lebanon: A pilot study  376 Stephanie Filep Denise Block Doses of specific allergens in early allergen intervention products associated with prevention of food allergy 442 Stephanie Filep Martin D. Chapman Doses of specific allergens in early allergen intervention products associated with prevention of food allergy 442 Laura Carucci Anna Luzzetti Atopic dermatitis and atopic march in children with history of non-IgE mediated gastrointestinal food allergy 1338 Laura Carucci Linda Cosenza Atopic dermatitis and atopic march in children with history of non-IgE mediated gastrointestinal food allergy 1338 Laura Carucci Pasqualina Capasso Atopic dermatitis and atopic march in children with history of non-IgE mediated gastrointestinal food allergy 1338 Laura Carucci Rita Nocerino Atopic dermatitis and atopic march in children with history of non-IgE mediated gastrointestinal food allergy 1338 Laura Carucci Roberto Berni Canani Atopic dermatitis and atopic march in children with history of non-IgE mediated gastrointestinal food allergy 1338 Laura Carucci Tommaso Cozzolino Atopic dermatitis and atopic march in children with history of non-IgE mediated gastrointestinal food allergy 1338 Laura Carucci Ylenia Maddalena Atopic dermatitis and atopic march in children with history of non-IgE mediated gastrointestinal food allergy 1338 Maria Gabriela Abreu Ram\\xadrez Aida Bermejo Monochorial-monoamniotic female twins with gluten-FPIES 910 Maria Gabriela Abreu Ram\\xadrez Elena Seoane Monochorial-monoamniotic female twins with gluten-FPIES 910 Maria Gabriela Abreu Ram\\xadrez Irene Garc\\xada-Gutirrez Monochorial-monoamniotic female twins with gluten-FPIES 910 Maria Gabriela Abreu Ram\\xadrez Sonsoles Infante Monochorial-monoamniotic female twins with gluten-FPIES 910 Naohiro Itoh Akiko Kawasaki Food protein-introduced enterocolitis syndrome developed after long-term sustained unresponsiveness of IgE-mediated cow&rsquo;s milk allergy 142 Naohiro Itoh Hiroki Murai Food protein-introduced enterocolitis syndrome developed after long-term sustained unresponsiveness of IgE-mediated cow&rsquo;s milk allergy 142 Naohiro Itoh Koji Suzuki Food protein-introduced enterocolitis syndrome developed after long-term sustained unresponsiveness of IgE-mediated cow&rsquo;s milk allergy 142 Naohiro Itoh Motoko Yasutomi Food protein-introduced enterocolitis syndrome developed after long-term sustained unresponsiveness of IgE-mediated cow&rsquo;s milk allergy 142 Naohiro Itoh Yusei Ohshima Food protein-introduced enterocolitis syndrome developed after long-term sustained unresponsiveness of IgE-mediated cow&rsquo;s milk allergy 142 Elisa Violeta Zubeldia-Varela Alma Villaseor Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Coral Barbas Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela David Rojo Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Domingo Barber Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Frank Blanco Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Jonathan Laio Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Marina Perez-Gordo Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Masako Toda Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Philipp Yu Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Stefan Vieths Metabolomics in the study of allergic enteritis 928 Elisa Violeta Zubeldia-Varela Toms Clive Barker-Tejeda Metabolomics in the study of allergic enteritis 928 La\\xads Souza Gomes Amanda Brolio Souza Endoscopic patterns and complications of eosinophilic esophagitis 1529 La\\xads Souza Gomes Ariana Campos Yang Endoscopic patterns and complications of eosinophilic esophagitis 1529 La\\xads Souza Gomes Fabio Fernandes Morato Castro Endoscopic patterns and complications of eosinophilic esophagitis 1529 La\\xads Souza Gomes Grazielly Fatima Pereira Endoscopic patterns and complications of eosinophilic esophagitis 1529 La\\xads Souza Gomes Jorge Kalil Endoscopic patterns and complications of eosinophilic esophagitis 1529 La\\xads Souza Gomes Larissa Queiroz Mamede Endoscopic patterns and complications of eosinophilic esophagitis 1529 Maria Lu\\xads Marques Borja Bartolom Eosinophilic esophagitis with fish and poultry allergy: An unexpected association 1371 Maria Lu\\xads Marques Carmo Abreu Eosinophilic esophagitis with fish and poultry allergy: An unexpected association 1371 Maria Lu\\xads Marques Helena Falco Eosinophilic esophagitis with fish and poultry allergy: An unexpected association 1371 Maria Lu\\xads Marques Ins Machado Cunha Eosinophilic esophagitis with fish and poultry allergy: An unexpected association 1371 Anna A. Barilo Irina V. Borisova The sensitization to food allergens among children with allergic rhinitis and asthma&nbsp; 564 Anna A. Barilo Svetlana V. Smirnova The sensitization to food allergens among children with allergic rhinitis and asthma&nbsp; 564 Sasho Stoleski Aneta Atanasovska Food hypersensitivity in a random adult population in the city of Skopje 1005 Sasho Stoleski Dragana Bislimovska Food hypersensitivity in a random adult population in the city of Skopje 1005 Sasho Stoleski Drgan Mijakoski Food hypersensitivity in a random adult population in the city of Skopje 1005 Sasho Stoleski Jordan Minov Food hypersensitivity in a random adult population in the city of Skopje 1005 Sasho Stoleski Jovanka Karadzinska-Bislimovska Food hypersensitivity in a random adult population in the city of Skopje 1005 Catarina Pereira Coutinho Borja Bartolom Limpet allergy with tolerance to other mollusks and crustaceans 656 Catarina Pereira Coutinho Leonor Esteves Caldeira Limpet allergy with tolerance to other mollusks and crustaceans 656 Catarina Pereira Coutinho Manuel Pereira Barbosa Limpet allergy with tolerance to other mollusks and crustaceans 656 Catarina Pereira Coutinho Marta Neto Limpet allergy with tolerance to other mollusks and crustaceans 656 sara urbani Arianna Aruanno Adverse reaction to Ficus carica: Case of a possible cross-reactivity with Der p1 867 sara urbani Eleonora Nucera Adverse reaction to Ficus carica: Case of a possible cross-reactivity with Der p1 867 Andrea  Alejandra Garban Camero Carlos Pastor Vargas Anaphylaxis in Asian restaurants: Think of buckwheat 937 Andrea  Alejandra Garban Camero Elba Redondo Vegas Anaphylaxis in Asian restaurants: Think of buckwheat 937 Andrea  Alejandra Garban Camero Montserrat Fernndez-Rivas Anaphylaxis in Asian restaurants: Think of buckwheat 937 Ins Falco Fernandes Helena Falco Milk and cow&rsquo;s meat allergy in a child: The missing pieces of the puzzle 1237 Ins Falco Fernandes Leonor Cunha Milk and cow&rsquo;s meat allergy in a child: The missing pieces of the puzzle 1237 Ins Falco Fernandes Maria Luis Marques Milk and cow&rsquo;s meat allergy in a child: The missing pieces of the puzzle 1237 Ins Falco Fernandes Moiss Labrador Horrilo Milk and cow&rsquo;s meat allergy in a child: The missing pieces of the puzzle 1237 Ctia Santa Ana Reis Ferreira Anaphylaxis due to mushroom allergy: Is it a neo-allergen? 1541 Ctia Santa Cristina Lara Valente Anaphylaxis due to mushroom allergy: Is it a neo-allergen? 1541 Ctia Santa Ins Lopes Anaphylaxis due to mushroom allergy: Is it a neo-allergen? 1541 Adela Jaqueline  Pazmio Oate Alejandra Gonzales Rausell Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Claudia Pereira Acha Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Javier Hernandez Arbeiza Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Manuela Alvarado Arenas Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Maria Isabel Alvarado Izquerdo Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Melvin Vasquez Suero Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Paula Jimenez Gallardo Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Sergio Porcel Carreo Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Adela Jaqueline  Pazmio Oate Soledad Jimenez Timon Alpha gal syndrome and anaphylaxis by cetuximab and red meat 505 Gordan Blagojevic Ivana Prokopijevic Tropomyson sensitization as a link between shellfish anaphylaxis and asthma reactivation 1184 Gordan Blagojevic Lidija Burazer Tropomyson sensitization as a link between shellfish anaphylaxis and asthma reactivation 1184 Annemarie Schaeffer  Senders Carsten Bindslev-Jensen The role of co-factors in primary hazelnut allergy 791 Annemarie Schaeffer  Senders Charlotte Gotthard Mortz The role of co-factors in primary hazelnut allergy 791 Annemarie Schaeffer  Senders Henrik Fomsgaard Kjaer The role of co-factors in primary hazelnut allergy 791 Yolanda Maria Puente Juan Carlos Daza Characteristics of 440 anaphylaxis 1261 Ricardo Moo Coutinho Alice Coimbra Is there a role for boiled milk in the management of cow&rsquo;s milk allergy? - a case report 1225 Ricardo Moo Coutinho Ana Margarida Mesquita Is there a role for boiled milk in the management of cow&rsquo;s milk allergy? - a case report 1225 Ricardo Moo Coutinho Jos Lu\\xads Plcido Is there a role for boiled milk in the management of cow&rsquo;s milk allergy? - a case report 1225 Karthik   Nagaraju Nagaraju Kuravi Specific oral tolerance induction (SOTI) to milk - case series of 5 patients from India 1253 Karthik   Nagaraju Sathya Srivatsav Specific oral tolerance induction (SOTI) to milk - case series of 5 patients from India 1253 Karthik   Nagaraju Venkata Kasyapi Voorakaranam Specific oral tolerance induction (SOTI) to milk - case series of 5 patients from India 1253 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#666666',\n",
       "  'type': 'Thematic Poster Session',\n",
       "  'category': 'Pediatrics',\n",
       "  'session': 'TPS 12 Pediatric',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921308,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#666666;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'TPS 12 Pediatric Vera Kalugina Anna Alekseeva The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Vera Kalugina Elena Dobrynina The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Vera Kalugina Elena Vishneva The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Vera Kalugina Julia Levina The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Vera Kalugina Kamilla Efendieva The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Vera Kalugina Leyla Namazova-Baranova The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Vera Kalugina Lilia Selimzianova The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Vera Kalugina Polina Arimova The results of long-term observation of adolescents with chronic spontaneous urticaria 613 Grazielly De Ftima Pereira Alessandra Pontillo Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Alice Grossi Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Fabio Fernandes Morato-Castro Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Francesco Caroli Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Isabella Ceccherini Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Jorge Elias Kalil Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Leonardo Oliveira Mendonca Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Marco Gattorno Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Myrthes Anna Maragna Toledo-Barros Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Pedro Francisco Giavina-Bianchi Junior Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Priscila Abreu Franco Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Grazielly De Ftima Pereira Rosana Cmara Agondi Clinical, genetic and therapeutical findings of two Brazilian patients with cutaneous mastocitosis associated with systemic autoinflammation  1525 Yoon Hee Kim Ga Eun Kim Analysis of airway microbiota in children with asthma exacerbation 373 Yoon Hee Kim Jae Hwa Jung Analysis of airway microbiota in children with asthma exacerbation 373 Yoon Hee Kim Kyung Won Kim Analysis of airway microbiota in children with asthma exacerbation 373 Yoon Hee Kim Min Jung Kim Analysis of airway microbiota in children with asthma exacerbation 373 Yoon Hee Kim Myung Hyun Sohn Analysis of airway microbiota in children with asthma exacerbation 373 Yoon Hee Kim Soo Yeon Kim Analysis of airway microbiota in children with asthma exacerbation 373 Zoia Nesterenko  Effect of GINA on asthma diagnosis and treatment in children 469 Francisca Tavares Ana Todo Bom Acute asthma in the emergency department of a tertiary pediatric hospital: Pacients with three or more visits due to asthma 1140 Francisca Tavares Carmelita Ribeiro Acute asthma in the emergency department of a tertiary pediatric hospital: Pacients with three or more visits due to asthma 1140 Francisca Tavares Fernanda Rodrigues Acute asthma in the emergency department of a tertiary pediatric hospital: Pacients with three or more visits due to asthma 1140 Francisca Tavares Jni Carvalho Acute asthma in the emergency department of a tertiary pediatric hospital: Pacients with three or more visits due to asthma 1140 Francisca Tavares Marta Alves Acute asthma in the emergency department of a tertiary pediatric hospital: Pacients with three or more visits due to asthma 1140 Francisca Tavares Marta Oliveira Martins Acute asthma in the emergency department of a tertiary pediatric hospital: Pacients with three or more visits due to asthma 1140 Helena Agens Anna Lindholm-Olinder Specific immunotherapy in relation to healt related quality of life and symptom score - a three year follow up 1293 Helena Agens Anna Lena Brorsson Specific immunotherapy in relation to healt related quality of life and symptom score - a three year follow up 1293 Helena Agens Gunnar Lilja Specific immunotherapy in relation to healt related quality of life and symptom score - a three year follow up 1293 Helena Agens Inger Kull Specific immunotherapy in relation to healt related quality of life and symptom score - a three year follow up 1293 Daria Levina Daniel Munblit Determinants of eosinophil levels in the first years of life: A pilot study 1407 Daria Levina Dmitrii Peshko Determinants of eosinophil levels in the first years of life: A pilot study 1407 Daria Levina Julia Petrova Determinants of eosinophil levels in the first years of life: A pilot study 1407 Daria Levina Marina Leontjeva Determinants of eosinophil levels in the first years of life: A pilot study 1407 Daria Levina Nilgyun Abbasova Determinants of eosinophil levels in the first years of life: A pilot study 1407 Daria Levina Oleg Blyuss Determinants of eosinophil levels in the first years of life: A pilot study 1407 Pia Kalm-Stephens Andrei Malinovschi Early predictors of self-reported allergic and respiratory symptoms in young adults<br />&nbsp; 883 Pia Kalm-Stephens Gunn Engvall Early predictors of self-reported allergic and respiratory symptoms in young adults<br />&nbsp; 883 Pia Kalm-Stephens Kjell Alving Early predictors of self-reported allergic and respiratory symptoms in young adults<br />&nbsp; 883 Pia Kalm-Stephens Lennart Nordvall Early predictors of self-reported allergic and respiratory symptoms in young adults<br />&nbsp; 883 Min-su Oh Ji-Won Kwon Autologous serum skin test helps to predict the treatment response in children with chronic spontaneous urticaria 1191 Min-su Oh Yu-Mi Park Autologous serum skin test helps to predict the treatment response in children with chronic spontaneous urticaria 1191 Deborah Elisabeth Marriage Anna Thursby-Pelham The investigation of children experiencing perioperative anaphylaxis in a tertiary UK hospital during a twelve month period 1440 Deborah Elisabeth Marriage Nicholas H Sargant The investigation of children experiencing perioperative anaphylaxis in a tertiary UK hospital during a twelve month period 1440 Amrit Dhesi Hannah Dobson Management of paediatric anaphylaxis in an NHS trust: Do we follow national guidelines and where are the gaps? 1269 Amrit Dhesi Jessamy Grace Reece Management of paediatric anaphylaxis in an NHS trust: Do we follow national guidelines and where are the gaps? 1269 Amrit Dhesi Moses Tongabiang Tarh Management of paediatric anaphylaxis in an NHS trust: Do we follow national guidelines and where are the gaps? 1269 Amrit Dhesi Sahra Adow Management of paediatric anaphylaxis in an NHS trust: Do we follow national guidelines and where are the gaps? 1269 Amrit Dhesi Tom Dawson Management of paediatric anaphylaxis in an NHS trust: Do we follow national guidelines and where are the gaps? 1269 Rosy Wells Aminath Aifa Aboobakuru Frey&rsquo;s syndrome in allergy clinic - a case report 861 Francisca Tavares Ana Todo Bom Mastocytosis during pediatric age: 5-year characterization in a central hospital 1162 Francisca Tavares Carmelita Ribeiro Mastocytosis during pediatric age: 5-year characterization in a central hospital 1162 Francisca Tavares Joana Azevedo Mastocytosis during pediatric age: 5-year characterization in a central hospital 1162 Francisca Tavares Jni Carvalho Mastocytosis during pediatric age: 5-year characterization in a central hospital 1162 Francisca Tavares Leonor Ramos Mastocytosis during pediatric age: 5-year characterization in a central hospital 1162 Francisca Tavares Marta Alves Mastocytosis during pediatric age: 5-year characterization in a central hospital 1162 Alba Juarez Guerrero Alberto Alvarez-Perea Baseline serum tryptase levels in a pediatric population 888 Alba Juarez Guerrero Alicia Dominguez Estirado Baseline serum tryptase levels in a pediatric population 888 Alba Juarez Guerrero Joaquin Navarro Capistegui Baseline serum tryptase levels in a pediatric population 888 Alba Juarez Guerrero Maria Luisa Baeza Ochoa De Ocariz Baseline serum tryptase levels in a pediatric population 888 Daniela  Brando Abreu Ana Margarida Mesquita Characterization of a paediatric population of patients with atopic dermatitis 978 Daniela  Brando Abreu Diana Silva Characterization of a paediatric population of patients with atopic dermatitis 978 Daniela  Brando Abreu Joana Miranda Characterization of a paediatric population of patients with atopic dermatitis 978 Daniela  Brando Abreu Jos Plcido Characterization of a paediatric population of patients with atopic dermatitis 978 Daniela  Brando Abreu Maria Joo Vasconcelos Characterization of a paediatric population of patients with atopic dermatitis 978 Daniela  Brando Abreu Ricardo Moo Coutinho Characterization of a paediatric population of patients with atopic dermatitis 978 Daniela  Brando Abreu Tiago A Rama Characterization of a paediatric population of patients with atopic dermatitis 978 Alameldin Mohamed Abdallah  Relationship between filaggrin, eosinophilic major basic protein and atopic diseases in children 13 Francesca Olivero Anna Maria Zicari Treatment with a probiotic mixture containing bifidobacterium animalis subsp. Lactis BB12 and enterococcus faecium L3 in children with allergic rhinitis: A preliminary study 774 Francesca Olivero Caterina Anania Treatment with a probiotic mixture containing bifidobacterium animalis subsp. Lactis BB12 and enterococcus faecium L3 in children with allergic rhinitis: A preliminary study 774 Francesca Olivero Daniela De Canditiis Treatment with a probiotic mixture containing bifidobacterium animalis subsp. Lactis BB12 and enterococcus faecium L3 in children with allergic rhinitis: A preliminary study 774 Francesca Olivero Giovanna De Castro Treatment with a probiotic mixture containing bifidobacterium animalis subsp. Lactis BB12 and enterococcus faecium L3 in children with allergic rhinitis: A preliminary study 774 Francesca Olivero Marzia Duse Treatment with a probiotic mixture containing bifidobacterium animalis subsp. Lactis BB12 and enterococcus faecium L3 in children with allergic rhinitis: A preliminary study 774 Francesca Olivero Vincenza Patrizia Di Marino Treatment with a probiotic mixture containing bifidobacterium animalis subsp. Lactis BB12 and enterococcus faecium L3 in children with allergic rhinitis: A preliminary study 774 Valentina Cvejoska-Cholakovska Emilija Vlashki Asthma and atopy in overweight children 593 Valentina Cvejoska-Cholakovska Mirjana Kocova Asthma and atopy in overweight children 593 Valentina Cvejoska-Cholakovska Vesna Velikj Stefanovska Asthma and atopy in overweight children 593 Yang Park  The efficacy of vitamin D supplementation on the effectiveness of house dust mite sublingual immunotherapy in children with allergic rhinitis 700 Chizuko Sugizaki Fumiko Goto Changes of allergic disease prevalence at the age of 5 years with a 12-year interval 366 Chizuko Sugizaki Motohiro Ebisawa Changes of allergic disease prevalence at the age of 5 years with a 12-year interval 366 Chizuko Sugizaki Noriyuki Yanagida Changes of allergic disease prevalence at the age of 5 years with a 12-year interval 366 Chizuko Sugizaki Sakura Sato Changes of allergic disease prevalence at the age of 5 years with a 12-year interval 366 Grzegorz Marek Brozek Ivane Chkhaidze Coexistence of asthmatic and non-respiratory allergic symptoms in children of the Batumi Region, Georgia: Occurrence and association with known diagnosis of asthma 824 Grzegorz Marek Brozek Jan Eugeniusz Zejda Coexistence of asthmatic and non-respiratory allergic symptoms in children of the Batumi Region, Georgia: Occurrence and association with known diagnosis of asthma 824 Grzegorz Marek Brozek Karaman Phagava Coexistence of asthmatic and non-respiratory allergic symptoms in children of the Batumi Region, Georgia: Occurrence and association with known diagnosis of asthma 824 Grzegorz Marek Brozek Sophio Beridze Coexistence of asthmatic and non-respiratory allergic symptoms in children of the Batumi Region, Georgia: Occurrence and association with known diagnosis of asthma 824 Grzegorz Marek Brozek Tamar Bakhtadze Coexistence of asthmatic and non-respiratory allergic symptoms in children of the Batumi Region, Georgia: Occurrence and association with known diagnosis of asthma 824 Grzegorz Marek Brozek Vakhtang Beridze Coexistence of asthmatic and non-respiratory allergic symptoms in children of the Batumi Region, Georgia: Occurrence and association with known diagnosis of asthma 824 Michaela Mcauley Claire Guy A dietetic led evaluation of patient satisfaction with the paediatric allergy service at a district general hospital, Northern Ireland, UK in 2018 657 Michaela Mcauley Khairy G Gad A dietetic led evaluation of patient satisfaction with the paediatric allergy service at a district general hospital, Northern Ireland, UK in 2018 657 Michaela Mcauley Lorraine Curran A dietetic led evaluation of patient satisfaction with the paediatric allergy service at a district general hospital, Northern Ireland, UK in 2018 657 Michaela Mcauley Megan Maguire A dietetic led evaluation of patient satisfaction with the paediatric allergy service at a district general hospital, Northern Ireland, UK in 2018 657 Myriam Kanchanatheera  Are we taking the right tests prior to walnut oral provocation challenges? Outcome analysis over a 2-year period of children who under went challenges at Bristol Royal Hospital for Children 1495 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Allergen immunotherapy     ',\n",
       "  'session': 'LB TPS 01 Allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921365,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 01 Allergen immunotherapy Cristiano Caruso Anna Volterrani The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Antonino Romano The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Barbara Tolusso The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Clara Di Mario The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Giorgio Celi The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Giovanni Fancello The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Manuela La Sorda The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Mario Caringi The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Cristiano Caruso Stefania Colantuono The effects of house dust mite subcutaneous immunotherapy (SCIT) on immunologic and clinical biomarkers 1654 Litty Johnson  Silica nanoparticles as novel adjuvant for allergen-specific immunotherapy: Impact on allergen processing 1732 Karl Christian Bergmann A. Graessel Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Karl Christian Bergmann J. Hiller Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Karl Christian Bergmann M. Tapparo Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Karl Christian Bergmann M. F. Kramer Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Karl Christian Bergmann O. Pfaar Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Karl Christian Bergmann S. Becker Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Karl Christian Bergmann S. Guethoff Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Karl Christian Bergmann S. Kugler Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber 1827 Sara Garrido-Fernndez Francisco Javier Iglesias-Souto Quali Study: Quality of life of patients allergic to house dust mites or pollens and treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1836 Sara Garrido-Fernndez Germn Snchez-Lpez Quali Study: Quality of life of patients allergic to house dust mites or pollens and treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1836 Sara Garrido-Fernndez Jenaro Hernndez-Pea Quali Study: Quality of life of patients allergic to house dust mites or pollens and treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1836 Sara Garrido-Fernndez Regina M Paulauskas-Vasaitis Quali Study: Quality of life of patients allergic to house dust mites or pollens and treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1836 Sara Garrido-Fernndez Valentina Natoli Quali Study: Quality of life of patients allergic to house dust mites or pollens and treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1836 Sara Garrido-Fernndez Cristina De Castro Gmez Quali Study: Evaluation of clinical parameters and use of symptom-relieving medication in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1838 Sara Garrido-Fernndez Gabriela Zambrano-Ibarra Quali Study: Evaluation of clinical parameters and use of symptom-relieving medication in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1838 Sara Garrido-Fernndez Jenaro Hernndez-Pea Quali Study: Evaluation of clinical parameters and use of symptom-relieving medication in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1838 Sara Garrido-Fernndez Maria Mar Escribano Rodr\\xadguez Quali Study: Evaluation of clinical parameters and use of symptom-relieving medication in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1838 Sara Garrido-Fernndez Paloma Poza-Guedes Quali Study: Evaluation of clinical parameters and use of symptom-relieving medication in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1838 Sara Garrido-Fernndez Valentina Natoli Quali Study: Evaluation of clinical parameters and use of symptom-relieving medication in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1838 Gino Scalone Enrico Compalati Safety of carbamylated monomeric grass pollen drops in patients with allergic rhinoconjunctivitis: A dose escalation trial 1675 Gino Scalone Franco Frati Safety of carbamylated monomeric grass pollen drops in patients with allergic rhinoconjunctivitis: A dose escalation trial 1675 Gino Scalone Paola Strada Safety of carbamylated monomeric grass pollen drops in patients with allergic rhinoconjunctivitis: A dose escalation trial 1675 Gino Scalone Rocco Longo Safety of carbamylated monomeric grass pollen drops in patients with allergic rhinoconjunctivitis: A dose escalation trial 1675 Gino Scalone Rosa Fasano Safety of carbamylated monomeric grass pollen drops in patients with allergic rhinoconjunctivitis: A dose escalation trial 1675 Fatma Merve Tepetam Cihan \\x96ren Asthma and bronchial hyperreactivity in adult allergic rhinitic individuals canbe reduced by subcutaneous immunotherapy? 1763 Fatma Merve Tepetam Ismet Bulut Asthma and bronchial hyperreactivity in adult allergic rhinitic individuals canbe reduced by subcutaneous immunotherapy? 1763 Fatma Merve Tepetam SELVER SEDA Mersi?n Asthma and bronchial hyperreactivity in adult allergic rhinitic individuals canbe reduced by subcutaneous immunotherapy? 1763 Fatma Merve Tepetam Seyma \\x96zden Asthma and bronchial hyperreactivity in adult allergic rhinitic individuals canbe reduced by subcutaneous immunotherapy? 1763 Fatma Merve Tepetam Tuge Yakut Asthma and bronchial hyperreactivity in adult allergic rhinitic individuals canbe reduced by subcutaneous immunotherapy? 1763 Cristiana  Cancela Ferreira Arminda Guilherme Safety of an ultrarush immunotherapy build-up schedule of subcutaneous immunotherapy in paediatric age 1872 Cristiana  Cancela Ferreira Ines Lopes Safety of an ultrarush immunotherapy build-up schedule of subcutaneous immunotherapy in paediatric age 1872 Sigridur Jonsdottir Eliane Marti Prophylactic vaccination against insect bite hypersensitivity of horses 1876 Sigridur Jonsdottir Ragna Bra Gunadottir Prophylactic vaccination against insect bite hypersensitivity of horses 1876 Sigridur Jonsdottir Sara Bjrk Stefansdottir Prophylactic vaccination against insect bite hypersensitivity of horses 1876 Sigridur Jonsdottir Sigurbjrg Torsteinsdottir Prophylactic vaccination against insect bite hypersensitivity of horses 1876 Sigridur Jonsdottir Vilhjalmur Svansson Prophylactic vaccination against insect bite hypersensitivity of horses 1876 Poul Sorensen Jaroslav Turnek Short-course AIT in a porcine allergic model by prolonged and enhanced oromucosal allergen presentation 1614 Poul Sorensen Josef Maek Short-course AIT in a porcine allergic model by prolonged and enhanced oromucosal allergen presentation 1614 Poul Sorensen Kees Leenhouts Short-course AIT in a porcine allergic model by prolonged and enhanced oromucosal allergen presentation 1614 Poul Sorensen Pavlina Turnek-Knotigov Short-course AIT in a porcine allergic model by prolonged and enhanced oromucosal allergen presentation 1614 Helen Igorevna Kashirina Dmitrii B Chudakov Safety of capsulated allergens for specific immunotherapy of allergy 1661 Helen Igorevna Kashirina Elena V Svirshchevskaya Safety of capsulated allergens for specific immunotherapy of allergy 1661 Helen Igorevna Kashirina Svetlana V Khlgatyan Safety of capsulated allergens for specific immunotherapy of allergy 1661 Madeleine Emilie Salzer Hans Jrgen Hoffmann Reactivity and sensitivity of the mast cell activation test with human serum and plasma are reproducible 1846 Madeleine Emilie Salzer Marlene Quach Reactivity and sensitivity of the mast cell activation test with human serum and plasma are reproducible 1846 Ignacio Garc\\xada Nez Begoa Madariaga Safety and tolerability of a cluster build-up schedule with a native HDM extract 1864 Ignacio Garc\\xada Nez Francisco-Javier Fuentes-Soltero Safety and tolerability of a cluster build-up schedule with a native HDM extract 1864 Ignacio Garc\\xada Nez Jose-Maria Ignacio-Garcia Safety and tolerability of a cluster build-up schedule with a native HDM extract 1864 Ignacio Garc\\xada Nez Maria-Angeles Algaba-Marmol Safety and tolerability of a cluster build-up schedule with a native HDM extract 1864 Ignacio Garc\\xada Nez Marina Suarez-Vergara Safety and tolerability of a cluster build-up schedule with a native HDM extract 1864 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Allergy and clinical immunology',\n",
       "  'session': 'LB TPS 02 Allergy and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921366,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB TPS 02 Allergy and clinical immunology Sheila Chua Anup Pingle Knowledge, attitude and practices among patients and physicians on allergic rhinitis (KAPPA): An outcome of an international survey from 6 countries 1741 Sheila Chua Jason Brinkley Knowledge, attitude and practices among patients and physicians on allergic rhinitis (KAPPA): An outcome of an international survey from 6 countries 1741 Sheila Chua Jeanne M Pimenta Knowledge, attitude and practices among patients and physicians on allergic rhinitis (KAPPA): An outcome of an international survey from 6 countries 1741 Sheila Chua Julie Pacer Knowledge, attitude and practices among patients and physicians on allergic rhinitis (KAPPA): An outcome of an international survey from 6 countries 1741 Sheila Chua Yoshitaka Okamoto Knowledge, attitude and practices among patients and physicians on allergic rhinitis (KAPPA): An outcome of an international survey from 6 countries 1741 Francis Gainsborough Charlotte Goodhead A monoclonal antibody improves clinical symptom scores and quality of life in children with Th2 allergic inflammatory disease: The ADAGIO complex 1865 Francis Gainsborough Jenny Underhill A monoclonal antibody improves clinical symptom scores and quality of life in children with Th2 allergic inflammatory disease: The ADAGIO complex 1865 Francis Gainsborough Louise Jane Michaelis A monoclonal antibody improves clinical symptom scores and quality of life in children with Th2 allergic inflammatory disease: The ADAGIO complex 1865 Francis Gainsborough Suzy Leech A monoclonal antibody improves clinical symptom scores and quality of life in children with Th2 allergic inflammatory disease: The ADAGIO complex 1865 Aleksandra Grska Marek Niedoszytko Typical symptoms of mastocytosis in patients in the polish center of excellence registry 1677 Aleksandra Grska Marlena Sztormowska Typical symptoms of mastocytosis in patients in the polish center of excellence registry 1677 Aleksandra Grska Marta Chelminska Typical symptoms of mastocytosis in patients in the polish center of excellence registry 1677 Poliana Mihaela Leru Vlad Florin Anton Severe anaphylaxis induced by hymenoptera venom as the red flag for systemic mastocytosis in young adults. report of two cases 1744 mahnaz sadeghi-shabestari Mandana Rafeey Association between fecal calprotectin concentration and mesenteric lymphadenopathy in children 1596 mahnaz sadeghi-shabestari Maryam Shoaran Association between fecal calprotectin concentration and mesenteric lymphadenopathy in children 1596 mahnaz sadeghi-shabestari Shirin Shirvani Association between fecal calprotectin concentration and mesenteric lymphadenopathy in children 1596 Zhao Wang Magda Babina Cytokine production elicited via allergic and pseudo-allergic activation in human skin mast cells - dominance of ERK1/2  1810 Zhao Wang Torsten Zuberbier Cytokine production elicited via allergic and pseudo-allergic activation in human skin mast cells - dominance of ERK1/2  1810 Dmitry V. Shabanov Anatoliy Mikhailovich Bala Significance of diagnosis of non-IgE allergy to venom bee apis mellifera 1817 Dmitry V. Shabanov E. A. Rybnikova Significance of diagnosis of non-IgE allergy to venom bee apis mellifera 1817 Dmitry V. Shabanov Tatiana Germanovna Fedoskova Significance of diagnosis of non-IgE allergy to venom bee apis mellifera 1817 Dmitry V. Shabanov Anatoliy Mikhailovich Bala The epidemiological of insect allergy in pediatri? practice in Moscow 1816 Dmitry V. Shabanov E A Rybnikova The epidemiological of insect allergy in pediatri? practice in Moscow 1816 Dmitry V. Shabanov Tatiana Germanovna Fedoslova The epidemiological of insect allergy in pediatri? practice in Moscow 1816 Ilknur Bostanci Gulmelek Cankurt Differential diagnosis in a child with rash after chickenpox: Acute infantile hemorrhagic edema 1805 Ilknur Bostanci Zeynep Sengul Emeksiz Differential diagnosis in a child with rash after chickenpox: Acute infantile hemorrhagic edema 1805 Anatoly Bala Dmitriy Vladimirovich Shabanov Sensitization in case of insect allergy 1814 Anatoly Bala Tatiana Germanovna Fedoskova Sensitization in case of insect allergy 1814 Anatoly Bala Yulia Vladimirovna Chursinova Sensitization in case of insect allergy 1814 Bere Mahoney Elaine Walklet Nonadherence to carrying and using adrenaline pens in adults with anaphylaxis: The impact of a theoretically informed training intervention on staff knowledge and beliefs 1581 Bere Mahoney Eleanor Bradley Nonadherence to carrying and using adrenaline pens in adults with anaphylaxis: The impact of a theoretically informed training intervention on staff knowledge and beliefs 1581 Bere Mahoney Steve O'Hickey Nonadherence to carrying and using adrenaline pens in adults with anaphylaxis: The impact of a theoretically informed training intervention on staff knowledge and beliefs 1581 Kseniia Suska Kateryna Gashynova Allergen-specific igG4 response to recombinant aspergillus fumigatus allergens in patients with non-cystic fibrosis bronchiectasis 1630 Kseniia Suska Valeriia Dmytrychenko Allergen-specific igG4 response to recombinant aspergillus fumigatus allergens in patients with non-cystic fibrosis bronchiectasis 1630 Konstantinos Kakleas Nafsika Sismanoglou Atopic keratoconjuctivitis: Is there any role for sublingual immunotherapy? A case report 1789 Elizabeth Powell Andrew Clark Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK 1706 Elizabeth Powell Helen Bailie Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK 1706 Elizabeth Powell Hena Salam Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK 1706 Elizabeth Powell Rachel Kirk Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK 1706 Elizabeth Powell Rebecca Tibbott Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK 1706 Elizabeth Powell Sarah Nethercott Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK 1706 Elizabeth Powell Zaraquiza Q Zolkipli Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK 1706 Florence Wilson Claudia Gore Exploring parental understanding and views on topical corticosteroids (TCS) and TCS labelling in paediatric atopic dermatitis 1745 Florence Wilson Erika Harnik Exploring parental understanding and views on topical corticosteroids (TCS) and TCS labelling in paediatric atopic dermatitis 1745 Deirdre Daly Bridget Teahan Education on anaphylaxis for primary school teachers in Ireland 1750 Deirdre Daly Ioana Maris Education on anaphylaxis for primary school teachers in Ireland 1750 Deirdre Daly Mary O'Dea Education on anaphylaxis for primary school teachers in Ireland 1750 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Allergy diagnosis and systems medicine',\n",
       "  'session': 'LB TPS 03 Allergy diagnosis and systems medicine',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921367,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 03 Allergy diagnosis and systems medicine Edsel Sinson Cindy Liao Quantitative comparison of traditional venipuncture blood draws and a novel microneedle-based capillary blood collection device on specific IgE in vitro diagnostic results 1830 Edsel Sinson Kelline Rodems Quantitative comparison of traditional venipuncture blood draws and a novel microneedle-based capillary blood collection device on specific IgE in vitro diagnostic results 1830 Edsel Sinson Lauren Dinh Quantitative comparison of traditional venipuncture blood draws and a novel microneedle-based capillary blood collection device on specific IgE in vitro diagnostic results 1830 Zita-Rose Manjaly Thomas Jamiolkowski Dagmar Allergy to cannabis \\x80\\x93 two illustrative cases of an old drug with new relevance 1688 Zita-Rose Manjaly Thomas Karin Hartmann Allergy to cannabis \\x80\\x93 two illustrative cases of an old drug with new relevance 1688 Zita-Rose Manjaly Thomas Kathrin Scherer Hofmeier Allergy to cannabis \\x80\\x93 two illustrative cases of an old drug with new relevance 1688 Zita-Rose Manjaly Thomas Sibylla Chantraine Allergy to cannabis \\x80\\x93 two illustrative cases of an old drug with new relevance 1688 Zita-Rose Manjaly Thomas Tina Trachsel Allergy to cannabis \\x80\\x93 two illustrative cases of an old drug with new relevance 1688 Rebecca Czolk Annette Kuehn Deep serum IgE-profiling in a Luxembourgish cohort of peanut-allergic children diagnosed by oral food challenge 1740 Rebecca Czolk Carsten Bindslev-Jensen Deep serum IgE-profiling in a Luxembourgish cohort of peanut-allergic children diagnosed by oral food challenge 1740 Rebecca Czolk Francoise Codreanu-Morel Deep serum IgE-profiling in a Luxembourgish cohort of peanut-allergic children diagnosed by oral food challenge 1740 Rebecca Czolk Julia Klueber Deep serum IgE-profiling in a Luxembourgish cohort of peanut-allergic children diagnosed by oral food challenge 1740 Rebecca Czolk Markus Ollert Deep serum IgE-profiling in a Luxembourgish cohort of peanut-allergic children diagnosed by oral food challenge 1740 Rebecca Czolk Paul Wilmes Deep serum IgE-profiling in a Luxembourgish cohort of peanut-allergic children diagnosed by oral food challenge 1740 Rebecca Czolk Tanja Scheuermann Deep serum IgE-profiling in a Luxembourgish cohort of peanut-allergic children diagnosed by oral food challenge 1740 Emilia Majsiak Karolina Miskiewicz Verification of new diagnostic method among polish patients with allergy 1662 Emilia Majsiak Magdalena Choina Verification of new diagnostic method among polish patients with allergy 1662 Emilia Majsiak Ryszard Kurzawa Verification of new diagnostic method among polish patients with allergy 1662 Nadine Offermann Margrit Fooke Comparison of a high sensitive reversed enzyme immuno assay for the quantitative determination of specific IgE with other in-vitro and in-vivo methods 1734 Nadine Offermann Margrit Fooke Evaluation of a new multiplex lateral flow assay for the simultaneous detection of allergen specific IgE within 20 minutes 1735 Youssouf Sereme Caroline Klingebiel Assessing cow\\x80\\x99s milk allergy and molecular profiles in the clinical lab with a chemiluminescence-based method 1784 Youssouf Sereme Joana Vitte Assessing cow\\x80\\x99s milk allergy and molecular profiles in the clinical lab with a chemiluminescence-based method 1784 Youssouf Sereme Caroline Klingebiel Comparison of two serum IgE specific assays in grass pollen sensitization 1861 Youssouf Sereme Joana Vitte Comparison of two serum IgE specific assays in grass pollen sensitization 1861 Youssouf Sereme Louis Kiyici Comparison of two serum IgE specific assays in grass pollen sensitization 1861 Jennifer Anh Hoang Ahuva Magder Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Aime Dubeau Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Alper Celik Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Arun Ramani Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Christian Lupinek Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Claire Lpine Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Julia E. M. Upton Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Klara Schmidthaler Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Lucy Duan Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Mara Alexanian-Farr Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang May G Brydges Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Padmaja Subbarao Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Rudolf Valenta Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Ruixue Dai Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Samantha Wong Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Thomas Eiwegger Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Jennifer Anh Hoang Zsolt Szpfalusi Modelling the conversion between multiplex specific IgE test platforms for peanut and tree nut allergens 1761 Anatoly Bala Dmitrii Vladimirovich Shabanov The frequency of sensitization to epidermal allergen 1787 Anatoly Bala Tatiana Germanovna Fedoskova The frequency of sensitization to epidermal allergen 1787 Anatoly Bala Yulia Vladimirovna Chursinova The frequency of sensitization to epidermal allergen 1787 Anatoly Bala Dmitriy Vladimirovich Shabanov IgE \\x80\\x93antibodies to the mites allergen component in Russian population 1815 Anatoly Bala Tatiana Germanovna Fedoskova IgE \\x80\\x93antibodies to the mites allergen component in Russian population 1815 Anatoly Bala Yulia Vladimirovna Chursinova IgE \\x80\\x93antibodies to the mites allergen component in Russian population 1815 Anatoly Bala Dmitriy Vladimirovich Shabanov The presence of serum IgE-antibodies to profilins as a marker of polysensitization 1818 Anatoly Bala Tatiana Germanovna Fedoskova The presence of serum IgE-antibodies to profilins as a marker of polysensitization 1818 Anatoly Bala Yulia Vladimirovna Chursinova The presence of serum IgE-antibodies to profilins as a marker of polysensitization 1818 Pedro Morais Silva Sara Nunes Clinical implications of phl p1/5 and ole e1 sensitization in patients with positive skin prick tests to grass and olive tree pollen 1880 Hanna Danielewicz Andrzej Boznanski Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Anna Debinska Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Anna Drabik-Chamerska Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Anna Myszkal Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Artur Gurgul Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Grzegorz Myszczyszyn Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Igor Jasielczuk Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Lidia Hirnle Pet ownership in pregnancy and methylation pattern in newborns 1674 Hanna Danielewicz Tomasz Szamtola Pet ownership in pregnancy and methylation pattern in newborns 1674 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Allied health and primary care  ',\n",
       "  'session': 'LB TPS 04 Allied health and primary care',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921368,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 04 Allied health and primary care Margaret Kelman Aziz Sheikh Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial 1683 Margaret Kelman Jrgen Schwarze Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial 1683 Margaret Kelman Lynn Morrice Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial 1683 Margaret Kelman Marilyn Kendall Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial 1683 Margaret Kelman Mome Mukherjee Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial 1683 Margaret Kelman Susan Harley Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial 1683 Margaret Kelman Victoria Suzan Hammersley Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial 1683 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Asthma',\n",
       "  'session': 'LB TPS 05 Asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921369,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 05 Asthma Janne Goossens Anne-Charlotte Jonckheere FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Camille Goossens FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Dominique Bullens FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Ellen Dilissen FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Jasmine Leus FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Jeroen Stappers FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Koen Peers FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Lieven Dupont FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Marc Raes FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Sam Moustie FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Sven Aertgeerts FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Sven Bogaerts FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Sven Seys FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Thierry Troosters FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Janne Goossens Vincent Vanbelle FeNO and AQUA questionnaire as prediction tool for atopy in early career athletes 1724 Mariola Galitskaya Alexandra Nikonova Clinical and immunological characteristics of the allergic asthma exacerbation due to different triggers (allergic provocation vs. viral infection) 1619 Mariola Galitskaya Igor Shilovskiy Clinical and immunological characteristics of the allergic asthma exacerbation due to different triggers (allergic provocation vs. viral infection) 1619 Mariola Galitskaya Musa Khaitov Clinical and immunological characteristics of the allergic asthma exacerbation due to different triggers (allergic provocation vs. viral infection) 1619 Mariola Galitskaya Natalya Ilyna Clinical and immunological characteristics of the allergic asthma exacerbation due to different triggers (allergic provocation vs. viral infection) 1619 Mariola Galitskaya Oksana Kurbacheva Clinical and immunological characteristics of the allergic asthma exacerbation due to different triggers (allergic provocation vs. viral infection) 1619 Mariola Galitskaya Yury Zhernov Clinical and immunological characteristics of the allergic asthma exacerbation due to different triggers (allergic provocation vs. viral infection) 1619 Taira Ariyoshi Hideki Hasegawa Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Hiroki Yasudo Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Hiroshi Itoh Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Komei Shirabe Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Ryo Atsuta Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Shouichi Ohga Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Shunji Hasegawa Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Takeshi Matsushige Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Tamaki Nakamura Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Taira Ariyoshi Yasufumi Sakata Enhanced airway hyperresponsiveness in asthma mouse model with influenza A(H1N1)pdm09 infection 1672 Anastasia Eleni Filiou Anders Sjolander Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Anna Asarnoj Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Cilla Sderhll Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Gunilla Hedlin Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Idun Holmdahl Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Jon Konradsen Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Katarina Stenberg-Hammar Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Marianne Van Hage Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Niclas Rydell Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Anastasia Eleni Filiou Tina Ekenkrantz Molecular allergy diagnostics in preschool wheezers \\x80\\x93 can childhood asthma be predicted? 1615 Helen Smith Cassie Hazell Written emotional disclosure in adults with asthma: How does the nature of the experience disclosed effect outcomes?  1593 Helen Smith Christina J Jones Written emotional disclosure in adults with asthma: How does the nature of the experience disclosed effect outcomes?  1593 Helen Smith Emma M Mclachlan Written emotional disclosure in adults with asthma: How does the nature of the experience disclosed effect outcomes?  1593 Rachel Lee Samantha Moss Self report assessment on severity of allergic rhinitis in relation to asthma control: A prospective cohort study 1730 Anna Zaleska Marek Jutel Intradermal test with aeroallergens a useful diagnostic tool for the dubious allergic profile of asthma 1622 secil subasi Cagatay Karaaslan Production of decellularized lung tissue scaffold by chemical method 1743 secil subasi Ebru Celebioglu Production of decellularized lung tissue scaffold by chemical method 1743 secil subasi Gulcin Gunal Karatas Production of decellularized lung tissue scaffold by chemical method 1743 secil subasi Halil Murat Aydin Production of decellularized lung tissue scaffold by chemical method 1743 secil subasi Sema Tuncer Production of decellularized lung tissue scaffold by chemical method 1743 Piotr Lacwik Adam Jerzy Bialas Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Joanna Milkowska-Dymanowska Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Justyna Sobczak Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Lukasz Gwadera Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Maciej Kupczyk Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Mateusz Kotecki Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Piotr Kuna Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Sebastian Majewski Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 Piotr Lacwik Wojciech Piotrowski Asthma control in patients with concomitant sarcoidosis- data from a tertiary pulmonary center 1626 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Basic and clinical immunology',\n",
       "  'session': 'LB TPS 06 Basic and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921370,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 06 Basic and clinical immunology Tamara Hoppenbrouwers Harry J. Wichers In vitro human moDC2s and consequent th2 cytokine release can be modulated by specific polyunsaturated fatty acids 1639 Tamara Hoppenbrouwers Johan Garssen In vitro human moDC2s and consequent th2 cytokine release can be modulated by specific polyunsaturated fatty acids 1639 Tamara Hoppenbrouwers Linette E.M. Willemsen In vitro human moDC2s and consequent th2 cytokine release can be modulated by specific polyunsaturated fatty acids 1639 Tamara Hoppenbrouwers Nicoletta Pellegrini In vitro human moDC2s and consequent th2 cytokine release can be modulated by specific polyunsaturated fatty acids 1639 Tamara Hoppenbrouwers Vincenzo Fogliano In vitro human moDC2s and consequent th2 cytokine release can be modulated by specific polyunsaturated fatty acids 1639 Ugur Musabak Tuba Erdogan The effect of immunoglobulin replacement therapy on hematoimmunological parameters in adult patients with common variable immunodeficiency: A single center experience 1571 Matthew Oliver Burgess Amanda Mcfarlane A heligmosomoides polygyrus induced serum-borne factor promotes monocytosis and protects against respiratory syncytial virus infection in the lung 1580 Matthew Oliver Burgess Hannah Mayr A heligmosomoides polygyrus induced serum-borne factor promotes monocytosis and protects against respiratory syncytial virus infection in the lung 1580 Matthew Oliver Burgess Heather Dolby A heligmosomoides polygyrus induced serum-borne factor promotes monocytosis and protects against respiratory syncytial virus infection in the lung 1580 Matthew Oliver Burgess Henry Mcsorley A heligmosomoides polygyrus induced serum-borne factor promotes monocytosis and protects against respiratory syncytial virus infection in the lung 1580 Matthew Oliver Burgess Jurgen Schwarze A heligmosomoides polygyrus induced serum-borne factor promotes monocytosis and protects against respiratory syncytial virus infection in the lung 1580 Matthew Oliver Burgess Karla Berry A heligmosomoides polygyrus induced serum-borne factor promotes monocytosis and protects against respiratory syncytial virus infection in the lung 1580 Neslihan Edeer Karaca Asude Durmaz A case with combined immunodeficiency disease due to a homozygous SPPL2a mutation 1645 Neslihan Edeer Karaca Ayca Aykut A case with combined immunodeficiency disease due to a homozygous SPPL2a mutation 1645 Neslihan Edeer Karaca Ezgi Yilmaz A case with combined immunodeficiency disease due to a homozygous SPPL2a mutation 1645 Neslihan Edeer Karaca Guzide Aksu A case with combined immunodeficiency disease due to a homozygous SPPL2a mutation 1645 Neslihan Edeer Karaca Necil Kutukculer A case with combined immunodeficiency disease due to a homozygous SPPL2a mutation 1645 Neslihan Edeer Karaca Ozgur Cogulu A case with combined immunodeficiency disease due to a homozygous SPPL2a mutation 1645 Ruta Kavaliauskaite Brigita Sitkauskiene Nijmegen breakage syndrome \\x80\\x93 the first case in Lithuania 1656 Ruta Kavaliauskaite Jurate Staikuniene Nijmegen breakage syndrome \\x80\\x93 the first case in Lithuania 1656 Ruta Kavaliauskaite Rasa Traberg Nijmegen breakage syndrome \\x80\\x93 the first case in Lithuania 1656 Ruta Kavaliauskaite Vilte Gintauskiene Nijmegen breakage syndrome \\x80\\x93 the first case in Lithuania 1656 Ruta Kavaliauskaite Virginija Asmoniene Nijmegen breakage syndrome \\x80\\x93 the first case in Lithuania 1656 Alina Poroshina Aleksandra Nikonova Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Alexander Mitin Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Alla Litovkina Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Elena Fedenko Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Evgeny Smolnikov Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Huey Huang Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Margarete Focke-Tejkl Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Marina Litvina Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Musa Khaitov Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Olga Elisyutina Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Oluwatoyin Adebanke Akinfenwa Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Raffaela Campana Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Rudolf Valenta Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Susanne Vrtala Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Alina Poroshina Yury Zhernov Bet v 1-specific CD4+ and CD8+ T-cells are increased in birch pollen-allergic patients shortly after the birch pollen season 1738 Nadezhda Knauer Alexey Sizikov Alterations of the telomerase activity profiles in rheumatoid arthritis upon stimulation by IL-7 and IL-15  1646 Nadezhda Knauer Anastasia Morenkova Alterations of the telomerase activity profiles in rheumatoid arthritis upon stimulation by IL-7 and IL-15  1646 Nadezhda Knauer Anna Sulutyan Alterations of the telomerase activity profiles in rheumatoid arthritis upon stimulation by IL-7 and IL-15  1646 Nadezhda Knauer Elena Blinova Alterations of the telomerase activity profiles in rheumatoid arthritis upon stimulation by IL-7 and IL-15  1646 Nadezhda Knauer Margarita Barkovskaya Alterations of the telomerase activity profiles in rheumatoid arthritis upon stimulation by IL-7 and IL-15  1646 Nadezhda Knauer Oxana Chumasova Alterations of the telomerase activity profiles in rheumatoid arthritis upon stimulation by IL-7 and IL-15  1646 Nadezhda Knauer Vladimir Kozlov Alterations of the telomerase activity profiles in rheumatoid arthritis upon stimulation by IL-7 and IL-15  1646 Fabiana Furci Annarita Dama The koebner phenomenon and mastocytosis: case report and review of literature  1696 Fabiana Furci Elisa Olivieri The koebner phenomenon and mastocytosis: case report and review of literature  1696 Fabiana Furci Ilaria Tanasi The koebner phenomenon and mastocytosis: case report and review of literature  1696 Fabiana Furci Luigi Scaffidi The koebner phenomenon and mastocytosis: case report and review of literature  1696 Fabiana Furci Michele Schiappoli The koebner phenomenon and mastocytosis: case report and review of literature  1696 Fabiana Furci Patrizia Bonadonna The koebner phenomenon and mastocytosis: case report and review of literature  1696 Fabiana Furci Roberta Zanotti The koebner phenomenon and mastocytosis: case report and review of literature  1696 Umesh Singh Jonathan A Bernstein Investigation of epidemiology of chronic cough in adult subjects using questionnaire surveys 1887 Caroline Schnider Carole Gengler ADA2 deficiency with pancytopenia 1623 Caroline Schnider Fabio Candotti ADA2 deficiency with pancytopenia 1623 Caroline Schnider Michal Hofer ADA2 deficiency with pancytopenia 1623 Caroline Schnider Orbicia Riccio ADA2 deficiency with pancytopenia 1623 Caroline Schnider Raffaele Renella ADA2 deficiency with pancytopenia 1623 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Dermatology',\n",
       "  'session': 'LB TPS 07 Dermatology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921371,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB TPS 07 Dermatology Andreea Florentina Mitra Felicia Mihai Chronic lymphocytic leukemia (CLL) associated eosinophilic dermatoses (ED) \\x80\\x93 a case series supporting the role of leukemic cells in ED pathogenesis 1773 Andreea Florentina Mitra Ileana Maria Ghiordanescu Chronic lymphocytic leukemia (CLL) associated eosinophilic dermatoses (ED) \\x80\\x93 a case series supporting the role of leukemic cells in ED pathogenesis 1773 Andreea Florentina Mitra Mara Madalina Mihai Chronic lymphocytic leukemia (CLL) associated eosinophilic dermatoses (ED) \\x80\\x93 a case series supporting the role of leukemic cells in ED pathogenesis 1773 Andreea Florentina Mitra Mihaela Popescu Chronic lymphocytic leukemia (CLL) associated eosinophilic dermatoses (ED) \\x80\\x93 a case series supporting the role of leukemic cells in ED pathogenesis 1773 Andreea Florentina Mitra Tiberiu Tebeica Chronic lymphocytic leukemia (CLL) associated eosinophilic dermatoses (ED) \\x80\\x93 a case series supporting the role of leukemic cells in ED pathogenesis 1773 Ying Zou Chengwen Fei Effect of scratching and rubbing skin in man in vivo 1877 Ying Zou Yafei Xu Effect of scratching and rubbing skin in man in vivo 1877 Ji Young Um Han Bi Kim Particulate matter aggravates skin diseases, like atopic dermatitis and psoriasis 1673 Ji Young Um Hye One kim Particulate matter aggravates skin diseases, like atopic dermatitis and psoriasis 1673 Myongsoon Sung Chul Sung Huh Human gut microbiome difference in infant according to the presence of atopic dermatitis 1721 Myongsoon Sung Hyunjoon Park Human gut microbiome difference in infant according to the presence of atopic dermatitis 1721 Dhanis Lad Alan D Irvine Parental compliance with an infant moisturization protocol in the first 2 months of life 1794 Dhanis Lad Carol N\\xad Chaoimh Parental compliance with an infant moisturization protocol in the first 2 months of life 1794 Dhanis Lad Georgios N Stamatas Parental compliance with an infant moisturization protocol in the first 2 months of life 1794 Dhanis Lad Jonathan O'B Hourihane Parental compliance with an infant moisturization protocol in the first 2 months of life 1794 Dhanis Lad Thierry Oddos Parental compliance with an infant moisturization protocol in the first 2 months of life 1794 Olga Elisyutina Anton Dvornikov Local immune response in Russian adult atopic dermatitis patients 1860 Olga Elisyutina Elena Fedenko Local immune response in Russian adult atopic dermatitis patients 1860 Olga Elisyutina Margarita Boldyreva Local immune response in Russian adult atopic dermatitis patients 1860 Olga Elisyutina Olga Shtyrbul Local immune response in Russian adult atopic dermatitis patients 1860 Omar AL ALI Faisal Yousef Aljaber Allergic contact dermatitis caused by mango fruit ingestion in France 1655 Omar AL ALI JEAN LUC Bourrain Allergic contact dermatitis caused by mango fruit ingestion in France 1655 Omar AL ALI NADIA Raison-Peyron Allergic contact dermatitis caused by mango fruit ingestion in France 1655 Omar AL ALI OLIVIER Dereure Allergic contact dermatitis caused by mango fruit ingestion in France 1655 zhouxian pan Christopher Chang Systemic contact dermatitis caused by acupuncture \\x80\\x93 a neglected route of allergen entry 1682 zhouxian pan Guang Chen Systemic contact dermatitis caused by acupuncture \\x80\\x93 a neglected route of allergen entry 1682 zhouxian pan Jing Zhang Systemic contact dermatitis caused by acupuncture \\x80\\x93 a neglected route of allergen entry 1682 zhouxian pan Jinlyu Sun Systemic contact dermatitis caused by acupuncture \\x80\\x93 a neglected route of allergen entry 1682 zhouxian pan Juncai Dong Systemic contact dermatitis caused by acupuncture \\x80\\x93 a neglected route of allergen entry 1682 zhouxian pan Rui Tang Systemic contact dermatitis caused by acupuncture \\x80\\x93 a neglected route of allergen entry 1682 zhouxian pan Yongshi Yang Systemic contact dermatitis caused by acupuncture \\x80\\x93 a neglected route of allergen entry 1682 Solange Oliveira Rodrigues Valle Guilherme Gomes Azizi Spiritual well-being and quality of life are impaired in chronic urticaria  1570 Solange Oliveira Rodrigues Valle Rafael Neves Moret Spiritual well-being and quality of life are impaired in chronic urticaria  1570 Solange Oliveira Rodrigues Valle Rossy Moreira Bastos Junior Spiritual well-being and quality of life are impaired in chronic urticaria  1570 Solange Oliveira Rodrigues Valle Sergio Duarte Dortas Junior Spiritual well-being and quality of life are impaired in chronic urticaria  1570 Miroslav Repko Beta oltsov Acute urticaria in children \\x80\\x93 theory and practice 1582 Miroslav Repko Vladim\\xadr Pohanka Acute urticaria in children \\x80\\x93 theory and practice 1582 Miao Yu Bo Liu Validation of the chinese version of urticaria control test (UCT) 1841 Miao Yu Xiaoting Song Validation of the chinese version of urticaria control test (UCT) 1841 Miao Yu Yudi Chen Validation of the chinese version of urticaria control test (UCT) 1841 Miao Yu Zuotao Zhao Validation of the chinese version of urticaria control test (UCT) 1841 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Drug allergy',\n",
       "  'session': 'LB TPS 08 Drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921372,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB TPS 08 Drug allergy Vanesa Snchez Moreno ANA Elices Non pigmenting multiple fixed drug eruption due to amoxicillin 1774 Vanesa Snchez Moreno ARIEL D\\xadaz Non pigmenting multiple fixed drug eruption due to amoxicillin 1774 Vanesa Snchez Moreno GALICIA Davila Non pigmenting multiple fixed drug eruption due to amoxicillin 1774 Vanesa Snchez Moreno Marta Chamorro Non pigmenting multiple fixed drug eruption due to amoxicillin 1774 Vanesa Snchez Moreno RICARDO Moreno Non pigmenting multiple fixed drug eruption due to amoxicillin 1774 Joo Afonso Gonzalez de Almeida Caires Eunice Dias De Castro Fixed drug eruption: A five-year review; 1812 Joo Afonso Gonzalez de Almeida Caires Joana Miranda Fixed drug eruption: A five-year review; 1812 Joo Afonso Gonzalez de Almeida Caires Josefina R Cernadas Fixed drug eruption: A five-year review; 1812 Joo Afonso Gonzalez de Almeida Caires Leonor Carneiro Leo Fixed drug eruption: A five-year review; 1812 Joo Afonso Gonzalez de Almeida Caires Maria J Vasconcelos Fixed drug eruption: A five-year review; 1812 Joo Afonso Gonzalez de Almeida Caires Ana M Mesquita Piperacilin/tazobactam as culprit in drug reaction with eosinophilia and systemic symptoms (DRESS): A five-year review; 1811 Joo Afonso Gonzalez de Almeida Caires Eunice Dias De Castro Piperacilin/tazobactam as culprit in drug reaction with eosinophilia and systemic symptoms (DRESS): A five-year review; 1811 Joo Afonso Gonzalez de Almeida Caires Joana Miranda Piperacilin/tazobactam as culprit in drug reaction with eosinophilia and systemic symptoms (DRESS): A five-year review; 1811 Joo Afonso Gonzalez de Almeida Caires Leonor Carneiro Leo Piperacilin/tazobactam as culprit in drug reaction with eosinophilia and systemic symptoms (DRESS): A five-year review; 1811 Joo Afonso Gonzalez de Almeida Caires Ricardo Moo Coutinho Piperacilin/tazobactam as culprit in drug reaction with eosinophilia and systemic symptoms (DRESS): A five-year review; 1811 Ins Machado Cunha Eva Gomes Allergy work-up on suspected beta-lactam allergy in children: safety of oral challenge without skin testing in non-immediate reactions 1685 Ins Machado Cunha Joana Gouveia Allergy work-up on suspected beta-lactam allergy in children: safety of oral challenge without skin testing in non-immediate reactions 1685 Ins Machado Cunha Maria Lu\\xads Marques Allergy work-up on suspected beta-lactam allergy in children: safety of oral challenge without skin testing in non-immediate reactions 1685 Giulia  Rinaldi Chris Rutkowski Prevalence and impact on care of contrast allergy amongst acute vascular admissions; a pilot study 1592 Giulia  Rinaldi Liam Musto Prevalence and impact on care of contrast allergy amongst acute vascular admissions; a pilot study 1592 Jane Chi Yan Wong Philip Hei Li Epidemiology and outcomes of geriatric patients with drug allergy 1627 Ileana Maria Ghiordanescu Adriana Maria Stefan Characteristics of non-steroidal anti-inflammatory drugs - induced hypersensitivity reactions in a 20-month retrospective analysis 1772 Ileana Maria Ghiordanescu Andreea Florentina Mitra Characteristics of non-steroidal anti-inflammatory drugs - induced hypersensitivity reactions in a 20-month retrospective analysis 1772 Ileana Maria Ghiordanescu Dana Chesa Characteristics of non-steroidal anti-inflammatory drugs - induced hypersensitivity reactions in a 20-month retrospective analysis 1772 Ileana Maria Ghiordanescu George Daniel Mitra Characteristics of non-steroidal anti-inflammatory drugs - induced hypersensitivity reactions in a 20-month retrospective analysis 1772 Juliana Fes Bianchini Garcia Jorge Kalil Desensitization to penicillin is safe and effective in allergic pregnant women with syphilis 1755 Juliana Fes Bianchini Garcia Marcelo Vivolo Aun Desensitization to penicillin is safe and effective in allergic pregnant women with syphilis 1755 Juliana Fes Bianchini Garcia Pedro Giavina-Bianchi Desensitization to penicillin is safe and effective in allergic pregnant women with syphilis 1755 Maria Joo Vasconcelos Josefina Cernadas Methotrexate hypersensitivity reactions in children: Experience with desensitization and intrathecal administration 1803 Maria Joo Vasconcelos Leonor Carneiro-Leo Methotrexate hypersensitivity reactions in children: Experience with desensitization and intrathecal administration 1803 Maria Joo Vasconcelos Marta Almeida Methotrexate hypersensitivity reactions in children: Experience with desensitization and intrathecal administration 1803 Leticia De las Vecillas Snchez Aurora Gutirrez Lpez Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Carlos Lopez Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez David San Segundo Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Elena Gonzalez Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Estefania Montenegro Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Eva Martinez De Castro Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Eva Morchon Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Fernando Rodriguez-Fernandez Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Maria Gutierrez Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Leticia De las Vecillas Snchez Veronica Diego Evidence-based efficacy of drug desensitization: A 2 years experience in handling HSRs to platins in A drug desensitization unit 1807 Carla Toledo-Salinas David Alejandro Mendoza-Hernandez Rapid drug desensitization using a 13-step protocol in a patient with suspected monogenic polyarteritis nodosa and Crohn's disease 1635 Carla Toledo-Salinas Diana Ramirez-Vasquez Rapid drug desensitization using a 13-step protocol in a patient with suspected monogenic polyarteritis nodosa and Crohn's disease 1635 Carla Toledo-Salinas Selma Cecilia Scheffler-Mendoza Rapid drug desensitization using a 13-step protocol in a patient with suspected monogenic polyarteritis nodosa and Crohn's disease 1635 Louise Collin Celine Beauvillain Successful one-bag desensitization protocol in a patient with pembrolizumab hypersensitivity 1839 Louise Collin Gonzague Dechabot Successful one-bag desensitization protocol in a patient with pembrolizumab hypersensitivity 1839 Louise Collin Maelle Lhuissier Successful one-bag desensitization protocol in a patient with pembrolizumab hypersensitivity 1839 Louise Collin Marina Babin Successful one-bag desensitization protocol in a patient with pembrolizumab hypersensitivity 1839 Louise Collin Martine Morisset Successful one-bag desensitization protocol in a patient with pembrolizumab hypersensitivity 1839 Louise Collin Thierry Urban Successful one-bag desensitization protocol in a patient with pembrolizumab hypersensitivity 1839 Tarin Moni Ijaz A. Ogeer Is it safe? Safety of penicillin testing and challenge in pregnancy with outcome of penicillin use at delivery in penicillin \\x80\\x9callergic\\x80\\x9d pregnant population 1779 Tarin Moni Jason Ohayon Is it safe? Safety of penicillin testing and challenge in pregnancy with outcome of penicillin use at delivery in penicillin \\x80\\x9callergic\\x80\\x9d pregnant population 1779 Tarin Moni Khadija Brouillette Is it safe? Safety of penicillin testing and challenge in pregnancy with outcome of penicillin use at delivery in penicillin \\x80\\x9callergic\\x80\\x9d pregnant population 1779 Tarin Moni Sofiya Portuhay Is it safe? Safety of penicillin testing and challenge in pregnancy with outcome of penicillin use at delivery in penicillin \\x80\\x9callergic\\x80\\x9d pregnant population 1779 Tarin Moni Vaidehi Bhatt Is it safe? Safety of penicillin testing and challenge in pregnancy with outcome of penicillin use at delivery in penicillin \\x80\\x9callergic\\x80\\x9d pregnant population 1779 Tarin Moni Vince Wu Is it safe? Safety of penicillin testing and challenge in pregnancy with outcome of penicillin use at delivery in penicillin \\x80\\x9callergic\\x80\\x9d pregnant population 1779 Tarin Moni Wardha Wardha Is it safe? Safety of penicillin testing and challenge in pregnancy with outcome of penicillin use at delivery in penicillin \\x80\\x9callergic\\x80\\x9d pregnant population 1779 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'ENT',\n",
       "  'session': 'LB TPS 09 ENT ',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921373,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 09 ENT  Mehmet Gkkaya Adam Chaker Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Antonia Todorova Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Athanasios Damialis Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Avidan Neumann Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Claudia Traidl-Hoffmann Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Fatima Ferreira Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Frank Redegeld Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Franziska Kolek Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Isabelle Beck Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Jens Brunner Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Lorenz Aglas Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Marie Amisi Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Nikolas Bounas-Pyrros Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Sebastian Bezold Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Stefanie Gilles Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Mehmet Gkkaya Thomas Nussbaumer Nasal biomarker-profiles to distinguish between high- and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study 1606 Jae-Yoon Kang Mi-Ra Choi Expression of \\x9f calcitonin gene related protein may be associated with pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyp 1579 Jae-Yoon Kang Seung Hyeon Choi Expression of \\x9f calcitonin gene related protein may be associated with pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyp 1579 Jae-Yoon Kang Sun Hee Yeon Expression of \\x9f calcitonin gene related protein may be associated with pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyp 1579 Jae-Yoon Kang Yong Min Kim Expression of \\x9f calcitonin gene related protein may be associated with pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyp 1579 Jingyun Li Luo Zhang Profiles of peripheral blood eosinophils in chronic rhinosinusitis in chinese adults 1670 Jingyun Li Yuan Zhang Profiles of peripheral blood eosinophils in chronic rhinosinusitis in chinese adults 1670 Lin Lin  Influences of CD8+CD25+foxp3+ treg cells on allergic rhinitis in vivo and in vitro 1786 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Environmental and occupational allergy',\n",
       "  'session': 'LB TPS 10 Environmental and occupational allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921374,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 10 Environmental and occupational allergy Ezgi Ulusoy Sevracan Aysegul Ertugrul Sensivitiy of chenopodium album in children: A single centre experience 1804 Ezgi Ulusoy Sevracan Ilknur Bostanci Sensivitiy of chenopodium album in children: A single centre experience 1804 Ezgi Ulusoy Sevracan Nevzat Baskaya Sensivitiy of chenopodium album in children: A single centre experience 1804 Alexander Kurganskiy Alexander Baklanov Incorporation of pollen data in source maps is vital for pollen dispersion models 1851 Alexander Kurganskiy Annika Saarto Incorporation of pollen data in source maps is vital for pollen dispersion models 1851 Alexander Kurganskiy Carsten Skjoth Incorporation of pollen data in source maps is vital for pollen dispersion models 1851 Alexander Kurganskiy Eigil Kaas Incorporation of pollen data in source maps is vital for pollen dispersion models 1851 Alexander Kurganskiy Elena Severova Incorporation of pollen data in source maps is vital for pollen dispersion models 1851 Alexander Kurganskiy Mikhail Sofiev Incorporation of pollen data in source maps is vital for pollen dispersion models 1851 Alexander Kurganskiy Sergei Smyshlyaev Incorporation of pollen data in source maps is vital for pollen dispersion models 1851 Xiang Gao Hang Lin Evolution of allergen spectrum in patients with allergic diseases for recent 12 years in Qingdao, China 1882 Xiang Gao Lifeng Zhang Evolution of allergen spectrum in patients with allergic diseases for recent 12 years in Qingdao, China 1882 Xiang Gao Yang Jiang Evolution of allergen spectrum in patients with allergic diseases for recent 12 years in Qingdao, China 1882 Karin Fieten Anita Dreher Indoor allergen exposure of Swiss schoolchildren living at 1560 m altitude 1783 Karin Fieten Cezmi Akdis Indoor allergen exposure of Swiss schoolchildren living at 1560 m altitude 1783 Karin Fieten Claudia Traidl-Hoffmann Indoor allergen exposure of Swiss schoolchildren living at 1560 m altitude 1783 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Food allergy',\n",
       "  'session': 'LB TPS 11 Food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921375,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB TPS 11 Food allergy Ugur Musabak Tuba Erdogan The role of lymphocyte transformation test in type 4 food hypersensitivity 1572 Agnes Sze Yin Leung Christine Yee Yan Wai Characteristics of fish-allergic patients in Hong Kong 1671 Agnes Sze Yin Leung Gary Wing Kin Wong Characteristics of fish-allergic patients in Hong Kong 1671 Agnes Sze Yin Leung Kary Jia Ying Xu Characteristics of fish-allergic patients in Hong Kong 1671 Agnes Sze Yin Leung Maco Cheuk Yin Lam Characteristics of fish-allergic patients in Hong Kong 1671 Agnes Sze Yin Leung Nicki Yat Hin Leung Characteristics of fish-allergic patients in Hong Kong 1671 Agnes Sze Yin Leung Ting Fan Leung Characteristics of fish-allergic patients in Hong Kong 1671 Emma Goksr Bo Lundbck Clusters of IgE levels to common food allergens in adults with asthma or rhinitis 1765 Emma Goksr Bright Nwaru Clusters of IgE levels to common food allergens in adults with asthma or rhinitis 1765 Emma Goksr Magnus Borres Clusters of IgE levels to common food allergens in adults with asthma or rhinitis 1765 Emma Goksr Rani Basna Clusters of IgE levels to common food allergens in adults with asthma or rhinitis 1765 Dra Solymosi Brigitte Diczig Food allergy vs. food intolerance in adulthood \\x80\\x93 experience from a perspective of an allergist-dermatologist 1777 Dra Solymosi Gyrgyi Pnyai Food allergy vs. food intolerance in adulthood \\x80\\x93 experience from a perspective of an allergist-dermatologist 1777 Dra Solymosi Mikls Srdy Food allergy vs. food intolerance in adulthood \\x80\\x93 experience from a perspective of an allergist-dermatologist 1777 Marta Vazquez-Ortiz Amanda Lefew Parental perspectives on clinical and research needs in food protein-induced enterocolitis syndrome (FPIES) 1634 Marta Vazquez-Ortiz Federico Martinon-Torres Parental perspectives on clinical and research needs in food protein-induced enterocolitis syndrome (FPIES) 1634 Marta Vazquez-Ortiz Joy Meyer Parental perspectives on clinical and research needs in food protein-induced enterocolitis syndrome (FPIES) 1634 Marta Vazquez-Ortiz Qian Yuan Parental perspectives on clinical and research needs in food protein-induced enterocolitis syndrome (FPIES) 1634 Marta Vazquez-Ortiz Sonsoles Infante Parental perspectives on clinical and research needs in food protein-induced enterocolitis syndrome (FPIES) 1634 Olga Kachalova Lydia Ilyenko The diet therapy of food allergy in breast-feeding infants 1710 Olga Kachalova Svetlana Denisova The diet therapy of food allergy in breast-feeding infants 1710 Olga Kachalova Tatyana Sentsova The diet therapy of food allergy in breast-feeding infants 1710 Panagiotis Chaslaridis Antonella Muraro Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis E N C Mills Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Erna Botjes Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Frida Run Thordardottir Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Helen A Brough Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Marcia Podest\\xa0 Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Rene W R Crevel Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Rikard \\x85sgrd Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Sabine Schnadt Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Sofia Romagosa Vilarnau Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Panagiotis Chaslaridis Stefania Arasi Fooddetectives: Quality of life, food allergen labelling and EU law  1798 Simone Andreou Durga Sigdel Prospective study of home baked egg and nut introduction and its impact on children and their families 1835 Simone Andreou Rumina Hassan-Ali Prospective study of home baked egg and nut introduction and its impact on children and their families 1835 Simone Andreou Stephen Goldring Prospective study of home baked egg and nut introduction and its impact on children and their families 1835 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CCCCCC',\n",
       "  'type': 'Late Breaking Thematic Poster Session',\n",
       "  'category': 'Pediatrics',\n",
       "  'session': 'LB TPS 12 Pediatric',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921376,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Thematic Poster Session' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CCCCCC;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Thematic Poster Session</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB TPS 12 Pediatric Adam Balogh  Risk factors for severe systematic wasp and honeybee sting reaction in children 1863 Olga Zaytseva Evelina Lokshina Role of family education style and level of anxiety in children with severe asthma 1607 Olga Zaytseva Olga Murtazaeva Role of family education style and level of anxiety in children with severe asthma 1607 Olga Zaytseva Svetlana Zaytseva Role of family education style and level of anxiety in children with severe asthma 1607 Zoia Nesterenko Anastasia Listopadova ECP and EDN in children with chronic esophagitis and asthma 1704 Zoia Nesterenko Elena Nevskaya ECP and EDN in children with chronic esophagitis and asthma 1704 Zoia Nesterenko Julia Zamyatina ECP and EDN in children with chronic esophagitis and asthma 1704 Zoia Nesterenko Olga Gurina ECP and EDN in children with chronic esophagitis and asthma 1704 Zoia Nesterenko Valeria Novikova ECP and EDN in children with chronic esophagitis and asthma 1704 Gloriana Lor\\xada-Chavarr\\xada Arturo Sol\\xads-Moya Childhood asthma in the tropics: Experience from an outpatient clinic in a tertiary center in Costa Rica 1858 Gloriana Lor\\xada-Chavarr\\xada Carolina Ortega-Sabor\\xado Childhood asthma in the tropics: Experience from an outpatient clinic in a tertiary center in Costa Rica 1858 Gloriana Lor\\xada-Chavarr\\xada Manuel Soto-Mart\\xadnez Childhood asthma in the tropics: Experience from an outpatient clinic in a tertiary center in Costa Rica 1858 John Joyce Edina M Moylett Analysis of referrals for paediatric beta-lactam allergy de-labelling: Is there sufficient information to risk stratify, facilitating a 'see and treat' single dose oral challenge? 1713 John Joyce Hilary I Allen Analysis of referrals for paediatric beta-lactam allergy de-labelling: Is there sufficient information to risk stratify, facilitating a 'see and treat' single dose oral challenge? 1713 Enza Carmina  D'Auria Anna Dighera Usefulness of specific-IgE antibodies to egg white and ovomucoid in predicting cooked egg challenge outcome  1848 Enza Carmina  D'Auria Chiara Gasparini Usefulness of specific-IgE antibodies to egg white and ovomucoid in predicting cooked egg challenge outcome  1848 Enza Carmina  D'Auria Erica Pendezza Usefulness of specific-IgE antibodies to egg white and ovomucoid in predicting cooked egg challenge outcome  1848 Enza Carmina  D'Auria Gian Vincenzo Zuccotti Usefulness of specific-IgE antibodies to egg white and ovomucoid in predicting cooked egg challenge outcome  1848 Enza Carmina  D'Auria Laura Gianolio Usefulness of specific-IgE antibodies to egg white and ovomucoid in predicting cooked egg challenge outcome  1848 Enza Carmina  D'Auria Marco Ugo Andrea Sartorio Usefulness of specific-IgE antibodies to egg white and ovomucoid in predicting cooked egg challenge outcome  1848 Enza Carmina  D'Auria Silvia Beretta Usefulness of specific-IgE antibodies to egg white and ovomucoid in predicting cooked egg challenge outcome  1848 Elizabeth Powell Alaa Ali Associations between clinical factors and clinical course in peanut oral immunotherapy 1849 Elizabeth Powell Andrew Clark Associations between clinical factors and clinical course in peanut oral immunotherapy 1849 Elizabeth Powell Pamela Ewan Associations between clinical factors and clinical course in peanut oral immunotherapy 1849 Elizabeth Powell Zaraquiza Q Zolkipli Associations between clinical factors and clinical course in peanut oral immunotherapy 1849 Katherine Irwin Andrew Clark Paediatric food allergy: An educational video for medical students 1875 Katherine Irwin Elizabeth A Powell Paediatric food allergy: An educational video for medical students 1875 Katherine Irwin Ian Gregory Paediatric food allergy: An educational video for medical students 1875 fereshteh karbasian Delara Babaei Non-celiac gluten sensitivity diagnosis: A case series 1850 fereshteh karbasian Golnaz Eslamian Non-celiac gluten sensitivity diagnosis: A case series 1850 fereshteh karbasian Hedieh Saneifard Non-celiac gluten sensitivity diagnosis: A case series 1850 Ilia Vorozhko Andrew A Sokolnikov TGF-\\x9f1 level and SNP VDR gene association in children with allergy diseases  1611 Ilia Vorozhko Diana Albagachieva TGF-\\x9f1 level and SNP VDR gene association in children with allergy diseases  1611 Ilia Vorozhko Elena Sakharova TGF-\\x9f1 level and SNP VDR gene association in children with allergy diseases  1611 Ilia Vorozhko Olga Tarasova TGF-\\x9f1 level and SNP VDR gene association in children with allergy diseases  1611 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Allergen immunotherapy     ',\n",
       "  'session': 'DCPD 01 Allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921310,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 01 Allergen immunotherapy Jenny Uhlig  Tolerability of subcutaneous allergen specific immunotherapy with native extracts of moulds 892 Christina Brandberg Anna Lundgren Increased production of allergenic specific IgG and IgG4 from stimulated memory B cells during allergen immunotherapy 1379 Christina Brandberg Bengt Andersson Increased production of allergenic specific IgG and IgG4 from stimulated memory B cells during allergen immunotherapy 1379 Christina Brandberg Emma Goksr Increased production of allergenic specific IgG and IgG4 from stimulated memory B cells during allergen immunotherapy 1379 Christina Brandberg Nicolae Miron Increased production of allergenic specific IgG and IgG4 from stimulated memory B cells during allergen immunotherapy 1379 Galina Ignatova Elena Blinova Dynamics of markers of systemic inflammation and cardiac events in use of conjugated pneumococcal vaccine in patients with COPD and IHD 925 Galina Ignatova Vladimir Antonov Dynamics of markers of systemic inflammation and cardiac events in use of conjugated pneumococcal vaccine in patients with COPD and IHD 925 Ryohei Suzuki Akiko Aota Successful sublingual immunotherapy for severe egg allergy in children; two case reports 403 Ryohei Suzuki Kenichi Akashi Successful sublingual immunotherapy for severe egg allergy in children; two case reports 403 Ryohei Suzuki Nagatoshi Sagara Successful sublingual immunotherapy for severe egg allergy in children; two case reports 403 Ryohei Suzuki Toshio Katsunuma Successful sublingual immunotherapy for severe egg allergy in children; two case reports 403 Stefan Zielen Astrid Clausen Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Denise Lee Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Kemi Oluwayi Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Lawrence Dubuske Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Marion Seybold Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Mohamed H. Shamji Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Murray A. Skinner Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Pieter Jan De Kam Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Stefan Zielen Ralph Msges Stepwise investigation of a subcutaneously administered tyrosine adsorbed modified grass allergen + MPL&nbsp;SCIT over two grass pollen seasons 864 Ernesto Nazeazeno Do-Nascimento-Ferreira Ana Beatriz Gorini Veiga Efficacy Double Blind Placebo Controlled assessment trial of allergen immunotherapy in children with asthma/wheeze, allergic rhinitis and respiratory infections at Public Health in South Brazil 678 Ernesto Nazeazeno Do-Nascimento-Ferreira Joel Henrique Ellwanger Efficacy Double Blind Placebo Controlled assessment trial of allergen immunotherapy in children with asthma/wheeze, allergic rhinitis and respiratory infections at Public Health in South Brazil 678 Ernesto Nazeazeno Do-Nascimento-Ferreira Jos Artur Bogo Chies Efficacy Double Blind Placebo Controlled assessment trial of allergen immunotherapy in children with asthma/wheeze, allergic rhinitis and respiratory infections at Public Health in South Brazil 678 Ernesto Nazeazeno Do-Nascimento-Ferreira Tiago Bittencourt Oliveira Efficacy Double Blind Placebo Controlled assessment trial of allergen immunotherapy in children with asthma/wheeze, allergic rhinitis and respiratory infections at Public Health in South Brazil 678 Ernesto Nazeazeno Do-Nascimento-Ferreira Valria De Lima Kaminski Efficacy Double Blind Placebo Controlled assessment trial of allergen immunotherapy in children with asthma/wheeze, allergic rhinitis and respiratory infections at Public Health in South Brazil 678 Arti Dhawal  Shah Dhawal Niranjan Shah Allergenic response of whole-body allergen extract of black ant in a pediatric patient 164 Arti Dhawal  Shah Swati Malani Allergenic response of whole-body allergen extract of black ant in a pediatric patient 164 HAGGAR ELBASHIR Ariharan Anantharachagan Comparative clinical effectiveness of two different subcutaneous immunotherapy (SCIT) regimens using validated health-related quality of life questionnaires<br /> 1564 HAGGAR ELBASHIR Kathryn Haworth Comparative clinical effectiveness of two different subcutaneous immunotherapy (SCIT) regimens using validated health-related quality of life questionnaires<br /> 1564 HAGGAR ELBASHIR Michele Andrea Turturo Comparative clinical effectiveness of two different subcutaneous immunotherapy (SCIT) regimens using validated health-related quality of life questionnaires<br /> 1564 HAGGAR ELBASHIR Pavaladurai Vijayadurai Comparative clinical effectiveness of two different subcutaneous immunotherapy (SCIT) regimens using validated health-related quality of life questionnaires<br /> 1564 Dragana Tadic Aleksandra Peric-Popadic Efficacy of three-years of sublingual immunotherapy against weed allergies in the Serbian population - our experiences 977 Dragana Tadic Milica Popovic Efficacy of three-years of sublingual immunotherapy against weed allergies in the Serbian population - our experiences 977 Dragana Tadic Vesna Tomic-Spiric Efficacy of three-years of sublingual immunotherapy against weed allergies in the Serbian population - our experiences 977 Dhawal Niranjan Shah Amrita Swati To evaluate effectiveness of sublingual immunotherapy in allergic rhinitis 732 Dhawal Niranjan Shah Arti Dhawal Shah To evaluate effectiveness of sublingual immunotherapy in allergic rhinitis 732 Dhawal Niranjan Shah Swati C Malani To evaluate effectiveness of sublingual immunotherapy in allergic rhinitis 732 Valery P. Mudrov Ekaterina S. Vorobyova Application of vascular endothelium growth factor in immunotropic therapy of periodontitis 666 Valery P. Mudrov Elena Yu. Lysyuk Application of vascular endothelium growth factor in immunotropic therapy of periodontitis 666 Valery P. Mudrov Ilija S. Fomenkov Application of vascular endothelium growth factor in immunotropic therapy of periodontitis 666 Valery P. Mudrov Sergey P. Kazakov Application of vascular endothelium growth factor in immunotropic therapy of periodontitis 666 Valery P. Mudrov Sergey Yu. Ivanov Application of vascular endothelium growth factor in immunotropic therapy of periodontitis 666 Valery P. Mudrov Vladimir N. Nelyubin Application of vascular endothelium growth factor in immunotropic therapy of periodontitis 666 Valery P. Mudrov Irina P. Balmasova Immunotropic correction and cytokine profile in diseases of the oral cavity with bone tissue resorption 660 Valery P. Mudrov Maxim M. Gultyaev Immunotropic correction and cytokine profile in diseases of the oral cavity with bone tissue resorption 660 Valery P. Mudrov Regina V. Krasheninnikova Immunotropic correction and cytokine profile in diseases of the oral cavity with bone tissue resorption 660 Valery P. Mudrov Sergey A. Trofimov Immunotropic correction and cytokine profile in diseases of the oral cavity with bone tissue resorption 660 Valery P. Mudrov Sergey P. Kazakov Immunotropic correction and cytokine profile in diseases of the oral cavity with bone tissue resorption 660 Valery P. Mudrov Vladimir N. Nelyubin Immunotropic correction and cytokine profile in diseases of the oral cavity with bone tissue resorption 660 Tetsuya Terada Masaya Matsuda Type 1 regulatory T (tr1) cells increased by sublingual immunotherapy (SLIT) suppressed allergic inflammation  15 Tetsuya Terada Ryo Kawata Type 1 regulatory T (tr1) cells increased by sublingual immunotherapy (SLIT) suppressed allergic inflammation  15 Tetsuya Terada Takeshi Nabe Type 1 regulatory T (tr1) cells increased by sublingual immunotherapy (SLIT) suppressed allergic inflammation  15 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Allergy and clinical immunology',\n",
       "  'session': 'DCPD 02 Allergy and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921312,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 02 Allergy and clinical immunology MARGHERITA DEIDDA Carla Masala Evaluation of gustatory function and depression in patients with Mastocytosis 1518 MARGHERITA DEIDDA Davide Firinu Evaluation of gustatory function and depression in patients with Mastocytosis 1518 MARGHERITA DEIDDA Giulia Costanzo Evaluation of gustatory function and depression in patients with Mastocytosis 1518 MARGHERITA DEIDDA Maria Pina Barca Evaluation of gustatory function and depression in patients with Mastocytosis 1518 MARGHERITA DEIDDA Maria Rita Messina Evaluation of gustatory function and depression in patients with Mastocytosis 1518 MARGHERITA DEIDDA Raffaella Piras Evaluation of gustatory function and depression in patients with Mastocytosis 1518 MARGHERITA DEIDDA Stefano Del Giacco Evaluation of gustatory function and depression in patients with Mastocytosis 1518 Ignacio J. Dvila Asuncin Garc\\xada-Snchez YRNAs as potential markers of allergic asthma: In vitro T-lymphocyte stimulation up-regulates Y_RNA.269-201, Y_RNA.575-201 and Y_RNA.231-201 expression 825 Ignacio J. Dvila Catalina Sanz YRNAs as potential markers of allergic asthma: In vitro T-lymphocyte stimulation up-regulates Y_RNA.269-201, Y_RNA.575-201 and Y_RNA.231-201 expression 825 Ignacio J. Dvila Cristina Mart\\xadn Garc\\xada YRNAs as potential markers of allergic asthma: In vitro T-lymphocyte stimulation up-regulates Y_RNA.269-201, Y_RNA.575-201 and Y_RNA.231-201 expression 825 Ignacio J. Dvila Francisco Javier Muoz-Bellido YRNAs as potential markers of allergic asthma: In vitro T-lymphocyte stimulation up-regulates Y_RNA.269-201, Y_RNA.575-201 and Y_RNA.231-201 expression 825 Ignacio J. Dvila Maria Isidoro YRNAs as potential markers of allergic asthma: In vitro T-lymphocyte stimulation up-regulates Y_RNA.269-201, Y_RNA.575-201 and Y_RNA.231-201 expression 825 Ignacio J. Dvila Mar\\xada Jess Mart\\xadn Mart\\xadn YRNAs as potential markers of allergic asthma: In vitro T-lymphocyte stimulation up-regulates Y_RNA.269-201, Y_RNA.575-201 and Y_RNA.231-201 expression 825 Ignacio J. Dvila Miguel Estrav\\xads YRNAs as potential markers of allergic asthma: In vitro T-lymphocyte stimulation up-regulates Y_RNA.269-201, Y_RNA.575-201 and Y_RNA.231-201 expression 825 Ella Vitalievna Churyukina Alexandr Alexeevich Afonin Immune-biochemical markers of early diagnosis of perinatal Central nervous system damage in newborns 588 Ella Vitalievna Churyukina Irina Vitalievna Panova Immune-biochemical markers of early diagnosis of perinatal Central nervous system damage in newborns 588 Ella Vitalievna Churyukina Tamara Andreevna Afonina Immune-biochemical markers of early diagnosis of perinatal Central nervous system damage in newborns 588 Gustavo Ojeda Alexandra Sayuri Watanabe Relationship of the severity of anaphylaxis caused by bee and venom poisons with the dosage of specific serum IgE 1551 Gustavo Ojeda Amanda Brolio De Souza Relationship of the severity of anaphylaxis caused by bee and venom poisons with the dosage of specific serum IgE 1551 Gustavo Ojeda Fabio Fernandez Morato Castro Relationship of the severity of anaphylaxis caused by bee and venom poisons with the dosage of specific serum IgE 1551 Gustavo Ojeda Jorge Kalil Relationship of the severity of anaphylaxis caused by bee and venom poisons with the dosage of specific serum IgE 1551 Gustavo Ojeda Keity Souza Santos Relationship of the severity of anaphylaxis caused by bee and venom poisons with the dosage of specific serum IgE 1551 Gustavo Ojeda La\\xads Souza Gomes Relationship of the severity of anaphylaxis caused by bee and venom poisons with the dosage of specific serum IgE 1551 Gustavo Ojeda Nayara Vivan Bin Relationship of the severity of anaphylaxis caused by bee and venom poisons with the dosage of specific serum IgE 1551 Gulzar Rafig Aliyeva Ilgar Almas Mustafayev Sarcoidosis in patient with overcame tuberculosis 726 Gulzar Rafig Aliyeva Irada Mirsaab Akhundova Sarcoidosis in patient with overcame tuberculosis 726 Gulzar Rafig Aliyeva Reyhan Sabir Hajiyeva Sarcoidosis in patient with overcame tuberculosis 726 Ins Falco Fernandes Filipa Rodrigues Dos Santos Immunotherapy to Hymenoptera venom in a child with anaphylaxis 523 Ins Falco Fernandes Helena Falco Immunotherapy to Hymenoptera venom in a child with anaphylaxis 523 Ins Falco Fernandes Leonor Cunha Immunotherapy to Hymenoptera venom in a child with anaphylaxis 523 Ins Falco Fernandes Maria Lu\\xads Marques Immunotherapy to Hymenoptera venom in a child with anaphylaxis 523 Niclas Rydell Anders Sjlander Technical performance of a novel automated immunoassay for measurement of eosinophil derived neurotoxin in multiple sample specimen 568 Niclas Rydell Helena Ekoff Technical performance of a novel automated immunoassay for measurement of eosinophil derived neurotoxin in multiple sample specimen 568 Niclas Rydell Maria Roca Technical performance of a novel automated immunoassay for measurement of eosinophil derived neurotoxin in multiple sample specimen 568 Niclas Rydell Mizuho Nagao Technical performance of a novel automated immunoassay for measurement of eosinophil derived neurotoxin in multiple sample specimen 568 Niclas Rydell Takao Fujisawa Technical performance of a novel automated immunoassay for measurement of eosinophil derived neurotoxin in multiple sample specimen 568 Niclas Rydell Tina Ekenkrantz Technical performance of a novel automated immunoassay for measurement of eosinophil derived neurotoxin in multiple sample specimen 568 Sabina Loredana Corcea Cristina Elena Bala Melkersson-Rosenthal syndrome overlap with ACE inhibitor-induced angioedema - a challenging case 1394 Sabina Loredana Corcea Roxana Silvia Bumbacea Melkersson-Rosenthal syndrome overlap with ACE inhibitor-induced angioedema - a challenging case 1394 Sabina Loredana Corcea Selda Ali Melkersson-Rosenthal syndrome overlap with ACE inhibitor-induced angioedema - a challenging case 1394 Kristy Semenza  Factitious Anaphylaxis: A case of &quot;Folie&nbsp;a deux&quot; 1391 Melvin Vsquez Suero Adela Pazmio Oate Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Francisco Javier Hernndez Arbeiza Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Manuela Alvarado Arenas Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Maria Alejandra Gonzalez Rausell Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Maria Claudia Pereyra Acha Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Maria Isabel Alvarado Izquierdo Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Maria Soledad Jimnez Timn Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Paula Jimenez Gallardo Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 Melvin Vsquez Suero Sergio Porcel Carreo Cold anaphylaxis vs non-clonal mast cell activation syndrome 979 \\x96zge Can Bostan Ali Fuat Kalyoncu Patients admitted to the emergency department due to anaphylaxis should be investigated in detail: Systemic mastocytosis 418 \\x96zge Can Bostan Ebru \\x87elebioglu Patients admitted to the emergency department due to anaphylaxis should be investigated in detail: Systemic mastocytosis 418 \\x96zge Can Bostan Gl Karakaya Patients admitted to the emergency department due to anaphylaxis should be investigated in detail: Systemic mastocytosis 418 \\x96zge Can Bostan Mehmet Erdem \\x87akmak Patients admitted to the emergency department due to anaphylaxis should be investigated in detail: Systemic mastocytosis 418 \\x96zge Can Bostan Saltuk Bugra Kaya Patients admitted to the emergency department due to anaphylaxis should be investigated in detail: Systemic mastocytosis 418 Tamar Kinaciyan Amlie Gorris WDEIA manifestation only in combination with selected drugs 248 Marina V. Smolnikova Alexander Kolomeytsev Relationship between the boluminescence and the activity of catalase during the period of intensive load 771 Marina V. Smolnikova Arina Fedotova Relationship between the boluminescence and the activity of catalase during the period of intensive load 771 Marina V. Smolnikova Ludmila Stepanova Relationship between the boluminescence and the activity of catalase during the period of intensive load 771 Marina V. Smolnikova Oksana Kolenchukova Relationship between the boluminescence and the activity of catalase during the period of intensive load 771 Marina V. Smolnikova Valentina Kratasyuk Relationship between the boluminescence and the activity of catalase during the period of intensive load 771 Laura Ortega Mart\\xadn A\\xadda Gmez-Cardeosa A new cause of anaphylaxis due to skin contact with fragrances contained in a hair dye 606 Laura Ortega Mart\\xadn Diana Betancor-Prez A new cause of anaphylaxis due to skin contact with fragrances contained in a hair dye 606 Laura Ortega Mart\\xadn Joaqu\\xadn Sastre A new cause of anaphylaxis due to skin contact with fragrances contained in a hair dye 606 Eralda Lekli Eris Mesonjesi Severe contact anaphylaxis to hair dye 562 Eralda Lekli Etleva Qirko Severe contact anaphylaxis to hair dye 562 Eralda Lekli Mehmet Hoxha Severe contact anaphylaxis to hair dye 562 RAHUL SETHI A. Ohanyan The action of leaf extracts of prunella vulgaris L. and ocimum araratum L. on the peroxidase activity of erythrocytes of patients with chronic obstructive pulmonary disease (COPD)  200 RAHUL SETHI Askhen Hovannisyan The action of leaf extracts of prunella vulgaris L. and ocimum araratum L. on the peroxidase activity of erythrocytes of patients with chronic obstructive pulmonary disease (COPD)  200 RAHUL SETHI Hasmik Zakharyan The action of leaf extracts of prunella vulgaris L. and ocimum araratum L. on the peroxidase activity of erythrocytes of patients with chronic obstructive pulmonary disease (COPD)  200 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Allergy diagnosis and systems medicine',\n",
       "  'session': 'DCPD 03 Allergy diagnosis and systems medicine',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921314,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 03 Allergy diagnosis and systems medicine Abigail S Burrows Justin T Marsh Evaluation of de-complexing strategies for in vivo detection of peanut proteins in human serum using mass spectrometry methods 1452 Abigail S Burrows Philip E Johnson Evaluation of de-complexing strategies for in vivo detection of peanut proteins in human serum using mass spectrometry methods 1452 Irada Mirsaab Akhundova Agigat Abdul Kadyrova Genotypical analysis of mycobacteria tuberculosis isolated from patients with extra-pulmonary tuberculosis of various localization 1249 Irada Mirsaab Akhundova Gulzar Rafig Aliyeva Genotypical analysis of mycobacteria tuberculosis isolated from patients with extra-pulmonary tuberculosis of various localization 1249 Irada Mirsaab Akhundova Mehriban Nadir Seyfaddinova Genotypical analysis of mycobacteria tuberculosis isolated from patients with extra-pulmonary tuberculosis of various localization 1249 Irada Mirsaab Akhundova Nazifa Nagi Sattarova Genotypical analysis of mycobacteria tuberculosis isolated from patients with extra-pulmonary tuberculosis of various localization 1249 Irada Mirsaab Akhundova Rafig Mahmud Abuzarov Genotypical analysis of mycobacteria tuberculosis isolated from patients with extra-pulmonary tuberculosis of various localization 1249 Ana Palhinha Ana Margarida Romeira Comparison of two different molecular allergy diagnostic tools &ndash; ISAC vs ALEX 1063 Ana Palhinha Irene Carrapatoso Comparison of two different molecular allergy diagnostic tools &ndash; ISAC vs ALEX 1063 Ana Palhinha Mariana Lobato Comparison of two different molecular allergy diagnostic tools &ndash; ISAC vs ALEX 1063 Ana Palhinha Paula Leiria-Pinto Comparison of two different molecular allergy diagnostic tools &ndash; ISAC vs ALEX 1063 Ana Palhinha Sara Prates Comparison of two different molecular allergy diagnostic tools &ndash; ISAC vs ALEX 1063 Ana Palhinha Vitria Matos Comparison of two different molecular allergy diagnostic tools &ndash; ISAC vs ALEX 1063 Tatsiana Novikova E Dotsenko Diagnostic utility of total IgE serum levels in assessing for evidence of presence of respiratory allergic disorders 931 Tatsiana Novikova L Maslova Diagnostic utility of total IgE serum levels in assessing for evidence of presence of respiratory allergic disorders 931 Tatsiana Novikova L M Dubuske Diagnostic utility of total IgE serum levels in assessing for evidence of presence of respiratory allergic disorders 931 Victoria Rodinkova L M Dubuske Up to 40 % of pollen allergic patients in Ukraine are sensitive to allergens from all pollen groups 828 Victoria Rodinkova O Palamarchuk Up to 40 % of pollen allergic patients in Ukraine are sensitive to allergens from all pollen groups 828 Victoria Rodinkova S Yuriev Up to 40 % of pollen allergic patients in Ukraine are sensitive to allergens from all pollen groups 828 Viktoriia S. Voloshkina Ekaterina Gashynova The structure of sensitization to tree pollen allergens in Dnipro region, Ukraine 335 Viktoriia S. Voloshkina Evgeniia Dytytkovska The structure of sensitization to tree pollen allergens in Dnipro region, Ukraine 335 Viktoriia S. Voloshkina Ekaterina Gashynova The structure of sensitization to grass and weed pollen allergens in Dnipro region, Ukraine 333 Viktoriia S. Voloshkina Evgeniia Dytytkovska The structure of sensitization to grass and weed pollen allergens in Dnipro region, Ukraine 333 Ella Vitalievna Churyukina Evgeny Alexandrovich Kokov The use of component diagnostics to clarify the structure of sensitization in patients with bronchial asthma and allergic rhinitis living in the South of Russia 116 Ella Vitalievna Churyukina Evgeny Fedorovich Filippov The use of component diagnostics to clarify the structure of sensitization in patients with bronchial asthma and allergic rhinitis living in the South of Russia 116 Ella Vitalievna Churyukina Lyudmyla Nicolaevna Kokova The use of component diagnostics to clarify the structure of sensitization in patients with bronchial asthma and allergic rhinitis living in the South of Russia 116 Ella Vitalievna Churyukina Natalia Vladislavovna Kolesnikova The use of component diagnostics to clarify the structure of sensitization in patients with bronchial asthma and allergic rhinitis living in the South of Russia 116 Zhifeng Huang Baoqing Sun Identifying potential co-sensitization and cross-reactivity patterns based on component-resolved diagnosis 75 Ilmira Sadullaevna  Razikova Gulmira Rustamovna Razikova Features of innovative diagnostics of chronic allergodermatosis in persons of adolescent and young age in Uzbekista 57 Ilmira Sadullaevna  Razikova Venera Faridovna Baybekova Features of innovative diagnostics of chronic allergodermatosis in persons of adolescent and young age in Uzbekista 57 Manisha Rai Isham Goel Diagnostic accuracy of skin prick test (SPT) and specific IgE serum cortisol in 75 Indian patients with respiratory allergy 21 Manisha Rai Neelam Kathuria Diagnostic accuracy of skin prick test (SPT) and specific IgE serum cortisol in 75 Indian patients with respiratory allergy 21 Manisha Rai P C Kathuria Diagnostic accuracy of skin prick test (SPT) and specific IgE serum cortisol in 75 Indian patients with respiratory allergy 21 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Allied health and primary care  ',\n",
       "  'session': 'DCPD 04 Allied health and primary care',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921315,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 04 Allied health and primary care Wenying Liu Yan Ruan Oral reaction after radiotherapy for nasopharyngeal carcinoma treated with self-made mouthwash 1348 Wenying Liu Yan Ruan Causes and nursing countermeasures of high intraocular pressure after senile cataract operation 1337 Ilmira Sadullaevna  Razikova Gulmira Rustamovna Razikova Improvement of the allergy service of Uzbekistan 78 Ilmira Sadullaevna  Razikova Nargiza Pulatovna Aydarova Improvement of the allergy service of Uzbekistan 78 Ilmira Sadullaevna  Razikova Venera Faridovna Baybekova Improvement of the allergy service of Uzbekistan 78 Tanja Deleva Jovanova Natasa Teovska Mitrevska Use of the dermatology life quality index (DLQI) in atopic dermatitis  221 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Asthma',\n",
       "  'session': 'DCPD 05 Asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921316,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 05 Asthma Maria Claudia Pereyra Acha Adela Jaqueline Pazmio Oante Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Alejandra Gonzlez Rausell Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Francisco Javier Hernndez Arbeiza Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Manuela Alvarado Arenas Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Maria Isabel Alvarado Izquierdo Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Mar\\xada Soledad Jimnez Timn Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Melvin Vsquez Suero Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Paula Jimnez Gallardo Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Maria Claudia Pereyra Acha Sergio Luis Porcel Carreo Characteristics and evolution of our patients allergic to mites in Complejo Hospitalario Universitario de C&aacute;ceres 1498 Remedios  Crdenas Contreras Aranzazu Vega Castro Mepolizumab effectiveness in a patient with difficult-to treat asthma, bronchiectasis and immunological response to A. Fumigatus 473 Remedios  Crdenas Contreras Belen Mateo Borrega Mepolizumab effectiveness in a patient with difficult-to treat asthma, bronchiectasis and immunological response to A. Fumigatus 473 Remedios  Crdenas Contreras Juan Mar\\xada Beitia Mazuecos Mepolizumab effectiveness in a patient with difficult-to treat asthma, bronchiectasis and immunological response to A. Fumigatus 473 Remedios  Crdenas Contreras Maria Isabel Pea Arellano Mepolizumab effectiveness in a patient with difficult-to treat asthma, bronchiectasis and immunological response to A. Fumigatus 473 Jin Tack Kim Hwan Soo Kim Role of eosinophil and neutrophils on lung function in children with acute asthma exacerbation 95 Jin Tack Kim Hyun Hee Kim Role of eosinophil and neutrophils on lung function in children with acute asthma exacerbation 95 Marufjon Salokhiddinov Muborak Sadullaeva The relationship between ventilation disorders and the diaphragm fatigue index with parameters of quality of life in patients with bronchial asthma 67 Paula Lopez-Gonzalez Ana Prieto-Moreno Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Diana Perez-Alzate Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Elisa Haroun-Diaz Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Francisco Javier Ruano Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Gabriela Canto Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Isabel Torres-Rojas Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Mar\\xada Vazquez De La Torre Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Maria Luisa Somoza Adverse reactions to biological treatment in severe asthma patients<br /> 586 Paula Lopez-Gonzalez Natalia Blanca-Lopez Adverse reactions to biological treatment in severe asthma patients<br /> 586 Bashir Omarjee Serge Kah Severity of dyspnea in patients with asthma in Reunion Island 585 Bashir Omarjee Suren Budhan Severity of dyspnea in patients with asthma in Reunion Island 585 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Basic and clinical immunology',\n",
       "  'session': 'DCPD 06 Basic and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921317,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 06 Basic and clinical immunology Svetlana Sciuca Cristina Tomacinschi Clinical and immunological interrelations in patients with primary immunodeficiency Ataxia Telangiectasia 1031 Svetlana Sciuca Gheorghe Railean Clinical and immunological interrelations in patients with primary immunodeficiency Ataxia Telangiectasia 1031 Svetlana Sciuca Rorica Selevestru Clinical and immunological interrelations in patients with primary immunodeficiency Ataxia Telangiectasia 1031 Svetlana Sciuca Serghei Ghinda Clinical and immunological interrelations in patients with primary immunodeficiency Ataxia Telangiectasia 1031 Svetlana Sciuca Stanislav Groppa Clinical and immunological interrelations in patients with primary immunodeficiency Ataxia Telangiectasia 1031 Cristina Tomacinschii Ana Ceban Related respiratory tract infections and primary immunodeficiencies in children &nbsp; 989 Cristina Tomacinschii Mihaela Bataneant Related respiratory tract infections and primary immunodeficiencies in children &nbsp; 989 Cristina Tomacinschii Rodica Selevestru Related respiratory tract infections and primary immunodeficiencies in children &nbsp; 989 Cristina Tomacinschii Svetlana Sciuca Related respiratory tract infections and primary immunodeficiencies in children &nbsp; 989 Adine Kanepa Natalja Kurjane Hereditary angioedema in Latvia&#39;s population 633 Adine Kanepa Signe Purina Hereditary angioedema in Latvia&#39;s population 633 Adine Kanepa Verners Lozovskis Hereditary angioedema in Latvia&#39;s population 633 Eman Alfares Niall Conlon Immune deficiency in the setting of rare syndromic conditions: A duet of cases 294 Eman Alfares Sinead Murphy Immune deficiency in the setting of rare syndromic conditions: A duet of cases 294 Marina V. Smolnikova Konstantin Dobretsov Role of vitamins of different groups in immunopathogenesis of acute bacterial rhinosinusitis 754 Marina V. Smolnikova Oksana Kolenchukova Role of vitamins of different groups in immunopathogenesis of acute bacterial rhinosinusitis 754 Marina V. Smolnikova Pavel Slavikovsky Role of vitamins of different groups in immunopathogenesis of acute bacterial rhinosinusitis 754 Marina V. Smolnikova Vadim Burdin Role of vitamins of different groups in immunopathogenesis of acute bacterial rhinosinusitis 754 Marina V. Smolnikova Boris Gubanov Indices of the chemiluminescent activity of neutrophilic granulocytes in obstructive jaundice in men with cholangiocarcinoma 342 Marina V. Smolnikova Olga Smirnova Indices of the chemiluminescent activity of neutrophilic granulocytes in obstructive jaundice in men with cholangiocarcinoma 342 Alina R Valeeva Alexey Luntsov Diagnostics of common variable immunodeficiency in patients treated for lymphoma 1355 Alina R Valeeva Naira Kurmaeva Diagnostics of common variable immunodeficiency in patients treated for lymphoma 1355 Cristina Tomacinschii Gheorghe Railean The multiple faces of clinical features in Ataxia Telangiectasia 1004 Cristina Tomacinschii Mihaela Bataneant The multiple faces of clinical features in Ataxia Telangiectasia 1004 Cristina Tomacinschii Rodica Selevestru The multiple faces of clinical features in Ataxia Telangiectasia 1004 Cristina Tomacinschii Stanislav Groppa The multiple faces of clinical features in Ataxia Telangiectasia 1004 Cristina Tomacinschii Svetlana Sciuca The multiple faces of clinical features in Ataxia Telangiectasia 1004 Cristina Tomacinschii Mihaela Bataneant Benign lymphoproliferative disorder in primary immunodeficiencies 932 Cristina Tomacinschii Rodica Selevestru Benign lymphoproliferative disorder in primary immunodeficiencies 932 Cristina Tomacinschii Svetlana Sciuca Benign lymphoproliferative disorder in primary immunodeficiencies 932 Sowmya Arudi Nagarajan Harsha N S DIARRHOEA as the tip of an iceberg! A harbinger of primary immunodeficiency disorder- common variable immunodeficiency 124 Lyudmila P Sizyakina D I Danilova Possible mechanisms of increasing of the replacement therapy effectiveness in the patients with primary hypo-agammaglobulinemia 87 Lyudmila P Sizyakina I I Andreeva Possible mechanisms of increasing of the replacement therapy effectiveness in the patients with primary hypo-agammaglobulinemia 87 Gonzalo Federico Chorzepa Nicolas Alejandro Cal\\xad IgE deficiency in adults: Case series of 20 subjects 973 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Dermatology',\n",
       "  'session': 'DCPD 07 Dermatology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921318,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 07 Dermatology Dan Sexton Guodong Zhang A novel dried blood spot assay of functional C1 inhibitor activity from patients with hereditary angioedema 675 Dan Sexton Jiang Wu A novel dried blood spot assay of functional C1 inhibitor activity from patients with hereditary angioedema 675 Dan Sexton Jonathan A Bernstein A novel dried blood spot assay of functional C1 inhibitor activity from patients with hereditary angioedema 675 Dan Sexton Neil Inhaber A novel dried blood spot assay of functional C1 inhibitor activity from patients with hereditary angioedema 675 Dan Sexton Priya S. Chockalingam A novel dried blood spot assay of functional C1 inhibitor activity from patients with hereditary angioedema 675 Dan Sexton Yongquan Lai A novel dried blood spot assay of functional C1 inhibitor activity from patients with hereditary angioedema 675 Dan Sexton Zhiwei Zhou A novel dried blood spot assay of functional C1 inhibitor activity from patients with hereditary angioedema 675 Khrystyna Lishchuk-Yakymovych L M Dubuske Viral infections and activaity of dermatomyositis 889 Khrystyna Lishchuk-Yakymovych O Synenkyy Viral infections and activaity of dermatomyositis 889 Khrystyna Lishchuk-Yakymovych R Pukalyak Viral infections and activaity of dermatomyositis 889 Khrystyna Lishchuk-Yakymovych V Chopyak Viral infections and activaity of dermatomyositis 889 R Khanferyan L Gevorkyan Correlation of production of chemokines and adipokines in obese and non-obese psoriasis patients 807 R Khanferyan L M Dubuske Correlation of production of chemokines and adipokines in obese and non-obese psoriasis patients 807 Marinella Viola Alessandro Buonomo Prevalence of metal sensitizations in consecutive Italian patients. A retrospective analysis 435 Marinella Viola Angela Rizzi Prevalence of metal sensitizations in consecutive Italian patients. A retrospective analysis 435 Marinella Viola Arianna Aruanno Prevalence of metal sensitizations in consecutive Italian patients. A retrospective analysis 435 Marinella Viola Caterina Sarnari Prevalence of metal sensitizations in consecutive Italian patients. A retrospective analysis 435 Marinella Viola Eleonora Nucera Prevalence of metal sensitizations in consecutive Italian patients. A retrospective analysis 435 Marinella Viola Gloria Andriollo Prevalence of metal sensitizations in consecutive Italian patients. A retrospective analysis 435 Emily Carne Antony Matthews Prophylactic treatment of Hereditary Angioedema with recombinant C1 esterase inhibitor concentrate: A case study 1223 Emily Carne Colin Price Prophylactic treatment of Hereditary Angioedema with recombinant C1 esterase inhibitor concentrate: A case study 1223 Emily Carne Stephen Jolles Prophylactic treatment of Hereditary Angioedema with recombinant C1 esterase inhibitor concentrate: A case study 1223 Emily Carne Tariq El-Shanawany Prophylactic treatment of Hereditary Angioedema with recombinant C1 esterase inhibitor concentrate: A case study 1223 Gonzalo Federico Chorzepa Luciano Lapissonde No rise in the frequency of hereditary angioedema episodes after breast augmentation surgery 998 Ilke Taskirdi Canan Sule Karkiner A single-center study: Evaluation of pediatric angioedema 547 Ilke Taskirdi Demet Can A single-center study: Evaluation of pediatric angioedema 547 Ilke Taskirdi Idil Akay Haci A single-center study: Evaluation of pediatric angioedema 547 Ilke Taskirdi Mehmet Sirin Kaya A single-center study: Evaluation of pediatric angioedema 547 Ilke Taskirdi \\x96mer Akal A single-center study: Evaluation of pediatric angioedema 547 Ilke Taskirdi Selime \\x96zen A single-center study: Evaluation of pediatric angioedema 547 Anna Bobckov Milos Jesenak HAE associated with another rare disease &ndash; case report 141 Maria Alexandra Rodrigues Glria Cunha Velho Omalizumab for the treatment of chronic spontaneous urticaria: A small case series 1331 Maria Alexandra Rodrigues Joel Reis Omalizumab for the treatment of chronic spontaneous urticaria: A small case series 1331 Maria Alexandra Rodrigues Manuela Selores Omalizumab for the treatment of chronic spontaneous urticaria: A small case series 1331 Galiya Tussupbekova  Experience with the use of omalizumab in the treatment of chronic spontaneous urticaria in Kazakhstan 960 Leyre Baptista Serna Alicia Gmez-Lpez Acrylate contact dermatitis in permanent manicure user 912 Leyre Baptista Serna Felipe Heras-Mendaza Acrylate contact dermatitis in permanent manicure user 912 Leyre Baptista Serna Marcela Valverde-Monge Acrylate contact dermatitis in permanent manicure user 912 Leyre Baptista Serna Victoria Villalobos-Violn Acrylate contact dermatitis in permanent manicure user 912 Marina V. Smolnikova Anna Barilo Gene polymorphisms IL23, IL31, IL33 in psoriatic diseases in Russians of East Siberia 345 Marina V. Smolnikova Svetlana Smirnova Gene polymorphisms IL23, IL31, IL33 in psoriatic diseases in Russians of East Siberia 345 Bidzina Kulumbegov Maia Gotua Successful treatment of chronic spontaneous urticaria with cyclosporine after failure omalizumab use: A case report 331 Tamar Kinaciyan Amelie Gorris Sensitization to methylisothiazolinone resulting 3 different types of eczema on various occasions 118 gokce eser Hulya Ercan Saricoban An interesting chronic urticaria that only comes out at night 1204 Rada Miskovic Aleksandra Peric Popadic Omalizumab for treatment of recalcitrant chronic spontaneous urticaria: Our experience 305 Rada Miskovic Aleksandra Plavsic Omalizumab for treatment of recalcitrant chronic spontaneous urticaria: Our experience 305 Rada Miskovic Maja Stojanovic Omalizumab for treatment of recalcitrant chronic spontaneous urticaria: Our experience 305 Rada Miskovic Natasa Kusic Omalizumab for treatment of recalcitrant chronic spontaneous urticaria: Our experience 305 Rada Miskovic Sanvila Raskovic Omalizumab for treatment of recalcitrant chronic spontaneous urticaria: Our experience 305 Rada Miskovic Vesna Tomic Spiric Omalizumab for treatment of recalcitrant chronic spontaneous urticaria: Our experience 305 Rada Miskovic Zikica Jovicic Omalizumab for treatment of recalcitrant chronic spontaneous urticaria: Our experience 305 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Drug allergy',\n",
       "  'session': 'DCPD 08 Drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921319,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 08 Drug allergy Antongiulio Demonte Marcello Montagni Aromatase inhibitors induced Lupus-like disease 1196 Antongiulio Demonte Silvia Peveri Aromatase inhibitors induced Lupus-like disease 1196 Diana Andrea Herrera Snchez Nora Hilda Segura Mendez Stevens Johnson syndrome and osmotic diuresis due to the use of gammaglobulin 1542 Diana Andrea Herrera Snchez Patricia Maria Ofarrill Romanillos Stevens Johnson syndrome and osmotic diuresis due to the use of gammaglobulin 1542 Ferdaous Chahed Amel Chaabane An original case of drug rash with eosinophilia and systemic symptoms syndrome related to cefotaxim and cross reactivity to all cephalosporins 1321 Ferdaous Chahed Haifa Ben Romdhane An original case of drug rash with eosinophilia and systemic symptoms syndrome related to cefotaxim and cross reactivity to all cephalosporins 1321 Ferdaous Chahed Karim Aouam An original case of drug rash with eosinophilia and systemic symptoms syndrome related to cefotaxim and cross reactivity to all cephalosporins 1321 Ferdaous Chahed Nadia Ben Fredj An original case of drug rash with eosinophilia and systemic symptoms syndrome related to cefotaxim and cross reactivity to all cephalosporins 1321 Ferdaous Chahed Najah Ben Ben Fadhel An original case of drug rash with eosinophilia and systemic symptoms syndrome related to cefotaxim and cross reactivity to all cephalosporins 1321 Anglica Gutirrez-Maturana Jimnez Almudena Delgado Gonzlez Hypersensitivity reactions to gadolinium-based constrast agents: A two-case report 1256 Anglica Gutirrez-Maturana Jimnez Ambrosia Angelina Vsquez Bautista Hypersensitivity reactions to gadolinium-based constrast agents: A two-case report 1256 Anglica Gutirrez-Maturana Jimnez Maria Del Mar Reao Martos Hypersensitivity reactions to gadolinium-based constrast agents: A two-case report 1256 Anglica Gutirrez-Maturana Jimnez Maria Teresa Blanco Ramos Hypersensitivity reactions to gadolinium-based constrast agents: A two-case report 1256 Anglica Gutirrez-Maturana Jimnez Marta Isabel Rodr\\xadguez Cabreros Hypersensitivity reactions to gadolinium-based constrast agents: A two-case report 1256 Alicia Gmez Lpez Beatriz Gonzlez-Cano Allergy due to triamcinolone 1211 Alicia Gmez Lpez Jos Antonio Caas Maas Allergy due to triamcinolone 1211 Alicia Gmez Lpez Leyre Baptista-Serna Allergy due to triamcinolone 1211 Alicia Gmez Lpez Manuel De Las Heras Gozalo Allergy due to triamcinolone 1211 Alicia Gmez Lpez Marcela Valverde-Monge Allergy due to triamcinolone 1211 Alicia Gmez Lpez Victoria Del Pozo Abejn Allergy due to triamcinolone 1211 Celine Galleani I Garc\\xada-Moguel Fixed drug eruption due to bismuth subcitrate 1188 Celine Galleani J F Crespo Fixed drug eruption due to bismuth subcitrate 1188 Celine Galleani R Barranco Fixed drug eruption due to bismuth subcitrate 1188 Celine Galleani R Mielgo Fixed drug eruption due to bismuth subcitrate 1188 Celine Galleani S Bautista Villanueva Fixed drug eruption due to bismuth subcitrate 1188 Christos Fokoloros Anna Syrmali Generalized bullous fixed drug eruption to Fluconazole without cross-reactivity to Itraconazole 1077 Christos Fokoloros Evangelia Papadavid Generalized bullous fixed drug eruption to Fluconazole without cross-reactivity to Itraconazole 1077 Christos Fokoloros Michael Makris Generalized bullous fixed drug eruption to Fluconazole without cross-reactivity to Itraconazole 1077 Christos Fokoloros Vasileia Damaskou Generalized bullous fixed drug eruption to Fluconazole without cross-reactivity to Itraconazole 1077 Christos Fokoloros Zoi Tsakiraki Generalized bullous fixed drug eruption to Fluconazole without cross-reactivity to Itraconazole 1077 Patricia Romero Apostolos Nakas Multifactorial Cutaneous Small Vessel Vasculitis (CSVV) and the importance of specific avoidance advice 1052 Patricia Romero John Mckenna Multifactorial Cutaneous Small Vessel Vasculitis (CSVV) and the importance of specific avoidance advice 1052 Patricia Romero Nasreen Khan Multifactorial Cutaneous Small Vessel Vasculitis (CSVV) and the importance of specific avoidance advice 1052 Remedios  Crdenas Contreras Arantza Vega Castro Iodinated contrast-induced Sweet&acute;s syndrome 950 Remedios  Crdenas Contreras Juan Mar\\xada Beitia Mazuecos Iodinated contrast-induced Sweet&acute;s syndrome 950 Remedios  Crdenas Contreras Mar\\xada Ben Mateo Borrega Iodinated contrast-induced Sweet&acute;s syndrome 950 Remedios  Crdenas Contreras Maria Isabel Pea Arellano Iodinated contrast-induced Sweet&acute;s syndrome 950 Laurys Restrepo Tinoco \\x81ngel Sastre Sastre Immediate hypersensitivity reaction induced by gentamicin 923 Laurys Restrepo Tinoco Celia Morales Rubio Immediate hypersensitivity reaction induced by gentamicin 923 Laurys Restrepo Tinoco Manuel Barcel Ivars Immediate hypersensitivity reaction induced by gentamicin 923 Laurys Restrepo Tinoco Marta Burchs Feliciano Immediate hypersensitivity reaction induced by gentamicin 923 Azahara Lpez Raigada A Alfranca Allopurinol-induced DRESS with cross-reactivity to febuxostat 921 Azahara Lpez Raigada A Vera Allopurinol-induced DRESS with cross-reactivity to febuxostat 921 Azahara Lpez Raigada C Blanco Allopurinol-induced DRESS with cross-reactivity to febuxostat 921 Azahara Lpez Raigada C Lopez-Sanz Allopurinol-induced DRESS with cross-reactivity to febuxostat 921 Azahara Lpez Raigada D Campodonico Allopurinol-induced DRESS with cross-reactivity to febuxostat 921 Azahara Lpez Raigada F Vega Allopurinol-induced DRESS with cross-reactivity to febuxostat 921 Azahara Lpez Raigada I Bartha Allopurinol-induced DRESS with cross-reactivity to febuxostat 921 Joyce T Hsu David I Hong Seizure as a rare complication of paclitaxel desensitization 902 Joyce T Hsu Mariana Castells Seizure as a rare complication of paclitaxel desensitization 902 Peter Kopac Ana Koren The basophil activation test is safe and useful for confirming paclitaxel-induced anaphylaxis 899 Peter Kopac Dusan Mangaroski The basophil activation test is safe and useful for confirming paclitaxel-induced anaphylaxis 899 Peter Kopac Maja Jost The basophil activation test is safe and useful for confirming paclitaxel-induced anaphylaxis 899 Peter Kopac Peter Korosec The basophil activation test is safe and useful for confirming paclitaxel-induced anaphylaxis 899 Adriana \\xa0rotov Doris Vokurkova Atracurium as a main suspect of severe perioperative immediate hypersensitivity reaction. However, is it the only culprit? 680 Giuseppe Parrinello Alessandro Buonomo A case of intraoperative anaphylaxis to chlorhexidine: An emerging problem in the perioperative setting 650 Giuseppe Parrinello Angela Rizzi A case of intraoperative anaphylaxis to chlorhexidine: An emerging problem in the perioperative setting 650 Giuseppe Parrinello Arianna Aruanno A case of intraoperative anaphylaxis to chlorhexidine: An emerging problem in the perioperative setting 650 Giuseppe Parrinello Eleonora Nucera A case of intraoperative anaphylaxis to chlorhexidine: An emerging problem in the perioperative setting 650 \\x96zge Can Bostan Ali Fuat Kalyoncu Allergic reactions due to concomitant administration of intravenous fluid with multiple drugs in emergency departments in Turkey 426 \\x96zge Can Bostan Ebru \\x87elebioglu Allergic reactions due to concomitant administration of intravenous fluid with multiple drugs in emergency departments in Turkey 426 \\x96zge Can Bostan Gl Karakaya Allergic reactions due to concomitant administration of intravenous fluid with multiple drugs in emergency departments in Turkey 426 \\x96zge Can Bostan Mehmet Erdem \\x87akmak Allergic reactions due to concomitant administration of intravenous fluid with multiple drugs in emergency departments in Turkey 426 \\x96zge Can Bostan Saltuk Bugra Kaya Allergic reactions due to concomitant administration of intravenous fluid with multiple drugs in emergency departments in Turkey 426 Teodora Varo Corina Ureche On the rise: Drug (muscle relaxant) related anaphylactic reactions in the county emergency hospital of T&acirc;rgu Mures, Romania 465 Teodora Varo Katalin Mako On the rise: Drug (muscle relaxant) related anaphylactic reactions in the county emergency hospital of T&acirc;rgu Mures, Romania 465 Teodora Varo Maria Salanta On the rise: Drug (muscle relaxant) related anaphylactic reactions in the county emergency hospital of T&acirc;rgu Mures, Romania 465 Aurora  Gutierrez Gonzalez Ana De Juan Ferre Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Blanca Mallagaray Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Carlos Lopez Lopez Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Estefania Alexandra Montenegro Echeverria Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Eva Martinez De Castro Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Eva Morchon Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Fernando Rodriguez Fernandez Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Leticia De Las Vecillas Sanchez Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Mar\\xada Soledad Duque Gomez Patients with drug allergy: The importance of a tailored management 1469 Aurora  Gutierrez Gonzalez Miriam Gutierrez Patients with drug allergy: The importance of a tailored management 1469 Tirca Simona Maria Tirca Mihaltan Florin Dumitru Mihaltan Tolerance of AINS in a patient with anchylosing spondilitys and asthma control in case of NSAID exacerbated respiratory disease / AERD 1454 Da Woon Sim  A case of fixed drug eruption and anaphylaxis induced simultaneously by erdosteine 980 Ignacio Garc\\xada Nez Luis-Manuel Entrenas-Costa NSAID intolerance patients and atopy: Descriptive study 805 Ignacio Garc\\xada Nez Maria-Angeles Algaba-Marmol NSAID intolerance patients and atopy: Descriptive study 805 Ignacio Garc\\xada Nez Sergio Castro-Acosta NSAID intolerance patients and atopy: Descriptive study 805 manar farouk mohamed Mariam Maged Amin Cephalosporin induced erthyma multiforme major in adult Egyptian patient 715 manar farouk mohamed Rasha Yusuf Shahin Cephalosporin induced erthyma multiforme major in adult Egyptian patient 715 manar farouk mohamed Sara Said Ragab Cephalosporin induced erthyma multiforme major in adult Egyptian patient 715 manar farouk mohamed Youssra Gadallah Mahfouz Cephalosporin induced erthyma multiforme major in adult Egyptian patient 715 Patricia Maria O Farrill Diana Andrea Herrera DRESS with secondary reactivation to Hydrochlorothiazide. Case report and review of literature 705 Patricia Maria O Farrill Eligio Angeles DRESS with secondary reactivation to Hydrochlorothiazide. Case report and review of literature 705 Patricia Maria O Farrill Nora Hilda Segura DRESS with secondary reactivation to Hydrochlorothiazide. Case report and review of literature 705 Patricia Maria O Farrill Ramon Fabricio Luna DRESS with secondary reactivation to Hydrochlorothiazide. Case report and review of literature 705 Roxana Lucia Sfrent Cornateanu Adela Ciobanu HLA genottiping in a case of hypersensitivity to carbamazepine for alcohol withdrawal syndrome 651 Roxana Lucia Sfrent Cornateanu Florin Dan Popescu HLA genottiping in a case of hypersensitivity to carbamazepine for alcohol withdrawal syndrome 651 Roxana Lucia Sfrent Cornateanu Ileana Constantinescu HLA genottiping in a case of hypersensitivity to carbamazepine for alcohol withdrawal syndrome 651 Luc\\xada Gonzlez Bravo Ana Gonzalez-Moreno Delayed reactions to lansoprazole and metronidazole 455 Luc\\xada Gonzlez Bravo Ana Nieto-Nieto Delayed reactions to lansoprazole and metronidazole 455 Luc\\xada Gonzlez Bravo Jimena Laiseca-Garcia Delayed reactions to lansoprazole and metronidazole 455 Luc\\xada Gonzlez Bravo Maria Dolores Alonso-Diaz De Durana Delayed reactions to lansoprazole and metronidazole 455 Luc\\xada Gonzlez Bravo Marianela Brandoni-Petrone Delayed reactions to lansoprazole and metronidazole 455 Luc\\xada Gonzlez Bravo Martina Privitera-Torres Delayed reactions to lansoprazole and metronidazole 455 Luc\\xada Gonzlez Bravo Sabela Perez-Codesido Delayed reactions to lansoprazole and metronidazole 455 Ayse Baccioglu A. Fusun Kalpaklioglu Contact dermatitis due to rivastigmine patch in a patient with alzheimer&rsquo;s disease 296 Ayse Baccioglu Betul Dumanoglu Contact dermatitis due to rivastigmine patch in a patient with alzheimer&rsquo;s disease 296 Ayse Baccioglu Dilek Okszer Cimsir Contact dermatitis due to rivastigmine patch in a patient with alzheimer&rsquo;s disease 296 Ayse Baccioglu Merve Poyraz Contact dermatitis due to rivastigmine patch in a patient with alzheimer&rsquo;s disease 296 Marta Reguero-Capilla Manuel Prados Castao Dress sindrome &amp; radiological contrast media 1420 Marta Reguero-Capilla Marta Ochando Diez-Canseco Dress sindrome &amp; radiological contrast media 1420 Marta Reguero-Capilla Teresa De Aramburu Mera Dress sindrome &amp; radiological contrast media 1420 Joana Calvo Francisca Alves Acute hypersensitivity reaction to infliximab followed by a delayed cutaneous reaction to adalimumab: A challenging case 1409 Joana Calvo Francisco Gil Acute hypersensitivity reaction to infliximab followed by a delayed cutaneous reaction to adalimumab: A challenging case 1409 Joana Calvo Margarida Gonalo Acute hypersensitivity reaction to infliximab followed by a delayed cutaneous reaction to adalimumab: A challenging case 1409 Joana Calvo Sofia Mendes Acute hypersensitivity reaction to infliximab followed by a delayed cutaneous reaction to adalimumab: A challenging case 1409 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Environmental and occupational allergy',\n",
       "  'session': 'DCPD 09 Environmental and occupational allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921320,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 09 Environmental and occupational allergy Ilknur Bostanci Aysegul Ertugrul Pediatric residents&rsquo; knowledge of tobacco and attitudes related to tobacco control in Turkey 1402 Ilknur Bostanci Aysin Tasar Pediatric residents&rsquo; knowledge of tobacco and attitudes related to tobacco control in Turkey 1402 Ilknur Bostanci Demet Tas Pediatric residents&rsquo; knowledge of tobacco and attitudes related to tobacco control in Turkey 1402 Ilknur Bostanci Emine Dibek Misirlioglu Pediatric residents&rsquo; knowledge of tobacco and attitudes related to tobacco control in Turkey 1402 Ilknur Bostanci Tanju Celik Pediatric residents&rsquo; knowledge of tobacco and attitudes related to tobacco control in Turkey 1402 Suzanne Kelly Bryan Santone Design of a mobile cat allergen exposure chamber 1401 Suzanne Kelly Edgar Matida Design of a mobile cat allergen exposure chamber 1401 Suzanne Kelly Jimmy Yang Design of a mobile cat allergen exposure chamber 1401 Suzanne Kelly Laura Haya Design of a mobile cat allergen exposure chamber 1401 Suzanne Kelly Stefan Van De Mosselaer Design of a mobile cat allergen exposure chamber 1401 Suzanne Kelly William H Yang Design of a mobile cat allergen exposure chamber 1401 Michel Thibaudon Gilles Oliver IRS (international ragweed society), an international tool to help ambrosia management 174 Michel Thibaudon Maira Bonini IRS (international ragweed society), an international tool to help ambrosia management 174 Michel Thibaudon Makra Laszlo IRS (international ragweed society), an international tool to help ambrosia management 174 Michel Thibaudon Olivier Pechamat IRS (international ragweed society), an international tool to help ambrosia management 174 Michel Thibaudon Roberto Albertini IRS (international ragweed society), an international tool to help ambrosia management 174 Michel Thibaudon Sandra Citterio IRS (international ragweed society), an international tool to help ambrosia management 174 Michel Thibaudon Sevcan Celenk IRS (international ragweed society), an international tool to help ambrosia management 174 Michel Thibaudon Uwe Starfinger IRS (international ragweed society), an international tool to help ambrosia management 174 Patricia Maria O Farrill Ana Luisa Torres Diagnosis of occupational asthma in Mexican patients in a third level hospital 704 Patricia Maria O Farrill Anabel Avila Diagnosis of occupational asthma in Mexican patients in a third level hospital 704 Patricia Maria O Farrill Diana Andrea Herrera Diagnosis of occupational asthma in Mexican patients in a third level hospital 704 Patricia Maria O Farrill Fabian Eduardo Alvarez Diagnosis of occupational asthma in Mexican patients in a third level hospital 704 Patricia Maria O Farrill Juan Tinajero Diagnosis of occupational asthma in Mexican patients in a third level hospital 704 Patricia Maria O Farrill Nora Hilda Segura Diagnosis of occupational asthma in Mexican patients in a third level hospital 704 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Food allergy',\n",
       "  'session': 'DCPD 10 Food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921321,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"DCPD 10 Food allergy Cludia Viseu Varandas Conceio Pereira Santos Wheat-dependent exercise-induced anaphylaxis: Implications of a correct diagnosis 1029 Cludia Viseu Varandas Joana Caiado Wheat-dependent exercise-induced anaphylaxis: Implications of a correct diagnosis 1029 Cludia Viseu Varandas Manuel Pereira-Barbosa Wheat-dependent exercise-induced anaphylaxis: Implications of a correct diagnosis 1029 Cludia Viseu Varandas Susana Lopes Da Silva Wheat-dependent exercise-induced anaphylaxis: Implications of a correct diagnosis 1029 SARA ANAYA Elena Bravo Hernndez Anaphylaxis after consumption of quail egg in adult patient without chicken egg allergy 388 SARA ANAYA Luis Palacios Colom Anaphylaxis after consumption of quail egg in adult patient without chicken egg allergy 388 SARA ANAYA Manuel Alcntara Villar Anaphylaxis after consumption of quail egg in adult patient without chicken egg allergy 388 SARA ANAYA Marcos Pealver Mellado Anaphylaxis after consumption of quail egg in adult patient without chicken egg allergy 388 Enza Carmina  D'Auria Erica Pendezza Prevalence of food allergy in children with atopic dermatitis 1413 Enza Carmina  D'Auria Francesca Rella Prevalence of food allergy in children with atopic dermatitis 1413 Enza Carmina  D'Auria Gian Vincenzo Zuccotti Prevalence of food allergy in children with atopic dermatitis 1413 Enza Carmina  D'Auria Marco Ugo Andrea Sartorio Prevalence of food allergy in children with atopic dermatitis 1413 Enza Carmina  D'Auria Simone Pilloni Prevalence of food allergy in children with atopic dermatitis 1413 Tnia Gonalves Miriam Arajo Recurrent anaphylaxis from unidentified food allergen 1408 Tnia Gonalves Paula Leiria Pinto Recurrent anaphylaxis from unidentified food allergen 1408 Tnia Gonalves Sara Prates Recurrent anaphylaxis from unidentified food allergen 1408 Maria Ins Silva Ftima Cabral Duarte Sunflower seed allergy &ndash; case report 1227 Maria Ins Silva Manuel Pereira Barbosa Sunflower seed allergy &ndash; case report 1227 Diana  Lucia  Silva Espinosa Carlos Daniel Serrano Reyes Allergy to coconut 1028 Diana  Lucia  Silva Espinosa Laura Del Mar Vasquez Castillo Allergy to coconut 1028 Anna A. Barilo Irina V. Borisova Allergen-specific IgG4 to milk, egg and wheat among children with atopic dermatitis 1017 Anna A. Barilo Svetlana V. Smirnova Allergen-specific IgG4 to milk, egg and wheat among children with atopic dermatitis 1017 Mnica Gonzlez Afonso Cristina Elena Gonzlez Colino Oats induced anaphylaxis with possible cross-reactivity with flat peach 1009 Mnica Gonzlez Afonso Elena Rodr\\xadguez Plata Oats induced anaphylaxis with possible cross-reactivity with flat peach 1009 Mnica Gonzlez Afonso Eva Mar\\xada Prez Rodr\\xadguez Oats induced anaphylaxis with possible cross-reactivity with flat peach 1009 Mnica Gonzlez Afonso Guacimara Luc\\xada Hernndez Santana Oats induced anaphylaxis with possible cross-reactivity with flat peach 1009 Mnica Gonzlez Afonso Juan Antonio Mart\\xadnez Tadeo Oats induced anaphylaxis with possible cross-reactivity with flat peach 1009 Norbert Roesch Alexander Mnzberg Comparison of app-based and paper-based diaries in food allergy diagnostics 617 Norbert Roesch Andreas Hein Comparison of app-based and paper-based diaries in food allergy diagnostics 617 Norbert Roesch Janina Sauer Comparison of app-based and paper-based diaries in food allergy diagnostics 617 Norbert Roesch Marco Eichelberg Comparison of app-based and paper-based diaries in food allergy diagnostics 617 Norbert Roesch Melissa Pirrung Comparison of app-based and paper-based diaries in food allergy diagnostics 617 Norbert Roesch Sonja Lmmel Comparison of app-based and paper-based diaries in food allergy diagnostics 617 Norbert Roesch Susanne Teichmann Comparison of app-based and paper-based diaries in food allergy diagnostics 617 Olga I. Sidorovich Ludmila V. Luss A 3-year follow-up of an elderly patient with a primary fish allergy 233 Olga I. Sidorovich Natalia V. Shartanova A 3-year follow-up of an elderly patient with a primary fish allergy 233 Marufjon Salokhiddinov Faxriddin Umarov Assessment of the relationship of food allergy and atopic dermatitis in children 66 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC33FF',\n",
       "  'type': 'Digital Congress Poster Display',\n",
       "  'category': 'Pediatrics',\n",
       "  'session': 'DCPD 11 Pediatric',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921322,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC33FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'DCPD 11 Pediatric Dominika Ambrozej Karolina Dumycz MFGMs supplementation in milk formulas - a systematic review of randomised controlled trials with meta-analysis 1515 Dominika Ambrozej Marek Ruszczynski MFGMs supplementation in milk formulas - a systematic review of randomised controlled trials with meta-analysis 1515 Dominika Ambrozej Piotr Dziechciarz MFGMs supplementation in milk formulas - a systematic review of randomised controlled trials with meta-analysis 1515 Yu-mi Park Ji-Won Kwon Parameters for predicting an inadequate response to treatment in children with chronic spontaneous urticaria 869 Yu-mi Park Min-Su Oh Parameters for predicting an inadequate response to treatment in children with chronic spontaneous urticaria 869 Harun Bayrak Aysegul Ertugrul Preschcool children with adenoid hypertrophy and the international study of asthma and allergies in childhood (ISAAC) questionnaire 814 Harun Bayrak Ilknur Bostanci Preschcool children with adenoid hypertrophy and the international study of asthma and allergies in childhood (ISAAC) questionnaire 814 Harun Bayrak Serap Ozmen Preschcool children with adenoid hypertrophy and the international study of asthma and allergies in childhood (ISAAC) questionnaire 814 Harun Bayrak Umut Kaygusuz Preschcool children with adenoid hypertrophy and the international study of asthma and allergies in childhood (ISAAC) questionnaire 814 Harun Bayrak Zeynep Hizli Demirkale Preschcool children with adenoid hypertrophy and the international study of asthma and allergies in childhood (ISAAC) questionnaire 814 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Allergen immunotherapy     ',\n",
       "  'session': 'LB DCPD 01 Allergen immunotherapy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921354,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB DCPD 01 Allergen immunotherapy Pawel Gajdanowicz Alexander Kettner The frequency of CD4+ CD25+ foxP3+ CD127- cells in betv 1 contiguous overlapping peptide immunotherapy as aputative marker of efficacy 1868 Pawel Gajdanowicz Andrzej Eljaszewicz The frequency of CD4+ CD25+ foxP3+ CD127- cells in betv 1 contiguous overlapping peptide immunotherapy as aputative marker of efficacy 1868 Pawel Gajdanowicz Dries Van Elst The frequency of CD4+ CD25+ foxP3+ CD127- cells in betv 1 contiguous overlapping peptide immunotherapy as aputative marker of efficacy 1868 Pawel Gajdanowicz Liam O'Mahony The frequency of CD4+ CD25+ foxP3+ CD127- cells in betv 1 contiguous overlapping peptide immunotherapy as aputative marker of efficacy 1868 Pawel Gajdanowicz Marek Jutel The frequency of CD4+ CD25+ foxP3+ CD127- cells in betv 1 contiguous overlapping peptide immunotherapy as aputative marker of efficacy 1868 Pawel Gajdanowicz Sylwia Smolinska The frequency of CD4+ CD25+ foxP3+ CD127- cells in betv 1 contiguous overlapping peptide immunotherapy as aputative marker of efficacy 1868 Paolo Luperto Carlo Cavaliere Nasal cytology as a tool for monitoring the anti-inflammatory effect of specific immunotherapy with sublingual monomeric allergoid 1679 Paolo Luperto Enrico Compalati Nasal cytology as a tool for monitoring the anti-inflammatory effect of specific immunotherapy with sublingual monomeric allergoid 1679 Paolo Luperto Franco Frati Nasal cytology as a tool for monitoring the anti-inflammatory effect of specific immunotherapy with sublingual monomeric allergoid 1679 Paolo Luperto Simonetta Masieri Nasal cytology as a tool for monitoring the anti-inflammatory effect of specific immunotherapy with sublingual monomeric allergoid 1679 Sara Garrido-Fernndez A Navarro Quali Study: Evaluation of adherence, satisfaction and safety in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1837 Sara Garrido-Fernndez Germn Snchez-Lpez Quali Study: Evaluation of adherence, satisfaction and safety in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1837 Sara Garrido-Fernndez Jenaro Hernndez-Pea Quali Study: Evaluation of adherence, satisfaction and safety in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1837 Sara Garrido-Fernndez Valentina Natoli Quali Study: Evaluation of adherence, satisfaction and safety in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1837 Sara Garrido-Fernndez V\\xadctor Matheu Quali Study: Evaluation of adherence, satisfaction and safety in allergic patients treated with sublingual allergen immunotherapy in liquid formulation standardized in IR/ml 1837 Yongshi Yang Fan Zhi The safety of omalizumab therapy in 138 cases with 442 injections: A retrospective study 1642 Yongshi Yang Hong Li The safety of omalizumab therapy in 138 cases with 442 injections: A retrospective study 1642 Yongshi Yang Jianqing Gu The safety of omalizumab therapy in 138 cases with 442 injections: A retrospective study 1642 Yongshi Yang Jinlyu Sun The safety of omalizumab therapy in 138 cases with 442 injections: A retrospective study 1642 Yongshi Yang Qing Wang The safety of omalizumab therapy in 138 cases with 442 injections: A retrospective study 1642 Yongshi Yang Rui Tang The safety of omalizumab therapy in 138 cases with 442 injections: A retrospective study 1642 Gayatri Pandit  Effectiveness of  single allergen immunotherapy in polysensitised patients in allergic rhinitis 1667 Fatma Merve Tepetam Ismet Bulut Due to the development of a hypersensitivity reaction to omalizumab therapy, we performed subcutaneous omalizumab desensitization in two cases successfully 1652 Fatma Merve Tepetam Selver Seda Mersin Due to the development of a hypersensitivity reaction to omalizumab therapy, we performed subcutaneous omalizumab desensitization in two cases successfully 1652 Fatma Merve Tepetam Seyma \\x96zden Due to the development of a hypersensitivity reaction to omalizumab therapy, we performed subcutaneous omalizumab desensitization in two cases successfully 1652 Fatma Merve Tepetam Tuge Yakut Due to the development of a hypersensitivity reaction to omalizumab therapy, we performed subcutaneous omalizumab desensitization in two cases successfully 1652 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Allergy and clinical immunology',\n",
       "  'session': 'LB DCPD 02 Allergy and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921355,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB DCPD 02 Allergy and clinical immunology Mark Kacar James A. Poulter Prolidase deficiency mimicking hyper-igE syndrome responsive to dupilumab 1819 Mark Kacar Sinisa Savic Prolidase deficiency mimicking hyper-igE syndrome responsive to dupilumab 1819 Beatriz Gonzlez-Cano Cristina Serrano Importance of electrophoretic serum proteinogram in omalizumab treated patients 1800 Beatriz Gonzlez-Cano Mar Fernndez-Nieto Importance of electrophoretic serum proteinogram in omalizumab treated patients 1800 Beatriz Gonzlez-Cano Marcela Valverde-Monge Importance of electrophoretic serum proteinogram in omalizumab treated patients 1800 Beatriz Gonzlez-Cano Raquel Tllez Importance of electrophoretic serum proteinogram in omalizumab treated patients 1800 ROCIO CASAS SAUCEDO Antonio Valero Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Federico De La Roca Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Giovanna Araujo Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Irina Bobolea Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Joan Bartra Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Mariona Pascal Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Patricia Roessler Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Paula Rib Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Rosa Muoz-Cano Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Sonia Gelis Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 ROCIO CASAS SAUCEDO Teresa Peralta Dysphonia as a laringeal criptococcosis manifestation in an asthmatic pacient in treatment with inhaled corticosteroid 1618 Irina Dorofeeva Andrey Shulzhenko Success of omalizumab therapy for chronic spontaneous urticaria with concomitant non-specific ulcerative colitis 1748 Irina Dorofeeva Inna Danilycheva Success of omalizumab therapy for chronic spontaneous urticaria with concomitant non-specific ulcerative colitis 1748 Irina Dorofeeva Natalya Bondarenko Success of omalizumab therapy for chronic spontaneous urticaria with concomitant non-specific ulcerative colitis 1748 Irina Dorofeeva Svetlana Shvets Success of omalizumab therapy for chronic spontaneous urticaria with concomitant non-specific ulcerative colitis 1748 Ana Rita Presa Cristiana Ferreira Nonasthmatic wheeze in an atopic 27-year old woman: Case report 1756 Ana Rita Presa Ins Lopes Nonasthmatic wheeze in an atopic 27-year old woman: Case report 1756 Ana Rita Presa Maria Joo Sousa Nonasthmatic wheeze in an atopic 27-year old woman: Case report 1756 Marta Pires Alves Ana Todo Bom Cold urticaria \\x80\\x93 case report 1855 Marta Pires Alves Ana Lu\\xadsa Moura Cold urticaria \\x80\\x93 case report 1855 Marta Pires Alves Carmelita Ribeiro Cold urticaria \\x80\\x93 case report 1855 Marta Pires Alves Francisca Cunha Cold urticaria \\x80\\x93 case report 1855 Marta Pires Alves Iolanda Alen Cold urticaria \\x80\\x93 case report 1855 Seyma \\x96zden Fatma Merve Tepetam A different perspective on allergic rhinitis treatment: Nasal cellulose powder 1601 Seyma \\x96zden Ismet Bulut A different perspective on allergic rhinitis treatment: Nasal cellulose powder 1601 Seyma \\x96zden Selver Seda Mersin A different perspective on allergic rhinitis treatment: Nasal cellulose powder 1601 Seyma \\x96zden Tuge Yakut A different perspective on allergic rhinitis treatment: Nasal cellulose powder 1601 Nataliia Nedogibchenko Yevgeniya Dytyatkovska Treatment of recurrent chronic urticaria 1694 Banu Bozkurt Bahar Gokturk Prevalence and treatment of shield ulcers related to vernal keratoconjunctivitis 1591 Banu Bozkurt Sulenur Acar Duyan Prevalence and treatment of shield ulcers related to vernal keratoconjunctivitis 1591 Derya Ufuk Altintas Dilek Karagz Profile of atopic dermatitis patients admitted to pediatric allergy polyclinic  1590 Derya Ufuk Altintas \\x96zgr \\x96kkes mart Profile of atopic dermatitis patients admitted to pediatric allergy polyclinic  1590 Rafael Bonamichi Jorge Kalil Blockade of PD-L1 inhibits anaphylaxis in a murine model 1771 Rafael Bonamichi Marcelo Vivolo Aun Blockade of PD-L1 inhibits anaphylaxis in a murine model 1771 Rafael Bonamichi Pedro Giavina-Bianchi Blockade of PD-L1 inhibits anaphylaxis in a murine model 1771 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Allergy diagnosis and systems medicine',\n",
       "  'session': 'LB DCPD 03 Allergy diagnosis and systems medicine',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921356,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB DCPD 03 Allergy diagnosis and systems medicine ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Asthma',\n",
       "  'session': 'LB DCPD 04 Asthma',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921357,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB DCPD 04 Asthma Natalia Nenasheva Alexander Emelyanov Characteristics, treatment and control in severe asthma patients included in the russian severe asthma registry (RSAR)  1641 Natalia Nenasheva Andrey Belevsky Characteristics, treatment and control in severe asthma patients included in the russian severe asthma registry (RSAR)  1641 Natalia Nenasheva Igor Leschenko Characteristics, treatment and control in severe asthma patients included in the russian severe asthma registry (RSAR)  1641 Natalia Nenasheva Natalia Kravchenko Characteristics, treatment and control in severe asthma patients included in the russian severe asthma registry (RSAR)  1641 Natalia Nenasheva Oksana Kurbacheva Characteristics, treatment and control in severe asthma patients included in the russian severe asthma registry (RSAR)  1641 Natalia Nenasheva Sergey Avdeev Characteristics, treatment and control in severe asthma patients included in the russian severe asthma registry (RSAR)  1641 soyoon sim Dong-Hyun Lee Clinical implications of dipeptidyl-peptidase 10 in asthma 1613 soyoon sim Hae-Sim Park Clinical implications of dipeptidyl-peptidase 10 in asthma 1613 soyoon sim Youngsoo Lee Clinical implications of dipeptidyl-peptidase 10 in asthma 1613 soyoon sim Youngwoo Choi Clinical implications of dipeptidyl-peptidase 10 in asthma 1613 Amelia Licari Alessia Marseglia Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Cristina Torre Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Enza D'Auria Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Fiorella Barocci Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Gian Luigi Marseglia Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Giorgia Testa Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Lucia Saccchi Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Mara De Amici Vitamin D values in asthmatic children: A case-controlled study  1878 Amelia Licari Silvia Caimmi Vitamin D values in asthmatic children: A case-controlled study  1878 Xiang Gao Hang Lin Effect of telephone and short message follow-ups on compliance and efficacy for asthmatic children treated with inhaled corticosteroid 1881 Di?lek Dogruel \\x87agla \\x87agli Etiology of preschool children applying wheezing to pediatric emergency policlinic  1584 Di?lek Dogruel Derya Ufuk Altintas Etiology of preschool children applying wheezing to pediatric emergency policlinic  1584 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Basic and clinical immunology',\n",
       "  'session': 'LB DCPD 05 Basic and clinical immunology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921358,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB DCPD 05 Basic and clinical immunology Soraya Soraya Mezouar Cline Chartier Placental mast cells as an innovative tool for predicting later occurrence of allergic diseases 1698 Soraya Soraya Mezouar Florence Bretelle Placental mast cells as an innovative tool for predicting later occurrence of allergic diseases 1698 Soraya Soraya Mezouar Jean-Louis Mege Placental mast cells as an innovative tool for predicting later occurrence of allergic diseases 1698 Soraya Soraya Mezouar Joana Vitte Placental mast cells as an innovative tool for predicting later occurrence of allergic diseases 1698 Soraya Soraya Mezouar Maria Katsogiannou Placental mast cells as an innovative tool for predicting later occurrence of allergic diseases 1698 Soraya Soraya Mezouar Moise Michel Placental mast cells as an innovative tool for predicting later occurrence of allergic diseases 1698 Soraya Soraya Mezouar Youssouf Sereme Placental mast cells as an innovative tool for predicting later occurrence of allergic diseases 1698 ahmet sezer Derya ufuk Altintas Deficiency of adenosine deaminase 2 a case series revealing clinical manifestations and genotypes  1583 ahmet sezer Dilek Karagz Deficiency of adenosine deaminase 2 a case series revealing clinical manifestations and genotypes  1583 Sematonyte Justina Brigita Sitkauskiene Fecal microbiota transplantation in the patient with humoral immunodeficienc 1768 Sematonyte Justina Ieva Bajoriuniene Fecal microbiota transplantation in the patient with humoral immunodeficienc 1768 Sematonyte Justina Juozas Kupcinskas Fecal microbiota transplantation in the patient with humoral immunodeficienc 1768 Sematonyte Justina Tadas Urbonas Fecal microbiota transplantation in the patient with humoral immunodeficienc 1768 Sematonyte Justina Vaida Mizariene Fecal microbiota transplantation in the patient with humoral immunodeficienc 1768 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Dermatology',\n",
       "  'session': 'LB DCPD 06 Dermatology',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921359,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB DCPD 06 Dermatology Karolina Dumycz Dominika Ambrozej Allergic contact dermatitis after hair dye application in 14-year old male 1753 Karolina Dumycz Izabela Pytlak Allergic contact dermatitis after hair dye application in 14-year old male 1753 Karolina Dumycz Joanna Zielinska Allergic contact dermatitis after hair dye application in 14-year old male 1753 Karolina Dumycz Wojciech Feleszko Allergic contact dermatitis after hair dye application in 14-year old male 1753 C. Figueroa A: Moreno Contact urticaria due to a glycosaminoglycan drug 1629 C. Figueroa JM Mira Contact urticaria due to a glycosaminoglycan drug 1629 C. Figueroa V. Martinez Contact urticaria due to a glycosaminoglycan drug 1629 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Drug allergy',\n",
       "  'session': 'LB DCPD 07 Drug allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921360,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB DCPD 07 Drug allergy Ignacio Jauregui Aritza Segurola Perioperative anaphylaxis of uncommon cause in a third level hospital 1806 Ignacio Jauregui Cristina Galn Gimeno Perioperative anaphylaxis of uncommon cause in a third level hospital 1806 Ignacio Jauregui Javier Sanchez De Vicente Perioperative anaphylaxis of uncommon cause in a third level hospital 1806 Ignacio Jauregui M Begoa Irazbal D\\xadez Perioperative anaphylaxis of uncommon cause in a third level hospital 1806 Ignacio Jauregui M Dolores Martinez Antn Perioperative anaphylaxis of uncommon cause in a third level hospital 1806 Ignacio Jauregui Pedro M. Gamboa Setin Perioperative anaphylaxis of uncommon cause in a third level hospital 1806 Ignacio Jauregui Yolanda Seras Miera Perioperative anaphylaxis of uncommon cause in a third level hospital 1806 Mnica Gonzlez Afonso Ariel Callero Viera Allergy to amiodarone, an unusual adverse effect 1822 Mnica Gonzlez Afonso Cristina Elena Gonzlez Colino Allergy to amiodarone, an unusual adverse effect 1822 Mnica Gonzlez Afonso Eva Mar\\xada Prez Rodr\\xadguez Allergy to amiodarone, an unusual adverse effect 1822 Mnica Gonzlez Afonso Jos Carlos Garc\\xada Robaina Allergy to amiodarone, an unusual adverse effect 1822 Mnica Gonzlez Afonso Juan Antonio Mart\\xadnez Tadeo Allergy to amiodarone, an unusual adverse effect 1822 Carolina Figueroa-Zorrilla A. Moreno Anaphylaxis due to an antidiarrheal treatment 1631 Carolina Figueroa-Zorrilla JM Mira Anaphylaxis due to an antidiarrheal treatment 1631 Carolina Figueroa-Zorrilla V. Martinez Anaphylaxis due to an antidiarrheal treatment 1631 Francisca Tavares Ana Todo Bom Desensitization to calcium folinate: Two cases report 1764 Francisca Tavares Carmelita Ribeiro Desensitization to calcium folinate: Two cases report 1764 Francisca Tavares Marta Alves Desensitization to calcium folinate: Two cases report 1764 Jni Costa Carvalho Candida Cancelinha Drug reaction with eosinophilia and systemic symptoms syndrome in an adolescent with autoimmune encephalitis 1788 Jni Costa Carvalho Conceio Robalo Drug reaction with eosinophilia and systemic symptoms syndrome in an adolescent with autoimmune encephalitis 1788 Jni Costa Carvalho Ema Grilo Drug reaction with eosinophilia and systemic symptoms syndrome in an adolescent with autoimmune encephalitis 1788 Jni Costa Carvalho Filipa Rodrigues Drug reaction with eosinophilia and systemic symptoms syndrome in an adolescent with autoimmune encephalitis 1788 Jni Costa Carvalho Iolanda Alen Drug reaction with eosinophilia and systemic symptoms syndrome in an adolescent with autoimmune encephalitis 1788 Jni Costa Carvalho Joana Ribeiro Drug reaction with eosinophilia and systemic symptoms syndrome in an adolescent with autoimmune encephalitis 1788 Joana Gouveia Eva Gomes Skin testing as a major tool in the study of immediate hypersensitivity reactions beyond antibiotics 1797 Joana Gouveia Ins Machado Cunha Skin testing as a major tool in the study of immediate hypersensitivity reactions beyond antibiotics 1797 Joana Gouveia Maria Lu\\xads Marques Skin testing as a major tool in the study of immediate hypersensitivity reactions beyond antibiotics 1797 Antonio Moreno A. Hoyo Anaphylaxis due to lovastatin 1633 Antonio Moreno C. Figueroa Anaphylaxis due to lovastatin 1633 Antonio Moreno J.L. Fontela Anaphylaxis due to lovastatin 1633 Antonio Moreno L. Miguel-Polo Anaphylaxis due to lovastatin 1633 Laima - Alesandraviciute Anzelika Chomiciene Never too late for anaphylaxis: Oral amoxicillin induced delayed anaphylaxis  1821 Laima - Alesandraviciute Audra Blaziene Never too late for anaphylaxis: Oral amoxicillin induced delayed anaphylaxis  1821 Laima - Alesandraviciute Kestutis Cerniauskas Never too late for anaphylaxis: Oral amoxicillin induced delayed anaphylaxis  1821 Laima - Alesandraviciute Laura Malinauskiene Never too late for anaphylaxis: Oral amoxicillin induced delayed anaphylaxis  1821 Mar\\xada Dotor Lavado Andrea Fernndez-Bol\\xadvar Iodinated contrast-induced sialadenitis 1695 Mar\\xada Dotor Lavado M. Angeles Gonzalo-Garijo Iodinated contrast-induced sialadenitis 1695 Mar\\xada Dotor Lavado Remedios Prez-Caldern Iodinated contrast-induced sialadenitis 1695 Cinthia Aracelis De la Cruz Martinez Antonio Luis Valero Santiago Eyelid angioedema due to cyclopentolate hydrochloride and phenylephrine contact dermatitis: A case report 1762 Cinthia Aracelis De la Cruz Martinez Isadora Suarez Lorenzo Eyelid angioedema due to cyclopentolate hydrochloride and phenylephrine contact dermatitis: A case report 1762 Cinthia Aracelis De la Cruz Martinez Lorena Lazaro Lopez Eyelid angioedema due to cyclopentolate hydrochloride and phenylephrine contact dermatitis: A case report 1762 Cinthia Aracelis De la Cruz Martinez Maria Rueda Garcia Eyelid angioedema due to cyclopentolate hydrochloride and phenylephrine contact dermatitis: A case report 1762 Cinthia Aracelis De la Cruz Martinez Mario Javier Pereira Gonzalez Eyelid angioedema due to cyclopentolate hydrochloride and phenylephrine contact dermatitis: A case report 1762 Cinthia Aracelis De la Cruz Martinez Vanesa Gonzalez Nuez Eyelid angioedema due to cyclopentolate hydrochloride and phenylephrine contact dermatitis: A case report 1762 Juan Mira Laguarda A. Moreno Allergy to triamcinolone manifested as asthma 1632 Juan Mira Laguarda C. Figueroa Allergy to triamcinolone manifested as asthma 1632 Juan Mira Laguarda V. Martinez Allergy to triamcinolone manifested as asthma 1632 Claudio Enrico Barzaghi Adriana Gobbi Evaluation and management of a clinic case: Corticosteroids hypersensitivity  1707 Claudio Enrico Barzaghi Alessandro Vismara Evaluation and management of a clinic case: Corticosteroids hypersensitivity  1707 Claudio Enrico Barzaghi Alessandro Maria Marra Evaluation and management of a clinic case: Corticosteroids hypersensitivity  1707 Claudio Enrico Barzaghi Fiorella Barocci Evaluation and management of a clinic case: Corticosteroids hypersensitivity  1707 Claudio Enrico Barzaghi Giuseppe Giuliani Evaluation and management of a clinic case: Corticosteroids hypersensitivity  1707 Joana Miranda Eunice Dias De Castro Can we say \\x80\\x9cyes\\x80\\x9d to the DRESS? A case report 1834 Joana Miranda Josefina Rodrigues Cernadas Can we say \\x80\\x9cyes\\x80\\x9d to the DRESS? A case report 1834 Joana Miranda Leonor Carneiro-Leo Can we say \\x80\\x9cyes\\x80\\x9d to the DRESS? A case report 1834 Jose Alejandro Lemus Calderon Carlos Jess Senent Sanchez Desensitization to bendamustine in a patient with waldenstrm macrogobulinemia 1809 Jose Alejandro Lemus Calderon Elena Villalba Lorenzo Desensitization to bendamustine in a patient with waldenstrm macrogobulinemia 1809 Jose Alejandro Lemus Calderon Gemma Tapia De Pedro Desensitization to bendamustine in a patient with waldenstrm macrogobulinemia 1809 Jose Alejandro Lemus Calderon Mar\\xada Nieves Cabaes Higuero Desensitization to bendamustine in a patient with waldenstrm macrogobulinemia 1809 Jose Alejandro Lemus Calderon Ral Gzman Rodriguez Desensitization to bendamustine in a patient with waldenstrm macrogobulinemia 1809 Jacklyn Sui  Unusual cases of an \\x80\\x98immediate\\x80\\x99 hypersensitivity reaction to co-amoxiclav 1873 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'ENT',\n",
       "  'session': 'LB DCPD 08 ENT',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921361,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB DCPD 08 ENT Armen Nazanyan Anna Shukrian The application of two different treatment modalities and their effectiveness in chronic rhinosinusitis with nasal polyps 1813 Armen Nazanyan Armen Ghosalmyan The application of two different treatment modalities and their effectiveness in chronic rhinosinusitis with nasal polyps 1813 Armen Nazanyan Arthur Shukuryan The application of two different treatment modalities and their effectiveness in chronic rhinosinusitis with nasal polyps 1813 Armen Nazanyan Bella Kalashyan The application of two different treatment modalities and their effectiveness in chronic rhinosinusitis with nasal polyps 1813 Armen Nazanyan Mikayel Narimanyan The application of two different treatment modalities and their effectiveness in chronic rhinosinusitis with nasal polyps 1813 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Environmental and occupational allergy',\n",
       "  'session': 'LB DCPD 09 Environmental and occupational allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921362,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': 'LB DCPD 09 Environmental and occupational allergy German  Dario Ramon Adrian M. Kahn Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Cecilia Ottaviano Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Emanuel Vanegas Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Ivan Cherrez-Ojeda Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Laura B. Barrionuevo Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Maria Sol Reyes Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Mariana Bertone Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Miguel Felix Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 German  Dario Ramon Solange Gaviot Allergen count and antiallergic prescription rate: Is there a significant correlation? \\x80\\x93 an argentinian report 1587 Jonathan Kilimajer Astudillo Corina Craciunesco A case of IgE \\x80\\x93 mediated occupational asthma due to morphine 1886 Jonathan Kilimajer Astudillo Javier Subiza A case of IgE \\x80\\x93 mediated occupational asthma due to morphine 1886 Jonathan Kilimajer Astudillo Maria Del Pilar Gonzalez A case of IgE \\x80\\x93 mediated occupational asthma due to morphine 1886 Jonathan Kilimajer Astudillo Maria Jos Narganes A case of IgE \\x80\\x93 mediated occupational asthma due to morphine 1886 Jonathan Kilimajer Astudillo Maria-Belen Muoz A case of IgE \\x80\\x93 mediated occupational asthma due to morphine 1886 Jonathan Kilimajer Astudillo Porifirio Cordoba A case of IgE \\x80\\x93 mediated occupational asthma due to morphine 1886 Jonathan Kilimajer Astudillo Concepcin Barjau Occupational asthma by subtilisine (serin protease) used as a contact lens cleane 1888 Jonathan Kilimajer Astudillo Enrique Fernandez Caldas Occupational asthma by subtilisine (serin protease) used as a contact lens cleane 1888 Jonathan Kilimajer Astudillo Eva Abel-Fernandez Occupational asthma by subtilisine (serin protease) used as a contact lens cleane 1888 Jonathan Kilimajer Astudillo Fernando Garc\\xada Occupational asthma by subtilisine (serin protease) used as a contact lens cleane 1888 Jonathan Kilimajer Astudillo Javier Subiza Occupational asthma by subtilisine (serin protease) used as a contact lens cleane 1888 Jonathan Kilimajer Astudillo Victor \\x81vila Occupational asthma by subtilisine (serin protease) used as a contact lens cleane 1888 ',\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Food allergy',\n",
       "  'session': 'LB DCPD 10 Food allergy',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921363,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB DCPD 10 Food allergy Maria Ins Silva Clia Costa LTP Syndrome: Characterization of the sensitization profile - ALEX macroarray method 1598 Maria Ins Silva Ftima Cabral Duarte LTP Syndrome: Characterization of the sensitization profile - ALEX macroarray method 1598 Maria Ins Silva Manuel Pereira Barbosa LTP Syndrome: Characterization of the sensitization profile - ALEX macroarray method 1598 Maria Ins Silva Maria Conceio Pereira Santos LTP Syndrome: Characterization of the sensitization profile - ALEX macroarray method 1598 Maria Ins Silva Marisa Paulino LTP Syndrome: Characterization of the sensitization profile - ALEX macroarray method 1598 Miori Sato Erika Kotaki A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Fumi Ishikawa A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Hideaki Morita A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Hiroya Ogita A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Ichiro Nomura A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Kenji Matsumoto A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Kenji Toyokuni A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Kiwako Yamamoto-Hanada A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Koji Nishimura A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Makoto Irahara A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Masami Narita A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Mayako Saito-Abe A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Naomi Harima-Mizusawa A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Shigenori Kabashima A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Tatsuki Fukuie A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Tomoyuki Kiguchi A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Yoshitsune Miyagi A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Yukihiro Ohya A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Yumiko Miyaji A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Miori Sato Yusuke Inuzuka A randomized, double-blind, placebo-controlled, parallel-group study exploring the effectiveness of fermented juice containing lactic acid bacteria in oral immunotherapy for milk allergy: Pilot study 1749 Vaidehi Bhatt Ijaz Ahmad Ogeer When does age matter? Impact of psychosocial stressors on parental quality of life. Is younger, better? 1857 Vaidehi Bhatt Jason A. Ohayon When does age matter? Impact of psychosocial stressors on parental quality of life. Is younger, better? 1857 Vaidehi Bhatt Khadija Brouillette When does age matter? Impact of psychosocial stressors on parental quality of life. Is younger, better? 1857 Vaidehi Bhatt Sofiya Portuhay When does age matter? Impact of psychosocial stressors on parental quality of life. Is younger, better? 1857 Vaidehi Bhatt Tarin Moni When does age matter? Impact of psychosocial stressors on parental quality of life. Is younger, better? 1857 Vaidehi Bhatt Vince Wu When does age matter? Impact of psychosocial stressors on parental quality of life. Is younger, better? 1857 Vaidehi Bhatt Wardha Wardha When does age matter? Impact of psychosocial stressors on parental quality of life. Is younger, better? 1857 Najla Alsediq Ashraf Elmetwally The level of knowledge of emergency room (ER) physicians about pediatric anaphylaxis guidelines for diagnosis and management 1638 Melike Kahveci Aysegl Akarsu Food induced anaphylaxis in East Mediterranean children aged 0-6 years 1770 Melike Kahveci Bulent Enis Sekerel Food induced anaphylaxis in East Mediterranean children aged 0-6 years 1770 Melike Kahveci Gizem Koken Food induced anaphylaxis in East Mediterranean children aged 0-6 years 1770 Melike Kahveci Ozge Soyer Food induced anaphylaxis in East Mediterranean children aged 0-6 years 1770 Melike Kahveci Umit Murat Sahiner Food induced anaphylaxis in East Mediterranean children aged 0-6 years 1770 fleur starcevic GARY Stiefel Simple, effective interventions to improve anaphylaxis management in a UK centre with a tetiary paediatric allergy service 1853 fleur starcevic TAYO Oladiran Simple, effective interventions to improve anaphylaxis management in a UK centre with a tetiary paediatric allergy service 1853 sara urbani Annalisa Tortora The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 sara urbani Antonio Gasbarrini The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 sara urbani Arianna Aruanno The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 sara urbani Francesca Fianchi The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 sara urbani Francesca Magiola The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 sara urbani Gianluca Ianiro The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 sara urbani Gloria Andriollo The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 sara urbani Rosario Landi The importance of allergy assessment in the diagnosis and therapeutic management of eosinophilic esophagitis 1595 Martina Votto Amanda Muir Remission rates in EoE patients referred to a center for eosinophilic disorders for a second opinion: The experience of the Children's Hospital of Philadelphia 1718 Martina Votto Antonella Cianferoni Remission rates in EoE patients referred to a center for eosinophilic disorders for a second opinion: The experience of the Children's Hospital of Philadelphia 1718 Martina Votto Bridget Godwin Remission rates in EoE patients referred to a center for eosinophilic disorders for a second opinion: The experience of the Children's Hospital of Philadelphia 1718 Martina Votto Terri Brown Whitehorn Remission rates in EoE patients referred to a center for eosinophilic disorders for a second opinion: The experience of the Children's Hospital of Philadelphia 1718 Mar\\xada Karina Magdalena Bethencourt Antonio Nieto Snchez Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Inmaculada Mar\\xada Snchez-Guerrero Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Jos Meseguer Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Jos Damin Lpez Snchez Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Juan Jos Corts Collado Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Mar\\xada Muoz Tornero Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Mar\\xada Pilar Lpez-Sez Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Mariola Navarro Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Miriam Alajar\\xadn Cervera Benralizumab therapy in eosinophilic esophagitis 1736 Mar\\xada Karina Magdalena Bethencourt Mnica Snchez Prez Benralizumab therapy in eosinophilic esophagitis 1736 Ral Guzmn Rodr\\xadguez Carlos Jess Senent Snchez Mushrooms: A rare allergy 1697 Ral Guzmn Rodr\\xadguez Fernando Pineda De La Losa Mushrooms: A rare allergy 1697 Ral Guzmn Rodr\\xadguez Jos Alejandro Lemus Caldern Mushrooms: A rare allergy 1697 Christoph T. Berger Karin Hartmann Tolerance to fir honey in anaphylaxis to blossom honey due to herb pollen allergy 1754 Christoph T. Berger Kathrin Scherer-Hofmeier Tolerance to fir honey in anaphylaxis to blossom honey due to herb pollen allergy 1754 Khadija Brouillette Ijaz Ogeer Who worries more about food allergy? Quantifying the difference in quality of life between pediatric age groups with food allergies 1703 Khadija Brouillette Jason Ohayon Who worries more about food allergy? Quantifying the difference in quality of life between pediatric age groups with food allergies 1703 Khadija Brouillette Sofiya Portuhay Who worries more about food allergy? Quantifying the difference in quality of life between pediatric age groups with food allergies 1703 Khadija Brouillette Tarin Moni Who worries more about food allergy? Quantifying the difference in quality of life between pediatric age groups with food allergies 1703 Khadija Brouillette Vaidehi Bhatt Who worries more about food allergy? Quantifying the difference in quality of life between pediatric age groups with food allergies 1703 Khadija Brouillette Vince Wu Who worries more about food allergy? Quantifying the difference in quality of life between pediatric age groups with food allergies 1703 Khadija Brouillette Wardha Wardha Who worries more about food allergy? Quantifying the difference in quality of life between pediatric age groups with food allergies 1703 Daniil Ilyashenko Olga Kachalova Nutritional status in infants with cow milk protein allergy 1714 Daniil Ilyashenko Svetlana Denisova Nutritional status in infants with cow milk protein allergy 1714 Daniil Ilyashenko Tatyana Sentsova Nutritional status in infants with cow milk protein allergy 1714 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''},\n",
       " {'day': '4212',\n",
       "  'colortype': '#CC99FF',\n",
       "  'type': 'Late Breaking Digital Congress Poster Display',\n",
       "  'category': 'Pediatrics',\n",
       "  'session': 'LB DCPD 11 Pediatric',\n",
       "  'room': '',\n",
       "  'time': '09:00-19:15',\n",
       "  'sessionfavourite': False,\n",
       "  'sessionid': 2921364,\n",
       "  'colorcategory': '',\n",
       "  'daycalendar': 'Recorded Scientific Content ',\n",
       "  'label': \"<li torder='0' labelreader='Late Breaking Digital Congress Poster Display' typeid='' class='list-group-item programme_label_type' href='#'><i style='color:#CC99FF;' class='fa fa-circle fa-fw programme_label_icon_type'></i>Late Breaking Digital Congress Poster Display</li>\",\n",
       "  'daycalendarCal': '2020-06-09 00:00:00',\n",
       "  'moreSearchInfo': \"LB DCPD 11 Pediatric Andrew Sokolnikov Diana Albagachieva Eosinophil cationic protein and eosinophil derived neurotoxin levels in children with food allergy 1612 Andrew Sokolnikov Elena Sakharova Eosinophil cationic protein and eosinophil derived neurotoxin levels in children with food allergy 1612 Andrew Sokolnikov Olga Tarasova Eosinophil cationic protein and eosinophil derived neurotoxin levels in children with food allergy 1612 Andrew Sokolnikov Tatyana Sentsova Eosinophil cationic protein and eosinophil derived neurotoxin levels in children with food allergy 1612 Amelia Licari Alessia Marseglia IgE sensitization to latex in a large pediatric cohort  1684 Amelia Licari Cristina Torre IgE sensitization to latex in a large pediatric cohort  1684 Amelia Licari Fiorella Barocci IgE sensitization to latex in a large pediatric cohort  1684 Amelia Licari GianLuigi Marseglia IgE sensitization to latex in a large pediatric cohort  1684 Amelia Licari Giorgia Testa IgE sensitization to latex in a large pediatric cohort  1684 Amelia Licari Lucia Sacchi IgE sensitization to latex in a large pediatric cohort  1684 Amelia Licari Mara De Amici IgE sensitization to latex in a large pediatric cohort  1684 Amelia Licari Silvia Caimmi IgE sensitization to latex in a large pediatric cohort  1684 HILAL - \\x9cNSAL Aysegl Akarsu Rate and spectrum of positive reactions in oral food challenge in IgE mediated food allergy 1769 HILAL - \\x9cNSAL Blent Enis Sekerel Rate and spectrum of positive reactions in oral food challenge in IgE mediated food allergy 1769 HILAL - \\x9cNSAL Goke Ozyilmaz Bozat Rate and spectrum of positive reactions in oral food challenge in IgE mediated food allergy 1769 HILAL - \\x9cNSAL Melike Kahveci Rate and spectrum of positive reactions in oral food challenge in IgE mediated food allergy 1769 HILAL - \\x9cNSAL Ozge Soyer Rate and spectrum of positive reactions in oral food challenge in IgE mediated food allergy 1769 HILAL - \\x9cNSAL Umit Murat Sahiner Rate and spectrum of positive reactions in oral food challenge in IgE mediated food allergy 1769 Papiiants Anna Anastasia Paneva Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Papiiants Anna Anna Galustyan Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Papiiants Anna Anna Nezabudkina Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Papiiants Anna Irina Hayduk Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Papiiants Anna Julia Peshehonova Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Papiiants Anna Ludmila Zhelenina Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Papiiants Anna Renata Arakelyan Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Papiiants Anna Zoya Arhagova Efficiency and safety assessment of allergen-specific immunotherapy in children. Prospective follow-up results 1717 Ha young Jo Hye Won Yoo Atopic dermatitis with invasive candidiasis 1604 Ha young Jo Hye-Young Kim Atopic dermatitis with invasive candidiasis 1604 Mahesh Katre Harsha Bilolikar Mast cell activation syndrome: Evolving diagnosis in children  1666 Amisha Mistry Laura Hambleton Variable symptomatology in hereditary alpha-tryptasaemia  1689 Amisha Mistry Peter Arkwright Variable symptomatology in hereditary alpha-tryptasaemia  1689 Amisha Mistry Tracy Briggs Variable symptomatology in hereditary alpha-tryptasaemia  1689 Ebru Arik Yilmaz Kadriye Yalcin The etiology of pruritus and factors affecting pruritus-related quality of life in children  1758 Ebru Arik Yilmaz Merve Akbay The etiology of pruritus and factors affecting pruritus-related quality of life in children  1758 Ebru Arik Yilmaz Seniz Duygulu The etiology of pruritus and factors affecting pruritus-related quality of life in children  1758 Alice White Andy Bush Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Alice White Dougal Hargreaves Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Alice White Heidi Makrinioti Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Alice White Ian Maconochie Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Alice White Mando Watson Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Alice White Niamh Mclaughlin Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Alice White Nour El-Hadi Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Alice White Polly Robinson Pilot study assessing the validity and efficacy of a novel PROM tool in preschool wheeze 1577 Yvett Gonzlez-Bobadilla Alan Eduardo Hernndez-Saavedra Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Alejandro Gabriel Gonzlez-Garay Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Alma Leticia Chvez-Zea Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla \\x81lvaro Pedroza-Melndez Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Gustavo Esteban Peralta-Abarca Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Jos Guadalupe Huerta-Lpez Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Karina cskarina_19@hotmail.com Clavijo-Snchez Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Mario No Mart\\xadnez-Gordillo Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Martha Ponce-Macotela Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Yvett Gonzlez-Bobadilla Sandra Gpe. Bautista-Garc\\xada Relationship between the control of asthma and serological positivity for toxocara canis in pediatric patients in a period of two years (2016-2018) 1687 Evgenii Furman Ekaterina Khuzina Tracheal leiomyoma in a 14-year-old teenager with initially misdiagnosed asthma 1586 Evgenii Furman Mariya Ponomareva Tracheal leiomyoma in a 14-year-old teenager with initially misdiagnosed asthma 1586 Evgenii Furman Natalya Grymova Tracheal leiomyoma in a 14-year-old teenager with initially misdiagnosed asthma 1586 Olaya Alvarez Garcia Benigno Monteagudo Snchez Fixed food eruption by spider crab 1660 Olaya Alvarez Garcia Idoia Rodr\\xadguez Zuazo Fixed food eruption by spider crab 1660 Olaya Alvarez Garcia Mnica Castro Murga Fixed food eruption by spider crab 1660 Olaya Alvarez Garcia Pilar Iriarte Sotes Fixed food eruption by spider crab 1660 Olaya Alvarez Garcia Raquel Lpez Abad Fixed food eruption by spider crab 1660 Irina Veronica Costache  Cow's milk protein allergy: A multidisciplinary challenge 1705 \",\n",
       "  'shared1': '',\n",
       "  'shared2': '',\n",
       "  'shared3': '',\n",
       "  'tags': ''}]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "daySessionData['data']"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
